Citrus Sinensis ID: 016884
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C5C0 | 615 | Mitogen-activated protein | yes | no | 0.994 | 0.616 | 0.891 | 0.0 | |
| Q9LUC3 | 598 | Mitogen-activated protein | no | no | 0.992 | 0.632 | 0.899 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | yes | no | 0.960 | 0.643 | 0.852 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.994 | 0.620 | 0.860 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.994 | 0.625 | 0.846 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.960 | 0.643 | 0.849 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.960 | 0.675 | 0.822 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.994 | 0.668 | 0.796 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.960 | 0.734 | 0.811 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.963 | 0.524 | 0.836 | 0.0 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function desciption |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/379 (89%), Positives = 359/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY++G+EG+NF+YP
Sbjct: 361 PQLLKDYMSGSEGSNFVYP 379
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 691 bits (1782), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/379 (89%), Positives = 359/379 (94%), Gaps = 1/379 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+N +EG++FLYP
Sbjct: 361 PQLLKDYMN-SEGSSFLYP 378
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 683 bits (1762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/366 (85%), Positives = 349/366 (95%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGDANRYKI EVIGKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T+ +RNEKAR+YL+ MRKK PVP ++FP DP AL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK EREPSCQPI+K+EFEFERR+VTK+D++ELI+REILEYHPQLLKDY+NGTE
Sbjct: 302 PYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTEK 361
Query: 374 TNFLYP 379
TNFLYP
Sbjct: 362 TNFLYP 367
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 326/379 (86%), Positives = 357/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFFTEYGDA+RYKI EVIGKGSYGVVC+AID HTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT+EH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRN+KAR+YL+ MRKK P+ QKFP+ DPLAL LLQ+L+AFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAK+EREPSCQPI+K+EFEFERRRVTK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDYINGTE T FLYP
Sbjct: 361 PQLLKDYINGTERTTFLYP 379
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/379 (84%), Positives = 357/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKD++NG + +FLYP
Sbjct: 361 PQLLKDHMNGADKASFLYP 379
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/366 (84%), Positives = 352/366 (96%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGD++RYKI E++GKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RN+KAR+YL+ MR+K PVP +KFPNVDPLAL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 AISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPISK+EFEFERR+VTKDDI+ELI+REILEYHPQLLKDY+NG+E
Sbjct: 302 PYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSEN 361
Query: 374 TNFLYP 379
T+FLYP
Sbjct: 362 TSFLYP 367
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 301/366 (82%), Positives = 345/366 (94%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTG+KVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPSPE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ +RNEKAR+YL MR+K P+P QKFPN DPLA+RLL+R++AFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFK +A ++REPS QPI+KLEFEFERRR+TK+DIRELIYREILEYHP++L++++ GTE
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 374 TNFLYP 379
T F+YP
Sbjct: 362 TGFMYP 367
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 659 bits (1701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 302/379 (79%), Positives = 349/379 (92%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
P++LK+Y++G+E TNF+YP
Sbjct: 361 PKMLKEYLDGSEPTNFMYP 379
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/366 (81%), Positives = 341/366 (93%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTGEKVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RNEKAR+YL+ MR+K P+P QKFPN DPLALRLL+R+++F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYF+ +A ++REPS QP++KLEFEFERRR+TK+DIRELIYR+ILEYHP +L++Y+ GTE
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 374 TNFLYP 379
F+YP
Sbjct: 362 AGFMYP 367
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/367 (83%), Positives = 346/367 (94%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
++FFTEYGDANRY+I EVIGKGSYGVVC+AID HT +KVAIKK+H++FEH+SDA RILRE
Sbjct: 95 EEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAARILRE 154
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLT+EH+QFFL
Sbjct: 155 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEHYQFFL 214
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+LRALKY+HTA+VYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DTP TVFWTDYVAT
Sbjct: 215 YQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWTDYVAT 274
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLLGTPS
Sbjct: 275 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 334
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+TI+ VRNEKAR+YL+ MRKK PVP QKFPN DPLAL+LLQRL+AFDPKDRPTAEEAL
Sbjct: 335 DTISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTAEEALT 394
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
DPYFKGL+KI+REPSCQPI KLEFEFE+++++K+DIRELI++EILEYHPQL K+Y NG E
Sbjct: 395 DPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNYRNGRE 454
Query: 373 GTNFLYP 379
FLYP
Sbjct: 455 RATFLYP 461
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | ||||||
| 183584854 | 383 | MAP kinase [Gossypium raimondii] | 0.994 | 0.989 | 0.912 | 0.0 | |
| 356556856 | 607 | PREDICTED: mitogen-activated protein kin | 0.994 | 0.624 | 0.920 | 0.0 | |
| 255575145 | 606 | big map kinase/bmk, putative [Ricinus co | 0.976 | 0.613 | 0.938 | 0.0 | |
| 224119110 | 596 | predicted protein [Populus trichocarpa] | 0.960 | 0.614 | 0.926 | 0.0 | |
| 224056591 | 610 | predicted protein [Populus trichocarpa] | 0.994 | 0.621 | 0.931 | 0.0 | |
| 356549594 | 588 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.994 | 0.644 | 0.915 | 0.0 | |
| 358348772 | 608 | Mitogen-activated protein kinase [Medica | 0.994 | 0.623 | 0.902 | 0.0 | |
| 4732123 | 608 | mitogen-activated protein kinase homolog | 0.994 | 0.623 | 0.899 | 0.0 | |
| 224062744 | 621 | predicted protein [Populus trichocarpa] | 0.994 | 0.610 | 0.881 | 0.0 | |
| 79365134 | 615 | mitogen-activated protein kinase 18 [Ara | 0.994 | 0.616 | 0.891 | 0.0 |
| >gi|183584854|gb|ACC63895.1| MAP kinase [Gossypium raimondii] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/379 (91%), Positives = 367/379 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KKELK+ DFFTEYGDANRYKILEVIGKGSYGVVCAA+DTHTGEKVAIKKI DVF
Sbjct: 1 MQQNQLKKELKEMDFFTEYGDANRYKILEVIGKGSYGVVCAALDTHTGEKVAIKKIQDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDAIRILREVKL+RLLRHPDIVEIKRIMLPPSKREFKD++VVFELMESDLHQVIKAN
Sbjct: 61 EHMSDAIRILREVKLVRLLRHPDIVEIKRIMLPPSKREFKDLFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDL+GTPS ETI+ VRN+KARKYL+EMRKK PVP QKFPN DPLA+RLLQRL+AFD
Sbjct: 241 ELITDLIGTPSLETISGVRNDKARKYLSEMRKKKPVPFSQKFPNADPLAVRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGL+KIEREPSCQPISKLEFEFERRRVTK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLSKIEREPSCQPISKLEFEFERRRVTKEDVRELIYREALEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+NG EG+NFLYP
Sbjct: 361 PQLLKDYLNGHEGSNFLYP 379
|
Source: Gossypium raimondii Species: Gossypium raimondii Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556856|ref|XP_003546736.1| PREDICTED: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/379 (92%), Positives = 366/379 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDMKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PETIA VRN+KARKYL EMRKK PVP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPETIAGVRNDKARKYLMEMRKKSPVPFEQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAK+EREPSCQPIS+LEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKVEREPSCQPISRLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+NGTEGT+FLYP
Sbjct: 361 PQLLKDYMNGTEGTHFLYP 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575145|ref|XP_002528477.1| big map kinase/bmk, putative [Ricinus communis] gi|223532086|gb|EEF33894.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/372 (93%), Positives = 363/372 (97%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
++LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI
Sbjct: 3 QDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREH
Sbjct: 63 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREH 122
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWT
Sbjct: 123 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWT 182
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
DYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVL+GKPLFPGKSVVHQLDLITDLL
Sbjct: 183 DYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLSGKPLFPGKSVVHQLDLITDLL 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
GTPSPET++ VRN+KARKYLTEMRKK PV QKFPN DPLALRLLQRL+AFDPKDRPTA
Sbjct: 243 GTPSPETVSGVRNDKARKYLTEMRKKHPVSFTQKFPNADPLALRLLQRLLAFDPKDRPTA 302
Query: 308 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDY 367
EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY
Sbjct: 303 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDY 362
Query: 368 INGTEGTNFLYP 379
+NG EGTNFLYP
Sbjct: 363 LNGNEGTNFLYP 374
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119110|ref|XP_002331327.1| predicted protein [Populus trichocarpa] gi|222873910|gb|EEF11041.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/366 (92%), Positives = 353/366 (96%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
+FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI++VFEHISDA RILREV
Sbjct: 2 EFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKINNVFEHISDAFRILREV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKYMHTAN+YHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWTDYVATR
Sbjct: 122 QMLRALKYMHTANMYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYT AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTRAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSLE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ VRN+KARKYLTEMRKK PVP QKFPN DP A RLLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TISRVRNDKARKYLTEMRKKQPVPFAQKFPNADPSAHRLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPI+KLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY+NG E
Sbjct: 302 PYFKGLAKVEREPSCQPITKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDYMNGNES 361
Query: 374 TNFLYP 379
TNFLYP
Sbjct: 362 TNFLYP 367
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056591|ref|XP_002298926.1| predicted protein [Populus trichocarpa] gi|222846184|gb|EEE83731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/379 (93%), Positives = 366/379 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK+LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTG+KVAIKKI+DVF
Sbjct: 1 MQQDHPKKDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGDKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPS ETI+ VRN+KARKYLTEMRKK PVP QKF NVDPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSSETISGVRNDKARKYLTEMRKKQPVPFAQKFLNVDPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR TAEEALADPYFKGLAK+EREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYH
Sbjct: 301 PKDRLTAEEALADPYFKGLAKVEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+NG E TNFLYP
Sbjct: 361 PQLLKDYMNGNENTNFLYP 379
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549594|ref|XP_003543177.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/379 (91%), Positives = 366/379 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDIKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRI+LPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIVLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHYQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPSPETIA VRN+KARKYL EMRKK PVP QKF N DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSPETIAGVRNDKARKYLMEMRKKSPVPFEQKFQNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGL+K+EREPSCQPISKLEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLSKVEREPSCQPISKLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+NGTEGT+FLYP
Sbjct: 361 PQLLKDYMNGTEGTHFLYP 379
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358348772|ref|XP_003638417.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355504352|gb|AES85555.1| Mitogen-activated protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/379 (90%), Positives = 362/379 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS Q IS++EFEFERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQSISRMEFEFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDYINGTEGTNF+YP
Sbjct: 361 PQLLKDYINGTEGTNFMYP 379
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4732123|gb|AAD28617.1|AF129087_1 mitogen-activated protein kinase homologue [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/379 (89%), Positives = 363/379 (95%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS QPIS++EF+FERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQPISRMEFDFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDYI+GTEGTNF+YP
Sbjct: 361 PQLLKDYISGTEGTNFMYP 379
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224062744|ref|XP_002300882.1| predicted protein [Populus trichocarpa] gi|222842608|gb|EEE80155.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/379 (88%), Positives = 364/379 (96%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFF+EYGDANRYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKNSTEMDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PSTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI++VRN+KAR+YLT MRKK PVPL QKFPN DPLALRLL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISLVRNDKARRYLTSMRKKQPVPLAQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLA++EREPSCQPI+K+EFEFERRRVTK+D+RELI+REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLARVEREPSCQPITKMEFEFERRRVTKEDVRELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+NGTE TNFLYP
Sbjct: 361 PQLLKDYLNGTERTNFLYP 379
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79365134|ref|NP_175756.2| mitogen-activated protein kinase 18 [Arabidopsis thaliana] gi|334302931|sp|Q9C5C0.4|MPK18_ARATH RecName: Full=Mitogen-activated protein kinase 18; Short=AtMPK18; Short=MAP kinase 18 gi|332194829|gb|AEE32950.1| mitogen-activated protein kinase 18 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/379 (89%), Positives = 359/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY++G+EG+NF+YP
Sbjct: 361 PQLLKDYMSGSEGSNFVYP 379
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 381 | ||||||
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.992 | 0.632 | 0.899 | 4.5e-185 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.994 | 0.616 | 0.891 | 1.2e-184 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.994 | 0.625 | 0.846 | 4.3e-180 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.994 | 0.668 | 0.796 | 3.8e-172 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.986 | 0.737 | 0.795 | 2.2e-169 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.979 | 0.647 | 0.780 | 1e-164 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.989 | 0.640 | 0.759 | 5.5e-164 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.965 | 0.757 | 0.762 | 2.2e-160 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.876 | 0.631 | 0.516 | 4.5e-91 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.860 | 0.872 | 0.504 | 1.9e-90 |
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1795 (636.9 bits), Expect = 4.5e-185, P = 4.5e-185
Identities = 341/379 (89%), Positives = 359/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY+N +EG++FLYP
Sbjct: 361 PQLLKDYMN-SEGSSFLYP 378
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1791 (635.5 bits), Expect = 1.2e-184, P = 1.2e-184
Identities = 338/379 (89%), Positives = 359/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKDY++G+EG+NF+YP
Sbjct: 361 PQLLKDYMSGSEGSNFVYP 379
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1748 (620.4 bits), Expect = 4.3e-180, P = 4.3e-180
Identities = 321/379 (84%), Positives = 357/379 (94%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQLLKD++NG + +FLYP
Sbjct: 361 PQLLKDHMNGADKASFLYP 379
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1673 (594.0 bits), Expect = 3.8e-172, P = 3.8e-172
Identities = 302/379 (79%), Positives = 349/379 (92%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYP 379
P++LK+Y++G+E TNF+YP
Sbjct: 361 PKMLKEYLDGSEPTNFMYP 379
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1647 (584.8 bits), Expect = 2.2e-169, P = 2.2e-169
Identities = 299/376 (79%), Positives = 345/376 (91%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D KK + +FFTEYG+A+RY+I EVIGKGSYGVV +AIDTH+GEKVAIKKI+DVFEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDL 123
SDA RILRE+KLLRLLRHPDIVEIK +MLPPS+REF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
T EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILAN++CKLK+CDFGLARV+F+D P
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD++
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
TDLLGTP PE IA +RNEKAR+YL MR+KPPVP KFP+VDPLALRLL RL+AFDPKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
RP+AEEALADPYF GLA ++REPS QPI KLEFEFERR++TK+D+RELIYREILEYHPQ+
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKDYINGTEGTNFLYP 379
L++Y+ G E T+F+YP
Sbjct: 362 LQEYLRGGEQTSFMYP 377
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1603 (569.3 bits), Expect = 1.0e-164, P = 1.0e-164
Identities = 291/373 (78%), Positives = 336/373 (90%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
KK + + +FFTEYG+ANRY+I EV+GKGSYGVV +AIDTHTGE+VAIKKI+DVF+HISDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
RILRE+KLLRLL HPD+VEIK IMLPPS+REF+D+YVVFELMESDLHQVIKANDDLT E
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
HHQFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D P +FW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQLD++TD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTP PE I+ +RN+KAR+YL MRKK PVP +KFP DP ALRLL+RLIAFDPKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366
AEEALADPYF GL+ REPS QPISKLEFEFER+++TKDDIRELIYREILEYHPQ+L++
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 YINGTEGTNFLYP 379
Y+ G +F+YP
Sbjct: 432 YLRGGNQLSFMYP 444
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 5.5e-164, P = 5.5e-164
Identities = 288/379 (75%), Positives = 340/379 (89%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ D KK + +FFTEYG+ANRY+I EV+GKGSYGVV +A+D+HTGE+VAIKKI+DVF
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPD+VEIK IMLPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD LGTP PE+I+ +RNEKAR+YL+ MRKK PVP KFP DPLALRLL+RL+AFD
Sbjct: 320 DLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFD 379
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR +AE+ALADPYF GL+ EREP+ QPISKLEF+FER+++ KDD+RELIYREILEYH
Sbjct: 380 PKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYH 439
Query: 361 PQLLKDYINGTEGTNFLYP 379
PQ+L++Y+ G + +F+YP
Sbjct: 440 PQMLEEYLRGGDQLSFMYP 458
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1562 (554.9 bits), Expect = 2.2e-160, P = 2.2e-160
Identities = 282/370 (76%), Positives = 336/370 (90%)
Query: 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR 71
+K+FFTEYG+A++Y+I EV+GKGSYGVV +A HTG KVAIKK+ +VFEH+SDAIRILR
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
E+KLLRLLRHPDIVEIK IMLPP ++EFKDIYVVFELMESDLH V+K NDDLT +HHQFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
LYQ+LR LK+MH+A+V+HRDLKPKNILANA+CK+K+CD GLARV+F+D+P VFWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGK+VVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
P T++ +RNEKARKYL MR+K PVP KFPN+DP+AL+LLQRLIAFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
ADPYF+GLA ++ EPS QPISKLEFEFERR++T+DD+REL+YREILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 372 EGTN--FLYP 379
E N FLYP
Sbjct: 363 ENINSHFLYP 372
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 175/339 (51%), Positives = 236/339 (69%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY I++ IG G+YGVVC+A D TGEKVAIKKI F+++ D R LRE+ LLR +H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK I+ P SK +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQMLR LK++H
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N +C LK+CD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ +KYT AIDIWS+GCIFAE+L KPLF GK +HQ+ LI + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+++ M +P V FP +P A+ LL+R++ FDP R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPS 444
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
EP C + K FE + +D ++ELIY E+L YHP+
Sbjct: 445 DEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 169/335 (50%), Positives = 242/335 (72%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L IG+G+YG+VCAA ++ TGE+VAIKKI + F++I DA R LRE+KLL+ + H +++ +
Sbjct: 46 LRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAV 105
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K I+ PP + F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQ+LR LKY+H+ANV
Sbjct: 106 KDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANV 165
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP N+L NANC LK+ DFGLAR S+T F T+YV TRWYRAPEL + S+
Sbjct: 166 LHRDLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SE 220
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267
YT AIDIWS+GCI E +T +PLFPGK VHQL LIT+L+G+P ++ +R++ AR+Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
++ + P +FPN+ A+ LL++++ FDP R T +EAL PY L I EP
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340
Query: 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
C + F+FE+ +T+++I+ELIYRE ++++PQ
Sbjct: 341 C--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5SN53 | MPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8524 | 0.9606 | 0.6432 | yes | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5162 | 0.8766 | 0.6313 | yes | no |
| O42781 | MAPK2_PNECA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5073 | 0.8766 | 0.9515 | N/A | no |
| Q40532 | NTF4_TOBAC | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5090 | 0.8503 | 0.8244 | N/A | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7814 | 0.9606 | 0.7233 | N/A | no |
| Q9C5C0 | MPK18_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8918 | 0.9947 | 0.6162 | yes | no |
| Q07176 | MMK1_MEDSA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5074 | 0.8425 | 0.8294 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.946 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 381 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-159 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-144 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-138 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-126 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-117 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-116 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-103 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-98 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-90 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-89 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-89 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-88 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-88 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-85 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-78 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-76 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-76 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-74 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-70 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-69 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-68 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-68 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-67 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-64 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-62 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-62 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-62 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-61 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-61 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-60 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-59 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-56 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-55 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-55 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-53 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-47 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-41 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-39 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-37 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-04 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 721 bits (1863), Expect = 0.0
Identities = 302/338 (89%), Positives = 325/338 (96%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKI+DVFEH+SDA RILRE+KLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EHHQFFLYQ+LRALKY+H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DTP +FWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDLITDLLGTPSPETI+ VRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+YL+ MRKK PVP QKFPN DPLALRLL+RL+AFDPKDRPTAEEALADPYFKGLAK+E
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
REPS QPI+KLEFEFERRR+TK+D+RELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 522 bits (1348), Expect = 0.0
Identities = 186/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY++L+ IG G+YGVVC+A+D TG KVAIKKI +VF+ + DA RILRE+KLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LK+CDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AIDIWS+GCIFAE+LT KPLFPG+ + QL+LI ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R YL + KKP PL + FP P A+ LL++++ FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
EP +P +F F+ +T+++++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 449 bits (1158), Expect = e-159
Identities = 182/338 (53%), Positives = 245/338 (72%), Gaps = 6/338 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+G+YG+VC+A ++ T EKVAIKKI + F++ DA R LRE+KLLR L H +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK IM PP + F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQ+LR LKY+H
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L NANC LK+CDFGLAR S+ F T+YV TRWYRAPEL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGD--FMTEYVVTRWYRAPELLLN 182
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AID+WS+GCIFAE+L KPLFPGK VHQL LIT+LLG+PS E + +RNEKA
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+Y+ + P + FP+ +PLA+ LL++++ FDP R T EEALA PY L
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
EP CQ + F+FE +T++DI+ELIY E+L YHP
Sbjct: 302 DEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 412 bits (1061), Expect = e-144
Identities = 168/334 (50%), Positives = 226/334 (67%), Gaps = 4/334 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L IG+G+YG+VC+A TG KVAIKKI FEH + R LRE+K+LR +H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKHEN 64
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY+H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N NC LK+CDFGLAR+A + T F T+YVATRWYRAPE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
YT AIDIWS+GCI AE+L+ +PLFPGK +HQL+LI +LGTPS E + + + +A
Sbjct: 184 S-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R Y+ + KP VP + FPN DP AL LL +++ F+P R T EEALA PY +
Sbjct: 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
EP + +FE + K+ ++ELI+ EI+
Sbjct: 303 DEPVAEEPFPFDFEL-FDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 396 bits (1019), Expect = e-138
Identities = 166/333 (49%), Positives = 235/333 (70%), Gaps = 5/333 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYK +E IG G+YGVVC+AIDT +G+KVAIKKI F+ + A R LRE+K+LR +H +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQ+LR LKY+H
Sbjct: 66 IIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ANV HRDLKP N+L N +C+L++ DFG+AR ++ S T F T+YVATRWYRAPEL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S +YT AID+WS+GCIFAE+L + LFPGK+ VHQL LI +LG+PS E + + +++
Sbjct: 185 SL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
RKY+ + +K PVP + FP P AL LL +++ FDP++R T E+AL P+
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
+ EP+C P +F+FE ++++ ++E I +E
Sbjct: 304 DDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 366 bits (942), Expect = e-126
Identities = 149/337 (44%), Positives = 214/337 (63%), Gaps = 11/337 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y+IL+ +GKG+YG+V AID T E VA+KKI D F + +DA R RE+ L+ L HP
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ ++ + KDIY+VFE ME+DLH VI+AN L H ++ +YQ+L+ALKY+
Sbjct: 68 NIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPMTVFWTDYVATRWYRAPE- 199
H+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS ++YT +D+WS+GCI E+L GKPLFPG S ++QL+ I +++G PS E I ++
Sbjct: 184 LLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
+ A L + +P PL + P AL LL++L+ F+P R TAEEAL PY
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 302 HNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-117
Identities = 160/339 (47%), Positives = 220/339 (64%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR- 80
RY++++ +G+G+YG+VC+A + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + + P F ++Y+ ELME+DLHQ+I++ LT H Q F+YQ+L L
Sbjct: 61 HKNITCLYDMDIVFPGN--FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV--FWTDYVATRWYRA 197
KY+H+ANV HRDLKP N+L NA+C+LK+CDFGLAR FS+ P F T+YVATRWYRA
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ SF YT AID+WS+GCI AE+L KP+F GK V QL+ I +LGTP ET++
Sbjct: 178 PEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KA+ Y+ + P P FPN +PLAL LL++L+AFDP R + EEAL PY
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ EP CQ FE E + +++R++I E+
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 340 bits (873), Expect = e-116
Identities = 149/346 (43%), Positives = 213/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + +RY+ L +G G+YG VC+A DT TG KVAIKK+ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A + HRDLKP NI N +C+LK+ DFGLAR D MT YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT----GYVATRWY 181
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + QL I +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP P + FE R +T D+ +EL+Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-105
Identities = 128/296 (43%), Positives = 179/296 (60%), Gaps = 18/296 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ LE +G+G+YGVV A D TGE VA+KKI ++ + I LRE+ LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
+IV++ ++ K +Y+VFE + DL + + L+ + +YQ+LR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF P+ + T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFG-IPLRTY-THEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG S + QL I +LGTP+ E+ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K Y K PP L + P +DP + LL +++ ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-104
Identities = 135/294 (45%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ L IG+G+YGVV A D TGE VAIKKI FE LRE+KLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
+++ + D+Y+VFE M++DL+++IK E + +LYQ+L+ L + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR S +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ +DIWS+GCIFAE+L+ +PLFPGKS + QL I LGTP PE +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
AR Y KK +PL + FPN P AL LL +++ +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = e-103
Identities = 154/343 (44%), Positives = 220/343 (64%), Gaps = 18/343 (5%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
F T + NRY L+ +G G++G+VC+A D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQ 134
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR LKY+H+A V HRDLKP NIL N NC LK+CDFGLAR+ D MT YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT----GYVSTRY 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ ++ KY +DIWS GCIFAE+L GKPLFPGK V+Q +ITDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +E +++ + K+ PVP +KF N DP A+ LL++++ FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 315 YFKGLAKIEREPSCQPISKLEFE--FERRRVTKDDIRELIYRE 355
Y +P+ +P+++ +F+ F + D + ++Y E
Sbjct: 290 YLAPY----HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = 1e-98
Identities = 143/353 (40%), Positives = 208/353 (58%), Gaps = 30/353 (8%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG G++GVV + D G++VA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LK+CDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE 269
A+DIWS+GCIFAE+L + LF +S + QLDLITDLLGTPS E + E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG--------- 318
KPP L+ A+ LL R++ FDP R +A +ALA PY
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCM 302
Query: 319 -----------LAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
+ + EPS P + E+E+ + ++E +++ ILE
Sbjct: 303 CKCCYTTSGGRVYTSDFEPSANP--PFDDEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (704), Expect = 2e-90
Identities = 142/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKY+
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LK+ DFGLAR +D MT YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT----GYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E + + +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ EP P + FE R + D+ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 272 bits (696), Expect = 4e-89
Identities = 134/339 (39%), Positives = 197/339 (58%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY L+ +G G+YG VC+AID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQML LKY+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LK+ DFGLAR A D MT YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMT----GYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P PE + + ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ + K P FP P A+ LL++++ D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ E QP E +++ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 7e-89
Identities = 140/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VC+A DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQ+LR LKY+
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L++ DFGLAR A D MT YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMT----GYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+L GK LFPG + QL I +++GTPSPE + + +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
ARKY+ + P L + F +PLA+ LL++++ D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP +P + E + T ++ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (686), Expect = 2e-88
Identities = 121/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPD 83
YK+++ +G G++G V A + TGE VAIKK+ F + + LREVK L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL- 200
+H +HRDLKP+N+L + +K+ DFGLAR S P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PET 254
S Y+ +DIW++GCI AE+ T +PLFPG S + QL I +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ A K + P L Q PN P A+ L++ ++ +DPK RPTA +AL P
Sbjct: 227 YKL-----ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 3e-88
Identities = 126/300 (42%), Positives = 167/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D I LRE+KLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRAL 139
HP+I+ + + K +I +VFE ME+DL +VIK LT + ++ LR L
Sbjct: 61 HPNIIGLLDVF--GHK---SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L F Y +D+WS+GCIFAE+L P PG S + QL I + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
V + E + PP PL Q FP AL LLQRL+ +P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 268 bits (686), Expect = 1e-87
Identities = 135/339 (39%), Positives = 206/339 (60%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ ++H +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQML+ LKY+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H A + HRDLKP N+ N +C+LK+ DFGLAR D+ M T YV TRWYRAPE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEM----TGYVVTRWYRAPEVIL 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ YT +DIWS+GCI AE+LTGKPLF G + QL I + GTPS E + +++E
Sbjct: 189 NWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ ++ + PN +PLA+ +L++++ D + R TA EALA PYF+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E P + F+ + ++ + L + EIL + P
Sbjct: 308 EDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 264 bits (676), Expect = 3e-87
Identities = 108/293 (36%), Positives = 154/293 (52%), Gaps = 40/293 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ILE +G+GS+G V A D TG+ VAIK I D RILRE+K+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+DIWS+G I E+LTGKP FPG QL + +G
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIG--------------- 210
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
KP P ++ P A L+++L+ DP+ R TAEEAL P+F
Sbjct: 211 ---------KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 5e-86
Identities = 115/297 (38%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ + IG+G+YG V A + TGE VA+KKI E I +RE+KLL+ LRHP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMH 143
V +K I+ K IY+VFE M+ DL ++ T + ++ Q+L L+Y+H
Sbjct: 61 VRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRD+K NIL N + LK+ DFGLAR ++ + T+ V T WYR PE L G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ ++Y P +D+WS+GCI AE+ GKP+F G + + QL+ I +L G+P+ E V
Sbjct: 176 A--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK-- 231
Query: 263 ARKYLTEMRKKPPVP--LFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ ++ K P L + F ++ DP AL LL +L+ DPK R +A++AL YF
Sbjct: 232 -LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 2e-85
Identities = 119/301 (39%), Positives = 176/301 (58%), Gaps = 24/301 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
RYKIL IG+G++G+V A D TGE VA+KK+ + I + LRE+K L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ +L+ +
Sbjct: 59 PYVVKLLDVFPHGS-----GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
YMH + HRDLKP N+L +A+ LK+ DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
G+ KY P +D+W++GCIFAE+L G PLFPG++ + QL ++ LGTP+ ET +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 260 N----EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + P+PL + FP+ P AL LL+ L+ +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 316 F 316
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 2e-82
Identities = 118/299 (39%), Positives = 176/299 (58%), Gaps = 16/299 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
N+Y++L V+G+G+YGVV + TGE VAIKK + + + ++ LREVK+LR LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRAL 139
H +IV +K +R+ + +Y+VFE +E L ++++A+ L + + +++Q+L+A+
Sbjct: 59 HENIVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPE 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G + Y +D+W+IGCI AE+L G+PLFPG S + QL LI LG P +
Sbjct: 172 LLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + P L +++P V AL L+ + DPK+R T +E L PYF
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 5e-82
Identities = 129/348 (37%), Positives = 195/348 (56%), Gaps = 24/348 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P EF+D+Y+V ELM+++L QVI DL E + LYQML +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + I + LGTPS E ++ +
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-------DPLALR------LLQRLIAFDPKDRPTAE 308
R Y+ K + FP+V L+ LL +++ DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+AL PY E P + + + R T ++ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-78
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++L +G GS+G V A TG+ VA+K + E RE+++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +K+ DFGLA+ + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y P +D+WS+G I E+LTGKP F G++++ QL
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----------------------- 208
Query: 264 RKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L PP+ K+ + A L+++ + DP RPTAEE L P+F
Sbjct: 209 --QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-77
Identities = 130/361 (36%), Positives = 194/361 (53%), Gaps = 44/361 (12%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKL 75
+ +RY L +G GS G+V +A+D+ ++VA+KKI ++D + LRE+K+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVF 185
H + F+YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + Q+ LI +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPETIAVVRNE-----------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
++ VVR E R E R+ PL P V+P AL L+
Sbjct: 234 --------SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 295 RLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYR 354
+++ F+P DR TAEEAL PY + EP +E E + + +I +IY
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD-DILLMTEIHSIIYN 340
Query: 355 E 355
Sbjct: 341 W 341
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 1e-76
Identities = 120/298 (40%), Positives = 168/298 (56%), Gaps = 17/298 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ L I +G+YGVV A D TGE VA+KK+ E + I LRE+ +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IV +K +++ IY+V E +E DL +++ + + + Q+L + +
Sbjct: 65 NIVTVKEVVV---GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LK+CDFGLAR + P+ + T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGS-PLKPY-TQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGKS + QL+ I LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K T K P L +KFP + LL RL+ +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT-FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 9e-76
Identities = 134/321 (41%), Positives = 179/321 (55%), Gaps = 32/321 (9%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVK 74
TE+ NR IG+G+YG+V A DT +GE VA+KK+ ++ D I I LRE+
Sbjct: 7 TEFEKLNR------IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREIT 58
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLY 133
LL LRHP+IVE+K +++ + I++V E E DL ++ + + +
Sbjct: 59 LLLNLRHPNIVELKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVAT 192
Q+LR L+Y+H + HRDLK N+L LK+ DFGLAR PMT V T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT----PKVVT 171
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WYRAPE L G + YT AID+W++GCI AE+L KPL PGKS + QLDLI LLGTP+
Sbjct: 172 LWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 252 PETI--AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E+I K+ + K+P L KFP + LRLL L+ +DPK R TAEE
Sbjct: 230 -ESIWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 310 ALADPYFKGLAKIEREPSCQP 330
AL YFK E+ C+P
Sbjct: 287 ALESSYFK-----EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 6e-74
Identities = 115/313 (36%), Positives = 166/313 (53%), Gaps = 28/313 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+IL +G+G++G V A TG VA+KKI E I LRE+K+L+ L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 83 DIVEIKRIML---PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLR 137
++V + + + SKR+ +Y+V M+ DL +++ N + Q ++ Q+L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--------TVFWTDY 189
+ Y+H ++ HRD+K NIL + LK+ DFGLAR P T +T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 190 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GKS + QL LI L G
Sbjct: 187 VVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 249 TPSPETIAVVRNEKARKYL---TEMRKKPPVP--LFQKFPNVDPLALRLLQRLIAFDPKD 303
TP+ ET R L + P L ++F + P L LL +L++ DP
Sbjct: 245 TPTEETWPGWR------SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-70
Identities = 119/297 (40%), Positives = 167/297 (56%), Gaps = 19/297 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI--RILREVKLLRLLRHP 82
Y+ +E IG+G+YGVV A D TGE VA+KKI E + + +RE+ LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALK 140
+IV + ++ +K +Y+VFE ++ DL + + L + +LYQ+L+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG S + QL I LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L + PN+D L LL +++ +DP R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-69
Identities = 108/306 (35%), Positives = 163/306 (53%), Gaps = 33/306 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLR- 80
Y+ L IG+G+YG V A D +TG VA+KK+ +S+ + LRE+ LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQM 135
HP+IV + + P + RE + +VFE ++ DL + L E + + Q+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDREL-KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR + ++H+ + HRDLKP+NIL ++ ++K+ DFGLAR+ + +T V T WY
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT----SVVVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS--- 251
RAPE L S Y +D+WS+GCIFAE+ +PLF G S QLD I D++G PS
Sbjct: 173 RAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 252 -PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +++ R + P P + L LL++++ F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 311 LADPYF 316
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-68
Identities = 117/299 (39%), Positives = 172/299 (57%), Gaps = 20/299 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI----LREVKLLRLL 79
+Y+ L IG+GSYGVV + TG+ VAIKK F D I LRE+++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+HP++V + + R + +++VFE + + L+++ K + + ++Q L+A
Sbjct: 58 KHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGKS V QL LI LG P +
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ K L+ + PL KFPN+ AL L+ + DP +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-68
Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 21/298 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLLRHP 82
+K LE +G+G+Y V + TGE VA+K+IH D E S AIR E+ L++ L+H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHE 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
+IV + ++ +K + +VFE M+ DL + + + L + F YQ+L+ +
Sbjct: 59 NIVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T WYRAP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +IDIWS+GCI AE++TG+PLFPG + QL I ++GTP+ T +
Sbjct: 171 VLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+Y + PP L Q FP+ DPL + LL RL+ +P+ R +A +AL P+F
Sbjct: 229 SQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 1e-67
Identities = 126/348 (36%), Positives = 195/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ IG G+ G+VCAA DT G VA+KK+ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + P S EF+D+Y+V ELM+++L QVI +L E + LYQML +K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ ++C LK+ DFGLAR A ++ M T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM----TPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +DIWS+GCI E++ G +F G + Q + + + LGTPS E + ++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARKYLTEMRKKPPVPLFQKFPN--------VDPL----ALRLLQRLIAFDPKDRPTAEEA 310
R Y+ + P + + FP+ D L A LL +++ DP R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
L PY + E P + + E R ++ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 3e-67
Identities = 111/302 (36%), Positives = 173/302 (57%), Gaps = 30/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD 83
YKIL IG+G++ V A TG+ AIK + F+ + LRE++ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH------QFFLYQML 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQ+L
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++L +MH ++HRD+KP+NIL + LK+ DFG R +S P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE L + Y P +DIW++GC+F E+L+ PLFPG + + Q+ I D+LGTP E
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ R + Y K L + PN L LL++L+A+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 315 YF 316
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 8e-64
Identities = 133/369 (36%), Positives = 205/369 (55%), Gaps = 31/369 (8%)
Query: 11 KDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
+D +F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDL 123
A R RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--EL 123
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 182
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + Q + +
Sbjct: 183 ---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-FPNV------------DPLAL 290
+ LGTP PE + ++ R Y+ E R K F+K FP+V A
Sbjct: 238 IEQLGTPCPEFMKKLQ-PTVRTYV-ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
LL +++ D R + +EAL PY + E P + + + R T ++ +E
Sbjct: 296 DLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 354
Query: 351 LIYREILEY 359
LIY+E+++
Sbjct: 355 LIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 1e-63
Identities = 120/302 (39%), Positives = 174/302 (57%), Gaps = 16/302 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ +E IG+G+YGVV A D T E +A+KKI E +RE+ LL+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH--QFFLYQMLRALK 140
+IV ++ ++ K +Y+VFE ++ DL + + ++ D + + +LYQ+LR +
Sbjct: 62 NIVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 141 YMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ F T V T WYRAPE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPE 173
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +DIWS+GCIFAE++ KPLFPG S + +L I +LGTP+ ET V
Sbjct: 174 ILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ Y + K PP L P ++P + LL +++ DP R TA AL YFK
Sbjct: 232 TS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 319 LA 320
L
Sbjct: 290 LG 291
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 117/306 (38%), Positives = 173/306 (56%), Gaps = 35/306 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHI-SDAIRILREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ D E + S A LRE+ LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N D+ E + F++Q+L+ L
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P+ + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARKYLTEMRKKPPVPLF-------QKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
E++ ++++ P P++ P ++ LLQ L+ +P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 127/361 (35%), Positives = 197/361 (54%), Gaps = 28/361 (7%)
Query: 15 FFTEYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 70 LREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERM 121
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 177
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LG
Sbjct: 178 YVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRL 296
TP PE + ++ R Y+ K + + FP+ A LL ++
Sbjct: 236 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ DP R + +EAL PY + E P + + + R T ++ +ELIY+E+
Sbjct: 295 LVIDPAKRISVDEALQHPYIN-VWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 353
Query: 357 L 357
+
Sbjct: 354 M 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 4e-62
Identities = 114/300 (38%), Positives = 167/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PD 83
Y+ LE IG+G+YG V A D +TG+ VA+KK + LRE+ LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRA 138
IV + + K +Y+VFE ++SDL + + +N L + + F+YQ+L+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LK+ D GL R AFS P+ + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG S + QL I LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V + E + P L + P++ P L LLQ+++ +DP R +A+ AL PYF
Sbjct: 238 GVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 4e-62
Identities = 110/304 (36%), Positives = 174/304 (57%), Gaps = 28/304 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+Y+ L ++G+GSYG+V TG+ VAIKK + + ++ +RE+++L+ LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-------QFFLY 133
H ++V + + R K +Y+VFE ++ H V+ DDL + + + +L+
Sbjct: 59 HENLVNLIEVF-----RRKKRLYLVFEFVD---HTVL---DDLEKYPNGLDESRVRKYLF 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P V+ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG S + QL I LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + + K PL ++FP + L L L ++ + DP DRP++ + L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 313 DPYF 316
+F
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 9e-62
Identities = 117/305 (38%), Positives = 169/305 (55%), Gaps = 21/305 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G YK L+ +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE +++DL Q + H+ + FL+Q+L
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR A S T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT--YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPET 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG V QL I +LGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 I-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEAL 311
V N + + Y PP PL P +D P L + + ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-61
Identities = 113/296 (38%), Positives = 168/296 (56%), Gaps = 16/296 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +E IG+G+YGVV + TG+ VA+KKI E +RE+ LL+ L+HP+I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQ---VIKANDDLTREHHQFFLYQMLRALKY 141
V ++ +++ S+ +Y++FE + DL + + + E + +LYQ+L+ + +
Sbjct: 62 VCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ V HRDLKP+N+L + +K+ DFGLAR AF P+ V+ T V T WYRAPE L
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS +Y+ +DIWSIG IFAE+ T KPLF G S + QL I +LGTP+ + V
Sbjct: 174 LGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-- 229
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L N+D L LL++++ +DP R +A++AL PYF
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 7e-61
Identities = 112/292 (38%), Positives = 164/292 (56%), Gaps = 15/292 (5%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+IV++
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA 145
++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L + H+
Sbjct: 65 LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L N +K+ DFGLAR AF P+ + T V T WYRAPE L G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCK 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP V +
Sbjct: 177 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP-- 232
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K + P +D LL +++ +DP R +A+ ALA P+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 2e-60
Identities = 117/315 (37%), Positives = 165/315 (52%), Gaps = 42/315 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-------------ILREVKLLR 77
+G+G+YG V A DT TG+ VAIKK+ + E +D + LRE+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137
++H +I+ + + + + +F I +V ++M SDL +V+ LT + L Q+L
Sbjct: 76 EIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----------TVFW 186
L +H HRDL P NI N+ K+ DFGLAR
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 187 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG++ + QL I +
Sbjct: 191 TSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 246 LLGTPSPETIAVVRNEKARKYL---TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
LLGTP+ + N K L TE + P L FPN A+ LLQ L+ +P
Sbjct: 249 LLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 303 DRPTAEEALADPYFK 317
+R +A+EAL YFK
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 3e-60
Identities = 115/300 (38%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ I+ IG+G+YG V A D TGE VA+KK+ E I +RE+K+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 85 VEIKRIMLPPS-----KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRA 138
V +K I+ K++ Y+VFE M+ DL ++++ + +H + F+ Q+L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y H N HRD+K NIL N ++K+ DFGLAR+ S+ +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186
Query: 199 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G +Y PAID+WS GCI E+ T KP+F + QL+LI+ L G+P P AV
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP---AV 241
Query: 258 VRNEKARKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y M+ K L ++F + AL LL ++ DP R TAEEAL P+
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-59
Identities = 114/324 (35%), Positives = 164/324 (50%), Gaps = 39/324 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRL 78
+Y+I IG+G+YG V A + G++ AIKK E IS + RE+ LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF-----LY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + R L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTD- 188
Q+L + Y+H+ V HRDLKP NIL +K+ D GLAR+ F+ + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-----KSVV----H 238
V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G K
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP------VPLFQKFPNVDPLALRL 292
QL+ I ++LGTP+ + ++ L + K +K D L
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292
Query: 293 LQRLIAFDPKDRPTAEEALADPYF 316
L++L+ +DP R TAEEAL PYF
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-57
Identities = 111/304 (36%), Positives = 155/304 (50%), Gaps = 11/304 (3%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++Y+ L IG+G++G V A T + VA+KK+ E I LRE+K+L+LL+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69
Query: 81 HPDIV---EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQML 136
H ++V EI R P R Y+VFE E DL ++ N T + + +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DTPMTVFWTDYVATRW 194
L Y+H + HRD+K NIL + LK+ DFGLAR AFS +T+ V T W
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
YR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 189 YRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 254 TI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
V + E +K +K V K DP AL L+ +L+ DP R A+ AL
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 313 DPYF 316
+F
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 4e-56
Identities = 117/306 (38%), Positives = 172/306 (56%), Gaps = 18/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y LE +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H+ + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG +V +L LI LLGTP+ ET
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ N++ + Y K P PL P +D + LL + + ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 YFKGLA 320
YF+ L
Sbjct: 288 YFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 2e-55
Identities = 115/307 (37%), Positives = 169/307 (55%), Gaps = 18/307 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + + H+ + FL+Q+L
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
++ NE+ + Y K L P +D LL +L+ F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 YFKGLAK 321
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 182 bits (462), Expect = 8e-55
Identities = 113/302 (37%), Positives = 169/302 (55%), Gaps = 18/302 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H+ + F++Q+L
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG +V +L LI LLGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ NE+ R YL + PL P +D + LL L+ ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYR--AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 315 YF 316
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 8e-53
Identities = 103/296 (34%), Positives = 168/296 (56%), Gaps = 11/296 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N++++L V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IVE+K R +Y+VFE +E ++ ++++ + + E + ++YQ+++A+ +
Sbjct: 61 NIVELKEAF-----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D+WS+GCI E+ G+PLFPG+S + QL I +LG E + + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L P L +++ + + L L++ L+ +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 9e-50
Identities = 108/304 (35%), Positives = 157/304 (51%), Gaps = 19/304 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A Y LE +G+GSY V I G+ VA+K I E +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLR 137
L+H +IV + I+ F VFE M +DL Q + + ++ + F++Q+LR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H ++ HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG S V QL+ I +LG P+ +T
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN---VDPLALRLLQRLIAFDPKDRPTAEEALA 312
V K Y E + P A L +++ PKDR +A++AL
Sbjct: 230 PGV--SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-49
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + RE+++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV E + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+Y A DIWS+GC E+ TGKP + + + + + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEP---------- 222
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P ++ A L++ + DPK RPTA+E L P+
Sbjct: 223 -----------PEIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 104/304 (34%), Positives = 162/304 (53%), Gaps = 26/304 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLR-- 80
+Y+ + IG+G+YG V A D G + VA+K++ + +REV +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKRI-MLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ +T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE--- 253
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+A+ R K P+ + ++D L LL + + F+P R +A AL+
Sbjct: 235 RDVALPRQAFH--------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 313 DPYF 316
PYF
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 3e-47
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKRIMLPPS-KREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLR 137
+ +K K+ K+I+ VV E + +H+ +K N L + + YQ+ R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G+S V QL I +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDPKDRPTAEEALADP 314
+ A +++ K L + FP P A+ + + + ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (414), Expect = 6e-47
Identities = 89/355 (25%), Positives = 147/355 (41%), Gaps = 35/355 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHPD 83
Y+IL +G+GS+G V A D + VA+K + E S + R LRE+++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA---FSDTPMTVFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ S + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ G + + + DIWS+G E+LTG P F G+ +T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ ++ + + P + A LL++L+A DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYIN 369
L E + S + + L D N
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-46
Identities = 70/196 (35%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+G+G +G V A D TG+KVAIK I S +LRE+++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVY 148
+ +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ SD + V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 25/303 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+ + IG G+YG V A D H+G VA+K + + +REV LL+ L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 84 IVEIKRIM----LPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLR 137
I R+M + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ +T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT----PVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PE 253
PE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P P
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + R + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 234 DVTLPRG--------AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 314 PYF 316
P+F
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 88/303 (29%), Positives = 142/303 (46%), Gaps = 55/303 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+I++ IGKGS+G V G+ +K+I + L EVK+L+ L HP+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------LYQ 134
I++ S E + +V E + DL Q IK ++ + F Q
Sbjct: 61 IIKYYE-----SFEEKGKLCIVMEYADGGDLSQKIKK----QKKEGKPFPEEQILDWFVQ 111
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V S + V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL-GTPSPE 253
Y +PELC + Y DIWS+GC+ E+ T K F G++ L+L +L G P
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPP- 222
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + +Y +E+R L LLQ+ DP++RP+ + L
Sbjct: 223 ----IPS----QYSSELRN---------------LVSSLLQK----DPEERPSIAQILQS 255
Query: 314 PYF 316
P+
Sbjct: 256 PFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-41
Identities = 81/302 (26%), Positives = 134/302 (44%), Gaps = 61/302 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++ILE IGKG +G V A TG++VAIK I + + +I+ E+++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE--KIINEIQILKKCKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
V+ L + +++V E L ++K+ + LT + ++L+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ SDT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY---------------------------SELP 201
Query: 263 ARKYLTEMRKKPPVPL---------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
K L ++ P L F+ F + LQ +P+ RPTAE+ L
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWSDEFKDFLK------KCLQ----KNPEKRPTAEQLLKH 251
Query: 314 PY 315
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 62/308 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y++LE IGKGS+G V G+ + K+I + ++++ + ++ EV +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------L 132
+IV RI+ ++ +Y+V E E DL Q+I+ ++ ++ L
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQK----CKKERKYIEEEFIWRIL 111
Query: 133 YQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+L AL H + V HRDLKP NI +AN +K+ DFGLA++ D+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---K 168
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
YV T +Y +PE Y DIWS+GC+ E+ P F ++ QL L + +
Sbjct: 169 TYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI- 222
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
K K+ +P L +++ ++ DP RP+
Sbjct: 223 --------------KEGKF-------RRIPYRYS----SELN-EVIKSMLNVDPDKRPST 256
Query: 308 EEALADPY 315
EE L P
Sbjct: 257 EELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-41
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 41/294 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ ++IG+G++GVV ++ TG+ VAIK+I I++E+ LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K I + Y++ E E+ L Q+IK ++YQ+L+ L Y+
Sbjct: 61 IV--KYIGSIETSDSL---YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRD+K NIL + +K+ DFG+A + V T ++ APE+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIE 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S + A DIWS+GC E+LTG P + DL P +V+++
Sbjct: 173 --MSGASTASDIWSLGCTVIELLTGNPPY--------YDL------NPMAALFRIVQDD- 215
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
PP+P + P L + DP RPTA++ L P+
Sbjct: 216 ----------HPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 3e-40
Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 17/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A+ Y+ LE +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+Q+LR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K + QL+ I +LGTP+ +T
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 256 AVVRNEKARK--YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K T K + K V+ A L +L+ PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH-AEDLASKLLQCFPKNRLSAQAALSH 288
Query: 314 PYFKGL 319
YF L
Sbjct: 289 EYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 114/330 (34%), Positives = 163/330 (49%), Gaps = 65/330 (19%)
Query: 31 IGKGSYGVVCAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L S R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK------FPNV-------------D 286
++G P A K ++RK P P QK + N D
Sbjct: 240 VMGFP------------ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYF 316
LLQ+L+ DP R T+E+AL DPYF
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 110/329 (33%), Positives = 166/329 (50%), Gaps = 63/329 (19%)
Query: 31 IGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L + R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 246 LLGTPS----------PETIAVVRNEKAR--------KYLTEMRKKPPVPLFQKFPNVDP 287
++G P+ PE ++++ + KY+ + + KP D
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----------DS 288
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYF 316
A LLQ+L+ DP R T+E+A+ DPYF
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 91/323 (28%), Positives = 143/323 (44%), Gaps = 59/323 (18%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DV 59
++ K LKD GD YK LE IG+G+ G V A D TG++VAIKK+
Sbjct: 2 EELKAALKD---IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
E I+ E+ +++ +HP+IV+ S +++VV E M+ L +I
Sbjct: 59 KE------LIINEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDII 106
Query: 118 KAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
N + + ++L+ L+Y+H+ NV HRD+K NIL + + +K+ DFG A
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 177 FSDTPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ +V V T ++ APE+ Y P +DIWS+G + E+ G+P + +
Sbjct: 167 TKEKSKRNSV-----VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
+ L LIT G P + P L
Sbjct: 220 PPLRALFLITT-KGIPPLKNPE---------------------------KWSPEFKDFLN 251
Query: 295 RLIAFDPKDRPTAEEALADPYFK 317
+ + DP+ RP+AEE L P+ K
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R++ IG G++G V A++ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + + RE +Y+ E L ++++ L + + Q+L L Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRAPEL- 200
H+ + HRD+KP NI + N +K+ DFG A ++ + T M T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G + A DIWS+GC+ E+ TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E + KPP+P + + P L R + DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+GKGS+G V TG+ A+K + + I + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 88 KRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
F+ +Y+V E +L + + E +F+ +++ AL+Y+H
Sbjct: 59 HY--------AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL +A+ +K+ DFGLA+ S+ T + T Y APE+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG 167
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+D WS+G + E+LTGKP F +
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPFYAED---------------------------- 197
Query: 264 RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPT---AEEALADPYF 316
RK + E K P+ +FP + P A L+ L+ DP R AEE A P+F
Sbjct: 198 RKEIYEKILKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP++V++ + + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 60 HPNVVKLLGVCTEE-----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW AP
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK-LPIRWM-AP 172
Query: 199 ELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
E S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 E---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--------------------- 208
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ +YL + P P P L L+ + A DP+DRPT E
Sbjct: 209 ---NEEVLEYLKNGYRLPQ-------PPNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
HP+IV++ + + +V E M DL ++ N L+ F Q+ R
Sbjct: 60 HPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW A
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWM-A 172
Query: 198 PELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 PE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-------------------- 209
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N + +YL + + P P P L +L+ + A DP+DRPT E
Sbjct: 210 ----NAEVLEYLKKGYRLPK-------PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 93/330 (28%), Positives = 144/330 (43%), Gaps = 86/330 (26%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLL 79
+ +K ++IG+GS+ V A + T ++ AIK K + E ++I +EV L RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 80 RHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
HP I IK F+D +Y V E + +L Q I+ L + +F+ ++
Sbjct: 60 GHPGI--IKLYY------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI 111
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-----------------AFS 178
L AL+Y+H+ + HRDLKP+NIL + + +K+ DFG A+V
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
+ +V T Y +PEL + D+W++GCI ++LTGKP F G +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-------FP-NVDPLAL 290
+YLT FQK FP N P A
Sbjct: 227 --------------------------EYLT----------FQKILKLEYSFPPNFPPDAK 250
Query: 291 RLLQRLIAFDPKDRPTA----EEALADPYF 316
L+++L+ DP+DR +E A P+F
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ ++V+G+GS GVV TG+ A+KKIH V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ +I +V E M+ L ++K + + Q+L+ L Y+HT
Sbjct: 63 KCYGAFYKEG-----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 145 -ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
++ HRD+KP N+L N+ ++K+ DFG+++V + + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ A DIWS+G E GK P P +L+ + P P A + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICDGPPPSLPAEEFSPE 231
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R +++ LQ+ DPK RP+A E L P+ K
Sbjct: 232 FRDFIS----------------------ACLQK----DPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 89/314 (28%), Positives = 137/314 (43%), Gaps = 76/314 (24%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI---------HDVFEHISDAIRILR-EVKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D ++ LR E++ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA------FSDTPM- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ K+ DFG+++ + + M
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
+VFW APE+ S+ Y+ +DIWS+GC+ E+ G+ + + +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
A L R PP+P N+ P+AL L +P
Sbjct: 219 --------------------AAMFKLGNKRSAPPIPP-DVSMNLSPVALDFLNACFTINP 257
Query: 302 KDRPTAEEALADPY 315
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-31
Identities = 92/305 (30%), Positives = 144/305 (47%), Gaps = 61/305 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRIL-REVKLLRLLR 80
R++ E++G GS+G V ++ G+ A+K + D + +A++ L +E+ LL L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV+ ++RE ++Y+ EL+ L +++K + + Q+L L
Sbjct: 61 HPNIVQYL-----GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRA 197
+Y+H N HRD+K NIL + N +K+ DFG+A+ V FS F + + ++ A
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMA 169
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y A DIWS+GC E+ TGKP + QL E +A
Sbjct: 170 PEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGVAA 210
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-------LRLLQRLIAFDPKDRPTAEEA 310
V K L PP+P D L+ L+ LQR DP RPTA E
Sbjct: 211 VFKIGRSKEL------PPIP--------DHLSDEAKDFILKCLQR----DPSLRPTAAEL 252
Query: 311 LADPY 315
L P+
Sbjct: 253 LEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRAL 139
P+IV + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +K+ DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
K+T D+WS G + E+ T G+ +PG S
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------------------- 209
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ + L + + P P P L L+ + A+DP+DRPT E
Sbjct: 210 -NEEVLELLEDGYRLPR-------PENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 84/301 (27%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I + ++ D ++L E +L + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVK- 57
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 58 ----LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D WS+GCI E L G P F G++ E + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKG 318
K + + V A+ L+ +L+ DP+ R A EE P+FKG
Sbjct: 217 KIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 319 L 319
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 70/220 (31%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +LE IGKGS+G V AID T + VAIK I D+ E + I +E++ L R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
I + L SK ++++ E DL + K L + F L ++L
Sbjct: 60 YITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLG 110
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFWTDY 189
L+Y+H HRD+K NIL + +K+ DFG++ R F TP FW
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWM-- 165
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWS+G E+ G+P
Sbjct: 166 -------APEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIR-ILREVKLLRLLRHP 82
+++L VIGKG++G VC T + A+K ++ + + ++R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+V + F+D +Y+V +L+ DL + + E +F++ +++ A
Sbjct: 61 FLVNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H+ + HRD+KP NIL + + + DF +A + +T T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLT---TSTSGTPGYMAP 168
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
E+ + Y+ A+D WS+G E L GK + G S
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A D TG +VA+KK+ D+ + + + EV ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL ++H V HR
Sbjct: 85 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LPYGT 194
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLQAMKRI 227
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
R P P + V P L R++ DP R TA E L P+
Sbjct: 228 RDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 63/304 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRH 81
Y + V+GKG++G T V K+++ +S+ R L E+ +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ--FFLYQM 135
P+I+ F D + ME L+ I E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--TVFWTDYVATR 193
+ A+ Y+H A + HRD+K NI +K+ DFG++++ S+ M TV V T
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-----VGTP 165
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG---TP 250
+Y +PELC KY DIW++GC+ E+LT K F + L+L+ ++ TP
Sbjct: 166 YYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP 220
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
Y +E+ L+ L+ DP+ RPTA+E
Sbjct: 221 VVS-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEV 250
Query: 311 LADP 314
L P
Sbjct: 251 LDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+KI + IGKG + VV AI G VA+KK+ +FE + R L+E+ LL+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLD 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK--ANDDLTREHHQF--FLYQM 135
HP++ I S E ++ +V EL ++ DL ++IK + Q+
Sbjct: 61 HPNV-----IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL++MH+ + HRD+KP N+ A +K+ D GL R FS V T +Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYY 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAE 223
+PE + Y DIWS+GC+ E
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + H+G +VA+K + D+ + + + EV ++R +H ++VE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-DLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + S V + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA---------------------------MKRL 229
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R PP P + + P+ L+R++ +P++R TA+E L P+
Sbjct: 230 RDSPP-PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/300 (23%), Positives = 132/300 (44%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILR-EVKLLR 77
++ +++G+G++G V D TG ++A+K++ F+ + L E++LL+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L+H IV+ + R+ + + + E M + +KA LT + + Q+L
Sbjct: 60 NLQHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+PE+ Y D+WS+GC E+LT KP + + E +A
Sbjct: 175 SPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPW------------AEF------EAMA 214
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + +P P Q +V P A L+R + K RP+AEE L +
Sbjct: 215 AIFK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y+++EVIG G+ VV AAI EKVAIK+I D+ + + + +EV+ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK---ANDDLTREHHQFFLYQMLRA 138
++V+ S ++++V + L ++K L L ++L+
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRA 197
L+Y+H+ HRD+K NIL + +K+ DFG++ T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKSVVHQLDLITDLLGTPSPE 253
PE+ Y DIWS G E+ TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------TLQNDPP- 225
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T K F+K ++L L + DP RPTAEE L
Sbjct: 226 -----------SLETGADYKKYSKSFRKM-----ISLCLQK-----DPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 82/301 (27%), Positives = 133/301 (44%), Gaps = 58/301 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE +G+GSYG V AI TG+ VAIK + V E + + I++E+ +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
V+ S + D+++V E SD+ ++ N LT E LYQ L+ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLE 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-----RVAFSDTPMTVFWTDYVATRWY 195
Y+H+ HRD+K NIL N + K+ DFG++ +A +T + T ++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--------VIGTPFW 165
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y DIWS+G E+ GKP +
Sbjct: 166 MAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPY------------------------ 199
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + + KPP P P +++ + DP++RP+A + L P+
Sbjct: 200 ---SDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 316 F 316
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-R 80
++++EVIG+G+YG V A TG+ VAIK + + + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELME----SDLHQVIKANDDLTREHH-QFFLYQ 134
HP+I + + D +++V EL +DL + ++ +E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L Y+H V HRD+K +NIL N ++K+ DFG++ A D+ + T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNT-FIGTPY 178
Query: 195 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ APE C + Y D+WS+G E+ GKP
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI--HDVF-----EHISDAIRILREVKLLRLLRHPD 83
+G G +G V A+K + + EHI E ++L HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI------FSEKEILEECNHPF 54
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV++ R FKD ++ LME +L +++ +F++ ++ A
Sbjct: 55 IVKLYR--------TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H + +RDLKP+N+L ++N +K+ DFG A+ S WT + T Y APE
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPE 162
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ +K Y ++D WS+G + E+LTG+P F
Sbjct: 163 II---LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 9e-24
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + HTG++VA+KK+ D+ + + + EV ++R H ++V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRREL-LFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------------------FNEPPLQAMRRI 230
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328
R P P + V + L ++ +P R TA+E L P+ K+ PSC
Sbjct: 231 RDNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
Y+ LE+IG+G+YG V TG VA+K I+ + +SD I REV LL LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQLRQ 58
Query: 82 PDIVEIKR----IMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
I + + P ++++ E E + ++KA + ++ + ++L
Sbjct: 59 SQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
ALKY+H V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWM 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y DIWS+G E+ TG P + + LI
Sbjct: 169 APEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP------------ 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALA 312
+ KPP + D +LL+ +A +PK+R +AEE L
Sbjct: 216 --------------KSKPP-----RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK 254
Query: 313 DPYFKGLAKIER 324
+ K +K
Sbjct: 255 SKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-23
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
V+GKG+YG+V AA D T ++AIK+I + + E+ L L+H +IV +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV---Q 69
Query: 90 IMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQ---FFLYQMLRALKYM 142
+ S+ F I+ ME L ++++ +++ Q F+ Q+L LKY+
Sbjct: 70 YLGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 143 HTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H + HRD+K N+L N + +K+ DFG ++ P T +T T Y APE+
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y DIWS+GC E+ TGKP F + LG P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP----------- 217
Query: 262 KARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+A + M K P +P ++ A + R DP R +A + L DP+
Sbjct: 218 QAAMFKVGMFKIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + TG+ +A+K I I++AI+ ILRE+ +L P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
DI + E M+ L +++K E +L+ L Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 144 TA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ HRD+KP NIL N+ ++K+CDFG++ + T +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQ 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ DIWS+G E+ TG+ FP D I +LL +V NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQ-------YIV-NEP 220
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + FQ F N L + DP++RP+ +E L P+ K
Sbjct: 221 PPRLPSGKFSPD----FQDFVN------LCLIK----DPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH---------DVFEHISDAIRILREVKLLRLLR 80
+IG GS+G V ++ +GE +A+K++ D + DA+ RE+ LL+ L+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQ 64
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +IV+ L YV + + L+ + L R F+ Q+L+ L
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLN 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H + HRD+K NIL + +K+ DFG+++ +++ T T R P L
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP QL I + S
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENAS 229
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE P N+ A+ L++ D RPTA E L
Sbjct: 230 PE--------------------IP-------SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-23
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 55/300 (18%)
Query: 24 RYKILEVIGKGSYGVV--CAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLL 79
+Y+ + V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--KANDDLTREHHQFFLYQML 136
HP+I+E L E K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRW 194
AL ++HT + HRDLK +NIL + + +K+ DFG++++ S + TV V T
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPC 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y +PELC Y DIW++GC+ E+ + K F ++ + I GT +P
Sbjct: 167 YISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAP-- 220
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ +Y ++R +L+ ++ DP RP + +A P
Sbjct: 221 -------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-23
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A +G+ VA+KK+ D+ + + + EV ++R +H ++VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE K + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R P P + V P L RL+ DP R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
+ L K + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 IRYYESFLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +K+ D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y D+W++G + E TGK F + A++
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQG------------------ALILKI 213
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PPV Q + +L+ + + D + RP + L +P
Sbjct: 214 IRGVF-------PPVS--QMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-22
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G+G++G V K VA+K + + + + + L+E ++++ L HP++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE--DASEEERKDFLKEARVMKKLGHPNV 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN---------DDLTREHHQFFLYQ 134
V + + +Y+V E ME DL ++ + L+ + F Q
Sbjct: 59 VRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + ++Y+ + HRDL +N L + +K+ DFGL+R + D + RW
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 195 YRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
APE S +T D+WS G + E+ T L TP P
Sbjct: 174 M-APE---SLKDGIFTSKSDVWSFGVLLWEIFT-------------------LGATPYPG 210
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ NE+ +YL + + P P L+ DP+DRPT E
Sbjct: 211 ----LSNEEVLEYLRK-GYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-22
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y +L V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
IV K S +Y+V E + DL Q IK + + QM ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H V HRD+K KNI N K+K+ DFG AR+ S P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
+ Y DIWS+GCI E+ T K F S
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 61/303 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRH 81
+K+L+ +GKGSYG V + A+K++ +S R + E+++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR-----EHHQFFLYQM 135
P+I+ K L +K + +V E DL + I + E + F+ Q+
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +K+ D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y+ DIWS+GC+ E+ T P F +S
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------------------- 205
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEAL 311
+ ++R K K+P + P+ + LQ I PK RP ++ L
Sbjct: 206 -----------MQDLRYK---VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 85/318 (26%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++++ IG G+YG V A D TGE VAIK I D FE I I +L+E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------ 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQM 135
RHP+IV R K +++V E D++QV L+ + +
Sbjct: 58 RHPNIVA----YFGSYLRRDK-LWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRET 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFW 186
L+ L Y+H HRD+K NIL + +K+ DFG++ R +F TP +W
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YW 167
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
APE Y DIW++G E+ +P P +H +
Sbjct: 168 M---------APEVAAVERKGGYDGKCDIWALGITAIELAELQP--P-MFDLHPM----- 210
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPV--------PLFQKFPNVDPLALRLLQRLI 297
+A +++ PP P+F F +++ +
Sbjct: 211 ----------------RALFLISKSNFPPPKLKDKEKWSPVFHDF----------IKKCL 244
Query: 298 AFDPKDRPTAEEALADPY 315
DPK RPTA + L P+
Sbjct: 245 TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-22
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+I++ IG+GS+G + A E IK+I + + +EV LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY--QMLRALK 140
IV S +E +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
++H + HRD+K +NI + N + K+ DFG+AR +D+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+C + Y DIWS+GC+ E+ T K F G + +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
D + I +VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF---- 131
+ HP+I+ ++ ++ +K + + ++ E ME+ + D RE+ F
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENG------SLDKFLRENDGKFTVGQ 107
Query: 132 LYQMLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV--AFSDTPMT-- 183
L MLR +KY+ N HRDL +NIL N+N KV DFGL+R T T
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
++ ++ +G GS+G V +G+ A+K + EH+ + RIL+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
RHP +V L S ++ ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +K+ DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 50/301 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----ILREVKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ V S+ + +E++L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R++ + +++V E M L + + + + Q+LR L
Sbjct: 66 I---RMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCK-LKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L++ DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G +Y + D+WS+GC+ E+ T KP + + + L LI + +
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---- 229
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P P + + LR L+ P+DRP + E L P F
Sbjct: 230 -----------------PSIPEHLS-PGLRDVTLRCLEL----QPEDRPPSRELLKHPVF 267
Query: 317 K 317
+
Sbjct: 268 R 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRH 81
++IL +G+G YG V A TGE VA+K++ + +R +L E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLR 137
+V++ F+D ++ ME D ++ L+ +H +F++ +M
Sbjct: 61 EWLVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+ +H HRDLKP+N L +A+ +K+ DFGL++ + V DY+ A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y +D WS+GC+ E L G P F G + ET
Sbjct: 167 PEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---------------NETWEN 209
Query: 258 VRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALADPY 315
++ K E ++ P++ N+ A L+ +LI DP R + E+ P+
Sbjct: 210 LKYWK------ETLQR---PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259
Query: 316 FKGL 319
FK +
Sbjct: 260 FKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+GS+G G++ IK+I+ + +EV +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV S + + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
C + Y DIW++GC+ E+ T K F G + ++R
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEA--------------GNMKNLVLKIIRG 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
PPV ++ L +L +R +P+DRP+ L +
Sbjct: 217 S-----------YPPVSS-HYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 93/296 (31%), Positives = 130/296 (43%), Gaps = 56/296 (18%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
K P K +Y+V + E H + DL+R +F+ ++L AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
YT A+D W++G + E+LTG P F ++V NE R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 265 KYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR---PTAEEALADPYF 316
K L E PL +FP D A LL L++ DP R A+E P+F
Sbjct: 204 KILQE-------PL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 48/297 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y + V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRAL 139
+IV + + E +Y+V E DL+ +K +Q + Q+ AL
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H ++ HRDLK +N+ +KV D G+ARV + M + + T +Y +PE
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSPE 172
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L F +K Y D+W++GC E+ T K F K +
Sbjct: 173 L---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------------------- 207
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y K PP+P + P L+ +++ P+ RP+ + L PY
Sbjct: 208 ---NSLVYRIIEGKLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 69/250 (27%), Positives = 119/250 (47%), Gaps = 33/250 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIH--------DVFEHISDAIRILREVKL 75
Y +LE +G G++G V + G+ +A+K+I+ D E I+ EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--- 130
++ LRHP+IV + L E +Y+V +L+E + L + + L + +F
Sbjct: 62 IKEQLRHPNIVRYYKTFL-----ENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEE 113
Query: 131 ----FLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
QM+ AL+Y+H + HRDL P NI+ + K+ + DFGLA+ ++ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T Y PE+ + Y D+W+ GCI ++ T +P F +++ I +
Sbjct: 171 -TSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 246 LLGTPSPETI 255
+ P PE +
Sbjct: 228 AVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
DA+ KI +VIG G +G VC+ G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ + D R+H QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENG------SLDAFLRKHDGQFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
MLR +KY+ HRDL +NIL N+N KV DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 90/330 (27%), Positives = 142/330 (43%), Gaps = 72/330 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++++VIG+G++G V D TG+ A+K + SD I+ ++ +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-----SDMIK-RNQIAHVRAER-- 52
Query: 83 DI-VEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
DI + + F+D +Y+V E M DL ++ D E +F++ +++
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSDTP 181
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 182 MTVFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
+ V D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F ++ ET + N K + L F P V P A+
Sbjct: 230 FYSDTLQ---------------ETYNKIINWK--ESLR----------FPPDPPVSPEAI 262
Query: 291 RLLQRLIAFDPKDR-PTAEEALADPYFKGL 319
L+ RL+ DP+DR + EE + P+FKG+
Sbjct: 263 DLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-20
Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+I+ + I+ E+ +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
P+F+ F L R + D + R +A+E L P+ K L
Sbjct: 243 -----------------PIFRDF----------LNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 1e-19
Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAV- 244
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
F+ F L R + D R +A+E L P+ K L
Sbjct: 245 -------------------FRDF----------LNRCLEMDVDRRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 20 GDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
GD + Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQF--FLYQM 135
+HP+IV L +++VV E L L V+ + + Q +
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCREC 124
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRW 194
L+AL+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T +
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPY 180
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---S 251
+ APE+ Y P +DIWS+G + E++ G+P + ++ + L LI GTP +
Sbjct: 181 WMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE ++ +F+ F L R + D + R +A+E L
Sbjct: 238 PEKLS--------------------AIFRDF----------LNRCLEMDVEKRGSAKELL 267
Query: 312 ADPYFKGLAK 321
P+ K +AK
Sbjct: 268 QHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
+ ++ +G G++G V D + A+K I +V +H+ + R+L+EV
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
HP I+ L ++ + + +Y++ E + +L ++ + + F+ +++
Sbjct: 59 --SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ T WT T Y
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPEYL 165
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
APE+ S + A+D W++G + E+L G P F +
Sbjct: 166 APEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 3e-19
Identities = 66/239 (27%), Positives = 120/239 (50%), Gaps = 18/239 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVV 258
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRI 69
+ F++ + L IG GS+G V A D T E VAIKK+ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDL 123
++EV+ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
+ L+ L Y+H+ HRD+K NIL +K+ DFG A + +P
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 184 VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLF 231
F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+VIG G +G V I G K VAIK + + L E ++ H +I+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNII 69
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRA----LK 140
++ ++ +FK ++ E ME+ L + ++ +D E + L MLR +K
Sbjct: 70 RLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ N HRDL +NIL N+N + KV DFGL+RV D P + T + RW AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAP 179
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
E + K+T A D+WS G + EV++
Sbjct: 180 EAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
D + KI EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
+ HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTV 184
MLR +KY+ N HRDL +NIL N+N KV DFGL+R SD T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-19
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
D + L+ +G G +GVV H G+ VAIK I + D I E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ L HP++V++ + + + I++V E M + + + RE +
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMA---NGCLL---NYLRERKGKLGTEW 101
Query: 136 L--------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
L A++Y+ + HRDL +N L + +KV DFGLAR D + T
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ +W PE+ +S+++ D+WS G + EV + GK + S
Sbjct: 162 KF-PVKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 40/307 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
K+ + D F + + L IG GS+G V A ++HT E VA+KK+ + ++
Sbjct: 6 KDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 68 R-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKAN 120
+ I++EVK L+ L+HP+ +E K L K+ + + +ME SDL +V K
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYL-------KE-HTAWLVMEYCLGSASDLLEVHK-- 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A + +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---S 172
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ KP LF
Sbjct: 173 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 221
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L ++ + NE T+ + QK P P + LL+
Sbjct: 222 NMNAMSALYHIAQNDSPTLQSNE-----WTDSFRGFVDYCLQKIPQERPASAELLRH--D 274
Query: 299 FDPKDRP 305
F +DRP
Sbjct: 275 FVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 67/306 (21%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L+ I KG++G V A TG+ AIK + SD I +V ++ R
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIA-KNQVTNVKAER------- 47
Query: 88 KRIMLPPSKREF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQM 135
IM+ + + KD +Y+V E L D +IK L + + ++ ++
Sbjct: 48 -AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV 106
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ ++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDY 159
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + G D WS+GC+ E L G P F TP
Sbjct: 160 LAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD--- 199
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEAL 311
AV N +R+ P A+ L+ RL+ DP R A +E
Sbjct: 200 -AVFDNILSRRINWPEE---------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249
Query: 312 ADPYFK 317
+ P+FK
Sbjct: 250 SHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L +G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 88 KRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQ-MLRALKYM 142
L S I + E E +++ +K E + + +L+ L Y+
Sbjct: 65 YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ + HRD+KP NIL ++K+CDFG++ + T + T +Y APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQ 176
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
G Y+ D+WS+G EV + FP + G P I ++
Sbjct: 177 GK---PYSITSDVWSLGLTLLEVAQNRFPFPPE-------------GEPPLGPIELL--- 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALADPYFK 317
Y+ M P P + P + I DP RPT + L P+ K
Sbjct: 218 ---SYIVNM----PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
Query: 318 GLAKIE 323
K +
Sbjct: 271 AQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 53/328 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R+KIL ++G+G++G V A D E A+K + +V ++ DA +I E++ + +R D
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQAD 186
Query: 84 IVEIKRIMLPPSKREFKD----IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R L +R F++ + +V L I + + H ++Q AL
Sbjct: 187 PAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 140 KYMHTA-NVYHRDLKPKNILANAN----------------CKLKVCDFGLARVAFSDTPM 182
Y HT ++ H DLKP+NIL + C++++CD G D
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----GCCDERH 300
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+ T V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + L L
Sbjct: 301 SR--TAIVSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356
Query: 243 ITDLLGTPSPETIAVVRNEKAR---------------KYLTEMRKKPPVPLFQKFPNVDP 287
+ LG E E+AR K+L + + PV + D
Sbjct: 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR----DD 412
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPY 315
L L+ L+ +D + R A + PY
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-------DAIRILREVKLL 76
RY + + +GKGS+G V D + +K V + I + ++ +E +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK----VLKEIPVGELNPNETVQANQEAQLL 56
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFF 131
L HP IV+ L E ++ E E L ++ L+ +
Sbjct: 57 SKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+L + YMH + HRDLK KNI N LK+ DFG++R+ + T +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTG 167
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GCI E+ F G++ L ++ ++ P+
Sbjct: 168 TPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT 222
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEA 310
P P L ++Q ++ DP RP+A E
Sbjct: 223 PS----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
Query: 311 LADPY 315
L +P+
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 31 IGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D I E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ + + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +KV DFG+ R D + + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
FSKY+ D+WS G + EV T GK F KS +++I+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 9e-18
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRILREVKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ +V + ++ EV LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V+ L + I + E + + ++ L + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTPMTVFWTDYVATRWY 195
V HRD+K N++ N +K+ DFG AR S+ ++ T Y +
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY-----W 174
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWSIGC E+ TGKP
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-18
Identities = 66/200 (33%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 47 TGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105
TG +VAIK + D E R RE L L HP+IV +L + ++ V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLFAV 57
Query: 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANA 161
FE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 162 NCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWS 216
KV DFG+ V +D T+ + T Y APE L G TP D+++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDLYA 174
Query: 217 IGCIFAEVLTGKPLFPGKSV 236
G IF E LTG+ + G SV
Sbjct: 175 WGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A + VA+KK+ +FE + R ++E+ LL+ L HP
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL Q+I K L E + + Q+
Sbjct: 63 NVIKYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEV 224
PE + Y DIWS+GC+ E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ + E + + E++LL+ L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
IV+ + P +R + E M + +K+ LT + + Q+L +
Sbjct: 64 ERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYR 196
Y+H+ + HRD+K NIL ++ +K+ DFG ++ + S T M T ++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM----KSVTGTPYWM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+PE+ Y DIWS+GC E+LT KP
Sbjct: 177 SPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 18/241 (7%)
Query: 28 LEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
L+V+G+GS+G +V G+ A+K + + D +R E +L + HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V++ K +Y++ + + DL + T E +F+L ++ AL ++H
Sbjct: 61 VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL + +K+ DFGL++ + + T Y APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTP---SPETIAVVR 259
+T + D WS G + E+LTG F GK + +I LG P SPE +++R
Sbjct: 173 --RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
Query: 260 N 260
Sbjct: 231 A 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + E++LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV+ + P +++ I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRA 197
+H+ + HRD+K NIL ++ +K+ DFG ++ + S T + T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----KSVTGTPYWMS 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
PE+ Y D+WS+ C E+LT KP
Sbjct: 178 PEVISG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 26 KILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HD-VFEHISDAIRILREVKLLRLL 79
K ++ +G+G +G V + +TGE+VA+K + H +H SD RE+++LR L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTL 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQM 135
H +IV+ K + P R + ++ E + S D Q + +L R F Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRL--LLFSSQI 118
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVATRW 194
+ + Y+ + HRDL +NIL + +K+ DFGLA+V V W
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE C SK++ A D+WS G E+ T
Sbjct: 179 Y-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 105/353 (29%), Positives = 161/353 (45%), Gaps = 69/353 (19%)
Query: 10 LKDKD----FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
LKD + FF E D + + L IG GS+G V A D T E VAIKK+ + +
Sbjct: 9 LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 65 DAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKAN 120
+ + I++EVK L+ ++HP+ +E K L RE ++V E SDL +V K
Sbjct: 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK-- 119
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A +A +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---S 176
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 177 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 225
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L E+ + NE + F+ F VD LQ++
Sbjct: 226 NMNAMSALYHIAQNESPTLQSNEWS-------------DYFRNF--VD----SCLQKI-- 264
Query: 299 FDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
P+DRPT+EE L K + + P I ++ TKD +REL
Sbjct: 265 --PQDRPTSEELL-----KHMFVLRERPETVLIDLIQ-------RTKDAVREL 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILR 71
F + D ++ ++I+E IGKG+YG V ++ G K A+K IHD+ E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + + +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-17
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 49/296 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + E++LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFG----LARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ HRD+K NIL ++ +K+ DFG L + S T + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI----RSVTGTPYWMSPEV 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETIAVVR 259
Y D+WS+GC E+LT KP + +++ + T P I+
Sbjct: 181 ISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS--- 235
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E AR +L I + + RP+AEE L P+
Sbjct: 236 -EHARDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + +G +A K IH E I AIR I+RE+K+L P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+I + E M+ L QV+K + +LR L Y+
Sbjct: 63 GFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL N+ ++K+CDFG+ S + +V TR Y +PE L G
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 ---THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L HP
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL ++I K L E + + Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
AL++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
PE + Y DIWS+GC+ E+ + F G
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 26 KILEVIGKGSYGVV--CA--AIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K ++ +GKG++G V C + +TGE VA+KK+ H EH+ D RE+++L+ L+
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLY--QMLR 137
H +IV+ K + +R + +V E L L ++ + + +H + LY Q+ +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICK 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR---- 193
++Y+ + HRDL +NIL + ++K+ DFGL +V D +Y R
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGE 172
Query: 194 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 173 SPIFWY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 31/239 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPD 83
+ + +G G +G V + +VAIK + D D +EV+ L+ LRH
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
++ + + + +Y++ ELME L +++ + L Q+ +
Sbjct: 64 LISLFAVC-----SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARV------AFSDTPMTVFWTDYVATRW 194
Y+ N HRDL +NIL + KV DFGLAR+ SD + WT
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG + D IT P P
Sbjct: 172 --APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
L IG GS+G V A D E VAIKK+ + ++ + I++EV+ L+ LRHP+ ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 87 IKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ L RE + + +ME SDL +V K L + L+ L
Sbjct: 80 YRGCYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAEVLTGKP 229
+ +Y +D+WS+G E+ KP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKL 75
+ +++ IG G +G+V G KVAIK I + D I E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKAND-DLTREHHQFFLY 133
+ L HP +V++ + E I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +KV DFG+ R D + T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26 KILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
V++ + S+ E IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARV-------AFSDTPMTVFWTDYVATRW 194
+ + N HRDL +NIL N K+ DFGLAR+ A + WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 40/312 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE G+ G A ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV------VHQLDLITDLLGT-PSPETI 255
Y PA+DIWS G + E+ T LF + Q+ LI GT P+ I
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 256 ---AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAE--- 308
A + RK PL+ + P+ L L+ +++AFD RP+AE
Sbjct: 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-PIDLEYLICKMLAFDAHHRPSAEALL 374
Query: 309 -----EALADPY 315
+ + DPY
Sbjct: 375 DFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREV 73
+++L+V+G G+YG +V TG +K A+ + EH +L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+ + P +V + +K YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL+++H + +RD+K +NIL ++ + + DFGL++ S+ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAE 308
T+ RN ++ ++ PP P + P A LL +L+ DPK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
++I+E IGKG+YG V + G A+K I DV E I IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQML 136
P++V+ + K +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L+++H + HRD+K NIL +K+ DFG V+ T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+++ E +G GS+G V A TGE AIK K ++ + + + +E +L L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + ++ F +VV + + L + + +D+ + F+ +++ A +Y+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK----FYHAELVLAFEYL 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +KV DFG A+ D T+ T Y APE+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTL-----CGTPEYLAPEVIQ 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 189 S--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 72/306 (23%), Positives = 136/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKILEVIGKGSYGVV--CAAIDTH-TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
+++L+V+G G+YG V + H +G+ A+K K + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
R P +V + +K Y+ + + L Q + + Q + +++ A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ + A+D WS+G + E+LTG SP T+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGA----------------------SPFTVDGE 213
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALAD 313
+N +A ++ +PP P + LA ++QRL+ DPK R P+ A+E
Sbjct: 214 KNSQAEISRRILKSEPPYP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 46/299 (15%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIV 85
++E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM----LRALKY 141
+ RE D+++ E+M++ L + K D + L ++ ++AL+Y
Sbjct: 64 TFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 142 MHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H+ +V HRD+KP N+L N N ++K+CDFG++ T+ + Y APE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPER 174
Query: 201 CGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ Y D+WS+G E+ TG+ FP S + ++ PSP
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP------ 226
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ + P FQ F N + L++ + K+RP E L P+F+
Sbjct: 227 ----------QLPAEKFSPEFQDFVN------KCLKK----NYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T E VAIK I E D I I +E+ +L P I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266
Y DIWS+G E+ G+P S +H + ++ L+ SP T
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPT------------ 220
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L KP F++F ++ + DP+ RPTA+E L
Sbjct: 221 LEGQYSKP----FKEF----------VEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 28 LEVIGKGSYGVVCAAIDTH---TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
L+V+GKG YG V TG+ A+K K + + D E +L ++HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV++ K +Y++ E L +L ++ + F+L ++ AL++
Sbjct: 61 FIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + +RDLKP+NIL +A +K+ DFGL + + + +T + T Y APE+
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEIL 172
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
S + A+D WS+G + ++LTG P F ++ +D I
Sbjct: 173 MR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 72/309 (23%), Positives = 132/309 (42%), Gaps = 52/309 (16%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDV--------FEHISDAIRILREV 73
+++L V+G G+YG +V G+ A+K + EH R R+V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT----RTERQV 57
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
L + R P +V + +K YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL ++H + +RD+K +NIL ++ + + DFGL++ ++ + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEA 310
T+ +N ++ ++ KPP P + A +Q+L+ DPK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 53/303 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + +G G+ G V TG +A K +H + S +ILRE++++ R P IV
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
L + +I + E M+ L ++ K + E ++ L Y++
Sbjct: 67 SFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 145 AN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRD+KP NIL N+ ++K+CDFG++ + T +V T Y +PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG 176
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFP-------GKSVVHQ---LDLITDLLGTPSPE 253
KYT D+WS+G E+ GK FP LDL+ ++ P P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ P FP + + DP +RPT ++ A
Sbjct: 232 ------------------RLPS----SDFP---EDLRDFVDACLLKDPTERPTPQQLCAM 266
Query: 314 PYF 316
P F
Sbjct: 267 PPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A SDT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
Y +D W +G + E+L G P F + V D I
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+K S D+Y+V + M +L ++ + + +F++ +++ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ +D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D +R I RE+++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL----YQMLRALKYMHT 144
+ +I V+ E M+ + + T + FL Q+L + Y+H
Sbjct: 139 DMF-----DHNGEIQVLLEFMD-------GGSLEGTHIADEQFLADVARQILSGIAYLHR 186
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPE---- 199
++ HRD+KP N+L N+ +K+ DFG++R+ A + P V T Y +PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC----NSSVGTIAYMSPERINT 242
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
L + Y A DIWS+G E G+ FP
Sbjct: 243 DLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 61/299 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++L +G G +G V + +T VA+K + D L E ++++ LR
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLR 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--FLYQMLR 137
HP ++++ + + E IY+V ELM+ L + ++ + Q Q+
Sbjct: 60 HPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDYV 190
+ Y+ N HRDL +N+L N KV DFGLARV D + WT
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT--- 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249
APE + +++++ D+WS G + E++T G+ +PG + L +
Sbjct: 172 ------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P P P L+ ++ DP DRPT E
Sbjct: 224 PCPPGC-------------------PKELYD-----------IMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 61/294 (20%)
Query: 29 EVIGKGSYGVVCAAIDT-HTGEKVAIK-KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
IG+G +G V + EK+A+ K S + L+E ++R HP IV+
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 87 -IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMH 143
I I P +++V EL +L ++ N L + YQ+ AL Y+
Sbjct: 72 LIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR------WYRA 197
+ HRD+ +N+L ++ +K+ DFGL+R D + Y A++ W A
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDE------SYYKASKGKLPIKWM-A 176
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE F ++T A D+W G E+L KP G + + I
Sbjct: 177 PESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNNDVI 218
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ N ++ P+P PN P L+ + A+DP RP E
Sbjct: 219 GRIENG----------ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ IGKG +G V + G+KVA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELME---------SDLHQVIKANDDLTREHHQFFLYQML 136
++ ++L + +Y+V E M S VI T F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVC 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---TPMTVFWTDYVATR 193
++Y+ N HRDL +N+L + + KV DFGLA+ A + V WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVV 237
APE K++ D+WS G + E+ + G+ P P K VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L L ++L+ L Y+H+
Sbjct: 67 YYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + + ++K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 42/221 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E+IG+G +G V +TG+KVA+K I DV A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLR-------AL 139
++L +Y+V ELM + +L ++ TR + Q+L+ +
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGM 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTVFWTDYVATRWYR 196
+Y+ + + HRDL +NIL + + KV DFGLARV ++ + V WT
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------- 164
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
APE K++ D+WS G + EV + G+ +P S+
Sbjct: 165 APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 27 ILEVIGKGSYGVV-----CAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ +G+G++G V + E VA+K + + +DA + RE +LL +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------DLTR 125
H +IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 67 HENIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+ + Y+ + + HRDL +N L + +K+ DFG++R V+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVY 173
Query: 186 WTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 174 TTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 84/273 (30%), Positives = 124/273 (45%), Gaps = 43/273 (15%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF +I E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------ERISE-LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
E +LR L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVELAIGRYPIPPPDA--KELEA 212
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP 275
I G P VV E+ + R +PP
Sbjct: 213 I---FGRP------VVDGEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 60/307 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL--- 79
++ L V+G+G +G V A TGE AIK K D+ D + L K +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANS 58
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
RHP +V + + V E DL I D + F+ ++
Sbjct: 59 ERHPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWY 195
L+Y+H + +RDLK N+L + +K+ DFGL + + F D T + T +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEF 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ + YT A+D W +G + E+L G+ FPG D
Sbjct: 168 LAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEA 310
++V +E + +F + + A+ +++RL+ +P+ R AE+
Sbjct: 212 SIVNDE---------------VRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDV 254
Query: 311 LADPYFK 317
P+F+
Sbjct: 255 KKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF KI E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------EKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+ +++ L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTE-MRKKPPVPLFQ 280
+ G P+ + R + +PP+ +F+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFE 253
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 78/313 (24%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +++ + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKRIMLPPSKREFKDIY-VVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ + D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-------GKPLFPGKSVV----HQLDLITDLLGTP- 250
KY DIWS G + E+L P P + V H L +I+ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 251 ----SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
P + + E + P FQ+ N+ L+ +++ FD RP+
Sbjct: 288 EFPRDPGS--RLVRGFIEYASLERQPYTRYPCFQRV-NLPIDGEFLVHKMLTFDAAMRPS 344
Query: 307 AEEALADPYFKGL 319
AEE L P F L
Sbjct: 345 AEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK--------LLRLLRH 81
VIGKGS+G V A G+ A+K + AI +E K LL+ ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHH------QFFL 132
P +V + K +Y V + + E H L RE +F+
Sbjct: 56 PFLVGLHYSFQTADK-----LYFVLDYVNGGELFFH--------LQRERSFPEPRARFYA 102
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYV 190
++ AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + S T T +
Sbjct: 103 AEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FC 157
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T Y APE+ Y +D W +G + E+L G P F + D I
Sbjct: 158 GTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 57/291 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR----ALK 140
+ + + + + IY+V EL+ S L + K + LT + L QM ++
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK----LLQMSLDAAAGME 107
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + N HRDL +N L N LK+ DFG++R + +W APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA 166
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ +YT D+WS G + E + G +PG S
Sbjct: 167 LN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS------------------------ 200
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N++ R+ + + P P + P + RL+ + A+DP++RP+ E
Sbjct: 201 NQQTRERIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSE 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD---VFEHISDAIRILREVKLLRLLRHPDIV 85
+VIGKGS+G V A G A+K + + + + I R V LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ K +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 60 GLHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPETIAV 257
Y +D W +G + E+L G P F + V D ++ L P +T+A
Sbjct: 171 -EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 81/312 (25%), Positives = 140/312 (44%), Gaps = 59/312 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLRLLRHPD 83
++I++VIG+G++G V A + E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFLYQMLRA 138
I + F+D ++ +M+ DL ++ K D L + +F++ +M+ A
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP N+L + N +++ DFG D TV + V T Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 199 ELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ + KY P D WS+G E+L G+ F +S+V ET
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 217
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP----NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ N + R FQ FP +V A L+QRLI ++R + +
Sbjct: 218 GKIMNHEER--------------FQ-FPSHITDVSEEAKDLIQRLIC--SRERRLGQNGI 260
Query: 312 AD----PYFKGL 319
D +F+G+
Sbjct: 261 EDFKKHAFFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIQQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 9e-14
Identities = 73/315 (23%), Positives = 124/315 (39%), Gaps = 61/315 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+L+ +GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVD 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMES---------DLHQVIKANDDLTREHHQFFLYQMLR 137
+Y+ E M++ + D L R + + + L+
Sbjct: 64 FYGAFFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLK 116
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
LK H N+ HRD+KP N+L N N ++K+CDFG++ + T + + Y A
Sbjct: 117 FLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-----NIGCQSYMA 169
Query: 198 PE----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDLLGTP 250
PE + YT D+WS+G E+ G+ +P + ++ QL I D G P
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +P A + + + P RPT +
Sbjct: 228 -----------------------PTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
Query: 311 LADPYFKGLAKIERE 325
L P+ + +
Sbjct: 260 LEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y +++VIG+G++G V + + +KV K+ FE I SD+ E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ + HRD+KP N+L + + LK+ DFG + +T M V V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM-VRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+ S Y D WS+G E+L G F S+V I D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 84/328 (25%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N Y++++ IG G +G V T E K I + +++ EV ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIK------------ANDDLTREHH 128
+IV I R + +++ +Y++ E ++ DL + I+ A D+TR
Sbjct: 73 NIVRYIDRFLNKANQK----LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR--- 125
Query: 129 QFFLYQMLRALKYMHT-------ANVYHRDLKPKNILANANCK----------------- 164
Q+L AL Y H V HRDLKP+NI + +
Sbjct: 126 -----QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
K+ DFGL++ + + V T +Y +PEL Y D+W++GCI E+
Sbjct: 181 AKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+GK F + QL ++E+++ P +P+ K
Sbjct: 237 CSGKTPFHKANNFSQL--------------------------ISELKRGPDLPIKGKSKE 270
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ L++ L+ K+RP+A + L
Sbjct: 271 LN----ILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 63/306 (20%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLRH 81
+GKG +G VCA TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRA 138
IV + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y ++D +++GC E++ G+ F +
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQR------------------------ 197
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + ++ L + V KF P A L + L+ DP+ R +A+E
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254
Query: 314 PYFKGL 319
P FK L
Sbjct: 255 PLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A TG A K I + E + D + E+ +L +HP+
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPN 63
Query: 84 IVEIKRIMLPPSKR----EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV + +K EF D + +M + LT ++ QML AL
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEAL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAP 198
++H+ V HRDLK NIL + +K+ DFG+ A+ + F + T ++ AP
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF----IGTPYWMAP 172
Query: 199 EL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ C +F Y DIWS+G E+ +P P ++ + ++ +L + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTL- 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
++ K+ + F F L+ + DP DRPTA E L P+
Sbjct: 229 -----DQPSKWSSS---------FNDF----------LKSCLVKDPDDRPTAAELLKHPF 264
Query: 316 F 316
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRL 78
D N + L IG G+ G V TG +A+K++ E RIL ++ ++ L
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-L 68
Query: 79 LRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF----- 131
H P IV+ + S D+++ ELM + L D L +
Sbjct: 69 KSHDCPYIVKCYGYFITDS-----DVFICMELMSTCL-------DKLLKRIQGPIPEDIL 116
Query: 132 ---LYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
+++AL Y+ V HRD+KP NIL +A+ +K+CDFG++
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLV 166
Query: 188 DYVA-TR-----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
D A TR Y APE KY D+WS+G E+ TG+ FP K+ +
Sbjct: 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTE 224
Query: 240 LDLITDLLGTPSPE 253
+++T +L P
Sbjct: 225 FEVLTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V A + +KV KI + +E + A E R R +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRA-----ETACFREERDV-L 55
Query: 85 VEIKRIMLPPSKREFKD---IYVVFEL-MESDLHQVI-KANDDLTREHHQFFLYQMLRAL 139
V + F+D +Y+V + + DL ++ K D L + +F+L +M+ A+
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+KP NIL + N +++ DFG D TV + V T Y +PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 200 LCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ + KY P D WS+G E+L G+ F +S+V
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
+V+GKGS+G V A T E AIK + DV D + E ++L L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP---- 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
L F+ +F +ME DL I+ + +F+ ++ AL ++
Sbjct: 57 ----FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V +RDLK NIL +A K+ DFG+ + + T T + T Y APE+
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQ 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+Y P++D W++G + E++ G+P F
Sbjct: 170 EL--EYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 86/324 (26%), Positives = 137/324 (42%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY I+ +IGKG G V A D +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ-----FFL---YQ 134
IV + I + Y+ ++S L V + + L++E + FL ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK-ESLSKELAEKTSVGAFLSIFHK 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTP----- 181
+ ++Y+H+ V HRDLKP NIL ++ + D+G A + D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 182 ---MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
MT+ V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 182 YSSMTIP-GKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FP----- 230
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
R +K RK P+ + + + P ++ + +
Sbjct: 231 --------------------YRRKKGRKISYRDVILSPIEV-APYREIPPFLSQIAMKAL 269
Query: 298 AFDPKDRPTAEEALAD---PYFKG 318
A DP +R ++ + L P+ +G
Sbjct: 270 AVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 62/250 (24%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFE-----HISDAIRILREVKLLRLLR 80
++VIG+G++G V TG A+KK+ ++ E H+ IL E
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------ 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
+P +V++ F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 60 NPWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL----------------------AR 174
A+ +H HRD+KP N+L +A +K+ DFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 175 VAFSDTPMT-------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ F PM+ V T Y APE+ + Y D WS+G I
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIM 229
Query: 222 AEVLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCAA--IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMH 143
+ I LP E + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +KV DFGLAR ++ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 15/218 (6%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHH 128
L+E ++++ LRH +V++ ++ + IY+V E M + L +K
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 129 QF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q Q+ + Y+ N HRDL+ NIL N KV DFGLAR+ D T
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 161
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE + + ++T D+WS G + E+ T G+ +PG LD +
Sbjct: 162 GAKFPIKW-TAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 246 LLGTPSP-ETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
P P E + + + + E ++P Q F
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 66/342 (19%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISD---------------A 66
+++++ + G++G +CA + T E A + ++ + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH-----QVIKAND 121
I++ E+ L L H +I++I+ I+ + + Y++ + + DL+ + D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
+ + + Q+L A++Y+H + HRD+K +NI N + K+ + DFG A + F +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF-EKE 320
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
F +V T +PE+ Y DIWS G I ++L+ H
Sbjct: 321 REAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLS-----------HDFC 367
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---------NVDPLALRL 292
I D G P + + ++ + E PP LF +V PL L
Sbjct: 368 PIGDGGGKPGKQLLKIID---SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424
Query: 293 ---------LQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
L +++ FD RP A E LA P F A+ E E
Sbjct: 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 26/236 (11%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
+ L D D A ++++EV+G G+YG V TG+ AIK + DV E + I
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 68 RILREVKLLRLLRHPDIVE------IKRIMLPPSKREFKDIYVVFELME----SDLHQVI 117
++ E+ +L+ H + IK+ PP + +++V E +DL +
Sbjct: 60 KL--EINMLKKYSHHRNIATYYGAFIKKS--PPGHDD--QLWLVMEFCGAGSVTDLVKNT 113
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K N L + + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 114 KGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---- 168
Query: 178 SDTPMTVFWTD-YVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ TV + ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRH 81
+ + ++G+G +G V + TG+ A+K + + + E + +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQML 136
P +P + F+D +Y+V E DL ++ +D E QF+L +++
Sbjct: 61 P--------WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
A+ +H HRD+KP+N+L + +K+ DFG A A V V T Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYI 170
Query: 197 APELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
APE+ G Y D WS+G I E++ G+ F +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 26 KILEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ + +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
V++ ++ +E IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ N HRDL+ NIL +A+ K+ DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
F +T D+WS G + E++T G+ +PG S
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K + F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +K+ DFGL + +D + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y A+D W +G + E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 80/333 (24%), Positives = 136/333 (40%), Gaps = 78/333 (23%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD--AIRILREVKLLRLLRH 81
+K ++++GKG G V TG+ A+K + D E I R+L E ++L L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLYQMLRA 138
P + L S + + +V + +L ++++ L+ E +F+ ++L A
Sbjct: 61 PFLPT-----LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM---------------- 182
L+Y+H + +RDLKP+NIL + + + + DF L++ + + P
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 183 ---------TVFWT-DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
F + +V T Y APE+ G + A+D W++G + E+L G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTT 230
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
F G + R+E L KK F P V A
Sbjct: 231 PFKGSN-----------------------RDETFSNIL----KKE--VTFPGSPPVSSSA 261
Query: 290 LRLLQRLIAFDPKDR----PTAEEALADPYFKG 318
L+++L+ DP R A E P+F+G
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVE 86
L IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKRIMLPPSKREFK--DIYVVFELMESDLHQVIK-ANDDLTREHHQFFL----YQMLRAL 139
+ F+ D ++ ELM+ L + K + L + L ++AL
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 140 KYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL + N +K+CDFG++ T D R Y AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR---D-AGCRPYMAP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQL 240
E + S Y D+WS+G EV TGK +P SV QL
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +K+ DFG+ + T + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y PA+D W++G + E+L G+ F G
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 72/313 (23%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 30 VIGKGSYG--VVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVE 86
+IGK +V A T VA+KKI+ D D + +E+ R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH---------QFFLYQMLR 137
+ S ++YVV LM + +DL + H F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS----DTPMTVFWTDYVATR 193
AL Y+H+ HR +K +IL + + K+ + + + F V
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS-- 251
+ +PE+ Y DI+S+G E+ G P K + L+ + GT
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCL 230
Query: 252 ------PETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDR 304
P + ++ R P + F + LQR DP+ R
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR----DPESR 286
Query: 305 PTAEEALADPYFK 317
P+A + L +FK
Sbjct: 287 PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 93 PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +K+CDFGLAR D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIV 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ P + ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + T + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLF 231
Y P++D W++G + E+L G F
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H N E F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + +++ D GLA + P V T Y AP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W +GC+ E++ GK F
Sbjct: 171 EVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQ------------------------- 203
Query: 259 RNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
R EK ++ E R K+ +KF A + ++L+ DP R AEE A
Sbjct: 204 RKEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 313 DPYFKGL 319
P+F+
Sbjct: 261 HPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 82/317 (25%)
Query: 26 KILEVIGKGSYGVV---CAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+GS+G+V A + +VAIK +++ + + I L E +++
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 81 HPDIVEIKRIML---PPSKREFKDIYVVFELM-ESDLHQVIKA---NDD-------LTRE 126
+V + ++ P VV ELM + DL +++ + T +
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 127 HHQFFLY--QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+F ++ + Y+ HRDL +N + + +K+ DFG+ R +
Sbjct: 120 --KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ TDY + RW APE +T D+WS G + E+ T + + G S
Sbjct: 170 YETDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295
L + D PE P L L L++
Sbjct: 227 NEEVLKFVIDGGHLDLPEN-------------------CPDKL-----------LELMRM 256
Query: 296 LIAFDPKDRPTAEEALA 312
++PK RPT E ++
Sbjct: 257 CWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 87/351 (24%), Positives = 150/351 (42%), Gaps = 54/351 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
KD T A +Y I V+G G+ G V A GE A+K + +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTR--- 125
V L IV+ R +++ ++ +++ DL Q IK+ R
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHHQFFLY-QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
EH L+ Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ ++ T
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDD 200
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244
+ T +Y APE+ Y+ D++S+G + E+LT K F G+++
Sbjct: 201 VGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------ 252
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304
V+ A +Y P+P P++ P ++ L++ DPK R
Sbjct: 253 ------------VMHKTLAGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADP----YFKGLAKI-EREPSCQPISKLEFEFERRRVTKDDIRE 350
P++ + L P + GL +I + +P F R I++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPG--------FSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+L+ IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDD--LTREHHQFFLYQMLRALKYM 142
++ +++ E +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DT-PMTVFWTDYVATRWYRAPE 199
N HRDL +N+L + + KV DFGL + A S DT + V WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVVHQLD 241
K++ D+WS G + E+ + G+ P P K VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V + KVA+K + + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--DLTREHHQFFLYQMLRALKYM 142
+ ++ +K E IY++ E M + L +K+++ + F Q+ + Y+
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ N+L + + K+ DFGLARV D T +W APE
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAIN 177
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
F +T D+WS G + E++T GK +PG S + + P E
Sbjct: 178 --FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+G G YG V + VA+K + + D + + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQ- 66
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHT 144
+L RE Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 67 ---LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELC 201
N HRDL +N L N +KV DFGL+R+ DT +T + ++ + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPE-- 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243
++K++ D+W+ G + E+ T G +PG + +L+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+ F G+
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++++ +G G+YG V A + HTGE A+K I E D I +E+ +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y DIW++G E+ +P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 57/267 (21%), Positives = 104/267 (38%), Gaps = 57/267 (21%)
Query: 50 KVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
+VA+K + EHI + LRE ++ L HP IV + + + +V EL
Sbjct: 25 EVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP------LMLVMEL 76
Query: 109 ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
L + +K ++ + +Q+ + Y+ + + HRDL +N+L + K+
Sbjct: 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKI 136
Query: 168 CDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCI 220
DFG++R + + Y AT +WY APE C ++ K++ D+WS G
Sbjct: 137 SDFGMSRALGAGS------DYYRATTAGRWPLKWY-APE-CINYG-KFSSKSDVWSYGVT 187
Query: 221 FAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF 279
E + G + + ++ P PE + P ++
Sbjct: 188 LWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE-------------------ECPQEIY 228
Query: 280 QKFPNVDPLALRLLQRLIAFDPKDRPT 306
++ + P+DRPT
Sbjct: 229 S-----------IMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 48/286 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + I+ L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ ++R+ IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LK+ DFG++R D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+Y+ D+WS G + E + G +PG + N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMT------------------------NQQAR 204
Query: 265 KYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + + R P QK P+ +++QR + P++RP E
Sbjct: 205 EQVEKGYRMSCP----QKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 38/293 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+++++ IG G+YG V A + +TGE AIK I E D + +E+ +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIW++G E+ +P + L L+T P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + F + +AL +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMAL-------TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 61/251 (24%), Positives = 120/251 (47%), Gaps = 21/251 (8%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K S + + V E +L + + + +F+ +++ AL Y+H+ +
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + + +K+ DFGL + SD + T Y APE+ +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
Y A+D W +G + E++ G+ F + + +L L+ ++ P T++ +A+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLS----PEAK 223
Query: 265 KYLTEMRKKPP 275
L + KK P
Sbjct: 224 SLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + +G G++G V A + KVA+K + H S+ ++ E+K++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMS 93
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLY 133
L H +IV L + I V+ E DL ++ + LT E F Y
Sbjct: 94 HLGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+ + + ++ + N HRDL +N+L +K+CDFGLAR +D+ V + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
W APE F YT D+WS G + E+ + G +PG
Sbjct: 209 WM-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
E IG+G++G V + VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRL- 58
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR-------ALKY 141
I + K+ IY+V EL++ L E + + ++++ ++Y
Sbjct: 59 -IGVCTQKQP---IYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LK+ DFG++R + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ R+ + + + P P + P A+ RL++R +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A K++ + L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES---DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+V + E KD + +V +M H N E F+ ++L L
Sbjct: 62 VVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ +H N +RDLKP+NIL + +++ D GLA P V T Y APE
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPE 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ + +YT + D W +GC+ E++ G+ F G+
Sbjct: 172 VLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 28 LEV-IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
L+V +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 87 IKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMH 143
+ ++ + IY+V E M + L +K D + Q Q+ + Y+
Sbjct: 66 LYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N HRDL+ NIL N K+ DFGLAR+ D T +W APE +
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AA 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ +G G +G V KVA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ S+ IY+V E M + L +K + + Q+ + Y+
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ NIL K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103
+TGE+VA+K K HI+D + +E+++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRALKYMHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++K+ DFGL + +D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +K+CDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPG 233
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRL 78
A ++++E++G G+YG V TG+ AIK + D E I I +L++ R
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQ 134
+ IK+ PP + +++V E +DL + K N L E + +
Sbjct: 65 IATYYGAFIKKN--PPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICRE 119
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATR 193
+LR L ++H V HRD+K +N+L N ++K+ DFG++ + TV + ++ T
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ +A +K+ DFG+ + T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y ++D W+ G + E+L G+P F G
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K + F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFF 205
V +RD+K +N++ + + +K+ DFGL + SD M F T Y APE+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLAPEVLED-- 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN--EKA 263
+ Y A+D W +G + E++ G+ F + +LI E I R +A
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLSPEA 222
Query: 264 RKYLTEMRKKPP 275
+ L + KK P
Sbjct: 223 KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+VIGKGS+G V A H E+ A+++L++ +L+ I+ +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFY------------AVKVLQKKAILKKKEEKHIMSER 46
Query: 89 RIMLPPSKREF-----------KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
++L K F +Y V + + +L ++ +F+ ++
Sbjct: 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYL 163
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
APE+ Y +D W +G + E+L G P F ++ D I
Sbjct: 164 APEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY-------QMLR 137
+ ++ + IY++ E ME+ L +K T E + + Q+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ D T +W A
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKW-TA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
PE + +T D+WS G + E++T G+ +PG
Sbjct: 172 PEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCAAI-DTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSD-----TPMTVFWTDYVATRWYRAPELCG 202
HRDL +N+L K+ DFGL++ +D W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 35/214 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G GS+GVV + +G K VA+K + + +SD + L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ + ++L + +V EL L + + ++ + Q+ +
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANGM 110
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--- 196
+Y+ + HRDL +NIL ++ K+K+ DFGL R A D+ +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN------EDHYVMEEHLKVP 163
Query: 197 ----APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 164 FAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEH 62
+ K++ K K Y D N + +G GS+G V+ A VAIK+ FE
Sbjct: 19 KEPKRKNKMK-----YEDFN---FIRTLGTGSFGRVILATYKNEDFPPVAIKR----FEK 66
Query: 63 ISDAIR------ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFE-LMESD 112
S I+ + E K+L + HP V + FKD +Y+V E ++ +
Sbjct: 67 -SKIIKQKQVDHVFSERKILNYINHPFCVNLYG--------SFKDESYLYLVLEFVIGGE 117
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
A+V + T T Y APE+ + + A D W++G E+L G P F
Sbjct: 178 AKVVDTRT------YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 75/328 (22%), Positives = 141/328 (42%), Gaps = 34/328 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L + + + ++ V E + DL I+++ +F+ +++ L+++H
Sbjct: 61 ----LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + + +K+ DFG+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR-- 264
KY ++D WS G + E+L G+ F G+ E + N++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED---------------EDELFDSILNDRPHFP 216
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324
+++++ K LF++ P +++ F D E+ P FK K++
Sbjct: 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFK--PKVKS 274
Query: 325 EPSCQPISKLEFEFERRRVTKDDIRELI 352
+ EF E+ R++ D ++L+
Sbjct: 275 PSDASNFDR-EFTNEKVRLSPVD-KKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 20/125 (16%)
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +K+CDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPG 233
+PG
Sbjct: 274 SPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 30 VIGKGSYGVVCAA---IDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + D+F SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKRIML-PPSKREFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLR 137
++ + L +K V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N + N N + V DFGL++ +S + +W
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L + YT D+W+ G E++T G+ + G
Sbjct: 185 ESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y++++VIG+G++G V + + KV K+ FE I SD+ E ++
Sbjct: 42 AEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ + +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ HRD+KP N+L + + LK+ DFG + V V T Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ S Y D WS+G E+L G F S+V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 35/307 (11%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+Y IL + GS G VC +KV +K + + RE+ +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I I L + R + +V + DL + + L E ++L AL Y
Sbjct: 146 RAI-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGT-----PS 251
L Y DIWS G + E+ GK V QL I + P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVP-LFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + ++ K +Y +R +P + +K+ ++D L+ +++ FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSAQD 371
Query: 310 ALADPYF 316
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+P F G+
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 112 DLHQVIKANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL++ IK +EH F YQ++ AL +H+ + HRDLK NI
Sbjct: 151 DLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+K+ DFG ++ +SD+ + + T +Y APEL +Y+ D+WS+G I E+
Sbjct: 208 IKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYEL 264
Query: 225 LTGKPLFPGKSVVHQLDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
LT F G S Q +++ +L G P V KA
Sbjct: 265 LTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVSSGMKA-------------------- 301
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
LL L++ +P RPT ++ L + K +A + ++
Sbjct: 302 --------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+++ L Y+ + + HRD+KP N+L N ++K+CDFG++ + T YV T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNA 158
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
Y APE +Y D+WS+G F E+ G+ +P
Sbjct: 159 YMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +K+CDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P V D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK-----VAIKKIHDVFE-HISDAIRILREVKLLRLL 79
+ LE +G+G++G V T E+ VAIK + + E + R +E +L+ L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAELMSDL 65
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQ----------VIKANDDLTREH- 127
+HP+IV + + + + ++FE + DLH+ V + D T +
Sbjct: 66 QHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 128 --HQFFL---YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182
FL Q+ ++Y+ + + HRDL +N L +K+ DFGL+R +S
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
V + RW PE + K+T DIWS G + E+
Sbjct: 181 RVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPET 254
APE+ + Y + D +S+GC+ ++L G F H++D +T + P++
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IA 256
+
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +K+ DFG++R +S V + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 31/228 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V V +K V+ A++IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKRIMLPPSKR-------EFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFL 132
E + +++ +R F+D ++ +M+ DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+M+ A+ +H HRD+KP N+L + N +++ DFG +D TV V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +S+V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMHTANVYHRD 151
P+K + + ++ D+ I D+L + F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL K+CDFGLAR +D+ V + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ ++V+G G++G V + GEK VAIK + + ++ IL E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR 137
HP +V + I L + ++ +LM L V D++ ++ + Q+ +
Sbjct: 67 DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +K+ DFGLA++ D V +W A
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-A 179
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
E YT D+WS G E++T G + G V DL+ P P
Sbjct: 180 LESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I + + + + E ++ + HP
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + L P+ I +V +LM L V + D++ + + Q+ + +
Sbjct: 70 HLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L + +K+ DFGLAR+ D + +W L
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---AL 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDA-IRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E A IR R++ L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-----LVE 57
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
D + ++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + + A+
Sbjct: 58 ADGAWVVKMFY--SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF----SDTPMTVF---- 185
+H HRD+KP N+L +A +K+ DFGL R F + P + F
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 186 ---------WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLIT-----DLLGT 249
APE+ + Y + D +S+GC+ ++L G F H++D +T +L +
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 250 PSPE 253
SPE
Sbjct: 222 FSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +K+CDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A + TG A K I E + D + E+++L HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV---EIEILATCNHPY 70
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++ K ++++ E I D LT Q QML AL+Y
Sbjct: 71 IVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRDLK N+L + +K+ DFG V+ + ++ T ++ APE+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 202 GSFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
K TP DIWS+G E+ +P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLL-RHPDIVE 86
+V+GKGS+G V A GE A+K + I D + + E ++L L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 87 IKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ + K+ ++ V E + DL H K DL R F+ +++ L+++
Sbjct: 61 LY------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPELC 201
H+ + +RDLK N++ + + +K+ DFG+ + F D + F T Y APE+
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEIL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KYT ++D WS G + E+L G+ F G
Sbjct: 169 QGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+E+K++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHHQFFLYQMLR--------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Y L +KY+ + N HRDL +N L N +K+ DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
S + + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/220 (21%), Positives = 90/220 (40%), Gaps = 21/220 (9%)
Query: 29 EVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
+++G+G +G V D + KVA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 85 VEIKRIMLPPSKRE-FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML------ 136
+++ + S + V+ M+ DLH + + + Q L
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVD 121
Query: 137 --RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+ N HRDL +N + + + V DFGL++ +S + +W
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L YT D+W+ G E+ T G+ +PG
Sbjct: 182 IAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 51/246 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHIS-DAIRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E IR R++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-------- 54
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
+VE + + F+D +Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 55 --LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF---------SDTP 181
A+ +H HRD+KP N+L ++ +K+ DFGL R F SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 182 MTVFWTDYVATRWYR----------------APELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+ A W R APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRH 81
++ +++I G+YG V T ++ A+KKI+ + + I ++ E +L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P +V + S + + +V E +E D ++K L + + + + + AL+
Sbjct: 61 PFVVS-----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAP 198
Y+H + HRDLKP N+L + +K+ DFGL+++ T + ++ TR +
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDK 174
Query: 199 ELCGS---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
++CG+ Y +D W++G I E L G F G +
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 20/251 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA- 145
K S + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLK +N++ + + +K+ DFGL + D M F T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----CGTPEYLAPEVLED- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y A+D W +G + E++ G+ F + +LI + P T++ +A+
Sbjct: 171 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFPRTLS----PEAK 224
Query: 265 KYLTEMRKKPP 275
L+ + KK P
Sbjct: 225 SLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +++ L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-ALNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + + +++ D GLA P V T Y AP
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W++GC+ E++ G+ F +
Sbjct: 171 EVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQR------------------------ 204
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + R+ + + K+ +KF P A L + L+ DPK+R A E
Sbjct: 205 KKKIKREEVERLVKEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 314 PYFKGL 319
P FK +
Sbjct: 262 PLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
L + + ++++ V E + DL I++ F+ +++ L+++H+
Sbjct: 61 -----LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK NIL + + +K+ DFG+ + T + T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEIL--LG 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KY ++D WS G + E+L G+ F G
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 55/245 (22%)
Query: 24 RYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIH-DVFEHISDAIRILREVKLLR 77
R + + +G+G++G V A +D VA+K + D E D ++ E+++++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K+ DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPMTVFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GK 228
+ DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 72/316 (22%), Positives = 134/316 (42%), Gaps = 63/316 (19%)
Query: 23 NRYKILEVIGKGSYGVV--CAAID------------THTGEKVAIKKIH-DVFEHISDAI 67
+ ++ E +G+G +G V C A VA+K + DV + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-- 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--------- 117
L+E+K++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +K+ DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+S + + RW + K+T A D+W+ G E+ T P
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFTLCKEQP-Y 233
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP--PVPLFQKFPNVDPLALRL 292
S++ +I + T RN+ + YL++ P P P+F+ L
Sbjct: 234 SLLSDEQVIEN--------TGEFFRNQGRQIYLSQ---TPLCPSPVFK-----------L 271
Query: 293 LQRLIAFDPKDRPTAE 308
+ R + D KDRPT
Sbjct: 272 MMRCWSRDIKDRPTFN 287
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 31 IGKGSYGVV----CAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQ 129
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
Q+ + Y+ + + HRDL +N L +K+ DFG++R +S V
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW PE + K+T DIWS G + E+ T GK + S ++ IT
Sbjct: 186 LPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L K+CDFGLAR +D+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
V + +W APE F YT D+WS G + E+ + GK +PG V
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F +Q+ R ++Y+ + HRDL +N+L K+K+ DFGL+R + + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 191 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+W A E S F YT D+WS G + E++T G P +PG
Sbjct: 192 PVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHPDIVEI 87
V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSRFVVSL 65
Query: 88 KRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYMH 143
E KD + +V +M DL H N + F+ ++ L+ +
Sbjct: 66 AYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL + +++ D GLA P V T Y APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 --EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L+ +G G +GVV G+ VAIK I E + E K++ L H +V
Sbjct: 8 FLKELGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT---REH-HQFFLYQMLR---- 137
++ + +K+ + IY+V E M +N L REH +F Q+L
Sbjct: 63 QLYGVC---TKQ--RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ Y+ + HRDL +N L + +KV DFGL+R D + + + RW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW 167
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
PE+ +SK++ D+W+ G + EV +
Sbjct: 168 -SPPEVL--LYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 48/294 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKRIMLPPSKRE-FKDIYVVFELME-SDLHQVI---KANDD---LTREHHQFFLYQMLRA 138
+ + L + E + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + V DFGL++ ++ + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARKYLTEMR--KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V N + YL + K+PP L D L L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCL-------DGL-YSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++I+ +G G++G V A + TG A K I E + + E+ +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKYM 142
V+ +L E +++++ E + + LT + Q L AL Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK NIL + +K+ DFG V+ +T ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 203 SFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
SK P D+WS+G E+ +P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V A T VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN--------DDLTREHH-QFFLYQM 135
+ + + + +VFE M+ DL++ ++A+ D R+ + L QM
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 136 LR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L + Y+ + + HRDL +N L AN +K+ DFG++R +S V
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K + + + I ++ K + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
+ E + +V+ + DL ++ L EH +F+ ++ AL Y+H +
Sbjct: 62 HSCF----QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N+L ++ +K+ D+G+ + T + + T Y APE+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--ED 172
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 12/217 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLLRHP 82
+ +++VIG+G++G V + + A+K + FE I SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ K +Y+V E M + +N D+ + +F+ +++ AL +
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ HRD+KP N+L + + LK+ DFG + M T V T Y +PE+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTA-VGTPDYISPEVLK 216
Query: 203 S--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
S Y D WS+G E+L G F S+V
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K I + + I ++ K + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V + A+K + H + I ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ +++V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+Y ++D W++G + E++ G+ F D+ITD
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
+GKG +G VCA +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 90 IMLPPSKREFKDIYVVFELME-SDL--HQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
SK + +V LM DL H L E + Q+ + ++H+ +
Sbjct: 61 AF--ESKTH---LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RD+KP+N+L + ++ D GLA V D T T Y APE+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPEILKE--E 169
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y+ +D +++GC E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 24 RY-KILEVIGKGSYGVVCA----AIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLL 76
RY K + V+G+G +G V + TGE VA+K K ++ S + E+ +L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
+ L H +IV+ K S++ K + ++ E + S + K +L + F Q
Sbjct: 61 KTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQ 115
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------RVAFSDTPMTV 184
+ + Y+H+ + HRDL +N+L + + +K+ DFGLA RV D V
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPV 174
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
FW A E K++ A D+WS G E+LT
Sbjct: 175 FWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 37/115 (32%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR + +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 47/201 (23%)
Query: 51 VAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIVEIKRIML--PPSKREFKDIYVVF 106
VA+K + SD R L+EVK+L L P+I + + PP + ++
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98
Query: 107 ELME-SDLHQVIKANDDLTREH--------HQFFLY---QMLRALKYMHTANVYHRDLKP 154
E ME DL+Q ++ + T LY Q+ ++Y+ + N HRDL
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--------VATRWYRAPELCGSFF- 205
+N L N +K+ DFG++R +S +DY + RW A E S
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS--------SDYYRVQGRAPLPIRWM-AWE---SVLL 206
Query: 206 SKYTPAIDIWSIGCIFAEVLT 226
K+T D+W+ G E+LT
Sbjct: 207 GKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPD 83
IG+G++G V A + VA+K + E S ++ RE L+ HP+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------------- 121
IV++ + K + ++FE M DL++ ++
Sbjct: 70 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 122 -DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ Q+ + Y+ HRDL +N L N +K+ DFGL+R +S
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 185 YYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + + L+EV+ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR-----ALKY 141
+ E +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +K+ D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 71/274 (25%), Positives = 109/274 (39%), Gaps = 52/274 (18%)
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG---LARVAFSDT 180
Q+L A+ Y+H + HRD+K +N+L N + + DFG AR ++S
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-- 315
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKS---- 235
T F T APE+ YTP++DIWS G IF + LF
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
Query: 236 ---------VVHQLDLITDLLGT-PSPETIAVVRNEKARKYLTEMRKKPPV--PLFQKFP 283
++ Q + D ++ R+ AR ++P P + ++
Sbjct: 372 RPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN------RRPAYTRPAWTRYY 425
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+D L+ R + FD RP+A E L P F+
Sbjct: 426 KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSKREFKDIYVVFELMESD-LHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVY 148
E + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L K+ DFGL++ +D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 35/114 (30%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE F YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHD-----VFEHISDAIRILREVKLL 76
+ L+++G G +G V I G+ VAIK I D F+ I+D + +
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS---- 65
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
L H IV + I S + +V +L S L V + D L + + Q
Sbjct: 66 --LDHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + + Y+ + HR+L +NIL ++ +++ DFG+A + + D + +W
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 178 M---ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+EVK+L L+ P+I+ + + + + ++ E ME+ DL+Q + ++
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 121 -DDLTREHHQFFL--YQML--------RALKYMHTANVYHRDLKPKNILANANCKLKVCD 169
+D H Y L +KY+ + N HRDL +N L N +K+ D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R ++ + + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 55/239 (23%)
Query: 31 IGKGSYGVVCAA----IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--------DLTREHHQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR V
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVH 185
Query: 186 WTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 24/124 (19%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLD 241
+ +W APE + F + YT D+WS G + E+ T G P +PG V
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 253
Query: 242 LITD 245
L+ +
Sbjct: 254 LLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE- 107
VAIK + D+ + + +E L+ L HP+IV +L +E + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLTREH---HQFFLY---QMLRALKYMHTANVYHR 150
L + DLH+ + +++D T + H FL+ Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +K+ D GL+R +S V + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRH 81
+K ++V+G G++G V + GEKV I I ++ E S IL E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L V + D++ ++ + Q+ + +
Sbjct: 69 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+ + HRDL +N+L +K+ DFGLA++ +D V +W
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 183 I---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 17/206 (8%)
Query: 31 IGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
IG G +G V+ + I T TG + K + L++ R+L+HP+I++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML----RALKYMHT 144
+ E +VFE E DL + R L +M + +MH
Sbjct: 63 QCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N H DL +N ++ +KV D+G+ + + + V RW APEL G F
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEF 176
Query: 205 F-----SKYTPAIDIWSIGCIFAEVL 225
++ T ++W++G E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP+I+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNII 66
Query: 86 EIKRIMLPPSKREFKDIYVVFE----------LMESDLHQVIKANDDLTREH---HQFFL 132
+ + R + +Y+ E L +S +V++ + +EH
Sbjct: 67 NL---LGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTS 118
Query: 133 YQMLR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+L+ ++Y+ HRDL +N+L N K+ DFGL+R T+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM- 177
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 178 --GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 31 IGKGSYGVVC--AAID---THTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+G G++G V A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML------- 136
V++ + L + Y++ ELME DL ++ L ++L
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYMHTANVYHRDLKPKNILA-----NANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+ Y+ + HRDL +N L +A+ +K+ DFGLAR + +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
RW APE K+T D+WS G + E+LT G+ +P +
Sbjct: 177 VRWM-APE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-R 77
+ N K +VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIK-----------RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
L HP+I+ + I P D ++E+D I + T
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 127 HHQF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
Q F + R + Y+ HRDL +NIL N K+ DFGL+R T+
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 ---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDL-----HQVIKANDDLTREH---HQFFLYQMLR 137
+ + R + + + + + L +V++ + + Q+L
Sbjct: 60 NL---LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+ Y+ HRDL +NIL N K+ DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
+ I++ I +G++G V + + A+K K + +++ ++ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKS 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQML 136
P IV L S + ++Y+V E + +S LH ++++ ++ ++
Sbjct: 64 PFIVH-----LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVA 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
AL Y+H + HRDLKP N+L + +K+ DFGL++V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I I + E+ S IL E ++ + P
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+ + I L + + +V +LM L V + D + + + Q+ + +
Sbjct: 70 YVCRLLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ + HRDL +N+L + +K+ DFGLAR+ D T + D V +W
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALE 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKSV 236
+ ++T D+WS G E++T KP P + +
Sbjct: 182 SI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 26 KILEVIGKGSYGVVCAA--IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +E +G+ +G V T GE+ VAIK + D E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ 66
Query: 81 HPDIVEI-------KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT----REHHQ 129
HP+IV + + + + S D++ F +M S V +DD T E
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 130 FF--LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
F + Q+ ++++ + +V H+DL +N+L +K+ D GL R ++ +
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW +PE + K++ DIWS G + EV +
Sbjct: 186 SLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRHPD 83
+GKG +G V A TG+ A KK++ +E RIL +V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFFLYQMLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V D Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
EL +Y ++D +++G E++ + F
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCAA----IDTHTGEKVAIKKIHDVFEHISDAIRIL---REVKLLRLLRHP 82
+G+G +G V A I+ GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---------LTREHHQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
Q+ + ++ A HRDL +N L ++ ++KV L++ ++ +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW APE ++ D+WS G + EV T G+ F G S
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------- 223
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKD 303
E + ++ K P P L +L+ R A +PKD
Sbjct: 224 ------DEEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---- 189
+M+ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 49/223 (21%), Positives = 84/223 (37%), Gaps = 39/223 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
D KI ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML- 136
H +IV ++ ++ + + +V E M + A D R+H Q Q++
Sbjct: 63 FDHSNIVRLEGVITRGNT-----MMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT------- 183
+KY+ H+ L +L N++ K+ F + S+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
V W APE + ++ A D+WS G + EV++
Sbjct: 172 VLWA---------APEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 75/266 (28%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
+ ++VIGKG++G V TG+ A+K + D H+ +L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFF 131
P +V + F+D ++ +ME DL ++ D + + +F+
Sbjct: 60 -----SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 106
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA------------------ 173
+ + + A++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 174 -----------RVAFSDTPMTVFWTDYVATRW----------------YRAPELCGSFFS 206
VA +T+ D +AT W Y APE+ F
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQ 222
Query: 207 K-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y D WS+G I E L G P F
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 57/252 (22%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLR-LLRHPDI 84
++ +G G++G VC A T A+K + DV A VK R +L D
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-----HVKAERDILAEADN 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ ++ ++ ++Y V + + D+ ++ + +F++ ++ A++ +H
Sbjct: 61 EWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL----------------ARVAFSDTPMTVFWT 187
HRD+KP NIL + + +K+ DFGL + + + W
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 188 D----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219
D V T Y APE+ YT D WS+G
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGV 236
Query: 220 IFAEVLTGKPLF 231
I E+L G+P F
Sbjct: 237 ILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 73/264 (27%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
++ +G G++G VC A T A+K + ++V L + H V+
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRK------------KDVLLRNQVAH---VKA 50
Query: 88 KRIMLPPSKRE--------FKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
+R +L + E F+D +Y V + + D+ ++ + +F++ ++
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL V
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 180 TPMTVFWTD----------------------------YVATRWYRAPELCGSFFSKYTPA 211
+ W D V T Y APE+ + YT
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQL 228
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKS 235
D WS+G I E+L G+P F ++
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQT 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 82/345 (23%), Positives = 130/345 (37%), Gaps = 90/345 (26%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHP 82
+ ++ IG G++G VC T A+K + DV + A + E +L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFEL-----MESDLHQVIKANDDLTREHHQFFLYQMLR 137
+V+ L S ++ ++Y V + M S L ++ +DL R F++ ++
Sbjct: 62 WVVK-----LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAELTC 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL------------------ARVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL R +
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 180 TPMTVFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIWSI 217
D V T Y APE+ + YT D WS+
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 230
Query: 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277
G I E+L G+P F L TP+ ET V N + T +
Sbjct: 231 GVILYEMLVGQPPF--------------LADTPA-ETQLKVINWE-----TTLHIPSQA- 269
Query: 278 LFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+ A L+ RL +DR A+E A P+FKG+
Sbjct: 270 ------KLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170
DL ++K L+ + + Q++ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
GL ++ TP Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLL 79
R + +++ +G++G + I E+V +K + D I +L+E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYGL 65
Query: 80 RHPDIVEIKR----------IMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
H +I+ I ++ P + K L E++ Q + T++
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS-----TQQLV 120
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ Q+ + Y+H V H+D+ +N + + ++K+ D L+R F + +
Sbjct: 121 HMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+W L +S A D+WS G + E++T
Sbjct: 180 NRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLA---RVAFSDTPMTV 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + K+ D G A RV + P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY-LTEMRK----KPPVP 277
++ FP L +D I R K Y L RK +
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 278 LFQKFPNVD---PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
L + F +D LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 50/247 (20%)
Query: 27 ILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G G++G V + +VA+K + + D L E ++ H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR--- 137
+IV + + R +++ ELM DL ++ N + +L
Sbjct: 69 QNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 138 ----ALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTD 188
KY+ + HRD+ +N L CK K+ DFG+AR ++
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRAS 173
Query: 189 Y--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237
Y + +W PE L G F SK D+WS G + E+ + G +PG++
Sbjct: 174 YYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 238 HQLDLIT 244
++ +T
Sbjct: 229 EVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 27 ILEVIGKGSYGVVCAAI--DTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G+GS+G+V D GE +VA+K +++ + + I L E +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTC 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA------NDDLTREHHQFFLYQ 134
+V R++ SK + VV ELM DL +++ N+ + Q
Sbjct: 69 HHVV---RLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 135 MLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
M + Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 175
Query: 190 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ + D+WS G + E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 81/342 (23%), Positives = 131/342 (38%), Gaps = 64/342 (18%)
Query: 26 KILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHP 82
++L VIG+G V A TGE V +++I ++ ++ + L+ E+ + +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+IV + + + +++VV M DL D ++ + L +L+A
Sbjct: 60 NIVPYRATFIADN-----ELWVVTSFMAYGSAKDL-ICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS------------DTPMTVFW 186
L Y+H HR +K +IL + + KV GL R S D P
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDG--KVYLSGL-RSNLSMINHGQRLRVVHDFPKYS-- 168
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
V + +PE+ Y DI+S+G E+ G P K + L+ L
Sbjct: 169 ---VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKL 223
Query: 247 LGT----------PSPETIAVVRNEKARKYLTEMR----------KKPPVPLFQKF-PNV 285
GT P+ E A L E + P + F P+
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ LQR +P RP+A L +FK +I+R S
Sbjct: 284 HHFVEQCLQR----NPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 78/332 (23%), Positives = 131/332 (39%), Gaps = 70/332 (21%)
Query: 31 IGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + ++ L+ EV L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALK 140
+ S ++V+ M + ++K ++ L L+ LR L
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLN 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGL------------ARVAFSDTPMTVFWTD 188
Y+H HR++K +IL + + + + GL A+V + D P F T
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTS 170
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
+ W +PEL Y DI+S+G E+ TG+ P + ++ L+ L G
Sbjct: 171 VLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKG 225
Query: 249 TP-SPETIAVVRNEKAR----------------------KYLTEMRKKPPVPLFQKFPNV 285
P SP I E++R + +T R + P
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS-----KTF 280
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P L++ + DP+ RP+A L+ +FK
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 31 IGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+GS+G+V I +VAIK +++ + + I L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA-NDDLTREHHQFF--LYQMLR---- 137
+ ++ + + V+ ELM DL +++ ++ Q L +M++
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY----- 189
+ Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++K+ DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
VI +G G G + +K+I+DV ++I E+ + L+HP+IV++
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIP-SSEIADMGKLQHPNIVKLIG 750
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TA 145
+ R K Y++ E +E +L +V++ +L+ E + + +AL+++H +
Sbjct: 751 LC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
V +L P+ I+ + + + L + +DT + + Y APE +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET-- 852
Query: 206 SKYTPAIDIWSIGCIFAEVLTGK 228
T DI+ G I E+LTGK
Sbjct: 853 KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 31 IGKGSYG-VVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
IG G +G V+ +++ +T +V +K++ V + + ++ L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLH---QVIKANDDLTREHH--QFFLYQMLRALKYM 142
E +V E DL + + + +T + Q ++ L ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H N H DL +N L A+ +K+ D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 203 SFFSKY-----TPAIDIWSIGCIFAEVL 225
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.17 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.12 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.78 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.66 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.82 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.37 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.26 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.24 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.01 | |
| PLN02236 | 344 | choline kinase | 96.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.21 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.32 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.1 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.01 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.99 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.92 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.73 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.5 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-78 Score=527.91 Aligned_cols=342 Identities=57% Similarity=0.976 Sum_probs=321.9
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..+....+|..++.||+|+||.|+.|.++.+|+.||||++.+.+.+...+++.+||+++|+.++|+||+.+.+++.++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 35677788888999999999999999999999999999999999999999999999999999999999999999988777
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+..+.+|+|+|+|+.||.++++++..+++++++.+++||++||+|+|+.+|+||||||+|+|++.++.+||||||+|+..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 78899999999999999999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .....++.++.|+||+|||++... ..|+.++||||+||||+||++|++.|+|.+..+++..|...+|+|+++.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 556667899999999999998764 789999999999999999999999999999999999999999999999999
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
...+..++.++.++...++.++...+++.++.+.||+.+||.+||.+|+|++|+|.||||..+.++++||.+++....
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~-- 331 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS-- 331 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCCccc
Q 016884 337 EFERRRVTKDDIRELIYREILEYHPQLL 364 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (381)
++.. .+.++|++++++|++.++|...
T Consensus 332 -~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 332 -FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred -cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 3444 8899999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-66 Score=444.19 Aligned_cols=290 Identities=37% Similarity=0.682 Sum_probs=252.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|+.+.++|+|+||+||+|+++.||+.||||++.....+..-.+-.+||+++|++|+|+|+|.++++| ...+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999987766666667789999999999999999999999 555679
Q ss_pred EEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
++|+|||+.++.+.++.. ..++.+.++.+++|++.|+.|||+++++||||||+|||++.+|.+||||||+|+.....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-- 154 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-- 154 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence 999999999888888765 36999999999999999999999999999999999999999999999999999986542
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
...+++++.|+||+|||++.|. ..|+.++||||+||++.||++|.+.|+|.++.+++-.|.+.+|...|.-...+...
T Consensus 155 -gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2346899999999999999875 68999999999999999999999999999999999999999999998866654432
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.+-.-+.--....+.++...+++++..+.||+++||+.||++|+|.+|+|.||||.++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 211111111223344566778899999999999999999999999999999999987643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-65 Score=427.55 Aligned_cols=288 Identities=41% Similarity=0.693 Sum_probs=251.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+|..+++||+|.||+||+|+|..||+.||||+++.......-....+||++.|+.++|+||+.++++|. ....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCce
Confidence 5799999999999999999999999999999999865333334456789999999999999999999994 44569
Q ss_pred EEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
.+|+|||+.+|..+++... .++..+++.++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998754 799999999999999999999999999999999999999999999999999998765443
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
. .+..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.+.|+|.++.+|+..|...+|+|.++.|+.+..-
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 3 2344899999999999886 78999999999999999999999999999999999999999999999988766543
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.. +.+ +...+..+....++..++++.||+.+||.+||.+|+|+.|+|+|+||++...+
T Consensus 233 pd--Y~~-~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 233 PD--YVK-IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred cc--HHH-HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 22 211 22344445555889999999999999999999999999999999999975443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-65 Score=461.12 Aligned_cols=291 Identities=38% Similarity=0.666 Sum_probs=253.6
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (381)
....+||.++++||.|+||.||+|..+.++..||||++++.+..-.+. .-+||+.-|++|+ ||||+++.+++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~-- 82 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND-- 82 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC--
Confidence 345678999999999999999999999999999999998776654444 4468999999998 999999999995432
Q ss_pred CCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.+|+|||||+.+|+++++.++ .+++..++.|++||++||+|+|.+|+.|||+||+|||+..+..+||+|||+||..
T Consensus 83 --~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 83 --RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred --ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 3799999999999999998754 7999999999999999999999999999999999999998889999999999976
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... .++.++.|+||+|||+++.. ..|+.+.||||+|||++|+.+-+++|+|.+..+++.+|..++|+|..+.+.
T Consensus 161 ~Skp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccCC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 5543 46889999999999998764 789999999999999999999999999999999999999999999987665
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.. ...+...--.+....+.++....+++++++.+||.+||.|||.+||||.++|+||||+.-.
T Consensus 236 eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 236 EG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred hH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 43 1111222223445666777778889999999999999999999999999999999998654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-64 Score=433.51 Aligned_cols=295 Identities=39% Similarity=0.608 Sum_probs=256.4
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
+....+.|+.+.+|++|+||+||+|+|+.|++.||+|+++............+|||.+|.+++|||||.+.+++...+.
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~- 149 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM- 149 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc-
Confidence 3344567999999999999999999999999999999998655544445567899999999999999999999876543
Q ss_pred CCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.+|||||||+.||..++...+ ++...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 150 --d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 --DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred --ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 5699999999999999998765 8999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... ..++..+.|.||+|||+++|. ..|+.++||||+|||++||+++++.|+|.+..+++.+|.+.+|+|+...|+
T Consensus 228 gsp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 228 GSPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 5542 235778999999999999986 789999999999999999999999999999999999999999999999988
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCC--CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+....+.+.+ .+...+...+...|+. ++....+|++.+|.+||.+|.||+|+|+|.||....
T Consensus 304 g~~~lp~~k~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 304 GYSELPAVKKM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred Cccccchhhcc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 77665544322 2333444444555555 459999999999999999999999999999998754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-62 Score=452.56 Aligned_cols=338 Identities=89% Similarity=1.434 Sum_probs=301.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|+||.||+|++..++..||+|++...........++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875544445566788999999999999999999998766555556799
Q ss_pred EEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
+|||||+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999997643333222
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
......+||+.|+|||++.+....++.++|||||||++|+|++|++||.+.+....+..+....|.|.++....+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 23345689999999999865335789999999999999999999999999999999999999999999999888888777
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhhhccC
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (381)
..++..+....+......++.+++.+.+||.+||+.||++|||++++|+||||+++......+..++.+...+.++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 77887777777777777778899999999999999999999999999999999999888888888899889999999999
Q ss_pred CHHHHHHHHHHHHHHhCC
Q 016884 344 TKDDIRELIYREILEYHP 361 (381)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~ 361 (381)
+.++.++.++++++++||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-63 Score=450.54 Aligned_cols=287 Identities=38% Similarity=0.633 Sum_probs=247.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|+.+++||+|+||.||+|++..||+.||+|++............+.|||.||++|+||||+++.++.... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4679999999999999999999999999999999986655556666778999999999999999999999765 2356
Q ss_pred EEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|||+|||+.||.-++.+.+ .+++.+++++|.||+.||.|||++||+|||||.+|||+|.+|.+||+|||+|+......
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999998744 79999999999999999999999999999999999999999999999999999765443
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ..++..+.|.||+|||+++|. ..|+.++|+||+||||.||++|++.|+|.+..+|+.+|.+++|.|.++.|....-
T Consensus 273 ~--~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 S--APYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred C--cccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 3 236788999999999999986 7899999999999999999999999999999999999999999999988762221
Q ss_pred HHHHHHHHHhcCCC--CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 261 EKARKYLTEMRKKP--PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 261 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
+.+ ..+.... ...+.+.+..+++.+.+|+..||..||.+|.||.++|+|+||..
T Consensus 350 P~~----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 PHA----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred Ccc----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 110 1111111 12233456789999999999999999999999999999999954
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-63 Score=438.13 Aligned_cols=264 Identities=33% Similarity=0.553 Sum_probs=220.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh-----HHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++++..... .....+.+|++||++|+|||||+++++|.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--- 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--- 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence 3467999999999999999999999999999999997543211 12335679999999999999999999994
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeec
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFG 171 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg 171 (381)
.....||||||++ |+|.+.+..++.+.++..+.+++|++.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 247 --~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 247 --VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred --cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 4456899999999 6999999999999999999999999999999999999999999999999877 779999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCChhh-HHHHHHHhhCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGT 249 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 249 (381)
+|+..... ..+.+.||||.|.|||++.+.... +..++||||+|||||.+++|.+||++..... ..+.|.+
T Consensus 325 lAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 325 LAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred hhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 99876533 345688999999999999763233 4448999999999999999999998765433 3333322
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.........|..++.++.+||.+||..||++|||++++|+||||+...
T Consensus 397 -----------------------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 -----------------------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -----------------------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 111112234567999999999999999999999999999999998653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-61 Score=445.44 Aligned_cols=260 Identities=32% Similarity=0.545 Sum_probs=232.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+|+..+.||+|||+.||.+++..+|+.||+|++.+. ........++.+||+|.+.|+|||||+++++| ++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 6799999999999999999999999999999999653 34556677899999999999999999999999 66678
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|||.|+|. ++|..+++.+++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.......
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 7999999999999999999999999999999999999999999999999999999999999998775443
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.. ..+.||||.|.|||++.. ...+..+||||+|||||.|+.|+|||...+-.+.+.+|...-
T Consensus 173 Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------------- 234 (592)
T KOG0575|consen 173 ER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------------- 234 (592)
T ss_pred cc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------------
Confidence 32 256799999999999987 789999999999999999999999999998888887776421
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
+..+..+|.++.|||.+||+.||.+|||++++|.|+||+.-..+.
T Consensus 235 ------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 235 ------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred ------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 222347899999999999999999999999999999996544333
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-60 Score=416.11 Aligned_cols=286 Identities=38% Similarity=0.656 Sum_probs=244.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|.-.+.+|.|+||.||+|....+++.||||++-.... --.+|+++|+.++|||||++.-+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 58889999999999999999999999999998853211 112699999999999999999888766544345778
Q ss_pred EEeeccccCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeecccccccC
Q 016884 104 VVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFS 178 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a~~~~~ 178 (381)
+|||||+.+|.+.++. +..++.-.++-+++||++||+|||+.|||||||||+|+|+|.+ |.+||||||+|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999984 5689999999999999999999999999999999999999987 8999999999998766
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
+.+. .++..|+.|+|||++.|. ..|+.+.||||.|||++||+.|++.|+|.+..+++..|.+.+|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 467899999999999885 78999999999999999999999999999999999999999999999998877
Q ss_pred cCHHHHHHHHHhcCCCCCCccc-cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
.......- ...-...++.. .....++++.||+.++|+++|.+|.|+.|+|.||||+.++++.
T Consensus 254 n~~y~~~~---~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 254 NPNYTEFK---FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred Cccccccc---CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 65432111 11112222222 4467899999999999999999999999999999999987763
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=412.39 Aligned_cols=294 Identities=38% Similarity=0.658 Sum_probs=249.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCC-cCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPS-KREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~-~~~~ 99 (381)
...|..+++||+|+||+||+|+++.+|+.||+|+++-............||+.+|+.|+|+| |+.+++++.+.+ .+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688899999999999999999999999999999865443333345679999999999999 999999997654 2334
Q ss_pred CcEEEEeeccccCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELMESDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..+++|+||+..+|.+++.... .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4699999999999999998755 588899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..-... .++..++|.||+|||++.|. ..|+...||||+|||++||+++++.|+|.+..+++..|.+.+|+|..+.|
T Consensus 170 ~~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 532222 25677999999999999885 57999999999999999999999999999999999999999999998877
Q ss_pred hhhcCHHHHHHHHHhcCCC-CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+.+..-..... ...... +.++....++.++.+.||+.+||+.+|.+|.||+.+|+||||.....
T Consensus 246 p~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 76543211111 222222 55566667778889999999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-59 Score=409.52 Aligned_cols=258 Identities=27% Similarity=0.483 Sum_probs=221.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+.+.++.||+|+.|+||+|+|+.|++.+|+|++... .......++.+|+++++.++||+||.+|++|+.+.. .++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 567889999999999999999999999999999532 445667789999999999999999999999976531 499
Q ss_pred EEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+ |+|.++++..++++|.....++.++++||.|||+ .+|+||||||+|||++..|.|||||||.+......
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999 6999999988999999999999999999999996 89999999999999999999999999999876544
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC--ChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
...+++||..|||||.+.+ ..|+.++||||||+.+.|+++|+.||... +..+.+..+......|+|
T Consensus 233 ---~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP------- 300 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP------- 300 (364)
T ss_pred ---hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC-------
Confidence 2357799999999999998 79999999999999999999999999774 222333333322222221
Q ss_pred CHHHHHHHHHhcCCCCCCccccCC-CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+ .. .+|+++++||..||++||.+|||+.|+|+|||++...
T Consensus 301 -----------------~l---P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 -----------------RL---PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred -----------------CC---CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11 12 4899999999999999999999999999999998653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=400.35 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=226.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
-..++|++++.||+|+||+|++++++.|++.+|+|++++.. -.........+|..||..++||+||+++-.| ++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence 34678999999999999999999999999999999997642 2224566788999999999999999999888 55
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+|+||+. |+|...+++.+.++++.++.++..|+.||.|||++||+||||||+|||++.+|.++|+|||+|+...
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 567999999999 5999999999999999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... ..+.|||+.|||||++.+ .+|+.++|+||||+++|+|++|.+||.+.+......+|...-
T Consensus 177 ~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------- 241 (357)
T KOG0598|consen 177 KDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------- 241 (357)
T ss_pred cCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------
Confidence 33222 245799999999999998 799999999999999999999999999998777776665421
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCC-CCHHHHHHHHHhccCCCCCCC----CHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (381)
....+. ++.+++|||+++|+.||++|. ++.++-+||||..+
T Consensus 242 ---------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 242 ---------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 011234 899999999999999999996 78999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-57 Score=410.88 Aligned_cols=261 Identities=30% Similarity=0.521 Sum_probs=227.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (381)
...+|.+++.||+|+|++|++|+++.+++.||||++.+..-. ....+-+.+|-.+|.+| .||.|++++-.| .+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 346899999999999999999999999999999998754221 22233466799999999 799999999988 44
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+|+||+. |+|.++|++-+.+++..++.++.||+.||.|||++|||||||||+|||++.|+++||+|||.|....
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 456999999999 7999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCC----------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 178 SDTPM----------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 178 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
..... ......++||..|.+||++.. ...++.+|||+||||+|+|+.|.+||.+.+..-...+|+++.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32211 111245899999999999988 788999999999999999999999999999988888887743
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
-. ..+++++.++|||+++|..||.+|+|+++|-+||||.++
T Consensus 304 y~-------------------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 304 YE-------------------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred cc-------------------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 22 235788999999999999999999999999999999876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-57 Score=387.22 Aligned_cols=335 Identities=36% Similarity=0.649 Sum_probs=282.9
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC-C
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP-S 95 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 95 (381)
+.+.+..||.-+..+|.|+- .|..|.|..++++||+|++..++.+...+.+..+|+.++..++|+||++++.++.+. .
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34556789999999999999 899999999999999999988888877888999999999999999999999999764 3
Q ss_pred cCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..++..+|+|||+|..+|.+.+. -.+.-..+..|++|+++|++|||+.||+||||||+||++..++.+||.|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 34567799999999999999988 3588899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.... ...+.++.|+.|+|||++.+ ..|.+.+||||+||++.||++|+..|+|.+..++..++.+.+|+|.+...
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 4333 34578999999999999998 56999999999999999999999999999999999999999999999887
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccC------------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
...... ++.+.....+.....+...+ +.-+..++||+.+||..||++|.|++++|+|||++-| -..
T Consensus 242 ~qL~~~-~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw-~~~ 319 (369)
T KOG0665|consen 242 KQLQPT-VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW-YDP 319 (369)
T ss_pred HHhhHH-HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee-ccc
Confidence 765432 23333322222222222222 2345678999999999999999999999999999944 344
Q ss_pred CCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCCc
Q 016884 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (381)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (381)
+++..+++...+..++.+..+.++|+++|++|+.+|.+.
T Consensus 320 ~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 320 DEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred ccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 555555555566777888899999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=395.54 Aligned_cols=261 Identities=31% Similarity=0.470 Sum_probs=224.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|.+.++||+|+||+||+|+++.++..||||.+.+........+.+..|+.+|+.++|||||.++++.. ..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DD 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cC
Confidence 3457899999999999999999999999999999999875546667778889999999999999999999994 44
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC------CCeEEeeecc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN------CKLKVCDFGL 172 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~------~~vkl~DFg~ 172 (381)
+.+|+|||||. |||..+++..+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 57999999999 7999999999999999999999999999999999999999999999999875 3589999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
|+....+. ...+.||+|.|||||++.. +.|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.-...+
T Consensus 162 AR~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~- 234 (429)
T KOG0595|consen 162 ARFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP- 234 (429)
T ss_pred hhhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-
Confidence 99875433 2357799999999999976 7899999999999999999999999999887766654433111100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.....+++...+|+...|+.+|..|.+..+-+.|+++..-
T Consensus 235 ---------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 235 ---------------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ---------------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 0012356777899999999999999999999999998753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=415.81 Aligned_cols=283 Identities=37% Similarity=0.644 Sum_probs=235.9
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-C-----CCccccceeecC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H-----PDIVEIKRIMLP 93 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~ 93 (381)
.+..+|.+++.||+|+||.|-+|.|..|++.||||++++ ......+...|+.+|..|+ | -|+|+++++|..
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 345589999999999999999999999999999999984 3345566778999999997 3 389999999955
Q ss_pred CCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC--CCeEEee
Q 016884 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCD 169 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~--~~vkl~D 169 (381)
. +++|||+|.++.+|.++++.++ .++...++.++.||+.||.+||+.||||+||||+|||+..- ..|||+|
T Consensus 260 r-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 260 R-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred c-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 4 5699999999999999999875 68999999999999999999999999999999999998753 4699999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+|+..... ...++.++.|+|||+++| .+|+.++||||||||++||++|.++|+|.+..+++..|+.++|.
T Consensus 335 FGSSc~~~q~------vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 335 FGSSCFESQR------VYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cccccccCCc------ceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 9999764322 237899999999999999 79999999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCHHHHHHHHH----------------------------hcCC--CC---CCccccCC-CCCHHHHHHHHH
Q 016884 250 PSPETIAVVRNEKARKYLTE----------------------------MRKK--PP---VPLFQKFP-NVDPLALRLLQR 295 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~--~~---~~~~~~~~-~~~~~~~dLi~~ 295 (381)
|++.++...... ..+++. .... .| .++..... .-...+.|+|++
T Consensus 407 Pp~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 407 PPPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 999988765432 112211 1111 11 11111222 223457999999
Q ss_pred hccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 296 LIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 296 ~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
||.+||.+|+|+.++|+||||....
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred HhccCchhcCCHHHHhcCccccccc
Confidence 9999999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=383.84 Aligned_cols=248 Identities=33% Similarity=0.481 Sum_probs=213.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|+|+++||+|+||.||++.+..+|..||.|.++-...+....+.+..|+.+|++|+|||||++++.-.. ++..-+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 56999999999999999999999999999999998655666677789999999999999999999883332 222348
Q ss_pred EEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceEecCCCCeEEeeeccc
Q 016884 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT--AN--VYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~--~~--i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
+||||+|+ |||.++|+. ...++|..+|.++.|++.||.+||+ .+ |+||||||.||+++.+|.|||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999 799999963 4479999999999999999999999 45 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
+...... .+..+++|||+||+||++.+ .+|+.+|||||+||++|||+.-++||.|.+-.+...+|....-.|.|.
T Consensus 176 r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 176 RFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 9865433 34467899999999999988 899999999999999999999999999998777777776543222221
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~ 307 (381)
.-+|.++..||..|+..||+.||+.
T Consensus 251 -----------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 -----------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred -----------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 1367889999999999999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=402.85 Aligned_cols=336 Identities=54% Similarity=0.985 Sum_probs=285.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.+.++|++.+.||+|+||+||+|.+..++..||+|.+............+.+|+.+++.++|+||+++++++........
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45678999999999999999999999999999999987654444445677789999999999999999998866544445
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..+|+|+||+.++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 67999999999999999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. .......++..|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+.......+....+.+.++.+....
T Consensus 162 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 162 G---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred c---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 1 122345688999999987642 358899999999999999999999999998888889999999999888777666
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhh
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (381)
......+................+.+++.+.+||++||+.||++|||++++|+||||..+..+...+..+. .+++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~ 315 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFE 315 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhh
Confidence 66666666655544444444455689999999999999999999999999999999999887777766554 4566777
Q ss_pred hccCCHHHHHHHHHHHHHHhCC
Q 016884 340 RRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
....+++++++++++|.+.+||
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 316 EDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhhcCHHHHHHHHHHHHhhcCC
Confidence 7789999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-55 Score=406.81 Aligned_cols=258 Identities=32% Similarity=0.518 Sum_probs=220.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC--C-hHHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 95 (381)
...++|.+.+.||+|+||+|+.|.+..++..||+|++.+... . ......+.+|+.+++.++ ||||+++++++.+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 345789999999999999999999999999999997765311 1 133456668999999999 99999999999554
Q ss_pred cCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeeccc
Q 016884 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a 173 (381)
.++|+|||||.| +|++.+...++++|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 449999999995 999999998999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCC-CC-CccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
.... .......+.|||+.|+|||++.+. . |+ .++||||+||+||.|++|+.||...+......+|.+.
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~--~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----- 238 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSGK--GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----- 238 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCCC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence 8753 122345678999999999999883 4 54 7899999999999999999999987766555554321
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCC-CHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.......+ |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 239 --------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 --------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11122334 999999999999999999999999999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=402.70 Aligned_cols=332 Identities=41% Similarity=0.802 Sum_probs=273.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 97 (381)
+.+.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 466789999999999999999999999999999999987654444455667899999999999999999998864322 2
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3356899999999999887764 569999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.++....
T Consensus 170 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 170 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 2345799999999998663 4688999999999999999999999999998889999999999998888777
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
........+...+...........+...++.+.+||.+||+.||.+|||+.++|+||||.....+...+...+. ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~ 319 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DES 319 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccc
Confidence 76666666665555444444444556788899999999999999999999999999999987665544433322 223
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCC
Q 016884 338 FERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
......+.+++++..+.+..++.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07878 320 PENKERTIEEWKELTYEEVSSFKP 343 (343)
T ss_pred hhhhhccHHHHHHHHHHHHHhcCC
Confidence 334455678889888888877665
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=411.11 Aligned_cols=262 Identities=29% Similarity=0.496 Sum_probs=229.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+-|++++.||.|+.|.|.+|.|..||+.+|||++.+.. ........+.+||-||+.+.|||++.+++++ ++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence 55899999999999999999999999999999997652 2334456788999999999999999999999 45567
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|.||+. |.|++++...+++++.++.++++||+.||.|||..+|+|||+||+|+|++.++.+||+|||+|.....+.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999998 6999999999999999999999999999999999999999999999999999999999999998754433
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.+.+.||+|.|+|||++.|. ...+.++||||+|||||.|++|+.||++.+....+.++...
T Consensus 167 ----lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G-------------- 227 (786)
T KOG0588|consen 167 ----LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG-------------- 227 (786)
T ss_pred ----cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC--------------
Confidence 35678999999999999983 33467999999999999999999999988776666665542
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (381)
.+....++++++.|||++||.+||++|+|.+||++|||+.+...+...
T Consensus 228 -----------------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 228 -----------------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred -----------------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 233446899999999999999999999999999999999987654433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=403.56 Aligned_cols=256 Identities=34% Similarity=0.585 Sum_probs=230.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+......+...+.+|++|++.++||||+.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999998888888888999999999999999999999999 555679
Q ss_pred EEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
++|+|||.|+|..++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+......
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998765433
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
...+..-|||.|||||++.+ ++|+..+|+||||||+|||.+|++||...+..+....|.+
T Consensus 155 -~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----------------- 214 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----------------- 214 (808)
T ss_pred -eeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc-----------------
Confidence 34567789999999999998 8999999999999999999999999988776555544432
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+..+ .+.++..++.|++.+|..||.+|+|-.++|.|||.++-
T Consensus 215 ----------d~v~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 215 ----------DPVKP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----------CCCCC----cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 11111 24789999999999999999999999999999998763
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=397.83 Aligned_cols=329 Identities=36% Similarity=0.645 Sum_probs=260.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (381)
...++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3568999999999999999999999999999999999865555556677889999999999999999999886542 233
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+||||++++|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 456899999999999888864 488999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...++.|.++.....
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 1234578999999999987 67999999999999999999999999999999999999999999988766544
Q ss_pred cCHHHHHHHHHhcCCCCCCc------------cccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPL------------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (381)
... ...+............ .......+..+++||.+||+.||.+|||+.++|+||||..+.++...+
T Consensus 253 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 253 QPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred hHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 322 2222222111111000 011122467899999999999999999999999999998876655433
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHH
Q 016884 327 SCQPISKLEFEFERRRVTKDDIRELIYREILE 358 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (381)
...+ ...+...+.+..+.+++++.++.++++
T Consensus 332 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 332 APPP-KIPDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred CCCC-CCCCccchhhhccHHHHHHHHHHHHHc
Confidence 2222 111223445567788899999988864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-57 Score=372.83 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=225.4
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...+.|.+.+.||+|.|+.|+++.+..||+.+|+|+++.........+.+.+|++|-+.|+||||+++++.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 345679999999999999999999999999999999875444445677889999999999999999999988 344
Q ss_pred CcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeeccccc
Q 016884 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg~a~~ 175 (381)
...|||+|+|.| +|..-|..+.-++|..+-.+++||++||.|+|.+||+|||+||.|+|+-.. .-+||+|||+|..
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 568999999995 888777766778999999999999999999999999999999999998643 4599999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...+ ......+|||.|||||++.. .+|+.++|||+.|||||-|+.|.+||.+.+.....+.|....-.
T Consensus 163 l~~g----~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd------ 230 (355)
T KOG0033|consen 163 VNDG----EAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD------ 230 (355)
T ss_pred eCCc----cccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC------
Confidence 5422 23467899999999999988 89999999999999999999999999998877777776653211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
-....|+.+++++++||++||..||.+|+|+.++|+|||+.+
T Consensus 231 ---------------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 231 ---------------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ---------------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 122356889999999999999999999999999999999975
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-55 Score=370.46 Aligned_cols=254 Identities=26% Similarity=0.489 Sum_probs=224.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
-++|++++.||.|+||.|.+++++.+|..+|+|++++. .-...+.+...+|..+|+.+.||+++++.+.+ .+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 35799999999999999999999999999999998753 12234455677899999999999999999988 4456
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++||||||.+ |.|..++++.+++++..++.++.||+.||.|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 7999999999 599999999999999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
..+.||||.|+|||++.. .+|+.++|.|||||++|||+.|.+||.+.+.....++|...-
T Consensus 198 ------T~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------------ 257 (355)
T KOG0616|consen 198 ------TWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------------ 257 (355)
T ss_pred ------EEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------------
Confidence 246799999999999988 799999999999999999999999999999888888886521
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCC-----CCHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~R-----pt~~~lL~hp~~~~~ 319 (381)
...++-++++++|||+++|+.|-.+| ....+|-+||||+++
T Consensus 258 -------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 258 -------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred -------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 11124589999999999999999999 357899999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=349.80 Aligned_cols=279 Identities=38% Similarity=0.652 Sum_probs=240.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|.-.++||+|.||+|++|+++.+++.||+|.++-...+..-....+||+.+|+.++|.|||+++++..+. ..+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----cee
Confidence 357778999999999999999999999999999976555555556788999999999999999999998433 459
Q ss_pred EEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
.+|+|||..+|..+..+ ++.+..+.++.++.|+++||.|+|++++.|||+||+|+|++.+|++||+|||+|+..+-.
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 99999999999999876 678999999999999999999999999999999999999999999999999999865332
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
...++..+.|.||++|.++.|. .-|+.+.|+||.|||++|+.. |++.|+|.+..+++.+|..++|+|..+.|+.+..
T Consensus 155 -vrcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred -eEeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 2234566899999999999885 679999999999999999997 8999999999999999999999999887765432
Q ss_pred HHHHHHHHHhcCCCC-------CCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPP-------VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+....+ ..+.+..++++...+||++++|..+|.+|++|+.+|+||||...
T Consensus 233 ---------lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 ---------LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ---------CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 122222 22334456778889999999999999999999999999999764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=389.11 Aligned_cols=285 Identities=36% Similarity=0.658 Sum_probs=234.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.-++|++.+.||.|+||+||+|++..++..||+|+++..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 75 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT-----E 75 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 4457899999999999999999999999999999998643221 223456789999999999999999999843 3
Q ss_pred CcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+.++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 76 RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 4689999999999999887644 589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ......+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.|.++.+...
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred CCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 211 12345789999999988653 56899999999999999999999999999999999999999999998877654
Q ss_pred cCHH-HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEK-ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.... +..+. .......+.....+.+++++.|||++||++||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 3321 11111 11111222233345789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=393.31 Aligned_cols=334 Identities=50% Similarity=0.872 Sum_probs=273.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..+++|++.+.||+|++|.||+|.+..+++.||+|++... ........+.+|+.+++.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4568999999999999999999999999999999998642 223345567889999999999999999998866555555
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..+|+|+||+.++|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 67899999999999988854 47999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
...........||+.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+.......+...++.|.++.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 2222222345789999999987542 468899999999999999999999999999888899999999999888777666
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhh
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (381)
......++.........+.....+..++++.+||.+||+.||++|||+.++++||||+.+.+...++..++...++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 65555555554444444444445678999999999999999999999999999999999887766666544444444333
Q ss_pred hccCCHHHHHHHHHHHHH
Q 016884 340 RRRVTKDDIRELIYREIL 357 (381)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~ 357 (381)
+...++.++++++.+++
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 45568899999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-53 Score=395.92 Aligned_cols=327 Identities=36% Similarity=0.661 Sum_probs=252.9
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (381)
...++|++++.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4568999999999999999999999999999999999765555556677889999999999999999999986543 233
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 456899999999998888754 589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+..+.|..+.....
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 1234578999999999987 68999999999999999999999999999988889999999999887665443
Q ss_pred cCHHHHHHHHHhcCCCCCCccc------------cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQ------------KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (381)
.. ....+.............. .....++.+++||.+||+.||++|||+.|+|+||||..+..+....
T Consensus 250 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 328 (359)
T cd07876 250 QP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328 (359)
T ss_pred HH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCccccc
Confidence 21 1222222211111111111 1122467899999999999999999999999999998765544322
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHH
Q 016884 327 SCQPISKLEFEFERRRVTKDDIRELIYREI 356 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (381)
...+. ......+.+....+++.+.+...+
T Consensus 329 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 357 (359)
T cd07876 329 APPPQ-IYDAQLEEREHAIEEWKELIYKEV 357 (359)
T ss_pred CCCcc-ccccccccccccHHHHHHHHHHHh
Confidence 21111 112222344555666666665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-53 Score=397.84 Aligned_cols=330 Identities=42% Similarity=0.711 Sum_probs=261.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|++.+.||+|+||.||+|.+..+++.||+|++...........++.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999876555555567888999999999999999999998765433445799
Q ss_pred EEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
+||||+.++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999976433221
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......+|+.|+|||++.+. ..++.++||||+||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 122345789999999998763 4578999999999999999999999999999999999999999998876554332 22
Q ss_pred HHHHHHhcCCCCC--CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc--------------------
Q 016884 264 RKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK-------------------- 321 (381)
Q Consensus 264 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~-------------------- 321 (381)
...+.......+. .........++++.+||.+||++||.+|||+.++|+||||....-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYT 316 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCC
Confidence 2222211111111 011223456899999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHh
Q 016884 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359 (381)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (381)
...+|.. ...+++..+....+..++++.+..++.+.
T Consensus 317 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (372)
T cd07853 317 SDFEPSA--NPPFDDEYEKNLTSVRQVKEELHQFILEQ 352 (372)
T ss_pred cccCCCC--CCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence 0111111 12334455555677788888888877654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=393.05 Aligned_cols=264 Identities=29% Similarity=0.468 Sum_probs=224.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|+++..||+|+||.||+|+.+.||..+|+|++++... ...+..-++.|-.+|....+|.||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 34689999999999999999999999999999999986533 234456788899999999999999999998 556
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.++||||||++ ||+..+|...+.|+++.++.++.+++.|+.-||..|++||||||+|+|||..|.+||+|||++.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 77999999999 59999999999999999999999999999999999999999999999999999999999999853211
Q ss_pred C--------------------CCCcc------------------------cccccccCccccCccccccccCCCCCccch
Q 016884 179 D--------------------TPMTV------------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (381)
Q Consensus 179 ~--------------------~~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 214 (381)
. ..... .....+|||.|+|||++.+ .+|+..+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 00000 0123589999999999999 789999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHH
Q 016884 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294 (381)
Q Consensus 215 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 294 (381)
||||||+||||.|.+||.+.+..+...+|...-.+. . ...-..+++++.|||.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------------~------fP~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------------K------FPEEVDLSDEAKDLIT 424 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------------c------CCCcCcccHHHHHHHH
Confidence 999999999999999999999998888887532110 0 0111357899999999
Q ss_pred HhccCCCCCCC---CHHHHhcCCCcCcC
Q 016884 295 RLIAFDPKDRP---TAEEALADPYFKGL 319 (381)
Q Consensus 295 ~~L~~dp~~Rp---t~~~lL~hp~~~~~ 319 (381)
+||. ||++|. +++||-+||||+++
T Consensus 425 rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999 999997 59999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=371.31 Aligned_cols=295 Identities=38% Similarity=0.632 Sum_probs=239.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.-..|+++..||+|.||.||+|..+.++. .+|||+++.............||+..++.++|||++.+..++...
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-- 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-- 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence 34579999999999999999997665543 689999976544434445677999999999999999999999764
Q ss_pred CCCCcEEEEeeccccCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC----CCeEE
Q 016884 97 REFKDIYVVFELMESDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKV 167 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~----~~vkl 167 (381)
...+++++||.+.||+++|+- ...++...++.|++||+.|++|||++.|+||||||.|||+..+ |.|||
T Consensus 100 --d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 --DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred --CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 246999999999999999963 2368999999999999999999999999999999999999887 89999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC---------hhh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---------VVH 238 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~ 238 (381)
+|||+|+.....-..-......+.|.||+|||+++|. ..|++++||||+|||++||++-.+.|.+.. ..+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999865543332233467899999999999886 789999999999999999999999997643 467
Q ss_pred HHHHHHHhhCCCCHHHHhhhcC-HHHHHHHHHhcCCCCCC-----ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 239 QLDLITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP-----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
++.+|.+++|+|..+.|+.... +.....+..++...... .......-++.+.+|+.+||.+||.+|+|++++|+
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 8999999999999988776543 23323333333221111 12233345677999999999999999999999999
Q ss_pred CCCcCcCc
Q 016884 313 DPYFKGLA 320 (381)
Q Consensus 313 hp~~~~~~ 320 (381)
|+||..-.
T Consensus 337 h~yF~~d~ 344 (438)
T KOG0666|consen 337 HPYFTEDP 344 (438)
T ss_pred ccccccCC
Confidence 99998643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=390.32 Aligned_cols=328 Identities=36% Similarity=0.639 Sum_probs=254.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 98 (381)
...++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34579999999999999999999999999999999998665555666778899999999999999999998865432 33
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+||||+++++.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 456899999999999888864 589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...++.+.++.....
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 1234579999999999987 67899999999999999999999999999998999999999999888766554
Q ss_pred cCHHHHHHHHHhcCCCCCC------------ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVP------------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (381)
... ...+........... ........+..+.+||.+||+.||++|||+.|+|+||||..+..+....
T Consensus 246 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~ 324 (355)
T cd07874 246 QPT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVE 324 (355)
T ss_pred cHH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhcc
Confidence 322 222222111110000 0111123467889999999999999999999999999998765432221
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHH
Q 016884 327 SCQPISKLEFEFERRRVTKDDIRELIYREIL 357 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (381)
... ........+....+.+++.+.++.+++
T Consensus 325 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T cd07874 325 APP-PQIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_pred CCC-ccccccchhhhhccHHHHHHHHHHHhh
Confidence 111 111111223344566777777776653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=388.15 Aligned_cols=330 Identities=50% Similarity=0.921 Sum_probs=277.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|++|.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCc
Confidence 457899999999999999999999999999999998765444445567788999999999999999999875543 3445
Q ss_pred cEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.+|+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred eEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999999999999888889999999999999999999999999999999999999999999999999987543322
Q ss_pred CC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ........++.+|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+....+..+....|.|+.+.+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 1112345789999999987653 458899999999999999999999999999999999999999999998888777
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhh
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (381)
..................+....+..++.+.++|.+||+.||++|||++++|.||||.+...++.++.+.+ .+++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFE 318 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC--CCCCChh
Confidence 77666666666555555555556778999999999999999999999999999999999888887777543 4566677
Q ss_pred hccCCHHHHHHHHHH
Q 016884 340 RRRVTKDDIRELIYR 354 (381)
Q Consensus 340 ~~~~~~~~~~~~~~~ 354 (381)
....+.+.+.+.|.+
T Consensus 319 ~~~~~~~~~~~~~~~ 333 (334)
T cd07855 319 AIELSREQLKEAIVK 333 (334)
T ss_pred hhhcChhhHHHHhhc
Confidence 777777777766543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=385.52 Aligned_cols=333 Identities=43% Similarity=0.819 Sum_probs=281.3
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+...++|++.+.||+|++|.||+|++..++..||+|++............+.+|+.+++.++|||++++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3456788999999999999999999999999999999987544444455677889999999999999999988755432
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.....+|+|+||++++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 33456899999999999998875 47999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.+..+.
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 322 2345788999999988652 367889999999999999999999999999888899999999999988888
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.+.......+...............+...++.+.+||.+||+.||++|||+.++|+||||..+...+.++... ..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~---~~~~ 318 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP---PYDQ 318 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccccc---ccCc
Confidence 7777777666665555544444445567799999999999999999999999999999999987776655522 2345
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCC
Q 016884 337 EFERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
+++...++.++|+++++.++++|.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 319 SFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred chhhhhcCHHHHHHHhHHHHHhccC
Confidence 6778889999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=375.40 Aligned_cols=275 Identities=29% Similarity=0.407 Sum_probs=225.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...+.|++.+.||.|..++||+|+...+++.||||++.-...+ ...+.+.+|+..|+.++||||++++..|....
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~---- 97 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS---- 97 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc----
Confidence 3467899999999999999999999999999999999754322 34778999999999999999999999996553
Q ss_pred CcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.+|+||.+|. |++.++++.. ..++|..+..|+++++.||.|||.+|-+|||||+.|||++.+|.|||+|||.+...
T Consensus 98 -~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 98 -ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred -eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 4999999999 7999999864 35999999999999999999999999999999999999999999999999987654
Q ss_pred cCCCCCcccc-cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.......... ...+||++|||||++.+.-.+|+.++||||||++..||++|..||.....+..+ +.++-+.|+--..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 4433322222 678999999999997655578999999999999999999999999876655443 3333343331111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
... .......++..++++|..||+.||.+||||+++|+|+||+....
T Consensus 255 ~~~-------------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 255 SGL-------------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ccC-------------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 111 11112346778999999999999999999999999999997654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=385.82 Aligned_cols=330 Identities=56% Similarity=0.975 Sum_probs=281.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999976544445566788999999999999999999998765434455799
Q ss_pred EEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
+||||+.++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||.+..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999887899999999999999999999999999999999999999999999999999997654432211
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++++|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.+..+....+....+.|.++.+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223455789999999999873 2789999999999999999999999999999999999999999999888776666677
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhhhccC
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (381)
..+..........+.....+.+++.+.+||.+||++||.+|||++++|+||||+++..+..++.......+. .++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 777776666666666666778999999999999999999999999999999999988877776665554331 3566678
Q ss_pred CHHHHHHHHHHH
Q 016884 344 TKDDIRELIYRE 355 (381)
Q Consensus 344 ~~~~~~~~~~~~ 355 (381)
++++.++++++|
T Consensus 319 ~~~~~~~~~~~~ 330 (330)
T cd07834 319 TEEELKELIYEE 330 (330)
T ss_pred CHHHHhHHhhcC
Confidence 999999888764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=381.49 Aligned_cols=290 Identities=34% Similarity=0.593 Sum_probs=225.7
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++..++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec-----
Confidence 45678999999999999999999999999999999998743222 223456789999999999999999999843
Q ss_pred CCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+||||+.++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 3569999999999999888764 568999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ......++|+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.. ..+.+..+....+.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 112345789999999998652 458889999999999999999999998754 445667777777777655443
Q ss_pred hhcCHHHHHHH-HHhcCCCCCCccccC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 257 VVRNEKARKYL-TEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 257 ~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...... .+. .......+......+ ...++.+.+||.+||+.||.+|||+.++|+||||+++.
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLP--HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhcc--ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 221100 000 000000011111111 13567899999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=378.28 Aligned_cols=285 Identities=35% Similarity=0.635 Sum_probs=225.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|+||+||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 4799999999999999999999999999999998754333344567789999999999999999999883 34569
Q ss_pred EEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+.+++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766665543 45799999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+....+..+.+........
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234578999999999987 67899999999999999999999999998888888888877777665544322111
Q ss_pred HHHHHHHHhcCCCCCC-ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVP-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.............+.. .......+++++.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000000000000 011123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=378.36 Aligned_cols=284 Identities=35% Similarity=0.594 Sum_probs=228.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~ 98 (381)
++|++++.||+|+||+||+|.+.. ++..||+|+++...........+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 568899999875433333334556777777665 6999999999986443344
Q ss_pred CCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+++||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 4569999999999999998753 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1234578999999999977 678999999999999999999999999999999999999988888765433
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...... ...+............+.+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211000 00111222233334446789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-53 Score=375.29 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=212.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..++...+.||+|+||.||++.+..+|..+|||.+... +......+.+|+.+|+.++|||||++++....... ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---ee
Confidence 45688999999999999999999999999999998754 22226678899999999999999999987433221 35
Q ss_pred EEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~ 178 (381)
+++.|||+. |+|.+++...+ .+++..++.+++||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 899999999 69999999876 7999999999999999999999999999999999999999 79999999999876543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC-ChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
............||+.|||||++.+. ...++++|||||||++.||+||.+||... ...+.+..+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-------------
Confidence 11111223457899999999999851 23345999999999999999999999763 2221111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
... ..+ .....+|++++++|.+||..||++||||+++|+|||.++.
T Consensus 237 -------------~~~-~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 237 -------------RED-SLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------------ccC-CCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111 111 3345699999999999999999999999999999999764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=396.44 Aligned_cols=287 Identities=35% Similarity=0.595 Sum_probs=228.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc---C
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~ 97 (381)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3568999999999999999999999999999999885321 123479999999999999999998765432 1
Q ss_pred CCCcEEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeecc
Q 016884 98 EFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGL 172 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~ 172 (381)
....+++||||++++|.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 223578999999998887775 345799999999999999999999999999999999999999764 699999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
|+....... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 976533222 2345789999999998653 46899999999999999999999999999999999999999999987
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+.+....... ... .+....+..+...+ ...++++.+||.+||++||.+|||+.|+|+||||..+..
T Consensus 293 ~~~~~~~~~~-~~~--~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPNY-ADI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchhh-hcc--cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 7655332110 000 00001111111112 247889999999999999999999999999999988754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=377.46 Aligned_cols=267 Identities=27% Similarity=0.438 Sum_probs=219.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc------------CChHHHHHHHHHHHHHHhcCCCCcccc
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF------------EHISDAIRILREVKLLRLLRHPDIVEI 87 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 87 (381)
..-++|++++.||+|.||+|.+|++..+++.||||++.+.. ......+++.+||.||++|.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999999999999999996321 112234578999999999999999999
Q ss_pred ceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
+++.-++ ..+.+|||+|||. |.+. +.-..++ +++.+++.|++.++.||.|||.+||+||||||+|+|++.+|+|
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9998554 3467999999999 4443 3333445 9999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCC--CCCcccccccccCccccCccccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 016884 166 KVCDFGLARVAFSD--TPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (381)
Q Consensus 166 kl~DFg~a~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 241 (381)
||+|||.+.....+ ......+...+|||.|+|||.+.+. ....+.+.||||+||+||.|+.|+.||.+....+...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999998654222 2223334557899999999998762 1335678999999999999999999999998888887
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+|.+.-- .....+.+.+.++|||.+||++||++|++..++-.|||....
T Consensus 330 KIvn~pL-----------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPL-----------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcc-----------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 7765110 011234678999999999999999999999999999998764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=377.30 Aligned_cols=291 Identities=38% Similarity=0.671 Sum_probs=238.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++..++|++++.||+|+||+||+|+++.+++.||+|.++..... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT----- 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 34557899999999999999999999999999999998643222 223456789999999999999999999843
Q ss_pred CCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....|+||||+.++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 3468999999999999888754 458999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......+|+.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2211 12344688999999988653 4688999999999999999999999999999999999999999998877665
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.......... ......+.......+.+++++.+||.+||+.||.+|||+.++|+||||+.+.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNY-NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhh-hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 4432211111 1222223333345567899999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=384.93 Aligned_cols=259 Identities=29% Similarity=0.506 Sum_probs=221.6
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.-+....|....+||+|+.|.||.|+...+++.||||.+....+ ....-+++|+.+|+..+|+|||++++.|...
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--- 342 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVG--- 342 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhccc---
Confidence 44556789999999999999999999999999999999975333 3345678999999999999999999998654
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.+++|||||+ |+|.+++... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++...
T Consensus 343 --deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 343 --DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred --ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 45999999999 4777777654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ...+.+|||+|||||++.. ..|++++||||||+++.||+-|.+||-..+....+..|.. -|+
T Consensus 420 ~~~~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~------- 486 (550)
T KOG0578|consen 420 SEEQS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT------- 486 (550)
T ss_pred ccccC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCC-------
Confidence 44433 3467799999999999987 7899999999999999999999999987666555444432 122
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
+.......+|+.++|||.+||+.|+++|+||.+||+||||+
T Consensus 487 --------------------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 487 --------------------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred --------------------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 22333467999999999999999999999999999999994
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=387.65 Aligned_cols=282 Identities=27% Similarity=0.369 Sum_probs=222.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||.||+|++..+++.||+|... ...+.+|+.+|+.++||||+++++++.. ....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCee
Confidence 57999999999999999999999999999999753 2345789999999999999999999844 3458
Q ss_pred EEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
|+|+|++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999865322111
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC-------ChhhHHHHHHHhhCCCCHHHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~ 255 (381)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. +...++..+....|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11234679999999999987 68999999999999999999999877543 234566777777777654322
Q ss_pred hhhcCHHHHHHH-HHhcCCC--C--CCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 256 AVVRNEKARKYL-TEMRKKP--P--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 256 ~~~~~~~~~~~~-~~~~~~~--~--~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.... ....... ....... + .+.......++.++.+||.+||++||.+||||+++|+||||+.+..+
T Consensus 315 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 315 IDAQ-ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred cchh-HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 1111 1111111 1111111 1 11111223467789999999999999999999999999999876543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=376.79 Aligned_cols=333 Identities=40% Similarity=0.749 Sum_probs=275.3
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+...++|++++.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3557789999999999999999999999999999999986544444445578899999999999999999998865432
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
......|+||||++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 22345799999998899888864 57999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+.......+.+..+.+..+...
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 322 1234678999999998652 357889999999999999999999999988888888888888888777777
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.........+...+....+.......+.+++.+.++|.+||+.||.+|||+.+++.||||+.....+.++...+ +..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~ 318 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDD 318 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---ccc
Confidence 66666556665555444443444455678999999999999999999999999999999998876655544333 455
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCC
Q 016884 337 EFERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
.+++...+.++|+.+..-|++++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 319 SFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred cHHhhccchHHHHHHHHHHHHhcCC
Confidence 6777788999999999999999876
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=379.23 Aligned_cols=327 Identities=38% Similarity=0.664 Sum_probs=258.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (381)
...++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... ..+
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3568899999999999999999999999999999998765555555667789999999999999999999886543 234
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
....|+||||+.++|.+.+... +++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 4568999999999999988754 89999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...++.|.++.....
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 171 SFM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 221 234568899999999987 68899999999999999999999999999988899999999999988766554
Q ss_pred cCHHHHHHHHHhcCCCCCCcccc-------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQK-------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (381)
.... ..+............... ....++.+.+||.+||++||++|||+.++|.||||+.+......
T Consensus 245 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~ 323 (353)
T cd07850 245 QPTV-RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEV 323 (353)
T ss_pred hhhh-hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccC
Confidence 3221 111111111111111010 12346678999999999999999999999999999987664433
Q ss_pred CCCCCCCCcchhhhhccCCHHHHHHHHHHHH
Q 016884 326 PSCQPISKLEFEFERRRVTKDDIRELIYREI 356 (381)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (381)
... .....+...+.+..+.++|++.++.++
T Consensus 324 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (353)
T cd07850 324 EAP-PPAPYDHSIDEREHTVEEWKELIYKEV 353 (353)
T ss_pred CCC-CCCccccccccccccHHHHHHHHHhhC
Confidence 221 112233445666778899998877653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=372.98 Aligned_cols=283 Identities=35% Similarity=0.596 Sum_probs=226.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+|++++.||+|+||+||+|+++.+++.||+|.++.............+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999999875332222223445677776655 799999999998655444456
Q ss_pred cEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 78999999999999988764 3589999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 211 234578999999999977 67899999999999999999999999998888888888888877765443221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.... ........+.......+.++..+.+||.+||+.||++|||+.++|.||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 00111122223334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=368.86 Aligned_cols=253 Identities=29% Similarity=0.531 Sum_probs=223.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..||++.+.||+|.||+|-+|++...|+.||||.+++. .....+...+.|||+||..|+||||+.++++| +..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 46899999999999999999999999999999998754 34556677899999999999999999999999 5556
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+.|||||.. |+|++++...+.+++.+++.+++||+.|+.|||.++++|||||.+|||+|.++++||+|||++..+..
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 6999999998 79999999999999999999999999999999999999999999999999999999999999976533
Q ss_pred CCCcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
..+..++||+|.|.+||++.| .+| ++.+|.|||||+||.|+.|..||+|.+....+..|......
T Consensus 206 ---~kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--------- 271 (668)
T KOG0611|consen 206 ---KKFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--------- 271 (668)
T ss_pred ---ccHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---------
Confidence 234678999999999999998 444 67899999999999999999999999877666665542111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
-+.-+..+.-||+.||-.||++|.|++++-+|=|.+
T Consensus 272 -----------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 -----------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 134567789999999999999999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-53 Score=356.03 Aligned_cols=291 Identities=42% Similarity=0.730 Sum_probs=247.9
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
+--+.||.|+||.||.+.|..+|+.||+|++...+.+....+++.+|+++|..++|.|++..+++..+.....+..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999999999999999998888888888899999999999999999999999988877777889999
Q ss_pred eeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 106 FELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 106 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
+|.|..+|..+|.+...++.++++-+++||++||+|||+.||.||||||.|+|++.|+.+||||||+|+....+.. ..
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LN 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987544332 33
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.+..+.|.+|+|||++.|. ..|+.++||||+|||+.||+..+.+|...+..+++..|.+++|+|+.|.+..-......-
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 4666889999999999885 789999999999999999999999999999999999999999999988765433322222
Q ss_pred HHHHhcCCCCCC-ccccCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVP-LFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~-~~~~~~--~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.++.-.+.+..+ ++...+ ....+..+++.+||.+||++|++..+++.|+|+...
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 222111111111 111111 345678999999999999999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=372.43 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=214.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 46999999999999999999999999999999986432 12234456788999999999999999998873 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999987643221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23479999999999987 67899999999999999999999999887655444333220
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
. ......+++.+.+||++||+.||.+||+ ++++++||||+.+
T Consensus 214 ------------~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 214 ------------K-----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ------------C-----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 0112346889999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=373.41 Aligned_cols=331 Identities=39% Similarity=0.743 Sum_probs=267.7
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 97 (381)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 455678999999999999999999999999999999987544333344567899999999999999999999865422 2
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....+|+|+||+..+|..++. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 334579999999988877653 368999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+....+..+....+.+.+.....
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 1345688999999998652 3578899999999999999999999999988888899999999888888777
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
........+...............++..++.+.+||.+||+.||.+|||++++|.||||+.+...+.++... .+..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~---~~~~~ 318 (342)
T cd07879 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQ---PYDDS 318 (342)
T ss_pred hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCC---cccch
Confidence 666555554444333333333444567889999999999999999999999999999999987654444322 23444
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCC
Q 016884 338 FERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
.+......+++...+|+|+.++.|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 319 LENEKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhhhhCCHHHHHHHhhhhhhccCC
Confidence 455567778999999999887765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=354.79 Aligned_cols=308 Identities=32% Similarity=0.510 Sum_probs=254.1
Q ss_pred cccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcccccee
Q 016884 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90 (381)
Q Consensus 11 ~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (381)
.+..++......+.|.-+.+||+|.||.||+|+.+.+|+.||+|++-............++|+++|..|+|+|++.++++
T Consensus 5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence 34455667788899999999999999999999999999999999875333333444567899999999999999999998
Q ss_pred ecCC---CcCCCCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeE
Q 016884 91 MLPP---SKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (381)
Q Consensus 91 ~~~~---~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vk 166 (381)
+-+. ...+...+|+||++|+.+|.-++... .+++..+++.++.+++.||.|+|++.|+|||+||.|+|++.+|.+|
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred HhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence 8643 22344569999999999999999765 5799999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCC-CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 167 VCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 167 l~DFg~a~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
|+|||+|+..... ......++..+.|.||++||++.|. ..|+++.|||..|||+++|.+|.+.|.+.+...++..|..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999754332 2223346777889999999999885 7899999999999999999999999999999999999999
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHH--hcCCCCCCcccc--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTE--MRKKPPVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
++|.-.++.|+.+.+-...+.++. +.+......... .-.-++++.||+.+||..||.+|++++++|+|.||..-
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 999999999988776655554421 111111111111 11236789999999999999999999999999999653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=371.83 Aligned_cols=332 Identities=42% Similarity=0.808 Sum_probs=273.7
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 97 (381)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456689999999999999999999999999999999997654444445678899999999999999999998864321 2
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.....|+++++++++|.+++... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 33458999999988998887654 69999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. .....+++.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+....+..+....+.+.+.....
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 1345788999999987652 4678899999999999999999999999888888888988899998888877
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
+.......++..+...............++.+.+||.+||+.||.+|||+.++|.||||.++..++.++...+ .+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~ 321 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQS 321 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCc
Confidence 7666666666555444444444444567899999999999999999999999999999999877776665432 3444
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCC
Q 016884 338 FERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
...+..-.+++....|.|+..|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 322 FESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred chhcccCHHHHHHHHHHHHHhcCC
Confidence 555566668899999999988876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=376.36 Aligned_cols=263 Identities=32% Similarity=0.502 Sum_probs=226.2
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
......|++.+.||+|.||.||.|+++.||+.+|+|.+.+.... ......+.+|+.+|++++ ||||+.++++|.+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--- 107 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--- 107 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc---
Confidence 44567899999999999999999999999999999999764332 234567889999999998 9999999999944
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC----CCeEEeeec
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFG 171 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~----~~vkl~DFg 171 (381)
...+|+|||+|. |+|.+.+... .+++..+..++.|++.|++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 108 --~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 --PDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred --CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 456999999999 6999998876 49999999999999999999999999999999999998643 479999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
+|..... .......+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+.......|...
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----- 253 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----- 253 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----
Confidence 9987654 223467899999999999987 78999999999999999999999999998876665544332
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...-....|+.++..+.++|++||..||.+|+|+.++|+|||+++..
T Consensus 254 ----------------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 254 ----------------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ----------------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 11223455788999999999999999999999999999999998753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=391.64 Aligned_cols=284 Identities=27% Similarity=0.420 Sum_probs=224.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC------CCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 95 (381)
.++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+.| .+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 478999999999999999999999999999999986421 222344567777777654 4577787777432
Q ss_pred cCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCC-----------
Q 016884 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANC----------- 163 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~----------- 163 (381)
..++|+|||+++++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 2468999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----CeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh
Q 016884 164 -----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (381)
Q Consensus 164 -----~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 238 (381)
.+||+|||.+...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCccc------cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987542211 234689999999999988 689999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc---------ccC--CCCCHHHHHHHHHhccCCCCCCCCH
Q 016884 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---------QKF--PNVDPLALRLLQRLIAFDPKDRPTA 307 (381)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~~~~~~~~dLi~~~L~~dp~~Rpt~ 307 (381)
.+..+.+.+|.++.++...........++.......+.... ... ...++.+.|||.+||++||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999998887766543333333333222111100000 000 0125678899999999999999999
Q ss_pred HHHhcCCCcCcCc
Q 016884 308 EEALADPYFKGLA 320 (381)
Q Consensus 308 ~~lL~hp~~~~~~ 320 (381)
+|+|+||||....
T Consensus 433 ~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 433 RQMTTHPYVLKYY 445 (467)
T ss_pred HHHhcCccccccC
Confidence 9999999998754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=351.33 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=221.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-----CCh-HHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-----EHI-SDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
..|.-.+.||+|..++|.++.++.+|..+|+|++.... ... .-.+.-.+|+.||+++ .||+|+.+.++|.+++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45888899999999999999999999999999986321 111 1123456799999998 5999999999996554
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|.|. |.|++++.+.-.+++...+.||+|+++|+.|||.++|+||||||+|||++++.++||+|||+|+
T Consensus 97 -----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 -----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred -----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 4899999999 8999999988889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
....+. .....||||.|+|||.+... ..+|+..+|+||+|||+|.|+.|.+||.....+-.+..|+..
T Consensus 172 ~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG---- 243 (411)
T KOG0599|consen 172 QLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG---- 243 (411)
T ss_pred ccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc----
Confidence 765543 34677999999999987432 256899999999999999999999999887665555555442
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...-....|.++|..++|||.+||+.||.+|+|++++|.||||.++.
T Consensus 244 -----------------------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 244 -----------------------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -----------------------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 12222345678999999999999999999999999999999997654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=375.58 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=214.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.+.|++.+.||+|+||.||+|+++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 367999999999999999999999999999999986431 122344568899999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 6999999998 599999998888999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------- 230 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------- 230 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 1 23579999999999987 67899999999999999999999999877654443333210
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
. ......+++.+.+||.+||+.||.+||+ ++++++||||+..
T Consensus 231 -------------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 231 -------------R-----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred -------------C-----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 0 0111347889999999999999999997 7999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=369.84 Aligned_cols=327 Identities=47% Similarity=0.816 Sum_probs=266.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+|++.+.||+|+||.||+|.+..+ +..||+|++............+.+|+.+++.+ +||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 89999999875444444456778899999999 5999999988754321 2335
Q ss_pred cEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.+|+++|+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997543222
Q ss_pred CC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ........||+.|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+....+..+...+|.|..+......
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112345789999999987552 468899999999999999999999999999899999999999999888777666
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhh
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (381)
.......................+..+..+.+|+.+||+.||.+|||+.+++.||||+.+.++...+.|.......++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 5555555444444444444445567789999999999999999999999999999999998888888886655444432
Q ss_pred hccCCHHHHHHHHHHH
Q 016884 340 RRRVTKDDIRELIYRE 355 (381)
Q Consensus 340 ~~~~~~~~~~~~~~~~ 355 (381)
+.+.++++.+|..+
T Consensus 318 --~~~~~~~~~~~~~~ 331 (332)
T cd07857 318 --EDSMEELRDMIIEE 331 (332)
T ss_pred --cccHHHHHHHHhhc
Confidence 34567777777655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=373.92 Aligned_cols=250 Identities=26% Similarity=0.458 Sum_probs=209.6
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999875322 22344567889999999999999999998843 456999999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
|+. ++|.+.+..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 58999998888999999999999999999999999999999999999999999999999999875322111 12
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 34579999999999987 6799999999999999999999999987665433332221
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.. ......+++++.+||.+||+.||++|| ++.++++||||.++
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----EE-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 011246889999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=381.49 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=220.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 100 (381)
++|++++.||+|+||+|++|..+.+++.+|||++++.. -...+.+....|.+|+...+ ||.++.++..| ++.+
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~~ 442 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTKE 442 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccCC
Confidence 57999999999999999999999999999999998643 23345667788999998885 99999999999 4456
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++|+||||+.| + .-.++..+.+++..++.|+..|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++-....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 79999999995 6 444455678999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ..+++||||.|+|||++.+ ..|+.++|.|||||+||||+.|..||+|.+..+..+.|..-
T Consensus 522 g~---~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------- 583 (694)
T KOG0694|consen 522 GD---RTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------- 583 (694)
T ss_pred CC---ccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 22 2367899999999999998 89999999999999999999999999999988887777541
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
....+..+|.++.++++++|..||++|.. +++|..||||+.+
T Consensus 584 ------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 584 ------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 11122468999999999999999999985 6889999999976
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=350.39 Aligned_cols=275 Identities=30% Similarity=0.463 Sum_probs=224.1
Q ss_pred cccCCCCCeEE-eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 17 TEYGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 17 ~~~~~~~~Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
.++.+.++|++ -++||-|-.|.|..|.++.|++.+|+|++.+ ..+..+|++..-.. .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 78888899988 4779999999999999999999999998853 35667899886666 599999999998543
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEe
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVC 168 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~ 168 (381)
.....++.+|||.|+ |+|+..++.++ .++|.++..|++||+.|+.|||+.+|.||||||+|+|++. |..+||+
T Consensus 128 -~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 -YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred -ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 345678999999999 59999999876 4999999999999999999999999999999999999975 5669999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
|||+|+.... .....+.|-||+|.|||+++. ..|+..+|+||+||++|.|++|.+||........
T Consensus 207 DfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--------- 271 (400)
T KOG0604|consen 207 DFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------- 271 (400)
T ss_pred ccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccC---------
Confidence 9999975432 223456799999999999987 7899999999999999999999999987653211
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (381)
++.+-.. ++..........|..+|.+++|+|+++|..+|.+|.|+.++++|||+.+.......+.+
T Consensus 272 --spgMk~r------------I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 272 --SPGMKRR------------IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred --ChhHHhH------------hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 1111111 11111112233456789999999999999999999999999999999987665555443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=368.56 Aligned_cols=281 Identities=35% Similarity=0.600 Sum_probs=214.3
Q ss_pred eeeecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 568999999999999975 4678999999864321 234668999999999999999999885432 2468999
Q ss_pred eeccccCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe----cCCCCeEEeeecc
Q 016884 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (381)
Q Consensus 106 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~----~~~~~vkl~DFg~ 172 (381)
|||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887532 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------hhHHHHH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i 243 (381)
|+...............+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 97654332222223456789999999998763 4589999999999999999999999975432 3567788
Q ss_pred HHhhCCCCHHHHhhhcCH-HHHHHHHHhcCCCCC------CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 244 TDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPV------PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
....|.|....+...... ............... .........+..+.|||.+||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 888888877655443211 111111111111000 0011112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=339.81 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=224.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
...-++|++.+.||+|.||.||+|+.+.++..||+|++.+. ........++.||++|...|+||||++++++|.+.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--- 94 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--- 94 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---
Confidence 34457899999999999999999999999999999998643 22233455788999999999999999999999554
Q ss_pred CCCcEEEEeeccc-cCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~--~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
..+|+++||.. |+|+..++ ...++++...+.++.|++.||.|+|..+++||||||+|+|++..+.+|++|||.+.
T Consensus 95 --~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 95 --KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred --ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 45999999998 79999998 56689999999999999999999999999999999999999999999999999886
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
.... ....+.|||..|.|||...+ ..++..+|+||+|++.||++.|.+||...+..+.+.+|.+..-.
T Consensus 173 ~~p~-----~kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~----- 240 (281)
T KOG0580|consen 173 HAPS-----NKRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK----- 240 (281)
T ss_pred ecCC-----CCceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-----
Confidence 5322 22356799999999999988 78999999999999999999999999998877777777653211
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
..+.++..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 241 --------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 --------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 12578999999999999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=369.61 Aligned_cols=329 Identities=44% Similarity=0.769 Sum_probs=265.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.++|++.+.||+|+||.||+|.+..+++.+|+|++............+.+|+.+++.+ +||||+++++++... +.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 45789999999999999999999999999999999865444444556677899999999 999999999987432 22
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..+|+||||+.++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 458999999999999998776 7899999999999999999999999999999999999999999999999998765433
Q ss_pred CCC--cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 180 TPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ........|++.|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+..+....+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1123345789999999987652 4678899999999999999999999999998888999999989888777766
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
.........+...............+.++.++.+||.+||+.||++|||+.++|+||||+.+.....++.........+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 65555555555444444444455566789999999999999999999999999999999998766666544333222222
Q ss_pred hhhccCCHHHHHHHHHHH
Q 016884 338 FERRRVTKDDIRELIYRE 355 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~ 355 (381)
+.+.+...+.+..+|+|
T Consensus 320 -~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred -ccceeeHHHHHhhhhhc
Confidence 44556666777767665
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=364.68 Aligned_cols=291 Identities=37% Similarity=0.642 Sum_probs=231.4
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++..++|++++.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----- 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT----- 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec-----
Confidence 34557899999999999999999999999999999998643222 223456789999999999999999999843
Q ss_pred CCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 3569999999999999988754 468999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......+++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 12334678999999988653 4578899999999999999999999999998888888888888887665443
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
......... ...............+.+++.+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 221110000 00000000111122356889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=371.36 Aligned_cols=261 Identities=26% Similarity=0.470 Sum_probs=217.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence 479999999999999999999999999999999874322 2234456788999999999999999999884 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 59999998888899999999999999999999999999999999999999999999999999875433
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 1234579999999999987 689999999999999999999999998877655544443211000
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .+ ........+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 218 -----------~-~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 218 -----------Q-RP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred -----------c-CC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 00 0000113578999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=374.35 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=212.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..++||||+++++.+. +...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence 469999999999999999999999999999999864321 2233456778999999999999999999984 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999987532211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC
Q 016884 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (381)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (381)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 000124579999999999987 68999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCC---CCC
Q 016884 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK---DRP 305 (381)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~---~Rp 305 (381)
.||.+.+..+....+....... .......+++++.+||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL---------------------------IFPPEVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc---------------------------cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 9998877665554443311100 001113478999999999876 444 458
Q ss_pred CHHHHhcCCCcCcC
Q 016884 306 TAEEALADPYFKGL 319 (381)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (381)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=372.33 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=214.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCC-cEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----- 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----- 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----
Confidence 3467999999999999999999876655 689999986432 222345567889999999999999999999843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 356999999997 6999999988899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 244 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------- 244 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Confidence 21 134579999999999987 678999999999999999999999998876544443332210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
......+++.+.++|++||+.||.+|+ |++++++||||+++
T Consensus 245 ---------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 245 ---------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011245788999999999999999995 89999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=374.82 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=214.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 46999999999999999999999999999999996432 122334567789999999999999999999843 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999986532211
Q ss_pred CCc-----------------------------------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHH
Q 016884 181 PMT-----------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (381)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll 225 (381)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00113469999999999987 68999999999999999999
Q ss_pred cCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC
Q 016884 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305 (381)
Q Consensus 226 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp 305 (381)
+|.+||.+.+..+....+..... .. .......+++++.+||.+||. +|.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~------------------------~~---~~~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE------------------------TL---QFPDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC------------------------cc---CCCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 99999988776544433322100 00 001112578999999999997 999999
Q ss_pred C---HHHHhcCCCcCcC
Q 016884 306 T---AEEALADPYFKGL 319 (381)
Q Consensus 306 t---~~~lL~hp~~~~~ 319 (381)
+ +.++|+||||+..
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.11 Aligned_cols=322 Identities=46% Similarity=0.845 Sum_probs=268.8
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+...++|++++.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++.+++...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---- 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence 4567899999999999999999999999999999999865444334456777899999999999999999988532
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
....|+|+||++++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 235899999999999888864 4689999999999999999999999999999999999999999999999999874322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. .....+++.|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.+.......+.+.+|.++.+.....
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1344678899999987542 46889999999999999999999999999888888888899999998887766
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhh
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (381)
.......++.......+.+.....+.+++.+.++|.+||+.+|++|||++++|.||||.....+..++.. ..++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCch
Confidence 6555555555555555555555566789999999999999999999999999999999988776655543 23678888
Q ss_pred hhccCCHHHHHHHHHH
Q 016884 339 ERRRVTKDDIRELIYR 354 (381)
Q Consensus 339 ~~~~~~~~~~~~~~~~ 354 (381)
+...+..+.|+-++|.
T Consensus 312 ~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 312 NDADLPVDTWKVMMYS 327 (328)
T ss_pred hcccCCHHHHHHHhcC
Confidence 8888999999877664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=366.27 Aligned_cols=248 Identities=31% Similarity=0.470 Sum_probs=207.9
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||+|+||+||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++. ....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 799999999999999999999999986432 22334557788999999999999999999884 335699999999
Q ss_pred c-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccc
Q 016884 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (381)
Q Consensus 110 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (381)
. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 59999998888899999999999999999999999999999999999999999999999999875322211 1234
Q ss_pred cccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 016884 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (381)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
.+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 579999999999987 6799999999999999999999999987665443332221
Q ss_pred HhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCCCcCcC
Q 016884 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGL 319 (381)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp---t~~~lL~hp~~~~~ 319 (381)
. .......+++.+.+||.+||+.||.+|| ++.++|+||||...
T Consensus 208 ----~----~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ----E----PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----C----CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0 0112246889999999999999999997 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=374.47 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=211.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.|++++.||+|+||+||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 5899999999999999999999999999999986432 233445678899999999999999999999843 4569
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|||||. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998 59999998888899999999999999999999999999999999999999999999999998753211000
Q ss_pred C--------------------------------------------cccccccccCccccCccccccccCCCCCccchHHH
Q 016884 182 M--------------------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217 (381)
Q Consensus 182 ~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 217 (381)
. .......+||+.|+|||++.+ ..++.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0 000123579999999999987 678999999999
Q ss_pred HHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhc
Q 016884 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (381)
Q Consensus 218 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L 297 (381)
||++|+|++|..||...+..+....+...... ........+++++.+||.+||
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------------LHIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------------cCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999887654443333211000 001112357999999999966
Q ss_pred cC--CCCCCCCHHHHhcCCCcCcC
Q 016884 298 AF--DPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 298 ~~--dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. +|..|+|++++++||||+.+
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCCC
Confidence 54 55559999999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=359.94 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=210.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.++|++|+++++++.. .+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 38899999999999999999999999999999864322 22233457789999999999999999998843 3569
Q ss_pred EEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+|||||. ++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 588877754 336899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----------- 218 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-----------
Confidence 1 1234579999999999987 6899999999999999999999999987654322222211110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (381)
. ........+++++.+|+++||+.||.+||| ++++++||||.+..
T Consensus 219 ------------~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 219 ------------E----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ------------c----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0 011223468899999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=376.58 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=212.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.|++++.||+|+||+||+|++..+++.||+|++.... ........+.+|+.+|+.++||||+++++.+. +.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence 46999999999999999999999999999999986421 11223456778999999999999999999984 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccCccccCccccccccCCCCCccchHHHHHH
Q 016884 181 P----------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (381)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 220 (381)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 678999999999999
Q ss_pred HHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCC
Q 016884 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (381)
Q Consensus 221 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~d 300 (381)
+|+|++|+.||.+.+..+....+..... .........+++++.+||.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET---------------------------TLHIPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc---------------------------cccCCCCCCCCHHHHHHHHHHh-cC
Confidence 9999999999988765444333321100 0001112468899999999987 59
Q ss_pred CCCCC---CHHHHhcCCCcCcC
Q 016884 301 PKDRP---TAEEALADPYFKGL 319 (381)
Q Consensus 301 p~~Rp---t~~~lL~hp~~~~~ 319 (381)
|.+|+ |+.++++||||+.+
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=375.09 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=212.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+|++++.||+|+||+||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCE
Confidence 36999999999999999999999999999999986432 122344577889999999999999999999843 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321100
Q ss_pred C--------------------------------------------CcccccccccCccccCccccccccCCCCCccchHH
Q 016884 181 P--------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (381)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 216 (381)
. ........+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123479999999999987 68999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHh
Q 016884 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (381)
Q Consensus 217 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~ 296 (381)
|||++|+|++|++||.+.+..+....+...... ........+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------------------LHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------------------cCCCCcccCCHHHHHHHHHH
Confidence 999999999999999887654443333221000 00111246799999999998
Q ss_pred ccCCCCCCCC---HHHHhcCCCcCcC
Q 016884 297 IAFDPKDRPT---AEEALADPYFKGL 319 (381)
Q Consensus 297 L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (381)
+ .||.+|++ ++++++||||+..
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 6 59999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=371.35 Aligned_cols=263 Identities=30% Similarity=0.489 Sum_probs=216.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|++..+++.||+|+++.... .......+.+|+.++..++||||+++++++. +..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 479999999999999999999999999999999874321 1234456788999999999999999998884 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999997 5999999888889999999999999999999999999999999999999999999999999987543322
Q ss_pred C--------------------------CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 181 P--------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234579999999999988 68999999999999999999999999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALAD 313 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-~~~lL~h 313 (381)
+.......+...... . .......+++++.+||.+||. ||.+||+ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~~~------------------------~---~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKES------------------------L---RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCc------------------------c---cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 755444444321100 0 011123478999999999998 9999999 9999999
Q ss_pred CCcCcCc
Q 016884 314 PYFKGLA 320 (381)
Q Consensus 314 p~~~~~~ 320 (381)
|||+.+.
T Consensus 286 p~~~~~~ 292 (350)
T cd05573 286 PFFKGID 292 (350)
T ss_pred CCcCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=374.28 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=211.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 46999999999999999999999999999999986421 122334567889999999999999999999843 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999997 6999999888889999999999999999999999999999999999999999999999999986321100
Q ss_pred CC------------c--------------------------------ccccccccCccccCccccccccCCCCCccchHH
Q 016884 181 PM------------T--------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (381)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 216 (381)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00012479999999999987 67999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHh
Q 016884 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (381)
Q Consensus 217 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~ 296 (381)
|||++|+|++|.+||.+.+..+....+...... . .......+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------------~---~~p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRET------------------------L---YFPDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc------------------------c---CCCCCCCCCHHHHHHHHHH
Confidence 999999999999999887765544443321000 0 0011235789999999999
Q ss_pred ccCCCCCC---CCHHHHhcCCCcCcC
Q 016884 297 IAFDPKDR---PTAEEALADPYFKGL 319 (381)
Q Consensus 297 L~~dp~~R---pt~~~lL~hp~~~~~ 319 (381)
|. +|.+| +|+.++++||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=365.95 Aligned_cols=250 Identities=24% Similarity=0.446 Sum_probs=208.7
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence 469999999999999999999999999875322 2334557788999999999999999998884 3356999999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
|+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 58998988888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 34579999999999987 6789999999999999999999999987665433322211
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
. .......+++++.+||++||+.||.+|+ ++.++++||||...
T Consensus 210 -----~-----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----E-----DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----C-----CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0111246789999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=365.20 Aligned_cols=258 Identities=29% Similarity=0.443 Sum_probs=221.1
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.....|+.++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+|.+++++||.++|+.|+...
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~---- 84 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT---- 84 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc----
Confidence 3456788899999999999999999999999999999753 23345667889999999999999999999997654
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.++++||||. |++.+.++....+.+..+..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+.....
T Consensus 85 -~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 85 -KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred -cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 4899999999 59999999988889999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ....+++|||.|||||++.+ ..|+.++||||||++.+||++|.+|+.....+..+..|
T Consensus 164 ~~---~rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------------- 223 (467)
T KOG0201|consen 164 TV---KRRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------------- 223 (467)
T ss_pred hh---hccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------------
Confidence 32 22367899999999999997 79999999999999999999999999887764333222
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.+..|..+. ..+|+.+++||..||+.||+.||||.++|+|+|++.
T Consensus 224 ------------pk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 ------------PKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ------------cCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 111121111 268999999999999999999999999999999986
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=367.64 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=229.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|..++.+|+|+||.+++++++..++.||+|.+............+..|+.+++++.|||||.+.+.|...+ ..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ce
Confidence 46899999999999999999999999999999999866555566667889999999999999999999985332 34
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+||||+||+ |+|.+.|+.. ..++++.+..|+.|++.||.|||+++|+|||||+.||+++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 5999999754 3699999999999999999999999999999999999999999999999999998655
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ...+.+|||.|++||++.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|......|.+
T Consensus 159 ~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------ 227 (426)
T KOG0589|consen 159 EDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------ 227 (426)
T ss_pred chh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC------
Confidence 432 2357799999999999999 89999999999999999999999999999999888888876655443
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
...+.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 228 ------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 ------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 467899999999999999999999999999998764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=355.24 Aligned_cols=282 Identities=37% Similarity=0.622 Sum_probs=226.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|++++.||+|++|.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 4899999999999999999999999999999987543333334567789999999999999999999843 35689
Q ss_pred EEeeccccCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+.++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888643 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.......+++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+....+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112334678899999988653 4578899999999999999999999999888777777777777766555433221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ..+..................+++++.+||++||+.||.+|||+.++++||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11111111111122222345689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=364.49 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=208.9
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
+.||+|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999999999999999875322 22344567789999999999999999998843 346999999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
|+. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 58999998888899999999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------- 210 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------------
Confidence 34579999999999987 67899999999999999999999999877654443332210
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
. ......+++++.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 211 ------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 211 ------E-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ------C-----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 011246789999999999999999998 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=355.14 Aligned_cols=281 Identities=33% Similarity=0.556 Sum_probs=224.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC--C----CccccceeecC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--P----DIVEIKRIMLP 93 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~iv~~~~~~~~ 93 (381)
...+||.++..+|+|.||.|..+.|..++..||||+++... ...+..+-|+++|.++.+ | -++.+.++|
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-- 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-- 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence 34789999999999999999999999999999999987431 222344569999999942 2 245555556
Q ss_pred CCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC----------
Q 016884 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---------- 161 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---------- 161 (381)
+..+++|||+|.++.++.+.+..++ +++..+++.+.+||+++++|||+.+++|.||||+|||+.+
T Consensus 161 ---dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 161 ---DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ---hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 4456799999999999999999876 7899999999999999999999999999999999999632
Q ss_pred ----------CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 016884 162 ----------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (381)
Q Consensus 162 ----------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 231 (381)
+..|+|+|||.|+...... +..+.|+.|+|||++++ -+++.++||||+||||+||.+|..+|
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceec
Confidence 2348999999998653332 45689999999999999 68999999999999999999999999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc---------------CCCCCCccccCCCC---CHHHHHHH
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR---------------KKPPVPLFQKFPNV---DPLALRLL 293 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~---~~~~~dLi 293 (381)
++.++.++++.|...+|..+..++...+ ..+++...+ ...+.++....... -..+.|||
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9999999999999999977766665542 222221110 01112222111222 23578999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 294 QRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 294 ~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
++||.+||.+|+|+.|+|.||||+..
T Consensus 387 ~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHHccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999999865
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=357.53 Aligned_cols=281 Identities=38% Similarity=0.604 Sum_probs=222.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|++..+|+.||+|.+............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 5999999999999999999999999999999986533322333466789999999999999999999843 35689
Q ss_pred EEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+|+||++++|.+.+.+ .+.+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988865 56799999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|..| |.+.+....+..+.+.++.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12344678999999988663 4578999999999999999998866 5667777778888888877765544322111
Q ss_pred HHHHHHHHhcCC-CCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.... ..... .........+.+++++.+||.+||+.||.+|||++++|+||||
T Consensus 232 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYK---PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccc---ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000 00000 0011122345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=351.10 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=220.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.+.|++++.||.|.-|+||+|+.+.++..+|+|++.+... ......++..|-.||..++||.++.+|..+ +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 4578999999999999999999999999999999976432 234456778899999999999999999999 4446
Q ss_pred cEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+|+|||||. |+|..+.+.. +.+++..++.++..++.||.|||-.|||+|||||+||||.++|.|.|+||.++....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 6999999999 5999888754 479999999999999999999999999999999999999999999999999874321
Q ss_pred C---------------------------------C-C-------------------CCcccccccccCccccCccccccc
Q 016884 178 S---------------------------------D-T-------------------PMTVFWTDYVATRWYRAPELCGSF 204 (381)
Q Consensus 178 ~---------------------------------~-~-------------------~~~~~~~~~~gt~~y~aPE~~~~~ 204 (381)
. . . +.......++||-.|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 00011234689999999999999
Q ss_pred cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCC
Q 016884 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284 (381)
Q Consensus 205 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (381)
.+.+.++|+|+||+++|||+.|..||.|.+..+.+..|.. .+. .....+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~l--------------------------~Fp~~~~ 359 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QPL--------------------------KFPEEPE 359 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CCC--------------------------cCCCCCc
Confidence 7899999999999999999999999999998877766543 111 0111236
Q ss_pred CCHHHHHHHHHhccCCCCCCCC----HHHHhcCCCcCcC
Q 016884 285 VDPLALRLLQRLIAFDPKDRPT----AEEALADPYFKGL 319 (381)
Q Consensus 285 ~~~~~~dLi~~~L~~dp~~Rpt----~~~lL~hp~~~~~ 319 (381)
++..++|||+++|.+||.+|.. |.+|=+||||+++
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 7799999999999999999998 9999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=360.44 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=226.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+.+-|.+.+.||+|.|.+|-+|+|.-||..||||++.+...+......+..|++.|+.++|||||++|++.- +..
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccc
Confidence 457799999999999999999999999999999999876555555567889999999999999999999984 345
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-CCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-~~~~vkl~DFg~a~~~~ 177 (381)
.+|+|+|+-+ |+|+++|.++ ..++++.++.++.||+.|+.|||...+|||||||+|+.+- .-|-|||+|||++....
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 5999999998 5999998754 4799999999999999999999999999999999999754 56899999999987654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.+. ..++.||+..|-|||+++| ..|+ +++||||||||||-|++|++||...++.+.+.+|++--.
T Consensus 171 PG~----kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 171 PGK----KLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred Ccc----hhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 443 3467899999999999998 5666 579999999999999999999999998888888876322
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
....-++.+++|||.+||..||.+|.|.++|.+|+|++.....
T Consensus 237 -----------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 237 -----------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred -----------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 2234689999999999999999999999999999999987543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=362.81 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=208.6
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|.++.+++.||+|++.... ........+.+|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987432 1223345667888888876 69999999999843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 211 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------------- 211 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 234579999999999987 67899999999999999999999999887765544443220
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCCcCcCc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~------~~lL~hp~~~~~~ 320 (381)
. ......+++++.+||++||+.||.+||++ +++++||||..+.
T Consensus 212 --------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 212 --------E----VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred --------C----CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 0 01123578999999999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=361.44 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=211.8
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~ 101 (381)
+|++++.||+|+||.||+|.+..+++.||+|++..... .......+..|..++..++|+ +|+++++++.. .+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 48999999999999999999999999999999875321 223455677899999999765 57788888743 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234579999999999987 678999999999999999999999998877655444433210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (381)
......+++++.+|+.+||..||.+|+++ +++++||||...
T Consensus 218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 01123578999999999999999999976 899999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=359.17 Aligned_cols=279 Identities=24% Similarity=0.391 Sum_probs=217.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|+.++||||+++++++... +.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CE
Confidence 468999999999999999999999999999999987532 233456788999999999999999999998443 46
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+++||||+. ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 899999998 59999998888899999999999999999999986 6999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH-----
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET----- 254 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 254 (381)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6789999999999999999999999987665433222 12111000
Q ss_pred -------------Hh-----hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 255 -------------IA-----VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 255 -------------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. .............+....... .....+++++.+||.+||++||++|||+.++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00 000001111122221111111 0113478899999999999999999999999999999
Q ss_pred CcC
Q 016884 317 KGL 319 (381)
Q Consensus 317 ~~~ 319 (381)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=360.82 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=207.7
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHH---HhcCCCCccccceeecCCCcCCCC
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLL---RLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|++++ +.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 789999999999999999999999999999987432 1223344566676665 45679999999999843 35
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+.+ +|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 69999999984 88777754 57999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------------ 217 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE------------ 217 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 11 1235679999999999987 678999999999999999999999998877655444332210
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
......+++.+.+||.+||+.||.+|| ++.++++||||+.+
T Consensus 218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 011235789999999999999999999 79999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=356.22 Aligned_cols=293 Identities=42% Similarity=0.649 Sum_probs=232.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 457899999999999999999999999999999998643332222335568999999999999999999985432 24
Q ss_pred cEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+.++|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 5899999999999888875 357999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......+++.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....+....
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12334568889999998653 467899999999999999999999999999999999999998888776554332
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.......+. ............+...++.+.+||.+||++||++|||+.++|.||||+...-
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 238 DLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 211100000 0011111112223456899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=364.54 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=214.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|.+.+.||+|+||+||+|.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 469999999999999999999999999999999975322 22344567789999999999999999988843 356
Q ss_pred EEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 68999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 226 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR------- 226 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 211 12334799999999998631 14678899999999999999999999988765544444332100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.......+.+++.+.+||.+||+ ||.+|||++++++||||...
T Consensus 227 --------------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 227 --------------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred --------------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 00011224688999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=366.84 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=213.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++. +.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 3468999999999999999999999999999999986421 12233445678999999999999999999884 34
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 56999999998 589988865 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------- 264 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-------- 264 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------
Confidence 211 112345799999999998652 13478999999999999999999999988776544444332100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
.........++.++.+||.+||+.+|.+ |+|++++++||||++.
T Consensus 265 -------------------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 265 -------------------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -------------------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0001122357999999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=350.55 Aligned_cols=285 Identities=40% Similarity=0.702 Sum_probs=232.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5999999999999999999999999999999987544333445678899999999999999999999844 45689
Q ss_pred EEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+||||++++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799998865 45799999999999999999999999999999999999999999999999999876533221
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.......++..|+|||.+.+. ..++.++||||+||++++|++|.+||.+.+....+..+....+.+.+..+.......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345789999999998652 457899999999999999999999999998888888888888888776554433211
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
....+ .............+++.+..+.+||++||+.||.+|||++++|+||||.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKI-TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcc-cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 11100 0111122223334567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=358.66 Aligned_cols=304 Identities=39% Similarity=0.667 Sum_probs=231.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC--
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR-- 97 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 97 (381)
+.+++|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 457899999999999999999999999999999999864322 3445677899999999999999999887553321
Q ss_pred -------CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEee
Q 016884 98 -------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCD 169 (381)
Q Consensus 98 -------~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~D 169 (381)
+...+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 1246899999999999888864 46999999999999999999999999999999999999985 55789999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||.++................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+.+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99987543221111112234678899999987542 46888999999999999999999999988877776666665554
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (381)
+.++......+... ............+.....+.++.++.+||.+||+.||.+|||+.++|.||||+.+..+...|..
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~ 315 (342)
T cd07854 238 VREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS 315 (342)
T ss_pred CChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence 44432222211111 1111111112222233345788999999999999999999999999999999977655444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=362.99 Aligned_cols=250 Identities=26% Similarity=0.459 Sum_probs=207.7
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
+.||+|+||+||+|.+..++..||+|++..... .......+.+|+++++.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999875322 22344567789999999999999999998843 356999999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
|+. ++|...+.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 5899988888889999999999999999999997 7999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------- 211 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 234579999999999987 67899999999999999999999999876654333322110
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
. ......+++++.+||.+||+.||++|+ ++.++++||||.+.
T Consensus 212 -------~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 212 -------E-----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred -------C-----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 0 011235789999999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=359.18 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=207.6
Q ss_pred eeeecccCCceEEEEEEc---CCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 28 LEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++.||+|+||.||+|++. .+++.||+|+++... ........+.+|+.+|+.++||||+++++++.. .+.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 468999999999999864 578899999986431 122334456789999999999999999999844 3469
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999998 59999998888899999999999999999999999999999999999999999999999999864322211
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------- 215 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------- 215 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 1234579999999999987 67899999999999999999999999887654443333210
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.....+.+++.+.+||.+||+.||++|| +++++++||||...
T Consensus 216 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 216 ----------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0112346789999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=361.15 Aligned_cols=261 Identities=24% Similarity=0.396 Sum_probs=208.8
Q ss_pred CeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (381)
.|++++.||+|+||+||+|++. .+++.||+|++.+.. ........+.+|+.+++.+ +||+|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 4899999999999999999864 478999999986431 1223345677899999999 5999999998884
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 3356899999998 599999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 332211 12345799999999998762 3578899999999999999999999975432221111111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
...... ......+++.+.+||.+||+.||++|| +++++++||||+..
T Consensus 222 ------------~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 222 ------------RILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred ------------HHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011100 011245789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=356.96 Aligned_cols=281 Identities=36% Similarity=0.588 Sum_probs=212.0
Q ss_pred eeeecccCCceEEEEEEcC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
..+||+|+||+||+|.++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.... ...+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEE
Confidence 4689999999999998654 56899999886432 1235678999999999999999999886532 2468999
Q ss_pred eeccccCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe----cCCCCeEEeeecc
Q 016884 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (381)
Q Consensus 106 ~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~----~~~~~vkl~DFg~ 172 (381)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999998887521 258899999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------hhHHHHH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i 243 (381)
++................||+.|+|||++.+. ..++.++||||+||++|+|++|++||..... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654332222223456789999999998653 4588999999999999999999999975432 3556777
Q ss_pred HHhhCCCCHHHHhhhcCHH-HHHHHHHhcCCCC--C----CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 244 TDLLGTPSPETIAVVRNEK-ARKYLTEMRKKPP--V----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+|.+..+.+....... ............. . .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7788877766554432110 0011110000000 0 0011112356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=359.35 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=208.6
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|.+..+++.||+|++.... ........+..|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999987532 1223345667899998876 79999999999844 34699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~------------------ 212 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD------------------ 212 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 234579999999999987 688999999999999999999999999877655554443210
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-------CHHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-------TAEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-------t~~~lL~hp~~~~~ 319 (381)
......+++++.+||.+||+.||++|| +++++++||||..+
T Consensus 213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 011134788999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=365.44 Aligned_cols=264 Identities=26% Similarity=0.364 Sum_probs=212.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----D 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 3468999999999999999999999999999999986421 222334457789999999999999999999843 4
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 56999999998 6999988654 689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ......+||+.|+|||++.+.. ..++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 266 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------ 266 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc------
Confidence 211 1123567999999999986521 237889999999999999999999998877655544443211100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
.......+++.+.+|+.+||..++.+ |+|+.++++||||+..
T Consensus 267 ---------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 267 ---------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred ---------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 01112357899999999999865543 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.92 Aligned_cols=282 Identities=38% Similarity=0.623 Sum_probs=227.3
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|++++.||.|++|.||+|.+..++..||||++............+.+|+++++.++||||+++++++. +....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 389999999999999999999999999999998654333333456788999999999999999999884 335689
Q ss_pred EEeeccccCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
+||||+.++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 34689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12334578899999988652 3468899999999999999999999999988888888888888877654442221
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+................+.+++++.++|.+||+.||.+|||++++|+||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 -LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111111222222222233345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=365.74 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=213.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.|++++.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.++..++||+|+++++.+. +...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 36999999999999999999999999999999986432 12233456778999999999999999999884 4456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. ++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999986432211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC
Q 016884 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (381)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (381)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000123579999999999987 68999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC---
Q 016884 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP--- 305 (381)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp--- 305 (381)
+||.+.+.......+...... . .......+++++.+||.+|+. ||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~------------------------~---~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKET------------------------L---VFPPEVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCCc------------------------e---ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 999887765544443321000 0 001112478999999999874 999998
Q ss_pred CHHHHhcCCCcCcC
Q 016884 306 TAEEALADPYFKGL 319 (381)
Q Consensus 306 t~~~lL~hp~~~~~ 319 (381)
+++++++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (360)
T cd05627 286 GVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHhcCCCCCCC
Confidence 58999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=357.37 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=205.3
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|.++.+++.||+|+++.... ..........|..++..+ +||||+++++++. +.+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999875321 112344566788888764 8999999999984 345699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999864322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------------------- 211 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------------------- 211 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999987 68999999999999999999999999877654433332210
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (381)
. ......++.++.+||.+||+.||++||++ +++++||||+..
T Consensus 212 --------~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 212 --------T----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred --------C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0 01113478899999999999999999997 588899999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=357.50 Aligned_cols=255 Identities=23% Similarity=0.394 Sum_probs=211.9
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+|.+++.||+|+||.||+|++..+++.||+|++.+... ..........|..++..+ .|++|+++++++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence 48899999999999999999999999999999875322 222344566788888877 5889999998884 3356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 1 1234579999999999987 689999999999999999999999998877655544443210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
......+++++.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0112357899999999999999999998 4899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=358.96 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=205.5
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|.+..+++.||+|++.... ........+.+|.. +++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986432 12223345556655 4678999999999998843 35689999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999864322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6799999999999999999999999988765444333321
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (381)
. .....+.+++.+.+||.+||+.||.+||++ .++++||||...
T Consensus 211 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 -------K----PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred -------C----CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 011235679999999999999999999987 699999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=355.87 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=204.9
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|.+..+++.||+|+++.... ..........|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999875321 122334556677777654 89999999998843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987543222 12
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------------- 211 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------------------- 211 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 234579999999999987 67899999999999999999999999887755444333210
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-~~lL~hp~~~~~ 319 (381)
. ......++.++.+||.+||+.||.+||++ .++++||||...
T Consensus 212 --------~----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 212 --------R----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred --------C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0 01123578899999999999999999986 588899999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=349.49 Aligned_cols=288 Identities=42% Similarity=0.654 Sum_probs=232.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ......+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999754322 2234456789999999999999999999854 35
Q ss_pred cEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 689999999889999998766 7999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.|....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334578889999988542 467889999999999999999999999988888888888777777665543222
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
... .+ .......+.+....+...+..+.+||.+||++||++|||+.++|.||||++...+.
T Consensus 232 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 232 SLP--DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccc--cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 111 00 01111222233344567789999999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=365.07 Aligned_cols=281 Identities=23% Similarity=0.310 Sum_probs=216.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++. ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~-----~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYR-----WK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEe-----eC
Confidence 457999999999999999999754 45678999987532 23457999999999999999999884 33
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..+|+|||++.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 56899999999999999977788999999999999999999999999999999999999999999999999998754432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh---hhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+.+.++..+.+...
T Consensus 239 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PD-TPQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc-cccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 22 112234679999999999987 6799999999999999999999999977543 44555555555544332211
Q ss_pred hhcCHHHHHHHHHhcC--CCCCCccc--cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 257 VVRNEKARKYLTEMRK--KPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.. .......+..... ..+..... ....++.++.+||.+||.+||++|||+.++|+||||..
T Consensus 316 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 316 NG-STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cc-chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11 1111111111111 11111111 11246788999999999999999999999999999975
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=359.67 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=208.9
Q ss_pred eeeecccCCceEEEEEE---cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 28 LEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
++.||+|+||.||++++ ..+|+.||+|++............+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEE
Confidence 36799999999999986 3578999999997543333344567789999999999999999999843 356999
Q ss_pred Eeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999875433211
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------- 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------- 213 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 1234579999999999987 67899999999999999999999999887655444333210
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
.......+++.+.+||++||+.||++||| +.++++||||..+
T Consensus 214 --------------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 --------------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 01112457899999999999999999999 7889999999865
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=356.92 Aligned_cols=259 Identities=23% Similarity=0.398 Sum_probs=205.3
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|..+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 469999999999999999999999999975322 223445677899999998 69999999999843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
|||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999864322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+. +... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~~--------~~~~ 212 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQN--------TEDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCccccccccc----------cccc--------chHH
Confidence 234679999999999987 6789999999999999999999999964321100 0000 0000
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (381)
......... ......+++.+.+||++||+.||.+|+| ++++++||||..+
T Consensus 213 ~~~~~~~~~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 213 LFQVILEKQ----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHHcCC----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 001111111 1122467899999999999999999987 7999999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=355.94 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=207.8
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|.+..++..||+|+++... ........+.+|..+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987432 1223345667899999888 69999999999843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999864322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6889999999999999999999999987765444333221
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (381)
.. ......+++.+.+||++||+.||.+|||+ .++++||||+..
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 -------DE----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CC----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 01123578999999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=350.85 Aligned_cols=297 Identities=34% Similarity=0.532 Sum_probs=228.8
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.....++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3455678999999999999999999999999999999986443333333456689999999999999999998865432
Q ss_pred --CCCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 97 --REFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 97 --~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
......|+||||+.++|.+.+.... .+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 2234679999999999988887543 7899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
......... ........++..|+|||.+.+. ..++.++|+||+||++|+|++|++||.+.+.......+....|..++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 754332211 1112344678899999987652 45788999999999999999999999999888888888888887776
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccc--cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
+............... ........... .....++.+.+||.+||..||.+|||++++|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 6544332211111000 00000000000 011246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=372.09 Aligned_cols=272 Identities=26% Similarity=0.341 Sum_probs=221.9
Q ss_pred cccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 15 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
--+.....++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.++..++|+||+++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 33444566899999999999999999999999999999999976544555666788999999999999999988877543
Q ss_pred Cc---CCCCcEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeE
Q 016884 95 SK---REFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (381)
Q Consensus 95 ~~---~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vk 166 (381)
.. .....+++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 21 11224789999998 699998864 34689999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHh
Q 016884 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (381)
|+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 184 L~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 184 LGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred EEecccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 9999998764332111 11234679999999999987 67999999999999999999999999887654443332210
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .....+.+++++.+|+.+||+.||.+|||+.++|+|||++.+
T Consensus 261 ~------------------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 261 R------------------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred C------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 0 011235688999999999999999999999999999998764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=354.09 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=210.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+++.++|+||+++++++. +..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence 47999999999999999999999999999999986421 12233455778999999999999999999984 3456
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 457999999999999999999999999999999999999999999999999998654332
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .....+||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 211 11234699999999998631 1457889999999999999999999998876555444432210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
.........+.+++.+++||++||..++.+ |+++.++++||||.++
T Consensus 225 -----------------~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 225 -----------------EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -----------------CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 001111223458999999999999765544 7899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=352.45 Aligned_cols=253 Identities=29% Similarity=0.397 Sum_probs=208.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcE-EEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.....+.+.||+|+||+||+|..+ |.. ||+|++............+.+|+.+|.+++|||||++++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 344566677999999999999654 666 9999998655554457789999999999999999999999965431
Q ss_pred cEEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEecCCC-CeEEeeeccccc
Q 016884 101 DIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANC-KLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~-i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~ 175 (381)
.++||||||. |+|.+++.. ...++...+..++.||++|+.|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999999 799999987 578999999999999999999999999 99999999999999998 999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... ...+...||+.|||||++.+....|+.++||||||++++||+||+.||.+.........+.....+|.
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 54321 12234689999999999984115899999999999999999999999999887444333322111111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+++.+.+|+.+||..||.+||++.+++.
T Consensus 267 -------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 -------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11238899999999999999999999999875
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=346.68 Aligned_cols=282 Identities=39% Similarity=0.700 Sum_probs=218.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|++|.||+|.++.+++.||+|++............+.+|+.+++.++|||++++++++.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 47999999999999999999999999999999886433222233456789999999999999999999843 3568
Q ss_pred EEEeeccccC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
++||||++++ |..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999964 455555556799999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......++..|+|||.+.+. ..++.++|+||+||++|+|++|.+||.+.+..+....+....+...+.........
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12344688899999998652 45788999999999999999999999988877777666665554433221111100
Q ss_pred HHHHHHHHhcCCC---CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. +........ ..+....++.++..+.+|+.+||+.||++|||+.+++.||||
T Consensus 232 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 Q---FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred c---ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000000000 011112245678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=353.41 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=205.4
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|++..+++.||+|+++.... ..........|..+++.. +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999875321 112334566788888764 89999999999844 34699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998878899999999999999999999999999999999999999999999999999864322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------------- 210 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 234579999999999987 6789999999999999999999999987765443333211
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCCcCcCc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~-~lL~hp~~~~~~ 320 (381)
..+ .....++.++.+||.+||+.||++||++. ++++||||+.+.
T Consensus 211 -------~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 211 -------DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 000 01134788999999999999999999996 899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=360.05 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=211.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----DR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 478999999999999999999999999999999986421 122334457789999999999999999998843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|||||. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 6999999998 5898888654 6899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCcccccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 196 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------- 265 (371)
T cd05622 196 GM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-------- 265 (371)
T ss_pred Cc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--------
Confidence 11 1123557999999999986521 23789999999999999999999999887765544444321110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
........++..+.+||.+||..++.+ |++++++++||||++.
T Consensus 266 -------------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 266 -------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred -------------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 001123468999999999999844433 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=356.70 Aligned_cols=278 Identities=24% Similarity=0.353 Sum_probs=208.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++... ...
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Cee
Confidence 4699999999999999999999999999999975432 234699999999999999999998543 458
Q ss_pred EEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|||++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99999999999998865 4579999999999999999999999999999999999999999999999999987532221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCCh---------hhHHHHHHHhhCCCC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV---------VHQLDLITDLLGTPS 251 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~---------~~~~~~i~~~~~~~~ 251 (381)
......||+.|+|||++.+ ..++.++|||||||++|+|+++. ++|..... ...+..+...++..+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1234579999999999987 67999999999999999999854 44443221 123333334444332
Q ss_pred HHHHhhhcCHHHHHHHHHhc-CCCCCCcc--ccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 252 PETIAVVRNEKARKYLTEMR-KKPPVPLF--QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+............++.... ...+.... -...+++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 22111111111112221110 01111110 0123567889999999999999999999999999999863
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=346.99 Aligned_cols=288 Identities=37% Similarity=0.630 Sum_probs=227.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998654333333456788999999995 699999999886544333345
Q ss_pred EEEEeeccccCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeeccccc
Q 016884 102 IYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~ 175 (381)
+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||.+..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999888642 35899999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 11234678899999987652 45789999999999999999999999999888888888888877776544
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
........ .. ......+.......+.+++.+.+||.+||+.||.+|||+.++|.||||+
T Consensus 237 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRD--WH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccc--hh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 32211110 00 0111111122223456899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=354.37 Aligned_cols=259 Identities=22% Similarity=0.397 Sum_probs=204.4
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|++..+++.||+|++.... ........+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 46999999999999999999999999997542 2233445677899988877 79999999999844 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~--------~~~~ 212 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQN--------TEDY 212 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------cccc--------cHHH
Confidence 234579999999999987 6789999999999999999999999953211000 0000 0000
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt------~~~lL~hp~~~~~ 319 (381)
........ .......++..+.+||++||+.||.+||| +.++++||||+..
T Consensus 213 ~~~~i~~~----~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 213 LFQVILEK----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHhcC----CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00011110 01123467899999999999999999998 5899999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=345.90 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=202.7
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||+|+||+||+|.+..+++.||+|++..... .......+..|+.+++.++||||+++.+++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 7999999999999999999999999864322 22234567789999999999999999988843 35689999999
Q ss_pred c-cCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 110 E-SDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 110 ~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
. ++|.+.+. .+..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 58877763 3356999999999999999999999999999999999999999999999999998754332221
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+..
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 234578999999999987 6889999999999999999999999976543211111110
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.... ........+++.+.+|+.+||+.||++|| |++++++||||++.
T Consensus 212 ----~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 212 ----RILN----DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----hhcc----cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0000 01112246889999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=365.35 Aligned_cols=282 Identities=24% Similarity=0.320 Sum_probs=211.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
....|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|+.++|+||+++++++... .
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----G 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----C
Confidence 3557999999999999999999999999999999642 12346899999999999999999987443 4
Q ss_pred cEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..|+|||++.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 58999999999999988764 46999999999999999999999999999999999999999999999999999764332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC-CCCC------hhhHHHHHHHhhCCCCH
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKS------VVHQLDLITDLLGTPSP 252 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~------~~~~~~~i~~~~~~~~~ 252 (381)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..++ .... ...++..+....+....
T Consensus 314 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 314 WST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 211 11234579999999999987 67999999999999999999987554 3221 12334444433332211
Q ss_pred HHHhhhcCHHHHHHHHHh----cCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 253 ETIAVVRNEKARKYLTEM----RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
+.-..........+.... ........+..+..+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 111000001111111100 111111122233457789999999999999999999999999999964
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=345.61 Aligned_cols=258 Identities=34% Similarity=0.584 Sum_probs=212.2
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999998653333333345669999999999999999999954 456899
Q ss_pred Eeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
|||++.+ +|.+++.....+++..++.++.||+.||++||++||+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999996 9999998778899999999999999999999999999999999999999999999999999875311 11
Q ss_pred ccccccccCccccCccccc-cccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 184 VFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.......+++.|+|||++. + ..++.++|+||||+++++|++|..||......+....+.............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------
Confidence 2234567899999999987 5 678999999999999999999999998875444444443322211111000
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.....++.+.++|.+||+.||++|||+.++++||||
T Consensus 225 ------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=346.76 Aligned_cols=286 Identities=38% Similarity=0.679 Sum_probs=222.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+..++|++.+.||+|++|.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++. +.
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~ 75 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIH-----TK 75 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEe-----cC
Confidence 4567899999999999999999999999999999998643222 12234568999999999999999999984 33
Q ss_pred CcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+.++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 569999999999999988754 4689999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ......++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.. ..+.+..+.+..+.+.++.+..
T Consensus 156 ~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 156 PSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred CCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 111 11233568889999988652 457889999999999999999999998766 5667777778888877665433
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
........ ........+.......+.++ ..+.+++.+||++||++|||+.++|+||||
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 22110000 00000011111222233445 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=351.97 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=210.3
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+|.+.+.||+|+||+||+|.++.+++.||+|++..... .......+..|..++..+. |++|+++++++.. .+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 47889999999999999999999999999999875321 2233456778999998886 5677788888743 346
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 1 1234579999999999987 678999999999999999999999998876554443332210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
......+++++.+|+.+||+.||.+|++ .+++++||||..+
T Consensus 218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0112457889999999999999999997 5899999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=348.34 Aligned_cols=287 Identities=41% Similarity=0.671 Sum_probs=230.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|++.+.||.|++|.||+|.+..+++.+|+|.++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 35799999999999999999999999999999998754333333345678999999999999999999885432 256
Q ss_pred EEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887644 59999999999999999999999999999999999999999999999999987643321
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......+++.|+|||.+.+. ..++.++|+||+||++++|++|.+||.+.+..+.+..+....+.|.+..+.....
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12344678899999988652 3468899999999999999999999999999888999999999888776554322
Q ss_pred HHHHHHHHHhcCCCCCCccccCCC--CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
-..... ..............++. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 111000 00011111122233344 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=346.35 Aligned_cols=288 Identities=39% Similarity=0.660 Sum_probs=228.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|++|+||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986543333334567789999999999999999999843 3569
Q ss_pred EEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccCC
Q 016884 103 YVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999999999988887654 3588899999999999999999999999999999999985 557999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......+++.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12344678899999988652 457889999999999999999999999988888888888888887766544322
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.. ..+................+.+++.+.++|.+||+.||++||++.++|+||||..+..
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 21 1111111111112222234578999999999999999999999999999999987643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=342.95 Aligned_cols=281 Identities=40% Similarity=0.665 Sum_probs=228.9
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++|||++++++++.. ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 678999999999999999999999999999987543333334567789999999999999999999843 356899
Q ss_pred EeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 105 VFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 105 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
||||++++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999989999998765 789999999999999999999999999999999999999999999999999865422211
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
......++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+....+..+.+..++|....+.....
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS-- 229 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh--
Confidence 11233568899999987652 3578899999999999999999999999888888888888888887765543211
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+................+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 112222222222233334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=343.31 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=218.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
-|.++.+||+|+||.||+|.|+.+|..+|||.+... .+...+.+|+.||.+++.|++|++|+.|+.++ +++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceE
Confidence 478899999999999999999999999999998642 56778899999999999999999999996654 499
Q ss_pred EEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
||||||+ |+..++++. +++++++++..+++..+.||.|||...-+|||||..|||++.+|..||+|||.|.......
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 9999999 899999975 5689999999999999999999999999999999999999999999999999986543322
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
....+.+|||.|||||++.. -.|+..+||||||++..||..|++||.+-..+..+-.|
T Consensus 184 --AKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------ 241 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------ 241 (502)
T ss_pred --HhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------
Confidence 22356789999999999987 78999999999999999999999999876544332111
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...|.+.......+|.++.|+|++||..+|++|.||-++++|||+++-
T Consensus 242 ----------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 ----------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ----------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 122223333445688999999999999999999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=344.08 Aligned_cols=285 Identities=36% Similarity=0.669 Sum_probs=220.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++. .....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 4699999999999999999999999999999988654333334456778999999999999999999983 34569
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+.+ .|..+......+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 555555555579999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.......++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+..+....+....+.............
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 122445788999999988652 45788999999999999999999999988877766666665554432211111100
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.....................++++..+.+|+.+||+.||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000000000001111222356789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=344.47 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=209.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 4899999999999999999999999999999986432 222233456789999999999999999998843 3469
Q ss_pred EEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5888777543 46999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ....+|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR------------- 216 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-------------
Confidence 11 123478999999999977 67899999999999999999999999876543322222111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
+... .......+++.+.+|+.+||+.||.+|| +++++++||||...
T Consensus 217 ----------~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 217 ----------VKED----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ----------hhhc----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0000 0112245789999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=354.66 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=204.6
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|.. +++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999999999999999864321 2233345556655 4677999999999988843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 58999998888999999999999999999999999999999999999999999999999999864322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6789999999999999999999999987765443333221
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (381)
. .....+..+..+.++|.+||+.||.+||++ .++++||||...
T Consensus 211 -------~----~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------K----PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------C----CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 011234678999999999999999999976 599999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=348.96 Aligned_cols=295 Identities=38% Similarity=0.627 Sum_probs=230.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--- 96 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 96 (381)
...++|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 34678999999999999999999999999999999886432222223456789999999999999999998765432
Q ss_pred CCCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.....+|+||||+.+++...+.. ...+++..++.++.||++||.|||++||+|+||||+||+++.++.++|+|||+++.
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 23456899999999988888765 34799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCC--------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 176 AFSDTPM--------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 176 ~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
....... ....+...+++.|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 4332211 1112344678899999987652 458899999999999999999999999999988888888888
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
+.+.+..+..+........ .......+......+..+++.+.++|.+||+.||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8777654432211100000 0001111112223345677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.08 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=211.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC---hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 4699999999999999999999999999999998643222 1234567889999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|+||+. ++|.+.+...+.+++..++.++.|++.||+|||+.||+||||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 46999999998 58999998888899999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ------------ 222 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc------------
Confidence 2221111134568889999999987 56899999999999999999999999765543322221110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ........++..+.++|.+||..+|.+|||+.++|+||||
T Consensus 223 --------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 --------------P---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------C---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0 0011224678899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=350.99 Aligned_cols=283 Identities=23% Similarity=0.370 Sum_probs=215.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.++||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++... +.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CE
Confidence 367999999999999999999999999999999887532 233456788999999999999999999998543 46
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 59999998888899999999999999999999985 7999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH-hhCCCCHHHHh--
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGTPSPETIA-- 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~-- 256 (381)
. .....|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+.. ..+.+......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 1 133478999999999987 6789999999999999999999999987654332221110 01111100000
Q ss_pred ---------hhc----C-HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 ---------VVR----N-EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ---------~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
... . .................. .....++++.+||.+||++||++|||+.+++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 0 000011111111111110 012467899999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=350.97 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=211.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.++..++|++|+++++++. +...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence 46999999999999999999999999999999986421 12223345778999999999999999999884 3356
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 11 112335799999999998531 1468899999999999999999999998877655554443210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
...........+++++.+||++||..++.+ |++++++++||||.++
T Consensus 225 -----------------~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 225 -----------------ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -----------------ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 000111223467999999999999765554 6899999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=352.13 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=204.1
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|.. +++.++||||+++++++.. .+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 469999999999999999999999999864311 1122334445544 5678899999999998843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------------- 211 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 235579999999999987 67999999999999999999999999887655444333210
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH----HHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE----EALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~----~lL~hp~~~~~ 319 (381)
.....+.+++.+.+||.+||+.||.+|+++. ++++|+||...
T Consensus 212 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 212 ------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ------------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0112356899999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=355.13 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=203.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++. ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence 357889999999999999999999999999999986432 2334557889999999999999999999983 3456
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||.+ +|.+ ....++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999995 6643 2346788889999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
. ......||..|+|||++... ....+.++|||||||++|+|++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12345799999999987431 12345689999999999999999999974332211111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.... ........+++++.+||.+||+.||++|||+.++|+||||..-
T Consensus 288 ------------~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 288 ------------ICMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------Hhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0000 0011224678999999999999999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=343.21 Aligned_cols=281 Identities=38% Similarity=0.681 Sum_probs=226.0
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++++.||.|++|.||+|.+..++..||+|+++..... .....+.+|+.+++.++||||+++++.+.. .+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 489999999999999999999999999999998753222 233456789999999999999999999844 34689
Q ss_pred EEeeccccCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+.++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988754 368999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+..+....+....+.|....+.....
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12334678899999987652 4578899999999999999999999999998888888888888887765544331
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. .+................+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 231 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LP--EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred Cc--hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1111111111111122234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.98 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=215.8
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
......++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+||||+++++++....
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~- 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA- 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence 3344457899999999999999999999999999999998765445556678889999999999999999999886432
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceEecC---
Q 016884 97 REFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-------NVYHRDLKPKNILANA--- 161 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-------~i~H~Dikp~NIl~~~--- 161 (381)
...+|||||||. ++|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 86 --~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 --NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 246899999998 599998864 35799999999999999999999995 4999999999999964
Q ss_pred --------------CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC
Q 016884 162 --------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (381)
Q Consensus 162 --------------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g 227 (381)
.+.+||+|||++........ ....+||+.|+|||++.+....++.++||||||||||+|++|
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 23489999999975432221 234579999999999865335688999999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH
Q 016884 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (381)
Q Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~ 307 (381)
..||...+....+..... ..+. ......++++.+||..||+.+|.+|||+
T Consensus 240 k~PF~~~~~~~qli~~lk--------------------------~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELK--------------------------RGPD----LPIKGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred CCCCCcCCcHHHHHHHHh--------------------------cCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence 999976554333221111 1110 0123568899999999999999999999
Q ss_pred HHHhcCCCcCcCcc
Q 016884 308 EEALADPYFKGLAK 321 (381)
Q Consensus 308 ~~lL~hp~~~~~~~ 321 (381)
.|+|.|||+..+..
T Consensus 290 ~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 290 LQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHhccHHHhhcCC
Confidence 99999999986643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=350.88 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=203.3
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|++..+++.||+|++.... ........+.+|.. +++.++||||+++++++. +.+.+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999986432 12223344555654 578899999999998884 335699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
|||. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 58988888888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 234579999999999987 6789999999999999999999999988765443332221
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (381)
. .....+..+..+.++|.+||+.||.+||++ .++++|+||..+
T Consensus 211 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 -------K----PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------C----CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0 011224578899999999999999999875 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.77 Aligned_cols=280 Identities=39% Similarity=0.728 Sum_probs=222.1
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
|++++.||+|+||.||+|.+..+++.||+|+++........ ....+|+.+++.+. |+|++++++++... ..+.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 78899999999999999999999999999998754333222 34457999999885 99999999998553 124689
Q ss_pred EEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+||||+.++|.+.+... ..+++..++.++.|++.||.|||+.||+||||+|+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888764 57899999999999999999999999999999999999999 9999999999876533222
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.....+++.|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+.+..........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1334688999999976442 457889999999999999999999999999888888888888888776533221111
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+ ..............+.++..+.+||.+||+.||++|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000001111112234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=355.34 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=202.2
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
||+|+||+||+|++..+++.||+|++.... ...........|..++..+ .||||+++++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 799999999999999999999999986421 1222334556677777665 69999999998843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999865322211 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 212 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------------------- 212 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 2345799999999998652 45889999999999999999999999887654433332210
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC----CHHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp----t~~~lL~hp~~~~~ 319 (381)
.... ....+++++.+||++||+.||.+|| ++.++++||||...
T Consensus 213 -------~~~~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 213 -------KVRF----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred -------CCCC----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 0000 0124788999999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.39 Aligned_cols=286 Identities=40% Similarity=0.691 Sum_probs=224.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|++|.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987544444445678899999999999999999999844 3468
Q ss_pred EEEeeccccCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~-l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+++++.+. ......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765554 44556799999999999999999999999999999999999999999999999999876544322
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.......++..|+|||++.+. ..++.++|+||+||++|+|++|++||.+.+..+.+..+....+...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122346788999999998772 27889999999999999999999999988888877777777776665443322211
Q ss_pred HHHHHHHHhcCCCCCCccccCC-CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
....-........+......++ .+++++.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000000000000000011122 348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=349.22 Aligned_cols=258 Identities=21% Similarity=0.385 Sum_probs=205.1
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..+ +||+|+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975422 223445677899999888 69999999998843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999874322111 1
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~-----------~~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TE-----------DY 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cH-----------HH
Confidence 234679999999999987 688999999999999999999999996432111000 00 00
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC------HHHHhcCCCcCcCc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGLA 320 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt------~~~lL~hp~~~~~~ 320 (381)
........ + ......++..+.++|.+||+.||.+|++ ++++++||||+.+.
T Consensus 211 ~~~~~~~~-~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVILEK-P---IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHhC-C---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00001111 0 1122457899999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=353.85 Aligned_cols=259 Identities=29% Similarity=0.531 Sum_probs=218.7
Q ss_pred CCCeEE--eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 22 ANRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..-|+| -+.||+|.||+||-|.++.+|+.||||++.+..........+.+|+.||..+.||.||.+.-.+ ++.
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ 635 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETP 635 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCC
Confidence 334655 4789999999999999999999999999987554445567888999999999999999999888 444
Q ss_pred CcEEEEeeccccCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeecccc
Q 016884 100 KDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg~a~ 174 (381)
+.+++|||-+.||+.++|.+ .+++++...+.++.||+.||+|||-++|+|+||||+|||+... -.+||||||+|+
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence 56999999999999998865 4689999999999999999999999999999999999999765 359999999999
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
++.... +....+|||.|+|||++.+ ..|..+-||||+|||+|.-++|..||....+.+ ..|.+.
T Consensus 716 iIgEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNA-------- 779 (888)
T KOG4236|consen 716 IIGEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNA-------- 779 (888)
T ss_pred ecchhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHhhcc--------
Confidence 876543 3456799999999999988 789999999999999999999999997654322 222221
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...-....|..+++++.|||..+|+..-.+|.|.+..|.|||+++..
T Consensus 780 -------------------aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 780 -------------------AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred -------------------ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11111223568999999999999999999999999999999998754
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=344.85 Aligned_cols=289 Identities=37% Similarity=0.606 Sum_probs=219.2
Q ss_pred CeEEeeeecccCCceEEEEEEcC--CCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 58999999999999999999988 89999999987532 1122335667899999999999999999998653 225
Q ss_pred cEEEEeeccccCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC----CCCeEEeeec
Q 016884 101 DIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----NCKLKVCDFG 171 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~----~~~vkl~DFg 171 (381)
.+|+||||++++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||+++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 69999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh---------hHHHH
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---------HQLDL 242 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~ 242 (381)
++.................+++.|+|||++.+. ..++.++|||||||++++|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 987654332211222345788999999987653 45789999999999999999999999865532 34556
Q ss_pred HHHhhCCCCHHHHhhhcCH-HHHHHHHHhcCCCCC-----CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 243 ITDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPV-----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
+...++.+.+..+...... ......+........ .........+..+.+++.+||++||++|||+.++++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 6666666655443321111 111111111100000 0011112577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=348.04 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=211.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.++..++|++|+.+++++. +.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999986421 12233445778999999999999999999884 3456
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. |+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999976 467999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCcccccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .....+||+.|+|||++.+.. ..++.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--------- 224 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---------
Confidence 211 112357999999999886421 357889999999999999999999998776554444333210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
...........+++.+.+||.+||..++.+ |++++++++||||+..
T Consensus 225 -----------------~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 225 -----------------ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred -----------------CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 001111223457899999999999976654 5799999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=338.43 Aligned_cols=285 Identities=37% Similarity=0.616 Sum_probs=218.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+..+.|++++.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~ 75 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT-----K 75 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----C
Confidence 4457899999999999999999999999999999998643221 222356789999999999999999999843 3
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+.+++.+.+.. ...+++..++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 46899999999888887764 34688999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... .....+++.|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+ ..+.+..+....+.|.+.....
T Consensus 156 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQT---YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCC---CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 2111 1234678999999998652 457889999999999999999999997654 3456666667777776654433
Q ss_pred hcCHHHHHHHHH-hcCCCCCCccccCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 258 VRNEKARKYLTE-MRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
..... .+... .....+......+. ..++.+.+++.+||..||.+|||+.++|.||||
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLP--NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcc--cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 22110 00000 00111111111111 236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=363.04 Aligned_cols=257 Identities=24% Similarity=0.310 Sum_probs=211.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCC-CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..|.+.+.||+|++|.||.|.+..+ +..||+|.+.. ........+.+|+.+|+.++||||+++++.+.. .+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCE
Confidence 3499999999999999999998877 78899997643 233444567789999999999999999999843 356
Q ss_pred EEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+|+||||+. ++|.+.+.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 447899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-------- 288 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-------- 288 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 33221 111235579999999999987 6899999999999999999999999987765444433322100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .....+++.+.+||.+||+.||++|||+.++|.|+|++..
T Consensus 289 -----------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 -----------------D-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -----------------C-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0 1123578899999999999999999999999999999754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=347.10 Aligned_cols=294 Identities=38% Similarity=0.579 Sum_probs=231.6
Q ss_pred cCCCCCeEE-eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChH------------HHHHHHHHHHHHHhcCCCCcc
Q 016884 19 YGDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------DAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 19 ~~~~~~Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv 85 (381)
++..++|.. .+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.+++.++||||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 456788975 5779999999999999999999999999864322110 012467899999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
++++++.. ....|+||||+.++|.+++.....+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999843 3468999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCC-----------CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 166 KVCDFGLARVAFSDT-----------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 166 kl~DFg~a~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
+|+|||.++...... ..........+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987543111 011112234578889999998763 45788999999999999999999999999
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
+..+.+..+...++.|.+..+....... .+ .......+.......+..+..+.++|.+||+.||++|||++++|.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 9888888888888888765433211000 00 00111112222233456789999999999999999999999999999
Q ss_pred CcCcCcc
Q 016884 315 YFKGLAK 321 (381)
Q Consensus 315 ~~~~~~~ 321 (381)
||+....
T Consensus 315 ~~~~~~~ 321 (335)
T PTZ00024 315 YFKSDPL 321 (335)
T ss_pred ccCCCCC
Confidence 9987543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=337.48 Aligned_cols=282 Identities=47% Similarity=0.768 Sum_probs=231.9
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999999876544434456788899999999999999999988443 56999
Q ss_pred EeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
|+||+.++|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 999999999988876 3589999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.+.+..+.+..+...++.+.++.+.......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA- 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-
Confidence 112345688899999998762 378999999999999999999999999999988888888888888776655443311
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...................+.++..+.++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11111122222222233445689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.42 Aligned_cols=284 Identities=25% Similarity=0.372 Sum_probs=215.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 36999999999999999999999999999999986432 23345568899999999999999999999844 3569
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999998 599999999999999999999999999986542221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH-----
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI----- 255 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 255 (381)
....++++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134578999999999877 57889999999999999999999999876543322222111000000000
Q ss_pred ----hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 ----AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
............+......+. ......+++++.+|+.+||..||++|||+.++++||||.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 000000011111111111110 0111237889999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=354.75 Aligned_cols=273 Identities=27% Similarity=0.397 Sum_probs=226.2
Q ss_pred hhhhhhccccc---ccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcC
Q 016884 5 QTKKELKDKDF---FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLR 80 (381)
Q Consensus 5 ~~~~~~~~~~~---~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~ 80 (381)
..+..|+|.++ |...+.-+.|.-++.||.|+||-||-|++..+.+.||||+++..... .....++++|+..|++++
T Consensus 5 ~r~GslKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~ 84 (948)
T KOG0577|consen 5 GRPGSLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR 84 (948)
T ss_pred CCCCCCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc
Confidence 44555665544 33445556788899999999999999999999999999999865433 345668999999999999
Q ss_pred CCCccccceeecCCCcCCCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe
Q 016884 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (381)
Q Consensus 81 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~ 159 (381)
|||++.+.++|.-.. ..|+|||||-|+-.+++.- .+++.+.++..|+.+.+.||+|||+.+.||||||..|||+
T Consensus 85 HPntieYkgCyLre~-----TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 85 HPNTIEYKGCYLREH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred CCCcccccceeeccc-----hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 999999999996543 3799999999988887764 3589999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCCcccccccccCccccCcccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh
Q 016884 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (381)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 238 (381)
++.|.|||+|||.|..... ..+++|||+|||||+++. ..+.|+-++||||||++..+|.-.+||+-..+.+.
T Consensus 160 se~g~VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 160 SEPGLVKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred cCCCeeeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 9999999999999976432 245799999999999864 23679999999999999999999999987777665
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.+--|..- ..|.- ..+.+|..++.+|..||+.-|.+|||++++|.|+|...
T Consensus 233 ALYHIAQN--------------------------esPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 233 ALYHIAQN--------------------------ESPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHhc--------------------------CCCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 55444321 11110 12467889999999999999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=337.61 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=207.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|++|+.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 47889999999999999999999999999999864322 22334457789999999999999999988843 3469
Q ss_pred EEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 5898888543 35899999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+............
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------- 215 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh--------------
Confidence 21 123478999999999987 6789999999999999999999999976542211111110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
...... ......+++++.+|+.+||+.||++||| ++++++||||+.+
T Consensus 216 ------~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 216 ------LVKEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ------hhhhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 000000 0112457889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=328.72 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=209.9
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|++++.||+|++|.||.|.++.+++.||+|++............+.+|+.+++.++|+|++++++.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4999999999999999999999999999999987544444555678889999999999999999887632 223589
Q ss_pred EEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+. ++|.+++... ..+++..++.++.|++.||++||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5899888753 468999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......+++.|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+....
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK------------- 218 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 1 1234568899999999987 678899999999999999999999998765433322221100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ......+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 219 -------------~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 -------------L----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------C----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=314.44 Aligned_cols=287 Identities=30% Similarity=0.599 Sum_probs=229.6
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
.+|..++|++++++|+|.|+.||.|++..+++.++||+++. -..+.+.||+.||..|. ||||++++++..++..
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 67888999999999999999999999999999999999874 44568899999999997 9999999999976543
Q ss_pred CCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeecccc
Q 016884 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a~ 174 (381)
....+|+||... +...+.. .++...++.++.+++.||.||||.||.|||+||.|++++.. -.++|+|+|+|.
T Consensus 108 ---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 108 ---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 456899999995 6666654 48889999999999999999999999999999999999975 459999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
....+.. +.-.+.+++|--||++-.. +.|+.+-|+|||||+++.|+..+.| |.|.++.+++.+|.+.+|+..-.
T Consensus 182 FYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 182 FYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 7655443 2345788999999999875 6799999999999999999998765 58899999999999999985432
Q ss_pred -HHhhhcCHHHHHHHHHhcCCCCCCccccC------CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKF------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.+....-....++-..+.... ...+..| .-.++++.||+.++|.+|..+|+||.+++.||||..+..
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~-rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHS-RKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHHccCCChhHhhHhhccc-cccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 122221111111111111111 1111111 125799999999999999999999999999999987644
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=336.05 Aligned_cols=281 Identities=43% Similarity=0.721 Sum_probs=231.3
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++++... ..+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6788999999999999999999999999999976543333445677899999999999999999998543 56999
Q ss_pred EeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+........
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999876433221
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
......++..|+|||.+.+. ..++.++|+|||||++++|++|++||.+.+..+.+..+...++.+.+..+....+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999998762 378899999999999999999999999999999999999999988877665443221
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.+...............++..+..+.++|.+||..||++||+++++++||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011111112222234455678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=345.40 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=205.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 100 (381)
+..|+++++||+||.+.||++... ....||+|++.....+......+..|+..|.+|+ |.+|+.++++-... +
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----G 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----c
Confidence 467999999999999999999753 3466777777655566777888999999999995 89999999987653 4
Q ss_pred cEEEEeeccccCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+||||||-+.||..++++... ++.-.++.+..|++.|++++|..||||.||||.|+|+-. |.+||+|||.|.....+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 6999999999999999987653 443588999999999999999999999999999999865 58999999999876554
Q ss_pred CCCcccccccccCccccCccccccccC---------CCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
+ +.+.....+||+.|||||.+..... ..++++||||||||||+|+.|++||..- ...++++... -.|
T Consensus 513 T-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI-~~P 588 (677)
T KOG0596|consen 513 T-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAI-TDP 588 (677)
T ss_pred c-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhh-cCC
Confidence 4 3455567899999999998854211 2678999999999999999999999532 1222222211 111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCC--HHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.. .-.|+.++ .++.++++.||.+||.+|||+.++|+|||++.
T Consensus 589 ~~--------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 589 NH--------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred Cc--------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 10 11122222 23899999999999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=350.21 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=225.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..+-|.+.+.||+|.|++|.+|++..|+..||||.+++...+......+.+|+++|+.++|||||+++.+..+ ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 3467999999999999999999999999999999999877776666778999999999999999999999944 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. |.+++++.+++.+.+..++.++.|++.|++|||+++|+|||||++|||++.+..+||+|||++......
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 6999999998 699999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. ...++||++.|+|||++.+. ...++.+|+||+|+++|.|+.|..||++.+....-
T Consensus 209 ~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------------------- 264 (596)
T KOG0586|consen 209 L----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------------------- 264 (596)
T ss_pred c----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccccc-------------------
Confidence 3 34578999999999999985 45678999999999999999999999987643221
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
...-.......-.++.++.+||+++|..+|.+|++.+++..|+|......
T Consensus 265 ------------~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 265 ------------PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ------------chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 11111122223357889999999999999999999999999999976544
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=339.40 Aligned_cols=291 Identities=38% Similarity=0.632 Sum_probs=227.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-----c
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-----K 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 96 (381)
.++|++.+.||+|+||.||+|.++.+++.||+|+++...........+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46799999999999999999999999999999998654332233346678999999999999999999886543 1
Q ss_pred CCCCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+...+|+|+||+++++...+... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888754 3689999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
....... ......++..|+|||.+.+. ..++.++||||+||++++|++|++||...+..+.+..+....+.+.+..+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5333211 11233567889999988652 45788999999999999999999999998888888888888888776544
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
............+. ...........+..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKP-KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccc-ccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 32211100000000 0000011122344678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=323.86 Aligned_cols=274 Identities=26% Similarity=0.406 Sum_probs=221.3
Q ss_pred eEE-eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcE
Q 016884 25 YKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 25 Y~~-~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
|++ .+.||+|+|+.|-.|....++..||||++.+... -...++.||++++.+++ |+||+.++++| ++....
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 555 5779999999999999999999999999986522 23568899999999995 99999999999 555669
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---CeEEeeecccccccC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVAFS 178 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~vkl~DFg~a~~~~~ 178 (381)
|+|||-|. |.|...|+.+..+++.++..++..|+.||.|||.+||.|||+||+|||...-. -||||||.++.....
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999998 59999999999999999999999999999999999999999999999987643 489999998754322
Q ss_pred C----CCCcccccccccCccccCcccc---ccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 179 D----TPMTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 179 ~----~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
. ........+.+|+..|||||+. .+....|+.++|.||||||+|.|++|.+||.|....+-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------------ 299 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------------ 299 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC------------
Confidence 2 2223345677899999999975 33335699999999999999999999999987643210
Q ss_pred HHHHhhhcCHH-----HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 252 PETIAVVRNEK-----ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 252 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.|...+ -..+++.+......-....|..+|.++.||++.+|..|+.+|.+|.++|+|||++.....
T Consensus 300 -----GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 300 -----GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred -----CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 011000 112344555555444455677899999999999999999999999999999999887543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=344.61 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=199.5
Q ss_pred CCCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 46899999999999999999975 244578999998743 2334456788999999999 899999999987432
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhC------------------------------------------------------
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 120 (381)
...+|+||||+. |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 235899999998 6999888642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccC
Q 016884 121 --------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (381)
Q Consensus 121 --------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt 192 (381)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 24778899999999999999999999999999999999999999999999999754322111 111223466
Q ss_pred ccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc
Q 016884 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271 (381)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+............
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-------------------------- 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-------------------------- 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--------------------------
Confidence 78999999977 678999999999999999997 9999987553222111110
Q ss_pred CCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... ......+++.+.+|+.+||+.||.+|||+.++++
T Consensus 292 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 0112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=326.87 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=211.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+... ...|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 48899999999999999999999999999999875444455667888999999999999999999988443 5689
Q ss_pred EEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+. ++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999997 5999998764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......|++.|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------- 217 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234568899999999987 678999999999999999999999998776443332222100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......++..+.+++.+||+.+|++||++.+++.|||+
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -----------------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 001112578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=334.66 Aligned_cols=254 Identities=25% Similarity=0.465 Sum_probs=214.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+++++.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 46999999999999999999999999999999986432 223345678899999999999999999999843 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+|+||+|.||+++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999995 799999988889999999999999999999999999999999999999999999999999998765333
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
....++++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134478999999999877 5788999999999999999999999987664333322221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (381)
.. ......+++.+.++|.+||..||.+|+ +++++++||||+.+.
T Consensus 213 -----------~~-----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GK-----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CC-----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 00 011235688999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.81 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=207.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 468999999999999999999999999999998864322 1233456788999999999999999999875432 2
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+++++||+. ++|.+.+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 46899999998 58999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
............++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+.. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~------- 226 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT------- 226 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC-------
Confidence 2111111223468889999999977 6789999999999999999999999976543322221110 000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
.......+++.+.+|+ +||..+|++|||++++++||||+
T Consensus 227 -------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 -------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0011134678889999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=335.41 Aligned_cols=285 Identities=40% Similarity=0.665 Sum_probs=226.8
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++++.||+|++|.||+|.+..+++.+|+|++............+.+|+.+++.++|||++++++++.... ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78899999999999999999999999999999765433344456788999999999999999999985431 256999
Q ss_pred EeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
|+||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999988765 5799999999999999999999999999999999999999999999999999876543321
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++..|+|||.+.+. ..++.++|||||||++++|++|+.||...+....+..+.+..+.+....+........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 112334678889999987652 4678999999999999999999999999988888888888888877655443222110
Q ss_pred HHHHHHhcCCCCCCccccCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 264 RKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...... ....+......+.. .++.+.+++.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000000 00000011112233 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=334.43 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=209.8
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+|++.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+|+.++|+||+.+.+.+.. .+.+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 4888999999999999999999999999999986432 122233457789999999999999999888843 3469
Q ss_pred EEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999998 5888777543 36999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.........+.......
T Consensus 156 ~~----~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--------- 220 (285)
T cd05632 156 ES----IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--------- 220 (285)
T ss_pred Cc----ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc---------
Confidence 11 234578999999999977 678999999999999999999999998765443332222111000
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
.......+++.+.+|+.+||+.||++||| +.+++.|+||+..
T Consensus 221 ------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 221 ------------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ------------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 00112457889999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=344.39 Aligned_cols=287 Identities=22% Similarity=0.312 Sum_probs=206.9
Q ss_pred Eeeeeccc--CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 27 ILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 27 ~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
++++||+| +|++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++... +..|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57889999 678999999999999999999975544444455677899999999999999999998543 45899
Q ss_pred Eeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 105 VFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 105 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
||||+. ++|.+++..+ ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999998 6899988653 4589999999999999999999999999999999999999999999999986543221111
Q ss_pred C----cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC------
Q 016884 182 M----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS------ 251 (381)
Q Consensus 182 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 251 (381)
. ........++..|+|||++.+....++.++||||+||++|+|++|+.||.............. +...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccccccc
Confidence 0 000112356778999999875324689999999999999999999999987654333222211 1110
Q ss_pred ---HHHHhhhcCH-HHHHHH-HH-----hc-CCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 252 ---PETIAVVRNE-KARKYL-TE-----MR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 252 ---~~~~~~~~~~-~~~~~~-~~-----~~-~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
++........ ...... .. .. .............+++.+.+||.+||++||++|||++++|+||||+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0000000000 000000 00 00 0000000111234678999999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.30 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||+|+||.||+|.++.+|+.||+|.+..... .......+..|+++++.++||||+++++++. ...++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence 7999999999999999999999999864222 1122334567999999999999999999884 345699999999
Q ss_pred c-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 110 E-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 110 ~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
. ++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----I 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----e
Confidence 8 58888875433 589999999999999999999999999999999999999999999999999875433221 2
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--------------------- 208 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---------------------
Confidence 34468999999999987 5699999999999999999999999976432111111100
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCcCcCc
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGLA 320 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~~~~~ 320 (381)
...... .......+++++.+||++||+.||++|||+ ++++.||||+.+.
T Consensus 209 --~~~~~~---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 209 --RTLEDE---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred --Hhhccc---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 000000 001123578999999999999999999999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=336.61 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=213.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+++++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 4799999999999999999999999999999998754322 234567889999999999999999999883 3456
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 899999998 4999988754 5799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCc--------------------------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 016884 179 DTPMT--------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (381)
Q Consensus 179 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 232 (381)
..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 11100 01123468899999999987 678999999999999999999999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC----HH
Q 016884 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT----AE 308 (381)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt----~~ 308 (381)
+.+.......+.. .... ......+++.+.++|.+||+.||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KEVT---FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CCcc---CCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 7765443322221 0000 1111237899999999999999999999 99
Q ss_pred HHhcCCCcCcCc
Q 016884 309 EALADPYFKGLA 320 (381)
Q Consensus 309 ~lL~hp~~~~~~ 320 (381)
++|+||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=331.26 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=222.6
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCCc
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.+ +|||++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999975433333344566788877666 5999999999987654333445
Q ss_pred EEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++++|||+.++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999999999887643 5899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 123457889999999987 678999999999999999999999999988888888887766655433221111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.... ...............+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 0011111122223334678889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=332.29 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=211.6
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....+.|++++.||.|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 81 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD---- 81 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC----
Confidence 34457899999999999999999999999999999998642 334566788899999999999999999988433
Q ss_pred CCcEEEEeecccc-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..+|+||||+.+ +|..++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 468999999995 77776654 457899999999999999999999999999999999999999999999999988653
Q ss_pred cCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
..... ......+++.|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+.. ..
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~--- 231 (292)
T cd06644 161 VKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SE--- 231 (292)
T ss_pred ccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CC---
Confidence 22211 12344688899999998531 14578899999999999999999999976554332222211 00
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+.......++.++.++|.+||+.||++||+++++|+||||..+.
T Consensus 232 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 232 ----------------------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ----------------------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 001112245788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.44 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=208.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~ 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----R 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----C
Confidence 3446899999999999999999999999999999998643 22334567789999999999999999998843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||++ ++|.+++...+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 56899999998 59999998888999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ......|++.|+|||.+.. ....++.++|+|||||++|+|++|..||...........+...
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS----------- 224 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----------
Confidence 211 1234578999999998742 1146888999999999999999999999655432222111100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
...+ +.......++..+.+++.+||+.||++|||++++++|||
T Consensus 225 --------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 --------------NFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------CCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0000 001112246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=331.87 Aligned_cols=261 Identities=23% Similarity=0.401 Sum_probs=208.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC-C
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR-E 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~ 98 (381)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++.+...... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4578999999999999999999999999999999986432 2234677899999998 699999999998654321 2
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...+|+||||+. ++|.+++... ..+++..++.++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 346899999998 5999988763 3689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
...... ......|++.|+|||++.+. ...++.++||||+||++|+|++|..||...........+..
T Consensus 161 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~------- 230 (272)
T cd06637 161 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------- 230 (272)
T ss_pred cccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc-------
Confidence 432211 12345789999999998531 14688899999999999999999999975543222211100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. ........++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 231 --------------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 --------------------NP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --------------------CC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=333.03 Aligned_cols=263 Identities=27% Similarity=0.470 Sum_probs=214.3
Q ss_pred ccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
.+..+...+|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++|||++++++.+..
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-- 88 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEe--
Confidence 4445666899999999999999999999999999999999865322 234567889999999999999999998854
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
....|+||||+. ++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.
T Consensus 89 ---~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 89 ---GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ---CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccch
Confidence 346899999998 589888864 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.. .+
T Consensus 165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~------ 232 (296)
T cd06654 165 QITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG------ 232 (296)
T ss_pred hcccccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC------
Confidence 5432211 1233478899999999877 6788999999999999999999999977654332211110 00
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+.......+++.+.+|+.+||..||++|||+.++++||||...
T Consensus 233 ---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 233 ---------------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ---------------------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00111224578899999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=331.28 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=211.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++.+... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 47999999999999999999999999999999986432 233445678899999999999999999988433 569
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|+||+. ++|.+++..+ ++++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998765 899999999999999999999999999999999999999999999999999976543321
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+...
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 213 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------- 213 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------
Confidence 1234568889999999987 56899999999999999999999999765533222221110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+... ....+++.+.+++.+||..||++|||++++++||||...
T Consensus 214 ------------~~~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 214 ------------NPPSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ------------CCCCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 00000 011278899999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=325.58 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=219.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.|..++.||+|.||+|-+|+.+.+++.+|+|++++..- .......-+.|-++|+..+||.+..+.-.| +....
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence 578889999999999999999999999999999986432 223444567899999999999999887766 34456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||.. |.|.-.+.....++++..+.+...|+.||.|||+++||.||||.+|+|++.+|.+||+|||+++-.....
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999998 5899999888889999999999999999999999999999999999999999999999999997533322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ...++||||.|+|||++.. ..|+.++|.|.+||++|||++|+.||...+.......|.--.
T Consensus 323 ~---t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------- 384 (516)
T KOG0690|consen 323 D---TTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------- 384 (516)
T ss_pred c---eeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------
Confidence 2 2357899999999999988 789999999999999999999999999988766665553210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
......++++++.|+..+|..||.+|. .|.++..|+||.++
T Consensus 385 ------------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 385 ------------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred ------------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 011246899999999999999999997 48999999999876
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=331.70 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=213.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
...+|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 4568999999999999999999999999999999986432 2334567889999999999999999999843 34
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|+||+. ++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 6999999998 488887765 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+... +
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~----------- 231 (296)
T cd06655 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G----------- 231 (296)
T ss_pred cc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-----------
Confidence 21 1123468889999999877 67889999999999999999999999887654333222110 0
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+.......+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 232 ----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 232 ----------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ----------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 011112346788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=330.49 Aligned_cols=286 Identities=29% Similarity=0.477 Sum_probs=225.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-----C---CCccccceeecCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----H---PDIVEIKRIMLPP 94 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~~~~~~ 94 (381)
+||.+.++||.|.|++||+|.|..+.+.||+|+++.. .-..+..+.||++|++++ | ..||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 8999999999999999999999999999999998732 223446678999999984 2 3699999998766
Q ss_pred CcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCC---------
Q 016884 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANAN--------- 162 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~--------- 162 (381)
+ ..+.++|||+|+++.+|+.+|+... .++...++.|++|||.||.|||.. ||+|.||||+|||+..+
T Consensus 155 G-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 G-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred C-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 5 5678999999999999999998653 699999999999999999999986 99999999999997110
Q ss_pred --------------------------------------------------------------------------------
Q 016884 163 -------------------------------------------------------------------------------- 162 (381)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (381)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CCe
Q 016884 163 -----------------------------------------------------------------------------CKL 165 (381)
Q Consensus 163 -----------------------------------------------------------------------------~~v 165 (381)
-++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 014
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC------ChhhH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------SVVHQ 239 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~ 239 (381)
||+|||.|+.... .++.-+.|+.|+|||++.| ..|++.+||||++|+++||+||..+|... .+.+.
T Consensus 394 KIaDlGNACW~~k------hFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 394 KIADLGNACWVHK------HFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred EEeeccchhhhhh------hhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 5555555543211 2345578899999999999 89999999999999999999999999643 35789
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHH------HhcCCCCCCccccC---CC----CCHHHHHHHHHhccCCCCCCCC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLT------EMRKKPPVPLFQKF---PN----VDPLALRLLQRLIAFDPKDRPT 306 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~---~~----~~~~~~dLi~~~L~~dp~~Rpt 306 (381)
++.|+.++|..+..++...+. .+.|+. .+.+-++.++...+ -. -..++.|+|.-||+++|++|||
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~--SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKY--SRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcc--hHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 999999999998877654432 223332 23333333332211 12 2345789999999999999999
Q ss_pred HHHHhcCCCcCcCccC
Q 016884 307 AEEALADPYFKGLAKI 322 (381)
Q Consensus 307 ~~~lL~hp~~~~~~~~ 322 (381)
|.++|+|||++.+..+
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999987664
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=351.03 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=216.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+-+.|+..||.|+||.||+|..+.++-..|.|++.. ........++-||.||..++||+||++++.|+..+ .
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----k 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----K 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----c
Confidence 3456789999999999999999999998899998853 34456678888999999999999999999996654 4
Q ss_pred EEEEeeccccCHHH-HHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELMESDLHQ-VIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~~~L~~-~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++|+.|||+|.-.+ ++. -...++++++..+++|+|.||.|||+++|+|||||..|||++-+|.++|+|||.+......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999999975444 333 3557999999999999999999999999999999999999999999999999987543222
Q ss_pred CCCcccccccccCccccCcccccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
......++|||+|||||+... ...+|+.++||||||++|.+|.-+.+|...-+.+..+-+|.+-.
T Consensus 184 ---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--------- 251 (1187)
T KOG0579|consen 184 ---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------- 251 (1187)
T ss_pred ---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC---------
Confidence 222357899999999998632 12689999999999999999999999999888877776665411
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+| ..-..+.++..+.|++++||..||..||++.++|+|||+++.
T Consensus 252 -----------------PP--TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 252 -----------------PP--TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------------CC--cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11 111234678899999999999999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=342.12 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=206.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..+++++.||+|.||.||.|.... ...||+|.++.. ......+.+|+++|++|+|++||++++++... ..+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cce
Confidence 346788999999999999997642 348999998743 23345677999999999999999999999443 349
Q ss_pred EEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|||||||. |+|.++++. ...+...+...++.||++|++||+++++|||||...||||++++.+||+|||+|+....+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999 899999997 457999999999999999999999999999999999999999999999999999943322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.-. .....--..-|.|||.+.. ..++.+||||||||+|+||+| |+.|+.+.+..+.+..+.+....|.|
T Consensus 357 ~Y~--~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------ 426 (468)
T KOG0197|consen 357 EYT--ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------ 426 (468)
T ss_pred cee--ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------
Confidence 111 1111223345999999987 789999999999999999999 99999999999888888765544432
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
..+++++.+++..||..+|++|||++.+.
T Consensus 427 ------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 427 ------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 47999999999999999999999999765
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=327.46 Aligned_cols=256 Identities=27% Similarity=0.465 Sum_probs=208.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh-------HHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
+|.+...||.|++|.||.|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 5788999999999999999999999999999886432211 123467789999999999999999998843
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
....++||||+. ++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||.++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 346899999998 49999998888899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCC---cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDTPM---TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
....... ........|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------ 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------
Confidence 5422111 111123458889999999877 67889999999999999999999999876543322221110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
........++..+.++|++||+.||.+||++.++++||||
T Consensus 228 ------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.29 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=208.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..|++.+.||+|+||.||.|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 57999999999999999999999999999999885322 12234567888999999999999999999874321 2
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||+. ++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 45899999998 59999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~------- 226 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPT------- 226 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCC-------
Confidence 2111111234468899999999877 678999999999999999999999997654332221111 1100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
. .......+..+.++|.+||. +|.+|||++++++|||+.
T Consensus 227 -----------------~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 -----------------N--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----------------C--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 01123567889999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=328.93 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=208.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +|||++++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 57899999999999999999999999999999998642 12234567899999998 799999999998654433445
Q ss_pred cEEEEeeccc-cCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 101 DIYVVFELME-SDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..|+||||+. ++|.+++. ....+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999998 58888775 245789999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCcccccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
....... .....|+..|+|||.+.... ..++.++||||+||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 4322211 12346889999999875421 2368899999999999999999999977654333322211
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
..+ .........+..+.+||.+||+.||++|||+.++|+||||+
T Consensus 248 --------------------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 00111234677899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.09 Aligned_cols=261 Identities=24% Similarity=0.422 Sum_probs=209.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 36899999999999999999999999999999886432 23345678899999999999999999998844 3569
Q ss_pred EEEeecccc-CHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 103 YVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||.+....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999995 888888763 379999999999999999999997 599999999999999999999999999986543
Q ss_pred CCCCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
... .....+++.|+|||.+.+. ...++.++|+||+||++|+|++|+.||...........+....
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 223 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV------ 223 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh------
Confidence 221 1234688899999998542 1235889999999999999999999997654332222221111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
... .....+.+++++.+||.+||+.+|++||+++++++||||.....
T Consensus 224 ------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 224 ------------------DGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ------------------hcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 100 11123458899999999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.09 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=213.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++++.||.|+||.||.+++..++..+++|.+............+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 6999999999999999999999999999999987554445556678899999999999999999999844 35699
Q ss_pred EEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999764 468999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......+++.|+|||.+.+ ..++.++|+||+||++++|++|..||...+..+....+.. +.
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~----------- 217 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GN----------- 217 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CC-----------
Confidence 1 1234578999999999887 5688899999999999999999999987665444433321 00
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......++..+.+++.+||..||.+|||+.++|+|||+
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 218 -----------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 001114578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=330.84 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=211.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||.|++|.||+|.+..++..||+|.+.. ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCe
Confidence 4679999999999999999999998999999999863 234455678899999999999999999999854 346
Q ss_pred EEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999985 888888764 47999999999999999999999999999999999999999999999999988654322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. ......+++.|+|||.+... ...++.++|+|||||++|+|++|++||.+.+.......+...
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 223 (280)
T cd06611 157 LQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS---------- 223 (280)
T ss_pred cc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC----------
Confidence 21 12345689999999987521 145778999999999999999999999876544333222110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .+.......++.++.++|.+||+.||.+|||+.++|+||||...
T Consensus 224 -----------------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 224 -----------------E-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------------C-CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0 00111123578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=328.34 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=207.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----R 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----C
Confidence 34567999999999999999999999999999999986432 2234467789999999999999999998843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||++ ++|.+++....++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 46899999998 58999998878899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ......+++.|+|||.+.+. ...++.++|+||+||++|+|++|+.||...+.......+...
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------- 224 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence 211 11344688999999987431 145788999999999999999999999654432211111000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
....+.......++..+.+||++||+.||++|||++++|+|+|
T Consensus 225 ---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ---------------NFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ---------------CCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000001112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=333.12 Aligned_cols=264 Identities=28% Similarity=0.471 Sum_probs=213.8
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
+..+..++|++++.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+..
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--- 87 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV--- 87 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 33455588999999999999999999999999999999986432 2334567889999999999999999999843
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
....|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 356899999998 588888865 4689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.. .+.
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~------ 232 (297)
T cd06656 165 ITPEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT------ 232 (297)
T ss_pred ccCCcc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCC------
Confidence 432221 1234468899999999987 6788999999999999999999999977553222111110 000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+.......+++.+.+|+.+||..||++|||+.++|+||||+....
T Consensus 233 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 233 ---------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ---------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 111122457888999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.05 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=209.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|+||.||.+.+..+++.||+|.+............+.+|+.+++.++||||+++++.+. .....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 599999999999999999999999999999998654333445567889999999999999999999883 345699
Q ss_pred EEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||+. ++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999887543 58999999999999999999999999999999999999999999999999987543321
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......|++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+..+....+...
T Consensus 156 ~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd08218 156 E---LARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------------- 216 (256)
T ss_pred h---hhhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--------------
Confidence 1 1123468888999999877 67889999999999999999999999766544433322210
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. ......++.++.++|.+||+.+|++||++.++|+||||
T Consensus 217 ------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 217 ------------SY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ------------CC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=324.12 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=212.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++++.||.|+||.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875544555667788999999999999999999877543 234689
Q ss_pred EEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH-----~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
++|||+. ++|.+++.. ..++++..++.++.||+.||+||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 589988865 357999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
........ ......+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 76543321 1234578999999999987 5688999999999999999999999987664332222211
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. ........+..+.+|+.+||+.+|++|||+.++|+|||+
T Consensus 225 -------------------~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 225 -------------------GK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------------CC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 011223578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=306.21 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=206.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
-..+||++.+.||+|||+.||++.+..++..||+|++... ...+....++|++..++++|||++++++.......+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 3468999999999999999999999999999999999754 35667788999999999999999999988765544455
Q ss_pred CcEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeecc
Q 016884 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
...||+++|.. |+|.+.+.. ...+++.++..|+.+|++||.+||+.. .+||||||.|||+.+.+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 66999999998 799998864 236999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCc------ccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 173 ARVAFSDTPMT------VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 173 a~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
++...-..... ..+.....|..|+|||++.-. ....++++|||||||+||.|+.|..||...- .
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------Q 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------h
Confidence 86532111111 011233467889999998431 2457889999999999999999999994211 0
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.-|.-.- ++. ..... ...-+.+|..+.+||+.||+.||.+||++.+++.+
T Consensus 247 ~GgSlaL----Av~-------------n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLAL----AVQ-------------NAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEEE----eee-------------ccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000000 000 00000 01113489999999999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=329.34 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=208.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-C
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-R 97 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~ 97 (381)
...+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++..... .
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3457899999999999999999999999999999988542 23345677899999998 69999999998864321 2
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
....+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 3457899999998 5899888753 458899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
....... ......|++.|+|||.+... ...++.++|+|||||++|+|++|..||...........+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~------ 240 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------ 240 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh------
Confidence 5432111 12345689999999987521 14688899999999999999999999976543322211110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. ........++.++.+||.+||+.||.+|||+.++|+||||
T Consensus 241 ---------------------~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 ---------------------NP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------CC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 00 0011123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.35 Aligned_cols=258 Identities=23% Similarity=0.392 Sum_probs=203.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+... ...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEE
Confidence 36889999999999999999999999999999986432 233445788999999999999999999998543 458
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
++||||+.+ +|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999996 55433 357899999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
....+||..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... +.+
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cch---------
Confidence 234578999999999987 67899999999999999999999999653211100 000
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...........+. .......++++.+++.+||+.||++||+++++++||||...
T Consensus 206 --~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDPP--VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCCC--CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0000000000000 01123478899999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.41 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=211.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||.|++|+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 46999999999999999999998899999999986543332 56678899999999999999999988843 3568
Q ss_pred EEEeeccc-cCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 103 YVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
|+|||++. ++|.+++... ..+++..++.++.|++.||+|||+.||+||||+|+||++++++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899998764 4589999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCc-ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... .......|+..|+|||.+... ..++.++|+|||||++++|++|..||...+........... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------ 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------ 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC------
Confidence 32221 112334688999999998763 36889999999999999999999999766543332222110 00
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...........+++.+.+++.+||+.||++|||+.++++||||
T Consensus 225 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 ----------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000111124678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.80 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=207.6
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|++.+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++||||+++++.+... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 68899999999999999999999999999998642 334556788899999999999999999988543 45899
Q ss_pred Eeecccc-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 105 VFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
|+||+.+ +|..++.. ..++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999984 77776654 45799999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccccCccccCcccccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 183 TVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
......+++.|+|||++.. ....++.++|+||+||++|+|++|++||...+.......+....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------------ 224 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC------------
Confidence 1234568899999999742 11457889999999999999999999998766444333322110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. ........++..+.+||.+||+.||.+|||++++++||||...
T Consensus 225 --------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 225 --------------P--PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------------C--CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0 0011123578899999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=324.19 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=207.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC----ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 588999999999999999976 4788999998864321 12234568889999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|+||+. ++|.+++.+...+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 56999999998 59999998878899999999999999999999999999999999999999999999999999875321
Q ss_pred CC---CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 179 DT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 179 ~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.. ..........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG------- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-------
Confidence 11 11112234568999999999987 6789999999999999999999999976553322211111000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
........++.++.++|.+||+.+|.+|||+.++|+||||
T Consensus 226 ---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 ---------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0011224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=325.35 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=210.3
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+|++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+++++.++||||+++++.+ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 48999999999999999999999999999999875322 224566788999999999999999999888 344569
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|+||+. ++|.+.+....++++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999877789999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.... ..+..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~---------------- 212 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRA---------------- 212 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHH----------------
Confidence 1234468889999999877 5689999999999999999999999987653211 01100
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH--HHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA--EEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~--~~lL~hp~~ 316 (381)
.... ......+.+++.+.++|.+||+.||.+||++ +++++||||
T Consensus 213 -------~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 213 -------KQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -------Hhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0010 0111224578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.50 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=211.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 369999999999999999999999999999999865322 2233457788999999999999999998884 3356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999986421111
Q ss_pred CC------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 181 PM------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 181 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
.. ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~- 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD- 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence 00 000112457888999999877 678999999999999999999999998765443332222100
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCCcCcC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (381)
... ......+++++.++|.+||+.||++||| +.++|+||||...
T Consensus 233 -------------------------~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 233 -------------------------IEW--PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -------------------------cCC--CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 000 0011257889999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=327.33 Aligned_cols=258 Identities=25% Similarity=0.451 Sum_probs=202.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||.||+|.+..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 46999999999999999999999999999999987543332 23455567665 667789999999999843 345
Q ss_pred EEEEeeccccCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+|+||||++++|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 899999999988887754 34689999999999999999999997 9999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 253 (381)
..... .+...++..|+|||.+.+. ...++.++|+||+||++|+|++|+.||.... ..+.+..+..
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 222 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--------
Confidence 32211 1234688899999987541 1357889999999999999999999996432 1111111110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+ ......++.++.++|.+||..+|++|||+.++++||||...
T Consensus 223 ------------------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 223 ------------------EPSP---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ------------------cCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000 00012478899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=365.88 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=223.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|.|++.||+|+||.|.+++++.|++.||.|++++.. ....+...|..|-.+|-.-+.+=|+.++-.| .+.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 467999999999999999999999999999999997532 2234455778899999998999999998888 5667
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++|+|||||. |||..++.+..+++++.++.++..|+.||.-||+.|.|||||||+|||++..|.+||+|||.+-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 8999999998 699999998889999999999999999999999999999999999999999999999999988654432
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHh---hCCCCHH
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL---LGTPSPE 253 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~ 253 (381)
. .......+|||.|.|||++... .+.|++.+|+||+||++|||+.|..||...+-.+.+.+|++. ++.|
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--- 303 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--- 303 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC---
Confidence 2 2334567999999999998432 256999999999999999999999999999999988888763 1111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (381)
.-..+|+++++||.++|. +|+.|.. ++++-+||||.++
T Consensus 304 ---------------------------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 304 ---------------------------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred ---------------------------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 113589999999999987 7788888 9999999999875
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.21 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=209.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||.|++|.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 367999999999999999999999999999999987432 2345678899999999999999999998843 356
Q ss_pred EEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|++|||+++ +|.+++... ..+++..++.++.|++.||+|||++||+|+||+|+||+++.++.+||+|||.+......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999995 888888776 68999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......++..|+|||.+.+. ...++.++|+||+||++|+|++|.+||.+.+.......+......+
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 223 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-------- 223 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Confidence 11 11345688899999998761 1268889999999999999999999998766544332222110000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
.........+.++.+++.+||..||.+|||+.+++.|+|
T Consensus 224 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 ------------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000112345778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=355.11 Aligned_cols=287 Identities=23% Similarity=0.301 Sum_probs=203.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC-cEEEEEEe--------------CC-ccCChHHHHHHHHHHHHHHhcCCCCcc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKI--------------HD-VFEHISDAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~--------------~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv 85 (381)
.++|++++.||+|+||+||+|..+... ..+++|.+ .+ ..........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765332 22222211 00 011222345678999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccccCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
++++++.. ....|+|++++.++|.+++... .......++.++.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999843 3458999999999988887542 2344677889999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCC--CChh
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KSVV 237 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~--~~~~ 237 (381)
.++.+||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..+ |.+ ....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA--FDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCccccc--ccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 9999999999999765332211 1234579999999999987 6799999999999999999998754 432 2334
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC-CCCCCccc--cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK-KPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
.++..+...++.+..+... .......++..... ..+..... ....++.++.++|.+||++||.+|||+.|+|+||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPD--PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHhcccChhhcCC--cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 4555555544433222110 00111122211110 00000000 0124677889999999999999999999999999
Q ss_pred CcCcC
Q 016884 315 YFKGL 319 (381)
Q Consensus 315 ~~~~~ 319 (381)
||...
T Consensus 456 ~f~~~ 460 (501)
T PHA03210 456 LFSAE 460 (501)
T ss_pred hhhcC
Confidence 99764
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.73 Aligned_cols=262 Identities=27% Similarity=0.451 Sum_probs=210.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc-CC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-RE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~ 98 (381)
..++|++.+.||.|++|.||+|.++.+++.+|+|++.... .....+.+|+.+++.+ .|+||+++++++..... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3578999999999999999999999999999999986432 2345688999999999 69999999999876543 34
Q ss_pred CCcEEEEeecccc-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
...+|+||||+.+ +|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5678999999994 88888764 357999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
........ ......|+..|+|||++... ...++.++|||||||++|+|++|.+||...+.......+.. .+
T Consensus 161 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~ 234 (275)
T cd06608 161 AQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NP 234 (275)
T ss_pred eecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cC
Confidence 75432221 12345689999999987531 13577899999999999999999999976544333222211 00
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.........++..+.+||.+||..||++|||+.++++|||+
T Consensus 235 -------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 -------------------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -------------------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00011112467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=326.17 Aligned_cols=280 Identities=41% Similarity=0.723 Sum_probs=223.6
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
|++.+.||+|++|+||+|....+++.||||++...... .......+|+..++.++ |||++++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999989999999998754332 22334557999999999 9999999999854 35689
Q ss_pred EEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
+||||+.++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999989999887754 789999999999999999999999999999999999999999999999999875433221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.....++..|+|||.+.+. ..++.++|+||||+++++|++|++||.+.+..+....+...++.+..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2345688999999987542 45789999999999999999999999999988888888888888876543221100
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ...........+.......+..++.+.++|++||+.||++|||+.|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000011111111222234457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=320.35 Aligned_cols=261 Identities=29% Similarity=0.448 Sum_probs=211.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
||.+.+.||+|++|.||+|.+..+++.||+|.++...........+.+|+.+++.++|+||+++++.... ...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 6999999999999999999999999999999987654444567788999999999999999999998733 35689
Q ss_pred EEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+|+||+. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 599999988778999999999999999999999999999999999999999999999999998765433222
Q ss_pred ccc-ccccccCccccCcccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 183 TVF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 183 ~~~-~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
... .....+++.|+|||.+.+.. ..++.++||||+||++++|++|+.||...+...........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------- 221 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-------------- 221 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--------------
Confidence 111 22356788999999987631 23788999999999999999999999765322111111000
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+.......+++.+.++|.+||+.||.+|||+.+++.|||+
T Consensus 222 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 222 -------------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -------------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0011111223468899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.79 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=208.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC----hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+|+..+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 488899999999999999999999999999998643211 123467889999999999999999999984 34
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~ 177 (381)
..+++|+||+. ++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 56899999999 58999998878899999999999999999999999999999999999998776 59999999986543
Q ss_pred CCCCCc-ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...........+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 321111 11123468889999999877 678899999999999999999999997554332222221100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
... ........+++.+.+++.+||..||++|||+.++|+||||+
T Consensus 225 ---------------~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 ---------------SAT--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------ccC--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 00112235788999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=320.42 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=208.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..++..+|+|.+............+.+|+.+++.++|||++++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 5999999999999999999999999999999987544444556678899999999999999999998743 35689
Q ss_pred EEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeecccccccCC
Q 016884 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~~~ 179 (381)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||++||+|+||+|+||+++.++ .+||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999763 3589999999999999999999999999999999999998654 5799999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+....
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------ 217 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------
Confidence 21 123468889999999977 678899999999999999999999998766443332221100
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......+++.+.+++.+||+.||++|||+.++|+||||
T Consensus 218 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 ------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 011123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=327.45 Aligned_cols=246 Identities=20% Similarity=0.237 Sum_probs=200.5
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh-HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
..||+|++|.||+|.. +|+.||+|.++...... .....+.+|+.+|++++||||+++++++.... .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 68999999987543322 22456779999999999999999999885521 22346899999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||. |+|.+++.....+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 58999998888899999999999999999999984 99999999999999999999999999987543221
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....|+..|+|||++.+....++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 241 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------- 241 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence 2346889999999987533578999999999999999999999998876554443332211100
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+|+.+||+.||++|||++++++
T Consensus 242 --------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 --------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111357889999999999999999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.56 Aligned_cols=260 Identities=28% Similarity=0.509 Sum_probs=210.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|.....||.|+||.||++.+..++..||||.+... .......+.+|+.+++.++||||+++++.+.. .+.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~ 93 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDE 93 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCe
Confidence 35567788899999999999999999999999998642 23345568899999999999999999998843 356
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.|+||||+.+ +|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 94 ~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 94 LWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 8999999985 7777765 4568999999999999999999999999999999999999999999999999986543222
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.....
T Consensus 173 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------------ 235 (292)
T cd06658 173 P---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP------------ 235 (292)
T ss_pred c---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 1 1234568999999999877 6789999999999999999999999987665433322221110
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.........+..+.+++.+||..||.+|||++++|+||||.....+
T Consensus 236 ----------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 236 ----------------PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ----------------CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0001123578889999999999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=352.32 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=204.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeec-CCCcCC-C
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIML-PPSKRE-F 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-~~~~~~-~ 99 (381)
.+++|.+.|.+|||+.||+|.+...+..||+|++-.. +......+.+|+++|+.|+ |+|||.+++... ...... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4678999999999999999999988899999998643 5566678889999999997 999999999433 221122 3
Q ss_pred CcEEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
-.+.|.||||. |+|.+++.. ...|++.++..|++|+++||++||..+ |||||||-+|||++.+|..||||||.|+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 46899999999 699999974 346999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCCCCcc---cc---cccccCccccCcccc---ccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 175 VAFSDTPMTV---FW---TDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 175 ~~~~~~~~~~---~~---~~~~gt~~y~aPE~~---~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
-......... .. -....|+.|+|||++ .+ .+.++++|||+|||+||-|+....||.+.....+++.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg--~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng--- 269 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSG--LPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG--- 269 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcC--CCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec---
Confidence 4332221110 00 123578999999976 44 5789999999999999999999999987643221100
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.--...++.++..+.+||+.||+.||++||++-|++.+
T Consensus 270 ------------------------------~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 ------------------------------NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ------------------------------cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 00112346789999999999999999999999998874
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=322.74 Aligned_cols=262 Identities=26% Similarity=0.462 Sum_probs=207.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC--------hHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--------ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 589999999999999999999999999999988532111 1123457789999999999999999998743
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 356899999998 5999999888889999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... ........++..|+|||.+.+....++.++|+||||+++++|++|..||...+....+..+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 5432211 111234468889999999876323478999999999999999999999975543322211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
............+.++..+.++|.+||..+|++|||++++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ----------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000011112234678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=324.48 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=207.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 5578999999999999999999999999999999876421 2234567899999999 69999999998865443445
Q ss_pred CcEEEEeeccc-cCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...|+||||++ ++|.+++. ....+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999998 58888764 23568999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
....... ......|++.|+|||++.+. ...++.++||||+||++|+|++|+.||...+....+..+..
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------ 243 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR------ 243 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc------
Confidence 5432211 12334689999999987531 14578899999999999999999999976543322211110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
... ........++..+.+|+.+||+.||++|||+.++|+|+||
T Consensus 244 ---------------------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 ---------------------NPP-PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---------------------cCC-CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000 0001112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.29 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=210.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|++|.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 368899999999999999999999999999999875432 24456788999999999999999999988543 569
Q ss_pred EEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+|+||+. ++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh--hhHHHHHHHhhCCCCHHHHhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ....++..|+|||.+.+ ..++.++|||||||++++|++|..||...+. ......+
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL-------------- 213 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------------
Confidence 11 12568889999999977 6789999999999999999999999976431 0011111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
......... ..... +++.+.++|.+||..||++|||+.+++.||||+.+
T Consensus 214 ----------~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 214 ----------QYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ----------HHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 111111100 01112 78899999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=328.53 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=211.2
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.....++|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-- 87 (307)
T cd06607 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-- 87 (307)
T ss_pred CCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC--
Confidence 3445577999999999999999999999999999999986432 2334456788999999999999999999998543
Q ss_pred CCCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...|+||||+.+++.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..
T Consensus 88 ---~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 88 ---HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred ---CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 45899999999998888764 45799999999999999999999999999999999999999999999999999865
Q ss_pred ccCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
.... ....+++.|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 165 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------- 229 (307)
T cd06607 165 VSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------- 229 (307)
T ss_pred cCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--------
Confidence 4221 234688899999987431 246888999999999999999999999776544332222110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
..+ ......++..+.++|.+||+.||++|||+.+++.||||..
T Consensus 230 ------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 230 ------------------DSP---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ------------------CCC---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 0001236788999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=341.68 Aligned_cols=265 Identities=28% Similarity=0.467 Sum_probs=221.8
Q ss_pred ccccccCCCCCe-EEeeeecccCCceEEEEEEcCCCcEEEEEEeC--CccCChHHHHHHHHHHHHHHhcCCCCcccccee
Q 016884 14 DFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90 (381)
Q Consensus 14 ~~~~~~~~~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (381)
..+-..+..+|| +...+||+|+|-+||+|.|..+|..||.-.++ +.........++..|+.+|+.|+||||++++..
T Consensus 30 ~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S 109 (632)
T KOG0584|consen 30 SEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS 109 (632)
T ss_pred ccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence 334455667788 66889999999999999999999999987654 334556667899999999999999999999999
Q ss_pred ecCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCC-CCeE
Q 016884 91 MLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANAN-CKLK 166 (381)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~-~~vk 166 (381)
|.+... ..+-+|+|.|. |+|..++++.+.++...++.|++||+.||.|||++. |+|||||-+||+|+.+ |.||
T Consensus 110 W~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 110 WVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 977543 56899999998 899999999999999999999999999999999996 9999999999999976 8999
Q ss_pred EeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHH-HHHH
Q 016884 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITD 245 (381)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~ 245 (381)
|+|+|+|+....... ...+|||.|||||++. ..|+..+||||||+++.||+|+..||....+..++- ++..
T Consensus 187 IGDLGLAtl~r~s~a-----ksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHA-----KSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred ecchhHHHHhhcccc-----ceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 999999987654432 3468999999999986 479999999999999999999999998877655442 2222
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
| .+|..+. .--.|+++++|.+||.. ..+|+|+.|+|.||||..-
T Consensus 259 --G------------------------iKP~sl~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 259 --G------------------------IKPAALS---KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --C------------------------CCHHHhh---ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1 1111111 12378899999999999 8899999999999999863
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=318.85 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=208.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+|+..+.||+|++|+||+|.+..++..||+|.+..... .......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 58888999999999999999988999999998864321 12345678899999999999999999998743 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|+||+. ++|.+++.....+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||.+......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 6899999998 599999988878999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. ......++..|+|||.+... ..++.++|+||+||++|+|++|+.||...........+....
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 218 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK------------ 218 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc------------
Confidence 2 12345688999999998762 238899999999999999999999997655332222211100
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
........+++.+.+++.+||+.+|++|||+.++|.|||+
T Consensus 219 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 -----------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0111224578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=320.29 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=208.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|++|.||+|.+..++..||+|.+... .....+.+|+.+++.++||||+++++.+... ..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence 36799999999999999999999988999999998643 2256788999999999999999999988543 56
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+++||+. ++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999 589998875 457899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......++..|+|||.+.+ ..++.++||||+||++++|++|+.||...+.......+..
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------- 213 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------------
Confidence 21 1123457889999999877 6789999999999999999999999976554322211100
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...........++..+.+++.+||+.||++|||+.++|.||||
T Consensus 214 --------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 214 --------------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0001111223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=326.49 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=199.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC----------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 85 (381)
.++|++.++||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997542 34479999987532 234456788999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHHQFFLYQMLRALKYMHTA 145 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------------~l~~~~~~~i~~qil~aL~~LH~~ 145 (381)
++++++... ...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 45899999998 59999886431 367788999999999999999999
Q ss_pred CccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHH
Q 016884 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (381)
Q Consensus 146 ~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll 225 (381)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999998754332211 11123345788999999877 67899999999999999998
Q ss_pred c--CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC
Q 016884 226 T--GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (381)
Q Consensus 226 ~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~ 303 (381)
+ +..||.+.+..+.+..+.... ............+.++..+.+|+.+||+.||.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF-----------------------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh-----------------------hhccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 567887665444333222111 000000011123467889999999999999999
Q ss_pred CCCHHHHhc
Q 016884 304 RPTAEEALA 312 (381)
Q Consensus 304 Rpt~~~lL~ 312 (381)
|||+.++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.26 Aligned_cols=258 Identities=29% Similarity=0.529 Sum_probs=210.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|...+.||+|++|.||+|.+..+++.+|+|++... .......+.+|+.+++.++||||+++++.+.. .+..
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence 4566678999999999999999999999999988532 22334567899999999999999999998843 3458
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|+||+. ++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||.+........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999997 589888876 6799999999999999999999999999999999999999999999999998865433221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
. .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+...
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------------- 230 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--------------- 230 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---------------
Confidence 1 123468999999999877 67899999999999999999999999776544333322211
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
. .+.......++..+.+++.+||+.||++|||+.++|+||||+...+
T Consensus 231 ------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 231 ------------L-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------C-CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 0011112347889999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=320.48 Aligned_cols=251 Identities=19% Similarity=0.272 Sum_probs=201.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||.||+|... ..+..||+|.++.... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 357999999999999999999765 4466899999875422 2344578899999999999999999999843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 345899999998 5888888764 47899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......++..|+|||.+.+ ..++.++||||+||++|++++ |..||.+.+..+.+..+.+....
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence 211110 0112235678999999877 688999999999999999775 99999887655444433221111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.71 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=204.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.|...+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. ||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 3567788999999999999999999999999998753322 44557889999999996 99999999988443 45
Q ss_pred EEEEeeccccCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 102 IYVVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+++|||+..++.++.. ....+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999876655432 235799999999999999999999975 999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCcccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...... .....|++.|+|||++.+.. ..++.++||||+||++|+|++|+.||..... ....+.....
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~------ 225 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK------ 225 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC------
Confidence 433221 12336888999999987621 2688999999999999999999999975431 1111111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+.........+++++.+|+.+||+.||++|||+++++.||||+..
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 226 -----------------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -----------------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 111111111224578999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=342.85 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=208.4
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeec
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 108 (381)
-.||+|.||+||.|+|..|..+.|||.+.. .+....+.+..||...+.|+|.|||++++.+ .+.+.+-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeec
Confidence 369999999999999999999999999864 3345566788999999999999999999997 444568899999
Q ss_pred cc-cCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCCc
Q 016884 109 ME-SDLHQVIKA-NDDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 109 ~~-~~L~~~l~~-~~~l--~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
.+ |+|..++++ .+++ ++..+..+.+||++||+|||++.|||||||-+|+|++. .|.+||+|||-++....-.+
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 98 599999976 4777 89999999999999999999999999999999999975 68999999998876533322
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
...++.||..|||||++.....+|+.++|||||||++.||.||+|||......... +.++ |
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-G--------------- 792 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-G--------------- 792 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-c---------------
Confidence 33577899999999999876688999999999999999999999999654332211 1110 0
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.... .......+|.+++.+|.+|+.+||.+||+|.++|..||++.-
T Consensus 793 -----myKv-----HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 793 -----MYKV-----HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -----ceec-----CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0000 111234678889999999999999999999999999999764
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=319.57 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=205.1
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 7999999999999999999999999865322 23345678899999999999999999998843 35689999999
Q ss_pred c-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccc
Q 016884 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (381)
Q Consensus 110 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (381)
. ++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888789999999999999999999999999999999999999999999999999987653332 1123
Q ss_pred cccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC--hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS--VVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
..+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.... .......+...
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 209 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------------------- 209 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--------------------
Confidence 468899999999876 678999999999999999999999997765 22222211100
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
.. ........++++.++|.+||+.||++||| +.|+++||||+++
T Consensus 210 ----~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 210 ----NG-----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ----CC-----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00 01112345789999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.61 Aligned_cols=259 Identities=30% Similarity=0.471 Sum_probs=213.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+.|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.++..++|+|++++++++... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 3689999999999999999999999999999998754332 4456788999999999999999999998543 569
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+||||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999887889999999999999999999999 999999999999999999999999999987653332
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--------------- 214 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--------------- 214 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---------------
Confidence 21 124568889999999877 6788999999999999999999999977642111111111
Q ss_pred HHHHHHHHHhcCCCCCCccccCCC-CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...... ...... ++..+.++|.+||..+|++|||+.++++|||++..
T Consensus 215 ---------~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 ---------ICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---------HhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 111100 111223 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=323.06 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=204.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 46999999999999999999876655 689999886432 233455688999999999999999999988433
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
...|++|||+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 45899999998 6999998754 4578899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.++|+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999875432211 111233457888999999877 678999999999999999998 9999988765444
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...+... .. ......+++++.+|+.+||+.||.+|||+.+++++
T Consensus 236 ~~~i~~~---------------------------~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSR---------------------------QL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcC---------------------------Cc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3333211 00 01124688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=316.20 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=209.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..|++.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++.+.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12234567889999999999999999999874432 2
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+++|+||+. ++|.+.+.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 45899999998 58999998877899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+ ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCC-------
Confidence 2111111234568899999999987 67889999999999999999999999765443332221 11111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......+++.+.++|.+||+ +|..|||+.++|+|||.
T Consensus 227 -------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 011234688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.13 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=212.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 100 (381)
++|.+.+.||+|++|.||+|.+..++..||+|++.... ........+.+|+.+++.++ ||||+++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 46999999999999999999999999999999987532 23344567788999999998 9999999998843 34
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..++|||++. ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 6899999995 799999998888999999999999999999999999999999999999999999999999998754332
Q ss_pred CCC-----------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 016884 180 TPM-----------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (381)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 242 (381)
... ........++..|+|||...+ ..++.++|+|||||+++++++|+.||...+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233467889999999877 5688899999999999999999999987764333322
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCc
Q 016884 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYF 316 (381)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~ 316 (381)
+... .......+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 234 ~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKL-------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhc-------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2110 011224568899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=335.71 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=197.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHG- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence 457999999999999999999865443 579999987542 223455788999999999 899999999988443
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhC------------------------------------------------------
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 120 (381)
..+|+|||||. |+|.+++...
T Consensus 115 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 115 ----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 45899999998 6998887532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 121 ----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 121 ----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788899999999999999999999999999999999999999999999998754332211 1
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...........+...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~----------------- 330 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR----------------- 330 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-----------------
Confidence 1122235667999999877 679999999999999999997 99999765432222111110
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. .. .......++++.+++.+||+.||.+|||+.++++
T Consensus 331 ------~-~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 331 ------G-YQ-----MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------c-cC-----ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00 0011246889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=325.77 Aligned_cols=260 Identities=28% Similarity=0.528 Sum_probs=210.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+...-|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.. .
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 90 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----G 90 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee-----C
Confidence 334556677789999999999999999999999999864222 234567889999999999999999998843 3
Q ss_pred CcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 568999999984 78776654 5689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+|+..|+|||.+.+ ..++.++||||+||++|+|++|..||...+.......+.. .
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~--------- 232 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---S--------- 232 (297)
T ss_pred ccc---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---c---------
Confidence 211 1234578999999999977 6789999999999999999999999987654433322211 0
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
..........+++.+.++|.+||+.+|.+|||+.++++||||....
T Consensus 233 ----------------~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 233 ----------------PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred ----------------CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 0111122346788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=316.42 Aligned_cols=249 Identities=29% Similarity=0.435 Sum_probs=205.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||.|+||.||++.+..++..||+|.++... .......+.+|+.+++.++||||+++++.+. +...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 5899999999999999999999999999999986432 2344567788999999999999999999984 345699
Q ss_pred EEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 589888864 3468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+.......+....
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 216 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------- 216 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-------------
Confidence 1 1234578899999999877 678999999999999999999999998765443332222100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......++..+.+||.+||+.||++|||+.++++-
T Consensus 217 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -----------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001123577889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=335.16 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=197.6
Q ss_pred CCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 96 (381)
++|++.+.||+|+||+||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 4799999999999999999964 3466789999986432 233456788999999999 899999999998443
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCC------------------------------------------------------
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------------------------------------ 121 (381)
...|+|||||. |+|.+++....
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 45899999998 69988886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 122 ---------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 122 ---------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47888999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+............
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------------- 331 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-------------- 331 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH--------------
Confidence 111 1112335667999999987 689999999999999999998 8899976543222111110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.... .......+.++.+|+.+||+.||++|||+.++++.
T Consensus 332 ------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 ------------EGYR---MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ------------hCcc---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0000 00113457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=320.41 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=196.6
Q ss_pred eecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHH---hcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLR---LLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.||+|+||.||+|.+..+++.||+|.+...... ........+|..+++ ..+||+|+.+++.+... +..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 489999999999999999999999988653222 122223344544443 34799999998888443 458999
Q ss_pred eeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
|||+. ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....|++.|+|||.+.+. ..++.++|+||+||++|+|++|..||......... .+....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~----------------- 211 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT----------------- 211 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh-----------------
Confidence 1234689999999988632 46889999999999999999999999764321111 010000
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcCc
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (381)
.. ........+++++.++|.+||+.||.+|| |+.++++||||+.+.
T Consensus 212 ------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 212 ------LT----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ------hc----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 00 00112346789999999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=319.38 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=206.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....++.+|+++++.++||||+++++++.... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeE
Confidence 468999999999999999999999999999999874322 244567889999999999999999999885432 2468
Q ss_pred EEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 3468999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh--hhHHHHHHHhhCCCCHHHH
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 255 (381)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .............+.+
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 226 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP--- 226 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch---
Confidence 2221 23457888999999877 6789999999999999999999999976532 0111111100000000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
........-...++.+.++|.+||..||++|||+.|++.||||...
T Consensus 227 ------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 227 ------------------ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ------------------hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 0000000011356789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=304.75 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=211.1
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.+.+..||+|+.|+||+++.+.+|...|||.+.+. .+..+.++++..+.++.... .|+||+.+++|..+. .++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 35678899999999999999999999999999865 44466778999999877664 899999999997764 389
Q ss_pred EEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|.||.|..-+..+++. .++++|..+-.+...++.||.||..+ ||+|||+||+|||+|..|.+||||||.+........
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999999766555553 35799999999999999999999865 899999999999999999999999999865544332
Q ss_pred CcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 182 MTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.+...|.+.|||||.+.-. ...|+-.+||||||+.++||+||+.||.+.+ +.+.+.++.+-
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~------------- 310 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE------------- 310 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-------------
Confidence 2445799999999998643 3569999999999999999999999999854 44455444431
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.| +....-.++|+.+.+|+..||..|+.+||...++|+|||+....
T Consensus 311 --------------eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 311 --------------EP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred --------------CC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 11 11112235899999999999999999999999999999987653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.56 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=210.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||+||+|.+..++..||+|++.... .......+.+|+++++.++||||+++++.+... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence 57999999999999999999999999999999886432 234456788999999999999999999998543 568
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999998 5898888887889999999999999999999997 589999999999999999999999999886432221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ....|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||........... . .
T Consensus 159 ~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~--------~ 215 (284)
T cd06620 159 A-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------D--------P 215 (284)
T ss_pred c-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------h--------h
Confidence 1 23478999999999877 6788999999999999999999999986543211000 0 0
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..............+... ....++..+.+|+.+||+.||++|||+.++++|+||..-
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 216 MGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000011111111111000 011367889999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.91 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=212.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..++..||+|++............+.+|+++++.++|||++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999999999999999976545555667788999999999999999999988543 5689
Q ss_pred EEeecccc-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 104 VVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 104 lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|++++ +|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999984 899988763 6799999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. .......|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 32 11234578899999999877 6788999999999999999999999977654333222211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. .......++..+.+++.+||..+|++|||+.++|+||||
T Consensus 218 --------------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 218 --------------GQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 011123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=321.83 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=209.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
...|+.++.||.|+||.||.|.+..++..||+|.+... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 35688999999999999999999999999999988643 223445678899999999999999999999843 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.|+||||++ ++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998 489888865 578999999999999999999999999999999999999999999999999987543322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--------------- 215 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--------------- 215 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---------------
Confidence 1 1123468889999999877 6789999999999999999999999977654322211100
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. .......++..+.+++.+||+.+|++|||+.++++||||...
T Consensus 216 ------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 216 ------------NN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ------------CC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 00 011123467889999999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=315.32 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=207.0
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|.+.+.||+|+||.||+|.++.++..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 5899999999999999999999999999999986532233345567899999999999999999998843 34689
Q ss_pred EEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC-eEEeeecccccccCC
Q 016884 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-LKVCDFGLARVAFSD 179 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~-vkl~DFg~a~~~~~~ 179 (381)
+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999887543 5799999999999999999999999999999999999998865 699999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......|++.|+|||.+.+ ..++.++|+||+||++++|++|..||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 ME---LAYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred cc---cccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 21 1123468899999999876 6788999999999999999999999976654332221111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ......+.++..+.++|.+||..+|++|||+.+++.||||
T Consensus 217 ------------~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 ------------G----YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------c----cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 0111224678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=315.99 Aligned_cols=249 Identities=23% Similarity=0.425 Sum_probs=202.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
...|.+.+.||+|++|.||+|.+..+++.||+|.+... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCC
Confidence 34699999999999999999999999999999998642 2335578899999999999999999998843 345
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+++||||+. ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999997 6999998754 3589999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 222 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------- 222 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence 22111 112234567999999877 678999999999999999998 999998766543332222100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ......+++++.+++.+||+.||++|||+.++++
T Consensus 223 -----------------~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 -----------------R---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred -----------------C---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 0112457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=322.31 Aligned_cols=260 Identities=28% Similarity=0.491 Sum_probs=211.1
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+..++|++.+.||+|+||+||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 88 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----G 88 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----C
Confidence 3457899999999999999999999889999999998632 22334567899999999999999999998844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+..|+|+||+. ++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 45899999998 5898888654 588999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 168 ~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------- 229 (293)
T cd06647 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------- 229 (293)
T ss_pred ccc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-------------
Confidence 221 1233468899999999877 6788999999999999999999999987654332211110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...+.......++..+.+++.+||..+|++||++.+++.||||+...
T Consensus 230 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 230 ---------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ---------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 00011112234678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=315.01 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=198.2
Q ss_pred eecccCCceEEEEEE--cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 30 VIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
+||+|+||.||+|.. ..++..+|+|+++...........+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999964 4567899999987554445556678899999999999999999988632 34699999
Q ss_pred ccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 108 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
|+. ++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887789999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~------------------ 215 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE------------------ 215 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------------------
Confidence 22234678999999876 678899999999999999998 999998766544433332110
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ......+++++.+||.+||+.||++|||+++|..
T Consensus 216 ---------~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 ---------R---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------C---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0 1122468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.85 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=202.6
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.. .+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6999999999999999999999999864322 12234456789999999999999999998843 35689999999
Q ss_pred c-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 110 E-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 110 ~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 8 59999887655 799999999999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 33467888999999877 5689999999999999999999999976553211111111
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcCc
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (381)
... .........+++.+.++|.+||+.||.+|| ++.++++||||..+.
T Consensus 209 --~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 --RTL----EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --ccc----cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 000 001112345799999999999999999999 999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=323.18 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=210.4
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.+..+.|...+.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++|||++++++++..
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 92 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK---- 92 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----
Confidence 4445568888999999999999999999999999999864322 33344578889999999999999999999844
Q ss_pred CCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....|+||||+.+++.+.+.. ..++++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...
T Consensus 93 -~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 93 -EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred -CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 356899999999998888765 457899999999999999999999999999999999999999999999999987542
Q ss_pred cCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.. .....|+..|+|||.+.+. ...++.++|||||||++|+|++|..||...+.......+...
T Consensus 172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------- 235 (313)
T cd06633 172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------- 235 (313)
T ss_pred CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------
Confidence 11 1234688999999997421 145888999999999999999999999876654433322210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
..+ ......++..+.+|+.+||+.+|.+|||+.+++.||||+.
T Consensus 236 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 236 -----------------DSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred -----------------CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 0112356788999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=318.45 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=204.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 35789999999999999999997652 34589999886432 233445678899999999999999999988433
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~ 164 (381)
...|+||||+. ++|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 82 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 82 ----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred ----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 45899999998 6999998642 23467788999999999999999999999999999999999999
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 243 (381)
++|+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred EEECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999987543222111 1122345677999999877 678999999999999999998 78899876554333222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc------CCCcC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA------DPYFK 317 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~------hp~~~ 317 (381)
... .........++.+.+++.+||+.||++|||+.++++ ||||+
T Consensus 235 ~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 235 MDG------------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 110 000112346789999999999999999999999987 99997
Q ss_pred cC
Q 016884 318 GL 319 (381)
Q Consensus 318 ~~ 319 (381)
++
T Consensus 285 ~~ 286 (288)
T cd05061 285 EV 286 (288)
T ss_pred CC
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=310.87 Aligned_cols=253 Identities=31% Similarity=0.503 Sum_probs=212.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+++++.++|||++++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 5899999999999999999999999999999997654444556788899999999999999999998843 35689
Q ss_pred EEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+|||++.+ +|.+++.....+++..++.++.|++.||.+||++||+||||+|+||+++.++.++|+|||.+.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999985 99999988888999999999999999999999999999999999999999999999999999765443221
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+..
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 213 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ----------------- 213 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------------
Confidence 233468889999999877 5588999999999999999999999976553222211110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ........+++.+.+++.+||..+|++|||+.+++.||||
T Consensus 214 ---------~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 ---------D----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------c----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 0011224678899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=323.40 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=207.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+.|++.+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+.. ....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCce
Confidence 458888999999999999999999999999998864322 2345678899999999999999999998844 3458
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||++ ++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 588888764 5789999999999999999999999999999999999999999999999999875433211
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1123468889999999987 678899999999999999999999997554322211110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
... .......++..+.++|.+||+.+|++|||+.++|+||||..+
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 215 ----------KNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ----------cCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 000 001123467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=327.66 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=200.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3468999999999999999999754 345789999987532 233455678899999999 799999999987533
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhC-----------------------------------------------------
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAN----------------------------------------------------- 120 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------------------- 120 (381)
...++++|||+. ++|.+++...
T Consensus 84 ----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 84 ----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 245899999998 5888887542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccC
Q 016884 121 --------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (381)
Q Consensus 121 --------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt 192 (381)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~ 238 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLP 238 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCC
Confidence 25789999999999999999999999999999999999999999999999999764332211 111233456
Q ss_pred ccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc
Q 016884 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271 (381)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (381)
..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.+.....
T Consensus 239 ~~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~-------------------------- 290 (337)
T cd05054 239 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK-------------------------- 290 (337)
T ss_pred ccccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh--------------------------
Confidence 78999999887 689999999999999999997 9999976543222111110
Q ss_pred CCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.... .......++++.+++.+||+.+|++|||+.++++|
T Consensus 291 ~~~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 291 EGTR---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 01123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=314.43 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=199.2
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++.. ....++|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEe
Confidence 45799999999999999999999999988642 33455678899999999999999999998843 356899999
Q ss_pred ccc-cCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCC
Q 016884 108 LME-SDLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 108 ~~~-~~L~~~l~~~-~~l--~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~~~~~ 182 (381)
|+. ++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999988764 455 88899999999999999999999999999999999976 67899999999875432221
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
......+++.|+|||.+.+....++.++|+||+|+++|+|++|+.||..............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----------------- 225 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----------------- 225 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-----------------
Confidence 1223468899999999865334588999999999999999999999965432111000000
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.... .......+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 226 ------~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 226 ------MFKI-----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------hhcc-----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0000 011123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.30 Aligned_cols=289 Identities=19% Similarity=0.227 Sum_probs=205.5
Q ss_pred eeeeccc--CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
...||.| +||+||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEE
Confidence 3456766 99999999999999999999987554444555678899999999999999999999844 3458999
Q ss_pred eeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 106 FELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999 5899888764 35899999999999999999999999999999999999999999999999865332111110
Q ss_pred -ccc---ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH---
Q 016884 183 -TVF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI--- 255 (381)
Q Consensus 183 -~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--- 255 (381)
... .....++..|+|||++.+....++.++||||+||++|+|++|+.||.+.................+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 000 0112345679999998763345789999999999999999999999877654443333221111000000
Q ss_pred ---hhhcCHH--HHH-HHHHhcC-----CC--CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 ---AVVRNEK--ARK-YLTEMRK-----KP--PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ---~~~~~~~--~~~-~~~~~~~-----~~--~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
....+.. ... ..+.... .. ..........+++.+.+|+++||++||++|||++++|+||||.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000 000 0000000 00 00000112346788999999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=311.57 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=209.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999875444445566778999999999999999999988543 5689
Q ss_pred EEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999997 589888865 35689999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+...
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------ 216 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG------------ 216 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------
Confidence 31 123468889999999977 67889999999999999999999999876644332222110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
. ........+.++.+++.+||+.+|++|||+.++|+||++
T Consensus 217 ---------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 ---------------K---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ---------------C---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0 001113578889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=318.29 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=207.3
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~ 100 (381)
.|++++.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+. |||++++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 48889999999999999999999999999999865322 234456788999999996 9999999998843 34
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 6899999998 489888865 47999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 12345788999999987642 457889999999999999999999997654332211110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...+... ....++.++.+++.+||+.||++|||+.+++.||||+...
T Consensus 216 ------------~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 216 ------------KSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ------------cCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 0000000 0113778999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=318.34 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=202.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.++.... ......+.+|+++++.++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 3569999999999999999998753 367899999875322 23456788999999999999999999998543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~ 161 (381)
...|+||||+. ++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 46899999998 59999987542 4789999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHH
Q 016884 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (381)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 240 (381)
++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999998754222111 11123346788999999987 679999999999999999998 99999876654433
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+.... .......++..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 235 ECITQGR------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3332110 00112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.29 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=195.9
Q ss_pred CCeEEeeee--cccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVI--GKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~l--g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+ +||||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 356666665 99999999999999999999999986432111 122222222 699999999998543
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~ 177 (381)
+.+|+||||+. ++|.+++..+..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 46999999998 69999998887899999999999999999999999999999999999999998 99999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhH-HHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 256 (381)
.. ....++..|+|||++.+ ..++.++|+||+||++|+|++|..||........ ...+.
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 220 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL------------ 220 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH------------
Confidence 22 12368899999999977 6789999999999999999999999975543210 01010
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKG 318 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-~~~lL~hp~~~~ 318 (381)
... . ......+.+++.+.+||.+||+.||.+||+ ++++|+||||.+
T Consensus 221 -----------~~~-~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 221 -----------KRQ-Q----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -----------Hhh-c----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000 0 111223468999999999999999999996 599999999963
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=316.84 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=196.2
Q ss_pred eecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHH---HHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILRE---VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E---~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.||+|+||.||+|.+..+++.||+|.+...... .........| +..++...||+|+.+++.+.. ...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999999999999999998653222 1112223333 344555689999999988843 3568999
Q ss_pred eeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
|||+. ++|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 99998 58988888888899999999999999999999999999999999999999999999999999865432211
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
...+|+..|+|||.+.+. ..++.++||||+||++|+|++|+.||.+.......... ..
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~------------------ 210 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RM------------------ 210 (278)
T ss_pred --cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HH------------------
Confidence 234789999999998652 45889999999999999999999999775322111000 00
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
. .. .........++.+.+++.+||..||.+|| ++.++++||||+..
T Consensus 211 -----~-~~---~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 211 -----T-LT---MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred -----h-hc---cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 0 00 00111234689999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=314.76 Aligned_cols=253 Identities=32% Similarity=0.524 Sum_probs=205.5
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++.+. .....|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864322 2244567889999999999999999998873 345689999999
Q ss_pred c-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC-----c
Q 016884 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----T 183 (381)
Q Consensus 110 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~-----~ 183 (381)
. ++|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998754333111 1
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
.......++..|+|||...+ ..++.++|+|||||++|+|++|..||...........+.. +
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~--------------- 216 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--G--------------- 216 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C---------------
Confidence 11234467889999999877 5688899999999999999999999987664433322221 0
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCCcCcC
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKGL 319 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~---~~lL~hp~~~~~ 319 (381)
... ......+++.+.+++.+||+.+|.+|||+ .++|+||||+.+
T Consensus 217 ---------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 217 ---------KIE---WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---------CcC---CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 000 00111258899999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=327.49 Aligned_cols=282 Identities=31% Similarity=0.499 Sum_probs=227.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC------CCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~~~~~~~~~~ 95 (381)
.++|.+....|.|-||+|..|.|...|..||||+|... ..-...-++|++||++|+. -|+++++..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--- 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--- 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh---
Confidence 57999999999999999999999999999999999742 2223345689999999963 37888888884
Q ss_pred cCCCCcEEEEeeccccCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeec
Q 016884 96 KREFKDIYVVFELMESDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg 171 (381)
..+++|||+|.+.-+|.++++.-+ .|....++.++.|++.||..|...||+|.||||+||||++. ..+||||||
T Consensus 505 --hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 --HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred --hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 446799999999999999998754 58899999999999999999999999999999999999986 558999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
.|....... .+.|..+..|+|||+++| .+|+.+.|+||+||+||||.||+..|+|.++.+.+...+.+-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 997653322 356788899999999999 7999999999999999999999999999999999999999999998
Q ss_pred HHHHhhhcCH--HHHHHHH----------------HhcCCCC-CCcccc------C----CCCCHHHHHHHHHhccCCCC
Q 016884 252 PETIAVVRNE--KARKYLT----------------EMRKKPP-VPLFQK------F----PNVDPLALRLLQRLIAFDPK 302 (381)
Q Consensus 252 ~~~~~~~~~~--~~~~~~~----------------~~~~~~~-~~~~~~------~----~~~~~~~~dLi~~~L~~dp~ 302 (381)
..++....-. -+.+.+. .+....| .++.+. . +.+-..+++||.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 8877643211 0000000 0000111 000000 0 11234589999999999999
Q ss_pred CCCCHHHHhcCCCcCc
Q 016884 303 DRPTAEEALADPYFKG 318 (381)
Q Consensus 303 ~Rpt~~~lL~hp~~~~ 318 (381)
+|.|..|+|.||||+.
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999964
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.41 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=209.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+....|...+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|||++++++++...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 97 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE---- 97 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC----
Confidence 44456899999999999999999999999999999986432 2234455788999999999999999999998443
Q ss_pred CCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...|+||||+.|+|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 98 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred -CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 45899999999998887754 4579999999999999999999999999999999999999999999999999886432
Q ss_pred CCCCCcccccccccCccccCcccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. ....+++.|+|||.+.+ ....++.++|+||+||++|+|++|..||.+.+.......+......
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 242 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------- 242 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-------
Confidence 21 23468889999998742 1146888999999999999999999999776544333333221000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
......+++.+.+|+.+||+.+|.+|||+.++++|+|+..
T Consensus 243 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 ----------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0011346788999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.82 Aligned_cols=266 Identities=27% Similarity=0.378 Sum_probs=218.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+.-|..-...||.|.||.||.|.+..+|...|+|.+.-..........+.+|..++..++|||+|+++++-.+. +
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----e 1307 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----E 1307 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----H
Confidence 34456678899999999999999999999999998864434445566778999999999999999999987554 3
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.++|.||||. |+|.++++...-.++...+.+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|......
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 4899999999 699999998888899999999999999999999999999999999999999999999999999876554
Q ss_pred C-CCcccccccccCccccCcccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 180 T-PMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
. ..........||+.|||||++.+.. .+.+.++||||||||+.||+||+.||...++.-++-.=+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V------------- 1454 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV------------- 1454 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------------
Confidence 3 2233445789999999999997742 456779999999999999999999997655432221100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.....++. +..+|++.+|+|.+||..||.+|+++.|+|.|.|-+.-.
T Consensus 1455 -----------~~gh~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1455 -----------AAGHKPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred -----------hccCCCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 11112221 235899999999999999999999999999999976543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=314.54 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=203.1
Q ss_pred eEEeeeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCC
Q 016884 25 YKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 100 (381)
|++++.||+|+||.||.|.... ++..||+|+++...........+.+|+.+++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998764 34789999987654445556678899999999999999999998765432 3334
Q ss_pred cEEEEeeccc-cCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
..++||||+. ++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 5899999998 6888887432 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG------ 231 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------
Confidence 7643322111 1112235667999999876 678999999999999999999 89999876654333222210
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
. .......+++.+.+++.+||+.||.+|||+.+++.+
T Consensus 232 ---------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 ---------------------N---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------------------C---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 011234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=314.22 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=199.4
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||.|+||.||+|.+..+++.||+|.+...... ......+..|..++ ...+|+|++++++++.. ...+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 5799999999999999999999999998643211 12223344555544 44589999999999843 35699999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999998875322
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 208 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------------------- 208 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 123468889999999887 55899999999999999999999999876654333222110
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCCcCcC
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (381)
...........+++.+.+++.+||+.||++||| ++|+|+||||+..
T Consensus 209 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 209 --------RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred --------ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 000011122357899999999999999999995 5899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=314.92 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=201.7
Q ss_pred eEEeeeecccCCceEEEEEEcCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCCc
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 101 (381)
|.+.+.||+|+||.||+|....++. .||+|.++...........+.+|+.+++.++||||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578899999999999999877765 69999887654455566788899999999999999999998754321 22345
Q ss_pred EEEEeeccc-cCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 102 IYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~------~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.++||||+. ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 799999998 688887742 2348999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYY-RQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCcccce-ecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 65332211 11122346678999999987 678999999999999999999 8999987654433322221
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
... ....+.++..+.++|.+||+.||++|||+.+++++
T Consensus 230 -------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 230 -------------------GNR---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 01124578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=315.66 Aligned_cols=254 Identities=20% Similarity=0.378 Sum_probs=200.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..++|++.+.||+|+||.||.|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 4567999999999999999999864 23568999988643 22334557889999999999999999999883
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~ 164 (381)
.....++||||+. ++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 80 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 --QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred --CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 3346899999998 59999886522 3577889999999999999999999999999999999999999
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 243 (381)
++|+|||+++......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987543221111 1122345778999999877 678999999999999999999 78999876654333322
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
... . .......+++.+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 MEG---------------------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HcC---------------------------C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 210 0 001123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.80 Aligned_cols=278 Identities=21% Similarity=0.264 Sum_probs=200.1
Q ss_pred CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc-cCH
Q 016884 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDL 113 (381)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 113 (381)
++|.||.+++..+++.||+|+++...........+.+|+.+++.++||||+++++++... ...|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 445667777778999999999976544455667899999999999999999999988543 45899999999 688
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC----ccccc
Q 016884 114 HQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM----TVFWT 187 (381)
Q Consensus 114 ~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~----~~~~~ 187 (381)
.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 8888753 46899999999999999999999999999999999999999999999999988654322111 11112
Q ss_pred ccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH
Q 016884 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (381)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...++..|+|||++.+....++.++|+||+||++++|++|..||.......... ....+..... +............
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~ 243 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LDKSTYPLYEDSM 243 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-cccCchhhhcCCc
Confidence 345778899999986633468899999999999999999999998765433221 1111111100 0000000000000
Q ss_pred HH----h--cCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 268 TE----M--RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 268 ~~----~--~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.. . ..............+++++.+|+.+||++||++|||++++|+||||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00 0 00000000111123567899999999999999999999999999998775
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=348.70 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=201.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|+++++||+|+||.||+|.+..+++.||+|++..... ......++.+|+.+++.++||||+++++++. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 689999999999999999999999999999999975432 2334567889999999999999999999884 3356
Q ss_pred EEEEeeccc-cCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEee
Q 016884 102 IYVVFELME-SDLHQVIKAN-----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-----------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~D 169 (381)
.|+||||++ ++|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999998 5898888631 2356677889999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCC---------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 170 FGLARVAFSDTPM---------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 170 Fg~a~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
||+++........ .......+||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999764211100 001123479999999999987 67899999999999999999999999765
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+....... .....| . .......+++.+.+++.+||+.||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~~P-------------------------~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVILSP-------------------------I-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhccCh-------------------------h-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221110 000000 0 001124678999999999999999999887666643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=333.81 Aligned_cols=244 Identities=30% Similarity=0.450 Sum_probs=201.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
....|.+...+|.|+||.|..+.+..+++..++|++.+.. ....+|+.++... +||||+++++++ .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCC
Confidence 3567999999999999999999999999999999997641 2233567665555 799999999999 555
Q ss_pred CcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe-cCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~-~~~~~vkl~DFg~a~~~~ 177 (381)
.++|+|||.+.| .+.+.+......+ ..+..|+.+|+.|+.|||++|++||||||+|||+ +..++++|+|||.++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 679999999995 5666666554444 7888899999999999999999999999999999 588999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. +.+.+-|..|.|||++.. ..|+++||+||||++||+|++|+.||...... ..|...++.+.-
T Consensus 468 ~~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----- 531 (612)
T KOG0603|consen 468 RS------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----- 531 (612)
T ss_pred hh------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-----
Confidence 33 234578899999999986 79999999999999999999999999766543 122222222110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...+|..++|||++||++||.+|+++.+++.||||
T Consensus 532 ------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 04689999999999999999999999999999999
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=321.67 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=201.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcE----EEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..+|++.+.||+|+||.||+|.+..++.. ||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 45799999999999999999987666654 899988643 2234456788999999999999999999988543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..++|+||+. |+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3689999998 69999988743 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-------- 227 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------- 227 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC--------
Confidence 54322211 1122334667999999977 688999999999999999997 99999876543322111110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. ....+.++..+.+++.+||..||.+|||+.+++.+
T Consensus 228 -----------------~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 -----------------ER-----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CC-----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01124567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=318.59 Aligned_cols=257 Identities=30% Similarity=0.534 Sum_probs=208.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|....+||+|+||.||++....++..||+|++... .......+.+|+.+++.++|+||+++++.+.. .++.
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEE
Confidence 3455567899999999999999999999999988532 22345568899999999999999999998843 3568
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+.+ +|.+++. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7777664 45789999999999999999999999999999999999999999999999998865432211
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+....
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 232 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 232 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--------------
Confidence 1133568899999999876 678899999999999999999999998766543332222110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
+ ........+++.+.+++.+||+.||.+|||+.++|.||||....
T Consensus 233 -------------~-~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 233 -------------P-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -------------C-cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0 00112245788999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.08 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=199.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCE
Confidence 56899999999999999999765 45689999876332 223567889999999999999999998843 3458
Q ss_pred EEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+||||+. ++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999998 6999988753 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
... .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||...+..+.+..+......
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------- 220 (256)
T cd05114 155 YTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------- 220 (256)
T ss_pred eec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------
Confidence 111 122235567999999877 678999999999999999999 99999887765554444321100
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+..+.+|+.+||+.||++|||++++++
T Consensus 221 --------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 --------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.93 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=194.2
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeec
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 108 (381)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46999999999999999999999999876432 23345678899999999999999999999843 3458999999
Q ss_pred cc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 109 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 5999998754 468999999999999999999999999999999999999999999999999987543221110 00
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+...
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~------------------- 212 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG------------------- 212 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-------------------
Confidence 11123456999999877 678999999999999999997 88999765543222222110
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
... ......+..+.+|+.+||+.||++|||+.++++
T Consensus 213 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 213 --------VRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred --------CCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 112356889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=351.19 Aligned_cols=265 Identities=32% Similarity=0.461 Sum_probs=202.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-------
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------- 95 (381)
.+|+.++.||+||||.||+|+++-+|+.||||++.-.. ......++.+|+..|.+|+|||||+++..+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35688999999999999999999999999999997654 4556678999999999999999999987762110
Q ss_pred ----------------------------------------------c--------------------CC-----------
Q 016884 96 ----------------------------------------------K--------------------RE----------- 98 (381)
Q Consensus 96 ----------------------------------------------~--------------------~~----------- 98 (381)
. ++
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 00
Q ss_pred ------------------------------CCcEEEEeeccccCHHHHH-HhCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 016884 99 ------------------------------FKDIYVVFELMESDLHQVI-KANDDL-TREHHQFFLYQMLRALKYMHTAN 146 (381)
Q Consensus 99 ------------------------------~~~~~lv~e~~~~~L~~~l-~~~~~l-~~~~~~~i~~qil~aL~~LH~~~ 146 (381)
...+||-||||+.++.+.+ ..+... ....+|++++||++||+|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0237999999997655554 444433 47899999999999999999999
Q ss_pred ccccCCCCCceEecCCCCeEEeeeccccccc---C------------CCCCcccccccccCccccCcccccccc-CCCCC
Q 016884 147 VYHRDLKPKNILANANCKLKVCDFGLARVAF---S------------DTPMTVFWTDYVATRWYRAPELCGSFF-SKYTP 210 (381)
Q Consensus 147 i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~---~------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~ 210 (381)
||||||||.||++++++.|||+|||+|+... . ........+..+||..|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 0 011122346789999999999998742 15999
Q ss_pred ccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHH
Q 016884 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290 (381)
Q Consensus 211 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (381)
++||||||+||+||+. ||.. .++....+.++... ..|.+ ...+.+--+...
T Consensus 798 KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g-----------------------~iP~~-~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKG-----------------------SIPEP-ADFFDPEHPEEA 848 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccC-----------------------CCCCC-cccccccchHHH
Confidence 9999999999999984 5643 33333333332111 11111 112233445668
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 291 dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
.+|++||+.||.+||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 899999999999999999999999986
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.92 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=201.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|+||.||+|++..+++.||+|.+... .........+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 5799999999999999999999999999999988642 2233445578899999999999999999998843 346
Q ss_pred EEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.|+|+||++ ++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 588887753 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh-hHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 255 (381)
..... ......+++.|+|||.+.+ ..++.++|+||+||++++|++|+.||...... ..+.......+.|+
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 227 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP---- 227 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC----
Confidence 32211 1123468889999999877 67889999999999999999999999654321 11111111001000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+..+.+++.+||+.+|++|||+.++|+
T Consensus 228 ------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 ------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=308.83 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=212.8
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 488999999999999999999999999999998765444456678889999999999999999999885432 25689
Q ss_pred EEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+|+|++. ++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988778999999999999999999999999999999999999999999999999998765443321
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+. ....+...
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~---------------- 216 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKI---------------- 216 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhc----------------
Confidence 01123468889999999877 5689999999999999999999999977651 11111110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.. ..........++..+.+++.+||+.||++|||+.++++||||
T Consensus 217 --------~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 217 --------GS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------cc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00 001112234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.61 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=213.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.+.|+.-+.||+|+||.||.++-+.||+-+|.|++.+. ..........++|-.||.+++.+.||.+--.| ++.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 46788999999999999999999999999999988542 22223445678899999999999999987776 4446
Q ss_pred cEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+|+|+..|. |||.-.|-..+ .+++..+..++.+|+.||.+||+.+||.||+||+|||+|+.|.++|+|.|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 6999999999 59988776544 79999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.+.+ ....+||..|||||++.+ ..|+.+.|.|||||++|+|+.|+.||...........+...
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----------- 401 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----------- 401 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-----------
Confidence 4433 245589999999999988 67999999999999999999999999765432222111110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
... .......++|+++++|.+.+|+.||.+|. +++++-+||||+.+
T Consensus 402 -------------~~~---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 402 -------------TLE---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred -------------Hhc---chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 001 11122357899999999999999999997 57899999999975
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.18 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=207.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+-|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++.+.. ....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeE
Confidence 34788999999999999999999999999999876432 22345578899999999999999999999843 3568
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+++ +|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 999999984 88888764 468999999999999999999999999999999999999999999999999986543221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+..
T Consensus 156 --~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 215 (277)
T cd06641 156 --IKRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---------------- 215 (277)
T ss_pred --hhhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc----------------
Confidence 11233468889999999876 6778899999999999999999999976543322221110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. .......++.++.+++.+||+.+|.+||++.++++||||...
T Consensus 216 -----------~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 216 -----------NN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -----------CC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 00 001123578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=310.96 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=202.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||+||+|....+ ...||+|.++... .......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 35799999999999999999988654 4579999886432 23345578899999999999999999998843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....|+||||+. ++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 345899999998 5999998764 47899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------ 227 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------ 227 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 4211111 1112234577999999877 678999999999999999998 99999766544433333221110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......++.+.+|+.+||+.+|++|||+.+++++
T Consensus 228 ------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.05 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=200.8
Q ss_pred CCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..|.+.+.||+|+||+||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE---- 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 46999999999999999999853 34567999988642 23445678899999999999999999999843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~ 163 (381)
...+++||||+. ++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred -CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 345899999998 69999987543 489999999999999999999999999999999999999999
Q ss_pred CeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHH
Q 016884 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (381)
Q Consensus 164 ~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 242 (381)
.+||+|||+++....... ........++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999875432211 111123345778999999987 678999999999999999998 9999987765444333
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
+.... . ......+++++.+|+.+||+.||.+|||+.+++.
T Consensus 235 i~~~~---------------------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQGR---------------------------V---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHcCC---------------------------c---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 32210 0 0112357889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.40 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=200.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|+++++||+|++|.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCC
Confidence 467999999999999999999864 5677999987642 2235678899999999999999999988843 345
Q ss_pred EEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 699998865 34689999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--------- 222 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2211 1122345678999999877 678899999999999999998 9999987665443333321110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......++.++.+++.+||..||++|||++++++
T Consensus 223 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 ---------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.17 Aligned_cols=260 Identities=32% Similarity=0.528 Sum_probs=214.5
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+..+.|++...||.|++|.||+|.+..++..||+|++..... ....+.+|+.+++.++|+|++++++.+...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG---- 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC----
Confidence 3566779999999999999999999998999999999874322 456778899999999999999999988543
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...|+|+||+. ++|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 45899999999 69999998876 8999999999999999999999999999999999999999999999999988654
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---------- 231 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---------- 231 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Confidence 32211 1123457889999999877 67899999999999999999999999766544332222110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .........++..+.++|.+||+.+|.+|||+.++|.||||...
T Consensus 232 -----------------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 232 -----------------G-IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------------C-CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 0 00111123478899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.51 Aligned_cols=252 Identities=21% Similarity=0.375 Sum_probs=200.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
+.|.+.+.||+|++|.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 569999999999999999999877 7789999987643 2233445688999999999999999999988443
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---CeE
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLK 166 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~vk 166 (381)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+|
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 44799999997 59999987543 489999999999999999999999999999999999998765 589
Q ss_pred EeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHH
Q 016884 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 245 (381)
|+|||+++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999998765222111 11112234567999999877 679999999999999999997 9999987765443322211
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. . ......++..+.+++.+||+.||++|||+.++|+|
T Consensus 237 ~~---------------------------~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GG---------------------------R---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CC---------------------------c---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 0 01124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=309.72 Aligned_cols=245 Identities=20% Similarity=0.316 Sum_probs=196.9
Q ss_pred eeecccCCceEEEEEEcCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 29 EVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 47999999999999876555 78999998754332 455678899999999999999999987632 347999
Q ss_pred eeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
|||+. ++|.+++.....+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998887899999999999999999999999999999999999999999999999999876533322111
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 263 (381)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~---------------- 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---------------- 215 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------------
Confidence 1111223457999999877 678999999999999999998 999997766543333222110
Q ss_pred HHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+++.+.+++.+||+.||++|||+.++++
T Consensus 216 --------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 --------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=316.44 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 579999999999999999999877765 4788877632 2334456788999999999 79999999998843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 45899999998 69999986532 48889999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 016884 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (381)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 241 (381)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864221111 111223456999999877 678999999999999999997 999998766544333
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.+.... .......+++.+.+|+.+||+.||.+|||++++++.
T Consensus 230 ~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLPQGY------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221100 011123578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.66 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=199.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCC
Confidence 367999999999999999999865 45789999987432 224567889999999999999999998743 345
Q ss_pred EEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++.... .+++..+..++.|++.||.+||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999995 79999997654 689999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+.....
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------- 222 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 21111 111223457999999877 678999999999999999999 9999987765444333322110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+..+.+++.+||+.||.+||++.++++
T Consensus 223 ---------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ---------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.11 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=208.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...+|...+.||+|++|.||+|++..++..||+|.+.... .......++.+|+.+++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 4566889999999999999999999999999999986432 2233455778899999999999999999988543
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...++||||+.+++.+.+.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 45899999999988887754 45689999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
. ....+++.|+|||.+.+. ...++.++|||||||++|+|++|..||...+..+....+...
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 229 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------- 229 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-----------
Confidence 1 234688899999987431 145788999999999999999999999765433322221110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..+ ......++..+.+||++||+.+|++|||+++++.|||+...
T Consensus 230 ---------------~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 230 ---------------ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------------CCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 000 00123578889999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=314.29 Aligned_cols=252 Identities=21% Similarity=0.380 Sum_probs=200.8
Q ss_pred CCeEEeeeecccCCceEEEEEEc----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..|++.+.||+|+||+||+|... .++..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 56899999999999999999853 45678999998743 2334446788899999999999999999988443
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
...|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 45899999998 5999988532 2478899999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCcce-ecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999764332211 11123346678999999877 678999999999999999998 9999987664433
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...+.. .. .......+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRK---------------------------RQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHc---------------------------CC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 332221 00 011224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.44 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=197.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcE--EEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.|++.+.||+|+||.||+|.++.++.. +|+|.+... ........+.+|+.++..+ +||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----C
Confidence 5799999999999999999998877764 577766532 2234455788899999999 89999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
+.+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 46899999998 69999986432 57899999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 016884 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (381)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 241 (381)
+.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 9999999999863211111 111234567999999876 678999999999999999998 999997765433322
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.+.. .. .......+++.+.+|+.+||+.+|++|||++++|++
T Consensus 235 ~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLPQ---------------------------GY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHhc---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2110 00 001123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=309.32 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=203.1
Q ss_pred eeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 29 EVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999998866 8899999987543332 46678899999999999999999998854 3568999
Q ss_pred eeccc-cCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 106 FELME-SDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
|||+. ++|.+++... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 6899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 223 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-------- 223 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence 543321 111234467888999999877 578999999999999999999 69999887654443333220
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
........+++++.+++.+||+.||.+|||+.+++++
T Consensus 224 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 ----------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=314.42 Aligned_cols=263 Identities=23% Similarity=0.394 Sum_probs=207.9
Q ss_pred CeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (381)
.|++.+.||.|+||.||.|.+. .+|..||+|++.... ........+.+|+.+++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 3889999999999999999875 478999999986432 1223345677899999999 59999999988843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++...
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 346899999999 599999988888999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 322111 1234568899999999875334578899999999999999999999965432211111111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (381)
......+ .....+++.+.+|+.+||+.||++|| ++++++.||||+...
T Consensus 223 ------------~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 223 ------------RILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ------------HhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 1100000 01235788999999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.85 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=198.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||.|.... +..||+|.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 3579999999999999999997653 4569999886432 2235678899999999999999999998433 45
Q ss_pred EEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 5899998764 36899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 220 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------- 220 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence 2111 112235567999999976 578999999999999999998 99999776544333333221100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 221 ---------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ---------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=326.92 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=198.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 94 (381)
..++|++++.||+|+||.||+|.+... +..||+|++... ........+.+|+.+|+.+. ||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 356899999999999999999987433 347999998653 22344567889999999996 9999999999843
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhC-----------------------------------------------------
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAN----------------------------------------------------- 120 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------------------------------------- 120 (381)
...+|+|||||. |+|.+++..+
T Consensus 113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 346999999998 6998887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 016884 121 -------------------------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (381)
Q Consensus 121 -------------------------------------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NI 157 (381)
..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2477888899999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCh
Q 016884 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (381)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 236 (381)
|++.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999998764332211 11123356788999999877 678999999999999999997 9999976532
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
........ ..... ......++..+.+++.+||+.||++|||+.++.+
T Consensus 346 ~~~~~~~~--------------------------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKI--------------------------KSGYR---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHH--------------------------hcCCC---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22111110 00000 0112357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.22 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=202.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 4679999999999999999998865543 79999886532 23345678899999999999999999998843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.+..|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 345899999998 5899998764 46899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..............++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------ 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------
Confidence 432211111112233567999999977 678999999999999999886 99999876654444333221110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 229 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 ------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=315.33 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=201.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 367999999999999999999876443 789999887532 234456788999999999 79999999998843
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKA----------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl 158 (381)
...+++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 345899999998 699998854 246899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChh
Q 016884 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (381)
Q Consensus 159 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 237 (381)
++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYY-RKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCccccccccccccce-eccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999764332211 11122234567999999877 678999999999999999997 99999876544
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+....+... . ........+..+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEG---------------------------Y---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcC---------------------------C---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 333222110 0 001123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=308.19 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=198.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.++||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 46799999999999999999988655 4699999874322 23467889999999999999999887622 34
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||.++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 5999999753 3589999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... .....++..|+|||...+ ..++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 221 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---------
Confidence 22111 122346678999999876 678999999999999999999 8899987665443333221100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......++..+.+|+.+||+.||++|||+.++++
T Consensus 222 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.45 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=200.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.+|++.+.||.|+||.||+|.+..+ +..||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 3588999999999999999987543 5789999987432 223345678899999999999999999998443
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
..+++++||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 45899999998 5888887521 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998754332211 11123356788999999876 678999999999999999998 8899987765544
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...+..... ......++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 236 ~~~i~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQV------------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 444332111 01124678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=345.06 Aligned_cols=148 Identities=24% Similarity=0.438 Sum_probs=132.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|.++++||+|+||+||+|.+..+++.||||+++.. .........+.+|+.+++.++||||++++.++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 46899999999999999999999999999999998743 223344567889999999999999999998873 345
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
++|+||||+. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 6999999997 6999999887889999999999999999999999999999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=304.24 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=207.9
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|.+.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++|+|++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999998999999999875322 3556788999999999999999999988543 4589
Q ss_pred EEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 104 VVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
+++||++ ++|.+++... ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999988775 5799999999999999999999999999999999999999999999999999876544321
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.. ...
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~------------ 214 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGP------------ 214 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCC------------
Confidence 234468889999999877 5688999999999999999999999987654333322211 000
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
........++..+.++|.+||+.||++|||+.++|+|||
T Consensus 215 ---------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 215 ---------------PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------------CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000111224788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=309.63 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=198.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRPI 74 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCce
Confidence 46899999999999999999875 467899998864322 23467789999999999999999998843 3458
Q ss_pred EEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+||||++ ++|.+++..+ ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999997 5899998764 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.....
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 219 (256)
T cd05059 155 YTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------- 219 (256)
T ss_pred ccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------
Confidence 111 111223457999999887 678999999999999999999 8999987665443333221110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......++.+.+++.+||+.+|++|||+.++++.
T Consensus 220 -------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 -------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=310.40 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=200.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..+|++++.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 3679999999999999999998777766 4899988643 2333456788999999999999999999988532
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..++++||+. |+|.+.+..+ +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 3689999998 6999998764 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+...
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------- 227 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-------- 227 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------
Confidence 5332211 11112235677999999877 678999999999999999998 89999765543322222110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. .......+..+.+++.+||+.||++|||+.+++.
T Consensus 228 -----------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 228 -----------------ER-----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------Cc-----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112457889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=313.71 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=202.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC----------------cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 85 (381)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 368999999999999999999876544 468999987542 224556788999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
++++++... ...++|||++. ++|.+++.... .+++..++.++.|++.||+|||++||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999988443 46899999998 59999987655 68999999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc--CCCCC
Q 016884 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLF 231 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf 231 (381)
|+||+++.++.++|+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999875432211 111123456778999999876 678999999999999999998 67888
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
...+..+.+..+.... ............+.++.++.+|+.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 235 EHLTDQQVIENAGHFF-----------------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCcChHHHHHHHHhcc-----------------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 7665444333322111 00001111112245678999999999999999999999996
Q ss_pred c
Q 016884 312 A 312 (381)
Q Consensus 312 ~ 312 (381)
+
T Consensus 292 ~ 292 (296)
T cd05051 292 L 292 (296)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=308.74 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=201.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++.+++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----F 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----C
Confidence 468899999999999999999876654 79999886432 23445678899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 45899999998 5898888753 578999999999999999999999999999999999999999999999999987553
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..............+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~------- 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL------- 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC-------
Confidence 32221111111223457999999877 678999999999999999997 99999776654444333221111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 230 -----------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 -----------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=310.30 Aligned_cols=252 Identities=22% Similarity=0.375 Sum_probs=201.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 467999999999999999999886544 78999998643 2334455778999999999999999999998443
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
...|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 55899999998 6999988643 236788999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (381)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999998754332211 11123356788999999876 678999999999999999998 999998766543332221
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. .. .......++..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 D---------------------------GG---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred c---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 00 01112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.36 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=202.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|++++.||.|+||.||+|.+.. +..+|+|.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCe
Confidence 469999999999999999999887 899999998643 22335567889999999999999999998843 3458
Q ss_pred EEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999999753 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---------- 222 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc----------
Confidence 111 123345678999999877 678999999999999999998 8999987765444433322110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+++.+||+.||.+|||+.++++
T Consensus 223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 --------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=307.24 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=201.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|++|.||+|.+..+++.||+|.++.. .........+.+|+.+++.++|+|++++++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5799999999999999999999999999999988642 22333456788999999999999999999998543 45
Q ss_pred EEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.++||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 599988864 345899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... ...+
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~------------- 216 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSL------------- 216 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHH-------------
Confidence 332211 133468889999999877 67899999999999999999999999654311 0000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.+........+ ...+.++..+.++|.+||..+|++|||+.++++
T Consensus 217 ----------~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 ----------CKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------HhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000000000 001256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=324.94 Aligned_cols=237 Identities=25% Similarity=0.378 Sum_probs=197.0
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.-++.||+|+.|-||+|+ -.++.||||+++.. -..+|+-|++|+||||+.+.+++... ..+|||
T Consensus 127 sELeWlGSGaQGAVF~Gr--l~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIi 190 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGR--LHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCII 190 (904)
T ss_pred hhhhhhccCcccceeeee--ccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEe
Confidence 346789999999999995 45889999988521 11478889999999999999999443 458999
Q ss_pred eeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
||||. |-|.++++....++......|..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++......
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---- 266 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---- 266 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh----
Confidence 99999 8999999999999999999999999999999999999999999999999999999999999887543321
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
..-.++||..|||||++.+ .+.+.++|||||||||+||+||..||.+-+...++ ...|...
T Consensus 267 TkMSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsNs------------- 327 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSNS------------- 327 (904)
T ss_pred hhhhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccCCc-------------
Confidence 1235799999999999998 89999999999999999999999999765532211 1111110
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
-.......+++-++=||++||+-.|..|||+.++|.|
T Consensus 328 ------------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 328 ------------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ------------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0011234678888899999999999999999999998
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=308.00 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=198.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|+++++||+|+||.||+|.+. .+..||+|.+...... ...+.+|+.+++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 467999999999999999999765 5667999998753222 3467899999999999999999987632 24
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999998753 3589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.....
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (260)
T cd05070 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--------- 221 (260)
T ss_pred cccc--cccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2211 1112235567999999876 678999999999999999999 8999987665444433322100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+..+.+|+.+||+.||++|||+.++++
T Consensus 222 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 ---------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=312.66 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=205.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..+.|++.+.||+|++|.||+|.+..+++.||+|.++..... .....+.+|+.++..+ .||||+++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 346799999999999999999999999999999998753222 3345666788777666 49999999999843 3
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+||||+.+++.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 46999999999888877765 4579999999999999999999997 599999999999999999999999999986543
Q ss_pred CCCCCcccccccccCccccCcccccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCCh-hhHHHHHHHhhCCCCHHH
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPET 254 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 254 (381)
.... .....++..|+|||.+.+.. ..++.++|+|||||++|+|++|+.||..... .+.+..+..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 233 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--------- 233 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------
Confidence 2221 12335788899999986531 3478899999999999999999999965322 111111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...+ .......++.++.+|+.+||..||.+|||+++++.||||....
T Consensus 234 -----------------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 234 -----------------EEPP--SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -----------------CCCC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 0000 0111124688999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.24 Aligned_cols=256 Identities=23% Similarity=0.292 Sum_probs=205.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..+...+...||+|.||+||+|++ .-.||||++..........+.|.+|+.++++-+|.||+-+.+++..+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~----- 461 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP----- 461 (678)
T ss_pred CHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-----
Confidence 345678899999999999999965 346999999987777788889999999999999999999999985443
Q ss_pred cEEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+.||+-+|+| +|+.++... ..+.......|++||++|+.|||.++|+|||||..||++.++++|||+|||++..-..
T Consensus 462 -~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred -eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 4999999997 899888643 4689999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
-. .........|...|||||++... ..+|++.+||||||||+|||++|..||........+-.+-...+.|.
T Consensus 541 w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------ 613 (678)
T KOG0193|consen 541 WS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------ 613 (678)
T ss_pred ec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc------
Confidence 11 11122344678889999998542 35799999999999999999999999994433222222111111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.++++|+..||.+++++||++.+||.
T Consensus 614 --------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 --------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12223467779999999999999999999999987
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=309.56 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 46899999999999999999999999999999886432 233445678899999999999999999998844 346
Q ss_pred EEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 899999998 488888763 346899999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh--hHHHHHHHhhCCCCHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPSPET 254 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 254 (381)
..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.... .....+
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 220 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------- 220 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh-----------
Confidence 33221 1234568899999999877 67889999999999999999999999754321 111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...... .......++.+.+++.+||+.||++|||+.++++
T Consensus 221 ----------------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 221 ----------------EQCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------------hcCCCC--CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000000 0011347889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=315.00 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=199.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (381)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4689999999999999999998643 23479999987532 234456788899999999 79999999999843
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
...+|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 345899999998 69999997532 47889999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
|+++.++.+||+|||.++........ .......+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998754321110 01112234567999999877 678999999999999999998 889997655
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..+....+.. .. .......++.++.+|+.+||..+|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKE---------------------------GH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHc---------------------------CC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4332222211 00 011224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=311.87 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=199.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC--------------cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (381)
++|++.+.||+|+||.||+|++..++ ..||+|.++... .......+.+|+++++.++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 359999987532 234455788999999999999999999
Q ss_pred eeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 016884 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKAND------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~ 155 (381)
+++... ...|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||||+
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 998443 45899999998 58998886432 3688899999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc--CCCCCCC
Q 016884 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (381)
Q Consensus 156 NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~ 233 (381)
||+++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999998754322111 11122345678999999877 678999999999999999988 6678877
Q ss_pred CChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.+..+.+..+.... .... ........+.+++.+.+|+.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFF--------------------RNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhh--------------------hhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66544433322110 0000 00111123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=306.41 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=201.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||.||+|.+. .+..||+|.+.... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 74 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EE 74 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CC
Confidence 3468999999999999999999875 45789999987432 234567889999999999999999998743 34
Q ss_pred cEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..++||||+. ++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 5899999998 59999997643 68999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ......++..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+....+..+......+
T Consensus 155 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 224 (261)
T cd05034 155 DDEYT--AREGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------ 224 (261)
T ss_pred chhhh--hhhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 22111 1112234567999999987 678999999999999999998 999998876555444433211111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+..+.+++.+||+.||++|||++++++
T Consensus 225 ------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 11345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=311.50 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=199.9
Q ss_pred CCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++|.+.+.||+|+||.||+|.+. .++..+++|.+.. ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD---- 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----
Confidence 56999999999999999999754 3456799998764 223344568899999999999999999998843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
....++||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 345899999998 69999987542 388999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999875433221 111233456788999999887 678999999999999999998 9999977665443
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...+... . ........+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQG---------------------------R---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCC---------------------------C---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 3222110 0 00112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.94 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=201.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----S 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----C
Confidence 569999999999999999999887665 69999986532 33445678899999999999999999998843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...++||||+. ++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 45899999998 5898888753 568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccc--ccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 178 SDTPMTVFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 178 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
............ ..+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~----- 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL----- 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence 322211111111 12457999999877 678999999999999999886 99999876654443333211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....++..+.+++.+||+.+|.+||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 -------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112356888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=310.10 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=198.9
Q ss_pred CCe-EEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y-~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 456 999999999999998764 34567899999987532 223455778899999999999999999987432
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....+|+||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2245899999998 5888888764 5999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ...+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~---~~~~---- 226 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIG---PKQG---- 226 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhc---cccc----
Confidence 432221111122345677999999876 67899999999999999999999998654321 001100 0000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
........... .... .......++..+.+++.+||+.||++|||++++++
T Consensus 227 ~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 QMTVVRLIELL---ERGM---RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccchhhhhhhh---hcCC---CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000011111 1100 01123457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=309.74 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=199.5
Q ss_pred CCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.+|++.++||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC---
Confidence 56889999999999999999743 35668999987642 334456788999999999999999999988443
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~---------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~ 161 (381)
...++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||+++
T Consensus 80 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 --RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred --CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 45899999998 69999887542 4789999999999999999999999999999999999999
Q ss_pred CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHH
Q 016884 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (381)
Q Consensus 162 ~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 240 (381)
++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 99999999999875432211 111122345678999999887 678999999999999999998 99999776554433
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+.... . ......+++.+.+|+.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~---------------------------~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGR---------------------------E---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCc---------------------------c---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3322110 0 0112357889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.56 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=199.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|+++++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 467999999999999999999854 567899999874322 23567889999999999999999987632 34
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 799999998 6999988653 3689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------- 222 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------
Confidence 2111 1122345678999999877 678999999999999999998 99999877654443333221110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+.++.+++.+||+.+|++|||++++++
T Consensus 223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.06 Aligned_cols=245 Identities=30% Similarity=0.480 Sum_probs=203.5
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 109 (381)
||.|+||.||.|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 699999999999999899999999986532 22234567889999999999999999998883 345699999999
Q ss_pred c-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccc
Q 016884 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (381)
Q Consensus 110 ~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~ 188 (381)
. ++|.+++.....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999998887899999999999999999999999999999999999999999999999999876533221 1234
Q ss_pred cccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 016884 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (381)
Q Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
..++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+..
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 207 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK----------------------- 207 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 568889999999877 5678899999999999999999999977654322222211
Q ss_pred HhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH---HHHhcCCCc
Q 016884 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYF 316 (381)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~---~~lL~hp~~ 316 (381)
.........+..+.+++++||..||++|||+ +++++||||
T Consensus 208 --------~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 208 --------DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0011223458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.22 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=196.6
Q ss_pred EEeeeecccCCceEEEEEEc----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 26 KILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+++++.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 47889999999999999887 4567899999964 24445577899999999999999999999999633 33
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+++|+|||. |+|.+++... ..+++..+..|+.||+.||+|||+++|+|+||+++||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6999999886 6899999999999999999999999999999999999999999999999999976522
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ............|+|||.+.+ ..++.++||||||++++||++ |+.||.+.+..+....+.+...
T Consensus 156 ~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------- 223 (259)
T PF07714_consen 156 KSK-YKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------- 223 (259)
T ss_dssp SSS-EEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---------
T ss_pred ccc-ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc---------
Confidence 211 111233456778999999877 568999999999999999999 7899988766555444432111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......++..+.++|.+||..||++|||+.++++
T Consensus 224 ---------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ---------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0112357899999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=305.97 Aligned_cols=252 Identities=28% Similarity=0.481 Sum_probs=201.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
||.+.+.||+|+||+||+|.+..++..+++|+++... ........+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 6999999999999999999998887777777765321 1223344667899999999999999999988433 4
Q ss_pred cEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..++|+||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 5899999998 488877753 457999999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
....... .....|++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+.......+.. .+
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~----- 221 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GP----- 221 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CC-----
Confidence 5332221 223468889999999876 6788899999999999999999999976554333222211 00
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......++.++.++|.+||..||++||++.++++||||
T Consensus 222 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 ----------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=311.13 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=217.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..+|..+..||+|+||+|.+|..+.|.+.+|||++++..- ...+.+--..|-++|... +-|.++.++.+| ++.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 3578899999999999999999999999999999875422 112233334577777766 478899999888 555
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+.+|+||||+. |+|--.|+.-+++.+..+..++..|+-||-+||++||+.||||.+|||++.+|.+||+|||+++-...
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 67999999999 59999999999999999999999999999999999999999999999999999999999999875333
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
+..+ ..++||||.|+|||++.= ++|+.++|.||+||+||||+.|++||.|.+..+....|++.-
T Consensus 503 ~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------- 566 (683)
T KOG0696|consen 503 DGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------- 566 (683)
T ss_pred CCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence 2222 257899999999999975 899999999999999999999999999999988887776521
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
......+|.++.++.+..|...|.+|.. -.++-.||||+.+
T Consensus 567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred --------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 1223568999999999999999999974 4678899999875
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.07 Aligned_cols=243 Identities=26% Similarity=0.429 Sum_probs=199.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|++.+.||.|++|.||+|.. .++.||+|.+..... ...++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 45799999999999999999975 488999999875422 45678899999999999999999999854 345
Q ss_pred EEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||.++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 59999998765 699999999999999999999999999999999999999999999999999876522
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. .....+..|+|||.+.+ ..++.++|+|||||++++|++ |..||...+..+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999876 678899999999999999997 9999976654332222211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
... ......+++.+.++|.+||..+|++|||+.+++.
T Consensus 215 ---------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 215 ---------------GYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------CCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 0112357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.92 Aligned_cols=242 Identities=25% Similarity=0.417 Sum_probs=196.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+|++.+.||+|+||.||+|.. .+..||+|.++.. .....+.+|+.+++.++|+|++++++++... ...+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCce
Confidence 5799999999999999999965 4788999988642 2345678999999999999999999876432 2458
Q ss_pred EEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999998 59999987644 4889999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+..
T Consensus 156 ~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------- 214 (256)
T cd05082 156 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 214 (256)
T ss_pred C------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------------
Confidence 1 12245567999999877 678999999999999999997 9999976654333222211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
... ......+++.+.+++.+||+.||++|||+.++++
T Consensus 215 --------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 215 --------------GYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 0122467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=311.08 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred CCCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.++... .......+.+|+.+++.+ +||||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 35799999999999999999975 3345689999887532 234456788999999999 799999999988443
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
..+|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 45899999998 69999987543 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
++........ .......++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+....+.......
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 8754332211 11122346778999999877 678999999999999999998 9999977553322211111
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... .......++.+.+|+.+||+.+|++|||+.++++
T Consensus 259 --------------------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 --------------------EGYR---MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------cCCc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 0112346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.95 Aligned_cols=244 Identities=21% Similarity=0.324 Sum_probs=192.7
Q ss_pred eecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEee
Q 016884 30 VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
.||+|+||.||+|... ..+..||+|++... ........+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 4899999999999765 44567999988643 223345578899999999999999999998732 34799999
Q ss_pred ccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 108 LME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 108 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
|++ ++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 589988875 457899999999999999999999999999999999999999999999999998754332221111
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 215 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK----------------- 215 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-----------------
Confidence 112233567999999876 678999999999999999996 999998766544333222110
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ....+..++++.+++.+||+.||++||++.++.+
T Consensus 216 ----------~---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 216 ----------R---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ----------C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0112457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.33 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=199.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (381)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999997632 34579999887432 234456788999999999 69999999998843
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 345899999998 6999998653 348889999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
||++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997543221111 0112234567999999877 678999999999999999999 899998766
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+....+.. .. .......++.++.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~---------------------------~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 242 VEELFKLLRE---------------------------GH---RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHHc---------------------------CC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5443333221 00 00112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.13 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=197.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 36799999999999999999987655 469999876432 223567789999999999999999887732 24
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||.++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 799999998 5999999754 3589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......++..|+|||...+ ..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 155 ~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (260)
T cd05069 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------- 221 (260)
T ss_pred Cccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2211 1122345677999999876 678999999999999999999 9999987665443333221100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+..+.+++.+||..||++|||++++++
T Consensus 222 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ---------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=307.70 Aligned_cols=269 Identities=22% Similarity=0.387 Sum_probs=200.4
Q ss_pred CCeEEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+|++++.||+|+||.||.|. +..++..||+|.+... .......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---
Confidence 579999999999999999997 4467889999998643 3344567889999999999999999999875432
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+++||||+. ++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 245899999997 6999998754 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..............++..|+|||.+.+ ..++.++|||||||++++|++|..++...... . ....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~----~~~~~~~~~~--- 228 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-F----MRMMGNDKQG--- 228 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-h----hhhccccccc---
Confidence 332221111112234456999999877 67899999999999999999988776443211 0 1111110000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
........+.+..... ......++..+.+|+.+||+.+|++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 ---QMIVYHLIELLKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---ccchHHHHHHHhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0000111111111111 1123467889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.97 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=197.8
Q ss_pred eeecccCCceEEEEEEcC-CCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 29 EVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
+.||+|++|.||+|.+.. .++ .||+|.+...... .....+.+|+.+++.++||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999998865 333 6999998754333 456678899999999999999999998844 458999
Q ss_pred eeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 106 FELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
|||+. ++|.+.+..+. .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 69999997754 6899999999999999999999999999999999999999999999999999765432221
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE--------------- 216 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc---------------
Confidence 111123456778999999877 678999999999999999998 99999876655443333210
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. .........+..+.+++.+||+.+|++|||+.++++
T Consensus 217 ---------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 217 ---------G-----ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ---------C-----CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 001112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.37 Aligned_cols=270 Identities=23% Similarity=0.375 Sum_probs=202.9
Q ss_pred CCeEEeeeecccCCceEEEEEE----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAID----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.-|++++.||+|+||.||+|.. ..++..||+|.++.. ........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3479999999999999999973 467889999998643 22344567889999999999999999999885431
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....++||||+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 245899999997 59999987643 6899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..............++..|+|||.+.+ ..++.++|||||||++|+|++++.|+..... ...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~-- 230 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM-- 230 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc--
Confidence 433222112233456778999999877 6789999999999999999998876543211 1111111111100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.............. ......+++.+.+|+.+||+.||++|||+.+++++
T Consensus 231 -----~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 -----TVTRLVRVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -----cHHHHHHHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00111111111111 12234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=306.41 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=197.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++|++++.||+|+||+||+|....++. .+++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 579999999999999999999877776 4777776432 222334567788889999999999999998732
Q ss_pred CCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...++++||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 23689999998 799999975 457899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.+
T Consensus 160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 226 (279)
T cd05111 160 YPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK---------- 226 (279)
T ss_pred cCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC----------
Confidence 33221 111233456778999999876 678999999999999999998 9999987654332221111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... ......+.++.+++.+||..||.+|||+.++++
T Consensus 227 -----------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 227 -----------------GERL---AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000 011235678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=307.88 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=204.7
Q ss_pred CeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (381)
.|++.+.||+|++|.||+|.+. .+++.||+|.++.... .......+.+|+.++..+ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4889999999999999999864 4678999999864321 123345677899999999 59999999988843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+|+||||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 346899999998 599999887778999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... ......|+..|+|||.+.+.....+.++|+||+|+++|+|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 332211 1123468899999999876323478899999999999999999999965432211111110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC---HHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt---~~~lL~hp~~~~~ 319 (381)
...... ......+++.+.++|.+||+.||++||| +.++|+||||+.+
T Consensus 223 ------------~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 223 ------------RILKSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred ------------HHHccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 000000 1122457889999999999999999998 5677999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=316.47 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=197.3
Q ss_pred CCCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 3567899999987532 223455788999999999 689999999987432
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhC------------------------------------------------------
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------------------------------------ 120 (381)
...+++|||||. |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 235899999999 6999888642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccccc
Q 016884 121 -------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187 (381)
Q Consensus 121 -------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 187 (381)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence 13677888899999999999999999999999999999999999999999998754322111 1111
Q ss_pred ccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...........
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------------- 295 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---------------------- 295 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----------------------
Confidence 2345677999999877 678999999999999999996 999997654322111110
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..... .......++.+.+++.+||+.||++|||+.++++|
T Consensus 296 ----~~~~~---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 296 ----KEGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----hccCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00000 00112367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.73 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=196.8
Q ss_pred CeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 47899999999999999998753 23568888876432 23445678899999999999999999998843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
....++|+||+. ++|.+++... ..+++..+..++.|++.||.|||++||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 345899999999 6898887642 247889999999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCC
Q 016884 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~ 232 (381)
|+|||+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999998754322211 11122345678999999876 678999999999999999998 999998
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
+.........+..... ......++..+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLKTGYR------------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHhCCCC------------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7654333222211000 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.43 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=200.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (381)
..+|.+.+.||+|+||.||.|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++.+..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 467999999999999999999753 234579999886432 234456788999999999 79999999998843
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 93 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 93 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 345899999998 5999998753 247888899999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
|+++.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999998764332211 11122345678999999877 678999999999999999998 889998766
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..+....+... .. ......++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEG---------------------------HR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcC---------------------------Cc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 54433332210 00 01124578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.67 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=198.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 579999999999999999998753 67899999887432 23344568889999999999999999998843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND----------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp 154 (381)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 345899999999 59999986432 478889999999999999999999999999999
Q ss_pred CceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCC
Q 016884 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233 (381)
Q Consensus 155 ~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~ 233 (381)
+||+++.++.++|+|||++.......... .......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred hheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999987543221111 0112234667999999877 678999999999999999997 8889977
Q ss_pred CChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.+..+....+.. .. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRD---------------------------GN---VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhc---------------------------CC---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 654433322211 00 00112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=302.57 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..+|.+.+.||+|+||.||+|.+... ...||+|..... ........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987644 357999987643 223455678899999999999999999998743
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...|+||||+. ++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 23689999998 69999997644 5899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
....... .+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 158 ~~~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------- 225 (270)
T cd05056 158 EDESYYK--ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------- 225 (270)
T ss_pred cccccee--cCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 3321111 112234567999999876 678999999999999999986 999998876554443332110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.....+.+++.+.+++.+||..+|++|||+.+++..
T Consensus 226 ----------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 226 ----------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=313.21 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
.+|++++.||+|+||.||.|.+... +..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 4799999999999999999986432 236999987643 2234456788999999999 79999999999843
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NI 157 (381)
...+|+||||+. ++|.+++.... .++...+..++.|++.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 345899999998 59999987532 477888999999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCh
Q 016884 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (381)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 236 (381)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999998754332111 11122234567999999977 678999999999999999998 8899987664
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.+....+... . ........+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEG---------------------------H---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcC---------------------------C---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4433322210 0 011124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=300.07 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=199.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.++||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence 3578999999999999999999754 4567999987632 2334578889999999999999999988743 3
Q ss_pred cEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 4799999998 6999999763 357889999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ......++..|+|||++.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (260)
T cd05073 154 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------- 221 (260)
T ss_pred CCCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC--------
Confidence 22211 1122345677999999877 678999999999999999998 9999987665443333221100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+.++.+++.+||+.||++|||+.++++
T Consensus 222 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ----------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=303.93 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=201.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.++|++.+.||+|+||.||+|.++.++. .||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4679999999999999999999876665 58999876442 23445678899999999999999999998854
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...++||||+. ++|.+++..+ ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 35899999998 6999998764 4699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
........ ......++..|+|||.+.+ ..++.++|+|||||++|++++ |+.||.+....+....+....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------- 228 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE------- 228 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-------
Confidence 54322211 1112224567999999876 678999999999999999998 999998765443332222110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
........+..+.+++.+||..||.+|||+.++++
T Consensus 229 -----------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 -----------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=305.37 Aligned_cols=266 Identities=16% Similarity=0.191 Sum_probs=194.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHH---------HHHHHHHHHHHhcCCCCccccc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVEIK 88 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~ 88 (381)
..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... .....++..+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347899999999999999999998877 6677887643221111000 1122344556667899999999
Q ss_pred eeecCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEe
Q 016884 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
++...... .....+++++++..++.+.+......++..++.++.|++.||+|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 87643321 11235788998888888887766667899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCC----cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHH
Q 016884 169 DFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 169 DFg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (381)
|||+|+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.........
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999765322111 011123469999999999987 679999999999999999999999998764322211111
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
+ ..+...+.... ...+..++.+.++++.|+..+|++||+.+++++
T Consensus 247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 01111111110 012456889999999999999999999999875
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=306.49 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=197.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC----------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 85 (381)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ........+.+|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 3457999988643 2233456788999999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
++++++... ...|+||||+. ++|.+++.... .+++..+..++.|++.||+|||+.||+|||||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999988443 45899999998 69999887532 36778899999999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc--CCCCC
Q 016884 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLF 231 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf 231 (381)
|+|||++.++.++|+|||+++......... ......++..|+|||...+ ..++.++|+|||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999987543322111 1122344678999998776 678999999999999999998 77888
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
...+..+....... ++... ...........+++.+.+|+.+||+.||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 235 SQLSDEQVIENTGE--------------------FFRDQ---GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred cccChHHHHHHHHH--------------------HHhhc---cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 76554333221111 00000 00011112245778999999999999999999999987
Q ss_pred c
Q 016884 312 A 312 (381)
Q Consensus 312 ~ 312 (381)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=303.52 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=202.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35689999999999999999999876 3578999987643 3445566788999999999999999999987543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEE
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl 167 (381)
....++++||+. ++|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 235799999998 6999988653 35899999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 246 (381)
+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|++++ |+.||...+..+....+...
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999997543322111 1122345677999999877 678999999999999999999 99999876544332222110
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. ......+++.+.+++.+||..||++|||+.++++
T Consensus 236 ---------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 ---------------------------YR---LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------------------------CC---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0112356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=299.38 Aligned_cols=248 Identities=29% Similarity=0.468 Sum_probs=201.2
Q ss_pred eEEeeeecccCCceEEEEEEcCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+++.+.||.|+||.||+|.+..++ ..||+|.+.... .......+..|+.+++.++|+||+++++++... +
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 357889999999999999998766 899999986432 222566788999999999999999999998543 4
Q ss_pred cEEEEeeccc-cCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..|++|||+. ++|.+++..... +++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 5899999998 599999976554 9999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
....... ....+++.|+|||.+.+ ..++.++|+||+||++++|++ |++||...+.......+....
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------- 221 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY--------- 221 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence 3311111 11236788999999866 678999999999999999998 889998765544433332110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. .......+..+.+++.+||+.||++|||+.++++
T Consensus 222 ------------------~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 ------------------R---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ------------------C---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0 0112347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.93 Aligned_cols=278 Identities=21% Similarity=0.261 Sum_probs=184.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 95 (381)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++..... ......| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 457899999999999999999999988 89999998764211 1111111 122222333333332222211
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp 154 (381)
......+++|+||++ ++|.+++..... .....+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134456899999998 589888865321 12345678999999999999999999999999
Q ss_pred CceEecC-CCCeEEeeecccccccCCCCCcccccccccCccccCcccccccc--------------------CCCCCccc
Q 016884 155 KNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (381)
Q Consensus 155 ~NIl~~~-~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~~D 213 (381)
+|||++. ++.+||+|||+|+....... ......++|+.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57899999999975433221 1124568999999999653311 12345679
Q ss_pred hHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCC---ccccCCCCCHHHH
Q 016884 214 IWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP---LFQKFPNVDPLAL 290 (381)
Q Consensus 214 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 290 (381)
|||+||++|+|+++..+ ..+....+..+....+.....+.... ....... ........+..+.
T Consensus 362 VwSlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLV------------EPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cHHHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhh------------ccccchhhhhhhhhccccchHHH
Confidence 99999999999986544 33433344444333333222111110 0000000 0111122345677
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 291 dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
|||.+||+.||.+|||+.++|+||||+...
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999999999999998754
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=302.54 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=200.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++|++++.||+|+||.||+|+.+. ..+.||+|.+... ........+.+|+++++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----
Confidence 579999999999999999999654 3467999987642 222345678899999999999999999998833
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEE
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~---------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl 167 (381)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 345899999998 69999998655 6899999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 246 (381)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 99999864332211 11233456778999999876 567899999999999999998 8889976544332222211
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
... .......++..+.+++.+||+.||.+|||+.+++.+
T Consensus 234 -------------------------~~~---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 -------------------------GKL---ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------CCc---CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 011124578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=317.81 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=198.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 95 (381)
.++|.+.+.||+|+||.||+|++. .++..||+|+++... .......+.+|+.+|..+. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 357889999999999999999853 355689999997542 2233456889999999997 99999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC-----------------------------------------------------
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------------------------------------------- 121 (381)
..+|+|||||. |+|.+++..+.
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 45899999999 69999886431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 122 ---------------------------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 122 ---------------------------------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
.+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35677788999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
||++.++.+||+|||+++......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999997543222111 1123357788999999977 678999999999999999998 889997654
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..+....... ... .......++.++.+|+.+||..+|.+||++++++..
T Consensus 347 ~~~~~~~~~~--------------------------~~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MNEQFYNAIK--------------------------RGY---RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred chHHHHHHHH--------------------------cCC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3332211110 000 001124578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=299.02 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=198.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++|||++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCc
Confidence 357999999999999999999875 467899998864322 23467789999999999999999998843 345
Q ss_pred EEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.|+||||+. ++|.+++... ..++++.++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5888888754 46899999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+.....
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 219 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---------- 219 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC----------
Confidence 1111 112235568999999876 678899999999999999998 9999987665443333221000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
. ......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 220 ---------------~-----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ---------------L-----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------C-----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0 0112357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=298.14 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=194.6
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeec
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 108 (381)
++||.|++|.||+|.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 479999999999999877 999999988754332 345678899999999999999999998843 3458999999
Q ss_pred cc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 109 ME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 109 ~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 589998865 3468999999999999999999999999999999999999999999999999987543211110 00
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+....+
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------- 213 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------- 213 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------
Confidence 11234566999999877 678999999999999999998 8899977654333222211000
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+..+.+++.+||+.+|.+|||+.++|+
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.43 Aligned_cols=228 Identities=26% Similarity=0.367 Sum_probs=185.2
Q ss_pred cCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc-cC
Q 016884 34 GSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SD 112 (381)
Q Consensus 34 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 112 (381)
|.+|.||+|++..+++.||+|.+.... ...+|...+....||||+++++++.. ....|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 889999999999999999999986531 12234455556679999999998843 356899999998 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccC
Q 016884 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (381)
Q Consensus 113 L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt 192 (381)
|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||.+....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 233567
Q ss_pred ccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC
Q 016884 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (381)
Q Consensus 193 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 67889999999999999999999887532110 0 00
Q ss_pred CCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCCc
Q 016884 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYF 316 (381)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-----~~lL~hp~~ 316 (381)
. ......+.+++.+.+||.+||+.||++|||+ +++++||||
T Consensus 192 ~---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 H---TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred c---cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0 0001123578899999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=301.83 Aligned_cols=242 Identities=25% Similarity=0.374 Sum_probs=190.8
Q ss_pred eeecccCCceEEEEEEcCCCc--EEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEE
Q 016884 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
+.||+|+||.||+|.+..++. .+|+|.++.. ........+.+|+.++..+ +||||+++++++... ..+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 368999999999999888775 4688877632 2234455788999999999 799999999998443 458999
Q ss_pred eeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEe
Q 016884 106 FELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
|||+. ++|.+++..+. .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999987532 47899999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhh
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (381)
|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 226 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 226 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--
Confidence 9999853221110 111234567999999876 678999999999999999997 9999977654333222211
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. .......++.++.+|+.+||+.||.+|||+.++++
T Consensus 227 -------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -------------------------GY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------------------CC---CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 00112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=298.58 Aligned_cols=240 Identities=26% Similarity=0.429 Sum_probs=195.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.+++.++|||++++++++... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 569999999999999999984 57889999998643 2335678899999999999999999987432 36
Q ss_pred EEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997643 5899999999999999999999999999999999999999999999999998753222
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||...+..+....+...
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------ 213 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG------------ 213 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC------------
Confidence 1 12234567999999876 678999999999999999997 99999876644332222110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. ......+++.+.+++.+||+.+|++|||+++++.
T Consensus 214 ---------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 ---------------YR---MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------------CC---CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.29 Aligned_cols=243 Identities=24% Similarity=0.412 Sum_probs=193.3
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeec
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 108 (381)
+.||+|+||.||+|... ++..||+|.++.... ......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 46899999999999864 688999998875432 23345688999999999999999999988433 458999999
Q ss_pred cc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccc
Q 016884 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (381)
Q Consensus 109 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~ 186 (381)
+. ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6898888653 468999999999999999999999999999999999999999999999999986532221111 1
Q ss_pred cccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHH
Q 016884 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (381)
Q Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 265 (381)
....++..|+|||.+.+ ..++.++|||||||++|++++ |..||.+.........+....
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~------------------ 211 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY------------------ 211 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 12234567999999876 678899999999999999998 999998765443322221100
Q ss_pred HHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......++..+.+++.+||+.+|++|||+.++++
T Consensus 212 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 ------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01122457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.13 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=200.5
Q ss_pred eEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC-CC
Q 016884 25 YKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FK 100 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-~~ 100 (381)
|++.+.||+|+||.||+|... .++..||+|++............+.+|+++++.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 35789999999766555566778889999999999999999999886543221 12
Q ss_pred cEEEEeeccc-cCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
..++++||+. ++|.+++... ..++...++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 6888776422 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+........ .......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 764332211 11122345677999999877 678899999999999999999 89999876544332222210
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
. .....+..++.+.+++.+||+.+|++|||+.+++++
T Consensus 232 ---------------------~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 ---------------------N---RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---------------------C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001123577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=316.16 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=224.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
...+++..||-|+||.|=++.-......+|+|++++.. -......-+..|-+||..+..|.||++|..| .+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 35677889999999999998766555568999887532 2334556788899999999999999999988 56678
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|++||-|- |.|+.++..++.+.+..++.++..+++|+.|||++||+.|||||+|++++.+|.+||.|||+|+....+.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999986 6999999999999999999999999999999999999999999999999999999999999999876654
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.+ -++||||.|.|||++++ ...+.++|.||||+++|||++|.+||++.+.+..++.|.+.+..-
T Consensus 575 KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------- 638 (732)
T KOG0614|consen 575 KT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------- 638 (732)
T ss_pred ce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence 32 46899999999999998 788999999999999999999999999999999998887744221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
..+..++..+.+||+++-..+|.+|.. +.+|-.|.||.++
T Consensus 639 -------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 639 -------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred -------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 112457889999999999999999985 8999999999875
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.28 Aligned_cols=238 Identities=18% Similarity=0.278 Sum_probs=186.2
Q ss_pred eeecccCCceEEEEEEcCCCc-------EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 29 EVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.||+|+||.||+|.+..++. .||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 469999999999998866544 4888877532 223445678899999999999999999998543 45
Q ss_pred EEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC--------eEEeeec
Q 016884 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--------LKVCDFG 171 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~--------vkl~DFg 171 (381)
.++||||+. ++|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 799999998 58999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCChhhHHHHHHHhhCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
.+...... ....++..|+|||.+.+. ..++.++|||||||++|+|++|. +||...+.........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------ 219 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------ 219 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------
Confidence 88643221 234678889999998753 45788999999999999999984 6665544322111100
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. .......+.++.+|+.+||+.||++|||++++++.
T Consensus 220 ---------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 ---------------------DR-----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------cc-----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 01123456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.39 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.++|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3678999999999999999999887776 57888876432 233344678899999999999999999988532
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..++++||+. |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 2579999998 68999987654 689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------- 227 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-------- 227 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC--------
Confidence 4332211 11123345678999999877 678999999999999999997 89999776533222211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. ....+..+..+.+++.+||..+|++|||+.++++.
T Consensus 228 -----------------~~-----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 228 -----------------ER-----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 01123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=297.75 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=187.9
Q ss_pred eeecccCCceEEEEEEcC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++||||+++++.+... ...|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence 469999999999996432 4457888877543 2233445678999999999999999999988433 4589999
Q ss_pred eccc-cCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
||+. ++|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 59999987643 24678889999999999999999999999999999999999999999999986432211
Q ss_pred CCcccccccccCccccCccccccc-----cCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
... ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+......
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI----- 228 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-----
Confidence 100 01223456779999987431 1357889999999999999999 78899876654433332211100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+.......+++...+++..|+ .||++|||++++++
T Consensus 229 --------------------~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 --------------------KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred --------------------cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00111122457888899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.88 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=189.6
Q ss_pred eeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEE
Q 016884 29 EVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++||||+++++++.... ...++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998653 3457999987532 23344567889999999999999999999764322 347899
Q ss_pred eeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 106 FELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 106 ~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
|||+. ++|.+++... ...++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 6999998764 356788888999999999999999999999999999999999999999999987543221100
Q ss_pred -ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 184 -VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 184 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---------------- 217 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---------------- 217 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc----------------
Confidence 01123345678999999876 678999999999999999999 5677876554332222211
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... .....+++.+.+++.+||+.+|++|||+.++++
T Consensus 218 -----------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 218 -----------GRRL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred -----------CCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 011246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.23 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=183.8
Q ss_pred eeecccCCceEEEEEEcC------------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 29 EVIGKGSYGVVCAAIDTH------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
+.||+|+||.||+|.... ....||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2236888987542 223345678899999999999999999998543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC-------eEE
Q 016884 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------LKV 167 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~-------vkl 167 (381)
...++||||++ ++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +++
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 34799999999 477777764 357999999999999999999999999999999999999987664 899
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHH-cCCCCCCCCChhhHHHHHHHh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~ 246 (381)
+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||......+.....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--- 222 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---
Confidence 999988654221 234678889999988632 56899999999999999998 588888765432211000
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
. .. .......++++.+|+.+||+.||.+||++.+||++
T Consensus 223 ---------------------~---~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ---------------------E---GQ-----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------------------h---cC-----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 00 00112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.72 Aligned_cols=269 Identities=23% Similarity=0.393 Sum_probs=201.8
Q ss_pred CCeEEeeeecccCCceEEEEEEc----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+|++.+.||+|+||.||+|... .++..||+|++...... .....+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--- 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG--- 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC---
Confidence 56889999999999999999864 34789999998754332 34567889999999999999999998874422
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....++||||+. ++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 346899999997 59999997654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..............++..|+|||.+.+ ..++.++|+|||||++++|++|..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~--- 229 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ--- 229 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc---
Confidence 432221111112345567999999877 678899999999999999999999986543211 0011110000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.........+..... ......++.++.+|+.+||+.||.+|||+.+++.
T Consensus 230 ----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 ----MIVTRLLELLKEGER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----ccHHHHHHHHHcCCc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000111111111111 1112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=321.04 Aligned_cols=265 Identities=25% Similarity=0.430 Sum_probs=220.7
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (381)
-+..+.+++.+.||.|.+|.||+++++.+++..|+|+...... ..+.+..|+++|+.+ .|||++.+++++......
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 4566789999999999999999999999999999998874332 234555799999988 599999999999876667
Q ss_pred CCCcEEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
..+.++||||||+ |+.-++++. ..++.|..+.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 7788999999999 588888864 4579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
....... ...+.+|||.|||||++... ...|+..+|+||||++..||.-|.+|+-+...+..+-.| ...
T Consensus 172 QldsT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRN-- 243 (953)
T KOG0587|consen 172 QLDSTVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN-- 243 (953)
T ss_pred eeecccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCC--
Confidence 6543322 23567899999999998542 235788999999999999999999999877655433222 111
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
|.+....+...+.++.|+|..||..|-.+||+..++|.|||++
T Consensus 244 -----------------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 244 -----------------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred -----------------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 2222233467889999999999999999999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=289.73 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=206.9
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCCcEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.+-+..||.|+||+|++..|+.+|+..|||+++.... ..+..+++.|.....+ -+.||||++++..+.++ ..|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----cee
Confidence 3456789999999999999999999999999975432 4566788888887544 47999999999986553 489
Q ss_pred EEeeccccCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 104 VVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 104 lv~e~~~~~L~~~l~-----~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
|.||.|+-+|..+.+ ....++|..+-.|+...+.||.||... .|+||||||+|||++..|.|||||||.+....
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999976655443 345799999999999999999999765 89999999999999999999999999986544
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.+.. -+.-.|.+.|||||.+.....+|+-+||+||||++|||++||+.|+.+-+ ..+++..+. .|.|+.
T Consensus 220 ~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~---- 289 (361)
T KOG1006|consen 220 DSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI---- 289 (361)
T ss_pred HHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe----
Confidence 3322 23447889999999997654569999999999999999999999997644 333333332 122211
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.......-.++..+..+|.-||..|...||...+++.+||++...
T Consensus 290 -------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 290 -------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 001111235889999999999999999999999999999998654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=299.14 Aligned_cols=237 Identities=19% Similarity=0.263 Sum_probs=183.4
Q ss_pred eecccCCceEEEEEEcCC------------------------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc
Q 016884 30 VIGKGSYGVVCAAIDTHT------------------------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 85 (381)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999974321 246889987532 223345678899999999999999
Q ss_pred ccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC
Q 016884 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (381)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~ 163 (381)
++++++... ...++||||++ ++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998543 35799999999 578888765 45789999999999999999999999999999999999997643
Q ss_pred -------CeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHH-cCCCCCCCCC
Q 016884 164 -------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKS 235 (381)
Q Consensus 164 -------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~ 235 (381)
.+|++|||.+...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987543221 123577889999988653 56899999999999999985 6999997654
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..+...... . .. ......++.+.++|.+||+.+|++|||+.++|++
T Consensus 227 ~~~~~~~~~------------------------~---~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERFYE------------------------K---KH-----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHH------------------------h---cc-----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 332211110 0 00 0112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=324.93 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=207.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..-+..+.||+|+||+||+|+-.. ....||||.++.. .......+|.||+..|..|+|||||++++++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~----- 559 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCR----- 559 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----
Confidence 456778999999999999997532 2357999999854 33345678999999999999999999999994
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
+.+-+|+|+|||. |||.+++..+. +++..+...|+.||+.|+.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 4455999999999 89999996432 28899999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 016884 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (381)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 241 (381)
..|||+|||+++......--. ......-...|||||.+.- +.|+.+|||||+||+|+|+++ |..|+.+.++.+.++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred eEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 999999999998654432111 1112234567999999876 789999999999999999998 999999999888887
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
.|... ...+...+++.++.+|+..||+.+|.+|||+.||=
T Consensus 717 ~i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 77541 11233468999999999999999999999999983
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=294.45 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=187.9
Q ss_pred eeecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.. ...+++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 46999999999999754 4567899998875432 2334578889999999999999999998843 34589999
Q ss_pred eccc-cCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
||+. ++|.+++.... ..++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9998 69999886432 45677888999999999999999999999999999999999999999999986432211
Q ss_pred CCcccccccccCccccCcccccccc-----CCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
. ........++..|+|||++.+.. ..++.++|||||||++|+|++ |+.||...+..+........
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-------- 225 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc--------
Confidence 1 11112345778899999986421 135789999999999999996 99999776544332211110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... ..........++.+.+++.+|+ .+|++|||+++++.
T Consensus 226 ---------------~~~~--~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 ---------------QQLK--LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------------ccCC--CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0000 0001111246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.37 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=194.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+.|.-...||+|+||.||+|.-.. +..||||++....... ...+.+|+.++.+++|||+|+++++|..... +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 567777899999999999997654 4899999887543221 4459999999999999999999999954321 48
Q ss_pred EEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~---i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+||+|||. |+|.+.+.... +++|.....|+.++++||+|||+.. |+||||||+|||+|.+...||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999 79999997654 8999999999999999999999964 999999999999999999999999999654
Q ss_pred cCCCCCccccccc-ccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
... ... .... .||..|+|||.+.. +..+.++||||||+++.||++|+.+.+.............. .
T Consensus 228 ~~~-~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~--------~ 294 (361)
T KOG1187|consen 228 PEG-DTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA--------K 294 (361)
T ss_pred Ccc-ccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH--------H
Confidence 331 111 1122 79999999999976 67899999999999999999999888754311111100000 0
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCC--CCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+....+.+.++ ..-.. ...+ ..-..+..+..+|++.+|.+||++.|++.
T Consensus 295 ~~~~~~~~~eiiD----~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 295 PLLEEGKLREIVD----PRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHCcchhheeC----CCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0011111111111 00000 0011 11123567888999999999999999754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.61 Aligned_cols=263 Identities=24% Similarity=0.414 Sum_probs=212.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.-|..++.||-|+||.|++++...|...||.|.+.+. ........-+..|-.||..-+.+-||+++-.| .+.++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 3488899999999999999999999999999988643 12223445667899999999999999999888 56677
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. ||+-.++...+-+.|+.++.++..+.+|+.+.|..|+|||||||+|||||.+|.+||+|||+++-..+..
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999996543221
Q ss_pred CCc---------------------------------------ccccccccCccccCccccccccCCCCCccchHHHHHHH
Q 016884 181 PMT---------------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (381)
Q Consensus 181 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 221 (381)
+.. ......+||+.|+|||++.. ..|+..||.||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 100 00124589999999999987 7899999999999999
Q ss_pred HHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCC
Q 016884 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301 (381)
Q Consensus 222 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp 301 (381)
|+|+.|++||...+..+...++.+ ++.++ ......++|+++.+||.++. .++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l----------~~~~~~~ls~e~~~li~kLc-~sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNFL----------HIPYQGNLSKEALDLIQKLC-CSA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhcc----------ccccccccCHHHHHHHHHHh-cCh
Confidence 999999999987765443322221 11111 11123578999999999864 477
Q ss_pred CCCC---CHHHHhcCCCcCcCc
Q 016884 302 KDRP---TAEEALADPYFKGLA 320 (381)
Q Consensus 302 ~~Rp---t~~~lL~hp~~~~~~ 320 (381)
+.|. .++|+-.||||+++.
T Consensus 914 d~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhhhhcCccccccc
Confidence 8886 478899999999863
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=311.66 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=205.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc---E-EEEEEeCC-ccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---K-VAIKKIHD-VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++-.+.++||+|+||.||+|.-+..+. . ||+|..+. ..........+.+|.++|++++|||||+++|+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 445567999999999999998765422 3 89998875 23455667789999999999999999999999966543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+|+|||+|. |+|.++++.++ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.
T Consensus 236 ----l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 ----LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ----cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 899999999 59999999887 499999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHH-hhCCCCHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD-LLGTPSPE 253 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 253 (381)
........ ...--...|+|||.+.. ..|++++||||+||+++|+.+ |..||.+....+....|.. ....+.
T Consensus 312 ~~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~-- 384 (474)
T KOG0194|consen 312 GSQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI-- 384 (474)
T ss_pred Ccceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC--
Confidence 43111110 01124567999999987 689999999999999999999 8899999988777666632 221111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+.++..++.+|+..||++|||+.++.+
T Consensus 385 ----------------------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 ----------------------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------------------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1256778889999999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=294.16 Aligned_cols=236 Identities=19% Similarity=0.280 Sum_probs=186.5
Q ss_pred eeecccCCceEEEEEEcCCC----------cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 29 EVIGKGSYGVVCAAIDTHTG----------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 358888765321 115678899999999999999999998854
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-------CeEEee
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-------KLKVCD 169 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-------~vkl~D 169 (381)
...++||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 23699999998 68999988765 799999999999999999999999999999999999999887 799999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
||++...... ....++..|+|||.+.+....++.++|||||||++++|++ |..||...+..........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~--- 221 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD--- 221 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc---
Confidence 9998764331 1235677899999987622368899999999999999999 5788866542211111100
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.... .......+.+++.+||..+|.+|||+.++++
T Consensus 222 ----------------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ----------------------QHRL-------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------------------CCCC-------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 0112378899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=296.52 Aligned_cols=245 Identities=27% Similarity=0.392 Sum_probs=192.7
Q ss_pred eeecccCCceEEEEEEcCCC------cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 29 EVIGKGSYGVVCAAIDTHTG------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+.||+|+||.||+|.+.... ..+|+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876544 689999876432 123455788899999999999999999988443 458
Q ss_pred EEEeeccc-cCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-----CeEEee
Q 016884 103 YVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCD 169 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-----~vkl~D 169 (381)
|+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999988642 3478899999999999999999999999999999999999887 899999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 229 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-- 229 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--
Confidence 99987543221111 1122345678999999877 678999999999999999998 99999876654433322110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
........++..+.+|+.+||+.+|.+|||++++++
T Consensus 230 ----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ----------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001112457889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=294.55 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=198.9
Q ss_pred CeEEeeeecccCCceEEEEEEcC-CCcEEEEEEeCCcc--------CChHHHHHHHHHHHHHHh-cCCCCccccceeecC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVF--------EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLP 93 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~ 93 (381)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......++.+|+.++.. ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999887 78899999875321 122334567789988875 799999999998843
Q ss_pred CCcCCCCcEEEEeecccc-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEE
Q 016884 94 PSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKV 167 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl 167 (381)
....++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 3569999999984 88877642 3468999999999999999999996 68999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
+|||.+....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+.......+....
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999987643322 2244578899999999987 678999999999999999999999997665443332222111
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..| . ....+++.+.+++.+||+.||++|||+.++..+
T Consensus 230 ~~~---------------------------~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 230 YEP---------------------------L--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCc---------------------------C--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 100 0 012468899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.66 Aligned_cols=278 Identities=26% Similarity=0.406 Sum_probs=216.6
Q ss_pred ccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-----ChHHHHHHHHHHHHHHhcCCCCccc
Q 016884 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-----HISDAIRILREVKLLRLLRHPDIVE 86 (381)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~ 86 (381)
...|.......+||-++..||+|+|+.||+|.|....+.||+|+-..... .....+-..||.+|.+.|.||.||+
T Consensus 452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 34555566777899999999999999999999999999999997542211 1222345678999999999999999
Q ss_pred cceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecC--
Q 016884 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-- 161 (381)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~-- 161 (381)
+|+++.-.+ ..+|-|+|||+| +|.-+++.+..+++.+++.|+.||+.||.||.... |+|-||||.|||+..
T Consensus 532 lYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 532 LYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 999995433 358999999997 88888998999999999999999999999999875 999999999999854
Q ss_pred -CCCeEEeeecccccccCCCCCc----ccccccccCccccCcccccc--ccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 162 -NCKLKVCDFGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 162 -~~~vkl~DFg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
.|.+||+|||++++........ ...+...||.||++||-+.- .....+.++||||+|||+|+++.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 4789999999998865543321 12235679999999996532 1245788999999999999999999999654
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
.....+-.-... +... .. ....-|-+++++.++|++||++.-++|....++-.||
T Consensus 688 qsQQdILqeNTI-----------------------lkAt-EV-qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 688 QSQQDILQENTI-----------------------LKAT-EV-QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred hhHHHHHhhhch-----------------------hcce-ec-cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 322211000000 0000 00 0112256899999999999999999999999999999
Q ss_pred CcCc
Q 016884 315 YFKG 318 (381)
Q Consensus 315 ~~~~ 318 (381)
||..
T Consensus 743 yllP 746 (775)
T KOG1151|consen 743 YLLP 746 (775)
T ss_pred cccc
Confidence 9964
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=288.77 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=186.7
Q ss_pred eeecccCCceEEEEEEcCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
++||+|+||+||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+... ...|+||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEE
Confidence 3699999999999975433 345677776542 2233456788999999999999999999998543 4589999
Q ss_pred eccc-cCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 107 ELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 107 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
||+. ++|.+++... ...++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999 5999998753 2467778889999999999999999999999999999999999999999998754221111
Q ss_pred CcccccccccCccccCccccccc-----cCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.......+++..|+|||++.+. ...++.++|||||||++|+|++ |..||...+..+.+..+......
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------ 227 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------ 227 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc------
Confidence 0111244688899999987531 1245789999999999999996 57888776654444333211000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. ........+++.+.+++..|| .+|++|||++++++
T Consensus 228 -----------------~~--~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 -----------------KL--FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------cc--CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00 001112347888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=315.74 Aligned_cols=207 Identities=29% Similarity=0.441 Sum_probs=173.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (381)
..-...-+.||.|+||.||+++++.||+.||||.++... .....++.-+|+++|++|+|||||+++++-.+.. .-...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 344567889999999999999999999999999987643 4455667789999999999999999988764332 01123
Q ss_pred cEEEEeeccc-cCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec--CCCC--eEEeeecc
Q 016884 101 DIYVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK--LKVCDFGL 172 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~--~~~~--vkl~DFg~ 172 (381)
.-.+|||||. |||...+++- ..+++.++..++..+..||.|||++||+||||||.||++- .+|+ -||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 4689999999 6999999752 3699999999999999999999999999999999999864 3344 69999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
|+....+. .+.+.+||+.|.+||++... ..|+..+|.|||||++|+++||..||-..
T Consensus 171 Arel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 98765544 45778999999999999742 68999999999999999999999999554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.79 Aligned_cols=251 Identities=23% Similarity=0.407 Sum_probs=207.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..-++.+.||+|+||.||.|.-.... ..||+|.+.+. ........|++|..+|+.++|||||++++++.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-- 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-- 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--
Confidence 45678999999999999999865433 34999988753 45567789999999999999999999999997744
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEee
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~D 169 (381)
..+|++|||. |||..+|++. ..++..+...++.+|++|+.||+++++|||||...|+|++....|||+|
T Consensus 769 ---~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 ---PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred ---CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 3799999999 6999999865 3589999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
||+|+......-... .....-...|||||.+.. +.++.++|||||||++||+++ |..||.+.++.+.+......-
T Consensus 846 FGlArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg- 921 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRK-HGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG- 921 (1025)
T ss_pred cchhHhhhhchheec-cCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence 999995433221111 011123356999999987 789999999999999999999 899999998877665433211
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+.++..+.+|+..||+.+|++||++..|++
T Consensus 922 -----------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -----------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11223578899999999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.52 Aligned_cols=262 Identities=23% Similarity=0.405 Sum_probs=211.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
-++|.+++.||+|+|++|.+++++.|.+.+|+|++++..-+ ..+..=+..|-.+..+- +||.+|.++.+|.+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 46899999999999999999999999999999999865332 23344455677777776 6999999999996554
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+++|.||.. |+|--.++...++++++++.+...|+-||.|||+.||+.||||.+|+|++..|.+||+|+|.++-...
T Consensus 325 -rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred -eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 4999999999 58888888888999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC--CChhhHHHHHHHhhCCCCHHHHh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG--KSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... .+++||||.|.|||++.+ ..|+.++|.|+|||+++||+.|+.||+- .++.+.
T Consensus 404 ~gd~---tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~----------------- 461 (593)
T KOG0695|consen 404 PGDT---TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM----------------- 461 (593)
T ss_pred CCcc---cccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecCCCccc-----------------
Confidence 3332 357899999999999999 7999999999999999999999999952 111110
Q ss_pred hhcCHHHHHHH-HHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC------CHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYL-TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP------TAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp------t~~~lL~hp~~~~~ 319 (381)
.-+.++ +.+..+ .......+|-.+..+++..|+.||.+|. ...++-.|+||+.+
T Consensus 462 -----ntedylfqvilek----qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 462 -----NTEDYLFQVILEK----QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred -----chhHHHHHHHhhh----cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 000111 111100 0112245777888999999999999996 47899999999865
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=288.39 Aligned_cols=287 Identities=29% Similarity=0.434 Sum_probs=214.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
..+.|.++++||+|+|++||+|.+.. ..+.||+|.+... +...++.+|+++|..+. +.||+++.+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~----- 104 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF----- 104 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----
Confidence 45679999999999999999999887 7889999988643 33457889999999995 89999999988
Q ss_pred CCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeecccc
Q 016884 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a~ 174 (381)
...+++.+|+||++. +..++... ++...++.+++.++.||+++|.+||+||||||+|+|.+.. +.-.|+|||+|.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 455679999999995 66666654 7789999999999999999999999999999999999875 668899999996
Q ss_pred cccCC--------------CC---------------------------CcccccccccCccccCccccccccCCCCCccc
Q 016884 175 VAFSD--------------TP---------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (381)
Q Consensus 175 ~~~~~--------------~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 213 (381)
..... .. .........||+.|+|||++... ...++++|
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiD 260 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAID 260 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccc
Confidence 21100 00 00111245799999999999764 56788999
Q ss_pred hHHHHHHHHHHHcCCCCC-CCCChhhHHHHHHHhhCCCCHHHHhhhcCH-------------HHHHHHH-----HhcCCC
Q 016884 214 IWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPETIAVVRNE-------------KARKYLT-----EMRKKP 274 (381)
Q Consensus 214 iwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------------~~~~~~~-----~~~~~~ 274 (381)
|||.|||+..+++++.|| ...++.+.+..|....|...-......... .....++ .+.+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999887 556666777777766665433322211111 1111111 122211
Q ss_pred C--CCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 275 P--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 275 ~--~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
. .....-....+..+.||+.+||..||.+|+||+++|.||||....
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 1 111112223566899999999999999999999999999998543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=297.60 Aligned_cols=241 Identities=26% Similarity=0.454 Sum_probs=199.2
Q ss_pred EeeeecccCCceEEEEEEcCC----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 27 ILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
+.+.||.|.||.||.|.-... .-.||||..+.... ....+.|+.|..+|+.++||||+++++++... -+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~ 465 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM 465 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence 356799999999999985432 23699998876433 34477899999999999999999999999543 37
Q ss_pred EEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+||||.+. |.|..+++.++ .++......+++||+.||+|||+.++|||||-..|||+....-|||+|||+++......
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999 89999998765 68999999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccccc--CccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 181 PMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 181 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
- +....| ..-|||||.+.- ..++.++|||.|||.++|++. |..||.|-.+.+.+..|.+....
T Consensus 546 y----YkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl-------- 611 (974)
T KOG4257|consen 546 Y----YKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL-------- 611 (974)
T ss_pred h----hhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC--------
Confidence 2 122222 334999999865 789999999999999999887 99999998776665544432222
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l 310 (381)
...+++++.+..|+.+||.+||.+||++.++
T Consensus 612 ----------------------P~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 612 ----------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ----------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 2346899999999999999999999987664
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=295.87 Aligned_cols=278 Identities=16% Similarity=0.226 Sum_probs=186.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc----------------CCCcEEEEEEeCCccCChH------------HHHHHHHH
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT----------------HTGEKVAIKKIHDVFEHIS------------DAIRILRE 72 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~~~~------------~~~~~~~E 72 (381)
..++|++.++||+|+||+||+|... ..++.||||++........ .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 3456799999864221100 01122346
Q ss_pred HHHHHhcCCCCc-----cccceeecCCC---cCCCCcEEEEeeccc-cCHHHHHHhC-----------------------
Q 016884 73 VKLLRLLRHPDI-----VEIKRIMLPPS---KREFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (381)
Q Consensus 73 ~~~l~~l~h~~i-----v~~~~~~~~~~---~~~~~~~~lv~e~~~-~~L~~~l~~~----------------------- 120 (381)
+.++.+++|.++ +++++++.... .......++||||+. ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766544 56666654321 112345899999999 5888877531
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCcc
Q 016884 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199 (381)
Q Consensus 121 -~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 199 (381)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 124567889999999999999999999999999999999999999999999986543322111 11224588999999
Q ss_pred ccccccC------------------CCC--CccchHHHHHHHHHHHcCCC-CCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 200 ~~~~~~~------------------~~~--~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.+..... .|+ ...||||+|||+|+|++|.. ||.+....... .. ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~-----------~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LR-----------QY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hh-----------hc
Confidence 8754210 122 24799999999999999874 77543211110 00 00
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCC---CCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP---KDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp---~~Rpt~~~lL~hp~~~~ 318 (381)
.+ .......... .......+...++.+.||+.+||..+| .+|+|++|+|+||||..
T Consensus 447 ~~--~~~~~r~~~~--~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 447 DN--DLNRWRMYKG--QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc--hHHHHHhhcc--cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0000000100 011123456789999999999999876 68999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=273.26 Aligned_cols=242 Identities=39% Similarity=0.647 Sum_probs=196.9
Q ss_pred CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecccc-CH
Q 016884 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113 (381)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L 113 (381)
+||.||+|.+..+++.+|+|++........ ...+.+|++.++.++|+|++++++.+... ...++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999998999999999875322211 56788999999999999999999988543 458999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCc
Q 016884 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (381)
Q Consensus 114 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~ 193 (381)
.+++.....++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999987654432 123456888
Q ss_pred cccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcC
Q 016884 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (381)
Q Consensus 194 ~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (381)
.|+|||.+.+ ..++.++|+||+|+++++|++|..||....... ....+..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------------------------- 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK--------------------------- 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---------------------------
Confidence 9999999876 678889999999999999999999997733222 2111111
Q ss_pred CCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
...........++..+.+++.+||..+|++||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0000011111277899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=306.76 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=191.9
Q ss_pred eeeecccCCceE-EEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V-~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.+.+|.|+.|+| |+|.- .|+.||||++-. .....+.||+..|+.- .||||+++++.- .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 467889998775 99954 588999998753 3445677999999988 599999988765 444669999
Q ss_pred eeccccCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---C--CCeEEeeecccccc
Q 016884 106 FELMESDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARVA 176 (381)
Q Consensus 106 ~e~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~--~~vkl~DFg~a~~~ 176 (381)
.|.|..+|.++++... ....-..+.++.|++.||++||+.+|+||||||+||||+. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1122455788999999999999999999999999999976 3 45899999999887
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..+...-....+..||-.|+|||++.. ..-..++||+|+|||+|+.++| ..||...-..+ ..|.. |
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~--~------- 728 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT--G------- 728 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc--C-------
Confidence 666655555667789999999999987 5567799999999999999996 89996543211 11111 0
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. .+...-+....++.|||.+||+++|..||||.++|.||+|-..
T Consensus 729 -----------------~~--~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 729 -----------------NY--TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred -----------------cc--ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 00 0000111111289999999999999999999999999999754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.44 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=221.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
...-+|.+.||.|.||.||+|+-+..++ .||||.++. .........|+.|..||-+++||||+++.+++...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks---- 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS---- 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC----
Confidence 3456789999999999999999887764 699999974 34556677899999999999999999999998433
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.-+.||+|||+ |+|..+++.+ +.++.-+...+++.|+.|++||-+.+.|||||-..|||++.+-..|++|||+++..
T Consensus 703 -~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 703 -KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred -ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 44899999999 8999999865 57999999999999999999999999999999999999999999999999999977
Q ss_pred cCCCCCccccccccc--CccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 177 FSDTPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 177 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
..+.+.. +++..| ...|.|||.+.- ..++.++||||+|++++|.++ |..||...++.+.++.|.+...-|+|
T Consensus 782 edd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP- 856 (996)
T KOG0196|consen 782 EDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP- 856 (996)
T ss_pred ccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC-
Confidence 6655322 222222 356999999977 789999999999999999776 99999999999999999887776664
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--hp~~~~~ 319 (381)
.+++..+..|+..||++|..+||++.||++ +..+++.
T Consensus 857 -----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 857 -----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 478999999999999999999999999987 3455543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=287.97 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=204.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++-.++++||+|.||.|.+|.- ..+..||+|.++.. ........+.+|+++|.+|+||||+++++++.... .+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence 4567899999999999999964 33689999999753 23333568999999999999999999999996543 38
Q ss_pred EEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++|+|||+ |+|.+++..+. .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||.++....+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 89999998773 2355666779999999999999999999999999999999999999999999866554
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc--CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..-... ...+-...|||+|.+.. +.++.++|+|++|+++||+++ ...||...++.+.......++..+.+
T Consensus 691 ~yy~vq-gr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----- 762 (807)
T KOG1094|consen 691 DYYRVQ-GRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----- 762 (807)
T ss_pred Cceeee-cceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-----
Confidence 322211 12345678999998876 689999999999999999876 67899887766655444443332221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
.-.....+-++..+.+|+.+|+..|-.+|||++++-
T Consensus 763 ------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 763 ------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 112233456788899999999999999999999984
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=292.57 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=209.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCC-C--cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHT-G--EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
++.++.++||+|.||.|++|..... | -.||||.++..... .....|++|+.+|.+|+|+|++++|+++.+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~q----- 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLDQ----- 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeeccc-----
Confidence 4567789999999999999987643 3 36999999754333 2677899999999999999999999999763
Q ss_pred CcEEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
-+.||||++. |+|++.+.. ...|.......++.||+.|+.||.++++|||||-..|+|+-..-.|||||||+.+..
T Consensus 184 -p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 184 -PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred -hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 2689999999 799999976 346888999999999999999999999999999999999999889999999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.............-....|+|||.+.. ..++.++|+|++||+++||++ |..||.|......+.+|-+..
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e-------- 332 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE-------- 332 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc--------
Confidence 665543322222234456999999988 789999999999999999998 789999998877776654211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.....+.++.++.+++..||..+|.+|||+..|...-++
T Consensus 333 ----------------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 333 ----------------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ----------------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 112235688999999999999999999999998644333
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=285.17 Aligned_cols=247 Identities=23% Similarity=0.421 Sum_probs=206.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+..+.++||-|.||.||.+..+...-.||||.++ .+......|++|..+|+.++|||+|+++++|..... +
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP-----F 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP-----F 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC-----e
Confidence 34567899999999999999999999999999987 344567889999999999999999999999965543 8
Q ss_pred EEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
|||+|||. |+|+++++... .++.-...+++.||..|+.||..+++|||||-..|+|+.++..||++|||+++....+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999998 89999998754 4777788889999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
+-+. ....--..-|.|||-+.= ..++.++|||+|||+|+|+.| |..||+|-+..+.+..+.+...
T Consensus 419 TYTA--HAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR---------- 484 (1157)
T KOG4278|consen 419 TYTA--HAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR---------- 484 (1157)
T ss_pred ceec--ccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc----------
Confidence 4221 111122345999998754 678999999999999999998 8899999876655554443221
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
.....++++.+.+|++.||+|+|.+||++.++-
T Consensus 485 --------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 485 --------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 112357999999999999999999999999883
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.44 Aligned_cols=268 Identities=25% Similarity=0.409 Sum_probs=221.8
Q ss_pred ccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecC
Q 016884 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (381)
Q Consensus 14 ~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (381)
|+..+ +...+|+++..+|+|+||.||+|+|+.+++..|+|+++.. ...+..-+..|+-+++.++||||+.+++.|..
T Consensus 7 disrr-nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 7 DISRR-NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred hhhhc-CCccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 44444 6778999999999999999999999999999999999743 22334456689999999999999999999854
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
. ..++++||||+ |+|.+.-.-.+++++.++.+.++..++||+|||+.|-+|||||-.|||+++.|.+|++|||.
T Consensus 84 ~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 84 R-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred h-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCc
Confidence 3 34899999999 58888888889999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccCccccCccccc-cccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
+..+..... ....+.|||+|||||+.. +..+.|...+|||++|+...|+.--++|......+..+..+.+-...|+
T Consensus 159 saqitati~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 159 SAQITATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhhhhhhhh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 865544332 235779999999999852 2226799999999999999999988888766666555555544322222
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
........++.+.+|++.+|..+|.+|||++.+|+|||...
T Consensus 236 --------------------------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 --------------------------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------------------------cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11223467888999999999999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=281.23 Aligned_cols=200 Identities=25% Similarity=0.411 Sum_probs=173.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH------HHHHHHHHHHHHhcC---CCCccccceeec
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------AIRILREVKLLRLLR---HPDIVEIKRIML 92 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~---h~~iv~~~~~~~ 92 (381)
-..|..++.+|+|+||.|++|.++.....|+||.+.+..--... .-.+-.||+||..++ |+||++++++|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF- 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF- 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-
Confidence 35699999999999999999999999999999998753211000 012346999999997 99999999999
Q ss_pred CCCcCCCCcEEEEeeccc-c-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeee
Q 016884 93 PPSKREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
++.+++||+||--+ | +|+++|.-...++|.+++.|++|++.|+++||+.||+|||||-+|+.++.+|-+||+||
T Consensus 639 ----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 ----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 56677999999988 5 99999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 232 (381)
|.|.....++ +..++||..|+|||+++|. ...+.+-|||+||++||.++....||.
T Consensus 715 gsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9997655443 3567999999999999984 445778999999999999999988885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=245.47 Aligned_cols=210 Identities=25% Similarity=0.440 Sum_probs=173.3
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCcEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
..-+..||+|++|.|-+.++..+|...|+|.+..... .....+.++|+.+..+. ..|.+|.+++.+.. ...++
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----egdvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----EGDVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----cccEE
Confidence 3456789999999999999999999999999986544 34566788899886554 79999999998743 35699
Q ss_pred EEeeccccCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 104 VVFELMESDLHQV----IKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 104 lv~e~~~~~L~~~----l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
|.||.|..+|..+ ++.++.++|..+-.|+..++.||.|||++ .++|||+||+|||++.+|+||+||||.+.....
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999999877654 45677899999999999999999999997 799999999999999999999999999977654
Q ss_pred CCCCcccccccccCccccCccccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCC-CChhhHHHHHH
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLIT 244 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~ 244 (381)
+... +-..|...|+|||.+... ...|+-++||||||+.+.||++++.||+. .+..+++..+.
T Consensus 202 SiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 202 SIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 4332 224688889999988542 24799999999999999999999999954 45555555544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.81 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=184.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
..|...+.||+|+||.||+|.+..++..||+|++...... ..+|+.++++++||||+++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 3466778899999999999999999999999998643211 12468889999999999999999543 448
Q ss_pred EEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH---~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
|+|||||+ ++|.++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999986 3899999999999999999999 6699999999999999999888775 665543211
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh-hHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 257 (381)
. ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 897 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-------- 897 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC--------
Confidence 1 22368899999999987 67999999999999999999999999543211 111111100000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......++ ...............++.+++.+||+.||++|||+.++++.
T Consensus 898 --~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 898 --DCHLDMWID----PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --ccchhheeC----ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000 00000000001122357789999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=259.36 Aligned_cols=273 Identities=22% Similarity=0.292 Sum_probs=195.1
Q ss_pred hhhhcccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHH--hcCCCCc
Q 016884 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR--LLRHPDI 84 (381)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~i 84 (381)
+..-+...++-+..+.++-.+++.||+|.||.||+|. ..|+.||||++.. .+.....||.+|.+ -|+|+||
T Consensus 195 SGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENI 267 (513)
T KOG2052|consen 195 SGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENI 267 (513)
T ss_pred CCCCCCchhHhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchh
Confidence 3334445555566778899999999999999999995 5599999999864 23344556666655 4699999
Q ss_pred cccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCC
Q 016884 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPK 155 (381)
Q Consensus 85 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~i~H~Dikp~ 155 (381)
+.+++.=.... ....+++||++|.+ |||++++.. ..++.+....++..++.||+|||.. .|.|||||..
T Consensus 268 LgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 268 LGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 99987654332 44567999999999 899999987 5799999999999999999999963 4999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCC-CCcccccccccCccccCccccccccCC--CC--CccchHHHHHHHHHHHcC---
Q 016884 156 NILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVATRWYRAPELCGSFFSK--YT--PAIDIWSIGCIFAEVLTG--- 227 (381)
Q Consensus 156 NIl~~~~~~vkl~DFg~a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~--~~~DiwslG~il~~ll~g--- 227 (381)
||||..+|..-|+|+|+|......+ .........+||..|||||++...-.. +. ..+||||||.|++|++..
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999997654442 234445678999999999998652110 11 258999999999999862
Q ss_pred -------CCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcc-ccCCCC--CHHHHHHHHHhc
Q 016884 228 -------KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF-QKFPNV--DPLALRLLQRLI 297 (381)
Q Consensus 228 -------~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~dLi~~~L 297 (381)
++||.+--.. ++.+++..+...-+..++.. ..|.+. -..+..|++.||
T Consensus 426 ggi~eey~~Pyyd~Vp~----------------------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPS----------------------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred CCEehhhcCCcccCCCC----------------------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 4677543211 11111111111111111111 111111 123567899999
Q ss_pred cCCCCCCCCHHHH
Q 016884 298 AFDPKDRPTAEEA 310 (381)
Q Consensus 298 ~~dp~~Rpt~~~l 310 (381)
..||.-|.||--+
T Consensus 484 ~~Np~aRltALri 496 (513)
T KOG2052|consen 484 YANPAARLTALRI 496 (513)
T ss_pred cCCchhhhHHHHH
Confidence 9999999998655
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.01 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=197.2
Q ss_pred EEeeeecccCCceEEEEEEc----C---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 016884 26 KILEVIGKGSYGVVCAAIDT----H---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (381)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+...+..|+++|+.+ .|+||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56679999999999999733 1 1457999998865444 6777899999999999 59999999999855
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
.+.+++|+||+. |+|.++++.+. .++..+...+.+||+.|+.||++.+++||||-..|||++
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 356999999999 89999998654 389999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCccccccccc--CccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC-h
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS-V 236 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~ 236 (381)
.+..+||+|||+|+.......... ....+ ...|||||.+.. ..|+.++||||+|++|||+++ |..|+++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986433322111 11122 334999999987 789999999999999999998 889998743 2
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.+.+..+.+ .. .......+++++.++++.||+.+|++||++.++..
T Consensus 529 ~~l~~~l~~------------------------G~------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKE------------------------GN------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhc------------------------CC------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 222221211 00 11122457999999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=257.98 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=189.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh--cCCCCccccceeecCCCcCCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
-..+.+.||+|.||.||+| +-+++.||||++.. ...+.+.+|-+|.+. ++|+||+++++.-.-.+. ..-.
T Consensus 211 pl~l~eli~~Grfg~V~Ka--qL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKA--QLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRME 282 (534)
T ss_pred chhhHHHhhcCccceeehh--hccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccc
Confidence 3567889999999999999 55679999999863 455567777777665 479999999876543331 2446
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEecCCCCeEEeeec
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---------~i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
++||++|.. |+|.++++.+ .+++....+++..+++||+|||+- .|+|||||..|||+..|++.-|+|||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 899999998 8999999875 699999999999999999999973 49999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCC-----CccchHHHHHHHHHHHcCCCCCC-CCChhhHHHHHHH
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKSVVHQLDLITD 245 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~ 245 (381)
+|.....+.+. ......+||..|||||++.+. .... .+.||||+|.||+||++....+. +....-++-.-.+
T Consensus 362 LAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred eeEEecCCCCC-cchhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99876544333 233457999999999999763 1222 25899999999999999764443 2211111111111
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCC--CCCHHHHHHHHHhccCCCCCCCCHHHH
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEA 310 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dLi~~~L~~dp~~Rpt~~~l 310 (381)
+-..|.-+.+. .+.-.-+.++. +.+.|. ..-..+++.+..||..||+-|.||.=+
T Consensus 440 vG~hPt~e~mq--------~~VV~kK~RP~--~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 440 VGNHPTLEEMQ--------ELVVRKKQRPK--IPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hcCCCCHHHHH--------HHHHhhccCCC--ChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 22223222111 11111111111 111111 234568899999999999999998643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=242.56 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=204.0
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
.....+.|.|.+.||+|.||.+-+|+|+.++..+|+|.+..+ ......+.+|...--.|. |.||+..+++-...
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-- 93 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-- 93 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc--
Confidence 445567899999999999999999999999999999998754 345678889998866674 89999998876433
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC--CCCeEEeeeccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLA 173 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a 173 (381)
.+.+.+++||++ |||..-+..+ .+.|...+.++.|+++|+.|+|++++||||||.+|||+-. ..+|||||||.+
T Consensus 94 --~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 --SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred --CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 346889999999 8999888764 5899999999999999999999999999999999999743 357999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
+..+..... .--+..|.+||++... .-...+.+|+|.||+|+|.+++|.+||......
T Consensus 171 ~k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~------------- 231 (378)
T KOG1345|consen 171 RKVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM------------- 231 (378)
T ss_pred cccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-------------
Confidence 754332211 1234558999976431 123677899999999999999999999743322
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCCcCc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKG 318 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~R---pt~~~lL~hp~~~~ 318 (381)
++.+.++........+ .....|..+++.+..+.++-|..+|++| .++.......|...
T Consensus 232 ---------d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 232 ---------DKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ---------CchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 2333344333333222 3344567789999999999999999999 67776666667643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=232.74 Aligned_cols=212 Identities=37% Similarity=0.624 Sum_probs=180.6
Q ss_pred ecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc
Q 016884 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME 110 (381)
Q Consensus 31 lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 110 (381)
||+|++|.||++.+..+++.+++|++....... ....+.+|++.++.++|++++++++++... ...++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987532221 346788999999999999999999998543 45899999999
Q ss_pred -cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccCCCCCccccc
Q 016884 111 -SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWT 187 (381)
Q Consensus 111 -~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~~~~~~~~~~ 187 (381)
++|.+++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999998765 47899999999999999999999999999999999999999 89999999999875433321 123
Q ss_pred ccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH
Q 016884 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (381)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 267 (381)
...+...|++||.+... ..++.++|+||+|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 34678889999998762 2778899999999999999
Q ss_pred HHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2356899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=264.32 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=201.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..+..++||+|+||+||+|.....|+ +||||++.. +........+++|+-+|..++|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch----
Confidence 34556889999999999998765554 689988764 344455678899999999999999999999996543
Q ss_pred CcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
+-||++||+ |.|.++++.+ .++.......|..||++|+.|||.++++||||-..||||..-..+|+.|||+|+...
T Consensus 772 --~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 772 --LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred --HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 689999999 7999999864 479999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .....-..+-|||-|.+.. ..|+.++||||+||+++|++| |..|+.+....+.-+.+.+..
T Consensus 850 ~d~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--------- 917 (1177)
T KOG1025|consen 850 PDEKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--------- 917 (1177)
T ss_pred cccccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc---------
Confidence 433221 1111123345888888876 789999999999999999998 999998876544333222210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+..+.++.++.-++.+||..|+..||+++++..
T Consensus 918 ---------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 ---------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ---------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 12334678899999999999999999999998865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=287.30 Aligned_cols=208 Identities=15% Similarity=0.188 Sum_probs=148.2
Q ss_pred hcCC-CCccccceeecCCCc--CCCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 016884 78 LLRH-PDIVEIKRIMLPPSK--REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 78 ~l~h-~~iv~~~~~~~~~~~--~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
.++| +||.++++.+..... .....+++++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 577777777633221 12245788999999999999975 3469999999999999999999999999999999
Q ss_pred CCceEecCCC-------------------CeEEeeecccccccCCCC-------------CcccccccccCccccCcccc
Q 016884 154 PKNILANANC-------------------KLKVCDFGLARVAFSDTP-------------MTVFWTDYVATRWYRAPELC 201 (381)
Q Consensus 154 p~NIl~~~~~-------------------~vkl~DFg~a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~ 201 (381)
|+|||++..+ .+|++|||+++....... ........+||++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 455666666543211000 00001124689999999999
Q ss_pred ccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCcccc
Q 016884 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK 281 (381)
Q Consensus 202 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (381)
.+ ..|+.++|||||||+||||++|.+|+..... ....+.... .| + .
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~------------------------~-----~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LP------------------------P-----Q 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cC------------------------h-----h
Confidence 87 6799999999999999999999888753221 111110000 00 0 0
Q ss_pred CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 282 FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 282 ~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.....+...+++.+||+.||.+|||+.++|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01124556789999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-31 Score=231.95 Aligned_cols=199 Identities=38% Similarity=0.681 Sum_probs=171.3
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999988999999998754322 2456788999999999999999999987433 45899
Q ss_pred Eeecccc-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 105 VFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
++|++.+ +|.+++..... +++..+..++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999987766 899999999999999999999999999999999999999999999999998765443211
Q ss_pred cccccccccCccccCcccc-ccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 016884 183 TVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 233 (381)
......++..|++||.+ .. ..++.++|+||||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~~~--~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLGG--KGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcCC--CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12344678889999998 44 6788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=266.57 Aligned_cols=270 Identities=26% Similarity=0.339 Sum_probs=204.8
Q ss_pred CCe-EEeeeecccCCceEEEEEEcCCCcEEEEEEeC----CccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..| .-...+|.|++|.|+.+......+.++.|.+. ...........+..|+.+-..+.|||++.....+...
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--- 393 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--- 393 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc---
Confidence 446 45788999999999998888777777777654 1111222222367788888999999998877776432
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+-+||||.+||+.++.+.+.++..++..++.||+.||+|+|+.||.|||+||+|++++.+|.+||+|||.+....
T Consensus 394 --~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 394 --DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred --ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 223444999999999999988889999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-cccccccccCccccCccccccccCCCCC-ccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... .......+|+..|+|||++.+ ..|++ ..||||.|+++..|++|+.||.-....+....-..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 33332 123457789999999999988 56665 68999999999999999999965543222100000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
..............+..++...+.+|.+||++||.+|.|+++|++.+||+.+..
T Consensus 540 ------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 ------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000011111222233457778899999999999999999999999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=217.72 Aligned_cols=165 Identities=21% Similarity=0.256 Sum_probs=127.3
Q ss_pred cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccccccc
Q 016884 111 SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (381)
Q Consensus 111 ~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~ 189 (381)
|+|.+++..+ ..+++..++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6889999874 46999999999999999999999998 999999999999999 9998764332 12
Q ss_pred ccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHH
Q 016884 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (381)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (381)
.||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+..+....
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------------------- 121 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM--------------------- 121 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh---------------------
Confidence 68999999999987 689999999999999999999999997654322 111111110
Q ss_pred HhcCCCCCCccccCCCCCH--HHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 269 EMRKKPPVPLFQKFPNVDP--LALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~--~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
....+.. ......++. .+.+++.+||..||.+|||+.+++.|+|+.
T Consensus 122 --~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 122 --PADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --ccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0000000 000112233 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=224.42 Aligned_cols=252 Identities=18% Similarity=0.303 Sum_probs=200.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC-----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.|+++...+-+|.||.||.|..+... +.|-+|.++.. ....+...++.|--.+..+.|||+..+.++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie---- 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE---- 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----
Confidence 56888899999999999999765433 34666766532 333456678899999999999999999998854
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEe
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
+....++++.+++ |+|..++.-. ..++..+...++.|+..|+.|||+.|++|.||-..|.++++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 3345789999998 8999998721 247788888999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhh
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (381)
|=.+++......-... .........||+||.+.+ ..|+.++|+|||||+++||+| |+.|+..-+..+....+.+..
T Consensus 439 DsaLSRDLFP~DYhcL-GDnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCL-GDNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred cchhccccCccccccc-CCCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 9999987654322111 112234556999999988 789999999999999999998 899998877666555554321
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ....-++++++..++..||..+|++||+.+|+..
T Consensus 516 R------------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 R------------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred e------------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 1123479999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=223.75 Aligned_cols=181 Identities=20% Similarity=0.210 Sum_probs=134.4
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcC-CCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
...++|.+.+.||+|+||+||+|+++. +++.||||++..... .......+.+|+++|+.++|+|++..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 345789999999999999999999876 677889998753211 223355688999999999999998533221
Q ss_pred cCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEecCCCCeEEeeeccc
Q 016884 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Di-kp~NIl~~~~~~vkl~DFg~a 173 (381)
...|+|||||.| +|. .+.. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 236999999986 665 2221 11 1568899999999999999999999 999999999999999999999
Q ss_pred ccccCCCCCcc-----cccccccCccccCccccccccC----CCCCccchH
Q 016884 174 RVAFSDTPMTV-----FWTDYVATRWYRAPELCGSFFS----KYTPAIDIW 215 (381)
Q Consensus 174 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Diw 215 (381)
+.......... ..+...+++.|+|||.+...+. ..+..+|-|
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 86543321111 1245678889999999854221 123346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-26 Score=210.53 Aligned_cols=266 Identities=33% Similarity=0.518 Sum_probs=204.2
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChH-HHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCCcE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~ 102 (381)
|.+...||.|+||.||.+.+. ..+|+|.+........ ....+.+|+.++..+.|+ +++++.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 889999999999999999887 8899999876544433 566788999999999988 799999998332 237
Q ss_pred EEEeecccc-CHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 016884 103 YVVFELMES-DLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~ 177 (381)
+++++++.+ ++.+++.... .++...+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999994 7777777664 799999999999999999999999999999999999999998 69999999987543
Q ss_pred CCCCCc---ccccccccCccccCcccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCCh---hhHHHHHHHhhCCC
Q 016884 178 SDTPMT---VFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTP 250 (381)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~ 250 (381)
...... ......+||..|+|||.+.+.. ..++...|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332211 1235678999999999987621 3678899999999999999999999877653 22222222211111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccC-CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.......... ......+.+++.+++..+|..|.+..+...+++.....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 0000000000 12235789999999999999999999999987766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=192.98 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=182.1
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 96 (381)
..-+.+.|+++++||+|+||.+|.|....+|..||||+-+....+ ..+..|.++.+.|++ ..|..+..+.
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~----- 80 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG----- 80 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc-----
Confidence 445678999999999999999999999999999999987643332 245678888888874 4565555444
Q ss_pred CCCCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeecc
Q 016884 97 REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGL 172 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg~ 172 (381)
.+..+-.+|||..+.+|.++..- +..++...+.-++-|++.-+.|+|..+++||||||+|+|..-+ ..+.|+|||+
T Consensus 81 ~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 81 TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 33345689999999999988863 4479999999999999999999999999999999999997643 4589999999
Q ss_pred cccccCCCCCc-c---cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh---hHHHHHHH
Q 016884 173 ARVAFSDTPMT-V---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITD 245 (381)
Q Consensus 173 a~~~~~~~~~~-~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~ 245 (381)
|+......... + ......||..|++-....+ ..-+...|+-|+|.+|..+..|..||.+-... ...++|.+
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 97654322211 1 1234679999999888777 45688999999999999999999999886543 34455554
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHh
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEM 270 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (381)
.--..+.+.++..-..++..++..+
T Consensus 239 kK~s~~ie~LC~G~P~EF~myl~Y~ 263 (341)
T KOG1163|consen 239 KKMSTPIEVLCKGFPAEFAMYLNYC 263 (341)
T ss_pred hhcCCCHHHHhCCCcHHHHHHHHHH
Confidence 4444444555444444444444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=207.84 Aligned_cols=256 Identities=20% Similarity=0.210 Sum_probs=187.4
Q ss_pred CeEEeeeecccCCceEEEEEEcCCC-cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC----CCccccceeecCCCcCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRH----PDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~ 98 (381)
+|++.++||+|+||.||.|.+..++ ..+|+|.......... ..+..|..++..+.. +++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 6889998764322111 145568888888863 57777777663 12
Q ss_pred CCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-----CCeEEeeec
Q 016884 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-----CKLKVCDFG 171 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-----~~vkl~DFg 171 (381)
...-|+||+.++.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 2457999999999999988654 479999999999999999999999999999999999999865 358999999
Q ss_pred ccc--cccCCCC-----CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHH
Q 016884 172 LAR--VAFSDTP-----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 172 ~a~--~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (381)
+|+ ....... .........||..|+++....+ ...++..|+||++.++.+++.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3221111 1110134569999999999888 678999999999999999999999997765433322222
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.... ..... . .....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~--------------------~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPR--------------------KLLTD---R---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhh--------------------hhccc---c---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1100 00000 0 112344566667776666788888887776553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-25 Score=192.73 Aligned_cols=242 Identities=21% Similarity=0.283 Sum_probs=188.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 99 (381)
++-.|+++++||.|+||..+.|...-++++||||.-.. .+.+.++..|++..+.|. .++|...+-+- .++
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 45579999999999999999999999999999996432 244567778888888885 57777654222 333
Q ss_pred CcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-----CeEEeeeccc
Q 016884 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCDFGLA 173 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-----~vkl~DFg~a 173 (381)
-+-.||+|.++.+|.++..-. ..++...+..++.|++.-+.++|++.+|.|||||+|+||..-+ .+.++|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 456799999999999888754 4799999999999999999999999999999999999997543 3889999999
Q ss_pred ccccCCCCCc-cc---ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC---ChhhHHHHHHHh
Q 016884 174 RVAFSDTPMT-VF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDL 246 (381)
Q Consensus 174 ~~~~~~~~~~-~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~ 246 (381)
+......... +. .....||..||+=.-..| ..-+...|+-|||-++++++.|..||.|. +..+..++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 8654432221 11 235679999999988888 67789999999999999999999999874 455666666665
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKK 273 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (381)
-...+.+.++..-..++..++...+.-
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~L 281 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRRL 281 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHhc
Confidence 555555666655555666666555443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=226.92 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=184.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.|...+.||++.|=+|.+|.|+. | .|+||++-+.. .......+.++|++ ...+++||.+.+..+..+. ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HH
Confidence 78889999999999999997653 3 49999986543 23344455566777 6677999999987775332 34
Q ss_pred EEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
.|||-+|...+|++.+..++-+..-+.+.|+.||+.||.-+|..||+|||||.+|||++.=+.+.|+||..-+...-..+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 69999999999999999988899999999999999999999999999999999999999988999999987654322222
Q ss_pred Cccc----ccccccCccccCccccccc--------cCC-CCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhh
Q 016884 182 MTVF----WTDYVATRWYRAPELCGSF--------FSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 182 ~~~~----~~~~~gt~~y~aPE~~~~~--------~~~-~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (381)
.... +.+...-..|.|||.+-.. ..+ .+++-||||+||+++||++ |++||.-.. +-... -
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr--~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYR--S 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHh--c
Confidence 2211 2222233459999987431 112 5678899999999999998 799994211 00000 0
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
| ......+.++.+ -+..++.||..|++.||++|.||++.|+-
T Consensus 250 ~----------~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 G----------NADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred c----------CccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 000111111111 13368899999999999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=223.42 Aligned_cols=230 Identities=25% Similarity=0.384 Sum_probs=172.8
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.......|..++.|..|+||-||.++|+.+.+++|+|+ ++. . .+ ++ ||..+.+
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq----~---li------lR-----nilt~a~-------- 130 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ----N---LI------LR-----NILTFAG-------- 130 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhcc-ccc----c---hh------hh-----ccccccC--------
Confidence 34455679999999999999999999999999999954 321 1 11 11 1222111
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..++| ||-...++..++++.+. +.|+.|||+.||+|||+||+|.+|+.-|.+|++|||++....
T Consensus 131 ---npfvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 131 ---NPFVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---Cccee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 12333 56666666666666544 789999999999999999999999999999999999987643
Q ss_pred CCCCCc------------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 178 SDTPMT------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 178 ~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
...... ......||||.|+|||++.. +.|+..+|+|++|+|+|+.+-|..||.+.+..+.+..+..
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 322211 11134589999999999987 7899999999999999999999999999987766655443
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC---CHHHHhcCCCcCcCc
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGLA 320 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp---t~~~lL~hp~~~~~~ 320 (381)
-... +.+.-...++++++++.++|+.+|..|. .+-++-+|+||+.+.
T Consensus 273 d~i~----------------------------wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 273 DDIE----------------------------WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred hhcc----------------------------ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 1111 1111245789999999999999999994 577788899998753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=198.46 Aligned_cols=240 Identities=21% Similarity=0.290 Sum_probs=151.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcC----------CCCccccceeec
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR----------HPDIVEIKRIML 92 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~----------h~~iv~~~~~~~ 92 (381)
.....+.||.|++|.||.+.|..|++.+|+|++..... .....+.+.+|.-....+. |-.++..+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45678899999999999999999999999998853322 2234455555554333322 222333333332
Q ss_pred CCCc-------CCCC-----cEEEEeeccccCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 016884 93 PPSK-------REFK-----DIYVVFELMESDLHQVIKA---NDD----LTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 93 ~~~~-------~~~~-----~~~lv~e~~~~~L~~~l~~---~~~----l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
.... .+.. +.+++|+-+.+||.+++.. ... +.......+..|+++.+++||+.|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0001 3478999999888887642 221 2233335566899999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccc------cCCCCCccchHHHHHHHHHHHcC
Q 016884 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 227 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwslG~il~~ll~g 227 (381)
|+|++++.+|.++|+||+.....+... .....+..|.|||+.... ...++.+.|.|+||+++|.|.+|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999775432211 112455779999976431 13478899999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCC
Q 016884 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (381)
Q Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~R 304 (381)
+.||......... . .. .....+++..+++||..||++||.+|
T Consensus 247 ~lPf~~~~~~~~~----------~------------------------~~-f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP----------E------------------------WD-FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS----------G------------------------GG-GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc----------c------------------------cc-chhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999765422100 0 01 12233789999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=192.08 Aligned_cols=176 Identities=11% Similarity=0.113 Sum_probs=133.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH-HHH------HHHHHHHHHhcCCCCccccceeecCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AIR------ILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
.++|++++.||.|+||.||++.+ ++..+|+|++......... ... +.+|++.+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999744 4778999999754433222 222 56899999999999999998886543
Q ss_pred CcC---CCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeee
Q 016884 95 SKR---EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 95 ~~~---~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
... .....++||||++| +|.++.. +++ ....+++.+|..||+.|++|||+||+||+++++| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12457999999997 7877632 333 3466999999999999999999999999999999 999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHH
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll 225 (381)
|..+........ ..+... ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~---------------d~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---------------DRIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---------------HHHHHH--hHhcccccccceeEeehHHH
Confidence 987643211110 012333 56778999999999888764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-27 Score=218.41 Aligned_cols=240 Identities=25% Similarity=0.397 Sum_probs=192.5
Q ss_pred eecccCCceEEEEEE---cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEEEE
Q 016884 30 VIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.+|.|+||.|++++. ...+..+|.|+.++..........-..|-.++...+ ||.+++++-.+.+. ..+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence 379999999998863 245678999988654322222223345777888886 99999998888444 458999
Q ss_pred eecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcc
Q 016884 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (381)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~ 184 (381)
+++..| +|...+.....+.+...+.+...++-|+.++|+.||+|||+|++||+++.+|.+++.|||+++......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999985 999988888889999999999999999999999999999999999999999999999999997653322
Q ss_pred cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
..|||..|||||++. +...++|.||+|+++++|++|..||.+ +....|.+..-
T Consensus 152 ---~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~---------------- 204 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL---------------- 204 (612)
T ss_pred ---hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc----------------
Confidence 228999999999986 357899999999999999999999987 33333332110
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcCc
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~~ 320 (381)
.....++..+.+++..|+..+|..|.- +.++++|++|+.+.
T Consensus 205 ---------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 205 ---------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred ---------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence 112357888999999999999999974 58999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=187.57 Aligned_cols=140 Identities=20% Similarity=0.228 Sum_probs=108.8
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------------------------AIRILREVKLLRLLRHPD 83 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~~ 83 (381)
...||+|++|.||+|.+. +|+.||+|+++........ .....+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999998643211100 112345999999998888
Q ss_pred ccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEecC
Q 016884 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANA 161 (381)
Q Consensus 84 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~i~H~Dikp~NIl~~~ 161 (381)
+.....+. . ...+|||||++| ++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus 81 v~~p~~~~-~------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPIL-L------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEE-e------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 75433322 1 113899999996 4444444456899999999999999999999 799999999999999998
Q ss_pred CCCeEEeeecccccc
Q 016884 162 NCKLKVCDFGLARVA 176 (381)
Q Consensus 162 ~~~vkl~DFg~a~~~ 176 (381)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=191.73 Aligned_cols=203 Identities=25% Similarity=0.338 Sum_probs=145.9
Q ss_pred CCCCccccceeecCCC----------------------cCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 016884 80 RHPDIVEIKRIMLPPS----------------------KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137 (381)
Q Consensus 80 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~ 137 (381)
+|||||++...|.+.- ..+...+|+||.....+|.+++-.+ ..+.....-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence 5999999988875421 2344569999999999999999875 4677788889999999
Q ss_pred HHHHHHhCCccccCCCCCceEec--CCCC--eEEeeecccccccCC---CCCcccccccccCccccCccccccccCC---
Q 016884 138 ALKYMHTANVYHRDLKPKNILAN--ANCK--LKVCDFGLARVAFSD---TPMTVFWTDYVATRWYRAPELCGSFFSK--- 207 (381)
Q Consensus 138 aL~~LH~~~i~H~Dikp~NIl~~--~~~~--vkl~DFg~a~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~--- 207 (381)
|+.|||.+||.|||+|.+|||+. +|+. +.|+|||++-..... -+-....-+..|+..-||||+.....++
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999974 4443 789999987432211 1111112244578889999997652221
Q ss_pred -CCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCC
Q 016884 208 -YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286 (381)
Q Consensus 208 -~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (381)
--.++|.|+.|.+.||+++...||.+...+..- .+.| ....+......++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----------------------~r~Y-------qe~qLPalp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----------------------TRTY-------QESQLPALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheec----------------------hhhh-------hhhhCCCCcccCC
Confidence 113789999999999999999999874322110 0000 0011122335689
Q ss_pred HHHHHHHHHhccCCCCCCCCH---HHHhc
Q 016884 287 PLALRLLQRLIAFDPKDRPTA---EEALA 312 (381)
Q Consensus 287 ~~~~dLi~~~L~~dp~~Rpt~---~~lL~ 312 (381)
+.+++|+..+|+.||++|+++ ..+|+
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999999984 44554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=179.99 Aligned_cols=141 Identities=21% Similarity=0.197 Sum_probs=110.8
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----------------------HH--HHHHHHHHHHHHhcCCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------------SD--AIRILREVKLLRLLRHP 82 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------------~~--~~~~~~E~~~l~~l~h~ 82 (381)
+.+.||+|++|.||+|.+. +|+.||||+++...... .. .....+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987532110 00 12235799999999999
Q ss_pred CccccceeecCCCcCCCCcEEEEeeccccC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEec
Q 016884 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (381)
Q Consensus 83 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~ 160 (381)
++.....+... ..|+||||++|. +.........++...+..++.|++.+|.++|+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87554443321 138999999963 43332344578899999999999999999999 9999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 016884 161 ANCKLKVCDFGLARVA 176 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~ 176 (381)
++.++|+|||+|+..
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 889999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=172.12 Aligned_cols=191 Identities=15% Similarity=0.055 Sum_probs=137.3
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC--hHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+...|++|+||+|+.+.. .+..++.+.+...... ......+.+|+++|++|. |+++++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3578899999999998844 6788887777543221 112235789999999995 57888887742 26
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Di-kp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|++|||+.| +|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 56543321 1 2357889999999999999999999 7999999999999999999997543222
Q ss_pred CC-----cccc-----cccccCccccCccccccccCCCC-CccchHHHHHHHHHHHcCCCCCCCCC
Q 016884 181 PM-----TVFW-----TDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKS 235 (381)
Q Consensus 181 ~~-----~~~~-----~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~ 235 (381)
.. .... .-...++.|++|+...-. ...+ ...+.++.|+-+|.++|++.++.+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0000 011257778888754332 1223 46788899999999999998876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=170.32 Aligned_cols=135 Identities=21% Similarity=0.222 Sum_probs=105.9
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-----CCCCccccceeecCCCcCCCCcE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-----RHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+.||+|++|.||. +..++.. +||++.... ......+.+|+.+++.+ +||||+++++++.+.. ..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 56899999999995 7777666 699886422 22345788999999999 5799999999996642 11333
Q ss_pred E-EEeeccc---cCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceEecCC----CCeEEeeecc
Q 016884 103 Y-VVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRAL-KYMHTANVYHRDLKPKNILANAN----CKLKVCDFGL 172 (381)
Q Consensus 103 ~-lv~e~~~---~~L~~~l~~~~~l~~~~~~~i~~qil~aL-~~LH~~~i~H~Dikp~NIl~~~~----~~vkl~DFg~ 172 (381)
+ +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 4 7899955 5999999764 56666 46788988888 89999999999999999999743 3799999543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=171.93 Aligned_cols=242 Identities=15% Similarity=0.221 Sum_probs=184.2
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
...++.+|.+...|..|+++ ..|..+++|++....-.......|..|.-.|+-+.||||+.+++.+-.+ .++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence 34567788999999999995 5677888898865433444455788899999999999999999998443 4589
Q ss_pred EEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEe--eecccccc
Q 016884 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVC--DFGLARVA 176 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~--DFg~a~~~ 176 (381)
++..||+ |+|+.++.... -....++..++..+++|++|||+.. |.---|....++++++.+.+|. |--++-.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999 89999997644 3677889999999999999999985 4444688889999998776543 3222211
Q ss_pred cCCCCCcccccccccCccccCcccccccc-CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.......|.|++||.+.... ..--.++|+|||+++++||.|...||..-+.++.--+|.-
T Consensus 343 ---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------- 403 (448)
T KOG0195|consen 343 ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------- 403 (448)
T ss_pred ---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------
Confidence 12335678899999886521 2233589999999999999999999988877654433321
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
+.++ ....|+++..+..|++-|++.||.+||.++.++
T Consensus 404 ------------eglr-------v~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ------------EGLR-------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ------------cccc-------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1111 234578999999999999999999999987764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=199.17 Aligned_cols=193 Identities=24% Similarity=0.319 Sum_probs=152.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 98 (381)
+..|.|-+.||+|+||.||.|.+.. |+.||+|+-+.+.. ..++=-.+++.+|+ -+.|+.+...+...
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccC----
Confidence 4579999999999999999999877 99999998654322 12222334455555 23444444444332
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-------CCCeEEeee
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDF 170 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-------~~~vkl~DF 170 (381)
+..++|+||.+ |+|.+++..++.+++..+..+..|++..|.+||..+|||+||||+|+|+.. .--++|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 22589999999 899999998889999999999999999999999999999999999999843 234899999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (381)
|.|-...--.+. ..+...++|-.+-.+|...| .+|+..+|.|.|+-+++.||.|+
T Consensus 846 G~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 988543222222 23456788889999999999 89999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=172.38 Aligned_cols=146 Identities=17% Similarity=0.145 Sum_probs=112.1
Q ss_pred CCCeEEeeeecccCCceEEEEE-EcCCCcEEEEEEeCCccCC--------------------hH--HHHHHHHHHHHHHh
Q 016884 22 ANRYKILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEH--------------------IS--DAIRILREVKLLRL 78 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~~--------------------~~--~~~~~~~E~~~l~~ 78 (381)
+.-|.+.+.||.|++|.||+|. +..+|+.||+|+++..... .. ....+.+|+.+++.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 6778999999998643210 00 11235689999999
Q ss_pred cCCCCccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCc
Q 016884 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKN 156 (381)
Q Consensus 79 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~-i~H~Dikp~N 156 (381)
+.+.+ +.+..++.. ...++||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||+|
T Consensus 107 L~~~~-i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEAG-VPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHhcC-CCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 97533 222233321 124899999997 55555444456777778899999999999999999 9999999999
Q ss_pred eEecCCCCeEEeeeccccc
Q 016884 157 ILANANCKLKVCDFGLARV 175 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~ 175 (381)
|+++ ++.++|+|||.|..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-22 Score=181.77 Aligned_cols=180 Identities=29% Similarity=0.461 Sum_probs=134.0
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.++||.|++|. .+|.+++..+. ..+....+.++.|+..|+.| +|.+|+|+||.||+...+..+||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46899999999 69999997443 46778899999999999999 9999999999999999999999999999876
Q ss_pred ccCCC---CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
..... ......+..+||.+||+||.+.+ ..|+.++||||||+||+||+.- |.... +....+.+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T~~--er~~t~~d------- 471 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FSTQF--ERIATLTD------- 471 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hccHH--HHHHhhhh-------
Confidence 44332 11223466789999999999998 7899999999999999999962 22111 11111111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
++.... ...+..-.|.-.+|+.+||...|.+||++...--|+|.
T Consensus 472 -----------------~r~g~i---p~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 -----------------IRDGII---PPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred -----------------hhcCCC---ChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111000 00011123456799999999999999987777667764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-22 Score=196.83 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=206.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 99 (381)
...|.+.+.||+|+|+.|-.+... .+...+|.|.+............+..|..+-+.++ |.|++.+++.. ...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 457999999999999999888664 34456777777654433344555667888888887 99999998887 344
Q ss_pred CcEEEEeeccc-cCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEecCCC-CeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVI-KAND-DLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l-~~~~-~l~~~~~~~i~~qil~aL~~LH-~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~ 174 (381)
+..++++++.. +++...+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 55899999977 4888877 5544 6788899999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCCccccccccc-CccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
...............+| ++.|+|||...+. ...++..|+||.|+++..+++|..|+......+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------- 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------- 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence 76552223333456678 9999999998773 35677899999999999999999998665432210
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
+.. ............+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 240 ------------~~~-~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ------------YSS-WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------cee-ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000 0011111123446778999999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=159.35 Aligned_cols=136 Identities=22% Similarity=0.295 Sum_probs=109.5
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh------HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++.||+|++|.||+|.. .+..|++|+........ ....++.+|+.++..+.|+++.....++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999976 67889999865322211 1224577899999999999987766665332 34
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.++||||++| +|.+++..... ....++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6899999985 88888865432 7888999999999999999999999999999999 78899999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=170.09 Aligned_cols=207 Identities=24% Similarity=0.328 Sum_probs=154.0
Q ss_pred HHhcCCCCccccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCC
Q 016884 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANV-YHRDL 152 (381)
Q Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i-~H~Di 152 (381)
|+.+.|.|+.++++..... ..+++|.+||. |+|.+.+.. ...++.-....+++.|+.||.|||+..| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678899999999999765 45899999999 899999986 4478888889999999999999999876 99999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccc--cC---CCCCccchHHHHHHHHHHHcC
Q 016884 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF--FS---KYTPAIDIWSIGCIFAEVLTG 227 (381)
Q Consensus 153 kp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~~~~~DiwslG~il~~ll~g 227 (381)
++.|.+++....+||+|||+...... ...........-...|.|||++.+. .. .-+.+.|+||+|++++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccc-cccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999876532 1111111222344569999998762 11 146679999999999999999
Q ss_pred CCCCCCCChhh----HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC
Q 016884 228 KPLFPGKSVVH----QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (381)
Q Consensus 228 ~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~ 303 (381)
..||....... .+..+.+ .......+.........+++..++..||..+|.+
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~------------------------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK------------------------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred cCccccccccCChHHHHHHHHh------------------------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhh
Confidence 99997643221 2222111 0111111211111245668999999999999999
Q ss_pred CCCHHHHhc
Q 016884 304 RPTAEEALA 312 (381)
Q Consensus 304 Rpt~~~lL~ 312 (381)
||+++++-.
T Consensus 211 rPs~~~i~~ 219 (484)
T KOG1023|consen 211 RPSIEQIRS 219 (484)
T ss_pred CccHHHHHh
Confidence 999998854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=154.50 Aligned_cols=137 Identities=21% Similarity=0.190 Sum_probs=104.9
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--------------------SDAIRILREVKLLRLLRHPD 83 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~~ 83 (381)
.|.+.+.||+|+||.||+|... +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999874 79999999875322100 01123567899999998775
Q ss_pred c--cccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 84 I--VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 84 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
+ +..++ . ...++||||+.| +|...... .....++.+++.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~---~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPID---W------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceee---c------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3 33222 1 235899999996 66544321 34667899999999999999999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 016884 161 ANCKLKVCDFGLARVA 176 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~ 176 (381)
.++.++|+|||.+...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=153.21 Aligned_cols=131 Identities=27% Similarity=0.370 Sum_probs=101.7
Q ss_pred eecccCCceEEEEEEcCCCcEEEEEEeCCcc-CCh-----HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.||+|++|.||+|. .++..|++|...... ... ....++.+|+++++.+.|+++....-+.... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 467889999864321 111 1235677899999999988755444333222 2368
Q ss_pred EEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 104 lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+||||++| +|.+.+..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=146.27 Aligned_cols=136 Identities=24% Similarity=0.259 Sum_probs=96.7
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----------------------ILREVKLLRLLRHPD-- 83 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~~-- 83 (381)
.+.||+|+||+||+|.+. +++.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999876 8999999988643221111111 135666666664433
Q ss_pred ccccceeecCCCcCCCCcEEEEeecccc-CHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEec
Q 016884 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLH-QVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (381)
Q Consensus 84 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~-~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~ 160 (381)
+.+.+.. ...++||||+++ .+. ..+.... .. ..+..++.+++.++.++|+ .||+|+||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 3333322 125899999996 221 1121111 11 6788999999999999999 9999999999999999
Q ss_pred CCCCeEEeeecccccc
Q 016884 161 ANCKLKVCDFGLARVA 176 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~ 176 (381)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-18 Score=167.51 Aligned_cols=137 Identities=23% Similarity=0.310 Sum_probs=105.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeC-CccCC-----hHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~-~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..|...+.||+|+||+||++... +..+++|+.. +.... .....++.+|+++++.++|++++....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34566899999999999999754 4445555432 21111 12235678999999999999988766555332
Q ss_pred CCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...++||||++| +|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 236899999985 8888775 356789999999999999999999999999999 677899999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-17 Score=143.89 Aligned_cols=139 Identities=21% Similarity=0.280 Sum_probs=103.0
Q ss_pred eeec-ccCCceEEEEEEcCCCcEEEEEEeCCcc------C-----ChHHHHHHHHHHHHHHhcCCCCc--cccceeecCC
Q 016884 29 EVIG-KGSYGVVCAAIDTHTGEKVAIKKIHDVF------E-----HISDAIRILREVKLLRLLRHPDI--VEIKRIMLPP 94 (381)
Q Consensus 29 ~~lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~ 94 (381)
..|| .|+.|+||.+.. .+..+|||.+.... . ......++.+|+.++..|.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 788888888855 37889999875311 0 11233567899999999998875 5555553322
Q ss_pred CcCCCCcEEEEeecccc--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 95 SKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
. ......++|||+++| +|.+++.. .++++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111124699999995 78888765 3566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 016884 173 ARV 175 (381)
Q Consensus 173 a~~ 175 (381)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-18 Score=162.36 Aligned_cols=257 Identities=25% Similarity=0.228 Sum_probs=200.1
Q ss_pred CCeEEeeeecc--cCCceEEEEEE--cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGK--GSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~--G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (381)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..........+-++|+...+.++ |++.++.+..+ .
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 45778899999 99999999998 888999999986655554444445567887777774 99999977776 4
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceEecCC-CCeEEeeec
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR----ALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~----aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg 171 (381)
+.+.+|+-+|+|+.+|..+...... ++...++..+.+... ||.++|+.+|+|-|+||.||+...+ ...+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 5566999999999999888876544 899999999999999 9999999999999999999999999 789999999
Q ss_pred ccccccCCCCCcccc--cccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC--ChhhHHHHHHHhh
Q 016884 172 LARVAFSDTPMTVFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLL 247 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~ 247 (381)
+.............. ...-|...|++||+..+ .++.+.|++|+|.++.+-.+|..++... +.+.++..+.
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--- 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--- 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence 987665544222111 11246677999999876 6789999999999999999988766544 3222211100
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
-..+.....+..+...+..|++.+|-.|++++.+++|+++...
T Consensus 343 -----------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 -----------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -----------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0011223566677779999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=128.26 Aligned_cols=131 Identities=22% Similarity=0.229 Sum_probs=105.8
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCCcEEE
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
+++.||+|.++.||++... +..+++|....... ...+.+|+..++.+.+ .++++++..... .+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 4678999999999999864 37899998865322 4567789999999976 478877766532 245899
Q ss_pred Eeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+|||+.+ .+..+ +......++.+++.+|+.+|.. +++|+|++|.||+++..+.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34322 5567778899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-16 Score=157.32 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=191.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
....+.+.+.+-+|+++.++.+.-..+|...++|+......- ......+.++-.++-...+|-++...-.+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 345677888999999999999988888877777765422111 01122222333333333445554433221 122
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+++|++|.+ ++|...+...+..+.+-++.+...+.+++.+||+..+.|+|++|.|++...++..+++|||.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 45899999998 59999998888888889999999999999999999999999999999999999999999984322110
Q ss_pred C--------CCC----------------c----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC
Q 016884 179 D--------TPM----------------T----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (381)
Q Consensus 179 ~--------~~~----------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (381)
- ... . .......||+.|.+||...+ ...+.++|+|++|+++++.++|.+|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 000 0 01123578999999999988 6778899999999999999999999
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH--
Q 016884 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-- 308 (381)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~-- 308 (381)
|...........|.. . ..++..-....++.+.+++..+|..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni~~---------------------------~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILN---------------------------R-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred CCCcchhhhhhcccc---------------------------C-CCCCCCCccccChhhhhhhhhhhccCchhccCcccc
Confidence 988775544332221 1 1112222345788999999999999999999877
Q ss_pred -HHhcCCCcCcC
Q 016884 309 -EALADPYFKGL 319 (381)
Q Consensus 309 -~lL~hp~~~~~ 319 (381)
++-.|+||+.+
T Consensus 1087 ~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDV 1098 (1205)
T ss_pred cccccCCccCCC
Confidence 88889999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=139.12 Aligned_cols=248 Identities=19% Similarity=0.199 Sum_probs=165.1
Q ss_pred eEEEEEEcCCCcEEEEEEeCCcc-CCh-HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc-cCHH
Q 016884 38 VVCAAIDTHTGEKVAIKKIHDVF-EHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLH 114 (381)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~~-~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 114 (381)
.||++.++..|..|+.-.++... .+. ........-+..|-++-|.||++++.++.+...++...+.++.|||. |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 35666666666666554442110 111 11112223345566678999999999998776667778999999999 7888
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeecccccccCC-CCCccccc
Q 016884 115 QVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWT 187 (381)
Q Consensus 115 ~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~-~~~~~~~~ 187 (381)
++++. ...+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|-+|++--........- ........
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 88864 336899999999999999999999986 999999999999999998887642211110000 00000011
Q ss_pred ccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...+-+.|.|||.-.. ...+.++|||++|....+|..|..- -.+.+....-..+.+.
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-------------------- 298 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-------------------- 298 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------------------
Confidence 2346678999997544 4567799999999999999887632 2222211111111110
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.+.--++.-++++.+||+-.|..||++.++|-||.+-+++.
T Consensus 299 --------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 299 --------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred --------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 01112233467899999999999999999999998766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.8e-14 Score=137.29 Aligned_cols=184 Identities=23% Similarity=0.332 Sum_probs=134.0
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
|.+ ...+-++.+..-.|..+.++.+|.|...+.... .....+.+-++.|+.++||||+++++.+ +....+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 665 445555555333466678899999998875322 3345567788999999999999999988 34457999
Q ss_pred EeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc
Q 016884 105 VFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (381)
Q Consensus 105 v~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~ 183 (381)
|+|.+.. |..+++. ++...+...++||+.||.||| +.+++|++|.-+.|+++..|..||++|..+.........
T Consensus 87 vTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~- 161 (690)
T KOG1243|consen 87 VTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP- 161 (690)
T ss_pred Eeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-
Confidence 9999873 3334443 347788889999999999997 567999999999999999999999999987643222210
Q ss_pred ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC
Q 016884 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (381)
Q Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g 227 (381)
.....---.|..|+.+.. -+-..|.|.|||++++++.|
T Consensus 162 --~~~~~~~~s~~~P~~~~~----s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 --AKSLYLIESFDDPEEIDP----SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cccchhhhcccChhhcCc----cccchhhhhHHHHHHHHhCc
Confidence 011122223677776533 12467999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.2e-15 Score=139.09 Aligned_cols=265 Identities=23% Similarity=0.247 Sum_probs=187.0
Q ss_pred hhcccccccccC----CCCCeEEeeeecccCCceEEEEEEc-CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCC
Q 016884 9 ELKDKDFFTEYG----DANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHP 82 (381)
Q Consensus 9 ~~~~~~~~~~~~----~~~~Y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 82 (381)
.++..+++...+ ...+|..+..||.|.|+.|+.+..+ .++..|++|.+.+..........-+.|+.+...+ .|.
T Consensus 247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc
Confidence 445555555433 3457889999999999999988766 6788999998876555544444556777777776 488
Q ss_pred CccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC
Q 016884 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (381)
Q Consensus 83 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~ 161 (381)
++++.+..+ ...++.|+-.|||.+ ++...+.....+.+...+.++.|++.|+.++|+..++|+|+||+||++..
T Consensus 327 ~~~g~~~~W-----~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 327 PSVGKNSSW-----SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN 401 (524)
T ss_pred ccCCCCCCc-----cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc
Confidence 888877776 334557899999974 44444443446889999999999999999999999999999999999988
Q ss_pred C-CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHH
Q 016884 162 N-CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240 (381)
Q Consensus 162 ~-~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 240 (381)
+ +.-+++|||.+....-... ....++..|-.+|++... ..+..+.|++|||.-+.+.++|.+.-........+
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i 475 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI 475 (524)
T ss_pred chhhhhccccccccccceecc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCcccccceee
Confidence 6 7788999998753211111 111233444224444332 67888999999999999999987543322211000
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
. .......+....++..+.+.|+..++..||++.++..|.=|..
T Consensus 476 ------------------------------~----~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 ------------------------------R----SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ------------------------------e----cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0 0011112344567888999999999999999999988876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.1e-14 Score=119.16 Aligned_cols=139 Identities=20% Similarity=0.228 Sum_probs=99.6
Q ss_pred eeeecccCCceEEEEEEcC------CCcEEEEEEeCCc---c-------------C----ChHHHHH----HHHHHHHHH
Q 016884 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDV---F-------------E----HISDAIR----ILREVKLLR 77 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~---~-------------~----~~~~~~~----~~~E~~~l~ 77 (381)
...||.|--+.||.|.... .+..+|||+.+.. + . ....... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997653 3579999987411 0 0 0111222 237999999
Q ss_pred hcCC--CCccccceeecCCCcCCCCcEEEEeeccccC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCC
Q 016884 78 LLRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLK 153 (381)
Q Consensus 78 ~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~i~H~Dik 153 (381)
++.. -+++.++.+. .-+|||||++++ +..-......+++..+..+..+++.+|..| |+.||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9953 4555555432 248999999863 322112223466677788899999999998 89999999999
Q ss_pred CCceEecCCCCeEEeeecccccc
Q 016884 154 PKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.|||+. ++.+.|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=140.47 Aligned_cols=142 Identities=20% Similarity=0.300 Sum_probs=95.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC---------------------------h-----HHHHH--
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---------------------------I-----SDAIR-- 68 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------------------~-----~~~~~-- 68 (381)
..|.. +.||+|++|.||+|+.+.+|+.||||+.+..... . .....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7899999999999999888999999998743110 0 00112
Q ss_pred ----HHHHHHHHHhcC----CCCccccceeecCCCcCCCCcEEEEeecccc-CHHHH--HHhCC----CCCHHHHHHHHH
Q 016884 69 ----ILREVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKAND----DLTREHHQFFLY 133 (381)
Q Consensus 69 ----~~~E~~~l~~l~----h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~----~l~~~~~~~i~~ 133 (381)
+.+|...+.++. +.+.+.+-.++..- ...-+|||||+.| .+.++ +...+ .+.+..+..++.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 334444444442 33334444444221 1235899999996 66653 33333 355555666666
Q ss_pred HHHHHHHHHHhCCccccCCCCCceEecCCC----CeEEeeecccccc
Q 016884 134 QMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVA 176 (381)
Q Consensus 134 qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vkl~DFg~a~~~ 176 (381)
|++ ..|++|+|+||.||+++.++ +++++|||++...
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 665 58999999999999999988 9999999998654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-13 Score=131.03 Aligned_cols=141 Identities=19% Similarity=0.256 Sum_probs=93.4
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH--------------------------------------HHHH
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD--------------------------------------AIRI 69 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~--------------------------------------~~~~ 69 (381)
.+.||+|++|.||+|+.+ +|+.||||+.+......-. ..++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 357999999999999864 7899999998642111000 0123
Q ss_pred HHHHHHHHhcC----CCCccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHH
Q 016884 70 LREVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLR-ALKYM 142 (381)
Q Consensus 70 ~~E~~~l~~l~----h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~-aL~~L 142 (381)
.+|...+..+. +.+-+.+-.++..-+ ..-++||||++| +|.+..... ... ....++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 34555555542 333333333432211 235899999986 666655421 112 23345566665 46789
Q ss_pred HhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 143 H~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
|..|++|+|+||.||+++.+++++|+|||++...
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=115.61 Aligned_cols=126 Identities=19% Similarity=0.193 Sum_probs=92.0
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCCcEEEEe
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~ 106 (381)
++.|+.|.++.||++... +..|++|....... ......+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~-----~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--P-----ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--C-----CCCeEEE
Confidence 567899999999999754 78899998754321 122456799999988655544 343332 1 1237999
Q ss_pred ecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEecCCCCeEEeeecccc
Q 016884 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV-----YHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 107 e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i-----~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
|+++| ++.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 01123467899999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.7e-12 Score=102.71 Aligned_cols=143 Identities=22% Similarity=0.307 Sum_probs=105.5
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEe-CCccCChH-----HHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHIS-----DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~-~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.+..|-+|+-+.|+++ ...|+.++||.- .+...++. ...+..+|++.|.++.--.|....-++.+..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 5778899999999999 556899888853 33223322 2346678999999987555554444443332
Q ss_pred cEEEEeecccc--CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeeeccc
Q 016884 101 DIYVVFELMES--DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (381)
Q Consensus 101 ~~~lv~e~~~~--~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DFg~a 173 (381)
.-.|+|||++| ++.+++.+.. .........++++|-+.+.-||.++|+|+||..+||++.+++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 8888887532 2333334789999999999999999999999999999987653 589999998
Q ss_pred ccc
Q 016884 174 RVA 176 (381)
Q Consensus 174 ~~~ 176 (381)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.5e-12 Score=102.01 Aligned_cols=130 Identities=22% Similarity=0.347 Sum_probs=93.9
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEE-eCCccCChHH-----HHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCC
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKK-IHDVFEHISD-----AIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFK 100 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~-~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~ 100 (381)
..+++|+-+.++.+.. -|..+++|. +.+...++.- ..+..+|.+++..+.--.| +-++++. + .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~-----~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P-----D 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C-----C
Confidence 4578999999999833 455677774 3333333332 2345679999998864444 3334433 2 2
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...|+|||.+| .|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++..++ +.++|||++..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 25799999998 556677664 245777888888899999999999999999998875 99999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-11 Score=114.46 Aligned_cols=215 Identities=16% Similarity=0.193 Sum_probs=155.3
Q ss_pred CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc--cC
Q 016884 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SD 112 (381)
Q Consensus 35 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--~~ 112 (381)
...+.|+|....+|..|++|+++...... ......-+++++++.|+|+|++.+++.+... ....+++|++|.+ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence 34677999999999999999994221111 1122245778899999999999999985443 3346899999988 47
Q ss_pred HHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 113 LHQVIK---------------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 113 L~~~l~---------------~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
|.++-- .+...+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 777652 22357899999999999999999999999999999999999999999998888765432
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh-hhH-HHHHHHhhCCCCHHHH
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQ-LDLITDLLGTPSPETI 255 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~-~~~i~~~~~~~~~~~~ 255 (381)
.+. . +.+.+ -.+-|.=.||.+++.|.||..-=...+. ... +..|
T Consensus 445 ~d~---------------~--~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDP---------------T--EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCC---------------C--cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 221 0 11221 2256888999999999999632111111 100 1111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
-+..+.+++++|.-+..-++++ -++.+++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1357888889999888888876 688888875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.6e-12 Score=123.29 Aligned_cols=156 Identities=24% Similarity=0.350 Sum_probs=113.7
Q ss_pred HHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCCCCCc-cccc-----ccccCccccCccccccccCCC
Q 016884 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT-VFWT-----DYVATRWYRAPELCGSFFSKY 208 (381)
Q Consensus 136 l~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~-~~~~-----~~~gt~~y~aPE~~~~~~~~~ 208 (381)
..|+.|+|.. ++||++|.|++|.++.++.+||+.|+++........-. ..++ -......|.|||++.+ ...
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TTN 186 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--ccc
Confidence 3899999976 89999999999999999999999999886543322210 0001 1123456999999988 678
Q ss_pred CCccchHHHHHHHHHHH-cCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCH
Q 016884 209 TPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287 (381)
Q Consensus 209 ~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (381)
++++|++|+||++|.+. .|+..+.+.........-.... .........++++
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------------------------~~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------------------------NAGAFGYSNNLPS 239 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------------------------ccccccccccCcH
Confidence 89999999999999999 5666665543322111111100 0011112257899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 288 ~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
++++=+.++|..++..||++..++..|||.+..
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 999999999999999999999999999998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-10 Score=102.37 Aligned_cols=136 Identities=15% Similarity=0.121 Sum_probs=94.1
Q ss_pred ceEEEEEEcCCCcEEEEEEeCCccCCh---------HHHHHHHHHHHHHHhcCCCCcccc--ceeecCCCcCCCCcEEEE
Q 016884 37 GVVCAAIDTHTGEKVAIKKIHDVFEHI---------SDAIRILREVKLLRLLRHPDIVEI--KRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 37 g~V~~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv 105 (381)
..|.++ ...|+.|.||......... .....+.+|...+..|..-+|... +.+...........-++|
T Consensus 36 rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 345555 3357789999764321100 011136789999888854444333 333322111112357899
Q ss_pred eecccc--CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-------CCCeEEeeecccc
Q 016884 106 FELMES--DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDFGLAR 174 (381)
Q Consensus 106 ~e~~~~--~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-------~~~vkl~DFg~a~ 174 (381)
||++++ +|.+++.. ..+.+......++.+++..+.-||.+||+|+|+++.|||++. +..+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999996 78888764 345667788899999999999999999999999999999975 4679999999774
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.9e-10 Score=102.57 Aligned_cols=259 Identities=18% Similarity=0.180 Sum_probs=162.2
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHH-HhcCCCCccccceeecCC----CcCCC
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPP----SKREF 99 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~----~~~~~ 99 (381)
....+.||+|+-+.+|..-. -...+.|+.+.+-... ..+ .+..| +.-.||-+.. .+.++. +.+..
T Consensus 13 i~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~--~aq---k~a~la~~p~~p~~~~--rvaWPqa~L~G~~~~ 82 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAA--QAQ---KVAELAATPDAPLLNY--RVAWPQATLHGGRRG 82 (637)
T ss_pred cCCCccccCCccceeeecch---hhchhheeecCCCchH--HHH---HHHHhccCCCCcchhh--hhcccHHHhhCCCcc
Confidence 34578899999999997732 2234568877542211 111 12222 2335665433 111111 11222
Q ss_pred CcEEEEeecccc--CHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeec
Q 016884 100 KDIYVVFELMES--DLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 100 ~~~~lv~e~~~~--~L~~~l~------~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
..+.+.|+.+.| ....+.. +.....++...+..+.|+.|.+.||..|.+-+|+.++|+|+.+++.|.|.|=.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 337899999885 4444443 23357889999999999999999999999999999999999999999999865
Q ss_pred ccccccCCCCCcccccccccCccccCccccc-ccc--CCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHHHHhh
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~ 247 (381)
.-.... ....+...+|.+.|.+||+-. +.. -.-+...|-|.||+++++++.| +.||.|-.. ..
T Consensus 163 sfqi~~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~ 229 (637)
T COG4248 163 SFQINA----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------IS 229 (637)
T ss_pred ceeecc----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cC
Confidence 433322 223345668999999999753 110 2346689999999999999986 999987421 11
Q ss_pred CCCCH-H-HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccC--CCCCCCCHHH
Q 016884 248 GTPSP-E-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF--DPKDRPTAEE 309 (381)
Q Consensus 248 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~--dp~~Rpt~~~ 309 (381)
..|.+ | .+......... +.-....+.+..-.+.-+++++..|..+|+.. ++.-|||++-
T Consensus 230 ~ap~p~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 230 DAPNPLETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCCcchhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11211 1 11111111111 11222333344444556889999999999875 3567999753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=7.3e-11 Score=102.91 Aligned_cols=143 Identities=17% Similarity=0.264 Sum_probs=100.7
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCC--CccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv 105 (381)
.+.|+.|..+.||++.... |..+++|........ .....+.+|+.+++.+.+. .+.+++....... ..+..++|
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEE
Confidence 3678999999999997643 588999987543221 1234677899999999754 3555655543221 12346899
Q ss_pred eecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 016884 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT---------------------------------------- 144 (381)
Q Consensus 106 ~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~---------------------------------------- 144 (381)
||+++| ++.+.+.. ..++......++.+++++|+.||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999996 44443321 346677777777788888877774
Q ss_pred ----------------CCccccCCCCCceEecC--CCCeEEeeeccccc
Q 016884 145 ----------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (381)
Q Consensus 145 ----------------~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a~~ 175 (381)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.5e-10 Score=95.96 Aligned_cols=127 Identities=27% Similarity=0.293 Sum_probs=81.5
Q ss_pred eEEEEEEcCCCcEEEEEEeCCc----------------cC-------C-hHHHHHHHHHHHHHHhcCCC--Cccccceee
Q 016884 38 VVCAAIDTHTGEKVAIKKIHDV----------------FE-------H-ISDAIRILREVKLLRLLRHP--DIVEIKRIM 91 (381)
Q Consensus 38 ~V~~a~~~~~~~~vaiK~~~~~----------------~~-------~-~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~ 91 (381)
.||.|.. ..|..+|+|+.+.. +. . ........+|.+.|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 45779999977410 00 0 01123467899999999755 456665443
Q ss_pred cCCCcCCCCcEEEEeeccc--cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEecCCCCeEEe
Q 016884 92 LPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~-LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
.-+|||||++ |.....+... .++......++.+++..+.. +|+.||+|+|+.+.|||++.+ .+.++
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1379999999 6322223221 12245667788888886655 689999999999999999988 89999
Q ss_pred eecccccc
Q 016884 169 DFGLARVA 176 (381)
Q Consensus 169 DFg~a~~~ 176 (381)
|||.|...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.4e-10 Score=96.78 Aligned_cols=110 Identities=24% Similarity=0.327 Sum_probs=85.9
Q ss_pred HHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCCcEEEEeecccc--CHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 016884 65 DAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALK 140 (381)
Q Consensus 65 ~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~L~~~l~~~~~l~~~~~~~i~~qil~aL~ 140 (381)
...+..+|...+..|..-+ .++.+.+..... ......++|+|++++ +|.+++......+......++.++...++
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 3446778999888885443 344444443322 112456899999986 79999987555778888999999999999
Q ss_pred HHHhCCccccCCCCCceEecCCC---CeEEeeeccccc
Q 016884 141 YMHTANVYHRDLKPKNILANANC---KLKVCDFGLARV 175 (381)
Q Consensus 141 ~LH~~~i~H~Dikp~NIl~~~~~---~vkl~DFg~a~~ 175 (381)
-||.+||+|+|++|.|||++.++ .+.|+||+.++.
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999999987 799999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.1e-10 Score=97.38 Aligned_cols=136 Identities=28% Similarity=0.281 Sum_probs=100.9
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCC-------cc---------CC----hHHHHHHHHHHHHHHhcCCC--
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-------VF---------EH----ISDAIRILREVKLLRLLRHP-- 82 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-------~~---------~~----~~~~~~~~~E~~~l~~l~h~-- 82 (381)
+.+..+||-|.-|.||.|.+. .|..+|+|.=+. .. .+ ......+.+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999865 689999994320 00 00 11223567899999999644
Q ss_pred CccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC
Q 016884 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (381)
Q Consensus 83 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~ 161 (381)
.+++.++. +.-.+|||+++| .|... ++.......++..|++-+..+-..||+|+|+++-||++++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55555433 235899999998 33322 2245666777888888888777999999999999999999
Q ss_pred CCCeEEeeeccccc
Q 016884 162 NCKLKVCDFGLARV 175 (381)
Q Consensus 162 ~~~vkl~DFg~a~~ 175 (381)
+|.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=86.15 Aligned_cols=140 Identities=19% Similarity=0.163 Sum_probs=101.7
Q ss_pred cccCCceEEEEEEcCCCcEEEEEEeCC----ccCChHHHHHHHHHHHHHHhcCCCCc--cccceeecC-CCcCCCCcEEE
Q 016884 32 GKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLRHPDI--VEIKRIMLP-PSKREFKDIYV 104 (381)
Q Consensus 32 g~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~-~~~~~~~~~~l 104 (381)
|+||-|-|+.... .|..+=+|.-.. ....+.....+.+|+..+..|..-+| ++.. +.. ......-.-+|
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv--f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV--FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc--eeeeeccCCceEEEE
Confidence 4688899988743 344688887541 11213345678899999999864443 3333 211 11112234689
Q ss_pred Eeecccc--CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC--eEEeeeccccc
Q 016884 105 VFELMES--DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (381)
Q Consensus 105 v~e~~~~--~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~--vkl~DFg~a~~ 175 (381)
|+|-+++ +|.+++... .+.+......++.++..+++-||+.|+.|+|+-+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 999888653 35677888899999999999999999999999999999987667 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.3e-08 Score=86.48 Aligned_cols=142 Identities=20% Similarity=0.249 Sum_probs=90.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH-HH------HHHHHHHHHHhcCCCCcccc---ceee
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AI------RILREVKLLRLLRHPDIVEI---KRIM 91 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-~~------~~~~E~~~l~~l~h~~iv~~---~~~~ 91 (381)
.++|++.+.+-......|.+. ...|..+++|..+........ .. ...+++..+..+...++..+ +.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467899999988887777766 556889999987643221111 11 12344554444433333332 2222
Q ss_pred cCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeee
Q 016884 92 LPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
.-....-.....+||||++| .|.+... +++ .+.-.|.+++.-||+.|++|+|.+|.|++++.++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 21121222345689999998 5544321 222 2445677889999999999999999999999665 999999
Q ss_pred cccc
Q 016884 171 GLAR 174 (381)
Q Consensus 171 g~a~ 174 (381)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-07 Score=81.47 Aligned_cols=138 Identities=19% Similarity=0.180 Sum_probs=95.8
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC--------------------ChHHHH--HHHHHHHHHHhcC--CC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------------------HISDAI--RILREVKLLRLLR--HP 82 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------------------~~~~~~--~~~~E~~~l~~l~--h~ 82 (381)
+...|+.|.-+.||.|.. ..+..+|+|++..... +..... =..+|+..|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345777888999999964 5688999998852211 111111 1246888888885 44
Q ss_pred CccccceeecCCCcCCCCcEEEEeeccccC--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEe
Q 016884 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILA 159 (381)
Q Consensus 83 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~--L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~ 159 (381)
.+++.+.+. .-.||||+++.. -.-.++. -++...++..+..++++.+.-|-. .|+||+||+.-|||+
T Consensus 131 rvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 131 RVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCCceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 445554443 237999999853 1111221 123344788889999999998876 899999999999999
Q ss_pred cCCCCeEEeeecccccc
Q 016884 160 NANCKLKVCDFGLARVA 176 (381)
Q Consensus 160 ~~~~~vkl~DFg~a~~~ 176 (381)
. ++.+.++|||.|...
T Consensus 201 ~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 201 H-DGEPYIIDVSQAVTI 216 (268)
T ss_pred E-CCeEEEEECcccccc
Confidence 9 778999999988654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-07 Score=94.80 Aligned_cols=204 Identities=16% Similarity=0.207 Sum_probs=138.4
Q ss_pred HHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 016884 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVY 148 (381)
Q Consensus 70 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~ 148 (381)
.-|+..+....|+|++.++.+-...-.. +..+.+..++|.+ ++...+++-+..+.+..+.+..++++||+++|+....
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~-g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFR-GIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcc-hHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 3466778888999999988776543211 1234566777874 8888998888999999999999999999999999665
Q ss_pred ccCCCCC---ceEecCCCCeEEe--eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHH
Q 016884 149 HRDLKPK---NILANANCKLKVC--DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (381)
Q Consensus 149 H~Dikp~---NIl~~~~~~vkl~--DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ 223 (381)
|.-+..+ +--.+..+.+..+ ||+.+........ ......+..+-+||.............|+|++|..+..
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 5554444 3334555666666 8887654322211 11223455577888776522233344799999999999
Q ss_pred HHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCC-HHHHHHHHHhccCCCC
Q 016884 224 VLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD-PLALRLLQRLIAFDPK 302 (381)
Q Consensus 224 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~dLi~~~L~~dp~ 302 (381)
+..|..+-.-.. .+..+ .+..+ ....+++.+|+.-+++
T Consensus 385 ~~~~~~i~~~~~------~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 385 LSQGEDISEKSA------VPVSL-----------------------------------LDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhcCccccccc------chhhh-----------------------------------hccccchhhhhhhhhhcchhhh
Confidence 998763321110 00000 01111 1678899999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q 016884 303 DRPTAEEALADPYFKGL 319 (381)
Q Consensus 303 ~Rpt~~~lL~hp~~~~~ 319 (381)
+|+++.++|.|+|.+..
T Consensus 424 ~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRFP 440 (1351)
T ss_pred hccchhhhhhchhcccc
Confidence 99999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.3e-09 Score=99.44 Aligned_cols=245 Identities=16% Similarity=0.126 Sum_probs=163.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~ 100 (381)
..-|...+-+++|+++++++++...+...+ .+.+... ....-++++|.+++||| .+..++-+ +...
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~ 307 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DGED 307 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Cccc
Confidence 345777888999999999999776665444 6665432 23345889999999999 44333332 4456
Q ss_pred cEEEEeeccccC--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELMESD--LHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~~~--L~~~l-~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+++++++.+. ....+ .+.-.+.+-+...+.+.-+++++++|+.-=+|+| ||+..+ +..+.+||+.+....
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC
Confidence 689999999842 22222 1122355566667788888999999999888998 777665 578999999876543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ......+++.++|||+..+ ..+....|.||+|+--.+|.-|-+|-...-. ... ..|..+
T Consensus 383 ~~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p------ 444 (829)
T KOG0576|consen 383 RTM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGP------ 444 (829)
T ss_pred ccc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCC------
Confidence 332 1245679999999999877 7889999999999887788777777644210 000 000000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHH-HHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-LRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. ..+... ...++.. .++...|+..-|..|++...++-|.+|++-
T Consensus 445 ----~s------------~~L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 ----NS------------PMLTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ----Cc------------cccchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00 000000 0011111 257788999999999999999999999863
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.8e-07 Score=78.43 Aligned_cols=133 Identities=17% Similarity=0.180 Sum_probs=78.5
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~ 106 (381)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-++ .+.+.+.. ..+..++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeee
Confidence 56899999999984 25578889875422 23346789999999864433 45555542 223468899
Q ss_pred eccccC--HHHHH---------------------HhC--CCCCHHH-HHHHHHH----------HHHH-HHHHH--h--C
Q 016884 107 ELMESD--LHQVI---------------------KAN--DDLTREH-HQFFLYQ----------MLRA-LKYMH--T--A 145 (381)
Q Consensus 107 e~~~~~--L~~~l---------------------~~~--~~l~~~~-~~~i~~q----------il~a-L~~LH--~--~ 145 (381)
|+++|. +...+ .+- ...+... ...+..+ +... ..+|. . .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999973 11111 000 0111111 0111000 1111 11122 1 2
Q ss_pred CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 146 ~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.++|+|+.|.||+++.++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999988 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-06 Score=75.05 Aligned_cols=139 Identities=18% Similarity=0.228 Sum_probs=78.8
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv 105 (381)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 59999987532 34567778999998885333 44555432221 222347999
Q ss_pred eecccc-CHHH----------------HH---HhC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 016884 106 FELMES-DLHQ----------------VI---KAN----DDLTREH------HQFF---------------LYQMLR-AL 139 (381)
Q Consensus 106 ~e~~~~-~L~~----------------~l---~~~----~~l~~~~------~~~i---------------~~qil~-aL 139 (381)
|+++.| .+.. .+ ... ..+.... .... ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999986 4443 11 011 1111100 0000 011111 22
Q ss_pred HHHH-------hCCccccCCCCCceEec-CCCCeEEeeecccc
Q 016884 140 KYMH-------TANVYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (381)
Q Consensus 140 ~~LH-------~~~i~H~Dikp~NIl~~-~~~~vkl~DFg~a~ 174 (381)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 23599999999999999 56666799999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.5e-06 Score=70.80 Aligned_cols=131 Identities=18% Similarity=0.243 Sum_probs=90.4
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEE
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 104 (381)
-++.+.|++|.+|.||++. ..|..+|+|+-+.. +....+..|.++|..++..++.+=+-.+ +...+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~i 89 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDFI 89 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEe--------chhhh
Confidence 3567889999999999995 45779999976532 3344677899999999877665422121 12356
Q ss_pred Eeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCceEecCCCCeEEeeecccccc
Q 016884 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK-PKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dik-p~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.|||+.| .|.+..... . +.-+..++++---|-..||-|+.|. |..+++..++.+.|+||..|+.-
T Consensus 90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 7999998 665544321 1 2234456666556788899999997 44444444448999999998743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.5e-06 Score=82.57 Aligned_cols=139 Identities=21% Similarity=0.329 Sum_probs=85.8
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccCC----------------------------hHHH----------HHHH
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----------------------------ISDA----------IRIL 70 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------------------~~~~----------~~~~ 70 (381)
..|+.++-|.||+|+-+ +|+.||||+.+..... .... -++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78999999999999865 4999999987521110 0000 1123
Q ss_pred HHHHHHHhcC----CCCccccceeecCCCcCCCCcEEEEeecccc-CHHHH--HHhCCCCCHHHHHHHHHHHHHH-HHHH
Q 016884 71 REVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKANDDLTREHHQFFLYQMLRA-LKYM 142 (381)
Q Consensus 71 ~E~~~l~~l~----h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~--l~~~~~l~~~~~~~i~~qil~a-L~~L 142 (381)
+|...+.++. ...-+.+-.+++.-+ ..-.|+|||+.| .+.+. +++ ...+...+ +..++++ +..+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~ 281 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHH
Confidence 4555555442 222233334443211 124899999997 55544 444 33443222 2222222 2223
Q ss_pred HhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 143 H~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
-..|++|.|.+|.||+++.+|++.+.|||.....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 3489999999999999999999999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-05 Score=70.95 Aligned_cols=71 Identities=14% Similarity=0.096 Sum_probs=45.1
Q ss_pred eeecccCC-ceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
..|..|.. +.||++.. .+..+++|+..... ...+.+|+.+++.+. +--+.+++...... +.-++||
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEE
Confidence 34555665 88899954 34678888765321 335567999988884 33344555544221 3468999
Q ss_pred ecccc
Q 016884 107 ELMES 111 (381)
Q Consensus 107 e~~~~ 111 (381)
|+++|
T Consensus 72 e~i~G 76 (244)
T cd05150 72 SAVPG 76 (244)
T ss_pred EeeCC
Confidence 99987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.2e-05 Score=65.64 Aligned_cols=129 Identities=19% Similarity=0.247 Sum_probs=88.6
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCcc--------------CChHHHHHHHHHHHHHHhcC------CCCcccc
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--------------EHISDAIRILREVKLLRLLR------HPDIVEI 87 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~~iv~~ 87 (381)
...||+|+.-.||.- . .....+||+..... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999998865 3 34567789886543 11122445566777666665 7899999
Q ss_pred ceeecCCCcCCCCcEEEEeeccc---c----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 88 KRIMLPPSKREFKDIYVVFELME---S----DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~---~----~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
++...++ ..+.+|+|.+. | +|.++++.. .+++ ... ..+-+-..+|-+++|+.+|++|.||++.
T Consensus 83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 9998544 44789999864 2 688888554 4665 333 3333445678899999999999999986
Q ss_pred CCC----CeEEee
Q 016884 161 ANC----KLKVCD 169 (381)
Q Consensus 161 ~~~----~vkl~D 169 (381)
.+. .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 542 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.8e-06 Score=68.83 Aligned_cols=132 Identities=27% Similarity=0.303 Sum_probs=91.1
Q ss_pred CCeEEeeeecccCC-ceEEEEEEcCCCcEEEEEEeCC-----------ccCC-h-------HHHHHHHHHHHHHHhc---
Q 016884 23 NRYKILEVIGKGSY-GVVCAAIDTHTGEKVAIKKIHD-----------VFEH-I-------SDAIRILREVKLLRLL--- 79 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~-g~V~~a~~~~~~~~vaiK~~~~-----------~~~~-~-------~~~~~~~~E~~~l~~l--- 79 (381)
..++.++.||.|.- |.||++. -.|+.+|+|++.. .... . .....+..|.+..-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999995 4688999999421 0000 0 1223566777776655
Q ss_pred CCCCc--cccceeecCCCc-------------CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 016884 80 RHPDI--VEIKRIMLPPSK-------------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144 (381)
Q Consensus 80 ~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~ 144 (381)
.+.++ ++.+++..-... .......||.||....- .++.. =+.+|++-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHH
Confidence 45566 888887753310 11123478888877532 22322 34677788889999
Q ss_pred CCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999987 3489999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.2e-05 Score=80.43 Aligned_cols=83 Identities=17% Similarity=0.237 Sum_probs=54.7
Q ss_pred EeeeecccCCceEEEEEEcCCC--cEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCCc
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTG--EKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKD 101 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~ 101 (381)
-++.|+.|.++.+|+......+ ..+++|+..... .......+.+|+++|+.+. |+++ .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3678899999999998654432 467888754321 1122346779999999995 6665 5555554332 12244
Q ss_pred EEEEeeccccC
Q 016884 102 IYVVFELMESD 112 (381)
Q Consensus 102 ~~lv~e~~~~~ 112 (381)
.|+|||+++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.9e-05 Score=69.54 Aligned_cols=30 Identities=33% Similarity=0.468 Sum_probs=25.2
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|+.|.||+++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876555799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.9e-05 Score=74.21 Aligned_cols=139 Identities=23% Similarity=0.304 Sum_probs=86.3
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHH-----------------------------------HHHHHHH
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-----------------------------------AIRILRE 72 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~-----------------------------------~~~~~~E 72 (381)
-+.||.-+.|.||+|+-+. |+.||||+-+........ .-++.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4679999999999998765 999999986532211100 0112334
Q ss_pred HHHHHhc----CCCC---ccccceeecCCCcCCCCcEEEEeecccc----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 016884 73 VKLLRLL----RHPD---IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRALKY 141 (381)
Q Consensus 73 ~~~l~~l----~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~----~L~~~l~~~~~l~~~~~~~i~~qil~aL~~ 141 (381)
.+...++ .|-+ -|.+-.++++-+ ..-.|+||||+| |+ +.|.+.+ ++.. .+...+.++...
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~---~i~~~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPH---DILNKLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHH---HHHHHHHHHHHH
Confidence 4433332 3444 122223333221 124899999997 55 5555543 4444 344444444332
Q ss_pred -HHhCCccccCCCCCceEecC----CCCeEEeeecccccc
Q 016884 142 -MHTANVYHRDLKPKNILANA----NCKLKVCDFGLARVA 176 (381)
Q Consensus 142 -LH~~~i~H~Dikp~NIl~~~----~~~vkl~DFg~a~~~ 176 (381)
+-..|++|+|=+|.||+++. ++.+.+-|||+....
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 45678999999999999984 678999999997654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.5e-05 Score=72.17 Aligned_cols=177 Identities=23% Similarity=0.354 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 016884 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143 (381)
Q Consensus 64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH 143 (381)
....+++-..++++.+.|+|....+++.... .....+|||+++.+|.+.+..+. +-.... +
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-LKDESL-------L------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-cchhhh-------c-------
Confidence 3456778889999999999998877765332 23489999999999999988654 221111 1
Q ss_pred hCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHH
Q 016884 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (381)
Q Consensus 144 ~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ 223 (381)
.+|+.| .|+ ++.+| .++.. | | .+.++++||||+|.++.+
T Consensus 85 ~~~~~~-----~~~-------~~~td-~~~t~-------------------~--~-------~~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLH-----LNI-------IYITD-HFLTK-------------------Y--P-------SPIGPKSDVWSLGFIILE 123 (725)
T ss_pred ccccce-----ehh-------hhccc-ccccc-------------------C--C-------CCCCcchhhhhHHHHHHH
Confidence 222222 122 22333 11100 0 1 122359999999999999
Q ss_pred HHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC
Q 016884 224 VLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (381)
Q Consensus 224 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~ 303 (381)
+.-|...+......+.+..+.+....+.....- .... .+. -.++....++..+|+-..|..
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~-a~e~----~~~--------------~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLST-AMEH----LIQ--------------LLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHH-HHHH----HHH--------------HhhhHhHHHHhccCCcccccc
Confidence 999999998888888887777765444322111 1111 000 135666789999999999999
Q ss_pred CCCHHHHhcCCCcCcC
Q 016884 304 RPTAEEALADPYFKGL 319 (381)
Q Consensus 304 Rpt~~~lL~hp~~~~~ 319 (381)
||...++..++-|..+
T Consensus 185 r~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RPLPMELSKRCSFTEV 200 (725)
T ss_pred ccchhHHhcCccHHHH
Confidence 9999999999999876
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.8e-06 Score=86.24 Aligned_cols=211 Identities=17% Similarity=0.073 Sum_probs=140.4
Q ss_pred HHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh
Q 016884 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHT 144 (381)
Q Consensus 70 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~ 144 (381)
+.|..-++...|+++.....-..+. +....|.+++++. |+++..+-++ .++.+.-+.....+.+.+..-+|+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 3455555667899887765554332 2244689999998 7999988643 345555555555555777777776
Q ss_pred CC-----ccccCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHH
Q 016884 145 AN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (381)
Q Consensus 145 ~~-----i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 219 (381)
.. -+|+++|+-|.++..+..+|++++|+.+.... .........+++.|++|++... -.++.++|+|+.|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHH
Confidence 52 79999999999999999999999999984322 2223345578889999998876 56788899999999
Q ss_pred HHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccC
Q 016884 220 IFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299 (381)
Q Consensus 220 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~ 299 (381)
-+|....|.++|-.. +..+.+ ... ... .......-.+.++-.....+|-+
T Consensus 1429 ~ly~rs~~n~~fi~f-----lq~~Lk---gii-------------------dn~---tf~sIe~l~pgdaNve~~~~Ll~ 1478 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIFF-----LQPALK---GII-------------------DNH---TFFSIEKLKPGDANVEALHRLLW 1478 (2724)
T ss_pred HHHHHhcccHHHHHH-----HHHHHc---Ccc-------------------ccc---ccccccccCCCcccHHHHHHHHH
Confidence 999999998777211 111110 000 000 00001111234455566667777
Q ss_pred CCCCCCCHHHHhcCCCcCc
Q 016884 300 DPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 300 dp~~Rpt~~~lL~hp~~~~ 318 (381)
.-..||.-...+.-+.|..
T Consensus 1479 K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1479 KYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred Hhhhcchhhhhcccccccc
Confidence 7788999988888777753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00022 Score=62.72 Aligned_cols=72 Identities=13% Similarity=0.221 Sum_probs=44.7
Q ss_pred eeeecccCCceEEEEEEcC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCCcEEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv 105 (381)
++.|..|-...+|++.... .+..|++|+...... ......+|+.+++.+...+++ +++... . -.+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence 4678888889999995432 357899997653211 112334689999988644443 333222 1 1479
Q ss_pred eecccc
Q 016884 106 FELMES 111 (381)
Q Consensus 106 ~e~~~~ 111 (381)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0004 Score=65.42 Aligned_cols=77 Identities=19% Similarity=0.174 Sum_probs=51.7
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCcc----C-ChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----E-HISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~-~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 99 (381)
.+.||.|.+..||++.....++.|+||.-.... . -.....+...|...|+.+. ..++++++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~----- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E----- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C-----
Confidence 578999999999999876444689999753111 1 1224456777888888863 23456665542 1
Q ss_pred CcEEEEeecccc
Q 016884 100 KDIYVVFELMES 111 (381)
Q Consensus 100 ~~~~lv~e~~~~ 111 (381)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.82 E-value=8.1e-05 Score=62.87 Aligned_cols=96 Identities=22% Similarity=0.243 Sum_probs=76.5
Q ss_pred HHHHHHHhcCC-CCccccceeecCCCcCCCCcEEEEeeccc-cCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 016884 71 REVKLLRLLRH-PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQV---IKANDDLTREHHQFFLYQMLRALKYMHT- 144 (381)
Q Consensus 71 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~---l~~~~~l~~~~~~~i~~qil~aL~~LH~- 144 (381)
.|.-+|+.+.+ +++++++|.+ . -.+|.||.+ +++... +..--..++.....|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58888899975 6999999998 1 267889988 455321 1111246899999999999999999988
Q ss_pred --CCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 145 --ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 145 --~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..+.-.|++|+|+-+++++++|++|...+..
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3488889999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0001 Score=65.71 Aligned_cols=132 Identities=17% Similarity=0.238 Sum_probs=74.6
Q ss_pred eecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCCcEEEEeec
Q 016884 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVFEL 108 (381)
Q Consensus 30 ~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~ 108 (381)
.+..|-.+.+|+.. .++..+++|......... .....+|..+++.+...++ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 45678888999885 456788898754321111 0134578999998864444 2333221 1 2689999
Q ss_pred ccc-CH--------------HHHHH---hC----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcc
Q 016884 109 MES-DL--------------HQVIK---AN----DDLTR-EHHQFFLYQM---------LRALKYMHT--------ANVY 148 (381)
Q Consensus 109 ~~~-~L--------------~~~l~---~~----~~l~~-~~~~~i~~qi---------l~aL~~LH~--------~~i~ 148 (381)
++| .+ .+.+. +. .+++. ..+..+..++ ...+..+-+ ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 886 21 11111 11 11121 1222222122 111222211 2489
Q ss_pred ccCCCCCceEecCCCCeEEeeeccccc
Q 016884 149 HRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 149 H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
|+|+.|.||+++.++ +.|+||..|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999887 78999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=8.7e-05 Score=67.71 Aligned_cols=141 Identities=15% Similarity=0.059 Sum_probs=80.0
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCC-CcCCCCcEE
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFKDIY 103 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~ 103 (381)
-++.|..|....+|++.. .+..+++|+... .....+..|+.++..+.+.+ +++++...... .....+..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 367788888889999843 445789998753 12345667888888885433 33333211000 001123468
Q ss_pred EEeecccc-CH-----------HHHH---H---hC--CC------CCHHH--HH--------HHHHHHHHHHHHHHh---
Q 016884 104 VVFELMES-DL-----------HQVI---K---AN--DD------LTREH--HQ--------FFLYQMLRALKYMHT--- 144 (381)
Q Consensus 104 lv~e~~~~-~L-----------~~~l---~---~~--~~------l~~~~--~~--------~i~~qil~aL~~LH~--- 144 (381)
+|+++++| .+ ...+ . .. .. ..+.. .. .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999986 21 0111 0 00 00 00000 00 011112334444443
Q ss_pred ----CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ----ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ----~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00028 Score=64.79 Aligned_cols=144 Identities=15% Similarity=0.109 Sum_probs=80.1
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCC-CcCCCCc
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFKD 101 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~ 101 (381)
..-++.++.|....+|++.. ++..+++|+..... ....+..|+.++..|...+ +++++...... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 44577788888889999853 34468889765321 1234456777777774333 33333211000 0011245
Q ss_pred EEEEeeccccC------HH------HHH---Hh-CCCC--------CHHH-----HH----------HHHHHHHHHHHHH
Q 016884 102 IYVVFELMESD------LH------QVI---KA-NDDL--------TREH-----HQ----------FFLYQMLRALKYM 142 (381)
Q Consensus 102 ~~lv~e~~~~~------L~------~~l---~~-~~~l--------~~~~-----~~----------~i~~qil~aL~~L 142 (381)
.++|++|++|. .. ..+ .. ...+ .... .. .....+...+.++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999998761 11 111 00 0000 0000 00 0011223344445
Q ss_pred Hh-------CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 143 HT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 143 H~-------~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 32 579999999999999998767899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00078 Score=61.43 Aligned_cols=78 Identities=15% Similarity=0.126 Sum_probs=52.0
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCCcE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH---PDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.-.+.||.|..+.||.... ++..+++|..+. . .....+.+|...|+.|.. ..++++++++.... ..+.-
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~ 88 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARS-F---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPD 88 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecc-c---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCe
Confidence 3467899999999999843 233577777432 1 123467789999998853 35666776654321 12347
Q ss_pred EEEeecccc
Q 016884 103 YVVFELMES 111 (381)
Q Consensus 103 ~lv~e~~~~ 111 (381)
++|||+++|
T Consensus 89 ~LVmE~i~G 97 (297)
T PRK10593 89 VLLLERLRG 97 (297)
T ss_pred EEEEeccCC
Confidence 999999885
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00071 Score=62.45 Aligned_cols=30 Identities=30% Similarity=0.296 Sum_probs=25.7
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976555799999764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=7.1e-05 Score=67.03 Aligned_cols=135 Identities=18% Similarity=0.199 Sum_probs=94.1
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCC-------------------ccCC-hHHHHHHHHHHHHHHhcCC-C
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-------------------VFEH-ISDAIRILREVKLLRLLRH-P 82 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~-------------------~~~~-~~~~~~~~~E~~~l~~l~h-~ 82 (381)
=|.++..||-|.-+-||.+-+ ..|++.++|.-+. .... .-....+.+|+..|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999975 4578888884210 0000 0011245689999998853 2
Q ss_pred -CccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 83 -DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 83 -~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
-+++.++. +.-++|||++.| .|.+.-.- ..+..+...+..-+.-|..+|+||+|..--||+++
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 23333332 346899999986 55543321 22344566666777789999999999999999999
Q ss_pred CCCCeEEeeecccc
Q 016884 161 ANCKLKVCDFGLAR 174 (381)
Q Consensus 161 ~~~~vkl~DFg~a~ 174 (381)
+++.++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999998653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00057 Score=62.56 Aligned_cols=72 Identities=17% Similarity=0.122 Sum_probs=44.0
Q ss_pred eeeecccCCceEEEEEEcC------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFK 100 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~ 100 (381)
++.|..|-...||++.... +++.+++|+..... .......+|..+++.+...++. +++.... +
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-----~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-----N-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-----C--
Confidence 4566777778899886433 25789999865422 1223456788888888643333 3333331 1
Q ss_pred cEEEEeecccc
Q 016884 101 DIYVVFELMES 111 (381)
Q Consensus 101 ~~~lv~e~~~~ 111 (381)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 357888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00065 Score=62.08 Aligned_cols=139 Identities=22% Similarity=0.301 Sum_probs=96.5
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCc----------------c------CChHHHHH--HHHHHHHHHhcCCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV----------------F------EHISDAIR--ILREVKLLRLLRHP 82 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----------------~------~~~~~~~~--~~~E~~~l~~l~h~ 82 (381)
|-..|.-|.-+.||.|.. ..|..+|||+++.+ + .++....+ +..|++.|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677888999999964 56788999987521 0 11122222 23588888998877
Q ss_pred CccccceeecCCCcCCCCcEEEEeeccccCH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEe
Q 016884 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDL--HQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILA 159 (381)
Q Consensus 83 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~i~H~Dikp~NIl~ 159 (381)
.|...--+..- .-.|||++++.+= .-.+ ..-.++...+..+-.|++.-+.-| |..++||.||.--|+|+
T Consensus 227 GIP~PePIlLk-------~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILLK-------NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceeee-------cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 76554433322 2379999998421 1122 234678888888888888888876 56799999999999998
Q ss_pred cCCCCeEEeeeccccc
Q 016884 160 NANCKLKVCDFGLARV 175 (381)
Q Consensus 160 ~~~~~vkl~DFg~a~~ 175 (381)
-.+ .+.++|-+.+.-
T Consensus 299 hdG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HDG-KLYIIDVSQSVE 313 (520)
T ss_pred ECC-EEEEEEcccccc
Confidence 654 699999987643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0019 Score=58.13 Aligned_cols=30 Identities=30% Similarity=0.552 Sum_probs=25.3
Q ss_pred CccccCCCCCceEecCCCCe-EEeeeccccc
Q 016884 146 NVYHRDLKPKNILANANCKL-KVCDFGLARV 175 (381)
Q Consensus 146 ~i~H~Dikp~NIl~~~~~~v-kl~DFg~a~~ 175 (381)
.++|+|++|.|||++.++.+ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975654 5999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0055 Score=55.86 Aligned_cols=145 Identities=18% Similarity=0.206 Sum_probs=81.4
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCCcEE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~ 103 (381)
.++..+..|....+|...+. ++.+++. ............+..+|+.+++.+.---+ ...++++.... ....|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf 101 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPF 101 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCce
Confidence 45555555555555666443 7778887 32223334556677789999998854333 33333332221 34579
Q ss_pred EEeecccc-CHH------------------HHHHh-------C-------CCCCHHHHHHHHHHH--------------H
Q 016884 104 VVFELMES-DLH------------------QVIKA-------N-------DDLTREHHQFFLYQM--------------L 136 (381)
Q Consensus 104 lv~e~~~~-~L~------------------~~l~~-------~-------~~l~~~~~~~i~~qi--------------l 136 (381)
.||+++.| .+. +.+.. . +.....++..+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999987 111 11100 0 000111111121111 1
Q ss_pred HHHHHHHhC--------CccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 137 RALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 137 ~aL~~LH~~--------~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.-..+|+.+ .++|+|+++.||+++.++.+=|.||+++...
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 122333322 3799999999999999988999999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0044 Score=57.31 Aligned_cols=82 Identities=15% Similarity=0.032 Sum_probs=51.5
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeC----C-ccCChHHHHHHHHHHHHHHhcC--CC-CccccceeecCCCcCCCC
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH----D-VFEHISDAIRILREVKLLRLLR--HP-DIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~-~~~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 100 (381)
+.||.|....||++.+...++.|+||.-. . .........+..-|...|+... -| .+++++.+- ..
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e 73 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TE 73 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------cc
Confidence 35899999999999875444689999643 1 1122344556677888887764 24 344443321 12
Q ss_pred cEEEEeecccc--CHHHHH
Q 016884 101 DIYVVFELMES--DLHQVI 117 (381)
Q Consensus 101 ~~~lv~e~~~~--~L~~~l 117 (381)
...+|||+++. .|.+.+
T Consensus 74 ~~~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 74 MAVTVMEDLSHHKIARKGL 92 (370)
T ss_pred cceehHhhCccchHHHHHH
Confidence 35699999863 454444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0024 Score=59.78 Aligned_cols=83 Identities=20% Similarity=0.144 Sum_probs=54.4
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeC----CccCChHHHHHHHHHHHHHHhcC--CC-CccccceeecCCCcCCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLLR--HP-DIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~ 100 (381)
++.||.|.-..||++.+...++.|+||.-. ......-...+..-|...|+... -| .+++++.+- ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence 788999999999999875446789999542 11122345667778999988774 34 344444321 12
Q ss_pred cEEEEeecccc--CHHHHH
Q 016884 101 DIYVVFELMES--DLHQVI 117 (381)
Q Consensus 101 ~~~lv~e~~~~--~L~~~l 117 (381)
...+|||+++. .|.+.+
T Consensus 107 ~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 107 MNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred HhhHHHHhCcccHHHHHHH
Confidence 35789999863 455544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.012 Score=54.08 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=25.3
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 578999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.012 Score=55.41 Aligned_cols=76 Identities=14% Similarity=0.156 Sum_probs=49.7
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-----ChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-----HISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~ 98 (381)
..+.||.|....||+..+. +..++||.-..... ..-...+...|...|+.+. ...+++++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 4788999999999999763 45799997541111 1113445556777777664 246677766652
Q ss_pred CCcEEEEeecccc
Q 016884 99 FKDIYVVFELMES 111 (381)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (381)
..-+++||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 224789999965
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.014 Score=54.36 Aligned_cols=137 Identities=13% Similarity=0.127 Sum_probs=76.5
Q ss_pred EEeeeecccCCceEEEEEEcC----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCC
Q 016884 26 KILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFK 100 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~ 100 (381)
.-+..|..|-...+|++.... .++.|++|+..... .....-.+|..+++.+..-++. ++++.+ ..
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~-- 108 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN-- 108 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEE-----CC--
Confidence 335566668888999986322 34689999875421 1111235689998888644443 344443 11
Q ss_pred cEEEEeecccc-CHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH-----------------HHH
Q 016884 101 DIYVVFELMES-DLH-----------QV---IK---AND------DLTREHHQFFLYQML-----------------RAL 139 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~-----------~~---l~---~~~------~l~~~~~~~i~~qil-----------------~aL 139 (381)
..|.+|+.+ .+. .+ +. +.. ....+.+..+..++. ..+
T Consensus 109 --g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 186 (344)
T PLN02236 109 --GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEI 186 (344)
T ss_pred --ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHH
Confidence 257777764 221 11 11 100 111233333332221 111
Q ss_pred HH----HH----hCCccccCCCCCceEecC-CCCeEEeeecccc
Q 016884 140 KY----MH----TANVYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (381)
Q Consensus 140 ~~----LH----~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~ 174 (381)
.. +. ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 187 ~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 187 NLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11 12 225899999999999986 4679999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.017 Score=52.95 Aligned_cols=30 Identities=17% Similarity=0.118 Sum_probs=27.5
Q ss_pred CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 146 ~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
++||+|+.+.|+|++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999997753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.011 Score=54.79 Aligned_cols=28 Identities=32% Similarity=0.433 Sum_probs=24.7
Q ss_pred ccccCCCCCceEecC-CCCeEEeeecccc
Q 016884 147 VYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (381)
Q Consensus 147 i~H~Dikp~NIl~~~-~~~vkl~DFg~a~ 174 (381)
++|+|+.+.|||+++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4789999999764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.029 Score=50.70 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=44.0
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCCc
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 101 (381)
-+-.+.++.|..+.+|+.. .+++.+.+|+-.. .....+..|..-|+.|. --.+++++.+.... +.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SC
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CC
Confidence 3457789999999999985 7788999997652 22235667888888883 33466666655332 22
Q ss_pred EEEEeeccc
Q 016884 102 IYVVFELME 110 (381)
Q Consensus 102 ~~lv~e~~~ 110 (381)
-|+||||++
T Consensus 87 ~fLlle~l~ 95 (288)
T PF03881_consen 87 AFLLLEFLE 95 (288)
T ss_dssp CEEEEE---
T ss_pred ceEEEEeec
Confidence 499999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.019 Score=52.67 Aligned_cols=73 Identities=22% Similarity=0.365 Sum_probs=58.9
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+..+.|++|++-++.+.-. ..-..+++..|+++-+..++-+..+ ..-|||+...|||++ +|.|-|+||-+++.
T Consensus 297 e~~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 3456899999988765321 2245678888999988888777765 689999999999999 99999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.12 Score=48.76 Aligned_cols=29 Identities=31% Similarity=0.315 Sum_probs=24.0
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+|.|+-+.||+.+.+ .+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 458999999999997654 59999998653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.67 Score=42.84 Aligned_cols=28 Identities=32% Similarity=0.323 Sum_probs=23.6
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.22 Score=48.08 Aligned_cols=73 Identities=8% Similarity=0.039 Sum_probs=43.5
Q ss_pred EeeeecccCCceEEEEEEcC--------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcC
Q 016884 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKR 97 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~ 97 (381)
-++.|..|=.-.+|++.... .++.|++++...... ....-.+|..+++.+..-+|- ++++.+ .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~ 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYNPISEFEVYKTMSKYRIAPQLLNTF-----S 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeCHHHHHHHHHHHHHCCCCCceEEEe-----C
Confidence 56777778788889886432 156898987653211 112334688888887644443 344433 1
Q ss_pred CCCcEEEEeecccc
Q 016884 98 EFKDIYVVFELMES 111 (381)
Q Consensus 98 ~~~~~~lv~e~~~~ 111 (381)
-+.|.||+.|
T Consensus 181 ----gg~I~efi~g 190 (442)
T PTZ00296 181 ----GGRIEEWLYG 190 (442)
T ss_pred ----CCEEEEeeCC
Confidence 1456788764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.13 Score=48.10 Aligned_cols=60 Identities=20% Similarity=0.184 Sum_probs=41.9
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEecCC
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~-LH~~~i~H~Dikp~NIl~~~~ 162 (381)
..++-+|+.| ++..+++. ...++...+.+..--..|+-- |--.+++|.|+.|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4567777777 77777754 345666666666666666554 445689999999999998543
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.17 Score=48.26 Aligned_cols=28 Identities=25% Similarity=0.361 Sum_probs=22.4
Q ss_pred ccccCCCCCceEecCCCC-----eEEeeecccc
Q 016884 147 VYHRDLKPKNILANANCK-----LKVCDFGLAR 174 (381)
Q Consensus 147 i~H~Dikp~NIl~~~~~~-----vkl~DFg~a~ 174 (381)
++|+||...|||.+.++. ..|+||-.+.
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 799999999999988543 4588887654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.02 Score=47.98 Aligned_cols=28 Identities=25% Similarity=0.382 Sum_probs=25.2
Q ss_pred ccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 147 VYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 147 i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998887 99999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.051 Score=49.56 Aligned_cols=75 Identities=24% Similarity=0.291 Sum_probs=44.7
Q ss_pred EEEEeeccccC-----HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCCCceEecCCC---------
Q 016884 102 IYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQMLRALKYMH----TANVYHRDLKPKNILANANC--------- 163 (381)
Q Consensus 102 ~~lv~e~~~~~-----L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH----~~~i~H~Dikp~NIl~~~~~--------- 163 (381)
-.+|++.+..+ +....+-+-.--.+-++.++.|++--.-.+- -...+|-||||+|||+-+..
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 35888886632 2222222212234566777788764332232 23599999999999974322
Q ss_pred ---------CeEEeeecccccc
Q 016884 164 ---------KLKVCDFGLARVA 176 (381)
Q Consensus 164 ---------~vkl~DFg~a~~~ 176 (381)
..+|.||.+|+..
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 3577788887653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.065 Score=48.00 Aligned_cols=45 Identities=29% Similarity=0.357 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHHHhC--CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 131 FLYQMLRALKYMHTA--NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 131 i~~qil~aL~~LH~~--~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+..+-.++.-.+.. -+||+|+.|+|+|.++.+.++|+||.-|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444444 489999999999999999999999987743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 381 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-89 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-89 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-82 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-82 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-82 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-82 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-82 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-82 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-82 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-82 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-82 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-82 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-82 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-82 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-82 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-81 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-81 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-81 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-81 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-80 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-80 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-80 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-80 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-79 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-79 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-77 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-77 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-76 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-76 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-74 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-74 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-74 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-74 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-73 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-72 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-72 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-71 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-71 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-70 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-66 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-66 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-66 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-65 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-62 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-57 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-57 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-56 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-56 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-55 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-55 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-55 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-55 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-55 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-54 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-54 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-54 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-54 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-54 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-54 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-54 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-54 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-54 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-54 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-54 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-53 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-53 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-53 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-53 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-52 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-52 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-52 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-47 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-45 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-44 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-43 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-43 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-43 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-43 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-43 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-43 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-43 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-43 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-43 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-43 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-43 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-43 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-43 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-43 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-43 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-43 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-43 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-43 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-40 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-39 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-39 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-39 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-39 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-39 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-38 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-38 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-38 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-38 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-38 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-38 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-38 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-38 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-37 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-36 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-36 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-36 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-36 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-23 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-23 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-23 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-22 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-22 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-21 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-21 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-21 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-14 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-08 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 554 bits (1430), Expect = 0.0
Identities = 134/426 (31%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M ++ +F + + Y I +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI 117
+FE + D RILRE+ +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K LT EH + LY +L ++H + + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 SDTPMTV-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
S+ + T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KSVVHQLDLITDLLGTP 250
CIFAE+L PLFPG KS QL++I +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ + + + + KY+ + P+ L QK+P++ + LL+ ++ F+P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYING 370
L PY K + K + E L F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 TEGTNF 376
NF
Sbjct: 419 IHENNF 424
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 549 bits (1416), Expect = 0.0
Identities = 156/362 (43%), Positives = 219/362 (60%), Gaps = 5/362 (1%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + RY L IG+G+YG+VC+A D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
H + R LRE+K+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L+ +H +FLYQ+LR LKY+H+ANV HRDLKP N+L N C LK+CDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
I +LG+PS E + + N KAR YL + K VP + FPN D AL LL +++ F+P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
R E+ALA PY + EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 QL 363
Sbjct: 361 GY 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 547 bits (1412), Expect = 0.0
Identities = 148/351 (42%), Positives = 220/351 (62%), Gaps = 13/351 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
Y ++ +++ ++G+G+YGVVC+A TGE VAIKKI + F+ A+R LRE+K+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +H +I+ I I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDY 189
RA+K +H +NV HRDLKP N+L N+NC LKVCDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG+ HQL LI ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPE-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P + + + + +AR+Y+ + P PL + FP V+P + LLQR++ FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEF--ERRRVTKDDIRELIYREIL 357
EAL PY + EP +PI FEF + +T D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 529 bits (1364), Expect = 0.0
Identities = 120/368 (32%), Positives = 183/368 (49%), Gaps = 21/368 (5%)
Query: 5 QTKKELKDKDFF-TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----- 58
Q K E +D + + Y + I GSYG VCA +D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH 114
+ R+LRE++LL HP+I+ ++ I + + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + +CDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R +D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADANK----THYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRL 292
+ +QL+ I +++GTP E + + + AR YL P P DP+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
+ +++ F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 528 bits (1361), Expect = 0.0
Identities = 136/385 (35%), Positives = 213/385 (55%), Gaps = 43/385 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y++++ +GKG+YG+V +ID TGE VA+KKI D F++ +DA R RE+ +L L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQ+++ +KY+
Sbjct: 70 NIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV------------------AFSDTPMTV 184
H+ + HRD+KP NIL NA C +KV DFGL+R +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG S ++QL+ I
Sbjct: 186 ILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF----------------PNVDP 287
++ PS E + +++ A+ + +++K + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
AL LL +L+ F+P R +A +AL P+ EP+C I + + + + DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDD 362
Query: 348 IRELIYREILEYHPQLLKDYINGTE 372
R L+Y EI +L+ + +
Sbjct: 363 YRNLVYSEISRRKRELISNKHQNVQ 387
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 526 bits (1357), Expect = 0.0
Identities = 132/341 (38%), Positives = 203/341 (59%), Gaps = 12/341 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P + +F D Y+V M +DL +++K L + QF +YQML+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E + ++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+A+ Y+ + + N PLA+ LL++++ D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
E EP Q + F+ T D+ + + Y+E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 529 bits (1363), Expect = 0.0
Identities = 145/417 (34%), Positives = 207/417 (49%), Gaps = 57/417 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
Q +K +++ +RY+I +IG GSYG VC A D VAIKKI VFE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
+ D RILRE+ +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA----- 176
LT H + LY +L +KY+H+A + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKSVV--------------------HQLDLITDL 246
GCIFAE+L PLFPG S QL++I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTPS E I + E A++Y+ K+ L ++FP A+ LL+R++ F+P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
E LA P+FK + E E + +L F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 522 bits (1347), Expect = 0.0
Identities = 131/340 (38%), Positives = 195/340 (57%), Gaps = 12/340 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +G G+YG VC+AID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQML+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A V HRDLKP N+ N +C+LK+ DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S+ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P E + + ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + P Q FP P A LL++++ D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E Q + E ++T D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 142/372 (38%), Positives = 210/372 (56%), Gaps = 18/372 (4%)
Query: 1 MQQDQTKKELKDKDFF------TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
M + F+ T + RY+ L +G G+YG VCAA DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ ++K LT +H QF +YQ+LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ QL LI L+GTP E + + +E AR Y+ + + P + F +PLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
++++ D R TA +ALA YF + EP P + E R + D+ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQLLK 365
E++ + P L
Sbjct: 350 DEVISFVPPPLD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 127/399 (31%), Positives = 201/399 (50%), Gaps = 29/399 (7%)
Query: 1 MQQDQTKKELKDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
+ K D F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + + P E F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI+ +L E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A + T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTAGTSF----MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-------- 285
+ + Q + + + LGTP PE + + R Y+ K + + FP+
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERR 341
A LL +++ DP R + ++AL PY P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPR 380
T ++ +ELIY+E++ + + G +
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVN 422
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 502 bits (1295), Expect = e-179
Identities = 122/353 (34%), Positives = 188/353 (53%), Gaps = 23/353 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 83 DIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E + LYQML +K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVI 198
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + + + LGTP PE + +
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEE 309
R Y+ K + FP+V A LL +++ D R + +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
AL PY + P + + + R T ++ +ELIY+E+++
Sbjct: 316 ALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-176
Identities = 119/315 (37%), Positives = 174/315 (55%), Gaps = 15/315 (4%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+RY L+ +G G G+V +A+D ++VAIKKI V LRE+K++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + Q+ LI + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
E + + Y+ +P PL Q P + A+ L++++ F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKIEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-162
Identities = 107/350 (30%), Positives = 172/350 (49%), Gaps = 27/350 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+R+++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQM 135
P+IV+++ +R+ +DIY VV E + LH+ + + FL+Q+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 136 LRALKYMH--TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+ P Y+ +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV----AYICS 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G + QL I +LG PS
Sbjct: 195 RYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF----PNVDPLALRLLQRLIAFDPKDRPTAE 308
E + + L +P F A LL L+ + P++R
Sbjct: 254 EVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 309 EALADPYFKGLAKIERE-PSCQPISKLEFEFERR--RVTKDDIRELIYRE 355
EAL PYF L + P+ + + + F F V + + + R+
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-148
Identities = 115/363 (31%), Positives = 188/363 (51%), Gaps = 30/363 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLR 137
++V++K K++ + +V E + +++ K + + ++YQ+LR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+L Y+H+ + HRD+KP+N+L + LK+ DFG A++ + P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG+S + QL I +LGTPS E I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P + F P P A+ L+ RL+ + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 315 YFKGLAKIE-REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
+F L E R P+ + + L F + + + +R + ++ H + + G +
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
Query: 374 TNF 376
NF
Sbjct: 379 HNF 381
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-146
Identities = 98/392 (25%), Positives = 180/392 (45%), Gaps = 66/392 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKRIM---------------------------------LPPSKREFKDIYVVFEL 108
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQ+ RA+ ++H+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
E++ GKPLF G++ + QL I ++GTP+ E + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 283 PNVDP-LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC----------QPI 331
P P LA+ LL++++ ++P R EA+A P+F L Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 332 SKL-EFEFERRRVTKDDIRELIYREILEYHPQ 362
+L F + ++ I + + +
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-143
Identities = 108/339 (31%), Positives = 169/339 (49%), Gaps = 25/339 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRA 138
IV ++ K++ + +V + + +++V + A L + + ++YQ+ R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + P + F P P A+ L RL+ + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKIE-REPSCQPISKL-EFEFERRRVTKDDIRELI 352
F L + P+ + L F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-129
Identities = 91/318 (28%), Positives = 155/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +I RE+K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA V VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL I +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-----VDPLALRLLQRLIAFDPKDRP 305
I E ++ + + + + V P AL L +L+ +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKIE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-123
Identities = 109/307 (35%), Positives = 167/307 (54%), Gaps = 12/307 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ + IG+GSYGVV + TG+ VAIKK + + LRE+++L+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 63 NLVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H N HRD+KP+NIL + +K+CDFG AR + P + D VATRWYR+PE L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G ++Y P +D+W+IGC+FAE+L+G PL+PGKS V QL LI LG P V
Sbjct: 175 VGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ + + PL KFPN+ AL LL+ + DP +R T E+ L PYF+ +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 321 KIEREPS 327
+IE
Sbjct: 293 EIEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-116
Identities = 99/297 (33%), Positives = 161/297 (54%), Gaps = 12/297 (4%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ L ++G+GSYG+V + TG VAIKK + + +RE+KLL+ LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 85 NLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ N+ HRD+KP+NIL + + +K+CDFG AR + P V+ D VATRWYRAPEL
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELL 196
Query: 202 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G KY A+D+W+IGC+ E+ G+PLFPG S + QL I LG P +
Sbjct: 197 VGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K PL +++P + + + L ++ + DP RP E L +F+
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-104
Identities = 115/301 (38%), Positives = 159/301 (52%), Gaps = 18/301 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRL 78
A RY+ L+ +G+G + V A D +T + VAIKKI D I LRE+KLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G+ Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ Y + P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 239 DMC--SLPDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 317 K 317
Sbjct: 296 S 296
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-104
Identities = 101/303 (33%), Positives = 146/303 (48%), Gaps = 18/303 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLL 79
+RY+ + IG G+YG V A D H+G VA+K + + I +REV LLR L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + L E + + Q
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L ++H + HRDLKP+NIL + +K+ DFGLAR +S M T V T W
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSY-QMA--LTPVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P +
Sbjct: 185 YRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 243 WPRD--VSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
Query: 315 YFK 317
Y
Sbjct: 299 YLH 301
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-103
Identities = 119/325 (36%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
++ G +Y+ LE +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAIRI--LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-N 120
+ I +RE+ LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + +LYQ+LR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
P+ + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG + Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLITDLLGTPSPET---IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L I +LGTP+P + + K R + + P P + LL +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
+ FDP R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 305 bits (785), Expect = e-103
Identities = 114/299 (38%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y LE IG+G+YGVV A + GE A+KKI E + I +RE+ +L+ L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV++ ++ + + +VFE ++ DL +++ L + FL Q+L +
Sbjct: 59 HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR AF P+ + T + T WYRAP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V
Sbjct: 171 VLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 229 T--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 113/331 (34%), Positives = 169/331 (51%), Gaps = 28/331 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
Y L+ +G+G+Y V T VA+K+I E + +REV LL+ L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + I+ + +VFE ++ DL Q + + + + + FL+Q+LR L
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR A S P + + V T WYR P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET---I 255
L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET I
Sbjct: 171 ILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
K Y K L P +D LL +L+ F+ ++R +AE+A+ P+
Sbjct: 229 LSNEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 316 FKGL----AKIEREPSCQPISKLEFEFERRR 342
F L K+ S + +++ + E
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-103
Identities = 115/302 (38%), Positives = 166/302 (54%), Gaps = 19/302 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ + + + LRE+ LL+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N DL E + FL+Q+L+ L
Sbjct: 60 HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P+ + + V T WYR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPD 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP+ E
Sbjct: 172 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 230 MT--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 318 GL 319
Sbjct: 288 DF 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-102
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 23/306 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+RY+ + +G+G+YG V AIDT T E VAIK+I EH + + +REV LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +I+E+K ++ + ++++FE E+DL + + N D++ + FLYQ++ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LK+ DFGLAR AF P+ F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG S + QL I ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K L + +D L LL ++ DP R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-102
Identities = 103/322 (31%), Positives = 161/322 (50%), Gaps = 26/322 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLL 79
+Y+ + IG+G+YG V A D + G VA+K++ + + + + +REV +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR +S M T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSF-QMA--LTSVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 185 YRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ K P+ + ++D L LL + + F+P R +A AL+ P
Sbjct: 243 WPRD--VALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 315 YFKGLAKIEREPSCQPISKLEF 336
YF+ L C+
Sbjct: 299 YFQDL------ERCKENLDSHL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-101
Identities = 112/338 (33%), Positives = 165/338 (48%), Gaps = 24/338 (7%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRL 78
+ ++Y+ L IG+G++G V A TG+KVA+KK+ E+ + I LRE+K+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKRIM---LPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---VA 191
+L L Y+H + HRD+K N+L + LK+ DFGLAR AFS Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTA 307
+PE V E K E+ K + + DP AL L+ +L+ DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRR 342
++AL +F + ++ S S E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-100
Identities = 113/312 (36%), Positives = 174/312 (55%), Gaps = 29/312 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLL 79
++++K LE +G G+Y V ++ TG VA+K++ D E S AIR E+ L++ L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKEL 60
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN------DDLTREHHQFFLY 133
+H +IV + ++ +K + +VFE M++DL + + + L ++F +
Sbjct: 61 KHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+L+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTL 172
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG + QL LI D++GTP+
Sbjct: 173 WYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTA 307
V K KY ++++PP L Q +D + L L+ +P R +A
Sbjct: 231 SLWPSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 308 EEALADPYFKGL 319
++AL P+F
Sbjct: 289 KQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 1e-86
Identities = 105/368 (28%), Positives = 170/368 (46%), Gaps = 58/368 (15%)
Query: 22 ANRYKIL-EVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+ ++ +G+G+YG V A D + A+K+I IS + RE+ LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF-------- 130
L+HP+++ ++++ L + + ++++F+ E DL +IK +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 131 -FLYQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVF 185
LYQ+L + Y+H V HRDLKP NIL ++K+ D G AR F+ P+
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 186 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 236 --VVHQLDLITDLLGTPS----------PETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
QLD I +++G P+ PE ++++ + Y + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY---TNCSLIKYMEKHKV 304
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP-ISKLEFEFERRR 342
D A LLQ+L+ DP R T+E+A+ DPYF E + + + +R
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKRE 359
Query: 343 VTKDDIRE 350
++ +
Sbjct: 360 FLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-73
Identities = 91/382 (23%), Positives = 147/382 (38%), Gaps = 65/382 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHP 82
+ +V+G G+ G + VA+K+I +D REV+LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
+++ ++++ + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 MHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K + DFGL + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE L T +DI+S GC+F V++ GKS+ Q +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------------- 239
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + D +A L++++IA DP+ RP+A+ L P+
Sbjct: 240 -------------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE------ 358
F L K IE+E PI K + E R V K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQLLKDYINGTEGTNFLYP 379
Y ++D + Y
Sbjct: 346 TYKGGSVRDLLRAMRNKKHHYR 367
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-66
Identities = 47/343 (13%), Positives = 90/343 (26%), Gaps = 61/343 (17%)
Query: 15 FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILRE 72
+ R K++E + G VV D E A+K S+ R+
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 73 VKLLRLLRHPDIVE---------------------IKRIMLPPSKREFKDIYVVFELMES 111
L E ++ + ++
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172
Query: 112 DLHQVIKANDDLTREHH-------QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL + D + Q++R + + + H P N+ + +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR 232
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
L + D + P + Y E + + +T A++ W +G V
Sbjct: 233 LMLGDVSALWKVGTRGPASSV------PVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
F + + L P ++ F
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDS----------------------LAFGSCTP 324
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ L+ R + FD + R EA+ P F +++ E S
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-64
Identities = 93/344 (27%), Positives = 151/344 (43%), Gaps = 48/344 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ D A RY++L+VIGKGS+G V A D + VA+K + + +
Sbjct: 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAA 141
Query: 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTR 125
E+++L LR D ++ F++ I + FEL+ +L+++IK N +
Sbjct: 142 E--EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMT 183
+ F + +L+ L +H + H DLKP+NIL +KV DFG + + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY 257
Query: 184 VFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
Y+ +R+YRAPE + G+ +Y ID+WS+GCI AE+LTG PL PG+ QL
Sbjct: 258 T----YIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 243 ITDLLGTPSPETI---------------------------AVVRNEKARKYLTEMRKKPP 275
+ +LLG PS + + +VV N +
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 276 VPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKG 318
D L++ + +DP R T +AL P+ +
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 72/327 (22%), Positives = 113/327 (34%), Gaps = 47/327 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
++ F + Y IL+ IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA 119
E+ L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ + + ML A+ +H + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T V + V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 TTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F I+ + + + P +
Sbjct: 239 FQQII-----------------NQISKLHAIIDPNH------EIEFP-----DIPEKDLQ 270
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317
+L+ + DPK R + E LA PY +
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-61
Identities = 70/358 (19%), Positives = 136/358 (37%), Gaps = 69/358 (19%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ F + G N + ++ +G G++G V + A+K + ++ + + + +
Sbjct: 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAK 79
Query: 69 ILREVKLLRLLRHPD-----IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD 122
I E +L+ +++ D IV+ + D + ++FE + L+++I N+
Sbjct: 80 I--EADILKKIQNDDINNNNIVKYHGKF------MYYDHMCLIFEPLGPSLYEIITRNNY 131
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---------------------- 158
E + + ++L+AL Y+ ++ H DLKP+NIL
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 159 ---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ +K+ DFG A F + TR YRAPE + + + D+
Sbjct: 192 QIYRTKSTGIKLIDFGCA--TFKSDYHG----SIINTRQYRAPEVILNL---GWDVSSDM 242
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL------- 267
WS GC+ AE+ TG LF + L ++ ++ + KY+
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 268 ------TEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + V + L L ++ DP RP+ E L + +
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 9e-61
Identities = 93/354 (26%), Positives = 154/354 (43%), Gaps = 57/354 (16%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDA 66
+ D+ + G+ +RY+I +IGKGS+G V A D E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--L 123
EV+LL L+ D I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TREHHQFFLYQMLRALKYMHT--ANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSD 179
+ + F QM AL ++ T ++ H DLKP+NIL +K+ DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212
Query: 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
+ Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G + V Q
Sbjct: 213 QRIY----QYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDLITDLLGTPSPETI--------------------------AVVRNEKARKYLTEMRKK 273
++ I ++LG P + + L +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 274 PPVPLFQKFPN------VDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ D L + L+ R++ +DPK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 9e-61
Identities = 94/355 (26%), Positives = 145/355 (40%), Gaps = 49/355 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAI 67
K+ GD RY+I+ +G+G++G V +D G +VA+K I +V +A
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAA 63
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LT 124
R+ E+ +L+ ++ D +L F + + FEL+ + + +K N+
Sbjct: 64 RL--EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-------------------ANANCKL 165
H + YQ+ AL+++H + H DLKP+NIL + N +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+V DFG A F T VATR YR PE+ + D+WSIGCI E
Sbjct: 182 RVADFGSA--TFDHEHHT----TIVATRHYRPPEVI--LELGWAQPCDVWSIGCILFEYY 233
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------------ARKYLTEMRK 272
G LF L ++ +LG I R +K + +
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
KP + L++R++ FDP R T EAL P+F GL ER
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 92/338 (27%), Positives = 144/338 (42%), Gaps = 51/338 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ RY+I++ +G+G++G V ID G VA+K + +V + +A R E+++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLR 137
D R + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVAFS 178
++ ++H+ + H DLKP+NIL N +KV DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 188 DEHHS----TLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 238 HQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFP 283
L ++ +LG I R K A +Y++ KP
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR-ACKPLKEFMLSQD 299
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
L+Q+++ +DP R T EAL P+F L K
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-59
Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 68 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V T Y PE
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 180
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 224
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 225 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 70/331 (21%), Positives = 115/331 (34%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V Y PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEA 227
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 271
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 272 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 320 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 350
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-57
Identities = 72/296 (24%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
++ L +G GSYG V G A+K+ F D R L EV ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
V +++ + E +Y+ EL L Q +A E +L L AL +
Sbjct: 118 CCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + H D+KP NI + K+ DFGL + V Y APEL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELL 228
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y A D++S+G EV L G QL
Sbjct: 229 Q---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--------------------- 264
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ P +L ++ DPK R TAE LA P +
Sbjct: 265 --------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-56
Identities = 75/338 (22%), Positives = 130/338 (38%), Gaps = 55/338 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
RY ++ +G G + V A D VA+K + + ++A E+KLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKRIMLPPSKREFKD-----------IYVVFELMESDLHQVIKANDD--LTREH 127
D + + M + D + +VFE++ +L +IK + + +
Sbjct: 74 DADNTK-EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 132
Query: 128 HQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK------LKVCDFGLARVAFSDT 180
+ Q+L L YMH + H D+KP+N+L +K+ D G A + D
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--- 236
T+ + TR YR+PE L G + + DIWS C+ E++TG LF
Sbjct: 191 HY----TNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243
Query: 237 ---VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-- 291
+ I +LLG + + R + + + +P D L +
Sbjct: 244 TKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 301
Query: 292 -----------LLQRLIAFDPKDRPTAEEALADPYFKG 318
L ++ DP+ R A + P+ K
Sbjct: 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-56
Identities = 88/310 (28%), Positives = 134/310 (43%), Gaps = 55/310 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A+ + E+++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + M T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 363
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 364 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 309 EALADPYFKG 318
EAL P+ +
Sbjct: 396 EALRHPWLQD 405
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 8e-56
Identities = 79/347 (22%), Positives = 134/347 (38%), Gaps = 49/347 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + +Y L+ IG+GS+G T G + IK+I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--IS 60
Query: 62 HISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+S R REV +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 119 -ANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+ARV
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
S + + T +Y +PE+C + Y DIW++GC+ E+ T K F S+
Sbjct: 176 NSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQR 295
+ + I P+ LR L+ +
Sbjct: 231 KNLVLKI---------------------------ISGSFPPV----SLHYSYDLRSLVSQ 259
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
L +P+DRP+ L + + P F +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 24/314 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T P + + P + L +L ++ D + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS--RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKI 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-55
Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 62/312 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
Y++L IG GSYG G+ + K++ + +++A + ++ EV LLR L+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP+IV ++ R +Y+V E E DL VI + Q+
Sbjct: 64 HPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKG----TKERQYLDEEFVLRV 116
Query: 132 LYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ ALK H + V HRDLKP N+ + +K+ DFGLAR+ DT
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--- 173
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
+V T +Y +PE Y DIWS+GC+ E+ P F S
Sbjct: 174 KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------- 221
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRP 305
E +R K F++ P L ++ R++ RP
Sbjct: 222 -----KELAGKIREGK----------------FRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 306 TAEEALADPYFK 317
+ EE L +P
Sbjct: 261 SVEEILENPLIL 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-55
Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 65/323 (20%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+K +E+IG G +G V A G+ IK++ + + REVK L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVE-----------IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV + S+ + K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+ + + Y+H+ + +RDLKP NI ++K+ DFGL +D T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ + D LLQ+L++ P+DRP
Sbjct: 232 -------------------------RDGIIS-----DIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 307 AEEALADPYFKGLAK--IEREPS 327
E L + ER +
Sbjct: 262 TSEILRTLTVWKKSPEKNERHTA 284
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-55
Identities = 70/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIV-------EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---F 131
IV E +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT---------PM 182
Q+ A++++H+ + HRDLKP NI + +KV DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQM-------- 231
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
E + + + + K+ PP+ P ++Q +++ P
Sbjct: 232 ----------ERVRTLTDVRNLKF-------PPLF-----TQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKIEREP 326
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-55
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 54/323 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A+ ++ + V+G+G++G V A + AIKKI E +S IL EV LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNH 61
Query: 82 PDIVEIK--------RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFF 131
+V + + ++ +++ E E L+ +I + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW----- 186
Q+L AL Y+H+ + HRDLKP NI + + +K+ DFGLA+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+ L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+ R N + ++++ LI D
Sbjct: 239 KKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKIE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-54
Identities = 89/319 (27%), Positives = 135/319 (42%), Gaps = 55/319 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAIK I A+ + E+++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + T T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGE---TSLMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 238
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 239 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 309 EALADPYFKGLAKIEREPS 327
EAL P+ + +
Sbjct: 271 EALRHPWLQDEDMKRKFQD 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-53
Identities = 65/351 (18%), Positives = 126/351 (35%), Gaps = 31/351 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD--L 246
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 247 LGTPSPETIAVVRNEKAR-KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
G PS V + E + +M + + L +L ++ D +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
++ A+ + S Q ++ + T EL+Y++
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQT 345
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-53
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP++++ S E ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+ AL++MH+ V HRD+KP N+ A +K+ D GL R S T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G +
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------ 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
++ + + Y PP+P + L + DP+ RP
Sbjct: 245 ----SLCKKIEQCDY-------PPLPSDHYSEELRQLVNMCINP----DPEKRPDVTYVY 289
Query: 312 ADPY 315
Sbjct: 290 DVAK 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+RYK V+GKGS+G V D TG++ A+K I + +D +LREV+LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ YMH + HRDLKP+N+L + + +++ DFGL+ + M D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ Y D+WS G I +L+G P F G + L +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------- 239
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ KY + V A L+++++ + P R +A +AL
Sbjct: 240 -------EKGKY--TFELPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 315 YFKGLAKIEREPSCQPISKL 334
+ + K + +
Sbjct: 284 WIQTYTKEQISVDVPSLDNA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 91/337 (27%), Positives = 143/337 (42%), Gaps = 51/337 (15%)
Query: 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKAN 120
D ILREV+LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAF 177
+ + Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 178 SDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+T M D + T +Y APE L G Y D+WS G I +L+G P F GK+
Sbjct: 176 QNTKM----KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L + + KY + + A L++++
Sbjct: 228 YDILKRV------------------ETGKY--AFDLPQ-------WRTISDDAKDLIRKM 260
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ F P R TA + L P+ + + S P +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 49/318 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ ++ +G G+YG V D T + AIK I S ++L EV +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+++ F+D Y+V E + +L I + Q+L
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L + +K+ DFGL+ V + M + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ KY D+WSIG I +L G P F G++ L +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------------ 249
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ KY + NV A L+++++ FD + R +A++AL P+
Sbjct: 250 ------EKGKY--TFDSPE-------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 316 FKGLAKIEREPSCQPISK 333
K + + P
Sbjct: 295 IKEMCSKKESGIELPSLA 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 82/340 (24%), Positives = 128/340 (37%), Gaps = 63/340 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 247
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P ++P+A L+Q+++ DP RPT E L
Sbjct: 248 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
D +F R P F + + + L
Sbjct: 291 NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-50
Identities = 69/321 (21%), Positives = 125/321 (38%), Gaps = 42/321 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ Q + + + R+ K IG+GS+ V +DT T +VA ++ D
Sbjct: 4 RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 63
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA 119
S+ R E ++L+ L+HP+IV K + K I +V ELM S L +K
Sbjct: 64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKR 122
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARVA 176
+ + + + Q+L+ L+++HT + HRDLK NI +K+ D GLA +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE+ KY ++D+++ G E+ T + +
Sbjct: 183 RASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
Q+ Y P + P +++
Sbjct: 235 AAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEIIEGC 266
Query: 297 IAFDPKDRPTAEEALADPYFK 317
I + +R + ++ L +F+
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQ 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+ D IL
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
REV+LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 70 REVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+ +T M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---- 180
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
D + T +Y APE L G Y D+WS G I +L+G P F GK+ L +
Sbjct: 181 KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 246 LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
G P+ + + A L+++++ F P
Sbjct: 235 ETGKYAFDLPQ----------------------------WRTISDDAKDLIRKMLTFHPS 266
Query: 303 DRPTAEEALADPYFKGLAKIE 323
R TA + L P+ + + E
Sbjct: 267 LRITATQCLEHPWIQKYSSEE 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 4e-50
Identities = 75/360 (20%), Positives = 132/360 (36%), Gaps = 74/360 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRH 81
N +++G GS G V + G VA+K++ F I L E+KLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQVIKANDDLTREHHQF-------F 131
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL-------------ANANCKLKVCDFGLAR-VAF 177
L Q+ + ++H+ + HRDLKP+NIL N ++ + DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 178 SDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
+ + + + + ++ A
Sbjct: 241 GD-------------------------KYSRESNIIRGIFSLDEMK-CLHDRSLIAEATD 274
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
L+ ++I DP RPTA + L P F +K + +S E E R + +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-49
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 22/343 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ E +G G +G V I TGE+VAIK+ + R E+++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRA 138
+V + + K D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + K+ D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
VV ++ P L + R LQ ++ + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHL---SGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
F+ L I ++ + VT+++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 63/306 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 221
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P +++P+A L+Q+++ DP RPT E L
Sbjct: 222 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 264
Query: 312 ADPYFK 317
D +F
Sbjct: 265 NDEFFT 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-49
Identities = 78/349 (22%), Positives = 126/349 (36%), Gaps = 85/349 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLL 79
+Y + IG+GSYGVV AI+ T AIK + + D RI EV+L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQMLRALKYMHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETIAVVRNEKARKYLTEMRK 272
S G + +L G FPG + + + L +P
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPN------------------- 299
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+ + PLA LL L+ + +R A AL P+ +
Sbjct: 300 ---------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 81/331 (24%), Positives = 130/331 (39%), Gaps = 62/331 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-----------HDVFEHISDAIRILR 71
Y + +G G+YG V + + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREH 127
E+ LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTV 184
+ Q+L + Y+H N+ HRD+KP+NIL N+ +K+ DFGL+ D +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
D + T +Y APE L KY D+WS G I +L G P F G++ + +
Sbjct: 206 --RDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ KY + N+ A L++ ++ +D
Sbjct: 260 ------------------EKGKY--YFDFND-------WKNISDEAKELIKLMLTYDYNK 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R TAEEAL + K A + + +
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-49
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 47/300 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + IG+GS+G V A+ T + A KKI + D R +E+++++ L HP+
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + DIY+V EL +L + + + +L A+ Y
Sbjct: 68 IIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H NV HRDLKP+N L + + LK+ DFGLA M V T +Y +P+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTPYYVSPQ 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G Y P D WS G + +L G P F + + I
Sbjct: 179 VLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------------- 219
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + +K + NV P A L++RL+ PK R T+ +AL +F+
Sbjct: 220 ---REGTF--TFPEKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 50/315 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPET 254
E L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE- 230
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V P A L+ ++ +PK R TA++AL P
Sbjct: 231 ---------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 315 YFKGLAKIEREPSCQ 329
+ ++ Q
Sbjct: 264 WICNRERVASAIHRQ 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-48
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 49/299 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LK+ DFG + A S + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+WS+G + E L GKP F + I
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------- 219
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ FP+ V A L+ RL+ +P RP E L P+
Sbjct: 220 --SRVEF--------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 55/320 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
Y+ E++G+G VV I T ++ A+K I E L+EV +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
Y APE + S Y +D+WS G I +L G P F + + L +I + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 250 ---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
SPE + + L+ R + P+ R T
Sbjct: 246 YQFGSPE----------------------------WDDYSDTVKDLVSRFLVVQPQKRYT 277
Query: 307 AEEALADPYFKGLAKIEREP 326
AEEALA P+F+ E
Sbjct: 278 AEEALAHPFFQQYVVEEVRH 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 52/335 (15%), Positives = 97/335 (28%), Gaps = 73/335 (21%)
Query: 22 ANRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLR 77
R + L V+G+ A D TGE + + S+AI ++ EV LR
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 78 LLR----------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQ 115
LLR P ++ R+ L + ++ M+S+L
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 116 VIKANDDLTREHHQ-------FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVL 225
F A A + + T A D W++G +
Sbjct: 254 GFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
+ + + I R +P
Sbjct: 312 CADLPNTDDAALGGSEWI--------------------------FRSCKNIP-------- 337
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
LL+ + + +DR +A+ P ++ L
Sbjct: 338 -QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-47
Identities = 85/327 (25%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP+
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 90 IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +PE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSPE 200
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 201 VLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE-- 253
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ ++ +PK R TA++AL P+
Sbjct: 254 --------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
++ Q +F RR
Sbjct: 288 ICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-47
Identities = 62/303 (20%), Positives = 105/303 (34%), Gaps = 43/303 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y ++ +G+G + V H G A+K+I E D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQ-QDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRA 138
I+ + L + + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP------MTVFWTDYVAT 192
L+ +H HRDLKP NIL + + D G A W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV----------------- 249
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+K ++ + +P + +LL ++ DP RP L
Sbjct: 250 --------FQKGDSVALAVQNQLSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 312 ADP 314
+
Sbjct: 299 SQL 301
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 6e-47
Identities = 52/335 (15%), Positives = 102/335 (30%), Gaps = 81/335 (24%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLR-- 80
V+G+ A D TGE + + S+AI+ ++ EV LRLLR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 81 --------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
P ++ R+ L + ++ M+S+L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEV 224
+ +V +R + PEL + T + D W++G + +
Sbjct: 254 VRDGARVVSSV-------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+ + + I R +P
Sbjct: 307 WCADLPITKDAALGGSEWI--------------------------FRSCKNIP------- 333
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
LL+ + + +DR +A+ P ++ L
Sbjct: 334 --QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-47
Identities = 82/327 (25%), Positives = 134/327 (40%), Gaps = 49/327 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + E Y++F+L+ +L + I A + + + Q+L A+ +
Sbjct: 72 IVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H V HR+LKP+N+L +K+ DFGLA + W + T Y +PE
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPE 183
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y +D+W+ G I +L G P F + I G PSPE
Sbjct: 184 VLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE-- 236
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ +++ +P R TA EAL P+
Sbjct: 237 --------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
+ + Q +F RR
Sbjct: 271 ISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-47
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 49/313 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+ + I +GKG +G V A + +A+K + E ++ RE+++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + + IY++ E +L++ ++ + + F+ ++ AL
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LK+ DFG + A S T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+W G + E L G P F S I
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
KFP + + L+ +L+ + P R + + P+ K
Sbjct: 225 --VNVDL--------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 319 LAKIEREPSCQPI 331
++ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 75/317 (23%), Positives = 124/317 (39%), Gaps = 53/317 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y++ E +G G + +V TG++ A K I I REV +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G++ L I
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFD 231
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F N LA ++RL+ DPK R T ++
Sbjct: 232 EEY----------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 311 LADPYFKGLAKIEREPS 327
L + K + +
Sbjct: 264 LEHSWIKAIRRRNVRGE 280
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-46
Identities = 73/308 (23%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+K+ ++GKGS+ V A HTG +VAIK I R+ EVK+ L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRAL 139
P I+E+ + +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 71 PSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYV 190
Y+H+ + HRDL N+L N +K+ DFGLA TP +Y+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+PE+ S + D+WS+GC+F +L G+P F +V + L+ +
Sbjct: 180 ------SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------- 224
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEE 309
Y + P+ + A L+ +L+ +P DR +
Sbjct: 225 -----------VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSS 259
Query: 310 ALADPYFK 317
L P+
Sbjct: 260 VLDHPFMS 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-46
Identities = 75/358 (20%), Positives = 136/358 (37%), Gaps = 62/358 (17%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
++ E K + Y++ +V+G G G V TG+K A+K +
Sbjct: 12 LEVLFQGPEPKKYAVT------DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--- 62
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI 117
D+ + +EV + P IV I + + + + ++ E ME +L I
Sbjct: 63 ----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRI 117
Query: 118 KANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKV 167
+ R F + + A++++H+ N+ HRD+KP+N+L + LK+
Sbjct: 118 QE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ + + T +Y APE+ G KY + D+WS+G I +L G
Sbjct: 173 TDFGFAKE-TTQNAL----QTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 225
Query: 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
P F T + + R + +Y + V
Sbjct: 226 FPPFYSN--------------TGQAISPGMKRRIRLGQY--GFPNPE-------WSEVSE 262
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
A +L++ L+ DP +R T + + P+ + + P E + V +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-46
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLL 76
+Y +VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L A+ ++H N+ HRDLKP+NIL + N ++++ DFG + + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPG 264
Query: 195 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
Y APE L S Y +D+W+ G I +L G P F + + L +I + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
SPE + + L+ RL+ DP+ R TA
Sbjct: 323 QFSSPE----------------------------WDDRSSTVKDLISRLLQVDPEARLTA 354
Query: 308 EEALADPYFK 317
E+AL P+F+
Sbjct: 355 EQALQHPFFE 364
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-46
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLR 80
+ LE IG G +G V + G AIK+ D LREV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR---EHH-QFFLYQM 135
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVA 176
R L+Y+H+ ++ H D+KP NI A+ K+ D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+P + A E+ ++ + P DI+++ +PL
Sbjct: 185 --SSPQVE-----EGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
H++ R+ + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
I DP+ RP+A + ++
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 80/337 (23%), Positives = 133/337 (39%), Gaps = 63/337 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLR 80
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLY------ 133
HP IVE+ +Y+VFE M+ +DL ++ + F+Y
Sbjct: 85 HPHIVELLETY-----SSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVAS 133
Query: 134 ----QMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V T + APE + Y +D+W G I +L+G F G
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYG------------ 235
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
+ KY +M + + ++ A L++R++ DP +R
Sbjct: 236 -------TKERLFEGIIKGKY--KMNPRQ-------WSHISESAKDLVRRMLMLDPAERI 279
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
T EAL P+ K + + + +F RR
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 76/316 (24%), Positives = 136/316 (43%), Gaps = 51/316 (16%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + + + +G G++G V + +G + IK I + +I
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIE 68
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD----LTR 125
E+++L+ L HP+I++I + ++ ++Y+V E E +L + I + L+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPM 182
+ + QM+ AL Y H+ +V H+DLKP+NIL + + +K+ DFGLA + SD
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T+ T Y APE T DIWS G + +LTG F G S+
Sbjct: 184 ----TNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
++ + + P A+ LL++++ DP
Sbjct: 236 KA------------------TYKEPNYA----------VECRPLTPQAVDLLKQMLTKDP 267
Query: 302 KDRPTAEEALADPYFK 317
+ RP+A + L +FK
Sbjct: 268 ERRPSAAQVLHHEWFK 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F + LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TAVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 78/339 (23%), Positives = 152/339 (44%), Gaps = 54/339 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++L+ IGKG++ V A TG +VAIK I + + ++ REV+++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +K+ DFG + + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
F KY P +D+WS+G I +++G F G++
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------------------ 218
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK-G 318
L E+R++ ++ + LL+R + +P R T E+ + D + G
Sbjct: 219 -------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 319 LAKIEREPSCQPISKLEFEF-----ERRRVTKDDIRELI 352
+ E +P +P + + ++++I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 77/347 (22%), Positives = 132/347 (38%), Gaps = 62/347 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 MLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+L + Y+H+ + H DLKP+NI+ ++K+ DFGLA
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----F 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
T + APE+ + D+WSIG I +L+G F G + L +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNY 234
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
F N LA ++RL+ DPK R T
Sbjct: 235 EFEDEY----------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+++L P+ K + R+ S + K + R++ L
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGL 313
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-45
Identities = 62/321 (19%), Positives = 129/321 (40%), Gaps = 62/321 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------------------HD 58
N+Y + + IGKGSYGVV A + + A+K +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 59 VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
+ ++ +E+ +L+ L HP++V++ ++ P++ +Y+VFEL+ + +V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVP 129
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
L+ + +F+ +++ ++Y+H + HRD+KP N+L + +K+ DFG++
Sbjct: 130 T-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NE 186
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
+ I + P P++ L+ R+
Sbjct: 246 MCLHSKI--------------------------KSQALEFP---DQPDIAEDLKDLITRM 276
Query: 297 IAFDPKDRPTAEEALADPYFK 317
+ +P+ R E P+
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 84/374 (22%), Positives = 140/374 (37%), Gaps = 69/374 (18%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
++K +Y +V+G G G V + T EK A+K + D +
Sbjct: 53 QIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPK 100
Query: 69 ILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTRE 126
REV+L R + P IV I + K + +V E ++ +L I+ R
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD-----RG 154
Query: 127 HHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVA 176
F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+
Sbjct: 155 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
S + T T +Y APE+ G KY + D+WS+G I +L G P F
Sbjct: 215 TSHNSL----TTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268
Query: 237 VHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
+ + +G P+PE + V
Sbjct: 269 LAISPGMKTRIRMGQYEFPNPE----------------------------WSEVSEEVKM 300
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
L++ L+ +P R T E + P+ K+ + P E + V ++ L
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 360
Query: 352 IYREILEYHPQLLK 365
+ ++ K
Sbjct: 361 ATMRVDYEQIKIKK 374
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-44
Identities = 69/306 (22%), Positives = 129/306 (42%), Gaps = 40/306 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 76/345 (22%), Positives = 136/345 (39%), Gaps = 51/345 (14%)
Query: 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+KD F+ Y + + +G+GS+ + + + + A+K I E
Sbjct: 1 MKDSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NT 52
Query: 70 LREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLT 124
+E+ L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTP 181
+ + +++ A+ +MH V HRDLKP+N+L N N ++K+ DFG AR+ D
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T Y APE L + Y + D+WS+G I +L+G+ F
Sbjct: 165 P---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+++ + I K + + + NV A L+Q L+ D
Sbjct: 219 TSAVEIM-----KKI------KKGDF--SFEGEA-------WKNVSQEAKDLIQGLLTVD 258
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
P R + + + +++ P P K
Sbjct: 259 PNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 68/362 (18%), Positives = 122/362 (33%), Gaps = 100/362 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 64
Query: 83 DIV-------------------------------------------------EIKRIMLP 93
IV
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 94 PSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ---FFLYQMLRALKYMHTAN 146
+ ++ M+ +L + L H Q+ A++++H+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARV---------AFSDTPMTVFWTDYVATRWYRA 197
+ HRDLKP NI + +KV DFGL + P T V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE + Y+ +DI+S+G I E+L E + +
Sbjct: 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFS--------------------TQMERVRI 282
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + + K+ P + F P ++Q +++ P +RP A + + + F+
Sbjct: 283 ITDVRNLKF-------PLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 318 GL 319
L
Sbjct: 331 NL 332
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 55/306 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ +G+G+ +V T + A+K + + D + E+ +L L HP+
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++K I P++ I +V EL+ +L I + + Q+L A+ Y+
Sbjct: 110 IIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + LK+ DFGL+++ M T Y APE
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTVCGTPGYCAPE 220
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT---PSPET 254
L G Y P +D+WS+G I +L G F + + I L SP
Sbjct: 221 ILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI--LNCEYYFISPW- 274
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V A L+++LI DPK R T +AL P
Sbjct: 275 ---------------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
Query: 315 YFKGLA 320
+ G A
Sbjct: 308 WVTGKA 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 54/340 (15%), Positives = 117/340 (34%), Gaps = 56/340 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---------------DVFEHISDAI 67
N Y+I+ + +G + + + A+KK D S
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTRE 126
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 127 HHQ--------FFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ + +L + Y+H N+ HRD+KP NIL + N ++K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 178 SDTPMTVFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T +++ PE + S +DIWS+G + F K
Sbjct: 204 DKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKAR---KYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ E +R + + + + L
Sbjct: 258 L--------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ + +P +R T+E+AL + + + + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 40/315 (12%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREPSCQPISKLE 335
K + P E
Sbjct: 271 KGAKRPRVTSGGVSE 285
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-43
Identities = 73/336 (21%), Positives = 130/336 (38%), Gaps = 62/336 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQF-------F 131
++ + F+D + ++ E + +L D + E ++ +
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELF------DRIAAEDYKMSEAEVINY 154
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q LK+MH ++ H D+KP+NI+ +K+ DFGLA D + V
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---- 210
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
AT + APE+ D+W+IG + +L+G F G+
Sbjct: 211 TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------------- 254
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
ET+ V+ + E F +V P A ++ L+ +P+ R T +
Sbjct: 255 -DLETLQNVK--RCDWEFDE----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
AL P+ KG + + +
Sbjct: 302 ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 38/313 (12%)
Query: 24 RYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H 81
Y++ +V+G+G++ V I+ T ++ A+K I HI + REV++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGH 70
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV----AFSDTPMTVFWTDYV 190
AL ++H + HRDLKP+NIL N +K+CDF L T
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
+ + KY E K + ++ A L+ +L+ D K R +A
Sbjct: 243 PACQNMLFESI---QEGKY--EFPDKD-------WAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 308 EEALADPYFKGLA 320
+ L P+ +G A
Sbjct: 291 AQVLQHPWVQGCA 303
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-43
Identities = 70/310 (22%), Positives = 118/310 (38%), Gaps = 48/310 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G+GS+G V D TG + A+KK+ E E+ L
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVACAGLS 108
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
P IV + + RE + + EL+E S L Q+IK L + ++L Q L
Sbjct: 109 SPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEG 162
Query: 139 LKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA-RVAFSDTPMTVFWTDYVA-TRWY 195
L+Y+HT + H D+K N+L +++ + +CDFG A + ++ DY+ T +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ +DIWS C+ +L G + + L + P P
Sbjct: 223 MAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPPP--- 274
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+P P+ PL + +Q + +P R +A E
Sbjct: 275 -----------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 316 FKGLAKIERE 325
+
Sbjct: 313 KALQEVGGLK 322
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 73/327 (22%), Positives = 132/327 (40%), Gaps = 50/327 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDL-HQVIKANDDLTREHHQFFLYQMLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +MH N H DLKP+NI+ + +LK+ DFGL + V T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ D+WS+G + +L+G F G++ ET+
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
V K+ + M F + +++L+ DP R T +AL P+
Sbjct: 366 RNV---KSCDW--NMDDSA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
R+ + +
Sbjct: 414 LTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 60/319 (18%), Positives = 127/319 (39%), Gaps = 54/319 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDAIRILREVKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + + +E++LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+++++ ++ K + +Y+V E ++ + + H +F Q++
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLIDG 121
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---- 194
L+Y+H+ + H+D+KP N+L LK+ G+A + F D
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA------LHPFAADDTCRTSQGSP 175
Query: 195 -YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
++ PE+ + ++ +DIWS G + TG F G +
Sbjct: 176 AFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----------------- 217
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ ++ + + + P LL+ ++ ++P R + +
Sbjct: 218 --------------IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 313 DPYF-KGLAKIEREPSCQP 330
+F K E P
Sbjct: 264 HSWFRKKHPPAEAPVPIPP 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 55/315 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + V+GKG+YG+V A D ++AIK+I + S + E+ L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLK 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM------TVFWTDY 189
LKY+H + HRD+K N+L N + LK+ DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
APE+ Y A DIWS+GC E+ TGKP F ++L
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELG-------- 229
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E A + + + P +P ++ A + + DP R A +
Sbjct: 230 ---EPQAAMF------KVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACAND 275
Query: 310 ALADPYFKGLAKIER 324
L D + K +K ++
Sbjct: 276 LLVDEFLKVSSKKKK 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-42
Identities = 62/307 (20%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + + +E+ +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQMLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + A D+WS+G + +L+G F + T+ +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAE---------TN------QQI 211
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +Y ++ F + A+ + RL+ + K R TA EAL P
Sbjct: 212 IENI---MNAEY--TFDEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 315 YFKGLAK 321
+ K +
Sbjct: 260 WLKQKIE 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-42
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
Y++ E IG GSY V I T + A+K I E++ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+H V HRDLKP NIL + +++CDFG A+ ++ T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGT--- 249
+ APE L Y A DIWS+G + +LTG F +++ G
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ +V A L+ +++ DP R TA
Sbjct: 243 SGGY----------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 310 ALADPYFKGLAKIEREPSCQPISK 333
L P+ ++ + + +
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 58/331 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
R ++ V+ +G + V A D +G + A+K++ + I++EV ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVI---KANDDLTREHHQFFLYQML 136
+IV+ + L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--- 191
RA+++MH + HRDLK +N+L + +K+CDFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YR PE+ +S DIW++GCI + + F + +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+V KY PP + L++ ++ +P++
Sbjct: 260 ------------RIVN----GKY-----SIPP------HDTQYTVFHSLIRAMLQVNPEE 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R + E + + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P+ ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 182
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F +
Sbjct: 183 SG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------------------- 215
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++ LL ++ DP R T ++ +FK
Sbjct: 216 ------VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 76/360 (21%), Positives = 126/360 (35%), Gaps = 90/360 (25%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++K +Y +V+G G G V + T EK A+K +
Sbjct: 3 HVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML------ 51
Query: 63 ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN 120
D + REV+L R + P IV I + K + +V E ++ +L I+
Sbjct: 52 -QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD- 108
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDF 170
R F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DF
Sbjct: 109 ----RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
G A E G KY + D+WS+G I +L G P
Sbjct: 165 GF------------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPP 197
Query: 231 FPGKSVVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
F + + +G P+PE + V
Sbjct: 198 FYSNHGLAISPGMKTRIRMGQYEFPNPE----------------------------WSEV 229
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
L++ L+ +P R T E + P+ K+ + P E + V +
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-41
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 62/327 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++ ++GKG +G V A +VAIK I + +SD++ EV LL +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 80 R----HPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLY 133
HP ++ + +V E DL I L + F
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG-----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + D P T F T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF----DGT 201
Query: 193 RWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
R Y PE +Y +WS+G + +++ G F +
Sbjct: 202 RVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------- 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ + P +V P L++R +A P RP+ EE L
Sbjct: 246 ------------------LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 312 ADPYFK-GLAKIEREPSCQPISKLEFE 337
DP+ + + PS + L +
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-41
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y I E +G+GS+G V A T +KVA+K I + + +R+ RE+ L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP+N+L + N +K+ DFGL+ + + + Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPEVIN 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y P +D+WS G + +L G+ F +
Sbjct: 181 G--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-------------------------- 212
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK ++ + P A L++R+I DP R T +E DP+F
Sbjct: 213 -----IPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
+Y++ ++G G +G V + I VAIK + + + + R+ EV LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG + DT T F TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF----DGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 255
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+R + V L++ +A P DRPT EE
Sbjct: 256 ----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 57/303 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLLR 77
+Y + +G G++G V A+D ++V +K I D + ++ E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
+ H +I+++ I +V E S DL I + L + Q+
Sbjct: 85 RVEHANIIKVLDIFENQGF-----FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A F T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF----CGTIEY 195
Query: 196 RAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ + Y P +++WS+G ++ + F
Sbjct: 196 CAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCE--------------------- 232
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PP V + L+ L+ P+ R T E+ + DP
Sbjct: 233 ---LEETVEAAI------HPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 315 YFK 317
+
Sbjct: 277 WVT 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 85/362 (23%), Positives = 136/362 (37%), Gaps = 55/362 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY ++ IG G++GV D T E VA+K I D + RE+ R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDE-NVQREIINHRSLRHPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K ++L P+ + ++ E +L++ I + + +FF Q+L + Y
Sbjct: 78 IVRFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
H+ + HRDLK +N L + +LK+CDFG ++ + + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 188
Query: 201 CGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
+Y D+WS G +L G F
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----------------- 227
Query: 258 VRNEKARKYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
RK + + K +P + P L+ R+ DP R + E +F
Sbjct: 228 ------RKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
Query: 317 -KGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTN 375
K L S E E + + D I ++I P + ++ N
Sbjct: 279 LKNLPADLMNESNTGSQFQEPEQPMQSL--DTIMQIISEAT---IPAVRNRCLDDFMTDN 333
Query: 376 FL 377
Sbjct: 334 LD 335
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 58/309 (18%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N Y + + +G+G + VV I TG++ A K + IL E+ +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI--KANDDLTREHHQFFLYQ 134
P ++ + + +++ I ++ E ++ + + + ++ + Q
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 135 MLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +K+ DFG++R + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT-- 249
T Y APE+ + T A D+W+IG I +LT F G+ I
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVD 251
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
F +V LA +Q L+ +P+ RPTAE
Sbjct: 252 YSEET----------------------------FSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 309 EALADPYFK 317
L+ + +
Sbjct: 284 ICLSHSWLQ 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-40
Identities = 89/347 (25%), Positives = 143/347 (41%), Gaps = 63/347 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++ EV+G+G++GVVC A + VAIK+I E A E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIES--ESERKAFI--VELRQLSRVN 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQFFLYQML 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYMHTAN---VYHRDLKPKNILANANCK-LKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LK+CDFG A T M T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHM----TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ V N +PP+ N+ L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHN----------GTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIV- 255
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359
K + + R L++ + +D R Y + E+
Sbjct: 256 ----KIMTHLMRYFPGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 54/315 (17%)
Query: 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ Y + E++G G +G V +T TG K+A K I + D + E+ ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKRIMLPPSKREF---KDIYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQM 135
H +++++ F DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++MH + H DLKP+NIL ++K+ DFGLAR + V T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE + F + D+WS+G I +L+G F G D
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGD---------ND------A 294
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
ET+ + R L + ++F ++ A + +L+ + R +A EAL
Sbjct: 295 ETLNNIL--ACRWDLED----------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 313 DPYFKGLAKIEREPS 327
P+ R +
Sbjct: 343 HPWLSDHKLHSRLSA 357
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 54/298 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-----REVKLLRLLR 80
+ + IGKG +G+V VAIK + + REV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI-KANDDLTREHHQFFLYQMLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYMHTAN--VYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
++YM N + HRDL+ NI NA KV DFGL++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F S
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ I ++R E R P +P + P +++ + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 187
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F
Sbjct: 188 SG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDH------------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++P + LL+ ++ DP R T ++ +FK
Sbjct: 221 ------VPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 38/287 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + IG GS+G V G+ VA+K ++ EV +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMH 143
P + +V + E S L+ + A++ + Q R + Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + + +K+ DFGLA S + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ D+++ G + E++TG+ + + I +V
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------------NNRDQIIEMV---- 238
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
R L V N RL+ + +RP+
Sbjct: 239 GRGSL--SPDLSKVR-----SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 77/339 (22%), Positives = 134/339 (39%), Gaps = 33/339 (9%)
Query: 4 DQTKKELKDKDFFTEYG---DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+Q +K L+ + + ++ + +G G+ GVV +G +A K IH +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE 69
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKA 119
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKK 124
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ + +++ L Y+ + HRD+KP NIL N+ ++K+CDFG++
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LI 183
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D+ F V TR Y +PE L G + Y+ DIWS+G E+ G+ P
Sbjct: 184 DSMANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---QKFPNVDPLALRLLQ 294
+ + + ET R M +PP+ +F N P L
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 295 RLIAF----------DPKDRPTAEEALADPYFKGLAKIE 323
+ F +P +R ++ + + K E
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
I E IG GS+G V A G VA+K + + H LREV +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +KVCDFGL+R+ S + T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ D++S G I E+ T + + ++ ++ AV
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVV-----------AAVGF 253
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
K+ +P N++P +++ +P RP+
Sbjct: 254 K----------CKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 53/314 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I ++ REV R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALKYM 142
+ M PP + ++ L + L+ V+ A L + ++++ + Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + N K+ + DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
++ D++++G I+ E+ + F + P+
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------------PAEA 250
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I + KP + + +L AF+ ++RPT + +
Sbjct: 251 IIWQMGT----------GMKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMD- 295
Query: 314 PYFKGLAKIEREPS 327
+ L K R S
Sbjct: 296 -MLEKLPKRNRRLS 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-38
Identities = 71/385 (18%), Positives = 133/385 (34%), Gaps = 53/385 (13%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ L + + + Y++L VIGKG V A TGE V +++I ++
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLE 63
Query: 61 EHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVI 117
++ + + E+ + +L HP+IV + + ++ ++VV M S +I
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGS-AKDLI 117
Query: 118 KA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
D + + L +L+AL Y+H HR +K +IL + + K+ +
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 176 AFSD----TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-- 229
S + F V + +PE+ Y DI+S+G E+ G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 230 --------LF----------PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271
L S + +L + + ++ +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 272 KKPPV-----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
P P F F V+ + LQR +P RP+A L +FK + + E
Sbjct: 298 PSHPYHRTFSPHFHHF--VE----QCLQR----NPDARPSASTLLNHSFFKQIKRRASEA 347
Query: 327 SCQPISKLEFEFERRRVTKDDIREL 351
+ + + D +
Sbjct: 348 LPELLRPVTPITNFEGSQSQDHSGI 372
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 60/296 (20%), Positives = 102/296 (34%), Gaps = 48/296 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+EVK++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVL 70
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ I + + + E ++ L +IK+ D F + + Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ N+ HRDL N L N + V DFGLAR+ + + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 203 SF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ Y +D++S G + E++ P P
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIR-ILREVKLLRLLRHPD 83
+ E+IG G +G V A G++VA+K D E IS I + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ ++ + L + +V E L++V+ + + + Q+ R + Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTANVY---HRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
H + HRDLK NIL +N LK+ DFGLAR T M+
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
W APE+ + S ++ D+WS G + E+LTG+ F G
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID---------------G 219
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V K P+P +L++ DP RP+
Sbjct: 220 LAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 82/303 (27%), Positives = 129/303 (42%), Gaps = 54/303 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
RYKI++ +G G V A DT KVAIK I + + R REV L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 81 HPDIVEIKRIMLPPSKREFKDI-------YVVFELME-SDLHQVIKANDDLTREHHQFFL 132
H +IV + D+ Y+V E +E L + I+++ L+ + F
Sbjct: 70 HQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV-A 191
Q+L +K+ H + HRD+KP+NIL ++N LK+ DFG+A+ A S+T +T T++V
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLG 174
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y +PE DI+SIG + E+L G+P F G +
Sbjct: 175 TVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNG----------------ET 216
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEA 310
+IA+ ++ P ++ ++ R D +R T +E
Sbjct: 217 AVSIAIKH----------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
Query: 311 LAD 313
D
Sbjct: 267 KDD 269
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-37
Identities = 84/374 (22%), Positives = 141/374 (37%), Gaps = 91/374 (24%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY ++ +G G + V + D + VA+K + EH ++ E++LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKRIMLPPSKREFKD-------IYVVFELMESDLHQVIKANDD--LTREHHQFFL 132
D + R M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQMLRALKYMHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
K+K+ D G A + T TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQ----TRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIA 256
S Y DIWS C+ E+ TG LF S + LI +LLG + I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 VVRNEKARKY------LTEMRKKPPVPLFQ------KFPNVD-PLALRLLQRLIAFDPKD 303
+ ++++ L + K P LF+ ++ + L ++ P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 304 RPTAEEALADPYFK 317
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L + + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
+ PP+ ++ M L+ V+ + + Q F M R + +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAP 198
+HT + L ++++ + + ++ + S M W AP
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E L + D+WS + E++T + F S + E
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
V E R P +P P + P +L++ + DP RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 52/299 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHP 82
Y++ ++G+G G V A DT VA+K + + R+ RE + L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 83 DIV------EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQM 135
+V EI + YV L+ DL +++ L + Q+
Sbjct: 95 HVVPIHDFGEIDGQL-----------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A +D +T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE S T DI+++ C+ E LTG P + G + +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALAD 313
+V ++ + P + ++ R +A +P+DR T + A
Sbjct: 241 SV-----MGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 47/313 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVK-LLRL 78
+ N + L +G G+ G V TG +A+K++ + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE-HHQFFLYQMLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSP 252
APE Y D+WS+G E+ TG+ P K+ L + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP 248
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + FQ F L + D + RP + L
Sbjct: 249 ------LLPGHMGFSGD---------FQSFVK------DCLTK----DHRKRPKYNKLLE 283
Query: 313 DPYFKGLAKIERE 325
+ K +E +
Sbjct: 284 HSFIKRYETLEVD 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 85/375 (22%), Positives = 144/375 (38%), Gaps = 70/375 (18%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M LKD D + + + L IG GS+G V A D E VAIKK+
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 DVFEHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQV 116
+ ++ + I++EV+ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDL 143
Query: 117 IKANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
++ + +E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGK 228
+F TP +W APE+ +Y +D+WS+G I E+ K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 -PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
PLF N A L + + P Q +
Sbjct: 251 PPLF----------------------------NMNAMSALYHIAQNES-PALQS-GHWSE 280
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
+ + P+DRPT+E L + +P + + +R + +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTKDAVRE 331
Query: 348 IRELIYREILEYHPQ 362
+ L YR++ + Q
Sbjct: 332 LDNLQYRKMKKILFQ 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 85/383 (22%), Positives = 140/383 (36%), Gaps = 88/383 (22%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---H 57
M D + L + D A ++++E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELME----SD 112
D E I I +L++ H +I + + D +++V E +D
Sbjct: 62 DEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L + K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG+
Sbjct: 117 LIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 173 A---------RVAFSDTPMTVFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCI 220
+ R F TP +W APE C + Y D+WS+G I
Sbjct: 176 SAQLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-I 222
Query: 221 FA-EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV--- 276
A E+ G P + L LI R P
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLIP--------------------------RNPAPRLKS 256
Query: 277 ----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332
FQ F + L++ + RP E+ + P+ + Q
Sbjct: 257 KKWSKKFQSF-----IESCLVK-----NHSQRPATEQLMKHPFIRDQPNER-----QVRI 301
Query: 333 KLEFEFERRRVTKDDIRELIYRE 355
+L+ +R + + + E Y
Sbjct: 302 QLKDHIDRTKKKRGEKDETEYEY 324
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-36
Identities = 80/320 (25%), Positives = 121/320 (37%), Gaps = 39/320 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ IGKG YG V GEKVA+K + R E+ L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT--TEEASWFR-ETEIYQTVLMRHENIL 94
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I + +Y++ + E+ L+ +K+ L + Y + L ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 144 TANVY--------HRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVATRW 194
T HRDLK KNIL N + D GLA SDT + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 195 YRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y PE L S + + D++S G I EV G +QL + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSDP 270
Query: 251 SPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
S E + +V +K R P P +L+ A +P R TA
Sbjct: 271 SYEDMREIVCIKKLR---------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 310 ALADPYFKGLAKIEREPSCQ 329
K LAK+ +
Sbjct: 322 VK-----KTLAKMSESQDIK 336
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-36
Identities = 79/328 (24%), Positives = 139/328 (42%), Gaps = 64/328 (19%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
+ +Q K L+ + GD IG+GS G+VC A + H+G +VA+K +
Sbjct: 25 VTHEQFKAALRM---VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-- 79
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+ EV ++R +H ++VE+ + L + ++V+ E ++ L ++
Sbjct: 80 LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVS 134
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----- 173
L E +L+AL Y+H V HRD+K +IL + ++K+ DFG
Sbjct: 135 QVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 174 ----RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
R + TP +W APE+ S Y +DIWS+G + E++ G+P
Sbjct: 194 DVPKRKSLVGTP---YWM---------APEVISR--SLYATEVDIWSLGIMVIEMVDGEP 239
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+ ++ + + +R PP P + V P+
Sbjct: 240 PY---------------------------FSDSPVQAMKRLRDSPP-PKLKNSHKVSPVL 271
Query: 290 LRLLQRLIAFDPKDRPTAEEALADPYFK 317
L+R++ DP++R TA+E L P+
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 51/304 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + R RE + L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 81 HPDIVEI--------KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFF 131
HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV- 190
+ +AL + H + HRD+KP NI+ +A +KV DFG+AR A +D+ +V T V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVI 180
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T Y +PE D++S+GC+ EVLTG+P F G S
Sbjct: 181 GTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------- 223
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEE 309
++V A +++ E P+P + + ++ + +A +P++R TA E
Sbjct: 224 ---PVSV-----AYQHVRE----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
Query: 310 ALAD 313
AD
Sbjct: 272 MRAD 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A+ + + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHHQFFLYQM 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ D + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
Y APE Y+ DIWS+G E+ + FP S + ++ PSP
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ L + F F + + L++ + K+RPT E +
Sbjct: 233 Q-------------LPADKFSAE---FVDFTS------QCLKK----NSKERPTYPELMQ 266
Query: 313 DPYFKGLAKIE 323
P+F
Sbjct: 267 HPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A K L IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHH-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 MLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ ++ T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250
Y APE + Y D+WS+G E+ TG+ P SV QL +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GD 246
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P+ + N + R++ F F N L + D RP +E
Sbjct: 247 PPQ----LSNSEEREFSPS---------FINFVN------LCLTK----DESKRPKYKEL 283
Query: 311 LADPYFK 317
L P+
Sbjct: 284 LKHPFIL 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 75/325 (23%), Positives = 132/325 (40%), Gaps = 64/325 (19%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++L+ GD +Y E IG+G+ G V A+D TG++VAI++++ +
Sbjct: 3 EEILEKLRS---IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQ 57
Query: 63 ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND 121
I+ E+ ++R ++P+IV L + ++VV E + L V+
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETC 112
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------- 173
+ + L+AL+++H+ V HRD+K NIL + +K+ DFG
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 174 -RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
R TP +W APE+ Y P +DIWS+G + E++ G+P +
Sbjct: 172 KRSTMVGTP---YWM---------APEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPY- 216
Query: 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRL 292
NE + L + P Q + +
Sbjct: 217 --------------------------LNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 249
Query: 293 LQRLIAFDPKDRPTAEEALADPYFK 317
L R + D + R +A+E L + K
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
A +Y++ I G G + A+D + G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV+I + + Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYL------YGTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + T A DI+++G A + P G+ V P
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP--------- 285
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALADPYFKG 318
P+ + + + L R + DP+ R TAEE A
Sbjct: 286 --------------EDDPVLKTYDSYGRLLRRAIDP----DPRQRFTTAEEMSAQ----- 322
Query: 319 LAKIEREPSCQP 330
L + RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 73/324 (22%), Positives = 119/324 (36%), Gaps = 47/324 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ E IGKG +G V GE+VA+K R E+ +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ K +++V + E L + +T E L
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYV 190
++H + HRDLK KNIL N + D GLA S T V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV +K R P +P + + ++++ + R
Sbjct: 272 PSDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 306 TAEEALADPYFKGLAKIEREPSCQ 329
TA K L+++ ++ +
Sbjct: 323 TALRIK-----KTLSQLSQQEGIK 341
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 39/308 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + Y++ EVIG G+ VV AA EKVAIK+I ++ + + +L+E++ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD-----LTREHHQFF 131
HP+IV + + +++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDY 189
L ++L L+Y+H HRD+K NIL + +++ DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
V T + APE+ Y DIWS G E+ TG + + ++ L
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
P V++++ K F+K ++L L + DP+ RPTA E
Sbjct: 243 DPPSLETGVQDKEMLKKYG--------KSFRKM-----ISLCLQK-----DPEKRPTAAE 284
Query: 310 ALADPYFK 317
L +F+
Sbjct: 285 LLRHKFFQ 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 84/341 (24%), Positives = 128/341 (37%), Gaps = 82/341 (24%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
M + L D + LE IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKA--DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ 115
E + I +E+ +L P + + L +K ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
R F TP FW APE+ S Y DIWS+G E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLGITAIELAR 214
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV------PLFQ 280
G+P + L LI + PP +
Sbjct: 215 GEPPHSELHPMKVLFLIP--------------------------KNNPPTLEGNYSKPLK 248
Query: 281 KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+F V+ L + +P RPTA+E L + AK
Sbjct: 249 EF--VE----ACLNK----EPSFRPTAKELLKHKFILRNAK 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 37/277 (13%), Positives = 81/277 (29%), Gaps = 49/277 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + ++G+G++ V A D +K +K + + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMER 120
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK-----ANDDLTREHHQ 129
L+ ++ L + +V EL L I + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL-----------ANANCKLKVCDFGLARVAFS 178
F +ML ++ +H + H D+KP N + + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
T+F T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 238 HQL---------------DLITDLLGTPSPETIAVVR 259
+ +L P + +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 69/331 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
++ +++LK D + + +LE +G+GSYG V AI TG+ VAIK++ V
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQV 116
+ + I++E+ +++ P +V+ + +++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--- 173
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG+A
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 174 ------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLT 226
R TP FW APE+ Y DIWS+G I A E+
Sbjct: 176 TDTMAKRNTVIGTP---FWM---------APEVIQE--IGYNCVADIWSLG-ITAIEMAE 220
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286
GKP P + + + + PP P F+K
Sbjct: 221 GKP--P-------------------------YADIHPMRAIFMIPTNPP-PTFRKPELWS 252
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+++ + P+ R TA + L P+ +
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 47/318 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+LE +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYMHTANVY--------HRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYV 190
++H HRDLK KNIL N + + D GLA + + S + V V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV ++ R P +P +L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 306 TAEEALADPYFKGLAKIE 323
TA K L KI+
Sbjct: 289 TALRIK-----KTLTKID 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 69/335 (20%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
+K + + + ++I+ +G G++G V A + TG A K I + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEEL 60
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD 122
+ E+++L HP IV++ K ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--------- 173
LT Q QML AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGK- 228
R +F TP +W APE+ K Y DIWS+G I E+ +
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPL 288
P + L ++ K P P
Sbjct: 221 PHH----------------------------ELNPMRVLLKIAKSDP-PTLLTPSKWSVE 251
Query: 289 ALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
L+ + +P+ RP+A + L P+ + +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
V++ F+D +Y ++ +L + I+ +F+ +++ A
Sbjct: 91 FFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H + HRDLKP+NIL N + +++ DFG A+V ++ + +V T Y +P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSP 201
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
EL + D+W++GCI +++ G P F + I
Sbjct: 202 ELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------------- 244
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALA 312
++ + P P A L+++L+ D R A
Sbjct: 245 -----------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 313 DPYFKGL 319
P+F+ +
Sbjct: 289 HPFFESV 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 71/325 (21%), Positives = 120/325 (36%), Gaps = 49/325 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++LEV +G +G V A E VA+K + + EV L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +I++ I S D++++ E L +KAN ++ M R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYMHTANVY----------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L Y+H HRD+K KN+L N + DFGLA F
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAF---- 299
+ PS E + VV ++K R P + + +L I
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLR-----DYWQKHAGMAMLCETIEECWDH 298
Query: 300 DPKDRPTAEEALADPYFKGLAKIER 324
D + R +A + + +++R
Sbjct: 299 DAEARLSAGCVG-----ERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 54/343 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + K+LE+IG+G YG V + VA+K + + + L+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVF---SFANRQNFINEKNIYRVPLME 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + +V E + L + + + + + R L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 140 KYMHTANVY---------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
Y+HT HRDL +N+L + + DFGL+ + + D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 190 ----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVV-H 238
V T Y APE L G+ +D++++G I+ E+ LFPG+SV +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 239 QLDLITDLLGTPSPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
Q+ T++ P+ E +V EK R P P + + LA+R L+ I
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQR---------PKFP---EAWKENSLAVRSLKETI 292
Query: 298 ----AFDPKDRPTAEEALADPYFKGLAKI----EREPSCQPIS 332
D + R TA+ A + +A++ ER S P +
Sbjct: 293 EDCWDQDAEARLTAQXAE-----ERMAELMMIWERNKSVSPTA 330
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 70/328 (21%), Positives = 135/328 (41%), Gaps = 63/328 (19%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+++ F +IL IGKGS+G VC T + A+K ++ +
Sbjct: 4 PVFDENEDVNFDHF----------EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--Q 51
Query: 62 HI--SDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLH 114
+ +R + +E+++++ L HP +V + F+D +++V +L+ DL
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLR 103
Query: 115 QVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
++ N E + F+ +++ AL Y+ + HRD+KP NIL + + + + DF +A
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ +T +T T+ Y APE + Y+ A+D WS+G E+L G+ +
Sbjct: 164 MLPRETQITTM----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
R+ + K + + V +P + L
Sbjct: 220 -------------------------RSSTSSKEIVHTFETTVV----TYPSAWSQEMVSL 250
Query: 293 LQRLIAFDPKDR-PTAEEALADPYFKGL 319
L++L+ +P R + PY +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 64
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKE 175
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 176 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 228
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 229 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 277
Query: 306 T 306
+
Sbjct: 278 S 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 95
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D Y
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKE 206
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 207 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 259
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 260 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 308
Query: 306 T 306
+
Sbjct: 309 S 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 45/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
K + +G+G +G V +TGE+VA+K + E + I + +E+++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLY 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +IV+ K I ++ I ++ E + S L + + N + + + + Q+ +
Sbjct: 82 HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ + HRDL +N+L + ++K+ DFGL + +D Y
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDSP 192
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE SK+ A D+WS G E+LT S + L ++G
Sbjct: 193 VFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPTH 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + L E ++ P P P + +L+++ F P +R +
Sbjct: 245 GQ----MTVTRLVNTLKEGKRLPC-------PPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + ++ Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVC---TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HRDL +N L N +KV DFGL+R+ DT Y A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 174
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP +V++ + L E I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +KV DFG+ R D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + +S VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 71/332 (21%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---- 57
+ + L DF + +IG+G +G V TG+ A+K +
Sbjct: 178 KNVELNIHLTMNDF----------SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 58 ---DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113
+ +L V P IV + P K + + +LM DL
Sbjct: 228 KMKQGETLALNERIMLSLVSTGD---CPFIVCMSYAFHTPDK-----LSFILDLMNGGDL 279
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
H + + + +F+ +++ L++MH V +RDLKP NIL + + +++ D GLA
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
P V T Y APE+ Y + D +S+GC+ ++L G F
Sbjct: 340 CDFSKKKPHA-----SVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
K + + M V + P + P L
Sbjct: 394 -------------------------HKTKDKHEIDRMTLTMAV----ELPDSFSPELRSL 424
Query: 293 LQRLIAFDPKDR-----PTAEEALADPYFKGL 319
L+ L+ D R A+E P+F+ L
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + KV DFGL + A S WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+L+ +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRA 138
HP +V+ + + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ ++ + HRDL +N L + + +KV DFG+ R D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
DA I +V+G G +G VC+ +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N KV DFGL RV D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + S V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 26 KILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++LE +G GS+GVV + VA+K + DV +REV + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
+++ + ++L P + +V EL L ++ + + Q+ +
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G + ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 33/251 (13%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K + +GKG++G V +TG VA+K++ H + D RE+++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALH 82
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
IV+ + + P + + + +V E + S L ++ + L + Q+ +
Sbjct: 83 SDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +NIL + +K+ DFGLA++ D YV
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK------DYYVVREPGQSP 193
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGT 249
WY APE + ++ D+WS G + E+ T K P + + D
Sbjct: 194 IFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VP 248
Query: 250 PSPETIAVVRN 260
+ ++
Sbjct: 249 ALSRLLELLEE 259
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHIS 64
+E++ K+ + D + + +G G++G V VA+K + + +
Sbjct: 4 EEIRPKEVYL---DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDL 123
+L E +++ L +P IV + I S +V E+ E L++ ++ N +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 114
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
++ ++Q+ +KY+ +N HRDL +N+L K+ DFGL++ +D
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 171
Query: 184 VFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
Y A +WY APE + K++ D+WS G + E + G+ + G
Sbjct: 172 ---NYYKAQTHGKWPVKWY-APE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 236 ---VVHQLD 241
V L+
Sbjct: 226 GSEVTAMLE 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 37/291 (12%), Positives = 69/291 (23%), Gaps = 65/291 (22%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
RY++L G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + ++ VV E + L +V + + + + A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
P DI IG +L + P V +A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGV---------------RSGLAPAE 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ A P+ ++ + R + D R +
Sbjct: 216 RDTA---------GQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
R ++ IG+G +G V I VAIK SD++R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ AL Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 49/307 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL+VIG+G++G V + + A+K ++ ++ E +L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 84 IVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQVIKANDDLTREHHQFFLYQMLRA 138
I + F+D +Y+V + DL + K D L E +F+L +M+ A
Sbjct: 136 ITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP NIL + N +++ DFG D + V T Y +P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SV-AVGTPDYISP 245
Query: 199 EL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ +Y P D WS+G E+L G+ F +S+V I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------------ 293
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALA 312
M K + +V A L++RLI + R E+
Sbjct: 294 --------------MNHKERFQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKK 338
Query: 313 DPYFKGL 319
P+F G+
Sbjct: 339 HPFFSGI 345
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+A+R I ++IG G G VC G+ VAIK + + L E ++
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMG 105
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQM 135
HP+I+ ++ ++ + +V E ME+ L ++ +D T L +
Sbjct: 106 QFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
++Y+ HRDL +N+L ++N KV DFGL+RV D Y T
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + + V+ ++
Sbjct: 216 IPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 61/331 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+ L+ DF +IL+VIG+G++ V TG+ A+K ++
Sbjct: 51 VRLKEVRLQRDDF----------EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQV 116
+ E +L I ++ F+D +Y+V E DL +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHF--------AFQDENYLYLVMEYYVGGDLLTLL 152
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
K + + E +F+L +++ A+ +H HRD+KP NIL + +++ DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 177 FSDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+D + V T Y +PE+ G Y P D W++G E+ G+ F
Sbjct: 213 RADGTVRS-LV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
S I + K + L V A
Sbjct: 271 YADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEARD 304
Query: 292 LLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+QRL+ P+ R A + P+F GL
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HR+L +N L N +KV DFGL+R+ DT Y A
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 381
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 382 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 34/238 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLL 76
+ L+V+G G +G V + GE V IK I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAI 69
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + +++V DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M + L ++ + + A
Sbjct: 78 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +N L N +KV DFGL+R D +Y ++
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFP 184
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW PE +SK++ DIW+ G + E+ + GK + + +
Sbjct: 185 VRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
H +I+ ++ ++ SK + + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVI---SKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE + K+T A D+WS G + EV+T G+ + S V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 71/328 (21%), Positives = 122/328 (37%), Gaps = 61/328 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+K +D+ ++++VIG+G++G V T + A+K +
Sbjct: 59 NKIRDLRMKAEDY----------EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI 117
SD+ E ++ P +V++ F+D +Y+V E M DL ++
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-RVA 176
N D+ + +F+ +++ AL +H+ HRD+KP N+L + + LK+ DFG ++
Sbjct: 161 S-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 177 FSDTPMTVFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
T V T Y +PE Y D WS+G E+L G F
Sbjct: 220 KEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
S+V I M K + F ++ A L+
Sbjct: 277 SLVGTYSKI--------------------------MNHKNSLT-FPDDNDISKEAKNLIC 309
Query: 295 RLIAFDPKDR---PTAEEALADPYFKGL 319
+ D + R EE +FK
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 320
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 426
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 427 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPD 83
+ E IG+G++G V + VA+K E + ++ L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
IV + + ++++ IY+V EL++ D ++ L + + ++Y
Sbjct: 174 IVRLIGVC---TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + HRDL +N L LK+ DFG++R V +W APE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE-- 285
Query: 202 GSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+ + +Y+ D+WS G + E + G +P S ++
Sbjct: 286 -ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R + DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 237
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 343
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 344 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 52/307 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
V+G+G +G V A TG+ A KK++ + + E K+L + I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DL----HQVIKANDDLTREHHQFFLYQMLRAL 139
V + + + +V +M D+ + V + N F+ Q++ L
Sbjct: 248 VSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H N+ +RDLKP+N+L + + +++ D GLA + T Y T + APE
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT---KGYAGTPGFMAPE 359
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L +Y ++D +++G E++ + F R
Sbjct: 360 LLLG--EEYDFSVDYFALGVTLYEMIAARGPFRA-------------------------R 392
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
EK K L + + V +P P + + L+ DP+ R + +
Sbjct: 393 GEKVENKELKQRVLEQAV----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 313 DPYFKGL 319
P F+ +
Sbjct: 449 HPLFRDI 455
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A KK+ + L E ++L +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + +V LM DL H F+ ++ L+
Sbjct: 246 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLKP+NIL + + +++ D GLA V T V T Y APE
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYMAPE 355
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +YT + D W++GC+ E++ G+ F R
Sbjct: 356 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQ-------------------------R 388
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
+K R+ + + K+ P ++ P A L +L+ DP +R +A E
Sbjct: 389 KKKIKREEVERLVKEVPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 313 DPYFKGL 319
P FK L
Sbjct: 445 HPLFKKL 451
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
+ K+L+ IGKG +G V + G KVA+K I + DA L E ++
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQ 242
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQM 135
LRH ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
A++Y+ N HRDL +N+L + + KV DFGL + A S +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT 353
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 354 -APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V + TGE VA+K K +H S +E+ +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTL 90
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +K+ DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE K+ A D+WS G E+LT S +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + + L + P P+ P + L++ + RPT
Sbjct: 253 GQ----MTVLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +KV DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 245 D 245
Sbjct: 247 Q 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTAN 146
+ + + +V E+ LH+ + + + + L+Q+ +KY+ N
Sbjct: 77 GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPE 199
HRDL +N+L K+ DFGL++ +D Y A +WY APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE 183
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-24
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 37/236 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQML 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT---- 192
+ ++ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG + V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 30/244 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
D N + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + V DFGL++ ++ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241
+W A E YT D+W+ G E+ T G +PG D
Sbjct: 204 RQGRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 242 LITD 245
+
Sbjct: 261 YLLH 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +K++ + HRDL +N + + +KV DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 245 D 245
Sbjct: 311 Q 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ + +G G +G V A KVA+K + + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLV 246
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ + IY++ E M L +K+++ + + F Q+ + ++
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWY 195
N HRDL+ NIL +A+ K+ DFGLARV + +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE F +T D+WS G + E++T G+ +PG S V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF 60
+ ++ + F ++ +G GS+G V +G A+K V
Sbjct: 31 ETPSQNTAQLDQF----------DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 61 -----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-- 110
EH + RIL+ V P +V+++ FKD +Y+V E +
Sbjct: 81 KLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAGG 126
Query: 111 ---SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
S L ++ + ++ R F+ Q++ +Y+H+ ++ +RDLKP+N+L + ++V
Sbjct: 127 EMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ T WT T APE+ S Y A+D W++G + E+ G
Sbjct: 183 TDFGFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAG 234
Query: 228 KPLF 231
P F
Sbjct: 235 YPPF 238
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 8e-23
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTA 145
+ + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 402 IGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAP 198
N HR+L +N+L K+ DFGL++ +D Y A +WY AP
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-AP 508
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
E F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 509 E--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 36/233 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ IG+G +G V I VAIK + S + L+E +R HP
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHP 451
Query: 83 DIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
IV++ ++ P ++++ EL +L ++ L + YQ+ AL
Sbjct: 452 HIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKLPI 556
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 557 KWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQ 129
HP + ++ + L +K V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
F+ + ++Y+ + N HRDL +N + + + V DFGL+R ++ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240
+ +W A E + YT D+W+ G E++T G+ + G
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 241 DLITD 245
+ +
Sbjct: 250 NYLIG 254
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 35/240 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+ VIGKG +GVV + + AIK + + E + LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMR 77
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
L HP+++ + IMLPP +V+ M DL Q I++ + T + F Q+
Sbjct: 78 GLNHPNVLALIGIMLPPEGL----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
R ++Y+ HRDL +N + + + +KV DFGLAR +Y +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--------EYYSVQQH 185
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E ++T D+WS G + E+LT G P + + H L
Sbjct: 186 RHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRL 78
E +G+G++ + + G+ +V +K + H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQML 136
L H +V + + + +V E ++ L +K N + + Q+
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RALKYMHTANVYHRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
A+ ++ + H ++ KNIL +K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W PE C A D WS G E+ + G + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 67/310 (21%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
++IL +G GS+G V H G A+K K V E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQ 134
I+ + F+D I+++ + +E S L + + + + + F+ +
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAE 114
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL+Y+H+ ++ +RDLKP+NIL + N +K+ DFG A+ T +T T
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YT-LCGTPD 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ + Y +ID WS G + E+L G F + + + I
Sbjct: 169 YIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------- 215
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEE 309
+ + P P + LL RLI D R E+
Sbjct: 216 ---------------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255
Query: 310 ALADPYFKGL 319
P+FK +
Sbjct: 256 VKNHPWFKEV 265
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 64/311 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L V+GKG YG V +TG+ A+K K + + D E +L ++
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ EL + ++ + F+L +
Sbjct: 80 HPFIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAE 129
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H + +RDLKP+NI+ N +K+ DFGL + + D +T + T
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIE 186
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE L S + A+D WS+G + ++LTG P F G++ +D I
Sbjct: 187 YMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI---------- 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AE 308
++ K +P P + A LL++L+ + R P A
Sbjct: 234 ----------------LKCKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 309 EALADPYFKGL 319
E A P+F+ +
Sbjct: 273 EVQAHPFFRHI 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L+++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ +K + + V E +L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 178
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 179 D---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------ 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ ++ P + P A LL L+ DPK R A+E + +F
Sbjct: 218 --------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 317 KGL 319
+
Sbjct: 265 LSI 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
L+++GKG++G V + TG A+K + +V + L E ++L+ RHP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+K + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 212 ALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
NV +RDLK +N++ + + +K+ DFGL + D + T Y APE+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED 323
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 324 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------------- 361
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKG 318
+ ++ P + P A LL L+ DPK R A+E + +F G
Sbjct: 362 ------LMEEIRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
Query: 319 L 319
+
Sbjct: 411 I 411
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 59/324 (18%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVF 60
++ + +LK +DF + +++GKGS+G V A T + AIK + DV
Sbjct: 6 ERPSLQIKLKIEDF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 61 EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
D + E ++L L HP + + ++ V E + DL I+
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQ 110
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VA 176
+ F+ +++ L+++H+ + +RDLK NIL + + +K+ DFG+ + +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T + T Y APE+ KY ++D WS G + E+L G+ F G+
Sbjct: 171 GDAKTNT-----FCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
I P P ++ A LL +L
Sbjct: 224 EELFHSI--------------------------RMDNPFYP-----RWLEKEAKDLLVKL 252
Query: 297 IAFDPKDR-PTAEEALADPYFKGL 319
+P+ R + P F+ +
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFREI 276
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 49/303 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ L V+GKGS+G V + T E A+K + DV D + E + L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ + +Y V E + DL I+ H F+ ++ L +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYIAPEII 514
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y ++D W+ G + E+L G+ F G+ I
Sbjct: 515 AY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------------------ 554
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
M P ++ A+ + + L+ P R + +F
Sbjct: 555 --------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
Query: 317 KGL 319
+ +
Sbjct: 602 RYI 604
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 52/257 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ +G+G++G V A VA+K + + S++ R RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-- 130
+LL +L+H IV + E + + +VFE M DL++ ++++ +
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Q+ + Y+ + HRDL +N L +K+ DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 SDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKSVVHQLDLITD 245
+ S +D IT
Sbjct: 259 QPWYQLSNTEAIDCITQ 275
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 4e-19
Identities = 70/310 (22%), Positives = 127/310 (40%), Gaps = 64/310 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L+V+G+GS+G V + + A+K K + D +R E +L +
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVN 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ +L + L + + ++ + F+L +
Sbjct: 85 HPFIVKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAE 134
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H+ + +RDLKP+NIL + +K+ DFGL++ + + T
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVE 191
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ +T + D WS G + E+LTG F GK + +I
Sbjct: 192 YMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----------- 238
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEE 309
++ K +P + P A LL+ L +P +R EE
Sbjct: 239 ---------------LKAKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 310 ALADPYFKGL 319
+F +
Sbjct: 279 IKRHSFFSTI 288
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 49/256 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ +G+G++G V A T VA+K + D + RE +L
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAEL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDLTR 125
L L+H IV+ + + + +VFE M+ DL++ ++A+ +
Sbjct: 71 LTNLQHEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 126 EHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ L QML + Y+ + + HRDL +N L AN +K+ DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 179 DTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
V+ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 230 LFPGKSVVHQLDLITD 245
+ S ++ IT
Sbjct: 235 PWFQLSNTEVIECITQ 250
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A+K + ++ D + E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 71 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 183 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 221 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 277 PFFRNV 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 60/308 (19%), Positives = 110/308 (35%), Gaps = 59/308 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKLLR 77
+ L V+GKGS+G V + T E A+K + D E R+L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--- 78
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
+ P + ++ + +Y V E + DL I+ H F+ ++
Sbjct: 79 --KPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L ++ + + +RDLK N++ ++ +K+ DFG+ + D T + T Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFCGTPDYI 188
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y ++D W+ G + E+L G+ F G+ I
Sbjct: 189 APEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------------- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEAL 311
M P ++ A+ + + L+ P R P +
Sbjct: 234 -------------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 276 EHAFFRYI 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLAR 174
Q++ ++Y+H+ N+ +RD+KP+N L + + DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A++ + ++ D + E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 114 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 225
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 226 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 263
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 264 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 320 PFFRNV 325
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 58/305 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHPDI 84
L+VIGKGS+G V A A+K + + I+ E LL+ ++HP +
Sbjct: 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 85 VEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
V + K +Y V EL H ++ +F+ ++ A
Sbjct: 102 VGLHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASA 151
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T T + T Y AP
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAP 208
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y +D W +G + E+L G P F ++ D I
Sbjct: 209 EVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------------- 251
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PTAEEALADP 314
+ K + PN+ A LL+ L+ D R E +
Sbjct: 252 -----------LNKPLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
Query: 315 YFKGL 319
+F +
Sbjct: 296 FFSLI 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ + +E +G+ +G V + VAIK + + +R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDL 123
L L+HP++V + ++ +K + + ++F DLH+ + DD
Sbjct: 64 MLRARLQHPNVVCLLGVV---TKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 124 TREHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
+ ++Y+ + +V H+DL +N+L +K+ D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FSDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-- 226
V+ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 227 GKPLFPGKSVVHQLDLITD 245
+P + G S +++I +
Sbjct: 228 LQP-YCGYSNQDVVEMIRN 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 249 KSNQEVLEFVTS 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 68/305 (22%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 27 ILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
+L+V+G G+YG +V TG+ A+K + + + E ++L +R
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 82 -PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V + +K ++++ + + +L + + T Q ++ +++ AL
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ +D + + T Y AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPD 230
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ S + A+D WS+G + E+LTG F + I+ +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------ 278
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALADP 314
++ +PP P + LA L+QRL+ DPK R P A+E
Sbjct: 279 ----------LKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 315 YFKGL 319
+F+ +
Sbjct: 324 FFQKI 328
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 50/254 (19%), Positives = 97/254 (38%), Gaps = 54/254 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+GS+G+V + + +VAIK ++ E S RI L E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 81
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---- 130
++ +V + ++ + + V+ ELM DL +++ +
Sbjct: 82 MKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 131 ------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--------I 188
Query: 185 FWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ TDY YR +PE +T D+WS G + E+ T + +
Sbjct: 189 YETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 232 PGKSVVHQLDLITD 245
G S L + +
Sbjct: 242 QGLSNEQVLRFVME 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
++ + V+GKGS+G V A TG+ A+K + DV D + E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ P + ++ V E + DL I+ + +F+ +++ AL +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLK N+L + K+ DFG+ + T T + T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L Y PA+D W++G + E+L G F ++ + I
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------------- 236
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR------PTAEEALA 312
+ + P + A +L+ + +P R L
Sbjct: 237 -----------LNDEVVYP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 313 DPYFKGL 319
P+FK +
Sbjct: 281 HPFFKEI 287
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 290 KSNQEVLEFVTS 301
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
NRY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I I+ E +V EL+ L + +F L
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLAR 174
QM+ ++Y+H+ N HRD+KP N L N + + DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 28/165 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
N++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ E +V +L+ L + + L
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCS------RKLSLKTVLMLA 109
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
QM+ ++++H+ + HRD+KP N L ++ + DFGLA+
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-17
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 32/168 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL------ANANCKLKVCDFGLAR 174
QML ++ +H ++ +RD+KP N L NAN + V DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 8e-17
Identities = 52/349 (14%), Positives = 93/349 (26%), Gaps = 75/349 (21%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------HDVFEHI 63
F+ + + E IG+G +G V I HT VAIK I FE I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 64 SDAIRILREVKLLRLL---RHPDIVEIKRIML-------------------------PPS 95
I I +E+ LL R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKP 154
+ +++V E + + + L+Q+ +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + T+ + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK------SSTIPSCGLQVSII------------DYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------ARKYL 267
+F +V + LF G +Q D I L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + + ++ F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 34/177 (19%), Positives = 68/177 (38%), Gaps = 35/177 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N++ + + IG G +G++ A T+ EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVEIKRIMLPPSKREFKDIY--------------VVFELMESDLHQVIKANDDLTREH 127
D ++ Y +V E + DL ++ ++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-------QKISGQN 145
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
F +ML L+Y+H H D+K N+L N + ++ + D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREVKL 75
+R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
D DYV +W APE F YT D+WS G + E+ + G
Sbjct: 200 KD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 230 LFPGKSVVHQL 240
+PG + +
Sbjct: 250 PYPGVKIDEEF 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 62/279 (22%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDV 59
K D + D N K +VIG+G++G V A G + AIK++ +
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES- 111
D E+++L +L HP+I+ +L +Y+ E
Sbjct: 64 ASK-DDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHG 111
Query: 112 DLHQVIKANDDLTREHHQF----------------FLYQMLRALKYMHTANVYHRDLKPK 155
+L ++ + L + F + R + Y+ HRDL +
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKY 208
NIL N K+ DFGL+R + YV RW A E +S Y
Sbjct: 172 NILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVY 218
Query: 209 TPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
T D+WS G + E+++ G P + G + + +
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 256
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 76/272 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
N + + IG+G++G V A + + VA+K + E S ++ RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKRIML--PPSKREFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
L+ Q+ + Y+ HRDL +N L N +K+
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R ++ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+ G + E+ + +P + G + + + D
Sbjct: 261 AYGVVLWEIFSYGLQP-YYGMAHEEVIYYVRD 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 62/251 (24%), Positives = 98/251 (39%), Gaps = 49/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLL- 76
NR + +G G++G V A + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF----- 130
L H +IV +L V+ E DL ++ D
Sbjct: 82 YLGNHMNIVN----LLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
+D ++YV +W APE F YT D+WS G E+ + G
Sbjct: 197 ND-------SNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 230 LFPGKSVVHQL 240
+PG V +
Sbjct: 247 PYPGMPVDSKF 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLL- 76
N + + +G G++G V A G+ KVA+K + H + ++ E+K++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMS 104
Query: 77 RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
L +H +IV +L P + V+ E DL ++ +
Sbjct: 105 HLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 130 F--------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR- 174
F F Q+ + + ++ + N HRD+ +N+L K+ DFGLAR
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 175 -------VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ + + V W APE F YT D+WS G + E+ +
Sbjct: 214 IMNDSNYIVKGNARLPVKWM---------APE--SIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 227 GKPLFPGKSVVHQL 240
G +PG V +
Sbjct: 263 GLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 64/266 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L+ + HP +++ + ++ + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 121 ----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT F +Q+ + ++Y+ + HRDL +NIL K+K+ DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 171 GLARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIF 221
GL+R V+ D YV +W A E S F YT D+WS G +
Sbjct: 195 GLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLL 242
Query: 222 AEVLT--GKPLFPGKSVVHQLDLITD 245
E++T G P +PG +L+
Sbjct: 243 WEIVTLGGNP-YPGIPPERLFNLLKT 267
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 63/263 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRILREVKL 75
++ + + +G+G++G V A ID + VA+K + D D ++ E+++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEM 93
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 94 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
LAR + D Y T +W APE F YT D+WS G + E
Sbjct: 203 LARDINNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWE 251
Query: 224 VLT-GKPLFPGKSVVHQLDLITD 245
+ T G +PG V L+ +
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKE 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 59/259 (22%), Positives = 110/259 (42%), Gaps = 55/259 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRI--LREV 73
++ + + +G+G +G V A ID + VA+K + + ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN----------- 120
+++ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 138 EMMKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 121 -----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 176 AFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ D Y T +W APE F YT D+WS G + E+ T
Sbjct: 253 INNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTL 301
Query: 227 GKPLFPGKSVVHQLDLITD 245
G +PG V L+ +
Sbjct: 302 GGSPYPGIPVEELFKLLKE 320
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 26/180 (14%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREVK 74
++K+ + + G++ A T T +K ++K + R+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDG--RLFNEQN 94
Query: 75 LL-RLLRHPDIVEIKRIMLPPS----------KREFKDIYVVFELMESDLHQVIKANDDL 123
R + + + K++ P + K ++V + L + +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-- 152
Query: 124 TREHHQFFL-------YQMLRALKYMHTANVYHRDLKPKNILANANCKLKV--CDFGLAR 174
H ++L AL+++H H ++ +NI + + +V +G A
Sbjct: 153 ---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 32/177 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A +K+ IG+G +G + A D ++ E V V SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVEIKRIMLPPS--------------KREFKDIYVVFELMESDLHQVIKANDDLTREH 127
P+ ++ K +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
+F ++L L+Y+H H D+K N+L N + ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 51/257 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-------DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R + + +G+G++G V A + KVA+K + D ++ E+++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 127
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
+ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 128 MKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-- 240
Query: 178 SDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
+ D Y T +W APE F YT D+WS G + E+ T G
Sbjct: 241 ------IHHIDYYKKTTNGRLPVKWM-APE--ALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 229 PLFPGKSVVHQLDLITD 245
+PG V L+ +
Sbjct: 292 SPYPGVPVEELFKLLKE 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 88/241 (36%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRH 81
+IG G +G V + G KVA+K+ F E++ L RH
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVALKRRTPESSQGIEEF---------ETEIETLSFCRH 94
Query: 82 PDIV-------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY- 133
P +V E ++L +++ ME N +L + H LY
Sbjct: 95 PHLVSLIGFCDERNEMIL------------IYKYME---------NGNL--KRH---LYG 128
Query: 134 -----QML-------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ R L Y+HT + HRD+K NIL + N K+ DFG+++
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK- 187
Query: 176 AFSDTPMTVFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGK 228
++ T +++T Y PE +F + T D++S G + EVL +
Sbjct: 188 KGTELDQT-----HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 229 P 229
Sbjct: 239 S 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 58/258 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLL- 76
+ +V+G G++G V A T +VA+K + + S+ ++ E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 103
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------------------------SD 112
+L H +IV +L IY++FE
Sbjct: 104 QLGSHENIVN----LLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
+ + + LT E F YQ+ + ++++ + HRDL +N+L +K+CDFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 173 AR-VAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAE 223
AR + YV +W APE S F YT D+WS G + E
Sbjct: 219 ARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWE 266
Query: 224 VLT-GKPLFPGKSVVHQL 240
+ + G +PG V
Sbjct: 267 IFSLGVNPYPGIPVDANF 284
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ ++ +E+K++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL--YQML- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL--LDRLSCLDGTPPLS 131
Query: 137 ------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPM 182
+ ++H + HRD+K NIL + K+ DFGLAR + F+ T M
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T Y APE L G + TP DI+S G + E++TG P
Sbjct: 192 T---SRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +K+C
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKSVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
++G+G +G V G VA+K++ + + + EV+++ + H +++ ++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 94
Query: 90 IMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDL---TREHHQFFLYQM------ 135
+ P++R +V+ M S L + ++ L R
Sbjct: 95 FCMTPTER-----LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 136 LRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVA 191
R L Y+H + HRD+K NIL + + V DFGLA++ + DT +T T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRG 197
Query: 192 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 1e-07
Identities = 60/404 (14%), Positives = 117/404 (28%), Gaps = 115/404 (28%)
Query: 43 IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101
+D TGE + K I VFE DA + K D+ ++ + +L SK E
Sbjct: 7 MDFETGEHQYQYKDILSVFE---DAFVDNFDCK--------DVQDMPKSIL--SKEEIDH 53
Query: 102 I----------YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQM--------LRALKYM 142
I +F + S ++++ +++ R +++F + + + Y+
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 143 HTANVYHRD-----------LKPKNILANANCKLKVCD---------FG---LARVAFSD 179
+ + D L+P L A +L+ G +A
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 180 T------PMTVFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEVL 225
+FW + + +PE L +T D S + +
Sbjct: 174 YKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 226 TGKP--LFPGKSVVHQLDLITD-----------------LLGTPSPETIAVVRNEKARKY 266
+ L K + L L+ LL T + +
Sbjct: 231 QAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA-DPYFKGL-AKIER 324
+ LL + + P+D P E L +P + A+ R
Sbjct: 290 SLDHHSMT----LTP-----DEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIR 338
Query: 325 EPSCQPISKLEFEFER-RRVTKDDIRELIYREILEYHPQLLKDY 367
+ ++ + V D + +I + P +
Sbjct: 339 DGLAT--------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.54 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.44 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.67 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.38 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-74 Score=541.63 Aligned_cols=345 Identities=48% Similarity=0.865 Sum_probs=298.9
Q ss_pred cccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 15 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
+...+.++++|++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++|||||++++++...
T Consensus 46 ~~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 46 FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp --CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 33445677899999999999999999999999999999999987766667778899999999999999999999998654
Q ss_pred C-cCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 95 S-KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 95 ~-~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
. ..+.+++|||||||+|+|.+++..++++++..++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 2 345578999999999999999999899999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDT-PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+...... .......+.+||++|+|||++.+. ..|+.++||||+|||+|+|++|++||.+.+..+++..|....|.|+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8653322 122234567999999999998773 46799999999999999999999999999999999999999999999
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~ 332 (381)
..+..........++..+....+.++...++.+++++.|||.+||++||.+||||+|+|+||||+...+++.+|.+.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~-- 362 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP-- 362 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--
Confidence 888877777777788877777777777888899999999999999999999999999999999999888887777654
Q ss_pred CcchhhhhccCCHHHHHHHHHHHHHHhCCc
Q 016884 333 KLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (381)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (381)
.+++.++....+.+++++++++|+.++|+.
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~~~~~~ 392 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIEDFHAR 392 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHHHHHHH
Confidence 346677788889999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-67 Score=469.13 Aligned_cols=254 Identities=31% Similarity=0.543 Sum_probs=206.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.++||||+++++++.+ .+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 689999999999999999999999999999999975432 22334578899999999999999999999944 456
Q ss_pred EEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
+|+|||||+|+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997643322
Q ss_pred CcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
...+.+||+.|+|||++.+ ..| +.++||||+||++|+|++|+.||.+.+.......+.+..
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------- 228 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------- 228 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2245689999999999987 454 689999999999999999999999887665555443311
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
......+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 229 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 ------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0112468999999999999999999999999999999964
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-67 Score=477.61 Aligned_cols=259 Identities=25% Similarity=0.451 Sum_probs=223.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+++|+.++|||||++++++. +.+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 357999999999999999999999999999999996431 11223457889999999999999999999994 445
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
++|||||||. |+|.++++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.-
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------ 250 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------------ 250 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Confidence 22 222356799999999999988 789999999999999999999999999988777666665411
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (381)
......+|+++++||.+||+.||++|||++| +++||||+++
T Consensus 251 -------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 251 -------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred -------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 0112468999999999999999999999987 5899999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-67 Score=479.70 Aligned_cols=258 Identities=29% Similarity=0.506 Sum_probs=221.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|+++++||+|+||+||+|+++.+|+.||||++...... ....+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 46799999999999999999999999999999999643222 23457899999999999999999999954 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|||||||. |+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999 599998876 579999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. ...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------- 288 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------- 288 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-----------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----------
Confidence 2 2356799999999999987 78999999999999999999999999998877766665442111
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
....+..+|+++.+||.+||+.||++|||++|+|+||||+...
T Consensus 289 -----------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 289 -----------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp -----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -----------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 1122346899999999999999999999999999999998643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-67 Score=481.47 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=219.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.-++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.|+|||||++++++.+ .+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CC
Confidence 3478999999999999999999999999999999998765566667789999999999999999999999943 45
Q ss_pred cEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+|||||||. |+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 6999999998 6999999754 357999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. .......+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 177 ~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------- 243 (350)
T 4b9d_A 177 ST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------- 243 (350)
T ss_dssp HH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred CC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence 21 112345689999999999988 78999999999999999999999999998877776666542111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.....+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 244 ----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 ----------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 123468999999999999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-66 Score=463.57 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=217.8
Q ss_pred CCCCe-EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++| ++.++||+|+||+||+|+++.++..||+|++............+.+|+.+|+.++|||||++++++.... ...
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCC
Confidence 34566 7888999999999999999999999999999765556666778999999999999999999999985432 223
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecC-CCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~ 175 (381)
..+|||||||. |+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+.
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 46899999998 699999998889999999999999999999999999 999999999999985 79999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+....+...... +.++
T Consensus 182 ~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~---- 248 (290)
T 3fpq_A 182 KRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP---- 248 (290)
T ss_dssp CCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC----
T ss_pred CCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCC----
Confidence 4322 1245689999999999865 5999999999999999999999999876554433222111 0000
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.......++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 249 -----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0112357889999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-65 Score=480.45 Aligned_cols=258 Identities=29% Similarity=0.513 Sum_probs=222.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..+.|+++++||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++|||||++++++.. .+
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~ 221 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GD 221 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CC
Confidence 34679999999999999999999999999999999965322 223467899999999999999999999954 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|||||||. |+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 6999999999 599998875 46999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....+||++|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.....
T Consensus 301 ~~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------- 364 (423)
T 4fie_A 301 VP---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------- 364 (423)
T ss_dssp CC---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred Cc---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence 22 2356799999999999987 7899999999999999999999999999887776665543211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+....+..+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 365 -----------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 365 -----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -----------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1122345789999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-64 Score=480.79 Aligned_cols=354 Identities=36% Similarity=0.652 Sum_probs=300.4
Q ss_pred ccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceee
Q 016884 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (381)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (381)
.....+.+.+.++|++++.||+|+||+||+|++..+++.||||++...........++.+|+.+|+.++||||+++++++
T Consensus 15 ~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 15 YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp CTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred hhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 34456677889999999999999999999999999999999999987777777788999999999999999999999999
Q ss_pred cCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeec
Q 016884 92 LPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
..........+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 77655555779999999999999999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc-------------------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc------
Q 016884 172 LARVAFSDTPMT-------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------ 226 (381)
Q Consensus 172 ~a~~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~------ 226 (381)
+|+......... ...+..+||++|+|||++.+. ..|+.++|||||||++|+|++
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence 998654332110 123567899999999986442 579999999999999999998
Q ss_pred -----CCCCCCCCC-----------------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCC
Q 016884 227 -----GKPLFPGKS-----------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284 (381)
Q Consensus 227 -----g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (381)
|.++|.+.+ ..+++..|.+.+|.|..+.+..+.......++.......+......++.
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 566676654 4688999999999999999999999999999988888888888888899
Q ss_pred CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCCccc
Q 016884 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLL 364 (381)
Q Consensus 285 ~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (381)
+++++.+||.+||++||.+|||++|+|+||||+++.....++.+.......+. +....+.+++++++++|+..++|...
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 99999999999999999999999999999999999887777654432222222 22468899999999999999999876
Q ss_pred ccc
Q 016884 365 KDY 367 (381)
Q Consensus 365 ~~~ 367 (381)
..-
T Consensus 413 ~~~ 415 (432)
T 3n9x_A 413 IPS 415 (432)
T ss_dssp CCH
T ss_pred CCC
Confidence 443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=470.79 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=214.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+++|++++.||+|+||+||+|++. .+++.||+|++++.........++.+|+.+|+.++|||||++++++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----- 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----
Confidence 468999999999999999999984 467899999997543222233467789999999999999999999944
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+.+|||||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 456999999999 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ...+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+..
T Consensus 178 ~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------- 242 (304)
T 3ubd_A 178 DHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---------- 242 (304)
T ss_dssp ---C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC----------
Confidence 3221 2346789999999999987 789999999999999999999999999988777666664311
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
...+..+|+++.+||.+||+.||++||| ++|+++||||+++
T Consensus 243 ---------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 243 ---------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 0112468999999999999999999998 5899999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-63 Score=482.60 Aligned_cols=351 Identities=41% Similarity=0.703 Sum_probs=287.4
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.+.+.++|++++.||+|+||+||+|+++.+++.||||++...........++.+|+.+|+.++||||+++++++.....+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 35667899999999999999999999999999999999987767777788899999999999999999999999776656
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred cCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 66789999999999999999988899999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC------------------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-------
Q 016884 178 SDTPM------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT------- 226 (381)
Q Consensus 178 ~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~------- 226 (381)
..... ....+..+||++|+|||++... ..|+.++||||||||+|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 22111 0123567899999999986432 579999999999999999998
Q ss_pred ----CCCCCCCCC--------------------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccC
Q 016884 227 ----GKPLFPGKS--------------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282 (381)
Q Consensus 227 ----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (381)
|+++|.+.+ ..+++..|.+.+|.|..+.+..........++..+.......+...+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 788888765 36889999999999999999999999888888888888888888889
Q ss_pred CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCCc
Q 016884 283 PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (381)
Q Consensus 283 ~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (381)
+..++++.+||.+||++||.+|||++|+|+||||+++.....++.+.......+. +....+.+++++.+++|+..++|.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~ 445 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPE 445 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCcc
Confidence 9999999999999999999999999999999999998776666554332222222 234678999999999999999998
Q ss_pred cccccccC
Q 016884 363 LLKDYING 370 (381)
Q Consensus 363 ~~~~~~~~ 370 (381)
........
T Consensus 446 ~~~~~~~~ 453 (458)
T 3rp9_A 446 IQLPRRSP 453 (458)
T ss_dssp CCCCC---
T ss_pred ccCCCCCC
Confidence 76655443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-64 Score=462.29 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=217.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++.+ ...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~-----~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE-----GPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3568999999999999999999999999999999975322 2369999999999999999999943 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~~~ 179 (381)
+|||||||. |+|.++++..+.+++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 59999999888999999999999999999999999999999999999999987 6999999999865433
Q ss_pred CCCcc--cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 180 TPMTV--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 180 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------- 271 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE----------- 271 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-----------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-----------
Confidence 21111 1234589999999999988 78999999999999999999999999987766665555431
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH-------------hcCCCcCcCccC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA-------------LADPYFKGLAKI 322 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l-------------L~hp~~~~~~~~ 322 (381)
+.+....++.+++++.+||.+||+.||.+|||+.|+ |+|||+.....+
T Consensus 272 -----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 272 -----------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 011223346799999999999999999999999997 679999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=458.44 Aligned_cols=335 Identities=39% Similarity=0.736 Sum_probs=284.3
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-c
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-K 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 96 (381)
.+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 456788999999999999999999999999999999999776666667778999999999999999999999997642 2
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.....+|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 100 DDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 33456899999998899999987 57999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ....++|++|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+.+..|.|+.+.+.
T Consensus 179 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 179 DSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 322 2456899999999998763 468999999999999999999999999999999999999999999999999
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.+.......++..+.......+...++..++.+.+||.+||+.||.+|||++++|+||||+.+..++.++...+ .++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~ 328 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDD 328 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCC
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCC
Confidence 99999899999888887777788888899999999999999999999999999999999999988877776653 455
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCCcc
Q 016884 337 EFERRRVTKDDIRELIYREILEYHPQL 363 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (381)
.++....+.++|++++++|+..++|+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC--
T ss_pred ChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 666677889999999999999999884
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-62 Score=458.05 Aligned_cols=336 Identities=41% Similarity=0.793 Sum_probs=281.6
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-c
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-K 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 96 (381)
.+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... .
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 456678999999999999999999999999999999999876666677788999999999999999999999986542 2
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.....+|+|||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred ccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 33466899999999999988876 57999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+.
T Consensus 183 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 ADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2456899999999998763 578999999999999999999999999999999999999999999999999
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.+.......++..+.......+...++..++.+.+||.+||++||.+|||++++|+||||+.+..+..++...+ +++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~ 332 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQ 332 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCc
Confidence 99998888888888777777777778899999999999999999999999999999999999888777776653 456
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCCccc
Q 016884 337 EFERRRVTKDDIRELIYREILEYHPQLL 364 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (381)
.++......++|++++++|+..++|...
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred chhhccCCHHHHHHHHHHHHHHhccCcc
Confidence 6677788999999999999999998853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-63 Score=459.85 Aligned_cols=287 Identities=28% Similarity=0.432 Sum_probs=223.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
...++|+++++||+|+||+||+|+++ .+++.||+|++... ....++.+|+++|+.+ +||||+++++++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~--- 90 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFR--- 90 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE---
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEE---
Confidence 34578999999999999999999875 46789999998653 2234678999999998 6999999999994
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeeccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a 173 (381)
+.+++|+|||||+ ++|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 91 --~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 91 --KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp --ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred --ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 3457999999998 69999884 59999999999999999999999999999999999999877 79999999999
Q ss_pred ccccCCCCC-------------------------cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC
Q 016884 174 RVAFSDTPM-------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (381)
Q Consensus 174 ~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~ 228 (381)
+........ ....++.+||++|+|||++.+. ..|+.++||||+|||+|+|++|+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTC
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCC
Confidence 754322110 1123456899999999998763 45899999999999999999999
Q ss_pred CCC-CCCChhhHHHHHHHhhCCCCHHHHhhhc-----------CHHHHHHHHHhcCC------------CCCCccccCCC
Q 016884 229 PLF-PGKSVVHQLDLITDLLGTPSPETIAVVR-----------NEKARKYLTEMRKK------------PPVPLFQKFPN 284 (381)
Q Consensus 229 ~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~------------~~~~~~~~~~~ 284 (381)
.|| .+.+..+++..|...+|++......... ........+..... ........+..
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 988 5677888999999998876543322111 11111111111110 00111234567
Q ss_pred CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 285 ~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+|+++.|||++||++||.+||||+|+|+||||+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-62 Score=459.49 Aligned_cols=339 Identities=39% Similarity=0.725 Sum_probs=270.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|.+..+++.||||++...........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 47899999999999999999999999999999999877677777888999999999997 99999999998653 234
Q ss_pred cEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.+|+|||||+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 6999999999999999987 479999999999999999999999999999999999999999999999999997643211
Q ss_pred ------------------CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 016884 181 ------------------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (381)
Q Consensus 181 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 242 (381)
......+..+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111223557899999999998763 5789999999999999999999999999999999999
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCC---CCCcccc-------------CCCCCHHHHHHHHHhccCCCCCCCC
Q 016884 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQK-------------FPNVDPLALRLLQRLIAFDPKDRPT 306 (381)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-------------~~~~~~~~~dLi~~~L~~dp~~Rpt 306 (381)
+...++.|..+.+..........++..+.... ....... ...+++++.+||.+||++||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 99999999999888776665555554433222 1111111 2368999999999999999999999
Q ss_pred HHHHhcCCCcCcCccCCCCCCCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCCccccc
Q 016884 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366 (381)
Q Consensus 307 ~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (381)
++|+|+||||+.+..+..++.+.......+. +....+.+++++++++|+..+++++...
T Consensus 323 ~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 323 ANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 9999999999999888777776554332222 2345688999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-61 Score=464.23 Aligned_cols=335 Identities=36% Similarity=0.656 Sum_probs=262.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 98 (381)
...++|++++.||+|+||+||+|++..+++.||||++...........++.+|+.+|+.++||||+++++++..... ++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 34689999999999999999999999999999999998766666777889999999999999999999999976532 34
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+|||||+++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 567999999999999888864 499999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ..+..+||++|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|.++.+...
T Consensus 217 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CC----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred Cc----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 22 2345789999999999988 68999999999999999999999999999999999999999999999887765
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCC------------CHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (381)
. .....++..........+...++.. ++++.+||.+||++||.+|||++|+|+||||+.+.++...+
T Consensus 291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~ 369 (464)
T 3ttj_A 291 Q-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 369 (464)
T ss_dssp C-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS
T ss_pred c-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc
Confidence 4 3444444333322222222222221 57799999999999999999999999999999876544322
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCCccc
Q 016884 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLL 364 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (381)
.. +....+...+....+.+++++++++|+..+++...
T Consensus 370 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 406 (464)
T 3ttj_A 370 AP-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTK 406 (464)
T ss_dssp CC-C-----------CCCHHHHHHHHHHHHHC------
T ss_pred CC-CCccCCcchhhccCCHHHHHHHHHHHHHHhhhccc
Confidence 21 12234455667778899999999999998776543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-62 Score=441.54 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=200.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-------
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------- 96 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------- 96 (381)
+|++++.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+.+|+.++|||||++++++.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999998643 233455678999999999999999999999865331
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
....++|+|||||. |+|.+++..... .++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12335899999998 699999987654 45567899999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHH
Q 016884 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (381)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 243 (381)
|+......... ...++.+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+.. +....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 98654322111 12245689999999999988 789999999999999999996 775432 222222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
........+. .++..++.+.+||++||+.||.+|||+.|+|+||||+++.
T Consensus 238 ~~~~~~~~p~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPP---------------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCH---------------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCC---------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 2222111111 1123467789999999999999999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=441.23 Aligned_cols=340 Identities=46% Similarity=0.815 Sum_probs=289.0
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++.+++|++++.||+|+||.||+|++..++..||+|++... ........+.+|+.+|+.++||||+++++++.......
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 45678999999999999999999999999999999999742 34455578889999999999999999999997765555
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 5679999999999999999764 699999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
...........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+...
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 33322233556899999999987552 56899999999999999999999999999999999999999999999999888
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchhh
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~~ 338 (381)
.+.....+..........+....++.+++++.+||.+||++||.+|||++|+|+||||+....+..++...... .+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~--~~~~ 337 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPF--KFDM 337 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC--CCC-
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcC--Cccc
Confidence 88887777777776666666677788999999999999999999999999999999999886665555443332 3344
Q ss_pred hhccCCHHHHHHHHHHHHHHhCCcc
Q 016884 339 ERRRVTKDDIRELIYREILEYHPQL 363 (381)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (381)
+....+.+++++++++|+..++|..
T Consensus 338 ~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 338 ELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp ----CCHHHHHHHHHHHTGGGCC--
T ss_pred ccccCCHHHHHHHHHHHHHHhhhhc
Confidence 5557889999999999999998864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-59 Score=436.21 Aligned_cols=333 Identities=39% Similarity=0.737 Sum_probs=284.0
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+...++|++.+.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 4566789999999999999999999999999999999998766666667788999999999999999999999965432
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.....+|+||||+.++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCEEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ccceeEEEEEccccccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 12234599999999999888843 5999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+...
T Consensus 195 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 195 DAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 322 2345799999999998763 568999999999999999999999999999999999999999999999998
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.........+...............++.+++.+.+||.+||++||++|||++|+|+||||+.+..+..+..... .+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~ 345 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDD 345 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCC
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCc
Confidence 88888888888777776666666777889999999999999999999999999999999998866554433322 2233
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCC
Q 016884 337 EFERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
..+....+.+++++.+++|+.+|+|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred chhhcccchHHHHHHHHHHHHhccc
Confidence 4455678899999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-59 Score=422.57 Aligned_cols=258 Identities=22% Similarity=0.273 Sum_probs=207.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..+++++.++||+|+||+||+|+.. ..||||+++...........+.+|+.+|++++|||||++++++.. +
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3578999999999999999999754 369999997655566667789999999999999999999998732 2
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|||||||+ |+|.+++... .++++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 4799999999 6999999754 5799999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .......+||+.|||||++.+. ...|+.++|||||||++|||+||+.||.+.+....+..+....
T Consensus 185 ~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~---------- 253 (307)
T 3omv_A 185 WSG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG---------- 253 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT----------
T ss_pred CCc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC----------
Confidence 221 1123456899999999998642 2468999999999999999999999998876554443332211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..........+++++.+.+|+.+||+.||++|||+.+++++
T Consensus 254 ---------------~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 254 ---------------YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---------------CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---------------CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01111223345789999999999999999999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=461.22 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=226.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
-++|++++.||+|+||+||+|+++.+|+.||+|++.. ........+.+|+.+|+.++||||+++++++.+ ...
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~ 228 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 228 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCE
Confidence 4689999999999999999999999999999999865 334556678899999999999999999999944 456
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC--CCeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~--~~vkl~DFg~a~~~~ 177 (381)
+|||||||. |+|.+++.. .+.+++..++.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999998 599999864 4689999999999999999999999999999999999999864 889999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+.
T Consensus 309 ~~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 376 (573)
T 3uto_A 309 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------ 376 (573)
T ss_dssp TTS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC------
T ss_pred CCC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC------
Confidence 322 2345689999999999988 7899999999999999999999999999988777766654322221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
...++.+|++++|||++||+.||.+|||+.|+|+||||+....+
T Consensus 377 ---------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 377 ---------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp ---------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ---------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 12345789999999999999999999999999999999875443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=423.70 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=212.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|.+.++||+|+||+||+|++. .++..||||+++.. .......+.+|+++|++++|||||++++++...
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-- 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-- 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence 357999999999999999999865 35789999999753 345567899999999999999999999999543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
+.+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++.+
T Consensus 88 ---~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 ---DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 45999999998 6999999754 369999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 016884 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (381)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 241 (381)
+.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999864332211 11234579999999999987 789999999999999999998 899999988766665
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+...... .....+++++.+|+.+||+.||++|||++++ |+|++++.
T Consensus 242 ~i~~~~~~------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 242 CITQGRVL------------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHHTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHHcCCCC------------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 55431110 1124689999999999999999999999999 55776653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=459.66 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=213.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc----CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
-++|++++.||+|+||+||+|+++.+|+.||||++.+.. ..........+++.+++.++|||||++++++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 367999999999999999999999999999999996421 111222233345677778899999999999944
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 456999999999 699999998889999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... ..+.+||+.|||||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.........
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--------- 407 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 407 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---------
Confidence 4332 2456999999999998642 579999999999999999999999998754332221111100
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
... ...+..+|+++++||.+||+.||.+|++ ++|+++||||+++
T Consensus 408 --------------~~~-----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 408 --------------TMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp --------------HCC-----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred --------------CCC-----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 000 1123568999999999999999999998 8999999999976
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=423.50 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=204.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|.+.++||+|+||+||+|+.+ .++..||||+++. ........+.+|+.+|+.++|||||++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTE--- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 357899999999999999999864 4688999999975 344556789999999999999999999999954
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
...+|||||||. |+|.+++... .++++.++..|+.||+.||+|||+++|+||||||+|||++
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 345999999999 6999999753 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999986533221 112234679999999999988 789999999999999999999 8999998887666
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+..+...... .....+++++.+|+.+||+.||++|||++|++++
T Consensus 270 ~~~i~~g~~~------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQGREL------------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHTCCC------------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCCC------------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6555432111 1124689999999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=423.86 Aligned_cols=332 Identities=39% Similarity=0.737 Sum_probs=281.8
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 97 (381)
+...++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 445689999999999999999999999999999999998765666667788999999999999999999999965432 1
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....+|+||||+.++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 2234699999999998887753 59999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.|..+....
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2345789999999998753 4689999999999999999999999999999999999999999999999888
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
........++..............++.+++.+.+||.+||+.||++|||++++|+||||+.+..++.++.... .+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~ 328 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDS 328 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccc
Confidence 8888777777776666555566667789999999999999999999999999999999998876555443322 23445
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCC
Q 016884 338 FERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
.+....+.++|++.+++|+.++.|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 329 LEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred hhhccCCHHHHHHHHHHHHHhhcc
Confidence 566788999999999999998876
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-58 Score=420.25 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=209.3
Q ss_pred CCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
++++++++||+|+||+||+|... .+++.||||+++.... ......+.+|+.+|++++|||||++++++...
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 56899999999999999999853 4678999999975432 23346789999999999999999999999543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
..+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 45899999999 6999999643 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhH
Q 016884 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (381)
Q Consensus 161 ~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 239 (381)
.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999986533221 112245689999999999987 789999999999999999998 8999999887666
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+..+...... .....+++.+.+|+.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~~~~~------------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVL------------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCC------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555431111 1234689999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=418.63 Aligned_cols=336 Identities=43% Similarity=0.807 Sum_probs=275.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++.+.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.......
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 45678999999999999999999999999999999999642 34455667889999999999999999999987655455
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+||||+.++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 577999999999999999876 4799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCc-------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 179 DTPMT-------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 179 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 21111 112345789999999987542 5688999999999999999999999999999999999999998886
Q ss_pred H-HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCC
Q 016884 252 P-ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP 330 (381)
Q Consensus 252 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~ 330 (381)
. .............+...............++.+++.+.+||.+||+.||.+|||++++|+||||+....+..++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 323 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCC
Confidence 3 333333444555555555544444555566789999999999999999999999999999999999877666555555
Q ss_pred CCC--cchhhhhccCCHHHHHHHHHHHHH
Q 016884 331 ISK--LEFEFERRRVTKDDIRELIYREIL 357 (381)
Q Consensus 331 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 357 (381)
++. .++...+...+.+++++++++|+.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 324 IPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 443 344445677899999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=426.10 Aligned_cols=332 Identities=36% Similarity=0.659 Sum_probs=257.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 98 (381)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3457999999999999999999999999999999999866556666778899999999999999999999986543 234
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+|||||+++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 457999999999999999864 599999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++.+...
T Consensus 180 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 1245689999999999987 67999999999999999999999999999999999999999999998877655
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCC------------CCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~ 326 (381)
. .....+...............++. .++.+.+||.+||+.||.+|||++++|+||||+.+..+....
T Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~ 332 (371)
T 2xrw_A 254 Q-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 332 (371)
T ss_dssp C-HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHT
T ss_pred h-hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccC
Confidence 3 223333332222111111111111 256899999999999999999999999999998765432211
Q ss_pred CCCCCCCcchhhhhccCCHHHHHHHHHHHHHHhCC
Q 016884 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
. .+........+.+..+.++|+++++.++..++-
T Consensus 333 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 2xrw_A 333 A-PPPKIPDKQLDEREHTIEEWKELIYKEVMDLEH 366 (371)
T ss_dssp C-CCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred C-CCCCCCChhhccccCcHHHHHHHHHHHHHHHhh
Confidence 1 111112334455677889999999999988753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=411.38 Aligned_cols=293 Identities=39% Similarity=0.645 Sum_probs=238.0
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..-+..++|++++.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 90 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--- 90 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc---
Confidence 45577889999999999999999999985 58999999997554444445678899999999999999999999843
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...+|+|||||.++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 91 --ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp --SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 35699999999999999887654 599999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.+..+
T Consensus 169 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 169 FGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred cCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 533221 12445789999999998653 46899999999999999999999999999999999999999999887665
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
........... ...............+.+++++.+||.+||++||.+|||++|+|+||||+++.
T Consensus 245 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 245 PQVQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GGGTTSHHHHS-CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhhhccchhhh-cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 54433221110 00011111223334567899999999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-56 Score=409.21 Aligned_cols=259 Identities=26% Similarity=0.482 Sum_probs=224.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 3468999999999999999999999999999999998766666677789999999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 6999999997 699999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. .....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 230 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----------- 230 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 2 2356689999999999987 454 478999999999999999999999887666555443311
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
......+++++.+||++||+.||.+|||++|+|+||||+....
T Consensus 231 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 231 --------------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred --------------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 0112357899999999999999999999999999999987644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=416.65 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=209.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC-----CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC-CCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 95 (381)
.++|++++.||+|+||+||+|.+..+ ++.||||+++.. ........+.+|+.+|++++| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 368999999753 334456678999999999975 8999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl 158 (381)
...+|||||||. |+|.++++.. ..+++..+..|+.||+.||+|||+++|+||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 235899999999 6999999753 34899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChh
Q 016884 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (381)
Q Consensus 159 ~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 237 (381)
++.++.+||+|||+|+....... .......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999986543322 122345689999999999988 789999999999999999998 99999886644
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+.+..+...-. . ......+++++.+|+.+||+.||++|||+.++++|
T Consensus 295 ~~~~~~i~~g~------------------------~-----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGT------------------------R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTC------------------------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCC------------------------C-----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 33322221100 0 01124689999999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=405.23 Aligned_cols=287 Identities=37% Similarity=0.598 Sum_probs=234.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 57999999999999999999999999999999997655555566788899999999999999999999843 3569
Q ss_pred EEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+|||||++++.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 56899999999999999999999999999999999999999999999999999976533221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+..+.+..+....+.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456789999999998762 3489999999999999999987655 788888889999999999887765443221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
... +................+.+++.+.+||.+||+.||++|||++|+|+||||+++.
T Consensus 233 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 233 LPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp STT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 100 0000000011122334457899999999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=409.70 Aligned_cols=332 Identities=35% Similarity=0.657 Sum_probs=264.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---------ChHHHHHHHHHHHHHHhcCCCCcccccee
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------HISDAIRILREVKLLRLLRHPDIVEIKRI 90 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (381)
...++|++++.||+|+||.||+|.+.. +..||||++..... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456789999999999999999999865 89999999864322 22334678899999999999999999999
Q ss_pred ecCCCcCCCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEee
Q 016884 91 MLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (381)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~D 169 (381)
+..........+|+||||+.++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8765544556799999999999999887654 799999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.
T Consensus 178 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 999975333221 2345799999999998763 46899999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCC-CCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~ 328 (381)
|..+............++...... .........+..++.+.+||.+||++||.+|||+.++|+||||+++..+......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 332 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEG 332 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTT
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccc
Confidence 998887777666665554433322 2233344556789999999999999999999999999999999987654333221
Q ss_pred CCCCCcchhhhhccCCHHHHHHHHHHHHHHhC
Q 016884 329 QPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (381)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (381)
.. ..+.+.....+..++++.++.|+.++.
T Consensus 333 ~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 333 LS---ERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp CC---CCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred cc---cccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 11 123444556778999999999998875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=401.75 Aligned_cols=284 Identities=38% Similarity=0.641 Sum_probs=229.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||+||+|.+ .+++.||+|++............+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5799999999999999999998 6789999999975433333345678999999999999999999998543 469
Q ss_pred EEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+.++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999976532211
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12345789999999998653 46899999999999999999999999999999999999988888765443322110
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
..+........+.+.......+++++.+||.+||+.||++|||++++|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000011112223333445678999999999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-55 Score=408.03 Aligned_cols=266 Identities=28% Similarity=0.439 Sum_probs=227.3
Q ss_pred ccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhcCCCCccccceee
Q 016884 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIM 91 (381)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (381)
+......++|++++.||+|+||+||+|+++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 444566788999999999999999999999999999999997543221 1245788999999999999999999998
Q ss_pred cCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC----CeE
Q 016884 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLK 166 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vk 166 (381)
.. ...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 85 ~~-----~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 EN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp EC-----SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred Ee-----CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEE
Confidence 43 456999999997 69999998888999999999999999999999999999999999999998877 799
Q ss_pred EeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHh
Q 016884 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (381)
|+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 160 l~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 160 LIDFGLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp ECCCSSCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred EEecCCceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 999999986543321 245689999999999987 68999999999999999999999999998877777666553
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.....+. .+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 234 SYDFDEE---------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CCCCCHH---------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCCCch---------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3322221 124689999999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=404.06 Aligned_cols=289 Identities=34% Similarity=0.564 Sum_probs=231.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---ChHHHHHHHHHHHHHHhc---CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLL---RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~ 94 (381)
..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35789999999999999999999999999999999863221 111123455677776666 599999999998765
Q ss_pred CcCCCCcEEEEeeccccCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 95 SKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
.......+++||||+.++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 4333446899999999999999987654 99999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
|+....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+..
T Consensus 167 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 167 ARIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp TTTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976533222 245689999999999987 67999999999999999999999999999999999999999988876
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..+........ ..+....+.......+.+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 241 DDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 54432211000 0111222233334456789999999999999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=401.21 Aligned_cols=293 Identities=37% Similarity=0.641 Sum_probs=231.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence 368999999999999999999999999999999997665555556778899999999999999999999843 356
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+++|||||.+ +|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 8999999995 677777777789999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+.+..+...+........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 12355799999999998653 5689999999999999999999999999999999999999888877654432221
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
.....................++++++.+.+||.+||++||.+|||++|+|+||||+++...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 110000000000001111223467899999999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=406.89 Aligned_cols=288 Identities=36% Similarity=0.631 Sum_probs=230.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 579999999999999999999999999999999864321 1111234579999999999999999999844 3458
Q ss_pred EEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999988654 699999999999999999999999999999999999999999999999999975432221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++.+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22345789999999998763 46899999999999999999999999999999999999999999987766544322
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
...... ..............+.+++++.+||.+||++||.+|||++|+|+||||.++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 211110 11112222233445678999999999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=405.67 Aligned_cols=290 Identities=34% Similarity=0.608 Sum_probs=219.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++.. .+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 76 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-----EN 76 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CC
Confidence 3568999999999999999999999999999999986432 22233567789999999999999999999843 35
Q ss_pred cEEEEeeccccCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 101 DIYVVFELMESDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 69999999999999998653 358999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 6533221 12355799999999998753 4689999999999999999999999999999999999999999887654
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCc-----cccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPL-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
+....... .+........+... ......+++++.+||.+||+.||++|||++|+|+||||+.....
T Consensus 233 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 233 WPSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CGGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 43321100 00000000000000 01123578999999999999999999999999999999987544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-55 Score=402.60 Aligned_cols=291 Identities=36% Similarity=0.561 Sum_probs=223.9
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.....++|++++.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH---- 104 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----
Confidence 3345578999999999999999999999999999999997654444445567899999999999999999999843
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-----CCCCeEEeeecc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-----ANCKLKVCDFGL 172 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-----~~~~vkl~DFg~ 172 (381)
...+|+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 105 -~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 105 -NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred -CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 35699999999999999999988999999999999999999999999999999999999995 445599999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..
T Consensus 184 a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 976532221 12445789999999998763 45899999999999999999999999999999999999998888876
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccc-cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..+........ +.............. ....+++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 260 TTWPGVTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTSTTGGGSTT--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhh--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 54432211000 000000000000000 011278999999999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=411.98 Aligned_cols=262 Identities=27% Similarity=0.459 Sum_probs=223.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++. +..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 346799999999999999999999999999999999765444555677889999999999999999999984 445
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec---CCCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~---~~~~vkl~DFg~a~~~ 176 (381)
.+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 6999999998 59999999988999999999999999999999999999999999999998 4578999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 164 ~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 232 (444)
T 3soa_A 164 EGEQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF------ 232 (444)
T ss_dssp CTTCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------
T ss_pred cCCCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC------
Confidence 43322 2245689999999999987 689999999999999999999999999888766665554422111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
....++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 ---------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 ---------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ---------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ---------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 122345789999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=398.61 Aligned_cols=257 Identities=26% Similarity=0.455 Sum_probs=218.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence 3679999999999999999999999999999999864211 11234567889999999999999999999954 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 6999999998 599999988888999999999999999999999999999999999999999999999999999753222
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 21 2245689999999999987 68999999999999999999999999887765554444321
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
. ......+++++.+||.+||+.||.+|| +++++++||||+++
T Consensus 221 -------------~-----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 221 -------------E-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -------------C-----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -------------C-----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 0 011246899999999999999999999 99999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=404.88 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=216.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. ........+.+|..+++.+ +||||+++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 468999999999999999999999999999999986431 1122345677899999988 79999999999944 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|.....
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 241 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------- 241 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CC---ccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 21 12345689999999999987 6799999999999999999999999999887766666543110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (381)
.....+++.+.+||++||+.||.+||++ +++++||||+++
T Consensus 242 ---------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 242 ---------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 1123588999999999999999999999 999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=399.50 Aligned_cols=305 Identities=33% Similarity=0.522 Sum_probs=238.0
Q ss_pred cccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 15 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
.+...+..++|++++.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 34444567899999999999999999999999999999999865444433445677999999999999999999998654
Q ss_pred Cc---CCCCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeee
Q 016884 95 SK---REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 95 ~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
.. ...+.+|+|||||.++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 21 113568999999999998888754 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC-CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 171 GLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 171 g~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
|+|+....... ........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99976432211 12223456799999999998763 46899999999999999999999999999999999999999998
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+.++.+...........+.... .......... ...++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred CChhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 8776554332211000000000 0000000000 013788999999999999999999999999999986543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=406.82 Aligned_cols=288 Identities=35% Similarity=0.630 Sum_probs=231.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~ 100 (381)
..+|++++.||+|+||+||+|.+..++. ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999887766 88887753211 11269999999999999999999875432 3344
Q ss_pred cEEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-CCCCeEEeeeccccc
Q 016884 101 DIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-~~~~vkl~DFg~a~~ 175 (381)
.+|+|||||.+++...+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 588999999987766554 356899999999999999999999999999999999999999 789999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+.+.+|+|..+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 533322 2356899999999998763 46899999999999999999999999999999999999999999998876
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCcccc-CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQK-FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (381)
.......... .+....+.++... .+.+++++.+||.+||++||.+|||+.++|+||||+.+.....
T Consensus 267 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 267 KTMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHCGGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HhhChhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 5443211000 0011111111111 2358999999999999999999999999999999998866543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=395.28 Aligned_cols=258 Identities=24% Similarity=0.438 Sum_probs=222.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.+..+++.||+|.+... ......+.+|+.+|+.++||||+++++++.. ..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES-----ME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CC
Confidence 457899999999999999999999999999999998642 2445568899999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC--CCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a~~~ 176 (381)
.+|+|||||. ++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 6999999998 59999997654 7999999999999999999999999999999999999997 789999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+......+...
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---
Confidence 4322 1245679999999999987 678999999999999999999999999988777766665533332221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.++.+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 226 ------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 ------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 235689999999999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=394.24 Aligned_cols=263 Identities=28% Similarity=0.443 Sum_probs=223.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
....++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN- 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence 345567999999999999999999999999999999986532221 134678899999999999999999999844
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC----CeEEee
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCD 169 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vkl~D 169 (381)
...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 86 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 86 ----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred ----CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 356999999997 69999998888899999999999999999999999999999999999999887 799999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 162 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 162 FGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CTTCEECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCCeECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 999976543221 234579999999999987 68999999999999999999999999988876666655543222
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.... .++.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 ~~~~---------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 236 FEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CCHH---------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cCcc---------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 2211 124678999999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=399.96 Aligned_cols=260 Identities=28% Similarity=0.467 Sum_probs=222.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||.||+|.++.+++.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 467999999999999999999999999999999997655555666788999999999999999999999844 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---CeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~vkl~DFg~a~~~~ 177 (381)
.|+|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 899999998 59999998888899999999999999999999999999999999999998654 59999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------- 249 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------- 249 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 322 1245689999999999987 689999999999999999999999999887666555554321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
....+..+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 250 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 250 --------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp --------------------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred --------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 111234679999999999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=389.82 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=218.8
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
-+..++|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG---- 89 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC----
Confidence 34567899999999999999999999999999999998643222 245678999999999999999999998543
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+|||||. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 90 -DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred -CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 45899999997 6999998765 69999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 168 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------- 234 (297)
T 3fxz_A 168 PEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------- 234 (297)
T ss_dssp STTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------
T ss_pred Cccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 3322 2245689999999999987 68999999999999999999999999887765554443321110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.......+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 235 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 235 --------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp --------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 011124578999999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=406.78 Aligned_cols=287 Identities=31% Similarity=0.648 Sum_probs=230.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc----
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---- 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 96 (381)
..++|++++.||+|+||+||+|.+..+++.||||++...... ..+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 357899999999999999999999999999999998643221 2369999999999999999999865432
Q ss_pred -----------------------------CCCCcEEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 016884 97 -----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH 143 (381)
Q Consensus 97 -----------------------------~~~~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH 143 (381)
.....+++|||||+++|.+.+. .+..+++..++.++.||+.||+|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2344589999999998777665 4568999999999999999999999
Q ss_pred hCCccccCCCCCceEec-CCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHH
Q 016884 144 TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (381)
Q Consensus 144 ~~~i~H~Dikp~NIl~~-~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 222 (381)
++||+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. ..++.++||||+||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999998 688999999999986533322 2355789999999998763 45899999999999999
Q ss_pred HHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccc-cCCCCCHHHHHHHHHhccCCC
Q 016884 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDP 301 (381)
Q Consensus 223 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLi~~~L~~dp 301 (381)
+|++|++||.+.+..+++..+.+.+|.|..+.+.......... .+.......+.. .....++++.+||.+||++||
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999987665443211000 000000111111 123588999999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCcc
Q 016884 302 KDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.+|||+.|+|+||||+.+..
T Consensus 311 ~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 311 DLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GGSCCHHHHHTSGGGHHHHH
T ss_pred hhCCCHHHHhcCHHHHHHHh
Confidence 99999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=399.74 Aligned_cols=256 Identities=32% Similarity=0.537 Sum_probs=214.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 36899999999999999999999999999999998642111 11124678999999999999999999999543 4
Q ss_pred cEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 69999999999999999888899999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.......
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------------- 217 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------------- 217 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------------
Confidence 2245689999999999987 444 78999999999999999999999875432211
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.............+++.+.+||++||+.||.+|||++|+++||||+..
T Consensus 218 ------------~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 218 ------------KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------------CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------------HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 111111122234589999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-55 Score=396.54 Aligned_cols=273 Identities=21% Similarity=0.212 Sum_probs=194.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 46799999999999999999976 5899999998642 122222335666677899999999999986532 12235
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEecCCCCeEEeeecc
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
+|||||||+ |+|.++++.. +++++.+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 6999999764 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCc-ccccccccCccccCcccccccc----CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 173 ARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
|+......... ......+||+.|||||++.+.. ..|+.++|||||||++|||+||.+||........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-------- 226 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-------- 226 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC--------
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc--------
Confidence 98654433221 1223468999999999986521 1367799999999999999999988754332110
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCC---CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
|...... ................ ..+........+..+.+|+.+||+.||++|||+.++++.
T Consensus 227 --p~~~~~~--~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 227 --PYYDLVP--SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp --TTTTTSC--SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred --cchhccc--ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000000 0000111111111111 111111111234568899999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=392.05 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=218.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 3679999999999999999999999999999999864211 11224567789999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 219 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------ 219 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 134589999999999987 689999999999999999999999999887666555554311
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
....+.+++++.+||.+||+.||.+|| +++++++||||+++
T Consensus 220 -------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 220 -------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 011246789999999999999999999 99999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=404.64 Aligned_cols=282 Identities=31% Similarity=0.528 Sum_probs=231.1
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc------CCCCccccceeecC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL------RHPDIVEIKRIMLP 93 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 93 (381)
....+|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.+ +|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 345789999999999999999999999999999999974 233445677888888877 57799999999843
Q ss_pred CCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC--eEEee
Q 016884 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCD 169 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~--vkl~D 169 (381)
...+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 171 -----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -----RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred -----CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 35699999999999999998754 5999999999999999999999999999999999999999987 99999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+|+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.
T Consensus 246 FG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 246 FGSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999754322 234589999999999987 67999999999999999999999999999999999999999999
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCC-----------------------------CCCccc-cCCCCCHHHHHHHHHhccC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKP-----------------------------PVPLFQ-KFPNVDPLALRLLQRLIAF 299 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~-~~~~~~~~~~dLi~~~L~~ 299 (381)
|+.+++...... ..++....... ...+.. .....++.+.+||.+||++
T Consensus 318 p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~ 395 (429)
T 3kvw_A 318 PSQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEW 395 (429)
T ss_dssp CCHHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCS
T ss_pred CCHHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCC
Confidence 999877654322 11111000000 000000 1123478899999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcC
Q 016884 300 DPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 300 dp~~Rpt~~~lL~hp~~~~~ 319 (381)
||++|||++|+|+||||+..
T Consensus 396 dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 396 DPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp STTTSCCHHHHHTSTTTC--
T ss_pred ChhhCCCHHHHhCChhhccC
Confidence 99999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=401.04 Aligned_cols=298 Identities=21% Similarity=0.300 Sum_probs=221.3
Q ss_pred cCCCCCeEEeeeeccc--CCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 19 YGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
....++|++++.||+| +||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--- 97 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--- 97 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence 4567899999999999 99999999999999999999998665555666788899999999999999999999954
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
.+.+|+|||||. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 98 --DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred --CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 356999999998 6999999875 67999999999999999999999999999999999999999999999999988
Q ss_pred ccccCCCC----CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 174 RVAFSDTP----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 174 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
........ ........+||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 64322111 11111234799999999998763346899999999999999999999999887766555433321100
Q ss_pred --------CCHHHHhhhcCH-HHHHHHHHhc------CCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 250 --------PSPETIAVVRNE-KARKYLTEMR------KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 250 --------~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
+..+........ .......... .............+++.+.+||.+||++||.+|||++++|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000000000 0000000000 0000111123456899999999999999999999999999999
Q ss_pred CcCcCcc
Q 016884 315 YFKGLAK 321 (381)
Q Consensus 315 ~~~~~~~ 321 (381)
||+.+..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=396.34 Aligned_cols=289 Identities=23% Similarity=0.413 Sum_probs=234.9
Q ss_pred hhcccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-----CCC
Q 016884 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----HPD 83 (381)
Q Consensus 9 ~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~ 83 (381)
++.+-.+-......++|+++++||+|+||+||+|++..+++.||||++.. .........+|+.+++.+. |||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 44455555566677899999999999999999999999999999999863 2344556778999999996 999
Q ss_pred ccccceeecCCCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC
Q 016884 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (381)
Q Consensus 84 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~ 161 (381)
|+++++++.. ...+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 98 IVKYHGKFMY-----YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp BCCEEEEEEE-----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred eecccceeeE-----CCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 9999999854 35699999999889999998754 5999999999999999999999999999999999999975
Q ss_pred -------------------------CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHH
Q 016884 162 -------------------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (381)
Q Consensus 162 -------------------------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 216 (381)
++.+||+|||+|+...... ...+||+.|+|||++.+ ..++.++||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Diws 244 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWS 244 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHH
Confidence 7889999999997643321 34579999999999988 68999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHH-------------------HHhcCCCCCC
Q 016884 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL-------------------TEMRKKPPVP 277 (381)
Q Consensus 217 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 277 (381)
|||++|+|++|+.||.+.+..+.+..+....+.++..............+. .......+
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-- 322 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP-- 322 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC--
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc--
Confidence 999999999999999999999999999999888887665433221110000 00000000
Q ss_pred ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 278 ~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
......++.+.+||.+||++||.+|||++++|+||||+
T Consensus 323 --~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 323 --LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp --HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred --ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00012357888999999999999999999999999995
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=403.30 Aligned_cols=288 Identities=34% Similarity=0.602 Sum_probs=230.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 101 (381)
.+|++++.||+|+||+||+|++..+++.||||++..... ...+|+.+|+.++||||+++++++..... .+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 379999999999999999999999999999999864311 12369999999999999999998865322 23345
Q ss_pred EEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeecccccc
Q 016884 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg~a~~~ 176 (381)
+++||||+.++|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999988777664 35689999999999999999999999999999999999999965 56899999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ....+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 33322 2356899999999998762 478999999999999999999999999999999999999999999887665
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccc-cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER 324 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~ 324 (381)
...... ..+ .+......++.. ..+.+++++.+||.+||++||.+|||+.++|+||||+.+..+..
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 432110 000 000000001111 12457899999999999999999999999999999998765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=390.53 Aligned_cols=303 Identities=39% Similarity=0.637 Sum_probs=234.0
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+...++|++++.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 45667899999999999999999999999999999999864 344556788899999999999999999998854321
Q ss_pred --------CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-CCCCeEE
Q 016884 97 --------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKV 167 (381)
Q Consensus 97 --------~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-~~~~vkl 167 (381)
.+...+|+||||+.++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence 23467899999999999999864 5799999999999999999999999999999999999997 5678999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
+|||+++................+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998654322222223445789999999987643 568899999999999999999999999999888888888877
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (381)
+.+..+......... ..+..........+.....+.+++++.+||.+||+.||.+|||++++|+||||+....+..+
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 242 PVVHEEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp CCCCHHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred CCCchhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 776655443322111 11112222222333344456799999999999999999999999999999999876554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=397.14 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=218.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (381)
..++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+++.+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 34789999999999999999999999999999999864211 112234567899999877 89999999999944
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 356999999997 5999999988889999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 2221 1345689999999999987 679999999999999999999999999887666555543210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~-~lL~hp~~~~~ 319 (381)
. .....+++++.+||.+||+.||.+|||+. ++++||||+++
T Consensus 235 ----------------~-----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 235 ----------------P-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp ----------------C-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ----------------C-----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 0 11235889999999999999999999998 99999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=396.49 Aligned_cols=289 Identities=38% Similarity=0.596 Sum_probs=228.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh---HHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..++|++++.||+|+||+||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---- 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----
Confidence 4578999999999999999999999999999999986432211 112367799999999999999999999843
Q ss_pred CCCcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 -KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp -TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred -CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 34589999999999999887654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|..+.+.
T Consensus 163 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 33221 22456899999999998652 458899999999999999999999999999999999999988888765443
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
...... .+ .........+....+..+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 239 ~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 239 DMCSLP--DY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp STTSST--TC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCc--cc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 221100 00 000011111222334678899999999999999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=398.81 Aligned_cols=266 Identities=22% Similarity=0.398 Sum_probs=213.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||+||+|+++.+++.||+|++++.... ......+.+|..+++.+ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 46899999999999999999999999999999999754322 23334677899999887 89999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+.... ..
T Consensus 206 ~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~------- 266 (396)
T 4dc2_A 206 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 266 (396)
T ss_dssp TTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CC-------
T ss_pred CCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hh-------
Confidence 221 2346789999999999988 7899999999999999999999999975432110000 00
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (381)
.....+.+. ... ......+++++.+||++||+.||.+||++ +++++||||+++
T Consensus 267 -~~~~~~~i~--~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 267 -EDYLFQVIL--EKQ-----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp -HHHHHHHHH--HCC-----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred -HHHHHHHHh--ccc-----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 000001111 111 11224689999999999999999999985 899999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=391.23 Aligned_cols=266 Identities=23% Similarity=0.400 Sum_probs=215.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.. ........+.+|..+++.+ +||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 367999999999999999999999999999999997543 3344566788999999988 89999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 56999999998 59999998888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ..
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~------- 223 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT------- 223 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------C-------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------cc-------
Confidence 211 2345689999999999987 6889999999999999999999999965321110000 00
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH------HHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~------~~lL~hp~~~~~ 319 (381)
.....+.+.. ... .....+++.+.+||.+||+.||.+|||+ +++++||||+++
T Consensus 224 -~~~~~~~i~~--~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 224 -EDYLFQVILE--KQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp -HHHHHHHHHH--CCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred -HHHHHHHHHc--CCC-----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 0000001111 111 1224689999999999999999999995 899999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=395.76 Aligned_cols=291 Identities=33% Similarity=0.595 Sum_probs=230.9
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
+...++|++++.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++. +
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----K 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----c
Confidence 34458899999999999999999999999999999998765555556667889999999999999999999984 3
Q ss_pred CCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+||||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 4568999999996 556666667789999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.+.....
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 12345799999999998762 3689999999999999999999999999999999999988888877654332
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
+..................+....++.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2110000000000000111122234578999999999999999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=394.15 Aligned_cols=255 Identities=21% Similarity=0.378 Sum_probs=219.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----N 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence 44789999999999999999999999999999999864211 11234567889999999999999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 56999999997 69999999888899999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 254 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------- 254 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 2 134589999999999987 689999999999999999999999999887666555554310
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 255 --------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 255 --------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 0112468999999999999999999998 9999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=393.64 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=218.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+|..+ +||+|+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 4689999999999999999999999999999999864311 112245677899999988 79999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 56999999998 59999999878899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 237 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 221 1245689999999999987 689999999999999999999999999887766655554310
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
......+++++.+||.+||+.||.+|| +++++++||||+.+
T Consensus 238 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 238 --------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 011246899999999999999999999 47999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=376.44 Aligned_cols=264 Identities=28% Similarity=0.465 Sum_probs=224.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----E 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----C
Confidence 34688999999999999999999999999999999997655566667788899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DFg~a~~ 175 (381)
...|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 56899999998 599999988888999999999999999999999999999999999999987655 99999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 225 (284)
T 3kk8_A 158 VNDSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 225 (284)
T ss_dssp CCSSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred cccCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc------
Confidence 433221 234679999999999987 67899999999999999999999999887766555544332111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.....+..+++.+.+||.+||+.||++|||++|+|+||||++...
T Consensus 226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 226 ---------------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ---------------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ---------------------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 111223578999999999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=395.67 Aligned_cols=261 Identities=25% Similarity=0.450 Sum_probs=216.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 468999999999999999999999999999999986421 111234567899999999999999999999954 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 6999999997 599999998889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence 2 23466899999999998642 145899999999999999999999999865433222111110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-HHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-~~~lL~hp~~~~~ 319 (381)
.. . .......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 233 ---------~~--~-----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 233 ---------ET--T-----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ---------HH--C-----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ---------hh--c-----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 00 0 01122468999999999999999999998 9999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=391.95 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=204.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 88 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTP---- 88 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeC----
Confidence 45568999999999999999999999999999999999753222 24577899999999999999999999543
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC--eEEeeeccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~--vkl~DFg~a~~ 175 (381)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.
T Consensus 89 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 89 -THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred -CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 46999999997 599999988888999999999999999999999999999999999999987765 99999999874
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCc-cchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
..... .....+||+.|+|||++.+ ..++.+ +|||||||++|+|++|+.||.+.+.......+...
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-------- 233 (361)
T 3uc3_A 168 SVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-------- 233 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH--------
T ss_pred ccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH--------
Confidence 32221 1234579999999999877 455544 89999999999999999999876543333222211
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...... .......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 234 ---------------~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 234 ---------------ILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---------------HHTTCC--CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---------------HhcCCC--CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000000 011123579999999999999999999999999999999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=385.77 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=209.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++++.||+|+||.||+|++. .+++.||+|+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 468999999999999999999985 6899999999975422 22334567789999999999999999999844
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+.+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 356999999998 69999998888899999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 171 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------- 237 (327)
T 3a62_A 171 SIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred cccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------
Confidence 322211 1235679999999999987 678999999999999999999999999887666555544311
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
....+.+++.+.+||.+||+.||.+|| ++.++++||||+.+
T Consensus 238 -----------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 238 -----------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 011246789999999999999999999 89999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=410.57 Aligned_cols=259 Identities=30% Similarity=0.497 Sum_probs=216.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++.++..||+|++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 357999999999999999999999999999999997543333345678899999999999999999999943 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg~a~~~~ 177 (381)
+|+|||||. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999998 5999999888889999999999999999999999999999999999999764 459999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..+........
T Consensus 191 ~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 257 (494)
T 3lij_A 191 NQK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------ 257 (494)
T ss_dssp TTB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 332 2245689999999999864 689999999999999999999999999887766666554322211
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 258 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 258 ---------------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ---------------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ---------------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 12345789999999999999999999999999999999865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=383.89 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=223.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
...++|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-- 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 44567999999999999999999999999999999986532221 134578899999999999999999999843
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC----CeEEeee
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDF 170 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vkl~DF 170 (381)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 87 ---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 356999999997 69999999888899999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 164 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp TTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred ccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99976543322 234579999999999987 678999999999999999999999999888776666555433222
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+. .+..+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 238 ~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 238 DEE---------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CHH---------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred Chh---------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 211 124678999999999999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=387.19 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=213.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 45789999999999999999999999999999999864321 1233567899999999999999999999843 45
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+...........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------- 223 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------- 223 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-------------
T ss_pred Cc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-------------
Confidence 21 1223456899999999998762 23477899999999999999999999876543222111110
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.. .....+..+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 224 ------------~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 224 ------------KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ------------TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------cc---ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 01112346889999999999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=402.42 Aligned_cols=293 Identities=33% Similarity=0.573 Sum_probs=215.3
Q ss_pred CCCeEE-eeeecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKI-LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~-~~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+.|++ .++||+|+||+||+|+++ .+++.||+|++...... ..+.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 91 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHA--- 91 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETT---
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCC---
Confidence 355777 558999999999999966 57889999998754222 35678999999999999999999985432
Q ss_pred CCcEEEEeeccccCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe----cCCCCe
Q 016884 99 FKDIYVVFELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKL 165 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~----~~~~~v 165 (381)
...+|+||||+.++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 3569999999999999888632 249999999999999999999999999999999999999 677899
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh---------
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--------- 236 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------- 236 (381)
||+|||+|+...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999998654332222233456899999999998763 4589999999999999999999999987654
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcC-HHHHHHHHHhcCCCCCC------ccccCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRN-EKARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~ 309 (381)
.+++..+...+|.|....+..... ................. ........++.+.+||.+||++||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 478899999999998765554322 11122222211110000 00112234788999999999999999999999
Q ss_pred HhcCCCcCcCccC
Q 016884 310 ALADPYFKGLAKI 322 (381)
Q Consensus 310 lL~hp~~~~~~~~ 322 (381)
+|+||||.....+
T Consensus 331 ~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQDPYFLEDPLP 343 (405)
T ss_dssp HHTSGGGTSSSCC
T ss_pred HhcChhhccCCCC
Confidence 9999999875443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=392.12 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=219.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++++.||+|+||+||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~ 120 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----K 120 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----S
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----C
Confidence 3456899999999999999999999999999999998643 23445578899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC--CCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a~~ 175 (381)
..+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 56999999998 59999997654 7999999999999999999999999999999999999974 46799999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 201 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~------ 268 (387)
T 1kob_A 201 LNPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------ 268 (387)
T ss_dssp CCTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC------
T ss_pred cCCCcc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 533221 234579999999999987 67899999999999999999999999988766655554331111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.....+..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 269 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 269 ---------------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ---------------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1122345789999999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=382.05 Aligned_cols=260 Identities=24% Similarity=0.447 Sum_probs=207.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC------------------------hHHHHHHHHHHHHHH
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH------------------------ISDAIRILREVKLLR 77 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~E~~~l~ 77 (381)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999998643211 112346789999999
Q ss_pred hcCCCCccccceeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 78 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
.++||||+++++++.... ...+|+||||+. ++|.+++ ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999986532 356899999998 4776654 34579999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccC-CCCCccchHHHHHHHHHHHcCCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 235 (381)
||++.++.+||+|||+++....... ......||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999976543221 2245689999999999876311 14678999999999999999999998876
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
.......+.... . .....+.+++.+.+||.+||+.||++|||+.++|+|||
T Consensus 245 ~~~~~~~~~~~~--------------------------~---~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKSQA--------------------------L---EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHCC--------------------------C---CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhccc--------------------------C---CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 544333332210 0 01122468999999999999999999999999999999
Q ss_pred cC
Q 016884 316 FK 317 (381)
Q Consensus 316 ~~ 317 (381)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 85
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=384.89 Aligned_cols=291 Identities=34% Similarity=0.594 Sum_probs=233.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~ 96 (381)
..++|++++.||+|+||.||+|++. .+++.||+|++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3478999999999999999999995 6789999999864332222223455677777666 89999999999863322
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.....+++||||+.++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3445799999999999999998753 49999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|....
T Consensus 169 ~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 54321 12345679999999999987 6799999999999999999999999999999999999998888887654
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+........ ...............+.+++.+.+||.+||+.||.+|||+.++|+||||+.+..
T Consensus 243 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred Cccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 432111000 011112222333445678999999999999999999999999999999987754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=400.82 Aligned_cols=264 Identities=25% Similarity=0.359 Sum_probs=217.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence 35689999999999999999999999999999999864210 00112246789999999999999999999943 4
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 56999999997 6999998764 699999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|+|++|++||.+.+..+....|.......
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 292 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------ 292 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc------
Confidence 21 11224568999999999987621 117899999999999999999999999988777776665421000
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
.......+++++.+||.+||+.+|.+ ||+++++++||||+++
T Consensus 293 ---------------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 293 ---------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ---------------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ---------------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 01112468999999999999999988 9999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=391.47 Aligned_cols=260 Identities=29% Similarity=0.453 Sum_probs=212.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||+||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 467999999999999999999999999999999985321 111124568899999999999999999999843
Q ss_pred CCcEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeee
Q 016884 99 FKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDF 170 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DF 170 (381)
...+|+|||||. ++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 356999999998 599887753 235899999999999999999999999999999999999987654 999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
|+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ......+.......
T Consensus 178 g~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 178 GVAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp TTCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred cceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 99976543221 1245689999999999987 678999999999999999999999998753 22333332211111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+ ..+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 252 ~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 252 NP---------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp CH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred Cc---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 11 1224689999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=402.79 Aligned_cols=265 Identities=25% Similarity=0.398 Sum_probs=219.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|+++.+++.||+|++.+... .......+.+|..++..++||||+++++++.. ..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----DN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CC
Confidence 4689999999999999999999999999999999864210 00111236789999999999999999999844 45
Q ss_pred cEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+|||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 6999999997 699999987 56899999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
... ......+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+..+....|......
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------ 299 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------ 299 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc------
Confidence 222 122446899999999998621 156899999999999999999999999998877777666531100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCC--CCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~--Rpt~~~lL~hp~~~~~ 319 (381)
.........+++++.+||++||+.+|++ |++++++++||||+++
T Consensus 300 --------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 300 --------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp --------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred --------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 0011123468999999999999998888 9999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=408.02 Aligned_cols=262 Identities=32% Similarity=0.525 Sum_probs=220.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.++.+++.||+|++............+.+|+.+|+.++||||+++++++.. ..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CC
Confidence 3467999999999999999999999999999999986432222335678899999999999999999999844 45
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec---CCCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~---~~~~vkl~DFg~a~~~ 176 (381)
.+|+|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 6999999998 59999998888899999999999999999999999999999999999995 4567999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 175 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 241 (486)
T 3mwu_A 175 QQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------ 241 (486)
T ss_dssp CCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS------
T ss_pred CCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------
Confidence 3332 1245689999999999875 58999999999999999999999999988776666554422111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
....+..+++++.+||.+||+.||.+|||+.++|+||||+....
T Consensus 242 ---------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 242 ---------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ---------------------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ---------------------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11223568999999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=391.22 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=211.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHH-HHhcCCCCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..+ ++.++||||+++++++..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----- 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----- 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----
Confidence 44689999999999999999999999999999999975432 22334456677777 577899999999999844
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 356999999998 5999999888889999999999999999999999999999999999999999999999999997533
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....|....
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 255 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------- 255 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----------
Confidence 2221 1245689999999999987 689999999999999999999999999887766555554310
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH----HHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~----~~lL~hp~~~~~ 319 (381)
....+.+++.+.+||.+||+.||.+||++ .++++||||+.+
T Consensus 256 ---------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 ---------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ---------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ---------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 11224689999999999999999999986 699999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=403.57 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=210.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 467999999999999999999999999999999986432 222334567789999999999999999999844 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+|||||. ++|.+++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 6999999998 5999999888899999999999999999999998 9999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 365 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------- 365 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 21 12345689999999999987 689999999999999999999999999887665554443211
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
......+++++.+||.+||+.||.+|| |++++|+||||+++
T Consensus 366 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 366 --------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 011245889999999999999999999 99999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=401.76 Aligned_cols=257 Identities=30% Similarity=0.513 Sum_probs=218.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|.+++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP----- 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 34789999999999999999999999999999999864211 112245688999999999999999999998543
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 46999999997 69999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCccccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. .....+||+.|+|||++.+ .. ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 169 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------- 232 (476)
T 2y94_A 169 GE----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI---------- 232 (476)
T ss_dssp TC----CBCCCCSCSTTCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------
T ss_pred cc----cccccCCCcCeEChhhccC--CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------
Confidence 22 2345689999999999987 44 4689999999999999999999999877655554443311
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
......+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 233 ---------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ---------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01123578999999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=387.99 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=212.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|.++.+++.||+|++...... ..+|+.++..+ +||||+++++++. +.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~-----~~ 88 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYD-----DG 88 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEE-----CS
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEE-----cC
Confidence 346799999999999999999999999999999999754322 34688888887 7999999999984 34
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC----CCeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~----~~vkl~DFg~a~ 174 (381)
..+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 56999999998 5999999988899999999999999999999999999999999999998543 349999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh---hhHHHHHHHhhCCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTPS 251 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~ 251 (381)
....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... .+....+..
T Consensus 169 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------ 237 (342)
T 2qr7_A 169 QLRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------ 237 (342)
T ss_dssp ECBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH------
T ss_pred cCcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc------
Confidence 6543322 1245689999999999987 5688999999999999999999999986432 122222211
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.........++.+++++.+||++||+.||.+|||+.++|+||||..+...
T Consensus 238 ---------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 238 ---------------------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp ---------------------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred ---------------------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 11111122346789999999999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=405.00 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=220.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh-----------HHHHHHHHHHHHHHhcCCCCccccc
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------SDAIRILREVKLLRLLRHPDIVEIK 88 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (381)
.+.++|++++.||+|+||+||+|.++.+++.||+|++....... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45688999999999999999999999999999999987532211 2245688999999999999999999
Q ss_pred eeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---C
Q 016884 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---K 164 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~ 164 (381)
+++. +...+|+|||||. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFE-----DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEE-----CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEE-----cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 9994 3456999999998 59999998888899999999999999999999999999999999999999876 6
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 244 (381)
+||+|||+|+...... .....+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999997654332 1245689999999999864 58999999999999999999999999988877776665
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
........ ..+..+++++.+||++||++||.+|||++++|+||||+...
T Consensus 261 ~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 261 KGKYYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HCCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cCCCCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 53222221 12356899999999999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=384.75 Aligned_cols=265 Identities=25% Similarity=0.437 Sum_probs=193.9
Q ss_pred CCeEEe---eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 016884 23 NRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~---~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 98 (381)
++|.+. +.||+|+||+||+|.+..+++.||+|++... ......+|+.+++.+. ||||+++++++..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----- 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD----- 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Confidence 457765 7899999999999999999999999998642 3456678999999997 9999999999943
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---CeEEeeecccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLAR 174 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~vkl~DFg~a~ 174 (381)
....|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 456899999998 59999999988999999999999999999999999999999999999998765 79999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------------- 218 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-------------- 218 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------------
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------------
Confidence 5433221 2245678999999999987 68999999999999999999999999875431100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.........+...........+..+++++.+||.+||+.||.+|||++++|+||||++....
T Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 219 ------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp ------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred ------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 00011111122211111112234689999999999999999999999999999999875443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=380.98 Aligned_cols=252 Identities=28% Similarity=0.333 Sum_probs=207.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|+++++||+|+||+||+|++..+++.||||++..............+|+..+..+ +||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 579999999999999999999999999999999876656656666667777776666 8999999999984 3456
Q ss_pred EEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +...+
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCCc--------
Confidence 1 234579999999999875 689999999999999999999877755432211 111 01010
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.....+++++.+||.+||+.||++|||++++|+||||++
T Consensus 272 -------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 -------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 112467899999999999999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=386.39 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=201.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CC
Confidence 456799999999999999999999999999999998753 233567789999999999999999999944 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~DFg~a~~~ 176 (381)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 6999999998 599999988888999999999999999999999999999999999999976 889999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh-HHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 255 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+..
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---------- 265 (349)
T 2w4o_A 202 EHQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---------- 265 (349)
T ss_dssp ---------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT----------
T ss_pred Cccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh----------
Confidence 3321 1234579999999999987 679999999999999999999999997765433 2222211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.........+..+++.+.+||.+||+.||++|||+.++|+||||.+.
T Consensus 266 -----------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 266 -----------------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -----------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -----------------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 11111122345789999999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=386.93 Aligned_cols=293 Identities=33% Similarity=0.571 Sum_probs=223.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc--CCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--REF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~ 99 (381)
.++|++.+.||+|+||+||+|.+..+++.||||++...... .....++++.++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 36899999999999999999999999999999988543221 2345578888899999999999999865432 222
Q ss_pred CcEEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEecC-CCCeEEeeecc
Q 016884 100 KDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILANA-NCKLKVCDFGL 172 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH--~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~ 172 (381)
..+++||||+.++|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3478999999988776554 4567999999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.|..
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 976543322 2345789999999998652 45899999999999999999999999999999999999999999988
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccc----cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQ----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~ 325 (381)
+.+.......... ........++.. .....++++.+||.+||+.||.+|||+.|+|+||||++...+...
T Consensus 254 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp HHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred HHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 7765443211000 000001111111 122367899999999999999999999999999999988765443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=372.81 Aligned_cols=263 Identities=24% Similarity=0.301 Sum_probs=218.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
...+..|++.+.||+|+||+||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CC
Confidence 34456789999999999999999999999999999999866556667778899999999999999999999885432 23
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEec-CCCCeEEeeecccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~-~~~~vkl~DFg~a~ 174 (381)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 456899999997 599999998788999999999999999999999999 99999999999998 78999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+................
T Consensus 181 ~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 247 (290)
T 1t4h_A 181 LKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----- 247 (290)
T ss_dssp GCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----
T ss_pred cccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-----
Confidence 543321 234579999999998865 5899999999999999999999999875544333221110000
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
........++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 248 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 -----------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01112356789999999999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=379.79 Aligned_cols=284 Identities=30% Similarity=0.505 Sum_probs=229.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEE-cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC------ccccceeec
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAID-THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIML 92 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~ 92 (381)
...++|++++.||+|+||+||+|.+ ..+++.||+|++... ......+.+|+.+++.++|++ ++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 4467999999999999999999998 568899999998642 344567788999999887654 888888884
Q ss_pred CCCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---------
Q 016884 93 PPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--------- 161 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~--------- 161 (381)
. ...+|+||||++++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 H-----HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp E-----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred c-----CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 3 35699999999989999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 016884 162 ----------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (381)
Q Consensus 162 ----------~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 231 (381)
++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCcccc------ccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 6689999999997643221 34579999999999987 68999999999999999999999999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHH--------------HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhc
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L 297 (381)
.+.+..+....+....+.++...+....... ...+....... ...........++.+.+||.+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHh
Confidence 9999999999999999888877665433211 11111111110 00111112234678999999999
Q ss_pred cCCCCCCCCHHHHhcCCCcCcCc
Q 016884 298 AFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 298 ~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
+.||.+|||+.|+|+||||+.+.
T Consensus 314 ~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 314 EYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGGG
T ss_pred CcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=371.31 Aligned_cols=258 Identities=31% Similarity=0.461 Sum_probs=220.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED-----NT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 446799999999999999999999999999999998754322 24578899999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~~ 176 (381)
.+|+||||+. ++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 6899999998 5999999888889999999999999999999999999999999999999 77889999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+......++..
T Consensus 160 ~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 229 (277)
T 3f3z_A 160 KPGKM----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK--- 229 (277)
T ss_dssp CTTSC----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred cCccc----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence 43221 234579999999999875 48999999999999999999999999888776666655433322221
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 230 ------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 230 ------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 123678999999999999999999999999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=405.09 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=223.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----K 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 34689999999999999999999999999999999864322 23345678899999999999999999999944 4
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~ 175 (381)
..+|+|||||. ++|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 56999999998 5999999988899999999999999999999999999999999999999 5678899999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----- 246 (484)
T 3nyv_A 179 FEASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF----- 246 (484)
T ss_dssp BCCCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred cccccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 543321 245579999999999865 58999999999999999999999999988777666655422111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
....+..+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 247 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 247 ----------------------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp ----------------------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred ----------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11223468999999999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=395.99 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=216.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|+++.+++.||+|++++... .......+.+|..++..++||||+++++++.+ .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 35789999999999999999999999999999999864211 11122346789999999999999999999944 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 56999999997 6999999864 479999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccc-----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
.... ......+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+..+....|......
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--- 288 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--- 288 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---
Confidence 3221 112346899999999998631 146899999999999999999999999998877766666531100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCC---CCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~R---pt~~~lL~hp~~~~~ 319 (381)
. . .......+++++++||++||+ +|.+| |+++++++||||+++
T Consensus 289 -----------------~-~-----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 289 -----------------L-S-----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp -----------------C-C-----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred -----------------c-C-----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 0 0 000124689999999999999 99998 599999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=371.38 Aligned_cols=258 Identities=30% Similarity=0.462 Sum_probs=209.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++. +.
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DY 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHhee-----cC
Confidence 4557899999999999999999999999999999998754322 23467889999999999999999999984 34
Q ss_pred CcEEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeec
Q 016884 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFG 171 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg 171 (381)
..+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 56999999998 499888853 3679999999999999999999999999999999999999 456789999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 173 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 242 (285)
T 3is5_A 173 LAELFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--- 242 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred cceecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---
Confidence 9976433221 234579999999999864 688999999999999999999999988775544333321100
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
........+++.+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 243 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 -------------------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -------------------------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -------------------------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011112357899999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=379.94 Aligned_cols=287 Identities=31% Similarity=0.583 Sum_probs=222.5
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
.++..++|++++.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.++ ||||+++++++....
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~- 104 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV- 104 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC-
Confidence 345568999999999999999999999999999999998742 2356789999999997 999999999986432
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~ 174 (381)
....++||||+. ++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 105 --~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 --SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp --TCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 356899999998 588888753 89999999999999999999999999999999999999777 89999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC-CCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2345799999999998653 56899999999999999999999998 4556667777777666643321
Q ss_pred H-HhhhcCHHHHHHHHHhcCCCCCCccc-----cCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 254 T-IAVVRNEKARKYLTEMRKKPPVPLFQ-----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
. +..........+...........+.. ....+++++.+||.+||++||.+|||++++|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1 11110000001111111111111111 1123799999999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=373.27 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=214.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence 3679999999999999999999999999999999864211 11123467889999999999999999999843 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..|+||||+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999988643322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 2 234579999999999987 6789999999999999999999999998776655544433111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.....+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 225 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 --------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred --------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11235789999999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=382.54 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=215.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence 346799999999999999999999999999999999754333 33446788999999999999999999998543
Q ss_pred CcEEEEeeccccCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+.|+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 4689999999999988885 456899999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
. ...+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 207 ~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~---------- 269 (348)
T 1u5q_A 207 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 269 (348)
T ss_dssp B-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------
T ss_pred C-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Confidence 1 245799999999998431 1568999999999999999999999998877655443332210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.+ ......+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 270 ----------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 270 ----------------SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 00 0112457899999999999999999999999999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=387.34 Aligned_cols=284 Identities=27% Similarity=0.410 Sum_probs=225.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC--------CCCccccceeec
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--------HPDIVEIKRIML 92 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~ 92 (381)
..++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 35789999999999999999999999999999999974 2344567889999999985 788999999885
Q ss_pred CCCcCCCCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCC------
Q 016884 93 PPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANC------ 163 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~------ 163 (381)
... .....+|+||||++++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 112 ~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 321 133569999999999888888654 4699999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------CeEEeeecccccccCCCCCcccccccccCccccCccc
Q 016884 164 -------------------------------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200 (381)
Q Consensus 164 -------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~ 200 (381)
.+||+|||+|+..... ....+||+.|+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChh
Confidence 7999999999765332 234579999999999
Q ss_pred cccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC------hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhc---
Q 016884 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR--- 271 (381)
Q Consensus 201 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 271 (381)
+.+ ..++.++|||||||++|+|++|+.||.+.+ ..+.+..+....|.++...+....... .++....
T Consensus 265 ~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~ 340 (397)
T 1wak_A 265 LIG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EFFTKKGDLK 340 (397)
T ss_dssp HHT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GTBCTTSSBS
T ss_pred hcC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cccCCccccc
Confidence 987 679999999999999999999999998765 456778888888988876654322110 0000000
Q ss_pred ---CCCCCC-------ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 272 ---KKPPVP-------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 272 ---~~~~~~-------~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
...+.. ........++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000000 00011224567899999999999999999999999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=380.89 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=220.3
Q ss_pred ccCCCCCeEEe-eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 016884 18 EYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (381)
Q Consensus 18 ~~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 95 (381)
.....++|.+. +.||+|+||+||+|++..+++.||+|++............+.+|+.+++.+. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--- 99 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--- 99 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE---
Confidence 33456789888 8999999999999999999999999999765444444567889999999995 699999999984
Q ss_pred cCCCCcEEEEeecccc-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEee
Q 016884 96 KREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCD 169 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~D 169 (381)
+...+|+|||||.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 100 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 100 --NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp --CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred --eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 34569999999984 898888543 57999999999999999999999999999999999999998 78999999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 178 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 178 FGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp GGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 999986533221 234579999999999987 68999999999999999999999999988876665555443222
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.. ...+..+++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 252 ~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 252 YS---------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp CC---------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred cC---------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 11 223457899999999999999999999999999999998764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=383.38 Aligned_cols=281 Identities=33% Similarity=0.515 Sum_probs=225.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CC-----CccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP-----DIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||+||+|++..+++.||||+++. .......+.+|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 35789999999999999999999999999999999974 2334556778999988885 55 48888888743
Q ss_pred CcCCCCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEec--CCCCeEEe
Q 016884 95 SKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILAN--ANCKLKVC 168 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH--~~~i~H~Dikp~NIl~~--~~~~vkl~ 168 (381)
...+|+||||++++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 128 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 ----RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ----TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ----CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 3569999999999999999875 46999999999999999999999 47999999999999995 46789999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
|||+|+..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+
T Consensus 204 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 204 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999765332 234589999999999988 6799999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCC--------------CCC--------------ccccCCC-------CCHHHHHHH
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKP--------------PVP--------------LFQKFPN-------VDPLALRLL 293 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~--------------~~~~~~~-------~~~~~~dLi 293 (381)
.|+........ ....++..+.... +.. ......+ .++++.+||
T Consensus 276 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 276 IPPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp SCCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred CCCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 99887665332 2222222111100 000 0000000 114789999
Q ss_pred HHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 294 QRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 294 ~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+||++||++|||++|+|+||||+..
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=375.43 Aligned_cols=255 Identities=29% Similarity=0.525 Sum_probs=213.7
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.|...+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ...|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 48889999999999999999999999999999864322 2345678999999999999999999998543 4589
Q ss_pred EEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 588888764 57999999999999999999999999999999999999999999999999998765432221
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-------------- 258 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 245689999999999987 6789999999999999999999999988776554443332110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
+.......+++.+.+||.+||+.||++|||+.++|+||||...
T Consensus 259 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 259 --------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0011123578999999999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=380.90 Aligned_cols=273 Identities=24% Similarity=0.333 Sum_probs=218.4
Q ss_pred cccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 17 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
+.....++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 344567899999999999999999999999999999999976433 3345567889999999999999999999885433
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
. .....|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~-~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 86 P-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp T-TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred C-CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 1 2234699999997 6999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP---- 238 (311)
T ss_dssp -----------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----
T ss_pred cccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC----
Confidence 65443322222344579999999999987 678999999999999999999999999887655544333221111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.......+++++.+||.+||+.||.+||++.++|.|+|++..
T Consensus 239 -----------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 -----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 111235689999999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=373.00 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=217.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYES-----T 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhccc-----C
Confidence 34568999999999999999999999999999999987432 2233567899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~ 175 (381)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 56899999998 5999999888889999999999999999999999999999999999999 7788999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----- 226 (304)
T 2jam_A 159 EQNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF----- 226 (304)
T ss_dssp CCCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC-----
T ss_pred cCCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence 3222 1234579999999999987 678999999999999999999999998877665555444321111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
....+..+++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus 227 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 227 ----------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ----------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ----------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1122356899999999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=378.48 Aligned_cols=263 Identities=26% Similarity=0.342 Sum_probs=208.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 98 (381)
.+++|++++.||+|+||+||+|.+ .+++.||+|++............+.+|+.+|+.++| |||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 457899999999999999999987 468999999997655566666788999999999986 999999999854
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...+|+|||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 35699999988889999999988999999999999999999999999999999999999997 67899999999976533
Q ss_pred CCCCcccccccccCccccCccccccc---------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ...+....
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~-- 234 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAII-- 234 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH--
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHHh--
Confidence 221 1122356799999999998531 146788999999999999999999999764321 11111111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
... .........++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 235 ---------------------~~~---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 ---------------------DPN---HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ---------------------CTT---SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ---------------------cCC---cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 000 0011123457789999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=375.08 Aligned_cols=281 Identities=25% Similarity=0.383 Sum_probs=207.9
Q ss_pred CCCCeEEe-eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 016884 21 DANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (381)
..++|++. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----- 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE----- 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----
Confidence 45689995 789999999999999999999999999975422 2345788999999985 79999999999844
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeeecccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLAR 174 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DFg~a~ 174 (381)
.+.+|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 356999999998 699999988888999999999999999999999999999999999999998776 9999999987
Q ss_pred cccCCCC----CcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 175 VAFSDTP----MTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+..-..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 5432111 11112345699999999998641 134789999999999999999999999876432100000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
....+ .........+...........+..+++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus 239 ~~~~~--------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 239 GEACP--------ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp --CCH--------HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cccch--------hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 00000 000011111111111111112346899999999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=383.20 Aligned_cols=268 Identities=28% Similarity=0.431 Sum_probs=214.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc---CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++++.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED----- 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-----
Confidence 468999999999999999999999999999999986421 123445678899999999999999999999943
Q ss_pred CCcEEEEeeccc-cCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHH
Q 016884 99 FKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHHQFFLYQMLR 137 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~ 137 (381)
...+|+|||||. ++|.+++.. ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 356999999997 699998842 112467889999999999
Q ss_pred HHHHHHhCCccccCCCCCceEecCCC--CeEEeeecccccccCCCC-CcccccccccCccccCccccccccCCCCCccch
Q 016884 138 ALKYMHTANVYHRDLKPKNILANANC--KLKVCDFGLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (381)
Q Consensus 138 aL~~LH~~~i~H~Dikp~NIl~~~~~--~vkl~DFg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 214 (381)
||+|||++||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999976433221 111234567999999999986543578999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHH
Q 016884 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294 (381)
Q Consensus 215 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~ 294 (381)
|||||++|+|++|+.||.+.+..+....+........ ...+..+++.+.+||.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~ 312 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---------------------------NPNYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT---------------------------SGGGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC---------------------------CcccccCCHHHHHHHH
Confidence 9999999999999999998887666555543211111 1122357899999999
Q ss_pred HhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 295 RLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 295 ~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
+||+.||.+|||+.++|+||||+++..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999999999999987643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=384.97 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=211.6
Q ss_pred CCeEE--eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 23 ~~Y~~--~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+.|.+ .+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CC
Confidence 34555 67899999999999999999999999998752 33456678899999999999999999999844 35
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe--cCCCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA--NANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~--~~~~~vkl~DFg~a~~~ 176 (381)
.+|+|||||. ++|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 6999999998 5998888654 469999999999999999999999999999999999999 56678999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 240 ~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~----- 308 (373)
T 2x4f_A 240 KPREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE----- 308 (373)
T ss_dssp CTTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-----
T ss_pred CCccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----
Confidence 43221 234579999999999977 6789999999999999999999999999887766666554221111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 309 ----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ----------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12235789999999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=376.64 Aligned_cols=283 Identities=30% Similarity=0.501 Sum_probs=227.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCC-cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIMLP 93 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~ 93 (381)
..++|++++.||+|+||+||+|.+..++ ..||+|+++. .......+.+|+.+++.++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 4579999999999999999999998777 6899999864 2344567788999999997665 7887777733
Q ss_pred CCcCCCCcEEEEeeccccCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe------------
Q 016884 94 PSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA------------ 159 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~------------ 159 (381)
...+|+||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 -----HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp -----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred -----CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 35699999999999998887654 79999999999999999999999999999999999999
Q ss_pred -------cCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCC
Q 016884 160 -------NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (381)
Q Consensus 160 -------~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 232 (381)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999997643322 34579999999999987 689999999999999999999999999
Q ss_pred CCChhhHHHHHHHhhCCCCHHHHhhhcCHH--------------HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhcc
Q 016884 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEK--------------ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298 (381)
Q Consensus 233 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~ 298 (381)
+.+..+.+..+.+..+.++..+........ ...+....... ...........++.+.+||.+||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhc
Confidence 999999999999999988877665433211 11111111100 000001112235688999999999
Q ss_pred CCCCCCCCHHHHhcCCCcCcCc
Q 016884 299 FDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 299 ~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.||.+|||+.++|+||||+++.
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGGCC
T ss_pred CChhhCcCHHHHhcChhhcCCC
Confidence 9999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=375.90 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=205.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc------
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------ 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------ 96 (381)
++|++++.||+|+||.||+|+++.+++.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 56999999999999999999999999999999997533 33455678899999999999999999998854321
Q ss_pred ----------------------------------------------CCCCcEEEEeeccc-cCHHHHHHhCC---CCCHH
Q 016884 97 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKAND---DLTRE 126 (381)
Q Consensus 97 ----------------------------------------------~~~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~ 126 (381)
.....+|+|||||. ++|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999998 59999998764 35667
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCc---------ccccccccCccccC
Q 016884 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT---------VFWTDYVATRWYRA 197 (381)
Q Consensus 127 ~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~---------~~~~~~~gt~~y~a 197 (381)
.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 799999999999999999999999999999999999999999999998654432111 11234579999999
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCC
Q 016884 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277 (381)
Q Consensus 198 PE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (381)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+........+
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~------------------------- 292 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP------------------------- 292 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC-------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC-------------------------
Confidence 999987 6899999999999999999998766521 11111111111110
Q ss_pred ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 278 ~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..+...++.+.+||.+||+.||.+|||++++|+||||+++
T Consensus 293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 0112356788999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=370.82 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=198.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|.+..+++.||+|++............+.++...++.++||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CC
Confidence 4689999999999999999999999999999999975433333333444555568888999999999998543 45
Q ss_pred EEEEeeccccCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.|+||||++++|.+++. ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 89999999998877765 356899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCcccccc--ccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh-hhHHHHHHHhhCCCCHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPE 253 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 253 (381)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||..... ...+.....
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 33322 133479999999999621 115688999999999999999999999976332 222211111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+ ......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 229 ------------------EPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ------------------SCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------------------cCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 1000 01123678999999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=402.09 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=215.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence 45679999999999999999999999999999999864211 11223457889999999999999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..+|+|||||. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 56999999997 69999998654 4999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 33221 245589999999999987 6799999999999999999999999987653222111111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.+.... ......+++++.+||.+||+.||.+|| |++++++||||+++
T Consensus 400 ---------~i~~~~-------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 400 ---------LVKEVP-------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------HHHHCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------Hhhccc-------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 011110 011246899999999999999999999 89999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=368.65 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=217.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC----hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 5799999999999999999999999999999998643221 1135678899999999999999999999854
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC----CeEEeeeccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vkl~DFg~a 173 (381)
....|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 356899999997 69999998878899999999999999999999999999999999999998877 7999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 76533221 234579999999999987 67899999999999999999999999988776655555432222111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
..++.+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 233 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 233 --------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 112467899999999999999999999999999999987643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=410.60 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=219.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ........+.+|..+|..+ +||+|+.+++++. +.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----CS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----eC
Confidence 468999999999999999999999999999999986421 1112234677899999988 6999999999984 44
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||+. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 56999999998 59999999888999999999999999999999999999999999999999999999999999975332
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|....
T Consensus 495 ~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------- 558 (674)
T 3pfq_A 495 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 558 (674)
T ss_dssp TTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-----------
T ss_pred CCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 222 1345689999999999987 789999999999999999999999999988776666554311
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCH-----HHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~-----~~lL~hp~~~~~ 319 (381)
......+++++.+||++||+.||.+||++ ++|++||||+.+
T Consensus 559 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 559 --------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 11124689999999999999999999997 999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=388.40 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=204.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4789999999999999999999999999999999864321 11122357799999999999999999998732
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---CeEEeeec
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFG 171 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~vkl~DFg 171 (381)
..+|+|||||. ++|.+.+..+..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 34799999998 59999998888999999999999999999999999999999999999997654 59999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHH-HHHHhhCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGT 249 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~ 249 (381)
+|+...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+......+. .+......
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~ 363 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence 998653322 22456899999999998531 2567889999999999999999999998765433222 22211111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.. ...+..+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 364 ~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 364 FI---------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CC---------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11 1123468999999999999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=367.89 Aligned_cols=264 Identities=28% Similarity=0.417 Sum_probs=223.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 86 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---- 86 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----
Confidence 345678999999999999999999999999999999986543 334556678899999999999999999999843
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.+.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 87 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 87 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 356899999998 699999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 230 (294)
T 2rku_A 166 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 230 (294)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Confidence 332221 234579999999999987 67899999999999999999999999887655443333210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
. ......+++.+.+||.+||+.||++|||++++|+||||.+...+.
T Consensus 231 ----------------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 231 ----------------E-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp ----------------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ----------------c-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 0 112246789999999999999999999999999999998765443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=369.57 Aligned_cols=256 Identities=24% Similarity=0.404 Sum_probs=216.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence 3679999999999999999999999999999999864211 11123567899999999999999999999844 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 6899999998 599999988888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------ 228 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD------------ 228 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc------------
Confidence 1 134579999999999987 678999999999999999999999998877655444333210
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
....+.+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 229 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 229 -------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011246789999999999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=380.69 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=210.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh------HHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
.++|++++.||+|+||+||+|++..+++.||+|++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 468999999999999999999999999999999987542211 123356679999999999999999999943
Q ss_pred cCCCCcEEEEeeccc-c-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 96 KREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
...+++||||+. | +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 456999999986 5 99999998889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.......
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 76543322 234579999999999877 444 789999999999999999999996532110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. ........+++++.+||.+||+.||.+|||++++|+||||++.
T Consensus 238 ------------------~-----~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 238 ------------------E-----AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------------------T-----TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------------------h-----hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 0011123579999999999999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=383.11 Aligned_cols=262 Identities=27% Similarity=0.352 Sum_probs=208.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC--CCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 99 (381)
+.+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.++ ||||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 4569999999999999999998865 899999999765555566778899999999996 59999999988543
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
..+|+|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 4599999977789999999988999999999999999999999999999999999999995 578999999999765332
Q ss_pred CCCcccccccccCccccCccccccc---------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChh-hHHHHHHHhhCC
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGT 249 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 249 (381)
.. .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 21 1122456899999999998641 135888999999999999999999999765321 11111111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.... .......++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 283 ----------------------~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 ----------------------PNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ----------------------TTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ----------------------cccc---CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0000 111233578899999999999999999999999999997543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=395.75 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=201.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHH---HHHhcCCCCccccc-------ee
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVK---LLRLLRHPDIVEIK-------RI 90 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------~~ 90 (381)
.++|++.+.||+|+||+||+|++..+|+.||||++... .........+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999999999999998643 233345677889995 45555799999998 44
Q ss_pred ecCCCc-------CCCC-----cEEEEeeccccCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCccccC
Q 016884 91 MLPPSK-------REFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHHQFFLYQMLRALKYMHTANVYHRD 151 (381)
Q Consensus 91 ~~~~~~-------~~~~-----~~~lv~e~~~~~L~~~l~~~~~l~~-------~~~~~i~~qil~aL~~LH~~~i~H~D 151 (381)
+..... .+.. ..|+||||++|+|.+++...+.+++ ..++.++.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 432210 0001 3799999999999999986555555 88888999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccC-----------CCCCccchHHHHHH
Q 016884 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (381)
Q Consensus 152 ikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----------~~~~~~DiwslG~i 220 (381)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .++.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999975322 1245577 99999999977 4 78999999999999
Q ss_pred HHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCC
Q 016884 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (381)
Q Consensus 221 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~d 300 (381)
+|+|++|+.||.+.+....... .....+.+++.+.+||.+||+.|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCC
Confidence 9999999999976543221111 11123578999999999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCc
Q 016884 301 PKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 301 p~~Rpt~~~lL~hp~~~~~~ 320 (381)
|.+|||+.++|+||||+++.
T Consensus 348 p~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHHH
T ss_pred chhCCCHHHHhhChHHHHHH
Confidence 99999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=376.53 Aligned_cols=259 Identities=28% Similarity=0.479 Sum_probs=216.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC--h----HHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--I----SDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
++|++.+.||+|+||.||+|.+..+|+.||||++...... . .....+.+|+.+++.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 5799999999999999999999999999999998654321 1 1234677899999999 79999999999843
Q ss_pred cCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
....|+||||+.+ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 3569999999985 999999887889999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
....... ....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543221 2456899999999998541 1358889999999999999999999998877665555554322221
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
.. ..+..+++.+.+||.+||+.||.+|||++++|+||||+
T Consensus 325 ~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 SS---------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CH---------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CC---------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 11 11246789999999999999999999999999999996
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=383.94 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=204.4
Q ss_pred CCCCCeEEe-eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHH-hcCCCCccccceeecCCCcC
Q 016884 20 GDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 20 ~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 97 (381)
...++|.+. +.||+|+||+||+|++..+++.||||++... ..+.+|+.++. ..+||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 345678887 7899999999999999999999999998632 34567888874 458999999999885321 1
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEeeec
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFG 171 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~DFg 171 (381)
+..++|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 2356899999998 59999998753 5999999999999999999999999999999999999998 7889999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh----HHHHHHHhh
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH----QLDLITDLL 247 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~ 247 (381)
+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+... ....+..
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-- 281 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 281 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--
Confidence 997643221 1245689999999999987 789999999999999999999999998765322 1111111
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.........+..+++++.+||++||+.||.+|||+.++|+||||.+..
T Consensus 282 -------------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 282 -------------------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp -------------------------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred -------------------------CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 000111123457899999999999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=374.59 Aligned_cols=264 Identities=28% Similarity=0.412 Sum_probs=223.5
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 112 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED---- 112 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 345678999999999999999999999999999999986543 334556678899999999999999999999844
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
.+.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 356999999998 599999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 257 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------- 257 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred ccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence 432221 234579999999999987 678999999999999999999999998876554443332210
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
......+++.+.+||.+||+.||.+|||++++|+||||.+...+.
T Consensus 258 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 258 ----------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 011246789999999999999999999999999999998765433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=369.83 Aligned_cols=267 Identities=20% Similarity=0.391 Sum_probs=217.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 478999999999999999999999999999999987421 1123456788999999999999999999998543 23
Q ss_pred CcEEEEeeccccCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 46899999999888888875 4579999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ........||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---------- 229 (305)
T 2wtk_C 161 PFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---------- 229 (305)
T ss_dssp TTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------
T ss_pred cccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC----------
Confidence 3221 12224557999999999987632334779999999999999999999998876554444332210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
......+++.+.+||.+||+.||.+|||++++|+||||+......
T Consensus 230 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 230 ---------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ---------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ---------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 112246789999999999999999999999999999998765443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=394.79 Aligned_cols=262 Identities=21% Similarity=0.335 Sum_probs=214.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----K 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----C
Confidence 34689999999999999999999999999999999864211 11223567889999999999999999999844 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
..+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 56999999998 5999998753 369999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
........ ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 338 ~~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~--------- 403 (543)
T 3c4z_A 338 ELKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------- 403 (543)
T ss_dssp ECCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---------
T ss_pred eccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---------
Confidence 65433221 234589999999999988 6899999999999999999999999987643211111111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
...... ......+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 404 --------------~i~~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 404 --------------RVLEQA----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp --------------HHHHCC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred --------------HHhhcc----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 000000 1112468999999999999999999995 5899999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=366.48 Aligned_cols=265 Identities=28% Similarity=0.342 Sum_probs=213.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
...++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++. +
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~ 82 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----E 82 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----C
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----e
Confidence 34578999999999999999999999999999999986433 34455678899999999999999999999984 3
Q ss_pred CCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+||||+.+ +|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 4569999999984 999999988899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------ 226 (294)
T 4eqm_A 163 ETSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------ 226 (294)
T ss_dssp --------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------
T ss_pred ccccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------
Confidence 32211 1234579999999999987 6789999999999999999999999988775443322221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+.......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-.
T Consensus 227 --------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 227 --------------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp --------------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred --------------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 111111122345789999999999999999999976777777765543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=367.24 Aligned_cols=257 Identities=27% Similarity=0.468 Sum_probs=191.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 4679999999999999999999999999999999863211 11123567899999999999999999999844 35
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 6899999997 5999999875 5799999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------- 225 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------- 225 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--------------
Confidence 2211 134579999999999987 678999999999999999999999998765432221110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. ........+++++.+||.+||+.||.+|||++++|+||||...
T Consensus 226 -------------~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 226 -------------L----ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------S----SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------h----cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 0111234578999999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=364.52 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=219.1
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---C----hHHHHHHHHHHHHHHhcC-CCCccccceee
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H----ISDAIRILREVKLLRLLR-HPDIVEIKRIM 91 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 91 (381)
+..++|++.+.||+|+||.||+|.+..+++.||+|++..... . ......+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999864321 1 122456789999999995 99999999998
Q ss_pred cCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeee
Q 016884 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
.. ....|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 94 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ET-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EC-----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cc-----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 43 356999999998 599999988888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHh
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (381)
|++........ .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99976543221 2345799999999988521 146889999999999999999999999887765555444332
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.... ....+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 245 ~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 NYQF---------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCC---------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred Cccc---------------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 1111 1112246789999999999999999999999999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=379.32 Aligned_cols=285 Identities=22% Similarity=0.337 Sum_probs=219.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.+..++..||+|++... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence 457899999999999999999999999999999998754 234556678899999999999999999999854 34
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+||||+. ++|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 6999999998 49999999888899999999999999999999996 999999999999999999999999999865432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh--
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA-- 256 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 256 (381)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.............
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234579999999999987 678999999999999999999999998877554433221111110000000
Q ss_pred -------------hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 257 -------------VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 257 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
...........+......... .....+++++.+||.+||++||.+|||++++|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000001111222222111111 11234789999999999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=364.51 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=207.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|.+..+++.||+|++............+.+|+..+..+ +||||+++++++.. ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 579999999999999999999999999999999986655556677888999999999 89999999999843 346
Q ss_pred EEEEeecccc-CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC--------------
Q 016884 102 IYVVFELMES-DLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-------------- 162 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-------------- 162 (381)
+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 8999999984 999999764 679999999999999999999999999999999999999844
Q ss_pred -----CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh
Q 016884 163 -----CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (381)
Q Consensus 163 -----~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 237 (381)
..+||+|||.+....... ...||+.|+|||++.+. ..++.++|||||||++|+|++|.+|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence 479999999987653321 23699999999998762 35668999999999999999999877544321
Q ss_pred hHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 238 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
..+.. .. .......+++.+.+||.+||+.||++|||+.++|+||||.
T Consensus 238 ---~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 238 ---HEIRQ---------------------------GR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp ---HHHHT---------------------------TC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred ---HHHHc---------------------------CC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 11111 00 0112246899999999999999999999999999999997
Q ss_pred cC
Q 016884 318 GL 319 (381)
Q Consensus 318 ~~ 319 (381)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 63
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=362.82 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=213.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 579999999999999999999999999999999864322 2345678899999999999999999999843 3568
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|+||||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999984 9999998877899999999999999999999999999999999999999999999999999875432221
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHH-HHHHHhhCCCCHHHHhhhcC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 260 (381)
........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..... ..+..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 223 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--------------- 223 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT---------------
T ss_pred -hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh---------------
Confidence 1122456799999999998762 22477899999999999999999999876543221 11110
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. .....+..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 224 -----------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 224 -----------KK---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------TC---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------cc---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 00 0011224678999999999999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=377.56 Aligned_cols=288 Identities=23% Similarity=0.364 Sum_probs=224.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-----------CCCccccce
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKR 89 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~ 89 (381)
..++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+++.++ ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35789999999999999999999999999999999873 3344566788999999886 899999999
Q ss_pred eecCCCcCCCCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecC-----
Q 016884 90 IMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANA----- 161 (381)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~----- 161 (381)
++.... .....+++|||+++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 123368999999988999999863 4699999999999999999999998 9999999999999953
Q ss_pred -CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-----
Q 016884 162 -NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (381)
Q Consensus 162 -~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----- 235 (381)
.+.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 347999999999765332 234579999999999987 679999999999999999999999998654
Q ss_pred -hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHH--hcCC-CCCC----------ccccCCCCCHHHHHHHHHhccCCC
Q 016884 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE--MRKK-PPVP----------LFQKFPNVDPLALRLLQRLIAFDP 301 (381)
Q Consensus 236 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~----------~~~~~~~~~~~~~dLi~~~L~~dp 301 (381)
..+.+..+...+|.++...+....... .++.. .... .... ........++++.+||.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhh--hhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 556778888888988876654332211 11000 0000 0000 000112356788999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCccC
Q 016884 302 KDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
.+|||++++|+||||++....
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTTC
T ss_pred cccCCHHHHhhChhhhcccCc
Confidence 999999999999999976443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=364.70 Aligned_cols=260 Identities=32% Similarity=0.538 Sum_probs=218.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 467999999999999999999999999999999987544444455678899999999999999999999844 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~vkl~DFg~a~~~~ 177 (381)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 899999997 5999998877789999999999999999999999999999999999999764 469999999987653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 176 ~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (287)
T 2wei_A 176 QNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-------- 240 (287)
T ss_dssp CCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred CCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 3221 234468999999999875 4899999999999999999999999988766555444331110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.....+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 241 -------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 241 -------------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -------------------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -------------------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 11122356899999999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=364.31 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=205.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++.. ...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence 46899999999999999999976 58899999998765566667788999999999999999999999844 345
Q ss_pred EEEEeeccc-cCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 102 IYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+|+||||+. ++|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987653 999999999999999999999999 99999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------- 256 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence 433211 1234579999999999987 6789999999999999999999999988776544433321111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (381)
.......+++.+.+||.+||+.||.+|||+.++++ .++++.
T Consensus 257 ----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 ----------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01123568999999999999999999999999997 455543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=364.72 Aligned_cols=265 Identities=22% Similarity=0.374 Sum_probs=212.1
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD--- 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC---
Confidence 345668999999999999999999999999999999998643 223356788999999999999999999998543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 89 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 89 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred --CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 45899999998 488888765 56799999999999999999999999999999999999999999999999998753
Q ss_pred ccCCCCCcccccccccCccccCcccccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
..... .......||+.|+|||++.. ....++.++|||||||++|+|++|..||...+.......+.....
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 239 (302)
T 2j7t_A 167 NLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---- 239 (302)
T ss_dssp HHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----
T ss_pred ccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC----
Confidence 21110 01124579999999999831 015788999999999999999999999988776554433332110
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
+ .......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ----------------------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 240 ----------------------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 0 0111235788999999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=368.65 Aligned_cols=275 Identities=23% Similarity=0.387 Sum_probs=213.2
Q ss_pred hcccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccc
Q 016884 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIK 88 (381)
Q Consensus 10 ~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 88 (381)
+..-++-......++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeee
Confidence 3344444455678899999999999999999999999999999999864322 235677899999999 799999999
Q ss_pred eeecCCCc-CCCCcEEEEeecccc-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC
Q 016884 89 RIMLPPSK-REFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164 (381)
Q Consensus 89 ~~~~~~~~-~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~ 164 (381)
+++..... .....+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC
Confidence 99865421 123578999999985 999999864 47999999999999999999999999999999999999999999
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 241 (381)
+||+|||++........ ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+......
T Consensus 168 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244 (326)
T ss_dssp EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999876432211 12345799999999998621 1568899999999999999999999998776554433
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.+... ..+ ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 245 ~~~~~--------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 245 LIPRN--------------------------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHS--------------------------CCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HhhcC--------------------------ccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 32210 000 01124678999999999999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=362.22 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=206.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 4789999999999999999999999999999999864211 11223467899999999999999999999844 35
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 6899999997 599999988888999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccccCCC-CCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------- 227 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred c----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Confidence 1 1234578999999999877 343 679999999999999999999998876554443332210
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
......+++.+.+||.+||+.||.+|||++++|+||||++.
T Consensus 228 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 --------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 01123578999999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=380.56 Aligned_cols=269 Identities=17% Similarity=0.164 Sum_probs=195.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhc--CCCCccccc-------eeec
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL--RHPDIVEIK-------RIML 92 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~~~ 92 (381)
.+|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 459999999999999999999999999999999986543 234455677785555544 699988755 3332
Q ss_pred CCCcC------------CCCcEEEEeeccccCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCC
Q 016884 93 PPSKR------------EFKDIYVVFELMESDLHQVIKAN-DDLTREHH------QFFLYQMLRALKYMHTANVYHRDLK 153 (381)
Q Consensus 93 ~~~~~------------~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~------~~i~~qil~aL~~LH~~~i~H~Dik 153 (381)
..... ....+|+|||||+++|.+++... ..+++... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 01458999999999999999863 23454455 5777999999999999999999999
Q ss_pred CCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC
Q 016884 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (381)
Q Consensus 154 p~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 233 (381)
|+|||++.++.+||+|||+|+...... ....+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998643211 13467799999999975334689999999999999999999999987
Q ss_pred CChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 234 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....... ...... ..............+.+++.+.+||.+||+.||++|||+.++|+|
T Consensus 296 ~~~~~~~-----~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKG-----SWKRPS-----------------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTT-----CCCBCC-----------------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCccccc-----chhhhh-----------------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6421100 000000 000001111122335789999999999999999999999999999
Q ss_pred CCcCcC
Q 016884 314 PYFKGL 319 (381)
Q Consensus 314 p~~~~~ 319 (381)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=362.05 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=216.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 34689999999999999999999999999999999976555556667889999999999999999999987542 224
Q ss_pred cEEEEeeccc-cCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEecCCCCeEEeee
Q 016884 101 DIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~-----i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 6899999998 5999998753 35999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 233 (279)
T 2w5a_A 161 GLARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233 (279)
T ss_dssp CHHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred chheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence 9997643321 11234578999999999987 6789999999999999999999999988775544443332110
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
......+++.+.+||.+||+.||.+|||+.++|+|+|+.+.
T Consensus 234 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 ----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ----------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01124678999999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=367.11 Aligned_cols=261 Identities=34% Similarity=0.536 Sum_probs=209.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 3679999999999999999999999999999999864321 112234577899999999999999999998432
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeeec
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFG 171 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DFg 171 (381)
..|+||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 3799999998 599999988889999999999999999999999999999999999999987664 9999999
Q ss_pred ccccccCCCCCcccccccccCccccCcccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHH-HHHHHhhCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT 249 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~ 249 (381)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+......
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 99764322 11234579999999999742 1156899999999999999999999999876543222 222211111
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..+ ..+..+++.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 239 ~~~---------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 239 FIP---------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CCH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cCc---------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 111 1124678999999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=377.98 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=210.5
Q ss_pred CCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccC--ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFE--HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 96 (381)
++|++++.||+|+||+||+|++. .+++.||||+++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 68999999999999999999984 5899999999864211 112233456799999999 69999999999843
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 346899999998 59999998888899999999999999999999999999999999999999999999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... .......+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+....
T Consensus 209 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------- 278 (355)
T 1vzo_A 209 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 278 (355)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred cccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--------
Confidence 43221 11223567999999999987633457899999999999999999999997654332222221100
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.... ......+++.+.+||.+||+.||.+|| |++++++||||+.+
T Consensus 279 --------------~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 279 --------------LKSE-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --------------HHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --------------hccC-----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0001 112246889999999999999999999 99999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=363.83 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=209.2
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 4578999999999999999999999999999999987532 23467889999999999999999999854 34
Q ss_pred cEEEEeecccc-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELMES-DLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+||||+.+ +|.+++. ....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 68999999985 9999987 456899999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 241 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----------- 241 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------
Confidence 221 1234579999999999987 678999999999999999999999998766544332221100
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.........+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 242 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 242 -----------------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp -----------------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred -----------------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 00111123478899999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=365.98 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=210.4
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
-..++|++.+.||+|+||+||+|.+..++. .||||+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--- 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG---
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence 345789999999999999999999986655 4999999753 234556678999999999999999999999843
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 --GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp --GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred --CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 345899999997 5999999754 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---- 273 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---- 273 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC----
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC----
Confidence 75444333322334457888999999987 678999999999999999999 99999888766555544332111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 274 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 --------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112468899999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=366.98 Aligned_cols=286 Identities=19% Similarity=0.305 Sum_probs=210.6
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence 3456789999999999999999999999999999999974321 223456779999999999999999999885432
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe----cCCCCeEEeee
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDF 170 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~----~~~~~vkl~DF 170 (381)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 246899999998 69999997643 39999999999999999999999999999999999998 77788999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh-HHHHH
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLI 243 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i 243 (381)
|+++....... ....+||+.|+|||++... ...++.++|||||||++|+|++|+.||....... ....+
T Consensus 161 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 161 GAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99986543322 2345799999999987521 1578999999999999999999999997544322 22222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
.......++..+........ ..+. .....+ ........+++.+.+||.+||++||++|||++|+|+||=
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~-~~~~-~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAEN-GPID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTT-CCEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccC-Cccc-cCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22211111111000000000 0000 000000 000111235667899999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=366.08 Aligned_cols=274 Identities=25% Similarity=0.365 Sum_probs=194.5
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.-..++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 85 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK---- 85 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS----
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec----
Confidence 3445789999999999999999999999999999998864321 23345678999999999999999999998543
Q ss_pred CCcEEEEeeccc-cCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEee
Q 016884 99 FKDIYVVFELME-SDLHQVIKA--------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~D 169 (381)
+..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 86 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 86 -DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp -SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred -CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 45899999997 599998863 45699999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCC--CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 170 FGLARVAFSDTP--MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 170 Fg~a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
||++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+..............
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999875433211 11112345799999999998652 358999999999999999999999998876655443222111
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
..... ...........+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 244 ~~~~~---------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 244 PPSLE---------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCCTT---------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCccc---------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00000 00011123456889999999999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=365.00 Aligned_cols=267 Identities=22% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
-..++|++++.||+|+||+||+|.+..++. .||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445789999999999999999999887765 89999997654455567789999999999999999999999865432
Q ss_pred C-CCCcEEEEeeccc-cCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEe
Q 016884 97 R-EFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 97 ~-~~~~~~lv~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
. .....++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 1223599999998 49999886432 59999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhh
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 247 (381)
|||+|+........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 180 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred eccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 99999764332211 11233457888999999987 679999999999999999999 999999887666554443211
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-------HHHHhcCCCcCcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-------AEEALADPYFKGL 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-------~~~lL~hp~~~~~ 319 (381)
. ....+.+++.+.+||.+||+.||.+||| ++++++|||+...
T Consensus 257 ~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 R------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp C------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred C------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1 1123568899999999999999999999 7888899999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=358.55 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=216.7
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 92 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD---- 92 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET----
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 3455789999999999999999999999999999999865422 23456788999999999999999999998543
Q ss_pred CCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+||||+.+ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 -~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 93 -TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp -TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred -CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 468999999985 89888864 579999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 171 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 234 (303)
T 3a7i_A 171 DTQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN----------- 234 (303)
T ss_dssp TTBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----------
T ss_pred cccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-----------
Confidence 3221 1235579999999999987 67899999999999999999999999876654433322210
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. .......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 235 ---------------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 235 ---------------N----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ---------------C----CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ---------------C----CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 011224688999999999999999999999999999999653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=366.58 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=208.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 93 (381)
.++|++.+.||+|+||+||+|.+. .++..||+|+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 468999999999999999999874 34567999998754 3344566889999999999 89999999999844
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 345899999998 59999998653 47999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999864332211 11234467889999999987 689999999999999999999 999998876
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..+....+..... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6554433322110 11224688999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=370.34 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=209.6
Q ss_pred CCCeEEeeeecccCCceEEEEE-----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++++.||+|+||+||+|. +..++..||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4689999999999999999999 5567889999998643 3345556788999999999999999999998543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC---Ce
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KL 165 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~---~v 165 (381)
...|+|||||. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 45799999997 5999999754 3589999999999999999999999999999999999999655 49
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (381)
||+|||+|+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999753221111 11234568999999999977 689999999999999999998 999999887665554443
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
..... .....+++.+.+||.+||+.||.+|||+.++++|.++-
T Consensus 301 ~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRM------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 31111 11246789999999999999999999999999998763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=364.07 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=191.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+. +++.++||||+++++++...
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~----- 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE----- 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----
Confidence 4578999999999999999999999999999999997543 2334445666666 67778999999999998543
Q ss_pred CcEEEEeeccccCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeeccc
Q 016884 100 KDIYVVFELMESDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
+..|+||||+.++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 46899999999998888763 56899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccc--cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
+....... .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.... .+...
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----- 242 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV----- 242 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-----
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH-----
Confidence 76533221 2334799999999998321 15689999999999999999999999976432100 00000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.....+.........+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 243 ------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 243 ------------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ------------------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------------------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00111111112234689999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=365.85 Aligned_cols=270 Identities=25% Similarity=0.386 Sum_probs=189.0
Q ss_pred ccccccCCCCCeEEee-eecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHH-HHHHhcCCCCccccceee
Q 016884 14 DFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV-KLLRLLRHPDIVEIKRIM 91 (381)
Q Consensus 14 ~~~~~~~~~~~Y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~ 91 (381)
.....+.+.++|.+++ .||+|+||+||+|+++.+++.||+|++... . ...+|+ ..++.++||||+++++++
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~----~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P----KARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H----HHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H----HHHHHHHHHHHhcCCCChHHHHHHH
Confidence 3345667788999965 599999999999999999999999998642 1 122233 346677999999999998
Q ss_pred cCCCcCCCCcEEEEeecccc-CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CCe
Q 016884 92 LPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKL 165 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~v 165 (381)
.... .....+|+|||||.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+
T Consensus 92 ~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 92 ENMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred hhcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 5422 123458999999985 9999998754 69999999999999999999999999999999999999864 559
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
||+|||+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 171 kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp EECCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred EEeccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 999999997543221 234578999999999976 6788999999999999999999999976553322111100
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.............+..+++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 244 -----------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 244 -----------------------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred -----------------------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 00000011111234578999999999999999999999999999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=368.34 Aligned_cols=273 Identities=19% Similarity=0.298 Sum_probs=211.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh---------------HHHHHHHHHHHHHHhcCCCCccc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---------------SDAIRILREVKLLRLLRHPDIVE 86 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~ 86 (381)
.++|++++.||+|+||.||+|.+ +++.||+|++....... .....+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47899999999999999999988 89999999986321110 11267889999999999999999
Q ss_pred cceeecCCCcCCCCcEEEEeecccc-CHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 016884 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQV------IKA--NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKN 156 (381)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~------l~~--~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~N 156 (381)
+++++... +.+|+||||+.+ +|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99998543 569999999985 99888 655 5689999999999999999999999 999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCC-ccchHHHHHHHHHHHcCCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~ 235 (381)
|+++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|+.||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999764332 22456799999999999772 25655 9999999999999999999998876
Q ss_pred h-hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 236 V-VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 236 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
. .+....+.......+.. .... ...............+++.+.+||.+||+.||.+|||++++|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLD-RNHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCS-SSSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccc-hhhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 5 33333332211100000 0000 000000000111256899999999999999999999999999999
Q ss_pred CcCcC
Q 016884 315 YFKGL 319 (381)
Q Consensus 315 ~~~~~ 319 (381)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=357.45 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=194.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||.||+|.+..+++.||||++............+.++..+++.++||||+++++++... ..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~ 98 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD 98 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence 4689999999999999999999999999999999975433333333444555678888999999999998543 46
Q ss_pred EEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~-~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+||||+++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 99 ~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 99 VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999997666666553 56899999999999999999999995 9999999999999999999999999998754332
Q ss_pred CCCcccccccccCccccCcccccc---ccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHH
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 255 (381)
.. .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 179 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 244 (318)
T 2dyl_A 179 KA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---------- 244 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH----------
T ss_pred cc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc----------
Confidence 21 234579999999999852 11568899999999999999999999997643 2222222221
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
... ........+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 245 ----------------~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 ----------------EEP--PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ----------------SCC--CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ----------------cCC--CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000 11112246899999999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=354.35 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=210.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CC
Confidence 35789999999999999999999999999999999854 345566788999999999999999999999854 35
Q ss_pred cEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 6899999998 599999987 56799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCc-----------ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 179 DTPMT-----------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 179 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------- 231 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------- 231 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------
Confidence 22211 01124579999999999987 78999999999999999999999998754321100
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
........... ...+.+++.+.+||.+||+.||++|||+.++++ |++.+
T Consensus 232 -----------~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 232 -----------FGLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp -----------SSBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -----------Hhhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00000111111 012467889999999999999999999999987 66554
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=365.07 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=209.2
Q ss_pred CCCCeEEeeeecccCCceEEEEE-----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
..++|++++.||+|+||.||+|. +..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35789999999999999999998 5667789999999753 3344556789999999999 789999999998543
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCCC---------------------------------------------------
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKANDD--------------------------------------------------- 122 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------------------------------------------- 122 (381)
. ..+++|||||. ++|.+++.....
T Consensus 99 ~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 99 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp T----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred C----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 2 34899999998 599999976533
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccccc
Q 016884 123 ---------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187 (381)
Q Consensus 123 ---------------l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~ 187 (381)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhcc
Confidence 89999999999999999999999999999999999999999999999999976533322 12234
Q ss_pred ccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHH
Q 016884 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (381)
Q Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 266 (381)
...||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+........
T Consensus 254 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------ 313 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT------------------ 313 (359)
T ss_dssp -CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC------------------
T ss_pred ccCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC------------------
Confidence 5678999999999987 689999999999999999998 9999988764433322221100
Q ss_pred HHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......+++++.+||.+||+.||.+|||+.++++|
T Consensus 314 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 314 -----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 011124578999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=355.30 Aligned_cols=264 Identities=26% Similarity=0.329 Sum_probs=207.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC--CCCccccceeecCCCcC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 97 (381)
..+++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++ ||||+++++++...
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--- 100 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--- 100 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS---
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC---
Confidence 44567999999999999999999885 5889999999765555666778899999999997 59999999998543
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus 101 --~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 --QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp --SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred --CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 45999999877899999999889999999999999999999999999999999999999964 789999999997653
Q ss_pred CCCCCcccccccccCccccCccccccc---------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
.... ........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||....... ..+...
T Consensus 178 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~-- 252 (313)
T 3cek_A 178 PDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAI-- 252 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHH--
T ss_pred Cccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHHHH--
Confidence 3221 1112345799999999998641 1367889999999999999999999997653211 111110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..... ........++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 253 ---------------------~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 ---------------------IDPNH---EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ---------------------HCTTS---CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ---------------------Hhccc---ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 00000 011123457889999999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=349.37 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=207.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 3478999999999999999999986 5778999999754332 3467899999999999999999999844 34
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+||||+. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 5899999998 5899999754 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (269)
T 4hcu_A 159 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------- 226 (269)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--------
Confidence 21 111234467888999999987 678999999999999999999 99999887766555444321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......++.+.+|+.+||+.||.+|||+.++++|
T Consensus 227 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 ----------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123578999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=356.17 Aligned_cols=271 Identities=21% Similarity=0.351 Sum_probs=206.4
Q ss_pred CCCCeEEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..++|++++.||+|+||+||+|+ +..+++.||+|++.. ........+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 35789999999999999999998 667899999999874 34455667889999999999999999999985432
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp --HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred --CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 235899999997 59999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
................+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc
Confidence 65443322222234567888999999987 67899999999999999999999998654211 111111111100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
............... ......+++++.+||.+||+.||++|||+.++++
T Consensus 236 ------~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 ------MIVFHLIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp ------HHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------hhHHHHHHHHhccCc---CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001111122222111 1223578999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=359.26 Aligned_cols=255 Identities=19% Similarity=0.197 Sum_probs=205.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (381)
-.+++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPC----- 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence 346789999999999999999999999999999999864322 23467899999999 89999999998844
Q ss_pred CCcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC-----eEEeeecc
Q 016884 99 FKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGL 172 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~-----vkl~DFg~ 172 (381)
....|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 356899999998899999986 468999999999999999999999999999999999999998887 99999999
Q ss_pred cccccCCCCCcc----cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHH---HHHHH
Q 016884 173 ARVAFSDTPMTV----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL---DLITD 245 (381)
Q Consensus 173 a~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~ 245 (381)
|+.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.. ..+..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 986543322110 1235689999999999988 67899999999999999999999999885543332 22211
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+.+ .....++ ++.+|+..||+.||.+|||++++++
T Consensus 235 ~~~~~~~~--------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIE--------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHH--------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHH--------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11000000 0112334 8999999999999999999998876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=353.27 Aligned_cols=263 Identities=27% Similarity=0.395 Sum_probs=202.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC------
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------ 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 95 (381)
.++|++++.||+|+||.||+|++..+++.||+|++.. .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999863 2344567889999999999999999999875431
Q ss_pred --cCCCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeec
Q 016884 96 --KREFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 96 --~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
......+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 123456899999998 59999998644 68899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhH
Q 016884 172 LARVAFSDTP-----------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQ 239 (381)
Q Consensus 172 ~a~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~ 239 (381)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||.... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9876432210 01122355799999999998762 468999999999999999998 554321 1111
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
...+. ..............++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 238 ~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 238 LKKLR---------------------------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHH---------------------------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHhcc---------------------------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111 11111111123456788999999999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=351.86 Aligned_cols=255 Identities=18% Similarity=0.214 Sum_probs=207.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.+++.+ +|+|++++++++. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecC-----CC
Confidence 46789999999999999999999999999999999864322 23467899999999 7999999999883 34
Q ss_pred CcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC-----eEEeeeccc
Q 016884 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLA 173 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~-----vkl~DFg~a 173 (381)
...|+||||++++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 5689999999889999998754 6999999999999999999999999999999999999987776 999999999
Q ss_pred ccccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhH---HHHHHHh
Q 016884 174 RVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ---LDLITDL 246 (381)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~ 246 (381)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 8654432211 11245679999999999987 6789999999999999999999999987543322 2222211
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...+. .....+.+++.+.+|+.+||+.||++|||++++++
T Consensus 237 ~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTP--------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSC--------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCcc--------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11010 11123468999999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=362.51 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=209.8
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhcC--CCCccccceeec
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIML 92 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~ 92 (381)
....++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 345688999999999999999999999999999999986432211 12234567999999996 599999999984
Q ss_pred CCCcCCCCcEEEEeeccc--cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-CCCCeEEee
Q 016884 93 PPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCD 169 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-~~~~vkl~D 169 (381)
. ....++|||++. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 119 ~-----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 R-----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp C-----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred c-----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 4 356899999997 69999999888899999999999999999999999999999999999999 778999999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
||+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... +..
T Consensus 194 fg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~---- 257 (320)
T 3a99_A 194 FGSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR---- 257 (320)
T ss_dssp CTTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----
T ss_pred Ccccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc----
Confidence 99997654322 2345799999999998762 2346789999999999999999999965321 000
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
.. ......+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 258 ----------------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 ----------------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ----------------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------------------cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00 011246899999999999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=351.13 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=204.3
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
+|.....||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEE
Confidence 344455899999999999999999999999998753 22345678899999999999999999999843 34689
Q ss_pred EEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-CCCeEEeeecccccccC
Q 016884 104 VVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (381)
Q Consensus 104 lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-~~~vkl~DFg~a~~~~~ 178 (381)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 69999997652 5679999999999999999999999999999999999987 89999999999976433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||..............
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 239 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG------------- 239 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------------
Confidence 211 1234579999999999876323488999999999999999999999975432211100000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
..... ......+++.+.+||.+||+.||++|||++++|+||||+...
T Consensus 240 ----------~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 240 ----------MFKVH-----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------HHCCC-----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------ccccc-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 00000 112346899999999999999999999999999999998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=347.93 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=206.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++. +..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence 3468999999999999999999765 5678999999754322 356789999999999999999999984 335
Q ss_pred cEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..|+||||+. ++|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 5899999997 58999997654 599999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 224 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------- 224 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC--------
Confidence 321 12234457788999999977 678999999999999999999 99999887765554443321110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......++.+.+||.+||+.||.+|||+.+++++
T Consensus 225 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ----------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123468899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=354.96 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=210.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..++|++.+.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3578999999999999999999883 45689999998743 344556788899999999999999999999844
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHHQFFLYQMLRALKYMHTANVYHR 150 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~~LH~~~i~H~ 150 (381)
...+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 345899999998 699999986543 8999999999999999999999999999
Q ss_pred CCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCC
Q 016884 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (381)
Q Consensus 151 Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 229 (381)
||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999976533221 112234467889999999987 678999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 016884 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (381)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~ 309 (381)
||.+.+.......+.... .......+++.+.+||.+||+.||.+|||+.+
T Consensus 252 p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 998877655443332211 01123468999999999999999999999999
Q ss_pred HhcC
Q 016884 310 ALAD 313 (381)
Q Consensus 310 lL~h 313 (381)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=348.69 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=199.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 357899999999999999999998654 457999988643 334456678899999999999999999998732
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+..|+||||+. ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 34799999999 59999998654 699999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------ 235 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------
Confidence 5332211 1223457789999999977 678999999999999999996 9999988776655544432111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....+.+++.+.+||.+||+.||++|||+.+++++
T Consensus 236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11235689999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=349.42 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=205.7
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
-..++|++++.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTK-----Q 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEec-----C
Confidence 45678999999999999999999776 6778999999754332 3567899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..+|+||||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 55899999997 699999976 4579999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.......
T Consensus 172 ~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 241 (283)
T 3gen_A 172 DDE--YTSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------ 241 (283)
T ss_dssp CHH--HHSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC------
T ss_pred ccc--cccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC------
Confidence 221 111233457788999999987 678999999999999999998 999998877665554443321111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.....++.+.+||.+||+.||.+|||+.++++|
T Consensus 242 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 ------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 123568899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=348.85 Aligned_cols=251 Identities=22% Similarity=0.408 Sum_probs=212.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
-..++|++.+.||+|+||+||+|.+..++..||+|++... ......+.+|+.+++.++||||+++++++.. .
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 81 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----E 81 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----C
Confidence 4567899999999999999999999999999999998742 2345678899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 45899999998 6999999864 35999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 162 ~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------- 230 (288)
T 3kfa_A 162 TGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 230 (288)
T ss_dssp CSSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------
T ss_pred cCCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-------
Confidence 43322 22234567889999999987 678999999999999999999 9999988776554443332111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+||.+||+.||.+|||++++++
T Consensus 231 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -----------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1122468899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=353.05 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=203.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
-..++|++.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998765 55689999997655556667788999999999999999999999976544
Q ss_pred CCCCcEEEEeeccc-cCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEee
Q 016884 97 REFKDIYVVFELME-SDLHQVIK------ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~------~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~D 169 (381)
......|+||||+. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 33446799999998 59999984 335699999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhC
Q 016884 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 170 Fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
||+++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 191 fg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 191 FGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred cCcceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 9999764332211 11233467889999999987 678999999999999999999 9999988776555444332111
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ------------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11124688999999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=374.61 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=193.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+|.+.+.||+|+||+|+. ....+++.||||++..... ..+.+|+.+|+.+ +||||+++++++. +...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCE
Confidence 4699999999999999763 4467899999999864321 1245799999999 7999999999884 3456
Q ss_pred EEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---C--CCeEEeeeccccc
Q 016884 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARV 175 (381)
Q Consensus 102 ~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~--~~vkl~DFg~a~~ 175 (381)
+|+|||||.++|.+++.... ..++..++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 89999999999999998654 4666677899999999999999999999999999999953 2 3578999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
..............+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||....... ...+ .+..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~~--- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGAC--- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTCC---
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hccC---
Confidence 54433222233456899999999998741 1467889999999999999999 899996543221 1111 1110
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...........+..+.+||.+||+.||.+|||++++|+||||..+
T Consensus 246 ---------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 246 ---------------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ---------------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ---------------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 001111112345668999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.43 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=210.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeec
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIML 92 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 92 (381)
..++|++.+.||+|+||+||+|.+..+ +..||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 347899999999999999999997543 357999999754 3445567888999999999 8999999999984
Q ss_pred CCCcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 016884 93 PPSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~ 155 (381)
. ...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 4 345899999998 59999998653 4999999999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 016884 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (381)
Q Consensus 156 NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 234 (381)
|||++.++.+||+|||+|+....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999976533221 111234567889999999987 689999999999999999999 99999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+..+....+..... ......+++++.+||.+||+.||++|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 75544433332110 11224689999999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.76 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=207.3
Q ss_pred CCCCeEEee-eecccCCceEEEEE--EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 21 DANRYKILE-VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 21 ~~~~Y~~~~-~lg~G~~g~V~~a~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..++|++.+ .||+|+||+||+|. +..+++.||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 347899998 99999999999995 45678899999997654444556788999999999999999999999822
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 34899999998 699999998888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..............+++.|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 443322222233456788999999977 678899999999999999999 999998877654433332210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 ----------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01123468999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=356.71 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=209.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
-..++|++++.||+|+||.||+|.+. .+++.||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAV- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence 34578999999999999999999987 35589999998753 234456678899999999999999999999844
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYH 149 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H 149 (381)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 122 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 122 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 345899999998 5999999763 56999999999999999999999999999
Q ss_pred cCCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CC
Q 016884 150 RDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228 (381)
Q Consensus 150 ~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~ 228 (381)
|||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCC
Confidence 999999999999999999999999754322111 11234568899999999887 679999999999999999999 99
Q ss_pred CCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH
Q 016884 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308 (381)
Q Consensus 229 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~ 308 (381)
.||.+.+..+....+.... .......+++.+.+||.+||+.||.+|||+.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGN------------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCCCChHHHHHHHhCCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 9998877654443332210 0112246889999999999999999999999
Q ss_pred HHhcC
Q 016884 309 EALAD 313 (381)
Q Consensus 309 ~lL~h 313 (381)
+++++
T Consensus 325 ~~~~~ 329 (343)
T 1luf_A 325 SIHRI 329 (343)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=362.26 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=196.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEc---CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 468999999999999999999876 46778999998753 234556688999999999999999999999844
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...+|+|||||. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 345899999997 69999998654 7999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..............+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~------ 269 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL------ 269 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 433222111122345778999999987 679999999999999999998 99999887765544443321111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 270 ------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 112357889999999999999999999999886
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=365.02 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=207.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 46899999999999999999999999999999998743 2334455788999999999999999999998443 45
Q ss_pred EEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+|||||. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 69999997643 6999999999999999999999999999999999999999999999999999753221
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 267 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 333 (377)
T 3cbl_A 267 VY-AASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---------- 333 (377)
T ss_dssp EE-ECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC----------
T ss_pred ce-eecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 11 000112235778999999977 678999999999999999998 9999988776544433322110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+||.+||+.||++|||++++++
T Consensus 334 --------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 --------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112457889999999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.64 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=202.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
-..++|++.+.||+|+||+||+|.+..++ ..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 34678999999999999999999987654 35999999753 234455678899999999999999999999843
Q ss_pred cCCCCcEEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 96 KREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
...+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 118 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 ---YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ---CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 3569999999985 999999764 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--- 269 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--- 269 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---
Confidence 765433222222223456788999999977 678999999999999999999 99999887765544433321111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1124678999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=350.38 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=208.9
Q ss_pred CCCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ........+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 457789999999753 3344567888999999999 899999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
...|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 45899999998 59999997654 48999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999765443221 12234567889999999877 679999999999999999999 999998766
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......+... ... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~-----------------------~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKE-----------------------GFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHH-----------------------TCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhcc-----------------------CCC------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44333222211 000 01124678999999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=357.46 Aligned_cols=274 Identities=23% Similarity=0.222 Sum_probs=206.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
-..++|++++.||+|+||+||+|.+. ++.||||++... ........+|+.+++.++||||+++++++..... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CC
Confidence 44578999999999999999999765 799999998642 2334455679999999999999999999865431 23
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceEecCCCCeEEe
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------NVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
..+|+|||||. ++|.+++... .+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 45899999998 5999999765 599999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCcccccccccCccccCcccccccc---CCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHH
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 245 (381)
|||+|+........ ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+............
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999765433221 1223467999999999987520 2455688999999999999999999987654333222222
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCC-cccc--CCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+....+ ..........+ .... ....++.+.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDM-----------QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHH-----------HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhh-----------hhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2223322211 11111111111 1111 1123456999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=344.14 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=204.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHH-----HHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-----IRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
-..++|++.+.||+|+||+||+|.+..+++.||+|++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44578999999999999999999999999999999986533222211 5788999999999999999999998432
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCC-----e
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCK-----L 165 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~-----v 165 (381)
.++||||+. ++|.+.+... ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. +
T Consensus 96 -------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 -------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 279999998 6998888654 47999999999999999999999999 999999999999988776 9
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhH--HHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ--LDLI 243 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i 243 (381)
||+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 99999998743221 245679999999999854335678899999999999999999999976553322 1111
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. ... .......+++.+.+||.+||+.||.+|||++++++
T Consensus 243 ~~------------------------~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 RE------------------------EGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HH------------------------SCC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc------------------------cCC-----CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11 000 01123468999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=348.08 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=200.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 34789999999999999999999999999999999875432 33445678899999999999999999999844 3
Q ss_pred CcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
..+|+||||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 568999999985 9999999888899999999999999999999999999999999999999999999999999875433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 187 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 249 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ------------- 249 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-------------
T ss_pred ccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-------------
Confidence 221 11234579999999999987 6789999999999999999999999987654322111111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-CHHHHhc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALA 312 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-t~~~lL~ 312 (381)
.........+.+++.+.+||.+||+.||++|| |++++++
T Consensus 250 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 250 ---------------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---------------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---------------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01111223467899999999999999999999 7888775
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=355.09 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=200.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEE----EEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
-..++|++++.||+|+||+||+|++..+++.+ |+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 34578999999999999999999998887754 77766532 1223346788999999999999999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
..++|+|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|
T Consensus 90 -----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 3688999988 699999876 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+......
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--- 238 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--- 238 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---
Confidence 865433221 11234457889999999987 789999999999999999999 99999887765544333321111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...+.++..+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1224578899999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=344.27 Aligned_cols=257 Identities=20% Similarity=0.231 Sum_probs=206.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 4568999999999999999999999999999999998654322 246789999999999988777766533 23
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~ 175 (381)
...|+||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 46899999998899999974 4579999999999999999999999999999999999999 4788999999999986
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh---hHHHHHHHhhC
Q 016884 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITDLLG 248 (381)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 248 (381)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 54432211 11235579999999999987 67899999999999999999999999874322 22222221110
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.++ .......+++.+.+|+.+||+.||.+|||++++++
T Consensus 236 ~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STP--------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSC--------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCc--------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 000 01112468899999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=346.40 Aligned_cols=257 Identities=20% Similarity=0.230 Sum_probs=202.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC----CC
Confidence 456899999999999999999999999999999998754322 2346789999999999988887776643 23
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeeccccc
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~ 175 (381)
...++||||++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 46899999998899999985 4579999999999999999999999999999999999999 7889999999999986
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhh---HHHHHHHhhC
Q 016884 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH---QLDLITDLLG 248 (381)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~ 248 (381)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 54432211 11235579999999999987 678999999999999999999999998754322 2222111100
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.. +.......+++.+.+||.+||+.||++|||++++++
T Consensus 236 ~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 ST--------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HS--------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cc--------------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00 011112467899999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=355.63 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=206.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3478999999999999999999973 456789999997432 223446788999999999 899999999998543
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHHQFFLYQMLRALKYMHTANVYHR 150 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~ 150 (381)
+.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||
T Consensus 122 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 122 -----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred -----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 45899999998 59999997653 37999999999999999999999999999
Q ss_pred CCCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCC
Q 016884 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (381)
Q Consensus 151 Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 229 (381)
||||+|||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999765443221 12234567889999999977 679999999999999999998 999
Q ss_pred CCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 016884 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (381)
Q Consensus 230 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~ 309 (381)
||.+.........+... .. .......+++.+.+||.+||+.||.+|||+.+
T Consensus 274 p~~~~~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQN--------------------------GF---KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHHT--------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHhc--------------------------CC---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99877644333222210 00 01112457899999999999999999999999
Q ss_pred HhcCC
Q 016884 310 ALADP 314 (381)
Q Consensus 310 lL~hp 314 (381)
+++|.
T Consensus 325 l~~~l 329 (344)
T 1rjb_A 325 LTSFL 329 (344)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=343.90 Aligned_cols=259 Identities=22% Similarity=0.263 Sum_probs=198.8
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
--..++|++.+.||+|+||+||+|.+. ..||+|+++...........+.+|+.+++.++||||++++++...
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 91 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----- 91 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-----
Confidence 344678999999999999999999754 359999998766666677789999999999999999999986522
Q ss_pred CCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..+++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 92 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 92 -PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp -SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred -CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 34799999998 699998864 457999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+....+.+..+....
T Consensus 171 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------- 241 (289)
T 3og7_A 171 SRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-------- 241 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT--------
T ss_pred ccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc--------
Confidence 32211 1122445799999999998621 1567889999999999999999999998866554433332211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
............+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 -----------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 242 -----------------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------------SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111122234578899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=354.52 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=201.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhc----CCCCccccceee
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLL----RHPDIVEIKRIM 91 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~~iv~~~~~~ 91 (381)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34578999999999999999999999999999999986532211 1223456799999998 899999999998
Q ss_pred cCCCcCCCCcEEEEeec-cc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec-CCCCeEEe
Q 016884 92 LPPSKREFKDIYVVFEL-ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVC 168 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~-~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~-~~~~vkl~ 168 (381)
.. .+..++|||+ +. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 108 ~~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ET-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred ec-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence 43 3458999999 55 69999999888899999999999999999999999999999999999999 78999999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
|||++....... .....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+... +..
T Consensus 183 dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--- 247 (312)
T 2iwi_A 183 DFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--- 247 (312)
T ss_dssp CCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH---
T ss_pred EcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh---
Confidence 999997654322 2345799999999998762 2334589999999999999999999965321 100
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
. .......+++.+.+||.+||+.||++|||++++|+||||+...
T Consensus 248 -----------------------~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 248 -----------------------A-----ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----------------------T-----CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----------------------h-----ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0 0111246889999999999999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=341.76 Aligned_cols=249 Identities=15% Similarity=0.198 Sum_probs=206.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 468999999999999999999874 889999999876556666778999999999999999999999986542 246
Q ss_pred EEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999987542
Q ss_pred cCCCCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.. ....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 229 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR------ 229 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC------
T ss_pred cc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC------
Confidence 21 234789999999998762 122333799999999999999999999887765544333221110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+||.+||+.||.+|||++++++
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123468999999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=351.32 Aligned_cols=253 Identities=20% Similarity=0.366 Sum_probs=208.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++.+.||+|+||.||+|.+. .+++.||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 578999999999999999999876 46789999998743 334455678899999999999999999999844
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
....|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 345899999998 5999998642 357999999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 244 (381)
||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCccccccccccc-cccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999975433221 111234467899999999987 678999999999999999999 899998876554443332
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
... .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 210 011234688999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=344.29 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=209.2
Q ss_pred CCCeEEee-eecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILE-VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~-~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 46788877 9999999999999864 46788999999754 344566788899999999999999999999832
Q ss_pred CCcEEEEeecccc-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 348999999985 999998654 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-------- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--------
Confidence 433322222234457899999999976 678999999999999999998 999998876554443332210
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
.....+.+++.+.+||.+||+.||.+|||+.++++|.+
T Consensus 231 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 231 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01123578999999999999999999999999998743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=355.08 Aligned_cols=267 Identities=15% Similarity=0.151 Sum_probs=201.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHH---------HHHHHHHHHHHHhcCCCCccccc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISD---------AIRILREVKLLRLLRHPDIVEIK 88 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~ 88 (381)
..++|++.+.||+|+||+||+|.+.. ++..||+|++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999987 7889999998753221111 12356788999999999999999
Q ss_pred eeecCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC--CeE
Q 016884 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC--KLK 166 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~--~vk 166 (381)
+++.... .....+|+|||||+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986532 2245699999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred EeeecccccccCCCC----CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC--hhhHH
Q 016884 167 VCDFGLARVAFSDTP----MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS--VVHQL 240 (381)
Q Consensus 167 l~DFg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~ 240 (381)
|+|||+|+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999976432211 1111245579999999999987 678999999999999999999999996532 21111
Q ss_pred HHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 241 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..........+.... ... ....+++.+.+||.+||+.||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~-------------~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVL-------------KWA---------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHH-------------HHS---------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHH-------------hhc---------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111111111100 000 01268899999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=366.82 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=193.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (381)
...+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++..
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----- 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT----- 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----
Confidence 34567888999999999999875 4568999999998642 234567899999876 89999999998843
Q ss_pred CCcEEEEeeccccCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---------
Q 016884 99 FKDIYVVFELMESDLHQVIKANDDL-------TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--------- 162 (381)
Q Consensus 99 ~~~~~lv~e~~~~~L~~~l~~~~~l-------~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~--------- 162 (381)
...+|+|||||+++|.+++...... ++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 3569999999999999999865433 233457899999999999999999999999999999754
Q ss_pred ----CCeEEeeecccccccCCCCC-cccccccccCccccCccccccc-----cCCCCCccchHHHHHHHHHHHc-CCCCC
Q 016884 163 ----CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (381)
Q Consensus 163 ----~~vkl~DFg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~~ll~-g~~pf 231 (381)
+.+||+|||+|+........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999865433221 1112345799999999998651 1468999999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
.+..... ..+...... ... ........+++++.+||.+||+.||.+|||+.++|
T Consensus 241 ~~~~~~~--~~i~~~~~~-----------------------~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 241 GDKYSRE--SNIIRGIFS-----------------------LDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp CSTTTHH--HHHHHTCCC-----------------------CCC-CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhH--HHHhcCCCC-----------------------ccc-ccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 7654322 111110000 000 00000123467899999999999999999999999
Q ss_pred cCCCcCc
Q 016884 312 ADPYFKG 318 (381)
Q Consensus 312 ~hp~~~~ 318 (381)
+||||..
T Consensus 295 ~hp~f~~ 301 (434)
T 2rio_A 295 RHPLFWP 301 (434)
T ss_dssp TSGGGSC
T ss_pred hCCccCC
Confidence 9999964
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.65 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=204.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcE----EEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
.-..++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 33457899999999999999999999888876 7777764321 11222356689999999999999999998732
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
...++||||+. ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 -----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 -----SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp -----SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred -----CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 34899999998 6999999764 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 162 a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 235 (325)
T 3kex_A 162 ADLLPPDDK-QLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--- 235 (325)
T ss_dssp GGGSCCCTT-CCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred ccccCcccc-cccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence 986543322 122345568889999999987 679999999999999999999 9999988765544433322110
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 236 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ---------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11123467789999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=342.57 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=204.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC---CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||+||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 4689999999999999999998654 3456999998754 234556788999999999999999999999743
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 23699999998 5999999764 46999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------ 233 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------ 233 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------
Confidence 332211 1233467889999999977 678999999999999999998 99999877665554443321111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 234 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1124578999999999999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=351.98 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=205.9
Q ss_pred CCCCeEEeeeecccCCceEEEEE-----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..++|++++.||+|+||.||+|. +..++..||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 45789999999999999999998 5677889999998643 3345566788999999999999999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC---CC
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CK 164 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~---~~ 164 (381)
...|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 45799999996 69999998653 48999999999999999999999999999999999999944 46
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 243 (381)
+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999998754332211 11234468899999999977 678999999999999999998 99999887765444333
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
..... ......+++.+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 259 ~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22110 111246889999999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=341.60 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=193.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC--hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 468999999999999999999874 889999998643222 1224578899999999999999999999854 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEecC--------CCCeEE
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANA--------NCKLKV 167 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~---i~H~Dikp~NIl~~~--------~~~vkl 167 (381)
..+|+||||+. ++|.+++. ...+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 45899999998 58887775 457999999999999999999999999 899999999999986 678999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 229 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-
Confidence 99999975433221 24579999999999987 67899999999999999999999999887654433322210
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 230 -------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 -------------------------KL---ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------------CC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CC---CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 00 011234678999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=353.52 Aligned_cols=271 Identities=21% Similarity=0.348 Sum_probs=212.5
Q ss_pred CCCCeEEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..++|++++.||+|+||.||+|+ +..+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-- 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC--
Confidence 34789999999999999999998 5678999999999753 445556788999999999999999999988643
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
+...+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 -GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp -SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred -CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 3356899999996 699999976 4569999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~--- 245 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER--- 245 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC------
T ss_pred ecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc---
Confidence 75444333333345578899999999987 6789999999999999999999999975432111 0000000
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
................. ....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 246 ----~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 ----DVPALSRLLELLEEGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -----CCHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----ccccHHHHHHHhhcccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011111222222111 11235789999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=349.87 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=207.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEc-------CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeec
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIML 92 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 92 (381)
..++|++.+.||+|+||+||+|.+. .++..||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3578999999999999999999975 45678999998753 3345566788999999999 8999999999984
Q ss_pred CCCcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 016884 93 PPSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~ 155 (381)
. ...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 112 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 112 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp S-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred c-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 4 345899999998 59999998653 3899999999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 016884 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (381)
Q Consensus 156 NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 234 (381)
|||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 99999999999999999976533221 111233467889999999877 678999999999999999999 99999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
+..+....+..... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65544433322110 11224688999999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=358.17 Aligned_cols=269 Identities=16% Similarity=0.141 Sum_probs=202.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCC-----CcEEEEEEeCCccCChHHH---------HHHHHHHHHHHhcCCCCccc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVE 86 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~h~~iv~ 86 (381)
..++|++++.||+|+||+||+|.+..+ ++.||+|++.......... ....+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 5889999986432111111 12345666777888999999
Q ss_pred cceeecCCCcCCCCcEEEEeeccccCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec--CCC
Q 016884 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANC 163 (381)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~--~~~ 163 (381)
+++++.... .....+|+|||||+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 223458999999988999999876 5799999999999999999999999999999999999999 889
Q ss_pred CeEEeeecccccccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhH
Q 016884 164 KLKVCDFGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239 (381)
Q Consensus 164 ~vkl~DFg~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 239 (381)
.+||+|||+|+......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 99999999997643321111 11134569999999999987 6799999999999999999999999986433222
Q ss_pred HHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 240 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......... .......+..... ...+++++.+|+..||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~-----------~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRY-----------RENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHH-----------HHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHh-----------hhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111000 0011111111110 1467899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=339.81 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=206.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----A 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC-----C
Confidence 3578999999999999999999886 6788999999754332 35678999999999999999999998543 4
Q ss_pred cEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 5899999998 5999999865 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ........+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~--------- 223 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------- 223 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc---------
Confidence 11 111233467888999999987 678999999999999999999 8999988776554444332110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......++.+.+|+.+||+.||.+|||+.+++++
T Consensus 224 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 ---------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=348.23 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred CCCCeEEeeeecccCCceEEEEEE-----cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++... ........+.+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 457899999999999999999985 457789999999754 3334556788999999999 699999999998543
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKANDD----------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----------------l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NI 157 (381)
. ..+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 104 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 G----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp T----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred C----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2 35899999998 599999987553 89999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCCh
Q 016884 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (381)
Q Consensus 158 l~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 236 (381)
+++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999976543322 122234578899999999987 678999999999999999998 9999987654
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......... .. .......+++.+.++|.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~-----------------------~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKE-----------------------GT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHH-----------------------TC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhcc-----------------------Cc------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3322211110 00 011124578999999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=352.43 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=190.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCC---cC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS---KR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~---~~ 97 (381)
..+|++.+.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 4589999999999999999999999999999998853 23455567889999999996 999999999885322 13
Q ss_pred CCCcEEEEeeccccCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEecCCCCeEEeeecc
Q 016884 98 EFKDIYVVFELMESDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
....+++||||+.|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 3456899999999999998864 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCccccCcccccc-ccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHH
Q 016884 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (381)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 242 (381)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 97654322211 01124569999999999831 115688899999999999999999999976543211100
Q ss_pred HHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCC
Q 016884 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (381)
Q Consensus 243 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~ 315 (381)
.. ........++.+.+||.+||+.||.+|||+.++++|-+
T Consensus 265 ---------------------------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ---------------------------KY------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------------C------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ---------------------------cc------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00 01112456788999999999999999999999999743
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=350.16 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=201.2
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEE----EEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
-..++|++++.||+|+||+||+|.+..+++.| |+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 34578999999999999999999998888765 666664322 223456788999999999999999999998543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a 173 (381)
..++|++++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 2788999988 699999876 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
+........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--- 238 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--- 238 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 765332221 11234457889999999987 689999999999999999999 99999887765544433321111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...+.+++++.+||.+||+.||.+|||+.++++
T Consensus 239 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 ---------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112467899999999999999999999999997
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=346.29 Aligned_cols=270 Identities=22% Similarity=0.371 Sum_probs=208.7
Q ss_pred CCCeEEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.++|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence 4569999999999999999998 67789999999997532 2233467889999999999999999999986532
Q ss_pred CCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
...+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 245899999998 599999954 45799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...............||..|+|||++.+ ..++.++|||||||++|+|++|..|+.... .......+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-- 246 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ-- 246 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG--
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc--
Confidence 6544332233345678899999999977 678899999999999999999998864321 1222222222211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
............... ....+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 -----~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 247 -----MTVTRLVNTLKEGKR---LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -----GHHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -----cCHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111122222222211 1223578999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=349.40 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=207.3
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCc-----EEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||+||+|.+..++. .||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 35789999999999999999999877664 7999998753 2344566788999999999 89999999999844
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKA--------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~--------------~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~ 159 (381)
...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 345899999998 599999864 3468999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhh
Q 016884 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVH 238 (381)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 238 (381)
+.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999765433221 12234567889999999887 678999999999999999998 999998765443
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+...... .......++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVKDGYQ-----------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 33222211000 0112357889999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=345.69 Aligned_cols=245 Identities=17% Similarity=0.279 Sum_probs=200.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC-------cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (381)
.++|++.+.||+|+||+||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999998877 47999998643 223456788999999999999999999998543
Q ss_pred CcCCCCcEEEEeeccc-cCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC--------
Q 016884 95 SKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------- 164 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~-------- 164 (381)
...|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 85 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 -----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp -----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred -----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 45799999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHH
Q 016884 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243 (381)
Q Consensus 165 vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i 243 (381)
+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++| .+||...+........
T Consensus 160 ~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998643221 234688999999998753 4689999999999999999995 4555554433222111
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.. . .......++.+.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~---------------------------~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 ED---------------------------R-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HT---------------------------T-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc---------------------------c-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 0 01123457889999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=368.04 Aligned_cols=249 Identities=22% Similarity=0.411 Sum_probs=209.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..+|++.+.||+|+||.||+|.++.++..||||+++.... ....+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 4679999999999999999999999999999999875332 245788999999999999999999998443 45
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999998 6999999864 4589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 437 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 437 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 221 11233456788999999977 678999999999999999999 9999998776554443322110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ---------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1123468899999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=342.38 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=196.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCc-cCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
....++|++.+.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 103 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE---- 103 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----
Confidence 34557899999999999999999999999999999999753 2344556788899999999999999999999854
Q ss_pred CCCcEEEEeecccc-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 98 EFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
...+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 104 -DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp -TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--
T ss_pred -CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 3468999999985 99988864 45799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChh--hHHHHHHHhhCCC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTP 250 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~ 250 (381)
+........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 183 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 251 (310)
T 2wqm_A 183 GRFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251 (310)
T ss_dssp -------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH------
T ss_pred eeeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh------
Confidence 875433221 1234578999999999987 67899999999999999999999999764321 1111111
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..... ......+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ---------------------~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 252 ---------------------QCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---------------------TTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------cccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 0112467899999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=351.88 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=206.1
Q ss_pred ccccccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEE--EEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccc
Q 016884 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIK 88 (381)
Q Consensus 12 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 88 (381)
+...|...+ .++|++.+.||+|+||.||+|++..++..+ |+|.+... ........+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~p~~~-~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 15 DPTIYPVLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp -CCCSSBCC-GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCccccccc-HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 344444433 368999999999999999999999888865 99988643 2223445788999999999 899999999
Q ss_pred eeecCCCcCCCCcEEEEeeccc-cCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 016884 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRD 151 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~D 151 (381)
+++.. ...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+|||
T Consensus 93 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 167 (327)
T 1fvr_A 93 GACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167 (327)
T ss_dssp EEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eeeee-----CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 99843 356999999997 59999997654 699999999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCC
Q 016884 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPL 230 (381)
Q Consensus 152 ikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p 230 (381)
|||+|||++.++.+||+|||+++...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.|
T Consensus 168 lkp~NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 168 LAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp CSGGGEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccceEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCC
Confidence 99999999999999999999987432211 1123457889999999977 678999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 016884 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (381)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l 310 (381)
|.+.+..+....+.... .......+++.+.+||.+||+.||.+|||++++
T Consensus 242 f~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 242 YCGMTCAELYEKLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp TTTCCHHHHHHHGGGTC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcHHHHHHHhhcCC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 98876544333222110 011224678999999999999999999999999
Q ss_pred hcC
Q 016884 311 LAD 313 (381)
Q Consensus 311 L~h 313 (381)
+++
T Consensus 292 l~~ 294 (327)
T 1fvr_A 292 LVS 294 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=346.76 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=197.1
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh--cCCCCccccceeecCCCcC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~ 97 (381)
...++|++++.||+|+||+||+|.+ +++.||||++... ......+|.+++.. ++||||+++++++.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence 3567899999999999999999976 6899999998642 33455667777776 79999999999875432 2
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEecCCCCeEEe
Q 016884 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
....+|+||||+. ++|.++++. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3356899999998 599999964 47999999999999999999999 9999999999999999999999999
Q ss_pred eecccccccCCCCCc-ccccccccCccccCccccccccC----CCCCccchHHHHHHHHHHHcC----------CCCCCC
Q 016884 169 DFGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPG 233 (381)
Q Consensus 169 DFg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwslG~il~~ll~g----------~~pf~~ 233 (381)
|||+|+......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654332221 11234579999999999876211 344689999999999999999 888865
Q ss_pred CChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 234 KSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 234 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..... ....+..... ........+........++.+.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVC--------------------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCSSCCHHHHHHHHT--------------------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCCcchhhhhHHHh--------------------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 32211 1111111000 00000001100011235578999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=338.90 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=203.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
-+|.+.+.||+|+||+||+|.+..++. .||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 95 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---- 95 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence 357888999999999999999765554 7999998753 34455678889999999999999999999985432
Q ss_pred CcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...++||||+. ++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 23489999997 699999986 4578999999999999999999999999999999999999999999999999997543
Q ss_pred CCCC-CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 178 SDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 178 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.... .........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------ 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------
T ss_pred CCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------
Confidence 2211 1111234568899999999987 678999999999999999999 55666665554444333321111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 248 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112457899999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=339.78 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=203.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..+|++.+.||+|+||+||+|.+..++ ..||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence 457999999999999999999875433 46899998753 3445567888999999999999999999986433
Q ss_pred CCcEEEEeecccc-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~~-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....|+||||+.+ +|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 2457999999985 99999976 346899999999999999999999999999999999999999999999999999754
Q ss_pred cCCCCC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 177 FSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 177 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...... ........+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 322111 111234567889999999977 678999999999999999999 67788776655544433321111
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112357889999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=347.45 Aligned_cols=270 Identities=22% Similarity=0.324 Sum_probs=207.1
Q ss_pred CCCCe-EEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 016884 21 DANRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (381)
Q Consensus 21 ~~~~Y-~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (381)
..++| ++++.||+|+||+||+|. +..+++.||+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34556 999999999999997775 4457899999999754 33455667889999999999999999999986532
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 107 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 107 ---AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp ---TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ---CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 356899999998 5999999765 49999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~ 255 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM 255 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch
Confidence 76444332222345568889999999987 67889999999999999999999999654321 111111111110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.............. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 256 -------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 -------TVLRLTELLERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -------HHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------hHHHHHHHHhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01111111111111 1223568999999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=360.24 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=203.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|+.++||||+++++++.... .
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----G 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----S
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----C
Confidence 3478999999999999999999764 7899999997532 3457889999999999999999999975432 3
Q ss_pred cEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+|+|||||. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 5899999998 59999998654 37999999999999999999999999999999999999999999999999997532
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------- 404 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------- 404 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 211 22357889999999987 689999999999999999998 9999988776555444432111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 405 ----------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ----------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1122468999999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.64 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=203.8
Q ss_pred eEEe-eeecccCCceEEEEEE--cCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 25 YKIL-EVIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 25 Y~~~-~~lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+.+. +.||+|+||+||+|.+ ..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CC
Confidence 4443 4799999999999954 4667899999998655555556789999999999999999999998832 24
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+++|||||. ++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 799999998 5999999988899999999999999999999999999999999999999999999999999998654433
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 591 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 591 (635)
T ss_dssp -----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred cccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22222234457889999999977 689999999999999999998 99999988776555444332111
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++++.+||.+||+.||++|||++++++
T Consensus 592 --------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 --------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 122468899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=347.26 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=203.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 35789999999999999999999999999999998854 33455677889999999999999999999986321 2234
Q ss_pred cEEEEeecccc-CHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 101 DIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 68999999995 99998875 46799999999999999999999999999999999999999999999999998865
Q ss_pred ccCCCCCc------ccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 176 AFSDTPMT------VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------- 254 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--------- 254 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---------
Confidence 32211100 011234579999999998652 12378899999999999999999999953211000
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....... ... .....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 255 -------------~~~~~~~---~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 255 -------------SVALAVQ---NQL---SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------CHHHHHH---CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------hhhHHhh---ccC---CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000000 000 011224688999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=353.02 Aligned_cols=260 Identities=14% Similarity=0.175 Sum_probs=200.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC--------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT--------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (381)
.++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.+++.++||||+++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57899999999999999999999874 889999998643 356789999999999999985432211
Q ss_pred CC-----------cCCCCcEEEEeeccccCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec
Q 016884 94 PS-----------KREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (381)
Q Consensus 94 ~~-----------~~~~~~~~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~ 160 (381)
.. ......+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 00 0123568999999988999999876 6899999999999999999999999999999999999999
Q ss_pred CCC--CeEEeeecccccccCCCCC----cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCC
Q 016884 161 ANC--KLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (381)
Q Consensus 161 ~~~--~vkl~DFg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 234 (381)
.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 998 8999999999764332111 111234579999999999987 67899999999999999999999999765
Q ss_pred C-hhhHHHHH-HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 235 S-VVHQLDLI-TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 235 ~-~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ....+... ......+. ........+..+++.+.+||.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG----------------------PFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC----------------------CEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh----------------------hhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 22211111 11100000 000011112357899999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.08 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=205.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 468999999999999999999875 46789999997532 235678899999999999999999999842 34
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 6999999754 3689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......+
T Consensus 337 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------- 405 (454)
T 1qcf_A 337 NE--YTAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------- 405 (454)
T ss_dssp HH--HHTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-------
T ss_pred Cc--eeccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 11 111123356788999999977 679999999999999999999 999999887666555443321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+++.+.+||.+||+.||++|||++++++
T Consensus 406 -----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 -----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12468899999999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.90 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=205.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 107 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----R 107 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----T
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 35679999999999999999999864 68999999886532 2345678899999999999999999999843 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 46899999998 59998886543 58999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 188 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------ 258 (321)
T 2qkw_B 188 KGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE------ 258 (321)
T ss_dssp ECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH------
T ss_pred cccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh------
Confidence 64322211 11234568999999999977 6799999999999999999999999976543322111100000
Q ss_pred HhhhcCHHHHHHHHHhcCC-CCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 255 IAVVRNEKARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
.... ..+... .+.......+..+..+.+|+.+||+.||++|||+.++++|.
T Consensus 259 --~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 259 --SHNN-------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --HHTT-------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --cccc-------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000 000000 00000111223456789999999999999999999999763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=337.78 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=204.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.. +
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 80 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------E 80 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------C
Confidence 3478999999999999999999875 567899999875332 24567899999999999999999998742 2
Q ss_pred cEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
..|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 4799999997 69999997543 69999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 161 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------- 228 (279)
T 1qpc_A 161 DNEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------- 228 (279)
T ss_dssp SSCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred Cccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC--------
Confidence 3221 11233457888999999976 678999999999999999999 9999988776554443322110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++.+.+|+.+||+.||++|||++++++
T Consensus 229 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ----------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112467899999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.26 Aligned_cols=242 Identities=29% Similarity=0.433 Sum_probs=193.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|.+. ++.||+|++... .....+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~ 73 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN-------P 73 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------T
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------C
Confidence 468999999999999999999764 789999998632 345678899999999999999999998742 3
Q ss_pred EEEEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceEecCCCC-eEEeeeccc
Q 016884 102 IYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHT---ANVYHRDLKPKNILANANCK-LKVCDFGLA 173 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~---~~i~H~Dikp~NIl~~~~~~-vkl~DFg~a 173 (381)
.|+||||+. ++|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +||+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence 699999998 59999998665 47899999999999999999999 89999999999999998887 799999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 154 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---------- 215 (307)
T 2eva_A 154 CDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---------- 215 (307)
T ss_dssp -----------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH----------
T ss_pred cccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH----------
Confidence 754322 123469999999999987 68999999999999999999999999764322111000
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...... .......+++.+.+||.+||+.||.+|||++++++
T Consensus 216 ---------------~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 216 ---------------AVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ---------------HHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------HHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000000 01123568899999999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=338.35 Aligned_cols=244 Identities=25% Similarity=0.405 Sum_probs=196.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++++.||+|+||+||+|.+ +++.||+|+++.. .....+.+|+.+++.++||||+++++++... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CC
Confidence 347899999999999999999976 4889999998643 2456788999999999999999999987543 23
Q ss_pred cEEEEeecccc-CHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 101 DIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+|+||||+.+ +|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 58999999985 99999976543 8999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+....
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 231 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------- 231 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------
Confidence 221 23367889999999977 678999999999999999998 999998776544433332110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 232 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ---------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01123468999999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=341.11 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=200.3
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcC-CCc--EEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~--~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (381)
..-..++|++++.||+|+||+||+|.+.. +++ .||+|+++... ........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34456789999999999999999998643 333 69999987532 233456688899999999999999999999854
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeec
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
. ..++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 93 ~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 93 P------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp S------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred C------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccc
Confidence 3 2799999998 6999988764 579999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
++.................+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-- 242 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-- 242 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC--
Confidence 99765443332222234567889999999977 678899999999999999999 9999988776554443322110
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+++.+.++|.+||+.||.+|||+.++++
T Consensus 243 ---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 243 ---------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01123468899999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=337.82 Aligned_cols=249 Identities=28% Similarity=0.376 Sum_probs=204.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC------
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------ 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------ 95 (381)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467999999999999999999999999999999986432 24568999999999999999999874311
Q ss_pred -----cCCCCcEEEEeecccc-CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEE
Q 016884 96 -----KREFKDIYVVFELMES-DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (381)
Q Consensus 96 -----~~~~~~~~lv~e~~~~-~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl 167 (381)
......+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 0123458999999995 999999754 57999999999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~-------- 227 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSK--F-------- 227 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--H--------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHHH--H--------
Confidence 99999876543321 234579999999999987 6789999999999999999999988742110 0
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
........ ....+++.+.+||.+||+.||.+|||+.++++|.+.-
T Consensus 228 -------------------~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 -------------------FTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -------------------HHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------HHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111110 1235788999999999999999999999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=339.50 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=191.3
Q ss_pred cCCCCCeEEe-eeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHH-HhcCCCCccccceeecCCCc
Q 016884 19 YGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 19 ~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~ 96 (381)
....++|.++ +.||+|+||.||+|.+..+++.||+|++.. .....+|+.++ +.++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~- 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY- 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-
Confidence 3445678887 789999999999999999999999999863 13456788888 5668999999999885411
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEeee
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDF 170 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~DF 170 (381)
.....+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 12356899999998 59999998754 6999999999999999999999999999999999999998 788999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCC
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 250 (381)
|++.... + ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 165 g~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---- 213 (299)
T 3m2w_A 165 GFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---- 213 (299)
T ss_dssp TTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS----
T ss_pred ccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH----
Confidence 9885421 1 35678999999999999999999999765432211000000
Q ss_pred CHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
............+..+++++.+||.+||+.||.+|||++++|+||||++....
T Consensus 214 -------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 214 -------------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp -------------------SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred -------------------HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 00000000011124689999999999999999999999999999999875543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.70 Aligned_cols=255 Identities=17% Similarity=0.202 Sum_probs=196.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCC-CCccc---------cceee
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRH-PDIVE---------IKRIM 91 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~---------~~~~~ 91 (381)
..|++.+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++| +|... ..++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 348899999999999999999999999999999873322 22234678899999999987 22211 11111
Q ss_pred c------------CCCcCCCCcEEEEeeccccCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 016884 92 L------------PPSKREFKDIYVVFELMESDLHQVIKA-------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (381)
Q Consensus 92 ~------------~~~~~~~~~~~lv~e~~~~~L~~~l~~-------~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Di 152 (381)
. .........++++|+++.++|.++++. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1 111111335799999999999988841 235788899999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCcccccc--------ccCCCCCccchHHHHHHHHHH
Q 016884 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEV 224 (381)
Q Consensus 153 kp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~DiwslG~il~~l 224 (381)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....++.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764322 244578 99999999831 114588899999999999999
Q ss_pred HcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCC
Q 016884 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (381)
Q Consensus 225 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~R 304 (381)
++|+.||.+.+....... .......+++.+.+||.+||+.||++|
T Consensus 311 ltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHHH-----------------------------------HHhhcccCCHHHHHHHHHHccCChhhC
Confidence 999999987653321110 111234688999999999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q 016884 305 PTAEEALADPYFKGL 319 (381)
Q Consensus 305 pt~~~lL~hp~~~~~ 319 (381)
||+.++|+||||+.+
T Consensus 356 pt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQAMETPEYEQL 370 (413)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCHHHHHH
Confidence 999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=350.11 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=196.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.+|++.+.||+|+||+||+|.+..++ ..||+|.++.. ........+.+|+.+++.++||||+++++++... .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 46889999999999999999875433 46899988643 3345567889999999999999999999987432 2
Q ss_pred CcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 35799999998 5999999865 468999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~------- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-------
Confidence 32211 111234467889999999987 689999999999999999999 7888987765544433322110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......+++.+.+|+.+||+.||++|||+.+++++
T Consensus 315 -----------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 -----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124578999999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=358.60 Aligned_cols=284 Identities=19% Similarity=0.307 Sum_probs=206.5
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++.+.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 80 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---
Confidence 3456789999999999999999999999999999999974321 223456779999999999999999999986432
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe----cCCCCeEEeee
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDF 170 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~----~~~~~vkl~DF 170 (381)
....|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 246899999997 59999997543 39999999999999999999999999999999999998 77778999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChh-hHHHHH
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLI 243 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i 243 (381)
|+++...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... .....+
T Consensus 161 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 161 GAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 9997643321 22456799999999987531 035678999999999999999999999753321 112222
Q ss_pred HHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.......++..+......... .+. .....+ ........+++.+.+||.+||++||++|||+++++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~-~~~-~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENG-PID-WSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTC-CEE-EESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCC-Ccc-cCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 222222111111100000000 000 000000 0001112355678999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=357.71 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=203.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4679999999999999999998865 46799999875432 23568899999999999999999999843 34
Q ss_pred EEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 599999974 34699999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 400 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 400 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 2211 1123457788999999977 679999999999999999999 99999988766555444321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (381)
...+.+++.+.+||.+||+.||++|||++++++ ..++..
T Consensus 401 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 112468899999999999999999999999987 345543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=348.05 Aligned_cols=271 Identities=20% Similarity=0.294 Sum_probs=203.3
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
....++|++.+.||+|+||+||+|.+ .+++.||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS----
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC----
Confidence 34568899999999999999999974 46899999998753211 1122578999999999999999999999543
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEecCCCCeEEeee
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDF 170 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~---~i~H~Dikp~NIl~~~~~~vkl~DF 170 (381)
...++||||+. ++|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 100 -TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred -CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 45799999998 59999997643 499999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-----hhhHHHHHHH
Q 016884 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-----VVHQLDLITD 245 (381)
Q Consensus 171 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~ 245 (381)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+..
T Consensus 179 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 179 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp SSCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99976533222 12244569999999999977 678999999999999999999999995211 1111111110
Q ss_pred hhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
........ .... ...........++.+.+|+.+||+.||.+|||+.++++|-.-.
T Consensus 255 ~~~~~~~~---------------~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLE---------------ALVD--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCST---------------TSSC--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred Hhhchhhh---------------hhcC--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00000000 0000 0000001112346789999999999999999999999986543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=377.12 Aligned_cols=286 Identities=25% Similarity=0.333 Sum_probs=210.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (381)
.++|++.+.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 37899999999999999999999999999999998753 34455677889999999999999999999875421 12346
Q ss_pred cEEEEeeccc-cCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCC---eEEeeeccc
Q 016884 101 DIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~---vkl~DFg~a 173 (381)
..|+|||||. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 6899999997 69999998644 6999999999999999999999999999999999999997765 899999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .........
T Consensus 172 ~~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~---~~i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH---GKVREKSNE 242 (676)
T ss_dssp CBTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS---TTCC-----
T ss_pred cccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh---hhhhcccch
Confidence 86543322 245689999999999987 789999999999999999999999997754321110 000000000
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
......... ... ..... ........+.+++.+.+||.+||.+||.+|||+.++|+||||+.+..
T Consensus 243 ~~~~~~~l~--g~~-~~~~~-lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 243 HIVVYDDLT--GAV-KFSSV-LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp -CCSCCCCS--SSC-CCCSS-SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhhhhhc--ccc-ccccc-cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000000000 000 00000 00011122346788999999999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=342.34 Aligned_cols=271 Identities=21% Similarity=0.354 Sum_probs=208.6
Q ss_pred CCCCeEEeeeecccCCceEEEEE----EcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..++|++++.||+|+||.||+|+ +..+++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45679999999999999999998 4678999999999753 3345667889999999999999999999986532
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 235899999998 5999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 65443322222234467888999999987 678899999999999999999999886432 11111222211100
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
. ........+...... .....+++.+.+||.+||+.||.+|||+.++++
T Consensus 267 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 001111112111111 123568999999999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=339.22 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=205.6
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
++....|...+.||+|+||+||+|.+ +++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 101 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--- 101 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec---
Confidence 34445566779999999999999975 68899999987532 233456678899999999999999999999844
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
....|+||||+. ++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 102 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 102 --GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred --CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 345899999997 699998863 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.........
T Consensus 180 ~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (307)
T 2nru_A 180 ARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255 (307)
T ss_dssp CEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred ccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence 976443222 112234579999999999875 4789999999999999999999999876654433333221111100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
. ...+ +.. .........++.+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~---------~~~~---~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 T---------IEDY---IDK----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp C---------HHHH---SCS----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred h---------hhhh---ccc----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0000 000 0011112345678999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.18 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=200.7
Q ss_pred CCCeEEee-eecccCCceEEEEEEcC--CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILE-VIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~-~lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+++.+.+ .||+|+||.||+|.++. ++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 34566666 89999999999998763 55679999997542 22345678899999999999999999999843
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.+|+|||||. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 34899999998 5999998754 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..............+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------- 557 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------- 557 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 332221111123346688999999977 689999999999999999998 9999998776655544432110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+++++.+||.+||+.||++|||+.++++
T Consensus 558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1122468999999999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=352.19 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=203.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++.+..+..+.. ...
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGV----EGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEE----ETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEe----eCC
Confidence 468899999999999999999999999999999988643222 246789999999988665555544422 335
Q ss_pred cEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe---cCCCCeEEeeecccccc
Q 016884 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~---~~~~~vkl~DFg~a~~~ 176 (381)
..||||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 6899999998899999985 5579999999999999999999999999999999999999 68899999999999865
Q ss_pred cCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
....... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---- 230 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 230 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----
Confidence 4432211 11225689999999999988 6799999999999999999999999987654333222221100
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
......+ ......+++++.+||.+||+.||++||++.+|++
T Consensus 231 --------~~~~~~~-----------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 231 --------KKVATSI-----------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------HHHHSCH-----------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------ccccccH-----------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000000 0112467899999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=345.17 Aligned_cols=282 Identities=20% Similarity=0.262 Sum_probs=195.5
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHH--HHHHHHhcCCCCccccceeecCCCcCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR--EVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~--E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
..++|++++.||+|+||+||+|.+ +++.||||++... ....+.. |+..+..++||||+++++.+.......
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 347899999999999999999965 6899999998632 1223333 444455689999999998654433344
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEecCCCCeEEe
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---------~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
...+|+|||||. ++|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 456899999997 5999999765 459999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCC-----CcccccccccCccccCcccccccc-----CCCCCccchHHHHHHHHHHHcCCCCC-CCCChh
Q 016884 169 DFGLARVAFSDTP-----MTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVV 237 (381)
Q Consensus 169 DFg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~ 237 (381)
|||+|+....... ........+||+.|+|||++.+.. ..++.++|||||||++|+|++|..|| .+.+..
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999976533211 111223457999999999987520 24567899999999999999996555 433322
Q ss_pred hHHHHHHHhh-CCCCHHHHhhhcCHHHHHHHHHhcCCCCC-CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc---
Q 016884 238 HQLDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPPV-PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--- 312 (381)
Q Consensus 238 ~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--- 312 (381)
.....+.... ..|..+... ............ ........+++.+.+||.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQ--------VLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHH--------HHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHH--------hhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 1111111111 111111110 001000000000 011111224567999999999999999999999954
Q ss_pred ---CCCcCc
Q 016884 313 ---DPYFKG 318 (381)
Q Consensus 313 ---hp~~~~ 318 (381)
++|-++
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 677654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.83 Aligned_cols=245 Identities=15% Similarity=0.179 Sum_probs=194.1
Q ss_pred CCCeEEeeeecccCCceEEEE-----EEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC---CCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~ 93 (381)
.++|++.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.+++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 467999999999999999999 46788999999998742 2345667888888886 9999999999854
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC------
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------ 161 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~------ 161 (381)
. +..|+|||||. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 139 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 139 Q-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp S-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred C-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 3 45899999998 699999973 457999999999999999999999999999999999999998
Q ss_pred -----CCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCCh
Q 016884 162 -----NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (381)
Q Consensus 162 -----~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 236 (381)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999975432222 223356689999999999988 6799999999999999999999999964332
Q ss_pred hhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCC
Q 016884 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (381)
Q Consensus 237 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp 314 (381)
.... ... ... ....++...+++..||+.+|.+|++..+.|.+.
T Consensus 291 ~~~~-----------------------------~~~-----~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 291 GECK-----------------------------PEG-----LFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp TEEE-----------------------------ECS-----CCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred Ccee-----------------------------ech-----hcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 1000 000 000 012466788999999999999997665555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.87 Aligned_cols=264 Identities=25% Similarity=0.319 Sum_probs=192.9
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc--CCCCccccceeecCCCc
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL--RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~ 96 (381)
....++|++++.||+|+||.||+|.+. ++.||||++... ......+|..++..+ +||||+++++++....
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~- 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT- 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-
Confidence 344578999999999999999999775 899999998532 223444566666554 8999999999986542
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEecCCCCeEE
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKV 167 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~i~H~Dikp~NIl~~~~~~vkl 167 (381)
.....+|+|||||. ++|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 12256899999998 5999999765 699999999999999999999999 9999999999999999999999
Q ss_pred eeecccccccCCCCC-cccccccccCccccCccccccccCCCCCc------cchHHHHHHHHHHHcC----------CCC
Q 016884 168 CDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG----------KPL 230 (381)
Q Consensus 168 ~DFg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~------~DiwslG~il~~ll~g----------~~p 230 (381)
+|||+|+........ .......+||+.|+|||++.+ ..++.. +|||||||++|+|++| ..|
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999754332221 111234579999999999977 444554 8999999999999999 566
Q ss_pred CCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 016884 231 FPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (381)
Q Consensus 231 f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~ 309 (381)
|....... ....+.. ...........+.......+++.+.+||.+||+.||.+|||+.+
T Consensus 262 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMRE--------------------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp TTTTSCSSCCHHHHHH--------------------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HhhhcCCCCchhhhHH--------------------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 64432110 0000000 00000000111111111245677999999999999999999999
Q ss_pred HhcC
Q 016884 310 ALAD 313 (381)
Q Consensus 310 lL~h 313 (381)
+++|
T Consensus 322 ll~~ 325 (337)
T 3mdy_A 322 VKKT 325 (337)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=359.73 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 4689999999999999999998865 46799999975432 23568899999999999999999999843 34
Q ss_pred EEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|||||||. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 799999998 599999974 24699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+......
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 483 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 483 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 11 111123456788999999877 679999999999999999999 99999988766555444321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC--CCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD--PYFK 317 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h--p~~~ 317 (381)
.....+++.+.+||.+||+.||++|||++++++. .+|.
T Consensus 484 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1124688999999999999999999999999873 4443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.70 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=204.9
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC---CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.++|++.+.||+|+||+||+|.+..+ +..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 46799999999999999999998654 457999988643 334455678899999999999999999998832
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+.+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 24799999998 69999998654 6999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------ 611 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 611 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 332211 1233457789999999977 689999999999999999997 99999988766555444331111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123468899999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=337.74 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=199.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
..++|++.+.||+|+||.||+|.+.. .||+|++............+.+|+.+++.++||||+++++++... .
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence 45789999999999999999998753 499999875433333344567899999999999999999998543 4
Q ss_pred cEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
.+++||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 5899999998 59999998754 699999999999999999999999999999999999998 67999999999865422
Q ss_pred CCC--CcccccccccCccccCccccccc-------cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCC
Q 016884 179 DTP--MTVFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (381)
Q Consensus 179 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 249 (381)
... .........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 259 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM-- 259 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC--
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC--
Confidence 111 11112345699999999998641 1357889999999999999999999998876554443332210
Q ss_pred CCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.+ ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 260 ------------------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 ------------------------KP---NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------------------CC---CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------------------CC---CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0111357889999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=349.28 Aligned_cols=254 Identities=17% Similarity=0.159 Sum_probs=189.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC------ChHHHHHHHHHHHHHHhcC---------CCCcc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLR---------HPDIV 85 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~~iv 85 (381)
..++|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346899999999999999999987 689999999975321 2223356788999988886 66666
Q ss_pred ccceeecCCC-------------------------cCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 016884 86 EIKRIMLPPS-------------------------KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139 (381)
Q Consensus 86 ~~~~~~~~~~-------------------------~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL 139 (381)
++.+++.... ..+...+|+|||||. |++.+.+.. ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6655542110 012467999999997 556655543 5789999999999999999
Q ss_pred HHHH-hCCccccCCCCCceEecCCC--------------------CeEEeeecccccccCCCCCcccccccccCccccCc
Q 016884 140 KYMH-TANVYHRDLKPKNILANANC--------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198 (381)
Q Consensus 140 ~~LH-~~~i~H~Dikp~NIl~~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aP 198 (381)
+||| ++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccCh
Confidence 9999 99999999999999999987 8999999999865332 34799999999
Q ss_pred cccccccCCCCCccchHHHHHH-HHHHHcCCCCCCCCChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCC
Q 016884 199 ELCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV 276 (381)
Q Consensus 199 E~~~~~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (381)
|++.+ .. +.++||||+|++ .+++++|..||.+..... ....+... ......
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~------------------------~~~~~~ 299 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ------------------------MTFKTK 299 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT------------------------CCCSSC
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh------------------------hccCcc
Confidence 99987 33 889999998777 778888999984321100 11111110 001111
Q ss_pred CccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh-cCCCcC
Q 016884 277 PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL-ADPYFK 317 (381)
Q Consensus 277 ~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL-~hp~~~ 317 (381)
.....++.+++++.+||++||++| |++|+| +||||+
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 111122357889999999999977 999999 999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=333.78 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=198.5
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh--cCCCCccccceeecCCCcC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~ 97 (381)
...++|++.+.||+|+||.||+|.+ +++.||+|++.. .....+.+|.++++. ++||||+++++++.... .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~ 110 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-G 110 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence 3457899999999999999999987 589999999864 234567789999988 78999999999986543 2
Q ss_pred CCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEecCCCCeEEe
Q 016884 98 EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 98 ~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
....+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 22368999999995 999999764 6999999999999999999999 8999999999999999999999999
Q ss_pred eecccccccCCCCCc-ccccccccCccccCccccccccC----CCCCccchHHHHHHHHHHHcC----------CCCCCC
Q 016884 169 DFGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPG 233 (381)
Q Consensus 169 DFg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwslG~il~~ll~g----------~~pf~~ 233 (381)
|||++.......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999997654432211 11234579999999999876211 233689999999999999999 778865
Q ss_pred CChhh-HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCC-CCCccc--cCCCCCHHHHHHHHHhccCCCCCCCCHHH
Q 016884 234 KSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP-PVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (381)
Q Consensus 234 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~ 309 (381)
....+ ....+.. ...... ...... .....++.+.+||.+||+.||++|||+.+
T Consensus 270 ~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 270 LVPSDPSVEEMRK-----------------------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp TSCSSCCHHHHHH-----------------------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred cCcCcccHHHHHH-----------------------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 43211 0111110 010000 000000 01234467899999999999999999999
Q ss_pred HhcC
Q 016884 310 ALAD 313 (381)
Q Consensus 310 lL~h 313 (381)
+++|
T Consensus 327 i~~~ 330 (342)
T 1b6c_B 327 IKKT 330 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.61 Aligned_cols=229 Identities=16% Similarity=0.089 Sum_probs=185.3
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
-..++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----- 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----
Confidence 4567899999999999999999999999999999999764333 4455788899999999999999999999844
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+..|+||||+. ++|.++++.+ ....++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 356999999998 5999998643 4666788999999999999999999999999999999999999998544
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+......
T Consensus 175 -----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~----------- 217 (286)
T 3uqc_A 175 -----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD----------- 217 (286)
T ss_dssp -----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-----------
T ss_pred -----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-----------
Confidence 222 3678999999999999999999999886643211000000
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
............+.+++.+.+||.+||+.||.+| |+.++++
T Consensus 218 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 218 -------------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp -------------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred -------------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0000111112335789999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=359.94 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=199.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC-CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++|++++.||+|+||+||+|.+.. +++.||||++... ........+.+|+.+++.++||||+++++++........
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 35899999999999999999999976 7899999988643 334455678899999999999999999999865433222
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 23799999998 488877654 79999999999999999999999999999999999999986 899999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
. ...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+..... .+..
T Consensus 234 ~-------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~------ 287 (681)
T 2pzi_A 234 F-------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED------ 287 (681)
T ss_dssp C-------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT------
T ss_pred C-------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc------
Confidence 2 34579999999999876 34889999999999999999999987532110 0000
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
......++.+.+||.+||+.||.+||++.+++.|+|+..
T Consensus 288 ---------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 ---------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000123578899999999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=300.00 Aligned_cols=187 Identities=17% Similarity=0.129 Sum_probs=133.3
Q ss_pred eeecccCCceEEEEEEcCCCcEEEEEEeCCccC--------ChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
..++.|++|.+..++..-+|+.||+|++.+... .......+.+|+++|+++ .|+||+++++++ ++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA 314 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence 346778888888888888999999999964321 123345688999999999 699999999999 455
Q ss_pred CcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+.+|||||||+| +|.++|...+++++. .|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 679999999995 999999998888875 4789999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCC
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~ 229 (381)
... ...+.+||+.|+|||++.+ .+..++|+||+|++++.|.++..
T Consensus 392 ~~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred CCc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 322 2345689999999999976 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=251.75 Aligned_cols=189 Identities=20% Similarity=0.246 Sum_probs=141.7
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-h-----HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-I-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
...+.||+|+||+||+| ...+..+|+|+....... . ....++.+|+.+|+.++||||+++..+....
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----- 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----- 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence 34678999999999999 556889999987532211 1 1234578999999999999999554444322
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
...|+|||||+ ++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 23699999998 699999875 5689999999999999999999999999999999 999999999986533
Q ss_pred CCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC
Q 016884 179 DTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (381)
Q Consensus 179 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 231 (381)
..... ......+||+.|+|||++.+....|+..+|+||..+-..+.+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21110 012356899999999999764456888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=210.48 Aligned_cols=161 Identities=17% Similarity=0.159 Sum_probs=122.5
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----------------HHHHHHHHHHHHHHhcCCCCccc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------SDAIRILREVKLLRLLRHPDIVE 86 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~iv~ 86 (381)
..|.+.+.||+|+||.||+|.+ .+|+.||+|+++...... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3455669999999999999999 889999999986421110 13456889999999999 5 66
Q ss_pred cceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
+.+++.. +..|+|||||+| +|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+
T Consensus 166 v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW------EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE------ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec------cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 6665522 346999999985 8877 421 34557999999999999999999999999999999 9999
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccc--------cCCCCCccchHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF--------FSKYTPAIDIWSI 217 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~~Diwsl 217 (381)
||+|||+|+. +..+.|||++... ...|+..+|+|.+
T Consensus 232 kl~DFG~a~~----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 232 WIIDFPQSVE----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EECCCTTCEE----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EEEECCCCeE----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9999999853 3346888876430 1235566676653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=184.60 Aligned_cols=140 Identities=18% Similarity=0.142 Sum_probs=109.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcE--EEEEEeCCccCC----------------------hHHHHHHHHHHHHHHh
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEH----------------------ISDAIRILREVKLLRL 78 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~----------------------~~~~~~~~~E~~~l~~ 78 (381)
.-|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3488999999999999999998778999 999987542111 0112357789999999
Q ss_pred cCCCCc--cccceeecCCCcCCCCcEEEEeecccc------CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccc
Q 016884 79 LRHPDI--VEIKRIMLPPSKREFKDIYVVFELMES------DLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYH 149 (381)
Q Consensus 79 l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~~i~H 149 (381)
+.|+++ +.++.. ...++||||+++ +|.+.... .++..+..++.||+.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 988865 223221 235899999953 67766543 345678899999999999999 999999
Q ss_pred cCCCCCceEecCCCCeEEeeecccccc
Q 016884 150 RDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 150 ~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=167.27 Aligned_cols=138 Identities=14% Similarity=0.156 Sum_probs=98.9
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC---------------ChHHH-----HHHHHHHHHHHhcCCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------------HISDA-----IRILREVKLLRLLRHPD 83 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------------~~~~~-----~~~~~E~~~l~~l~h~~ 83 (381)
-|++...||.|++|.||+|.+. +|+.||||+++.... ..... ....+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999874 699999998752110 00000 11245777777775544
Q ss_pred ccccceeecCCCcCCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 84 iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
+.... .+.. ...+|||||++| .|.++. ..+....++.||+.+|.+||++|||||||||.|||++.+
T Consensus 175 v~vp~-p~~~------~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPE-PIAQ------SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCC-EEEE------ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred CCCCe-eeec------cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 42221 1111 113799999996 554332 123456789999999999999999999999999999987
Q ss_pred CC----------eEEeeeccccc
Q 016884 163 CK----------LKVCDFGLARV 175 (381)
Q Consensus 163 ~~----------vkl~DFg~a~~ 175 (381)
+. +.|+||+.+..
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcccccccccceEEEEeCCccc
Confidence 73 88999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.5e-13 Score=118.28 Aligned_cols=137 Identities=12% Similarity=0.126 Sum_probs=104.6
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.|++...++.|+.+.||++.. .+..+++|+....... ....+.+|+.+++.+. +..+.+++++... .+..
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 488999999999999999964 3689999998642111 1235778999999985 6677788877632 3458
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------- 144 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~------------------------------------- 144 (381)
|+|||+++| +|.+.+. +......++.++..+|+.||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 6665431 122345788999999999998
Q ss_pred ----------------------CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ----------------------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ----------------------~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=7.1e-12 Score=113.66 Aligned_cols=184 Identities=16% Similarity=0.251 Sum_probs=118.5
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCCcEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~l 104 (381)
++.++.|..+.||++ +..+++|+... ......+.+|..+|+.+. +..+ .+.+... .........|+
T Consensus 25 i~~~~~G~~n~v~~v-----~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI-----NRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEES-----TTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEE-----CCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 456999999999987 25689998643 234567889999999884 3333 2332221 11112223589
Q ss_pred Eeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 016884 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------------------------------------- 144 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~--------------------------------------- 144 (381)
||++++| .+.+... ..++..+...++.|+...|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 4543322 247778888888888888888886
Q ss_pred -------------------CCccccCCCCCceEecC--CCCeEEeeecccccccCCCCCcccccccccCccc---cCccc
Q 016884 145 -------------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY---RAPEL 200 (381)
Q Consensus 145 -------------------~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y---~aPE~ 200 (381)
..++|+|++|.||+++. ++.+.|+||+.+....... +. ...... ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl-----~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DF-----ISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HH-----HTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HH-----HHHHhhccccCHHH
Confidence 13799999999999998 4557899999886532211 00 000001 12221
Q ss_pred cccccCCCC------------CccchHHHHHHHHHHHcCCCCC
Q 016884 201 CGSFFSKYT------------PAIDIWSIGCIFAEVLTGKPLF 231 (381)
Q Consensus 201 ~~~~~~~~~------------~~~DiwslG~il~~ll~g~~pf 231 (381)
.......|+ ...+.|++|.+++.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111001111 1258999999999999998766
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.9e-11 Score=107.97 Aligned_cols=133 Identities=16% Similarity=0.070 Sum_probs=94.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFK 100 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~ 100 (381)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++.+... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 3466655445666799999953 56778999987643 1234668999999886444 4556666532 24
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--------------------------------- 146 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--------------------------------- 146 (381)
..++|||+++| ++ . .. ..+ ...++.++...|+.||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 21 122 2356778888888888754
Q ss_pred -------------------------ccccCCCCCceEecCCCCeEEeeecccc
Q 016884 147 -------------------------VYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 147 -------------------------i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=5.7e-11 Score=110.29 Aligned_cols=144 Identities=16% Similarity=0.233 Sum_probs=103.4
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeC--CccCChHHHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCC
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~ 100 (381)
...++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+++.+.. ..+++++....... ..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccC
Confidence 345788999999999999643 5688898765 21 111234467789999999974 45677777664331 224
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT----------------------------------- 144 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------- 144 (381)
..|+|||+++| .+.+. ....++......++.+++.+|+.||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57999999997 33221 12247788889999999999999997
Q ss_pred -----------------------CCccccCCCCCceEecCCCC--eEEeeeccccc
Q 016884 145 -----------------------ANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (381)
Q Consensus 145 -----------------------~~i~H~Dikp~NIl~~~~~~--vkl~DFg~a~~ 175 (381)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35999999999999998754 68999998865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.4e-07 Score=85.22 Aligned_cols=134 Identities=19% Similarity=0.220 Sum_probs=90.5
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCC---CccccceeecCCCcCCCCcEEE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREFKDIYV 104 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~l 104 (381)
++.++.|....||+. +..+++|+.. .......+.+|..+|+.+.+. .+.+.+.+... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 556889999999988 5778899753 223456788999999999753 23444444321 1234689
Q ss_pred Eeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 016884 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-------------------------------------- 145 (381)
Q Consensus 105 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-------------------------------------- 145 (381)
|||+++| .+.+..- ..++......+..++...|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4444221 1245555555555555555555542
Q ss_pred ----------------------CccccCCCCCceEecC---CCCe-EEeeecccccc
Q 016884 146 ----------------------NVYHRDLKPKNILANA---NCKL-KVCDFGLARVA 176 (381)
Q Consensus 146 ----------------------~i~H~Dikp~NIl~~~---~~~v-kl~DFg~a~~~ 176 (381)
.++|+|++|.||+++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999998 4564 79999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=4.2e-07 Score=80.42 Aligned_cols=132 Identities=16% Similarity=0.190 Sum_probs=91.1
Q ss_pred eecccCCc-eEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCcEEEEee
Q 016884 30 VIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (381)
Q Consensus 30 ~lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e 107 (381)
.+..|..| .||+......+..+++|+-.. .....+.+|...|+.+. +--+.+++.+... .+..|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence 34455554 689988777778899998642 34557788999999885 2235556665532 245799999
Q ss_pred cccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 016884 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------------- 145 (381)
Q Consensus 108 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------------- 145 (381)
+++| ++.+..... ......+..++...|+-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 555554331 123344566666667666642
Q ss_pred -----------------CccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 146 -----------------NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 146 -----------------~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 158999999999999877677999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=9.5e-07 Score=82.82 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=48.1
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC--C---hHHHHHHHHHHHHHHhcCC--CC-ccccceeecCCCcCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H---ISDAIRILREVKLLRLLRH--PD-IVEIKRIMLPPSKRE 98 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~ 98 (381)
-.+.||.|..+.||++....+++.|++|....... . .....++.+|..+|+.+.. |. +.+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 46789999999999997666678999998653211 0 0112356679999888742 33 33444332 1
Q ss_pred CCcEEEEeecccc
Q 016884 99 FKDIYVVFELMES 111 (381)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (381)
...++|||++++
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124899999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=3e-06 Score=77.46 Aligned_cols=30 Identities=27% Similarity=0.348 Sum_probs=27.1
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-06 Score=79.34 Aligned_cols=85 Identities=8% Similarity=0.131 Sum_probs=51.8
Q ss_pred eEEeeee-cccCCceEEEEEEcC------CCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcC-C--CCccccceeecC
Q 016884 25 YKILEVI-GKGSYGVVCAAIDTH------TGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-H--PDIVEIKRIMLP 93 (381)
Q Consensus 25 Y~~~~~l-g~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~ 93 (381)
-...+.| +.|..+.+|++.... ++..+++|+...... .......+.+|+.+|+.+. + ..+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 889999999886430 156899997643210 0001134567888888874 2 345666665533
Q ss_pred CCcCCCCcEEEEeecccc
Q 016884 94 PSKREFKDIYVVFELMES 111 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~ 111 (381)
.. ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 11346899999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.02 E-value=7.8e-05 Score=62.48 Aligned_cols=96 Identities=18% Similarity=0.133 Sum_probs=64.7
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccccccc
Q 016884 112 DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (381)
Q Consensus 112 ~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH-~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~ 189 (381)
+|.++++. +.+++++++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999986 568999999999999999998762 22212333457899999999987664 2110
Q ss_pred ccCccccCccccccccCCCCCccchHHHHHHHHHHHc
Q 016884 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226 (381)
Q Consensus 190 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~ 226 (381)
.....+.|||... ...+.+.=|+|||+++|.-+-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 1122356888753 245677889999999999885
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00011 Score=69.32 Aligned_cols=33 Identities=15% Similarity=0.269 Sum_probs=28.6
Q ss_pred HhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 143 H~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
+...++|+|++|.|||++.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456799999999999999877 999999988653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.3e-05 Score=67.99 Aligned_cols=68 Identities=13% Similarity=0.038 Sum_probs=42.0
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCCcEEEEe
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~ 106 (381)
++.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~-----~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--P-----ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--T-----TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--C-----CCCEEEE
Confidence 788999999999999 568889875321 111122468888877753333 3444332 1 1136899
Q ss_pred ecc-cc
Q 016884 107 ELM-ES 111 (381)
Q Consensus 107 e~~-~~ 111 (381)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00033 Score=63.08 Aligned_cols=74 Identities=16% Similarity=0.088 Sum_probs=53.9
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCCcE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.-.+.|+.|....+|+... .+..+++|+.... ....+.+|...|+.|. ...+++++..... .+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCce
Confidence 3467899999999999964 4678999986531 2456778999998884 2456666666532 2458
Q ss_pred EEEeecccc
Q 016884 103 YVVFELMES 111 (381)
Q Consensus 103 ~lv~e~~~~ 111 (381)
++|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00095 Score=59.27 Aligned_cols=76 Identities=12% Similarity=0.018 Sum_probs=51.1
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCC---CccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~ 99 (381)
.+..-++.+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.|.-. -+++++.+-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 3456688999999999999964 5688999997643211 1123466899999988532 233333321
Q ss_pred CcEEEEeeccc
Q 016884 100 KDIYVVFELME 110 (381)
Q Consensus 100 ~~~~lv~e~~~ 110 (381)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 1378999986
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00081 Score=60.64 Aligned_cols=144 Identities=13% Similarity=0.091 Sum_probs=76.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCCC--cCCC
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS--KREF 99 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~--~~~~ 99 (381)
.-.-++.|+.|....+|++... +..+++|+.... .....+..|+.+++.+...+ +.+++... ... ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEEC
Confidence 3445677888988999999643 337889988642 11234456788877774222 23332211 000 0011
Q ss_pred CcEEEEeeccccC-H-----H------HH---HH-hCC----C----CCHHHHHHH---------------HHHHHHHHH
Q 016884 100 KDIYVVFELMESD-L-----H------QV---IK-AND----D----LTREHHQFF---------------LYQMLRALK 140 (381)
Q Consensus 100 ~~~~lv~e~~~~~-L-----~------~~---l~-~~~----~----l~~~~~~~i---------------~~qil~aL~ 140 (381)
+..++||++++|. + . .. +. ... + ......... ...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 3468999999862 1 0 01 11 100 0 111110000 011334445
Q ss_pred HHHh-------CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 141 YMHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 141 ~LH~-------~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+.. .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5542 369999999999999987656899999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00044 Score=64.00 Aligned_cols=136 Identities=13% Similarity=0.165 Sum_probs=79.7
Q ss_pred eeeecccCCceEEEEEEcC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREF 99 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~ 99 (381)
++.|..|-...+|++.... .+..|++|+.... ......+.+|..+++.|...+ ..++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence 5678788889999997532 3578999985321 112345568999998885333 34555544 11
Q ss_pred CcEEEEeecccc-CH-----------HHH---HH---hC-----CCC--CHHHHHHHHHHHHH-----------------
Q 016884 100 KDIYVVFELMES-DL-----------HQV---IK---AN-----DDL--TREHHQFFLYQMLR----------------- 137 (381)
Q Consensus 100 ~~~~lv~e~~~~-~L-----------~~~---l~---~~-----~~l--~~~~~~~i~~qil~----------------- 137 (381)
.+||||++| .| ..+ +. .. ... -+.++..+..++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 389999975 11 111 11 11 111 23566666655432
Q ss_pred --HHHHH----HhC----CccccCCCCCceEecCC----CCeEEeeeccccc
Q 016884 138 --ALKYM----HTA----NVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (381)
Q Consensus 138 --aL~~L----H~~----~i~H~Dikp~NIl~~~~----~~vkl~DFg~a~~ 175 (381)
.+..| ... .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 12332 222 49999999999999876 7899999997753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00059 Score=64.40 Aligned_cols=72 Identities=14% Similarity=0.148 Sum_probs=48.0
Q ss_pred EeeeecccCCceEEEEEEcC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKRE 98 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~ 98 (381)
-++.|+.|....||++.... .+..+++|+.... .. ...+.+|..+++.|...++ +++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 46778889899999997542 2578999987432 11 1344579999988853344 4555544 11
Q ss_pred CCcEEEEeecccc
Q 016884 99 FKDIYVVFELMES 111 (381)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (381)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0006 Score=61.93 Aligned_cols=31 Identities=29% Similarity=0.441 Sum_probs=27.0
Q ss_pred CCccccCCCCCceEecCC----CCeEEeeeccccc
Q 016884 145 ANVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~----~~vkl~DFg~a~~ 175 (381)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6789999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0017 Score=58.59 Aligned_cols=139 Identities=16% Similarity=0.088 Sum_probs=76.4
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCCC--cCCCCcEE
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS--KREFKDIY 103 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~--~~~~~~~~ 103 (381)
+..|+ |....||++.. .+|+.+++|....... ....+..|..+++.+.... +++++.. ... ....+..+
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF 103 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence 34566 88889998843 3466899998863211 2335567888888774222 3444332 110 01123568
Q ss_pred EEeeccccC------HHH------HH---H---hCC------CCCHHHH----------------------HHHHHHHHH
Q 016884 104 VVFELMESD------LHQ------VI---K---AND------DLTREHH----------------------QFFLYQMLR 137 (381)
Q Consensus 104 lv~e~~~~~------L~~------~l---~---~~~------~l~~~~~----------------------~~i~~qil~ 137 (381)
+||++++|. ... .+ . ... ..+.... ...+.+++.
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 899999861 111 11 0 100 1121111 111122222
Q ss_pred HHHHH----HhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 138 ALKYM----HTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 138 aL~~L----H~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222 234589999999999999 4 799999997653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0023 Score=58.25 Aligned_cols=31 Identities=16% Similarity=0.300 Sum_probs=27.5
Q ss_pred CCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00082 Score=62.00 Aligned_cols=73 Identities=7% Similarity=0.005 Sum_probs=42.2
Q ss_pred EeeeecccCCceEEEEEEcC--------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcC
Q 016884 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKR 97 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~ 97 (381)
-+..|+.|....+|++.... .+..+++|+..... .......+|..+++.+...+ ..+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 46678888889999997543 13688999765321 11112346888888875333 34555443 1
Q ss_pred CCCcEEEEeecccc
Q 016884 98 EFKDIYVVFELMES 111 (381)
Q Consensus 98 ~~~~~~lv~e~~~~ 111 (381)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.036 Score=52.52 Aligned_cols=73 Identities=19% Similarity=0.204 Sum_probs=46.2
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCCcEEEE
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVV 105 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv 105 (381)
-++.|+.|-...+|++.....+..+++|+....... .....+|..+++.|...++ .++++.+ .. .+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFF-----TN----GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEE
Confidence 366788899999999976544578999987432111 1112479999999975554 4555554 11 359
Q ss_pred eecccc
Q 016884 106 FELMES 111 (381)
Q Consensus 106 ~e~~~~ 111 (381)
|||++|
T Consensus 180 ~e~I~G 185 (458)
T 2qg7_A 180 EEFMDG 185 (458)
T ss_dssp EECCCS
T ss_pred EEeeCC
Confidence 999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.25 E-value=0.09 Score=49.18 Aligned_cols=73 Identities=10% Similarity=0.028 Sum_probs=46.0
Q ss_pred EeeeecccCCceEEEEEEcCC-------CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKRE 98 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 98 (381)
-++.|..|-...+|++..... +..|++++..... .......+|..+++.+...+ ..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 466788888899999976421 5789999864321 11112347888888885333 34455433 1
Q ss_pred CCcEEEEeecccc
Q 016884 99 FKDIYVVFELMES 111 (381)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (381)
-++||||++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.67 E-value=0.18 Score=46.80 Aligned_cols=29 Identities=31% Similarity=0.416 Sum_probs=24.6
Q ss_pred ccccCCCCCceEe------cCCCCeEEeeeccccc
Q 016884 147 VYHRDLKPKNILA------NANCKLKVCDFGLARV 175 (381)
Q Consensus 147 i~H~Dikp~NIl~------~~~~~vkl~DFg~a~~ 175 (381)
++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.38 E-value=0.022 Score=54.05 Aligned_cols=64 Identities=14% Similarity=0.085 Sum_probs=18.6
Q ss_pred EEeeeecccCCceEEEEEEcCCCcEEEE------EEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeec
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTGEKVAI------KKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIML 92 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~~~vai------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (381)
.+.+.|| ||.||++........||+ |..+...........+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556676 999999987655568888 665432222333456778999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 381 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-96 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-87 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-75 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-73 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-67 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-66 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-61 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-52 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 289 bits (739), Expect = 2e-96
Identities = 155/342 (45%), Positives = 215/342 (62%), Gaps = 5/342 (1%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY L IG+G+YG+VC+A D +VAIKKI FEH + R LRE+K+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ANV HRDLKP N+L N C LK+CDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK + QL+ I +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
KAR YL + K VP + FPN D AL LL +++ F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 272 bits (697), Expect = 5e-90
Identities = 141/346 (40%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLAR T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F + EP P + FE R + D+ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 2e-87
Identities = 134/346 (38%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQM
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+ L+Y+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+++++A+ Y+ + + N PLA+ LL++++ D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F+ L E EP Q K + F+ T D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 5e-77
Identities = 121/354 (34%), Positives = 190/354 (53%), Gaps = 23/354 (6%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
+ + RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +I+ + + P EF+D+Y+V ELM+++L QVI+ D E + LYQM
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LGTP PE +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKD 303
+ R Y+ K + + FP+ A LL +++ DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
R + ++AL PY + P + + + R T ++ +ELIY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 6e-77
Identities = 102/301 (33%), Positives = 155/301 (51%), Gaps = 7/301 (2%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ L IG+G++G V A TG+KVA+KK+ E I LRE+K+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRA 138
++V + I + + IY+VF+ E DL + T + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRD+K N+L + LK+ DFGLAR + + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V N + + L ++ +K V K DP AL L+ +L+ DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-75
Identities = 102/330 (30%), Positives = 168/330 (50%), Gaps = 19/330 (5%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRA 138
IV ++ +++ + + +V + + +++V +A L + + ++YQ+ R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ +++ P +F P P A+ L RL+ + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDD 347
L + + F F + ++ +
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 6e-73
Identities = 108/312 (34%), Positives = 153/312 (49%), Gaps = 22/312 (7%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI---RILREVKLLRLLRHPD 83
L+ +G+G + V A D +T + VAIKKI + LRE+KLL+ L HP+
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + S I +VF+ ME+DL +IK N + H + ++ L+ L+Y+
Sbjct: 62 IIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP N+L + N LK+ DFGLA+ S +T V TRWYRAPEL
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL- 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
+ P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 233 DYVT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN---- 285
Query: 323 EREPSCQPISKL 334
P P +L
Sbjct: 286 --RPGPTPGCQL 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (578), Expect = 1e-72
Identities = 100/307 (32%), Positives = 157/307 (51%), Gaps = 16/307 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-- 79
+Y+ + IG+G+YG V A D G VA+K++ + +REV +LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + +VFE ++ DL + + + E + ++Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYR 182
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 183 APEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + K P+ + ++D L LL + + F+P R +A AL+ PYF
Sbjct: 241 RDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 317 KGLAKIE 323
+ L + +
Sbjct: 297 QDLERCK 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-72
Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 28/311 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ ++ + +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV +I + E M+ L QV+K + + +++ L Y
Sbjct: 65 YIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 142 MHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ + + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPER 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y+ DIWS+G E+ G+ P + + + ET R
Sbjct: 175 L--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN-------------VDPLALRLLQRLIAFDPKDRPTA 307
M +PP+ +F+ + + + +P +R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 308 EEALADPYFKG 318
++ + + K
Sbjct: 293 KQLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (565), Expect = 7e-71
Identities = 107/300 (35%), Positives = 161/300 (53%), Gaps = 13/300 (4%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++ +E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
IV++ ++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
Y K + P +D LL +++ +DP R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 216 bits (550), Expect = 8e-69
Identities = 104/295 (35%), Positives = 152/295 (51%), Gaps = 11/295 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y LE IG+G+YGVV A + + GE A+KKI E +RE+ +L+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ + + + V L + + L + FL Q+L + Y
Sbjct: 61 NIVKLYDVI----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N +LK+ DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V +
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--E 230
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 105/298 (35%), Positives = 148/298 (49%), Gaps = 11/298 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ LE IG+G+YG V A + T E VA+K++ + LRE+ LL+ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + K V + N DL E + FL+Q+L+ L +
Sbjct: 62 NIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLF 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ +ID+WS GCIFAE+ PLFPG V QL I LLGTP+ E +
Sbjct: 175 G-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT-- 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV +++VV E + + + + L+AL+++
Sbjct: 78 NIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y P +DIWS+G + E++ G+P + ++ + L LI
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------- 228
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P Q + + L R + D + R +A+E L + K
Sbjct: 229 ---------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 215 bits (549), Expect = 5e-68
Identities = 95/326 (29%), Positives = 164/326 (50%), Gaps = 27/326 (8%)
Query: 7 KKELKDKDFFT-EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD 65
+E D + E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 74
Query: 66 AIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDL 123
+I RE+K+L LR P+I+ + I+ P R +VFE + +D Q+ + L
Sbjct: 75 --KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---L 126
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPM 182
T +F++Y++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL
Sbjct: 186 ---YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF------PNVDPLALRLLQR 295
I +LGT N + ++ + +++F V P AL L +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAK 321
L+ +D + R TA EA+ PYF + K
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 1e-67
Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 43/327 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y +V+G G++ V A D T + VAIK I + E+ +L ++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + I +Y++ +L+ +L I T ++Q+L A+KY
Sbjct: 68 NIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+H + HRDLKP+N+L + + K+ + DFGL+++ + ++ T Y AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y+ A+D WSIG I +L G P F ++ + I
Sbjct: 179 EVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------------- 221
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K + ++ A ++ L+ DP+ R T E+AL P+ G
Sbjct: 222 ------------LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTK 345
+++ +++ F + + +
Sbjct: 270 DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-67
Identities = 74/344 (21%), Positives = 149/344 (43%), Gaps = 54/344 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
K+ + +Y I E +G+G +G+V ++T + + K + +D + + +E
Sbjct: 1 KELY------EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKE 51
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQF 130
+ +L + RH +I+ + +++ ++FE + D+ + I + +L
Sbjct: 52 ISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+++Q+ AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + +T
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT- 165
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y APE+ + A D+WS+G + +L+G F ++ ++ I +
Sbjct: 166 ---APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T E F + A+ + RL+ + K R TA
Sbjct: 221 TFDEE---------------------------AFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
EAL P+ K KIER S + I L+ + K D+ ++
Sbjct: 254 EALQHPWLKQ--KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-66
Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LK+ DFG + A S T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ +D+WS+G + E L GKP F + I
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R + P V A L+ RL+ +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-66
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 37/296 (12%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++ +G+G+YG V A++ T E VA+K + D+ + I +E+ + ++L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLH-QVIKANDDLTREHHQFFLYQMLRALKY 141
++V+ + Y+ E I+ + + Q F +Q++ + Y
Sbjct: 64 NVVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRD+KP+N+L + LK+ DFGLA V F T Y APEL
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELL 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +D+WS G + +L G+ + S Q
Sbjct: 178 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------ 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
K + +D L LL +++ +P R T + D ++
Sbjct: 219 ----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 211 bits (538), Expect = 4e-66
Identities = 70/332 (21%), Positives = 131/332 (39%), Gaps = 45/332 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALK 140
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ + L
Sbjct: 84 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH N H DLKP+NI+ + +LK+ DFGL + V T + AP
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAP 194
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+WS+G + +L+G F G++ L +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 237
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ F + +++L+ DP R T +AL P+
Sbjct: 238 ------------KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
R+ P S+ + + D E
Sbjct: 286 GNAPGRDSQI-PSSRYTKIRDSIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 210 bits (536), Expect = 1e-65
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
++ + + ++ ++ E + +L I A D ++ ++ Q LK
Sbjct: 87 KLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH ++ H D+KP+NI+ +K+ DFGLA D + AT + AP
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAP 197
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+W+IG + +L+G F G+ + L +
Sbjct: 198 EIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------------- 240
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
++ F +V P A ++ L+ +P+ R T +AL P+ KG
Sbjct: 241 ------------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 206 bits (526), Expect = 3e-65
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 49/307 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-------RILREVKLL 76
Y+ E++G+G VV I T ++ A+K I A L+EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
++ + L+ R + P+ R TAEEA
Sbjct: 228 --------------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 4e-65
Identities = 76/355 (21%), Positives = 134/355 (37%), Gaps = 50/355 (14%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D EL KD + + L IG GS+G V A D E VAIKK+ +
Sbjct: 1 DPDVAELFFKDDPEK-----LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 64 SDAI-RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND 121
++ I++EV+ L+ LRHP+ ++ + L ++V E S +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK 110
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
+V T ++ APE + +Y +D+WS+G E+ KP + + L
Sbjct: 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
I + + P + + + +
Sbjct: 224 YHI--------------------------AQNESPAL---QSGHWSEYFRNFVDSCLQKI 254
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
P+DRPT+E L + +K + E + +++++++E
Sbjct: 255 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK-DAVRELDNLQYRKMKKILFQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-64
Identities = 79/304 (25%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A Y++L IG GSYG G+ + K++ ++ ++ EV LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----LTREHHQFFLYQML 136
P+IV ++ + +Y+V E E DL VI L E + Q+
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F S I +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K +P ++ R++ RP+ EE L
Sbjct: 229 -------------------GKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 312 ADPY 315
+P
Sbjct: 265 ENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-64
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 43/300 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A + T A K I + + + E+ +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKY 141
IV++ +++++ E + + LT Q Q L AL Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLK NIL + +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---DSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
SK Y D+WS+G E+ +P + + L I
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------------- 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K P + L++ + + R T + L P+
Sbjct: 229 --------------KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-64
Identities = 83/351 (23%), Positives = 141/351 (40%), Gaps = 46/351 (13%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLR 80
+ YK+ +V+G G G V + T EK A+K + D + REV+ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 64 CPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ S +T T +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPY 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 179 YVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
T +R ++ V L++ L+ +P R T E + P
Sbjct: 226 ------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLK 365
+ K+ + P L+ + ER K+++ + ++Y +K
Sbjct: 274 WIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-62
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV K + K I +V ELM S L +K + + + + Q+L+ L
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYMHTAN--VYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+++HT + HRDLK NI +K+ D GLA + + V + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ +T K P +++ I + +R + ++ L +F
Sbjct: 222 -------YRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-61
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
V++ K +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + +++ DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ D+W++GCI +++ G P F + I
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA------LADPY 315
++ + P P A L+++L+ D R EE A P+
Sbjct: 223 --------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 190 bits (484), Expect = 6e-59
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + D+ S +R RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV + + Y+V E ++ L ++ +T + + +AL
Sbjct: 66 HPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H + HRD+KP NI+ +A +KV DFG+AR + T Y +PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
D++S+GC+ EVLTG+P F G S V
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------------- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALAD 313
++ P+P + + ++ + +A +P++R TA E AD
Sbjct: 228 ------------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-59
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLR 137
++HP+++ + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 70 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 138 ALKYMHTANVYHRDLKPKNILAN----ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++K+ DFGLA + T
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTP 180
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE+ D+WSIG I +L+G F G + L ++ + E
Sbjct: 181 EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
F N LA ++RL+ DPK R T +++L
Sbjct: 239 ---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 314 PYFKG 318
P+ K
Sbjct: 272 PWIKP 276
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-57
Identities = 57/295 (19%), Positives = 104/295 (35%), Gaps = 38/295 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + + IG GS+G V VA+K ++ EV +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +K+ DFGLA V + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E + + Y+ D+++ G + E++TG+ + + Q+ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
R L + N RL+ + +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-56
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLL-RLLR 80
+ + +++GKGS+G V A T + AIK + DV D + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP + + + ++++ V E + DL I++ F+ +++ L
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H+ + +RDLK NIL + + +K+ DFG+ + + T Y APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ KY ++D WS G + E+L G+ F G+ I
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------- 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKG 318
P P ++ A LL +L +P+ R + P F+
Sbjct: 216 ----------RMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
Query: 319 L 319
+
Sbjct: 261 I 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLR 77
++Y++ ++G G +G V + I VAIK + + + + R+ EV LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+R + V L++ +A P DRPT EE
Sbjct: 217 -----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 313 DPYFKGL 319
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-55
Identities = 68/304 (22%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
N + L+++GKG++G V + TG A+K + +V + + E ++L+ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALK 140
P + +K + + V E L + T E +F+ +++ AL+
Sbjct: 65 PFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEV 176
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------- 217
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPY 315
+ ++ P + P A LL L+ DPK R A+E + +
Sbjct: 218 ---------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 316 FKGL 319
F +
Sbjct: 264 FLSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (455), Expect = 1e-53
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
N + + +IG+G +G V TG+ A+K + + + + A+ + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
P IV + P K + + +LM DLH + + + +F+ +++
Sbjct: 64 GDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L++MH V +RDLKP NIL + + +++ D GLA P T Y A
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMA 173
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y + D +S+GC+ ++L G F +
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------------- 215
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALA 312
E+ + + + P LL+ L+ D R A+E
Sbjct: 216 -----------EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 313 DPYFKGL 319
P+F+ L
Sbjct: 265 SPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 174 bits (442), Expect = 3e-52
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + ++ + I+++ + +E + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +K+ DFG A+ T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y +ID WS G + E+L G F + + + I
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFK 317
+ + P P + LL RLI D R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-50
Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 49/302 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+++ ++ +G GS+G V +G A+K + + L E ++L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
P +V+++ K V+ + ++ ++ + H +F+ Q++ +Y
Sbjct: 101 PFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ ++ +RDLKP+N+L + ++V DFG A+ T APE+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEII 210
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S Y A+D W++G + E+ G P F + + I
Sbjct: 211 LS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------ 250
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ K P + LL+ L+ D R + +F
Sbjct: 251 --------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 317 KG 318
Sbjct: 298 AT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-50
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + KV DFGL + A S + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G + E+ + G+ +P + + +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K P P +++ D RP+ +
Sbjct: 216 --------------GYKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-49
Identities = 56/307 (18%), Positives = 100/307 (32%), Gaps = 44/307 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
NRY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ R E +V EL+ S + + + QM+ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFSDTPMTVFW----TDYVATR 193
Y+H+ N HRD+KP N L + + DFGLA+ + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------ 223
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EA 310
KY KK P+ L + D+P +
Sbjct: 224 -----------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-49
Identities = 71/316 (22%), Positives = 111/316 (35%), Gaps = 55/316 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLR 70
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N KV DFGLAR+ + + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE ++T D+WS G + E+ T G+ +PG LD + P P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
P L+ + +P++RPT E A +
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 315 YFKGLAKIEREPSCQP 330
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 44/308 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIH--DVFEHISDAIRILREVKLLR 77
+++L+V+G G+YG V TG+ A+K + + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 84 HIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+++H + +RD+K +NIL ++N + + DFGL++ F + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMA 198
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+ G S + A+D WS+G + E+LTG F + I
Sbjct: 199 PDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------- 244
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEAL 311
++ +PP P + LA L+QRL+ DPK R A+E
Sbjct: 245 ---------SRRILKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-49
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 30 VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
I E + +V E+ E L++ ++ N + ++ ++Q+ +KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRDL +N+L K+ DFGL++ +D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 207 KYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265
K++ D+WS G + E + G+ + G ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------------- 223
Query: 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALADPYFKGL 319
E ++ P L+ +D ++RP L + Y+ +
Sbjct: 224 ---EKGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-49
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 35/322 (10%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A + E IGKG +G V GE+VA+K E + E+ +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVA 191
++H + HRDLK KNIL N + D GLA S T + + V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
T+ Y APE+ + + DI+++G +F E+ + G +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
PS E + RK + E + +P +P + + ++++ + R TA
Sbjct: 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 308 EEALADPYFKGLAKIEREPSCQ 329
L+++ ++ +
Sbjct: 286 LRIKKT-----LSQLSQQEGIK 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-48
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 48/310 (15%)
Query: 23 NRYKILEV-IGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQL 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLR 137
+P IV + + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 67 DNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+KY+ N HRDL +N+L K+ DFGL++ +D + + A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G E L+ G+ + + I
Sbjct: 181 PECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALAD 313
E K+ P P P L+ + +DRP +
Sbjct: 226 ------------EQGKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 314 PYFKGLAKIE 323
Y+ +K+E
Sbjct: 269 CYYSLASKVE 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 3e-48
Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 51/321 (15%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILRE 72
F + D + KI +VIG G +G VC+ G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT--D 188
L + +KY+ N HRDL +NIL N+N KV DFGL+R DT + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247
+ AP + K+T A D+WS G + EV++ G+ + + ++ I
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
E + P P + +L+ D RP
Sbjct: 247 ---------------------EQDYRLPPP-----MDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEALADPYFKGLAKIEREPSC 328
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-47
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 44/303 (14%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILR 71
T ++LE +G GS+GVV + VA+K + DV +R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQ 129
EV + L H +++ + ++ + +V EL S L ++ K
Sbjct: 61 EVNAMHSLDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q+ + Y+ + HRDL +N+L +K+ DFGL R + V
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248
+ APE + ++ A D W G E+ T G+ + G + L I
Sbjct: 175 KVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----- 227
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ ++ P P + ++ + A P+DRPT
Sbjct: 228 -------------------DKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 309 EAL 311
Sbjct: 264 ALR 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDL---HQVIKANDDLTREHHQFFLYQMLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ + + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE + +T D+WS G + E++T G+ +PG + + + P+
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
N +L++ P+DRPT + + +
Sbjct: 234 ---------------------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 315 YF 316
+F
Sbjct: 267 FF 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 1e-47
Identities = 51/298 (17%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
+ + +E +V +L+ L ++ + + QML ++
Sbjct: 60 CTGIPN----VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YMHTANVYHRDLKPKNILANANC-----KLKVCDFGLARVAFSDTPMTVFW----TDYVA 191
+H ++ +RD+KP N L + V DFG+ + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---------- 223
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
KY KK PL + + + P +
Sbjct: 224 -------------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-47
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 46/296 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +KV DFGL+R D + + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ SK++ DIW+ G + E+ + GK + + + I L P
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---- 224
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ +RPT + L++
Sbjct: 225 --------------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 2e-47
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 37/335 (11%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY ++ +G G + V A D VA+K + + E+KLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDA 69
Query: 83 DIVEIKRIMLP------------PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF 130
D + + + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTD 188
Q+L L YMH + H D+KP+N+L + +A + + +T+
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTN 188
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV------VHQLDL 242
+ TR YR+PE+ + + DIWS C+ E++TG LF +
Sbjct: 189 SIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 243 ITDLLGTPSPETIAVVRNEK----ARKYLTEMRKKPPVPL-------FQKFPNVDPLALR 291
I +LLG + + + +R L + K PL ++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
L ++ DP+ R A + P+ K +E
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-47
Identities = 68/323 (21%), Positives = 119/323 (36%), Gaps = 69/323 (21%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
+ +V+G G++G V A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT E F YQ+ + ++++ + HRDL +N+L +K+CDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR SD+ V + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+PG V + + K P
Sbjct: 266 PYPGIPVDANFYKL------------------------IQNGFKMDQP-----FYATEEI 296
Query: 290 LRLLQRLIAFDPKDRPTAEEALA 312
++Q AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-46
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V +KVAIK I + D + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFFLYQMLRA 138
HP +V++ + L + I +VFE ME L ++ L +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +KV DFG+ R D T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ FS+Y+ D+WS G + EV + GK + +S ++ I+ P
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---- 225
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+++ P+DRP L
Sbjct: 226 --------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 2e-45
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + + + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIK 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +KV DFGL+R+ DT + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+K++ D+W+ G + E+ T G +PG + +L+ PE
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE------ 239
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L++ ++P DRP+ E
Sbjct: 240 ------------------------GCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-45
Identities = 61/339 (17%), Positives = 123/339 (36%), Gaps = 52/339 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+K ++V+G G++G V + GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+P + + I L + + + L V + D++ ++ + Q+ + +
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +K+ DFGLA++ ++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
YT D+WS G E++T G + G ++
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
++ P P P ++ + D RP E + +
Sbjct: 229 -----------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
+K+ R+P L + + R YR +++
Sbjct: 268 SKMARDPQ----RYLVIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-44
Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 50/314 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE K+T A D+WS G + EV+T G+ + S + I D P+P
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP- 235
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ +L+ + + RP + ++
Sbjct: 236 -----------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 314 PYFKGLAKIEREPS 327
L K+ R P
Sbjct: 267 -----LDKLIRAPD 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQM 135
HP IV++ ++ ++++ EL + L + YQ+
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE ++T A D+W G E+L G F G + I +
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 224
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ P+P PN P L+ + A+DP RP E A
Sbjct: 225 ----------------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 2e-43
Identities = 57/320 (17%), Positives = 106/320 (33%), Gaps = 70/320 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + + IG+G++G V A + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L+ Q+ + Y+ HRDL +N L N +K+ DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R +S D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
G + + + D P N
Sbjct: 244 YGMAHEEVIYYVRD-------------------------GNILACP-----ENCPLELYN 273
Query: 292 LLQRLIAFDPKDRPTAEEAL 311
L++ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-42
Identities = 65/317 (20%), Positives = 111/317 (35%), Gaps = 64/317 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
NR + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+D+ V + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V + + + P + +++
Sbjct: 252 PVDSKFYKMIK------------------------EGFRMLSP-----EHAPAEMYDIMK 282
Query: 295 RLIAFDPKDRPTAEEAL 311
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 63/313 (20%), Positives = 110/313 (35%), Gaps = 63/313 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLL-R 77
D N K +VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ + F + R + Y+ HRDL +NIL N K+ DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G +
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299
+ + + P N D L+++
Sbjct: 236 YEKLPQ-------------------------GYRLEKP-----LNCDDEVYDLMRQCWRE 265
Query: 300 DPKDRPTAEEALA 312
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-42
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 44/291 (15%)
Query: 29 EVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EVIG+G +G V A+K ++ + I + + L E +++ HP+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ--FFLYQMLRALKYMH 143
+ I L VV M+ + N+ F Q+ + +K++
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYVATRWYRAPELCG 202
+ HRDL +N + + +KV DFGLAR + +V T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ K+T D+WS G + E++T G P +P + +
Sbjct: 208 T--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------------- 249
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ P ++ + + RP+ E ++
Sbjct: 250 ---------GRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-41
Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREV 73
+R + + +G+G++G V A + KVA+K + D ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V L+ + + P N +++
Sbjct: 242 PVEELFKLLKE-------------------------GHRMDKP-----SNCTNELYMMMR 271
Query: 295 RLIAFDPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-41
Identities = 53/320 (16%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + +G+GS+G+V + +VAIK +++ + I L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243
+ + +PE +T D+WS G + E+ T + + G S L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ P N + L++ ++PK
Sbjct: 249 ME-------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKM 278
Query: 304 RPTAEEALA------DPYFK 317
RP+ E ++ +P F+
Sbjct: 279 RPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-40
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 59/314 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R K+ + +G+G++G V A T T VA+K + + H + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
+ + + P P + +
Sbjct: 244 EEFCRR------------------------LKEGTRMRAP-----DYTTPEMYQTMLDCW 274
Query: 298 AFDPKDRPTAEEAL 311
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 2e-21
Identities = 24/203 (11%), Positives = 60/203 (29%), Gaps = 27/203 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--------DVFEHISDAIRILREVKLL 76
I +++G+G V + +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATRWY 195
+ + + H DL N+L + + + DF + + + D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 381 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.35 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.98 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-66 Score=483.08 Aligned_cols=333 Identities=40% Similarity=0.745 Sum_probs=280.4
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+.+.++|+++++||+|+||+||+|+++.+|+.||||+++...........+.+|+++|+.++||||+++++++.....
T Consensus 13 ~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 13 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 3567899999999999999999999999999999999998766666677789999999999999999999999976532
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
....++|+|||||+.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 93 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 33456899999998888887765 47999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
... .+..+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.
T Consensus 172 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 172 DSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 332 2456899999999998763 467899999999999999999999999999999999999999999999998
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.....................+...++.+++++.|||++||++||.+|||++|+|+||||+++...+++|..+. .+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~---~~~ 321 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDD 321 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCC---CCC
Confidence 88888877777777777777777788899999999999999999999999999999999999887777766543 345
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCC
Q 016884 337 EFERRRVTKDDIRELIYREILEYHP 361 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (381)
+++....+.+++++++++|+++|+|
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp C-----CCHHHHHHHHHHHHHTCCC
T ss_pred chhhhhcCHHHHHHHHHHHhhcCCC
Confidence 5566667889999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-65 Score=471.74 Aligned_cols=341 Identities=45% Similarity=0.807 Sum_probs=285.3
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
.+.++.+|+++++||+|+||+||+|+++.+|+.||||+++.. .......++.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 356778999999999999999999999999999999999753 3445567889999999999999999999999776655
Q ss_pred CCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
....+|+++++++++|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55678888888889999999765 69999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
............+||+.|+|||++... ..++.++||||+||++|+|++|++||.+.+..+....+...++.+.......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333334567899999999998553 5789999999999999999999999999999999999999999999888777
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcchh
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~~ 337 (381)
...................+....++.+++++.+||.+||+.||.+||||+|+|+||||+....+.+++..... ..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~ 317 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFD 317 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C---
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCC
Confidence 77776666666666666666667788999999999999999999999999999999999987766655544333 3345
Q ss_pred hhhccCCHHHHHHHHHHHHHHhCCcc
Q 016884 338 FERRRVTKDDIRELIYREILEYHPQL 363 (381)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (381)
.+....+.+++++++++|...++|+.
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 56667889999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-64 Score=469.97 Aligned_cols=334 Identities=42% Similarity=0.794 Sum_probs=287.2
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK- 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 96 (381)
.+++++||+++++||+|+||+||+|++..+|+.||||+++..........++.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 3566789999999999999999999999999999999998776666777789999999999999999999999875533
Q ss_pred CCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
++...+|+++++++++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|...
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 33445667766666899998864 57999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+..+...
T Consensus 172 ~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred Cc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 22456899999999987763 457899999999999999999999999999999999999999999999888
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCCCCCCCCcch
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEF 336 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~~~~~~~~~~ 336 (381)
.....................+...+.++++++.|||++||+.||.+||||+|+|+||||+++.++..++...+. ..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~ 321 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQ 321 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CC
Confidence 777777777766666666666666778899999999999999999999999999999999999888888776544 45
Q ss_pred hhhhccCCHHHHHHHHHHHHHHhCCc
Q 016884 337 EFERRRVTKDDIRELIYREILEYHPQ 362 (381)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (381)
+++....+.+++++++++|++++.|.
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVISFVPP 347 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred cccchhcCHHHHHHHHHHHhhccCCC
Confidence 67778899999999999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-65 Score=451.36 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=218.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence 56999999999999999999999999999999986421 111224567899999999999999999999954 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+..
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------------- 220 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 220 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 235689999999999988 689999999999999999999999999887766655543311
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
......+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus 221 ------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 221 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0112458999999999999999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-65 Score=452.88 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=214.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 4679999999999999999999999999999999875322 2234568899999999999999999999954 356
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999998 5999999888899999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccccCccccCccccccccCC-CCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. ....+..+||+.|+|||++.+ .. ++.++||||+||++|+|++|++||.+.+.............
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~----------- 223 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------- 223 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-----------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------
Confidence 1 222356789999999999977 44 46789999999999999999999987654433222211100
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.....+..+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 224 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 224 -----------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp -----------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011123468999999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-64 Score=451.42 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=219.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
+..++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+|+.+|+.++||||+++++++.. .
T Consensus 17 dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~ 89 (293)
T d1yhwa1 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-----G 89 (293)
T ss_dssp CTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----C
Confidence 3456899999999999999999999999999999998753222 24568899999999999999999999954 3
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+++|+|||||. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 56999999998 589888765 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+
T Consensus 169 ~~~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~-------- 234 (293)
T d1yhwa1 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP-------- 234 (293)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC--------
T ss_pred ccc---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC--------
Confidence 322 2345689999999999988 789999999999999999999999999887766555443311 00
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.....+.+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 235 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 -------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -------------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -------------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 01122468999999999999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-62 Score=457.61 Aligned_cols=328 Identities=36% Similarity=0.648 Sum_probs=255.9
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 99 (381)
+.++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++..... +..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3478999999999999999999999999999999998766666777789999999999999999999999975532 355
Q ss_pred CcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 7899999999998888774 46999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
. .....++|+.|+|||++.+ ..+++++||||+||++|+|++|++||.+.+.......+....+.+.++.+....
T Consensus 173 ~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp ------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred c----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 2 2345689999999999988 689999999999999999999999999999999999999999999988776654
Q ss_pred CHHHHHHHHHhcCCCCCCcccc------------CCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCCCCCC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQK------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~~~~~ 327 (381)
. .................... ....++++.|||++||++||++||||+|+|+||||+...+++....
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~ 325 (355)
T d2b1pa1 247 P-TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA 325 (355)
T ss_dssp H-HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTC
T ss_pred h-hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccC
Confidence 3 33333333222211111111 1124678999999999999999999999999999998654333222
Q ss_pred CCCCCCcchhhhhccCCHHHHHHHHHHHHHH
Q 016884 328 CQPISKLEFEFERRRVTKDDIRELIYREILE 358 (381)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (381)
. +....+.+.+.+..+.++|++++++|+++
T Consensus 326 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (355)
T d2b1pa1 326 P-PPQIYDKQLDEREHTIEEWKELIYKEVMN 355 (355)
T ss_dssp C-CC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred C-CCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence 2 22334556677788999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-63 Score=441.13 Aligned_cols=259 Identities=25% Similarity=0.339 Sum_probs=216.0
Q ss_pred CCCe-EEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y-~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.+|| ++.++||+|+||+||+|+++.++..||+|++............+.+|+++|++++||||+++++++.... ....
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence 4456 7888999999999999999999999999999765555566778899999999999999999999986432 2235
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEec-CCCCeEEeeecccccc
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLARVA 176 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--i~H~Dikp~NIl~~-~~~~vkl~DFg~a~~~ 176 (381)
.+|+|||||+ |+|.+++.....+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 6899999998 599999998889999999999999999999999999 99999999999997 4789999999999754
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+......+...... +.++
T Consensus 166 ~~~~-----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~----- 231 (270)
T d1t4ha_ 166 RASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----- 231 (270)
T ss_dssp CTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC-----
T ss_pred cCCc-----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC-----
Confidence 3221 245689999999999865 5999999999999999999999999876544333221110 1110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~ 317 (381)
.......++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011235789999999999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-63 Score=444.02 Aligned_cols=257 Identities=30% Similarity=0.459 Sum_probs=210.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+++|+.++||||+++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 46799999999999999999999999999999999876556666778899999999999999999999986532 245
Q ss_pred EEEEeeccc-cCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEecCCCCeEEeeec
Q 016884 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFG 171 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~-----i~H~Dikp~NIl~~~~~~vkl~DFg 171 (381)
+|+|||||. |+|.+++.. +..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999998 599998853 467999999999999999999999976 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
+|+....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~---- 230 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---- 230 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----
Confidence 9986543222 2245689999999999987 689999999999999999999999999887766555543311
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.......+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 231 --------------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 --------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 011224689999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-63 Score=449.91 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=207.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
++.++|++++.||+|+||+||+|+++.+++.||||++...... .....+.+|+.+|+.++||||+++++++.+ .
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~ 79 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-----G 79 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 3457799999999999999999999999999999999754322 223467799999999999999999999944 4
Q ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec---CCCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~---~~~~vkl~DFg~a~~ 175 (381)
+.+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+.
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 56999999998 69999999988999999999999999999999999999999999999995 478999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+...
T Consensus 160 ~~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------- 226 (307)
T d1a06a_ 160 EDPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------- 226 (307)
T ss_dssp -----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-------
T ss_pred ccCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------
Confidence 53322 1245689999999999988 7899999999999999999999999998877665555543211
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
......++.+|+++.+||.+||+.||++|||++|+|+||||++.
T Consensus 227 --------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 227 --------------------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11122345789999999999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-62 Score=444.77 Aligned_cols=266 Identities=28% Similarity=0.445 Sum_probs=226.8
Q ss_pred ccccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC----ChHHHHHHHHHHHHHHhcCCCCccccceee
Q 016884 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (381)
Q Consensus 16 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (381)
|..-.+.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++||||+++++++
T Consensus 3 ~~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp CBCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4445566889999999999999999999999999999999864322 112356788999999999999999999999
Q ss_pred cCCCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC----CeE
Q 016884 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLK 166 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~----~vk 166 (381)
.+ ...+|||||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 83 ~~-----~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 83 EN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp EC-----SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred EE-----CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceE
Confidence 44 456999999998 69999999888999999999999999999999999999999999999998876 499
Q ss_pred EeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHh
Q 016884 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (381)
Q Consensus 167 l~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 246 (381)
|+|||+|+....... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 158 l~DfG~a~~~~~~~~----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp ECCCTTCEECTTSCB----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred ecchhhhhhcCCCcc----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 999999976543321 245689999999999987 68999999999999999999999999998877777666553
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
...+.+. .++.+|+++.+||++||+.||++|||++|+|+||||+..
T Consensus 232 ~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 232 NYEFEDE---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CCCCCHH---------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCCCch---------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3222221 124689999999999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-63 Score=451.19 Aligned_cols=283 Identities=36% Similarity=0.558 Sum_probs=227.1
Q ss_pred EeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh---HHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEE
Q 016884 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 103 (381)
.++.||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++||||+++++++.. .+++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence 5789999999999999999999999999986432221 113468899999999999999999999954 35689
Q ss_pred EEeeccccCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCC
Q 016884 104 VVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (381)
Q Consensus 104 lv~e~~~~~L~~-~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~ 182 (381)
+|||||.+++.. +...+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999999975544 444466899999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHH
Q 016884 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (381)
Q Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 262 (381)
.....+||+.|+|||++.+. ..|+.++||||+||++|+|++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 12456899999999998652 568999999999999999999999999999999999999999998876543322110
Q ss_pred HHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.. .........+....++.+++++.|||.+||++||++||||+|+|+||||++...
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 233 DY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp TC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 00 001111222333445678999999999999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-63 Score=448.43 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=217.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 56999999999999999999999999999999986421 111234568899999999999999999999944 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....|.+..
T Consensus 163 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~------------- 226 (288)
T d1uu3a_ 163 K-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE------------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-------------
T ss_pred c-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 122345689999999999988 689999999999999999999999999887766655554311
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHH------HhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~------lL~hp~~~~~ 319 (381)
......+++++++||++||+.||.+|||++| +++||||+++
T Consensus 227 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 227 ------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp ------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 0112468999999999999999999999987 5889999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-63 Score=445.28 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=217.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.+.|++++.||+|+||+||+|+++.+++.||+|++... .......+.+|+++|+.++||||+++++++.. .+.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCe
Confidence 35699999999999999999999999999999998753 22345678899999999999999999999954 356
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999998 589988764 567999999999999999999999999999999999999999999999999998653221
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
.......+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------- 232 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--------
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 1122456899999999998431 25689999999999999999999999998887766655543110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
+.....+.+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 233 --------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 233 --------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 111223468999999999999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-64 Score=458.73 Aligned_cols=283 Identities=23% Similarity=0.358 Sum_probs=218.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++||||+++++++.+. .+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 357999999999999999999999999999999997543 234456788999999999999999999999543 56
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+|||||. |+|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 59999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhH-HHHHHHhhCCCCHHHHh--
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIA-- 256 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~-- 256 (381)
. ..+.+||++|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+.... ...+....+.+......
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245689999999999988 7899999999999999999999999987664332 22222222222111000
Q ss_pred ------------hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 257 ------------VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 257 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
........+.........+.... ...+|+++.|||.+||++||.+||||+|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000111122222222221111 12468999999999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-62 Score=452.94 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=223.4
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
-++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+.+|+.++||||+++++++.. .+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 35799999999999999999999999999999999753 34456678899999999999999999999943 456
Q ss_pred EEEEeeccc-cCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC--CCCeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~--~~~vkl~DFg~a~~~~ 177 (381)
+|+|||||. |+|.+++. ..+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999998 59999985 4557999999999999999999999999999999999999964 5789999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+......+.
T Consensus 178 ~~~~----~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 245 (350)
T d1koaa2 178 PKQS----VKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------ 245 (350)
T ss_dssp TTSC----EEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC------
T ss_pred cccc----cceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 3322 245689999999999987 6899999999999999999999999999887777766654332221
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
...++.+|+++++||.+||+.||++|||++|+|+||||+....
T Consensus 246 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 246 ---------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp ---------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ---------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1223468999999999999999999999999999999987543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-62 Score=449.41 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=221.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++. +...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence 469999999999999999999999999999999974311 1223466889999999999999999999994 4456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 6999999998899999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------------- 221 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------- 221 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-------------
Confidence 2 2346789999999999988 789999999999999999999999999988766555443311
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
...+..+|+++.+||++||++||.+|++ ++++++||||+++
T Consensus 222 ------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 222 ------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 1123468999999999999999999994 9999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-62 Score=446.53 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=216.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-hHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
.++|++++.||+|+||+||+|++..+++.||||+++..... ......+.+|+.+|+.++||||+++++++.+. +
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----H 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----C
Confidence 35699999999999999999999999999999999754333 34456789999999999999999999999543 5
Q ss_pred cEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|||||.+ +|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 69999999995 56666677788999999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
...+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 169 -------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~----------- 230 (309)
T d1u5ra_ 169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------- 230 (309)
T ss_dssp -------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred -------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 345899999999998652 2468999999999999999999999999887666554443311
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.+. .....+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus 231 ---------------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 231 ---------------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ---------------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 000 112457999999999999999999999999999999965
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-62 Score=446.01 Aligned_cols=289 Identities=37% Similarity=0.613 Sum_probs=233.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|++++.||+|+||+||+|.+..+|+.||||+++...........+.+|+++|++++||||+++++++.+ ..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 57999999999999999999999999999999997543333335678899999999999999999999954 4569
Q ss_pred EEEeeccccCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
|+|||||.+++.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776653 4579999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..+.+..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23456899999999987663 4568899999999999999999999999999999999999888887654432211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~ 322 (381)
. ...................+.+++++.|||++||+.||++|||++|+|+||||+++.++
T Consensus 233 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 M--PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp S--TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred c--cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0 00001111111122233456789999999999999999999999999999999987554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.4e-62 Score=449.39 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=224.0
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.+.++|++++.||+|+||+||+|+++.+|+.||||+++.. .......+.+|+.+|+.++||||+++++++.. .
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~ 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----K 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----S
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 3446799999999999999999999999999999998753 33445678899999999999999999999943 4
Q ss_pred CcEEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEec--CCCCeEEeeeccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~--~~~~vkl~DFg~a~~ 175 (381)
+.+|+|||||+ |+|.+.+...+ ++++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 56999999999 59998876544 799999999999999999999999999999999999998 568999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+......+
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----- 247 (352)
T d1koba_ 179 LNPDEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----- 247 (352)
T ss_dssp CCTTSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred cCCCCc----eeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence 543322 245689999999999988 789999999999999999999999999988877776665432221
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
....++.+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 248 ----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 ----------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 122346789999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-62 Score=443.12 Aligned_cols=290 Identities=34% Similarity=0.602 Sum_probs=235.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCC-CcEEEEEEeCCccCChHHHHHHHHHHHHHHhc---CCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~ 97 (381)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999765 66799999865433332333455777777665 799999999998655444
Q ss_pred CCCcEEEEeeccccCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~~~L~~~l~--~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
....+|++||+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 556799999999976655443 345799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
.... ......+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..+++..+....+.|....+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 22356789999999999987 78999999999999999999999999999999999999999999887654
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
........ .........+.......+++.+.|||++||++||++||||+|+|+||||+++..
T Consensus 240 ~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 240 PRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 42211110 011222333344456678999999999999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-61 Score=441.15 Aligned_cols=253 Identities=26% Similarity=0.458 Sum_probs=220.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 46999999999999999999999999999999986432 112234578899999999999999999999954 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+|||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999998 589999999899999999999999999999999999999999999999999999999999999875332
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------- 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 235689999999999987 689999999999999999999999999988766665554311
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
....+.+++++.+||.+||+.||.+|+ |++++|+||||+++
T Consensus 218 ------------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 218 ------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 112246899999999999999999996 99999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-61 Score=445.95 Aligned_cols=253 Identities=21% Similarity=0.377 Sum_probs=220.3
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++||||+++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 68999999999999999999999999999999986421 112234568899999999999999999999944 456
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
+|+||||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999998 599999988889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------ 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------ 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------------
Confidence 234689999999999988 7899999999999999999999999998887666655543211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcC
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~ 319 (381)
.....+++++.+||++||+.||.+|+ |++++|+||||++.
T Consensus 256 -------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 11246899999999999999999995 99999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-60 Score=427.41 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=221.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC-------hHHHHHHHHHHHHHHhcC-CCCccccceeecC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-------ISDAIRILREVKLLRLLR-HPDIVEIKRIMLP 93 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 93 (381)
.++|++.+.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|+.++ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 47899999999999999999999999999999998653221 112346789999999997 999999999994
Q ss_pred CCcCCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecc
Q 016884 94 PSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 94 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
+.+.+|||||||. |+|.++++.++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ----cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 4456999999998 59999999888999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccc----cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhC
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 248 (381)
|+....... .+..+||+.|+|||.+.+. ...++.++||||+||++|+|++|+.||.+.+..+....+...-.
T Consensus 157 a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 986543322 2456899999999998531 24578899999999999999999999999887666655543211
Q ss_pred CCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
. ......+++|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 233 ~---------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 233 Q---------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp C---------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred C---------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1 1112235789999999999999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-61 Score=433.59 Aligned_cols=284 Identities=38% Similarity=0.641 Sum_probs=231.2
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|+++++||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++... +..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 58999999999999999999985 789999999976543334456788999999999999999999999544 459
Q ss_pred EEEeeccccCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
|++||++.+++...+ ...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997655554 5567899999999999999999999999999999999999999999999999999976533222
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCH
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 261 (381)
......|++.|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....+.|....+......
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 12345799999999998763 56799999999999999999999999999999999999999998876544322111
Q ss_pred HHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
...........+.+.....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0111112223333444556778999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=435.01 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=221.5
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++.+++.||+|+++.. ......+.+|+.+|+.++||||+++++++. +.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~ 75 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCE
Confidence 47899999999999999999999999999999999753 233456789999999999999999999994 3456
Q ss_pred EEEEeeccc-cCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC--CCeEEeeeccccccc
Q 016884 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVAF 177 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~--~~vkl~DFg~a~~~~ 177 (381)
+|||||||. ++|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 999999999 59999998765 79999999999999999999999999999999999999854 479999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... .....++|+.|+|||.+.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..|.+....++..
T Consensus 156 ~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---- 225 (321)
T d1tkia_ 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---- 225 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----
T ss_pred cCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh----
Confidence 322 1245679999999999987 689999999999999999999999999998887777776543333222
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~ 318 (381)
.++.+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus 226 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 -----------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -----------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -----------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 23468999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-60 Score=440.29 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=213.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc----CChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ..........+|+.+++.++||||+++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----- 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence 57999999999999999999999999999999986321 111222233345777788889999999999944
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
.+.+|+|||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 356999999998 6999999988899999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 159 ~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------- 224 (364)
T d1omwa3 159 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------- 224 (364)
T ss_dssp SSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--------
T ss_pred CCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence 332 2345899999999998642 56899999999999999999999999876544333222111111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCC-----HHHHhcCCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt-----~~~lL~hp~~~~~ 319 (381)
....+..+|+++.+||.+||+.||.+||| |+++|+||||+++
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 11223468999999999999999999999 8999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=439.39 Aligned_cols=286 Identities=35% Similarity=0.593 Sum_probs=232.5
Q ss_pred CeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCCcE
Q 016884 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFKDI 102 (381)
Q Consensus 24 ~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 102 (381)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++||||+++++++.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999965322 1237999999999999999999986543 2344578
Q ss_pred EEEeeccccCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeeccccccc
Q 016884 103 YVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (381)
Q Consensus 103 ~lv~e~~~~~L~~~l----~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~~~~ 177 (381)
|+|||||++++...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997665544 3456899999999999999999999999999999999999999875 89999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ....+||+.|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+..+++..+.+.+|.+..+.+..
T Consensus 175 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCcc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 3322 2456899999999988653 5789999999999999999999999999999999999999999999887664
Q ss_pred hcCHHHHHHHHHhcCCCCCCc-cccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCccCC
Q 016884 258 VRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~~~ 323 (381)
......... +......+. ....+..++++.+||.+||++||++||||.|+|+||||+++..+.
T Consensus 250 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 250 MNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp HCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 432211000 011111111 122356899999999999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-60 Score=436.24 Aligned_cols=299 Identities=33% Similarity=0.546 Sum_probs=232.1
Q ss_pred cCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 016884 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-- 96 (381)
Q Consensus 19 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 96 (381)
.+..++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 445689999999999999999999999999999999987554444445678899999999999999999999865421
Q ss_pred -CCCCcEEEEeeccccCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 -REFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 -~~~~~~~lv~e~~~~~L~~~l-~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
....++|+|||||.+++.... .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 223568999999997666554 445689999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCC-CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
....... ........+||++|+|||++.+. ..|+.++||||+||++|+|++|++||.+.+.......+....+.+.++
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 5432221 11222346899999999998763 578999999999999999999999999999999999999999999887
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccC--CCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..................... ......+ ...++++.|||.+||++||++||||+|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TSTTCCCC-------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hccccchhhhhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 665544433322222111110 0000000 1247889999999999999999999999999999853
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-60 Score=433.54 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=217.7
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-CChHHHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKREFK 100 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 100 (381)
++|++++.||+|+||+||+|.++.+++.||||++++.. ........+.+|..++. .++||||+++++++.. .+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996421 11122345667777765 6899999999999944 45
Q ss_pred cEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 101 ~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
.+|+|||||. |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 6999999998 599999998889999999999999999999999999999999999999999999999999999754332
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhc
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 259 (381)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+... .|
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--------- 220 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--------- 220 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------
Confidence 22 2345689999999999988 78999999999999999999999999998876666555321 11
Q ss_pred CHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH-HHhcCCCcCcC
Q 016884 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGL 319 (381)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~-~lL~hp~~~~~ 319 (381)
.....+|+++.+||++||+.||.+|||+. ++++||||+++
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11246899999999999999999999995 89999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-59 Score=420.33 Aligned_cols=288 Identities=36% Similarity=0.570 Sum_probs=234.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
++|+++++||+|+||+||+|++..+++.||||+++..........++.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 58999999999999999999999999999999997655555667889999999999999999999999944 3568
Q ss_pred EEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCC
Q 016884 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (381)
Q Consensus 103 ~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~ 181 (381)
++|++++.+ ++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 6777777788999999999999999999999999999999999999999999999999999986543322
Q ss_pred CcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCC-CCCCChhhHHHHHHHhhCCCCHHHHhhhcC
Q 016884 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (381)
Q Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 260 (381)
. .....+++.|+|||++.+. ..++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+.....
T Consensus 157 ~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 C---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 1 2345688999999998763 4578999999999999999999877 567777888888888888877654332211
Q ss_pred HHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCcc
Q 016884 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (381)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~~ 321 (381)
.. ..................+.+++.+.|||++||++||.+||||+|+|+||||+++.+
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00 000000001112233445678999999999999999999999999999999987654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-60 Score=432.88 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=208.8
Q ss_pred CCCCeEEee-eecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHh-cCCCCccccceeecCCCcCC
Q 016884 21 DANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 21 ~~~~Y~~~~-~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~ 98 (381)
+.++|+++. .||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++||||+++++++.+.. ..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence 346799875 599999999999999999999999998642 356689998655 58999999999985421 22
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEeeecc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGL 172 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~DFg~ 172 (381)
...+|+|||||+ |+|.+++... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 356999999998 5999999864 36999999999999999999999999999999999999986 46799999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
|+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 161 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~---- 230 (335)
T d2ozaa1 161 AKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 230 (335)
T ss_dssp CEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC----
T ss_pred eeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh----
Confidence 986544322 245689999999999988 6899999999999999999999999987765444333322111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
..........++.+|+++.+||++||+.||++|||+.|+|+||||.+.
T Consensus 231 -------------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 231 -------------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp -------------------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred -------------------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000000011123589999999999999999999999999999999653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-60 Score=421.88 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=208.7
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCCh----HHHHHHHHHHHHHHhcC--CCCccccceeecCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIMLPP 94 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~ 94 (381)
..++|++.+.||+|+||+||+|++..+|+.||||++....... ....++.+|+.+|+.++ ||||+++++++..
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence 3578999999999999999999999999999999986432111 11234568999999997 8999999999944
Q ss_pred CcCCCCcEEEEeeccc--cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC-CCeEEeeec
Q 016884 95 SKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (381)
Q Consensus 95 ~~~~~~~~~lv~e~~~--~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~-~~vkl~DFg 171 (381)
.+.+|+||||+. +++.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 81 ----~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 81 ----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ----CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 456999999997 4888899888899999999999999999999999999999999999999854 789999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 172 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh------
Confidence 99764332 23456899999999998762 3356789999999999999999999976321 111
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcC
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~ 319 (381)
.. ....+.+|+++.+||++||+.||++|||++|+|+||||++.
T Consensus 219 --------------------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 --------------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --------------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --------------------cc-----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00 11224689999999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.6e-59 Score=417.08 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=213.8
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
...++|++.+.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.... ..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence 456889999999999999999999999999999999976543 3455667899999999999999999999986543 22
Q ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
...+|+|||||. ++|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 345899999999 5999999888899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
............+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~----------- 229 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----------- 229 (277)
T ss_dssp ----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred cccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-----------
Confidence 44433334456789999999999987 68999999999999999999999999988766555444331
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~ 316 (381)
.+.+.....+.+|+++.+||.+||+.||.+||+..+.|.|+|.
T Consensus 230 ----------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 230 ----------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ----------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 1122233446799999999999999999999954444456665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-58 Score=421.54 Aligned_cols=287 Identities=31% Similarity=0.557 Sum_probs=222.7
Q ss_pred ccCCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 016884 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (381)
Q Consensus 18 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 96 (381)
.++..++|+++++||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 456778999999999999999999999999999999998742 2356789999999995 99999999998543
Q ss_pred CCCCcEEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCC-CeEEeeecccc
Q 016884 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~-~vkl~DFg~a~ 174 (381)
....+|+|||||.+ +|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 23569999999995 765543 4699999999999999999999999999999999999998765 59999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCC-CChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~ 253 (381)
....... ....++|+.|+|||.+.+. ..++.++||||+||++|+|++|+.||.. .+..++...+...+|.|...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 6543322 2456899999999998763 4689999999999999999999999965 45566777777777765433
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCC-C-----ccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcCCCcCcCc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPV-P-----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~hp~~~~~~ 320 (381)
....................... . .......+++++.|||++||++||.+|||++|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 22211110000000001111110 0 0111234789999999999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=410.63 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=205.4
Q ss_pred eeecccCCceEEEEEEc--CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcEEEEe
Q 016884 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 29 ~~lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
++||+|+||+||+|.++ .+++.||||+++...........+.+|+.+|++++||||+++++++.. +..|+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999864 456789999997654455556789999999999999999999999843 2379999
Q ss_pred eccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCCCCccc
Q 016884 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (381)
Q Consensus 107 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~ 185 (381)
|||+ |+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9998 699999999889999999999999999999999999999999999999999999999999999875444333333
Q ss_pred ccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHH
Q 016884 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (381)
Q Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 264 (381)
.....||+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+.+...
T Consensus 167 ~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---------------- 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------------- 228 (277)
T ss_dssp ----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------
T ss_pred ccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 345579999999999987 678999999999999999998 8999998876655444432110
Q ss_pred HHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCCcC
Q 016884 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFK 317 (381)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l---L~hp~~~ 317 (381)
......+++++.+||.+||+.||++|||++++ |+|+|++
T Consensus 229 --------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 --------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 11224689999999999999999999999998 4566653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=406.25 Aligned_cols=257 Identities=21% Similarity=0.263 Sum_probs=207.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|+. +..||||+++...........+.+|+.+|++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 47899999999999999999964 3469999997655555667789999999999999999999998632 24
Q ss_pred EEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+|||||+ |+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 6999999754 57999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ........||+.|+|||++.+. ...|+.++|||||||++|||+||+.||.+.+....+..+.....
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------- 226 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---------- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS----------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC----------
Confidence 22 1223456899999999998652 24589999999999999999999999988766554433322111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
..........++++++.+||.+||+.||++|||+++++++
T Consensus 227 ---------------~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 227 ---------------LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111223345789999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-56 Score=406.37 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=200.1
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCc---EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
..++|++.+.||+|+||+||+|+++.+++ .||||.+... ........+.+|+.+|+.++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--- 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence 45689999999999999999999987765 5889987643 3344566789999999999999999999999543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+.+|+|||||. |+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 --~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 --TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp --SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 45899999999 5899988764 4799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcc--cccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCH
Q 016884 176 AFSDTPMTV--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (381)
Q Consensus 176 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 252 (381)
......... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+......|
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-- 253 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 543322111 1123468999999999987 689999999999999999998 899999888766655554321111
Q ss_pred HHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 124689999999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-57 Score=405.74 Aligned_cols=257 Identities=22% Similarity=0.344 Sum_probs=212.9
Q ss_pred CCeEEeee-ecccCCceEEEEEEcCC--CcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEV-IGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~-lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
++|.+.+. ||+|+||+||+|.++.+ +..||||+++.. ........+.+|+++|++++||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 56888884 99999999999987644 457999999754 344566789999999999999999999998843
Q ss_pred CcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
+.+|+|||||+ |+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 24899999999 599998765 4579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
............+||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+.+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-------- 230 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------- 230 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 44333333345678999999999987 689999999999999999998 9999998776655544432110
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH---hcCCCcCc
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFKG 318 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l---L~hp~~~~ 318 (381)
....+.+++++.+||.+||+.||++|||+.++ |+|+|++-
T Consensus 231 ----------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11235689999999999999999999999888 66888753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-57 Score=406.69 Aligned_cols=249 Identities=22% Similarity=0.378 Sum_probs=206.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEee-----CCe
Confidence 4689999999999999999999999999999999875432 34568899999999999999999999954 345
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 899999999 6999998754 4789999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCC-CCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|..|| .+.+.......+....
T Consensus 168 ~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------- 233 (287)
T d1opja_ 168 DTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 233 (287)
T ss_dssp SSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------
T ss_pred CCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------
Confidence 3221 2234568999999999987 78999999999999999999966554 4444333222221100
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.......+++++.+||.+||+.||++|||++++++
T Consensus 234 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01123468999999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=398.64 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=198.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+++|++++.||+|+||+||+|++. +++.||||+++..... ...+.+|+++++.++||||+++++++... ..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-----Cc
Confidence 468999999999999999999876 5678999998753332 35688999999999999999999999543 45
Q ss_pred EEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 899999998 6999988754 56899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+..+......+
T Consensus 155 ~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------- 222 (263)
T d1sm2a_ 155 QYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------- 222 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------
T ss_pred Ccee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC--------
Confidence 2211 234578999999999987 689999999999999999999 577777776655555444321111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....+++++.+|+.+||+.||++|||++++|+|
T Consensus 223 ----------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 ----------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 123578999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=410.11 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=206.8
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc-----EEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 96 (381)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 689999999999999999999876554 69999886432 223445788999999998 899999999999543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN-----------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~-----------------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Di 152 (381)
+.+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 45899999998 6999999754 24899999999999999999999999999999
Q ss_pred CCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCC
Q 016884 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (381)
Q Consensus 153 kp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf 231 (381)
||+|||++.++.+||+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999865443322 22345678999999999987 789999999999999999997 89999
Q ss_pred CCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHh
Q 016884 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (381)
Q Consensus 232 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL 311 (381)
.+.+....+..+...-.. ......+++++.+||.+||+.||++|||++||+
T Consensus 268 ~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFK-----------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC-----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 887655544443321100 112246899999999999999999999999999
Q ss_pred cC
Q 016884 312 AD 313 (381)
Q Consensus 312 ~h 313 (381)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=402.48 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=208.0
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||+||+|+++ ++..||||+++..... .+.+.+|+.+|++++||||+++++++.. +.
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 368999999999999999999875 5788999999754322 3568899999999999999999998743 24
Q ss_pred EEEEeeccc-cCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. |+|.+++... .++++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 799999998 6898877543 3699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ........||+.|+|||++.+ ..++.++|||||||++|||+|| .+||...+..+.+..+......
T Consensus 162 ~~--~~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------- 229 (272)
T d1qpca_ 162 NE--YTAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------- 229 (272)
T ss_dssp SC--EECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred Cc--cccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 22 122245578999999999987 6799999999999999999995 5666666655544444321111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCCcCc
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--hp~~~~ 318 (381)
.....+++++.+|+.+||+.||++|||++++++ |+||++
T Consensus 230 ----------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 ----------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 112468899999999999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=395.03 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=210.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
+++|+++++||+|+||+||+|+++ +++.||||+++..... ...+.+|+.+++.++||||+++++++... +.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cc
Confidence 467999999999999999999985 7789999999754332 35688999999999999999999998543 45
Q ss_pred EEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCC
Q 016884 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~ 179 (381)
+++|||||. |+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 688888664 457999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhhh
Q 016884 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+.+....+
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 221 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------- 221 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 222 2234679999999999987 689999999999999999998 899999988776665554322111
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
....+++++.+||++||+.||++|||++++|+|
T Consensus 222 ----------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 ----------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 123578899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=409.34 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=215.6
Q ss_pred CCeEEeeeecccCCceEEEEEE---cCCCcEEEEEEeCCcc--CChHHHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 96 (381)
++|++++.||+|+||+||+|++ +.+|+.||||++++.. ........+.+|+.+|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 6799999999999999999987 4478999999986432 122234567789999999976 89999999984
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
+...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 3456999999999 59999999988999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
...... .......|++.|+|||.+.+....++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~------- 249 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL------- 249 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-------
Confidence 433222 12345689999999999876434678899999999999999999999988776555544433110
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCC-----CHHHHhcCCCcCcCc
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rp-----t~~~lL~hp~~~~~~ 320 (381)
.... .....+|+++.+||++||++||.+|| |++|+|+||||+++.
T Consensus 250 ---------------~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 250 ---------------KSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ---------------HCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------------cCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0111 12346899999999999999999999 589999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-55 Score=391.72 Aligned_cols=253 Identities=24% Similarity=0.330 Sum_probs=196.7
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCC----cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (381)
+++|++.+.||+|+||+||+|..+.++ ..||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence 467999999999999999999987655 47999999753 3334556789999999999999999999999543
Q ss_pred CCCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccc
Q 016884 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (381)
Q Consensus 98 ~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~ 175 (381)
..+++|||||. +++.+.+... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 --~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 82 --KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred --CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 45899999998 4777777654 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCChhhHHHHHHHhhCCCCHHH
Q 016884 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPET 254 (381)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~ 254 (381)
...............||+.|+|||++.+ ..++.++|||||||++|||++|. +||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----- 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----- 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-----
Confidence 5443332222334578999999999987 78999999999999999999965 555555544433333221110
Q ss_pred HhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
.....+++.+.+||.+||+.||++|||+.++++
T Consensus 233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 112468899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=391.96 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=199.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
++|++++.||+|+||+||+|++..++ ..||||.++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 68999999999999999999987554 46899988643 334456678999999999999999999999842
Q ss_pred CcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeeccccccc
Q 016884 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~ 177 (381)
+.+|+|||||. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 34899999998 688887665 4579999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHh
Q 016884 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (381)
Q Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 256 (381)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------- 227 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------- 227 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 32221 2234578999999999987 789999999999999999998 8999998887766655543111
Q ss_pred hhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...++++++.+.+||.+||+.||++|||++++++|
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11235789999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=389.91 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=204.3
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++.+.||+|+||+||+|+++.+ +.||||+++..... .+.+.+|+.+|++++|||||++++++.. +.
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 46899999999999999999998765 57999999754333 3568899999999999999999998732 23
Q ss_pred EEEEeeccc-cCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+|||||. |+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 588877753 35799999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++| .+|+.+....+.+..+.+....
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------- 233 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 233 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 2221 1234579999999999987 7899999999999999999995 5566666655555444331111
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc--CCCcCcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~--hp~~~~~ 319 (381)
...+.+++++.+||.+||+.||++|||++++++ ++||+..
T Consensus 234 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 123568999999999999999999999999988 8899764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=395.27 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=201.6
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCc----EEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (381)
.+|++++.||+|+||+||+|.+..+|+ .||+|+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 569999999999999999999988876 58888876432 223456789999999999999999999998543
Q ss_pred CCcEEEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccc
Q 016884 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (381)
Q Consensus 99 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~ 176 (381)
..++++|++. ++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3577788877 6888877654 57999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHH
Q 016884 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (381)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 255 (381)
..... ........||+.|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+.+....
T Consensus 162 ~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~------ 232 (317)
T d1xkka_ 162 GAEEK-EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------ 232 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC------
T ss_pred ccccc-cccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 43322 122234568999999999987 689999999999999999998 89999887766555444331111
Q ss_pred hhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
...+.+++.+.+|+.+||+.||.+|||+.++++|
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1124688999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=386.38 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=200.4
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcC-CC--cEEEEEEeCCccC-ChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTH-TG--EKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
..++|++++.||+|+||.||+|+... ++ ..||||+++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-- 83 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 83 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence 34679999999999999999998653 33 3689999875433 334456789999999999999999999999542
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.+++|||||. +++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 84 ----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 84 ----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 3699999998 688877654 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHH
Q 016884 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (381)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 253 (381)
................|+..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+.+..+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~---- 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---- 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----
T ss_pred hcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC----
Confidence 76554443333345578889999999987 689999999999999999998 89999998877666555431111
Q ss_pred HHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
....+.+++.+.+||.+||+.||++|||++++++
T Consensus 234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123578999999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=386.39 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=197.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 96 (381)
++|++++.||+|+||+||+|.+.. +++.||||+++.. ........+.+|..++.++ +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 679999999999999999999754 4468999998743 3334456777888888777 688999999887543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEe
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~ 159 (381)
...+++|||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 245899999999 6999999653 248999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhh
Q 016884 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVH 238 (381)
Q Consensus 160 ~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~ 238 (381)
+.++.+||+|||+|+....... .......+||+.|+|||++.+ ..++.++||||+||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999986543322 222345689999999999987 7899999999999999999986 57887766444
Q ss_pred HHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 239 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.+..+...-.. ......+++++.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTR-----------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCC-----------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33322211000 11224689999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-53 Score=385.45 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=207.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 357999999999999999999875 35678999998753 3344566789999999999999999999999543
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRD 151 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~~------------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~D 151 (381)
..+++||||+. |+|.+++.... .+++..+..|+.||+.||+|||++||+|||
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 45899999998 69999986432 489999999999999999999999999999
Q ss_pred CCCCceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC-CC
Q 016884 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 230 (381)
Q Consensus 152 ikp~NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~-~p 230 (381)
|||+|||++.++.+||+|||+|+....... .......+||+.|+|||.+.+ ..|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999975433221 122245678999999999987 78999999999999999999985 78
Q ss_pred CCCCChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHH
Q 016884 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (381)
Q Consensus 231 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~l 310 (381)
|.+.+..+....+.+... ......+++++.+||.+||+.||++|||+.|+
T Consensus 243 ~~~~~~~e~~~~v~~~~~------------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNI------------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTTSCHHHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 988877666555433111 11234689999999999999999999999999
Q ss_pred hc
Q 016884 311 LA 312 (381)
Q Consensus 311 L~ 312 (381)
++
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=379.11 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=198.2
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
.++|++++.||+|+||.||+|++ +|+.||||+++.. ...+.+.+|+.+|++++||||+++++++.... +.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----Cc
Confidence 35799999999999999999987 4789999999753 23457889999999999999999999885432 34
Q ss_pred EEEEeeccc-cCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccC
Q 016884 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~ 178 (381)
+|+||||+. |+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 799999998 69999986543 589999999999999999999999999999999999999999999999999975433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCChhhHHHHHHHhhCCCCHHHHhh
Q 016884 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (381)
Q Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 257 (381)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+.+...
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------- 218 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------- 218 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 22 23468899999999987 689999999999999999998 7899988776655544432110
Q ss_pred hcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
......+++.+.+||++||+.||.+|||+.+++++
T Consensus 219 ---------------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 219 ---------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11234688999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=380.38 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=204.6
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCC-------cEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeec
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIML 92 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 92 (381)
..++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|...+.++ +||||+++++++.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3578999999999999999999976654 37999998754 3344556788899999888 7999999999995
Q ss_pred CCCcCCCCcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 016884 93 PPSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (381)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~ 155 (381)
.. ..+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 QD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp SS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 43 45899999998 6999999754 35899999999999999999999999999999999
Q ss_pred ceEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCC
Q 016884 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (381)
Q Consensus 156 NIl~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 234 (381)
|||++.++.+||+|||+++........ ......+||+.|+|||.+.+ ..|+.++|||||||++|+|++ |.+||.+.
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999865443322 22345679999999999987 789999999999999999998 79999887
Q ss_pred ChhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 235 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
+.......+..... ......+++++.+||.+||+.||.+|||+.|+|+
T Consensus 242 ~~~~~~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 242 PVEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CHHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 76554443322110 0122468999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=383.87 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcE--EEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 99 (381)
++|++.+.||+|+||+||+|+++.++.. ||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 6899999999999999999999888874 6778775332 223455788999999999 799999999999543
Q ss_pred CcEEEEeeccc-cCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCC
Q 016884 100 KDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (381)
Q Consensus 100 ~~~~lv~e~~~-~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~ 162 (381)
+.+|+|||||. |+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 45999999999 6999998644 579999999999999999999999999999999999999999
Q ss_pred CCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCC-CCCCCCChhhHHH
Q 016884 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241 (381)
Q Consensus 163 ~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~ 241 (381)
+.+||+|||+|+........ ....||+.|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+...
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999754332221 24468999999999987 78999999999999999999965 6788777655444
Q ss_pred HHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 242 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
.+.+.. .......+++++.+||.+||+.||++|||++++|+|
T Consensus 238 ~i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGGGTC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcC------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332210 011234689999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=378.53 Aligned_cols=252 Identities=20% Similarity=0.351 Sum_probs=209.8
Q ss_pred CCCeEEeeeecccCCceEEEEEEcC-----CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (381)
.++|++++.||+|+||+||+|.+.. ++..||||+++.. ........+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC--
Confidence 4899999999999999999998753 3578999999754 3445556789999999999999999999999443
Q ss_pred CCCCcEEEEeeccc-cCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCe
Q 016884 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (381)
Q Consensus 97 ~~~~~~~lv~e~~~-~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~v 165 (381)
..+++|||||. |+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++++
T Consensus 96 ---~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 ---QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ---CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 45899999998 6999988532 247899999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcC-CCCCCCCChhhHHHHHH
Q 016884 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLIT 244 (381)
Q Consensus 166 kl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~ 244 (381)
||+|||+|+....... ........||+.|+|||.+.+ ..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 222344578999999999987 7899999999999999999998 58888877766655554
Q ss_pred HhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
+... ......+++.+.+||.+||+.||++|||++++++
T Consensus 250 ~~~~------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 EGGL------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCC------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3111 1122468899999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=375.74 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=209.1
Q ss_pred CCCeEEeeeecccCCceEEEEEEc-----CCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 95 (381)
.++|++.+.||+|+||.||+|... .+++.||||+++.. ........+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 479999999999999999999853 46679999999754 3445566788999999999 699999999999543
Q ss_pred cCCCCcEEEEeeccc-cCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 016884 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (381)
Q Consensus 96 ~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~N 156 (381)
..+|+|||||. |+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 45899999998 69999986543 58999999999999999999999999999999999
Q ss_pred eEecCCCCeEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHc-CCCCCCCCC
Q 016884 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (381)
Q Consensus 157 Il~~~~~~vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 235 (381)
||++.++.+|++|||.++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987544332 223345689999999999987 689999999999999999998 677777766
Q ss_pred hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 236 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+.+..+...-..+ .....+++.+.+||.+||+.||.+|||++++|+
T Consensus 253 ~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRM-----------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCC-----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 555444433211000 112457899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-52 Score=376.36 Aligned_cols=266 Identities=20% Similarity=0.246 Sum_probs=204.6
Q ss_pred CCCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 016884 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 20 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (381)
.++++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|++++..+..+.. +.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~ 75 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----EG 75 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEE----ET
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEe----cC
Confidence 3567999999999999999999999999999999988653222 246789999999998877666555432 23
Q ss_pred CcEEEEeeccccCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC---CCCeEEeeeccccc
Q 016884 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARV 175 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~---~~~vkl~DFg~a~~ 175 (381)
...++|||||++++.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 46899999999988877764 457999999999999999999999999999999999999764 45799999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhhCCCC
Q 016884 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (381)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 251 (381)
........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-- 231 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 231 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH--
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc--
Confidence 54332211 12245689999999999988 67999999999999999999999999876654433222211000
Q ss_pred HHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHH---HHhcCCCcCc
Q 016884 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EALADPYFKG 318 (381)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~---~lL~hp~~~~ 318 (381)
.. ..+......++|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 232 -----------------~~----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 -----------------KM----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----------------HH----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------------cC----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00 0011112357899999999999999999999987 4567777643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-50 Score=377.42 Aligned_cols=282 Identities=22% Similarity=0.340 Sum_probs=211.9
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-----------CCCccccceee
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRIM 91 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~ 91 (381)
+||+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+++++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5799999999999999999999999999999999742 233456778999888875 47889898887
Q ss_pred cCCCcCCCCcEEEEeeccc--cCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEecCCCC--
Q 016884 92 LPPSKREFKDIYVVFELME--SDLHQVI--KANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK-- 164 (381)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~--~~L~~~l--~~~~~l~~~~~~~i~~qil~aL~~LH~-~~i~H~Dikp~NIl~~~~~~-- 164 (381)
.... ....+++++++. ++..... .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 5422 234566666654 3333333 334579999999999999999999998 89999999999999987653
Q ss_pred ----eEEeeecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-----
Q 016884 165 ----LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (381)
Q Consensus 165 ----vkl~DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----- 235 (381)
++++|||.|....... ...+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||...+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 9999999987543322 34589999999999887 689999999999999999999999997543
Q ss_pred -hhhHHHHHHHhhCCCCHHHHhhhcCHHHHHHHHH--hcCC-CCCC----------ccccCCCCCHHHHHHHHHhccCCC
Q 016884 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE--MRKK-PPVP----------LFQKFPNVDPLALRLLQRLIAFDP 301 (381)
Q Consensus 236 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~----------~~~~~~~~~~~~~dLi~~~L~~dp 301 (381)
..+.+..+...+|.++.+......... .++.. .... .... ........++++.|||.+||++||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccc--cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 345677778888988877654332211 00000 0000 0000 001112356789999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCc
Q 016884 302 KDRPTAEEALADPYFKGLA 320 (381)
Q Consensus 302 ~~Rpt~~~lL~hp~~~~~~ 320 (381)
.+||||+|+|+||||++..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTCGGGTTCT
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=367.46 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=198.6
Q ss_pred EEeeeecccCCceEEEEEEcCCC---cEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCcE
Q 016884 26 KILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (381)
Q Consensus 26 ~~~~~lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 102 (381)
.+.++||+|+||+||+|++..++ ..||||+++.. .......++.+|+++|++++||||+++++++... ...+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 34678999999999999986543 36999998742 4555667899999999999999999999987532 2358
Q ss_pred EEEeeccc-cCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEeeecccccccCCC
Q 016884 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (381)
Q Consensus 103 ~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~~~~~~~ 180 (381)
++|||||. ++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999 6888888754 367888999999999999999999999999999999999999999999999998654332
Q ss_pred CC-cccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCC-hhhHHHHHHHhhCCCCHHHHhhh
Q 016884 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAVV 258 (381)
Q Consensus 181 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 258 (381)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|..||.... ..+....+...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g------------ 250 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------------ 250 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT------------
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence 22 122234578999999999887 689999999999999999999777765432 22222222110
Q ss_pred cCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhcC
Q 016884 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (381)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~h 313 (381)
... ...+.+++.+.+||.+||+.||++|||+.|+++|
T Consensus 251 -------------~~~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 -------------RRL-----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -------------CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCC-----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 000 1124678999999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-50 Score=365.18 Aligned_cols=255 Identities=18% Similarity=0.211 Sum_probs=205.0
Q ss_pred CCCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCC
Q 016884 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 21 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 99 (381)
++++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +|++.+++++. ..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 73 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 73 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEee-----cC
Confidence 36899999999999999999999999999999998864322 2346679999999975 89999988874 34
Q ss_pred CcEEEEeeccccCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecC-----CCCeEEeeeccc
Q 016884 100 KDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLA 173 (381)
Q Consensus 100 ~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~-----~~~vkl~DFg~a 173 (381)
...|+|||||+++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence 5689999999999999987654 7999999999999999999999999999999999999974 577999999999
Q ss_pred ccccCCCCCc----ccccccccCccccCccccccccCCCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHH---HHh
Q 016884 174 RVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI---TDL 246 (381)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~ 246 (381)
+......... ......+||+.|+|||++.+ ..+++++|||||||++|+|++|..||.+.+........ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 8754322211 12235689999999999988 68999999999999999999999999876543332222 111
Q ss_pred hCCCCHHHHhhhcCHHHHHHHHHhcCCCCCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
...+ +.....+++++++.+++..|+..+|++||+.+.+.+
T Consensus 232 ~~~~--------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQST--------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHS--------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCC--------------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0000 111223568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=368.41 Aligned_cols=272 Identities=21% Similarity=0.206 Sum_probs=193.6
Q ss_pred CCCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCCc
Q 016884 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 22 ~~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.. ........+|+..++.++||||+++++++.... .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 46799999999999999999975 6899999998642 111122234555566789999999999987543 23346
Q ss_pred EEEEeeccc-cCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceEecCCCCeEEeeecc
Q 016884 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------ANVYHRDLKPKNILANANCKLKVCDFGL 172 (381)
Q Consensus 102 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~--------~~i~H~Dikp~NIl~~~~~~vkl~DFg~ 172 (381)
+|+|||||. |+|.+++++. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 899999998 6999999875 69999999999999999999996 5999999999999999999999999999
Q ss_pred cccccCCCCCc-ccccccccCccccCccccccccC----CCCCccchHHHHHHHHHHHcCCCCCCCCChhhHHHHHHHhh
Q 016884 173 ARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (381)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 247 (381)
++......... ......+||+.|+|||++.+... .++.++|||||||++|||+||.+||.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-hhccc
Confidence 98654433221 12345689999999999865211 25678999999999999999998885433211000 00000
Q ss_pred CCCCHHHHhhhcCHHHHHHHHHhcCCC---CCCccccCCCCCHHHHHHHHHhccCCCCCCCCHHHHhc
Q 016884 248 GTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (381)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~dLi~~~L~~dp~~Rpt~~~lL~ 312 (381)
..+. ............ ..+...........+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~-----------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPS-----------VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCC-----------HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccch-----------HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0011 011111111111 11111111123345889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.1e-27 Score=201.23 Aligned_cols=171 Identities=16% Similarity=0.090 Sum_probs=121.0
Q ss_pred eEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCC----------------hHHHHHHHHHHHHHHhcCCCCccccc
Q 016884 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----------------ISDAIRILREVKLLRLLRHPDIVEIK 88 (381)
Q Consensus 25 Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (381)
|.+.++||+|+||+||+|.+. +|+.||||+++..... ........+|+..+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999875 6899999987531110 01123455789999999999998877
Q ss_pred eeecCCCcCCCCcEEEEeeccccCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEecCCCCeEEe
Q 016884 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (381)
Q Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i~H~Dikp~NIl~~~~~~vkl~ 168 (381)
+.. . .+++|||+++... ..++...+..++.|++.||+|||++||+||||||+|||+++++ ++|+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEEC
T ss_pred Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEE
Confidence 654 1 2799999996321 1255666788999999999999999999999999999999765 9999
Q ss_pred eecccccccCCCCCcccccccccCccccCccccccccCCCCCccchHHHHHH
Q 016884 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (381)
Q Consensus 169 DFg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 220 (381)
|||+|.......... .....+.. ..+.+ . ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~~----~~~~f-~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVRN----IITYF-S--RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHHH----HHHHH-H--HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHHH----HHHHH-c--CCCCCcccHHHHHHH
Confidence 999987543221110 00000000 01112 1 468899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.7e-07 Score=80.39 Aligned_cols=138 Identities=12% Similarity=0.128 Sum_probs=87.4
Q ss_pred CCeEEeeeecccCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCCc
Q 016884 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (381)
Q Consensus 23 ~~Y~~~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 101 (381)
..|+.++..+.++.+.||+.. ..+..+++|+....... ....+.+|...++.+. +--+.+++.+.. ..+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCc
Confidence 457777776666678999884 56777889987643221 1224567888888774 333455555542 2245
Q ss_pred EEEEeecccc-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 016884 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------- 145 (381)
Q Consensus 102 ~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------------------------------- 145 (381)
.|+||++++| .+.+..... .....+..++...++.||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 7999999987 443332211 11222344444444445421
Q ss_pred ------------------------CccccCCCCCceEecCCCCeEEeeecccc
Q 016884 146 ------------------------NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 146 ------------------------~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 25899999999999987666799999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=3e-06 Score=77.01 Aligned_cols=77 Identities=17% Similarity=0.052 Sum_probs=47.1
Q ss_pred eeeecccCCceEEEEEEcCCCcEEEEEEeCCcc-----CChHHHHHHHHHHHHHHhcC-C--CCccccceeecCCCcCCC
Q 016884 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-----EHISDAIRILREVKLLRLLR-H--PDIVEIKRIMLPPSKREF 99 (381)
Q Consensus 28 ~~~lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 99 (381)
.+.||.|....||++.+..+++.|++|.-.... .......+..+|...|+.+. + ..+++++.+- .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~----- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence 667999999999999888888899999653211 11122345567888888763 2 2344444332 1
Q ss_pred CcEEEEeecccc
Q 016884 100 KDIYVVFELMES 111 (381)
Q Consensus 100 ~~~~lv~e~~~~ 111 (381)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 124789999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=2.3e-05 Score=66.25 Aligned_cols=71 Identities=8% Similarity=-0.016 Sum_probs=44.3
Q ss_pred eecccC-CceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCCcEEEEe
Q 016884 30 VIGKGS-YGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVF 106 (381)
Q Consensus 30 ~lg~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~ 106 (381)
.+..|. .+.||+... ..+..+++|...... ...+.+|...|+.+.... +.+++.+... .+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 344444 467898864 456678899765321 223556888888774333 4555555422 24579999
Q ss_pred ecccc
Q 016884 107 ELMES 111 (381)
Q Consensus 107 e~~~~ 111 (381)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.35 E-value=0.00052 Score=60.04 Aligned_cols=74 Identities=14% Similarity=0.049 Sum_probs=43.3
Q ss_pred cCCceEEEEEEcCCCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCCccccceeecC--CCcCCCCcEEEEeecccc
Q 016884 34 GSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP--PSKREFKDIYVVFELMES 111 (381)
Q Consensus 34 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~~~~~lv~e~~~~ 111 (381)
+.--.||++.. .+|..|++|+.+... .....+..|+..+..|...++.-..-.... .........+.+++++.|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 33468999964 568889999876321 234556778988888853333211111111 111223457889998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.08 E-value=0.0014 Score=58.85 Aligned_cols=72 Identities=15% Similarity=0.132 Sum_probs=47.9
Q ss_pred EeeeecccCCceEEEEEEcC-------CCcEEEEEEeCCccCChHHHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCC
Q 016884 27 ILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKRE 98 (381)
Q Consensus 27 ~~~~lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~ 98 (381)
-++.|+.|-.-.+|++.... .++.|++++.... . ......+|..+++.+.-.+ ..++++++ .+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~---~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~ 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E---TESHLVAESVIFTLLSERHLGPKLYGIF-----SG 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C---CHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c---hhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC
Confidence 35779889999999997643 3456777776521 1 1234557999999885334 44666665 11
Q ss_pred CCcEEEEeecccc
Q 016884 99 FKDIYVVFELMES 111 (381)
Q Consensus 99 ~~~~~lv~e~~~~ 111 (381)
.+|+||+.|
T Consensus 117 ----g~I~efi~g 125 (395)
T d1nw1a_ 117 ----GRLEEYIPS 125 (395)
T ss_dssp ----EEEECCCCE
T ss_pred ----ceEEEEecc
Confidence 688999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.98 E-value=0.00099 Score=57.77 Aligned_cols=30 Identities=30% Similarity=0.282 Sum_probs=26.4
Q ss_pred CCccccCCCCCceEecCCCCeEEeeecccc
Q 016884 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (381)
Q Consensus 145 ~~i~H~Dikp~NIl~~~~~~vkl~DFg~a~ 174 (381)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 369999999999999988767899999774
|